Sentence,class,file
• IgG4 non-RSD Mimicking MS http://jkms.org   1831 http://dx.doi.org/10.3346/jkms.2013.28.12.1830 A B C D E F Fig.,Non-OADS,/arxiv_data1/oa_pdf/49/91/jkms-28-1830.PMC3857383.pdf
• IgG4 non-RSD Mimicking MS 1832  http://jkms.org http://dx.doi.org/10.3346/jkms.2013.28.12.1830 A CB D Fig.,Non-OADS,/arxiv_data1/oa_pdf/49/91/jkms-28-1830.PMC3857383.pdf
• IgG4 non-RSD Mimicking MS http://jkms.org   1833 http://dx.doi.org/10.3346/jkms.2013.28.12.1830 A CB D Fig.,Non-OADS,/arxiv_data1/oa_pdf/49/91/jkms-28-1830.PMC3857383.pdf
"• IgG4 non-RSD Mimicking MS 1834  http://jkms.org http://dx.doi.org/10.3346/jkms.2013.28.12.1830nostic criteria for IgG4-related disease (IgG4-RD), 2011.",Non-OADS,/arxiv_data1/oa_pdf/49/91/jkms-28-1830.PMC3857383.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357A Case of Liver Fibrosis with Splenomegaly after Oxaliplatin- Based Adjuvant Chemotherapy for Colon Cancer  Previous studies reported that oxaliplatin is associated with sinusoidal obstruction  syndrome.",Non-OADS,/arxiv_data1/oa_pdf/22/71/jkms-28-1835.PMC3857384.pdf
"Key Words:  Liver Cirrhosis; Splenomegaly; Oxaliplatin Gu Hyum Kang,1 Hee Seok Moon,1   Eaum Seok Lee,1 Seok Hyun Kim,1   Jae Kyu Sung,1 Byung Seok Lee,1   Hyun Yong Jeong,1 Heon Young Lee,1   and Dae Young Kang2  Departments of 1Internal Medicine and 2Pathology,  Chungnam National University School of Medicine,  Daejeon, Korea Received: 3 July 2013 Accepted: 8 October 2013 Address for Correspondence: Hee Seok Moon, MD Department of Internal Medicine, Chungnam National  University Hospital, 33 Munwha-ro, Jung-gu, Daejeon 301-721,  Korea Tel: +82.42-280-7164, Fax: +82.42-257-5753 E-mail: mhs1357@cnuh.co.krhttp://dx.doi.org/10.3346/jkms.2013.28.12.1835  • J Korean Med Sci 2013; 28: 1835-1838CASE REPORT  Gastroenterology & Hepatology INTRODUCTION Oxaliplatin-based chemotherapy regimens are currently a stan - dard of care for the treatment of colorectal cancer in both the  adjuvant treatment and metastatic disease setting.",Non-OADS,/arxiv_data1/oa_pdf/22/71/jkms-28-1835.PMC3857384.pdf
• Liver Fibrosis after Oxaliplatin-Based Adjuvant Chemotherapy 1836  http://jkms.org http://dx.doi.org/10.3346/jkms.2013.28.12.1835isolated metastatic lesion in S6 and S8 lobe.,Non-OADS,/arxiv_data1/oa_pdf/22/71/jkms-28-1835.PMC3857384.pdf
• Liver Fibrosis after Oxaliplatin-Based Adjuvant Chemotherapy http://jkms.org   1837 http://dx.doi.org/10.3346/jkms.2013.28.12.1835Fig.,Non-OADS,/arxiv_data1/oa_pdf/22/71/jkms-28-1835.PMC3857384.pdf
"• Liver Fibrosis after Oxaliplatin-Based Adjuvant Chemotherapy 1838  http://jkms.org http://dx.doi.org/10.3346/jkms.2013.28.12.1835chemotherapy-associated liver injury, long term chemotherapy  should be avoided and response to therapy assessed as a prog - nostic indicator of outcome.",Non-OADS,/arxiv_data1/oa_pdf/22/71/jkms-28-1835.PMC3857384.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357A Case of Acute Motor and Sensory Axonal Neuropathy  Following Hepatitis A Infection  Acute motor and sensory axonal neuropathy (AMSAN) are recently described subtypes of  Guillain-Barré syndrome characterized by acute onset of distal weakness, loss of deep  tendon reflexes, and sensory symptoms.",Non-OADS,/arxiv_data1/oa_pdf/48/be/jkms-28-1839.PMC3857385.pdf
"Key Words:  Guillain-Barre Syndrome; Acute Motor and Sensory Axonal Neuropathy;  Peripheral Nervous System Diseases; Hepatitis A; Molecular MimicryYoon-Sik Jo,1 Sang-Don Han,1   Jin-Yong Choi,1 Ick Hee Kim,2   Yong-Duk Kim,3 and Sang-Jun Na3 Departments of 1Neurology and 2Surgery, Konkuk  University School of Medicine, Chungju;  3Department of Neurology, Konyang University  College of Medicine, Daejeon, Korea Received: 29 May 2012 Accepted: 20 September 2012 Address for Correspondence: Sang-Jun Na, MD Department of Neurology, Konyang University Hospital,  158 Gwanjeodong-gil, Seo-gu, Daejeon 302-718, Korea Tel: +82.42-600-8814, Fax: +82.42-545-0050  E-mail: nukedoc@hanmail.net http://dx.doi.org/10.3346/jkms.2013.28.12.1839  • J Korean Med Sci 2013; 28: 1839-1841CASE REPORT Neuroscience INTRODUCTION Many infectious agents and immunological mechanisms may  play a role in pathogenesis of Guillain-Barré syndrome (GBS).",Non-OADS,/arxiv_data1/oa_pdf/48/be/jkms-28-1839.PMC3857385.pdf
"• Axonal Neuropathy Following Hepatitis A  1840  http://jkms.org http://dx.doi.org/10.3346/jkms.2013.28.12.1839and posterior tibial nerves, without evidence of demyelination.",Non-OADS,/arxiv_data1/oa_pdf/48/be/jkms-28-1839.PMC3857385.pdf
"• Axonal Neuropathy Following Hepatitis A  http://jkms.org   1841 http://dx.doi.org/10.3346/jkms.2013.28.12.1839eral nerve antigens remains a possibility, but any molecular re - semblance between hepatotropic viruses and structural com - ponents of peripheral nerves has not been explored (9).",Non-OADS,/arxiv_data1/oa_pdf/48/be/jkms-28-1839.PMC3857385.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357http://dx.doi.org/10.3346/jkms.2013.28.12.1842   •  J Korean Med Sci 2013; 28: 1842CORRESPONDENCE Erratum: Correction of Title Longitudinal Standards for Height and Height Velocity in Korean Children and  Adolescents: the Kangwha Cohort Study Hyun Wook Chae,1* Il Suh,2* Ah Reum Kwon,1 Ye Jin Kim,1 Yong Hyuk Kim,1 Dae Ryong Kang,3 Ha Yan Kim,3 Sun Min Oh,2   Hyeon Chang Kim,2 Duk Hee Kim,4 and Ho-Seong Kim1 1Department of Pediatrics, Endocrine Research Institute, 2Department of Preventive Medicine, 3Biostatistics Collaboration Unit, Yonsei University College of Medicine; 4Sowha Children’s Hospital, Seoul, Korea To the Editor: We found an error in our published article.",Non-OADS,/arxiv_data1/oa_pdf/65/2e/jkms-28-1842.PMC3857386.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2013  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseSeptember 2013 |  79  | e50634 | Page 1 of 10Video Article Label-free Isolation and Enrichment of Cells Through Contactless Dielectrophoresis Elizabeth S. Elvington1, Alireza Salmanzadeh1,2, Mark A. Stremler1,2, Rafael V. Davalos1,2 1School of Biomedical Engineering and Science, Virginia Tech 2Department of Engineering Science and Mechanics, Virginia Tech Correspondence to: Rafael V. Davalos at davalos@vt.edu URL: http://www.jove.com/video/50634 DOI: doi:10.3791/50634 Keywords: Biomedical Engineering, Issue 79, Medicine, Cellular Biology, Molecular Biology, Bioengineering, Anatomy, Physiology, Biophysics, Physics, Microfluidics, Cell Separation, Microfluidic Analytical Techniques, Electrophoresis, Microchip, cancer diagnosis, cell enrichment, cell sorting, microfluidics, dielectrophoresis, Lab on a chip, cells, imaging Date Published: 9/3/2013 Citation: Elvington, E.S., Salmanzadeh, A., Stremler, M.A., Davalos, R.V.",Non-OADS,/arxiv_data1/oa_pdf/62/14/jove-79-50634.PMC3857390.pdf
"Video Link The video component of this article can be found at http://www.jove.com/video/50634/ Introduction Biological sample enrichment and particle sorting is often necessary for subsequent analysis.1 For instance, isolation of rare cells from body fluids has important applications in cancer detection and individualized medicine.",Non-OADS,/arxiv_data1/oa_pdf/62/14/jove-79-50634.PMC3857390.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2013  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseSeptember 2013 |  79  | e50291 | Page 1 of 9Video Article A Method for High Fidelity Optogenetic Control of Individual Pyramidal Neurons In vivo Shinya Nakamura*1,2, Michael V. Baratta*1,2, Donald C. Cooper1,2 1Institute for Behavioral Genetics, University of Colorado Boulder 2Department of Psychology and Neuroscience, University of Colorado Boulder *These authors contributed equally Correspondence to: Donald C. Cooper at D.Cooper@colorado.edu URL: http://www.jove.com/video/50291 DOI: doi:10.3791/50291 Keywords: Neuroscience, Issue 79, Genetic Techniques, Genetics, Behavioral, Biological Science Disciplines, Neurosciences, genetics (animal and plant), Investigative Techniques, Behavior and Behavior Mechanisms, Behavioral Disciplines and Activities, Natural Science Disciplines, Optogenetics, prefrontal cortex, subiculum, virus injection, in vivo  recording, Neurophysiology, prelimbic, optrode, molecular neurogenetics, Gene targeting Date Published: 9/2/2013 Citation: Nakamura, S., Baratta, M.V., Cooper, D.C. A Method for High Fidelity Optogenetic Control of Individual Pyramidal Neurons In vivo .",Non-OADS,/arxiv_data1/oa_pdf/90/62/jove-79-50291.PMC3857391.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/50291/ Introduction The ability to activate or silence a specific cell type within a neural circuit in a temporally precise fashion is critical for understanding how neural circuits process different types of information underlying emotion and cognition.,Non-OADS,/arxiv_data1/oa_pdf/90/62/jove-79-50291.PMC3857391.pdf
"Virus Storage and Preparation 1.The use of replication-incompetent AAV vectors for delivering opsin genes to rodent brain is approved for Biosafety Level 1 (BSL-1) and requires proper protection and handling procedures as outlined in the U.S. Government publication, Biosafety in Microbiology and Biomedical Laboratories, available at the Centers for Disease Control's website at ( http://www.cdc.gov/biosafety/publications/bmbl5/index.htm).",Non-OADS,/arxiv_data1/oa_pdf/90/62/jove-79-50291.PMC3857391.pdf
Many of the opsin constructs with cell-type specific promoters are commercially available in a variety of AAV serotypes from vector core facilities such as the University of Pennsylvania (http://www.med.upenn.edu/gtp/vectorcore) or the University of North Carolina at Chapel Hill ( http://genetherapy.unc.edu).,Non-OADS,/arxiv_data1/oa_pdf/90/62/jove-79-50291.PMC3857391.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/21/7e/JCB_201302022.PMC3857474.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/21/7e/JCB_201302022.PMC3857474.pdf
"http://dx.doi   .org/10.1242/jcs.05415 5 Brenner, S. 1974.",Non-OADS,/arxiv_data1/oa_pdf/21/7e/JCB_201302022.PMC3857474.pdf
"http://dx.doi.org/10.1038/nn180 8 de Bono, M., and A.V.",Non-OADS,/arxiv_data1/oa_pdf/21/7e/JCB_201302022.PMC3857474.pdf
"http://dx.doi.org/   10.1146/annurev.neuro.27.070203.14425 9 Deken, S.L., R. Vincent, G. Hadwiger, Q. Liu, Z.W.",OADS,/arxiv_data1/oa_pdf/21/7e/JCB_201302022.PMC3857474.pdf
"http://dx.doi.org/   10.1523/JNEUROSCI.0804-05.200 5 Dresbach, T., B. Qualmann, M.M.",Non-OADS,/arxiv_data1/oa_pdf/21/7e/JCB_201302022.PMC3857474.pdf
"http://dx.doi.org/10.1007/PL0000078 1 Eimer, S., A. Gottschalk, M. Hengartner, H.R.",Non-OADS,/arxiv_data1/oa_pdf/21/7e/JCB_201302022.PMC3857474.pdf
"26:4313– 4323. http://dx.doi.org/10.1038/sj.emboj.760185 8 Feeney, C.J., S. Karunanithi, J. Pearce, C.K.",Non-OADS,/arxiv_data1/oa_pdf/21/7e/JCB_201302022.PMC3857474.pdf
"http://dx.doi.org/10.1002/(SICI)1096-9861(19981214)   402:2<197::AID-CNE5>3.0.CO;2- Q Fiala, J.C. 2005.",OADS,/arxiv_data1/oa_pdf/21/7e/JCB_201302022.PMC3857474.pdf
http://dx.doi.org/10.1111/j.1365-2818.2005.01466.,Non-OADS,/arxiv_data1/oa_pdf/21/7e/JCB_201302022.PMC3857474.pdf
http://dx.doi.org/10.1895/wormbook.1.62.,Non-OADS,/arxiv_data1/oa_pdf/21/7e/JCB_201302022.PMC3857474.pdf
"http://dx.doi.org/   10.1038/2575 7 Hallam, S.J., A. Goncharov, J. McEwen, R. Baran, and Y. Jin.",Non-OADS,/arxiv_data1/oa_pdf/21/7e/JCB_201302022.PMC3857474.pdf
"http://dx.doi   .org/10.1038/nn95 9 Harlow, M.L., D. Ress, A. Stoschek, R.M.",OADS,/arxiv_data1/oa_pdf/21/7e/JCB_201302022.PMC3857474.pdf
"http://dx.doi.org/10.1038/3505400 0 Kaufmann, N., J. DeProto, R. Ranjan, H. Wan, and D. Van Vactor.",OADS,/arxiv_data1/oa_pdf/21/7e/JCB_201302022.PMC3857474.pdf
"http://dx.doi.org/10.1016/S0896-   6273(02)00643- 8 Kittel, R.J., C. Wichmann, T.M.",OADS,/arxiv_data1/oa_pdf/21/7e/JCB_201302022.PMC3857474.pdf
"http://dx.doi.org/10.1126/science.112630 8 Ko, J., M. Na, S. Kim, J.R. Lee, and E. Kim.",OADS,/arxiv_data1/oa_pdf/21/7e/JCB_201302022.PMC3857474.pdf
"http://dx.doi.org/10.1074/jbc   .M30756120 0 Kremer, J.R., D.N.",OADS,/arxiv_data1/oa_pdf/21/7e/JCB_201302022.PMC3857474.pdf
"http://dx.doi.org/10.1006/jsbi.1996.001 3 Lawrence, A., J.C. Bouwer, G. Perkins, and M.H.",OADS,/arxiv_data1/oa_pdf/21/7e/JCB_201302022.PMC3857474.pdf
"http://dx.doi   .org/10.1016/j.jsb.2005.12.01 2 Liewald, J.F., M. Brauner, G.J.",OADS,/arxiv_data1/oa_pdf/21/7e/JCB_201302022.PMC3857474.pdf
"http://dx.doi.org/10.1038/nmeth.125 2PEG 4000, and 100 mM DTT).",OADS,/arxiv_data1/oa_pdf/21/7e/JCB_201302022.PMC3857474.pdf
Online supplemental material is avail - able at http://www.jcb.org/cgi/content/full/jcb.201302022/DC1.,Non-OADS,/arxiv_data1/oa_pdf/21/7e/JCB_201302022.PMC3857474.pdf
"http://dx.doi.org/10.1523/JNEUROSCI   .0002-11.201 1 van Roessel, P., D.A.",OADS,/arxiv_data1/oa_pdf/21/7e/JCB_201302022.PMC3857474.pdf
"http://dx.doi.org/10.1016/j.cell   .2004.11.02 8 Wagh, D.A., T.M.",OADS,/arxiv_data1/oa_pdf/21/7e/JCB_201302022.PMC3857474.pdf
"http://dx.doi.org/10.1016/j.neuron.2006.02.00 8 Wagner, O.I., A. Esposito, B. Köhler, C.W.",OADS,/arxiv_data1/oa_pdf/21/7e/JCB_201302022.PMC3857474.pdf
"http://dx.doi.org/10.1038/4158 0 Wang, Y., X. Liu, T. Biederer, and T.C.",OADS,/arxiv_data1/oa_pdf/21/7e/JCB_201302022.PMC3857474.pdf
"http://dx.doi   .org/10.1523/JNEUROSCI.2350-06.200 6 Wojcik, S.M., and N. Brose.",OADS,/arxiv_data1/oa_pdf/21/7e/JCB_201302022.PMC3857474.pdf
"http://dx.doi.org/10.1016/j.neuron.2007.06.01 3 Wyszynski, M., E. Kim, A.W.",OADS,/arxiv_data1/oa_pdf/21/7e/JCB_201302022.PMC3857474.pdf
"http://dx.doi.org/10.1016/   S0896-6273(02)00640- 2 Yeh, E., T. Kawano, R.M.",OADS,/arxiv_data1/oa_pdf/21/7e/JCB_201302022.PMC3857474.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.4978-04.200 5 Zanazzi, G., and G. Matthews.",Non-OADS,/arxiv_data1/oa_pdf/21/7e/JCB_201302022.PMC3857474.pdf
"http://dx.doi.org/   10.1007/s12035-009-8058- z Zhai, R.G., and H.J.",Non-OADS,/arxiv_data1/oa_pdf/21/7e/JCB_201302022.PMC3857474.pdf
"http://dx.doi.org/10.1371/journal.pgen.100070 0 Ohtsuka, T., E. Takao-Rikitsu, E. Inoue, M. Inoue, M. Takeuchi, K. Matsubara,  M. Deguchi-Tawarada, K. Satoh, K. Morimoto, H. Nakanishi, and Y.  Takai.",OADS,/arxiv_data1/oa_pdf/21/7e/JCB_201302022.PMC3857474.pdf
"http://dx.doi.org/10.1083/jcb.20020208 3 Patel, M.R., and K. Shen.",OADS,/arxiv_data1/oa_pdf/21/7e/JCB_201302022.PMC3857474.pdf
"http://dx.doi.org/10.1126/   science.116902 5 Patel, M.R., E.K.",OADS,/arxiv_data1/oa_pdf/21/7e/JCB_201302022.PMC3857474.pdf
"http://dx.doi   .org/10.1038/nn180 6 Phillips, G.R., J.K. Huang, Y. Wang, H. Tanaka, L. Shapiro, W. Zhang, W.S.",Non-OADS,/arxiv_data1/oa_pdf/21/7e/JCB_201302022.PMC3857474.pdf
"http://dx.doi.org/10.1016/S0896-6273(01)00450- 0 Prokop, A., and I.A.",OADS,/arxiv_data1/oa_pdf/21/7e/JCB_201302022.PMC3857474.pdf
"http://dx.doi   .org/10.1016/j.semcdb.2005.11.01 0 Regus-Leidig, H., and J.H.",OADS,/arxiv_data1/oa_pdf/21/7e/JCB_201302022.PMC3857474.pdf
http://dx.doi.org/10   .1111/j.1748-1716.2011.02355.,Non-OADS,/arxiv_data1/oa_pdf/21/7e/JCB_201302022.PMC3857474.pdf
"http://dx.doi .org/10   .1083/jcb.17.1.20 8 Richmond, J.",Non-OADS,/arxiv_data1/oa_pdf/21/7e/JCB_201302022.PMC3857474.pdf
http://dx.doi.org/10.1895/wormbook.1.69.,Non-OADS,/arxiv_data1/oa_pdf/21/7e/JCB_201302022.PMC3857474.pdf
http://dx.doi.org/10.3791/116 5.,Non-OADS,/arxiv_data1/oa_pdf/21/7e/JCB_201302022.PMC3857474.pdf
"http://dx.doi.org/10.1177/00221554040520010 1 Schoch, S., and E.D.",OADS,/arxiv_data1/oa_pdf/21/7e/JCB_201302022.PMC3857474.pdf
"http://dx.doi.org/10   .1007/s00441-006-0244- y Schoch, S., P.E.",Non-OADS,/arxiv_data1/oa_pdf/21/7e/JCB_201302022.PMC3857474.pdf
"415:321– 326. http://dx.doi.org/10.1038/415321 a Serra-Pagès, C., Q.G.",Non-OADS,/arxiv_data1/oa_pdf/21/7e/JCB_201302022.PMC3857474.pdf
"http://dx.doi.org/10   .1074/jbc.273.25.1561 1 Shin, H., M. Wyszynski, K.H.",Non-OADS,/arxiv_data1/oa_pdf/21/7e/JCB_201302022.PMC3857474.pdf
"http://dx.doi.org/10.1074/jbc.M21187420 0 Sieburth, D., Q. Ch’ng, M. Dybbs, M. Tavazoie, S. Kennedy, D. Wang, D. Dupuy,  J.F.",Non-OADS,/arxiv_data1/oa_pdf/21/7e/JCB_201302022.PMC3857474.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.6164-10.201 1 Sudhof, T.C.",Non-OADS,/arxiv_data1/oa_pdf/21/7e/JCB_201302022.PMC3857474.pdf
"http://dx.doi.org/10.1146/annurev.neuro.26.041002.13141 2 Takao-Rikitsu, E., S. Mochida, E. Inoue, M. Deguchi-Tawarada, M. Inoue, T.  Ohtsuka, and Y. Takai.",OADS,/arxiv_data1/oa_pdf/21/7e/JCB_201302022.PMC3857474.pdf
"http://dx.doi.org/10.1083/jcb.20030710 1 Tao-Cheng, J.H., J.",OADS,/arxiv_data1/oa_pdf/21/7e/JCB_201302022.PMC3857474.pdf
http://dx.doi.org/10.1023/A:100716823132 3,Non-OADS,/arxiv_data1/oa_pdf/21/7e/JCB_201302022.PMC3857474.pdf
"Importantly, they identify a new local function for cyto - plasmic Fus with implications for ALS pathology.The RNA-binding protein Fus directs translation of  localized mRNAs in APC-RNP granules Kyota Yasuda,1 Huaye Zhang,2 David Loiselle,3 Timothy Haystead,3 Ian G. Macara,4 and Stavroula Mili1 1Laboratory of Cellular and Molecular Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 2Department of Neuroscience and Cell Biology, Robert Wood Johnson Medical School, Rutgers, The State University of New Jersey, Piscataway, NJ 08854 3Department of Pharmacology and Cancer Biology, Duke University, Durham, NC 27710 4Department of Cell and Developmental Biology, Vanderbilt University Medical Center, Nashville, TN 37232 This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No  Mirror Sites license for the first six months after the publication date (see http://www.rupress   .org/terms).",Non-OADS,/arxiv_data1/oa_pdf/46/20/JCB_201306058.PMC3857475.pdf
Online supplemen - tal material is available at http://www.jcb.org/cgi/content/full/jcb   .201306058/DC1.,Non-OADS,/arxiv_data1/oa_pdf/46/20/JCB_201306058.PMC3857475.pdf
Additional data are available in the JCB DataViewer  at http://dx.doi.org/10.1083/jcb.201306058.dv.The matrix solution consisted of -cyano-4-hydroxycinnamic acid  (Sigma-Aldrich) saturating a solution of 1:1:0.02 acetonitrile/25 mM am - monium citrate in water/trifluoroacetic acid.,OADS,/arxiv_data1/oa_pdf/46/20/JCB_201306058.PMC3857475.pdf
"http://dx.doi.org/10.1083/jcb.151.6.125 7 Kennell, J., and K.M.",OADS,/arxiv_data1/oa_pdf/46/20/JCB_201306058.PMC3857475.pdf
"http://dx.doi.org/10.1007/978-1-4419-1145-2_ 1 Kroboth, K., I.P .",Non-OADS,/arxiv_data1/oa_pdf/46/20/JCB_201306058.PMC3857475.pdf
"http://dx.doi.org/10.1091/mbc   .E06-03-017 9 Lagier-Tourenne, C., M. Polymenidou, and D.W. Cleveland.",Non-OADS,/arxiv_data1/oa_pdf/46/20/JCB_201306058.PMC3857475.pdf
"http://dx.doi.org/10.1093/hmg/ddq13 7 Lagier-Tourenne, C., M. Polymenidou, K.R.",Non-OADS,/arxiv_data1/oa_pdf/46/20/JCB_201306058.PMC3857475.pdf
"http://dx.doi   .org/10.1038/nn.323 0 Leung, K.M., F.P .",Non-OADS,/arxiv_data1/oa_pdf/46/20/JCB_201306058.PMC3857475.pdf
"http://dx.doi   .org/10.1038/nn177 5 Li, Z., L. Wang, T.S.",OADS,/arxiv_data1/oa_pdf/46/20/JCB_201306058.PMC3857475.pdf
"http://dx.doi.org/10.1083/jcb.20070700 7 Liu-Yesucevitz, L., G.J.",Non-OADS,/arxiv_data1/oa_pdf/46/20/JCB_201306058.PMC3857475.pdf
"http://dx.doi.org/10   .1523/JNEUROSCI.4105-11.201 1 Mackenzie, I.R., R. Rademakers, and M. Neumann.",OADS,/arxiv_data1/oa_pdf/46/20/JCB_201306058.PMC3857475.pdf
"http://dx.doi.org/10.1016/S1474-4422(10)70195- 2 Meerbrey, K.L., G. Hu, J.D.",OADS,/arxiv_data1/oa_pdf/46/20/JCB_201306058.PMC3857475.pdf
"http://dx.doi.org/10.1038/nature0688 8 Mitchell, J.C., P. McGoldrick, C. Vance, T. Hortobagyi, J. Sreedharan, B. Rogelj,  E.L. Tudor, B.N.",Non-OADS,/arxiv_data1/oa_pdf/46/20/JCB_201306058.PMC3857475.pdf
"http://dx.doi.org/10.1007/s00401-012-1043- z Nagaoka, K., T. Udagawa, and J.D.",OADS,/arxiv_data1/oa_pdf/46/20/JCB_201306058.PMC3857475.pdf
"3:675. http://dx.doi.org/10.1038/ncomms167 8 Näthke, I.S.",OADS,/arxiv_data1/oa_pdf/46/20/JCB_201306058.PMC3857475.pdf
"http://dx.doi   .org/10.1146/annurev.cellbio.20.012103.09454 1 Rogelj, B., L.E.",OADS,/arxiv_data1/oa_pdf/46/20/JCB_201306058.PMC3857475.pdf
"2:603. http://dx.doi.org/10.1038/srep0060 3 Sabatelli, M., A. Moncada, A. Conte, S. Lattante, G. Marangi, M. Luigetti,  M. Lucchini, M. Mirabella, A. Romano, A. Del Grande, et al.",Non-OADS,/arxiv_data1/oa_pdf/46/20/JCB_201306058.PMC3857475.pdf
"http://dx.doi.org/10.1093/hmg/ddt32 8 Sansom, O.J., K.R.",OADS,/arxiv_data1/oa_pdf/46/20/JCB_201306058.PMC3857475.pdf
"http://dx.doi.org/10.1101/gad.28740 4 Schmidt, E.K., G. Clavarino, M. Ceppi, and P. Pierre.",Non-OADS,/arxiv_data1/oa_pdf/46/20/JCB_201306058.PMC3857475.pdf
"http://dx.doi.org/10.1038/nmeth.131 4 Shestakova, E.A., R.H. Singer, and J. Condeelis.",OADS,/arxiv_data1/oa_pdf/46/20/JCB_201306058.PMC3857475.pdf
"http://dx.doi.org/10.1002/path.237 6 Weil, T.T., R.M.",Non-OADS,/arxiv_data1/oa_pdf/46/20/JCB_201306058.PMC3857475.pdf
"http://dx.doi.org/10   .1038/ncb262 7We thank Ian Mackenzie (University of British Columbia, Vancouver, BC, Can - ada) for generously providing tissue sections of ALS-Fus and FTLD-Fus patients  and Mariann Bienz (MRC LMB, Cambridge, England, UK) for plasmids.",Non-OADS,/arxiv_data1/oa_pdf/46/20/JCB_201306058.PMC3857475.pdf
"http://dx.doi.org/10.1016/j.tibs.2007.12.00 3 Andersson, M.K., A. Ståhlberg, Y .",OADS,/arxiv_data1/oa_pdf/46/20/JCB_201306058.PMC3857475.pdf
"9:37. http://dx.doi.org/10.1186/1471-2121-9-3 7 Bassell, G.J., and S.T.",Non-OADS,/arxiv_data1/oa_pdf/46/20/JCB_201306058.PMC3857475.pdf
"60:201– 214. http://dx.doi.org/10.1016/j.neuron.2008.10.00 4 Besse, F., S. López de Quinto, V .",OADS,/arxiv_data1/oa_pdf/46/20/JCB_201306058.PMC3857475.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/46/20/JCB_201306058.PMC3857475.pdf
"http://dx.doi.org/10 .1083/   jcb.20070516 3 Bosco, D.A., N. Lemay, H.K.",Non-OADS,/arxiv_data1/oa_pdf/46/20/JCB_201306058.PMC3857475.pdf
"http://dx.doi   .org/10.1093/hmg/ddq33 5 Buchan, J.R., and R. Parker.",OADS,/arxiv_data1/oa_pdf/46/20/JCB_201306058.PMC3857475.pdf
"http://dx.doi.org/10.1016/j.molcel   .2009.11.02 0 Buchan, J.R., D. Muhlrad, and R. Parker.",OADS,/arxiv_data1/oa_pdf/46/20/JCB_201306058.PMC3857475.pdf
"http://dx.doi.org/10.1242/jcs.07844 4 Damgaard, C.K., and J. Lykke-Andersen.",OADS,/arxiv_data1/oa_pdf/46/20/JCB_201306058.PMC3857475.pdf
"197:45– 57. http://dx.doi.org/10.1083/jcb.20111214 5 Dieterich, D.C., J.J. Lee, A.J.",Non-OADS,/arxiv_data1/oa_pdf/46/20/JCB_201306058.PMC3857475.pdf
"http://dx.doi.org/10.1038/nprot.2007.5 2 Dormann, D., R. Rodde, D. Edbauer, E. Bentmann, I. Fischer, A. Hruscha,  M.E.",OADS,/arxiv_data1/oa_pdf/46/20/JCB_201306058.PMC3857475.pdf
"http://dx.doi .org/10.1038/   emboj.2010.14 3 Gilks, N., N. Kedersha, M. Ayodele, L. Shen, G. Stoecklin, L.M.",Non-OADS,/arxiv_data1/oa_pdf/46/20/JCB_201306058.PMC3857475.pdf
"http://dx.doi.org/10   .1091/mbc.E04-08-071 5 Harris, E.S., and W.J.",OADS,/arxiv_data1/oa_pdf/46/20/JCB_201306058.PMC3857475.pdf
"http://dx.doi   .org/10.1091/mbc.E10-03-023 5 Hengst, U., A. Deglincerti, H.J.",OADS,/arxiv_data1/oa_pdf/46/20/JCB_201306058.PMC3857475.pdf
"http://dx.doi.org/10.1038/ncb191 6 Holt, C.E., and S.L.",OADS,/arxiv_data1/oa_pdf/46/20/JCB_201306058.PMC3857475.pdf
"http://dx.doi.org/10   .1126/science.117648 8 Huang, C., H. Zhou, J. Tong, H. Chen, Y .J.",OADS,/arxiv_data1/oa_pdf/46/20/JCB_201306058.PMC3857475.pdf
"http://dx.doi.org/10.1371/journal.pgen.100201 1 Kedersha, N., M.R.",Non-OADS,/arxiv_data1/oa_pdf/46/20/JCB_201306058.PMC3857475.pdf
"Our study un - derscores the complexity of actin regulation at cell–cell  contacts that involves actin activators, inhibitors, and   stabilizers to control adhesive strength, epithelial behav - ior, and permeability barrier integrity.FSGS3/CD2AP is a barbed-end capping   protein that stabilizes actin and strengthens  adherens junctions Vivian W. Tang and William M. Brieher Department of Cell and Developmental Biology, University of Illinois, Urbana-Champaign, IL 61820 © 2013 Tang and Brieher  This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).",Non-OADS,/arxiv_data1/oa_pdf/22/c8/JCB_201304143.PMC3857477.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/22/c8/JCB_201304143.PMC3857477.pdf
"http://dx.doi.org/10.1083/jcb.91.2.34 0 Baum, B., and M. Georgiou.",Non-OADS,/arxiv_data1/oa_pdf/22/c8/JCB_201304143.PMC3857477.pdf
"http://dx.doi.org/10.1083/jcb.20100914 1 Baum, B., and N. Perrimon.",OADS,/arxiv_data1/oa_pdf/22/c8/JCB_201304143.PMC3857477.pdf
"http://dx.doi.org/   10.1038/ncb1001-88 3 Bennett, J.P., K.S.",Non-OADS,/arxiv_data1/oa_pdf/22/c8/JCB_201304143.PMC3857477.pdf
"http://dx.doi.org/10.1021/bi00316a03 9 Bernadskaya, Y .Y ., F.B.",OADS,/arxiv_data1/oa_pdf/22/c8/JCB_201304143.PMC3857477.pdf
"http://dx.doi.org/10.1091/mbc.E10-10-086 2 Brieher, W.M., H.Y.",Non-OADS,/arxiv_data1/oa_pdf/22/c8/JCB_201304143.PMC3857477.pdf
"http://dx.doi.org/10   .1083/jcb.20060314 9 Bruck, S., T.B.",Non-OADS,/arxiv_data1/oa_pdf/22/c8/JCB_201304143.PMC3857477.pdf
"http://dx.doi.org/10.1074/jbc.M60016620 0 Cavey, M., and T. Lecuit.",OADS,/arxiv_data1/oa_pdf/22/c8/JCB_201304143.PMC3857477.pdf
"http://dx.doi   .org/10.1101/cshperspect.a00299 8 Cavey, M., M. Rauzi, P.F.",Non-OADS,/arxiv_data1/oa_pdf/22/c8/JCB_201304143.PMC3857477.pdf
"http://dx.doi.org/10.1038/nature0695 3 Chen, Z., D. Borek, S.B.",OADS,/arxiv_data1/oa_pdf/22/c8/JCB_201304143.PMC3857477.pdf
"http://dx.doi.org/10.1038/nature0962 3 Chu, Y.S., W.A.",OADS,/arxiv_data1/oa_pdf/22/c8/JCB_201304143.PMC3857477.pdf
"http://dx.doi.org/10   .1083/jcb.20040304 3 Chu, D., H. Pan, P. Wan, J. Wu, J. Luo, H. Zhu, and J. Chen.",OADS,/arxiv_data1/oa_pdf/22/c8/JCB_201304143.PMC3857477.pdf
"http://dx.doi.org/10.1242/dev.07949 1 Cooper, J.A., and D. Sept. 2008.",Non-OADS,/arxiv_data1/oa_pdf/22/c8/JCB_201304143.PMC3857477.pdf
"http://dx.doi.org/10   .1073/pnas.030429710 1 Dominguez, R. 2009.",Non-OADS,/arxiv_data1/oa_pdf/22/c8/JCB_201304143.PMC3857477.pdf
"http://dx.doi.org/10   .1016/S0092-8674(00)81608- 6 Etienne-Manneville, S. 2012.",Non-OADS,/arxiv_data1/oa_pdf/22/c8/JCB_201304143.PMC3857477.pdf
"http://dx.doi.org/10.1007/978-94-007-4186-7_1 0 Furman, C., A.L.",Non-OADS,/arxiv_data1/oa_pdf/22/c8/JCB_201304143.PMC3857477.pdf
"http://dx.doi   .org/10.1083/jcb.20070500 2 Furuse, M., T. Hirase, M. Itoh, A. Nagafuchi, S. Yonemura, S. Tsukita, and S.  Tsukita.",OADS,/arxiv_data1/oa_pdf/22/c8/JCB_201304143.PMC3857477.pdf
http://dx.doi.org/10   .1083/jcb.123.6.177 7and CD2AP (immunofluorescence using N-terminal antibodies).,Non-OADS,/arxiv_data1/oa_pdf/22/c8/JCB_201304143.PMC3857477.pdf
Online supplemental material is available  at http://www.jcb.org/cgi/content/full/jcb.201304143/DC1.,Non-OADS,/arxiv_data1/oa_pdf/22/c8/JCB_201304143.PMC3857477.pdf
"http://dx.doi.org/10.1021/bi952470 p Mayor, R., and C. Carmona-Fontaine.",Non-OADS,/arxiv_data1/oa_pdf/22/c8/JCB_201304143.PMC3857477.pdf
"http://dx.doi   .org/10.1016/j.tcb.2010.03.00 5 Morita, H., S. Nandadasa, T.S.",OADS,/arxiv_data1/oa_pdf/22/c8/JCB_201304143.PMC3857477.pdf
"http://dx.doi.org/10.1242/dev.04319 0 Nandadasa, S., Q. Tao, N.R.",Non-OADS,/arxiv_data1/oa_pdf/22/c8/JCB_201304143.PMC3857477.pdf
"http://dx.doi.org/10.1242/   dev.03120 3 Nishimura, T., and M. Takeichi.",OADS,/arxiv_data1/oa_pdf/22/c8/JCB_201304143.PMC3857477.pdf
"http://dx.doi.org/10   .1016/S0070-2153(09)89002- 9 Sato, T., N. Fujita, A. Yamada, T. Ooshio, R. Okamoto, K. Irie, and Y .",OADS,/arxiv_data1/oa_pdf/22/c8/JCB_201304143.PMC3857477.pdf
"http://dx.doi.org/10   .1074/jbc.M51007020 0 Scott, J.A., A.M. Shewan, N.R.",Non-OADS,/arxiv_data1/oa_pdf/22/c8/JCB_201304143.PMC3857477.pdf
"http://dx.doi.org/10.1091/mbc.E05-07-064 4 Shih, N.Y ., J. Li, V .",OADS,/arxiv_data1/oa_pdf/22/c8/JCB_201304143.PMC3857477.pdf
"http://dx.doi   .org/10.1126/science.286.5438.31 2 Shimono, Y ., Y .",OADS,/arxiv_data1/oa_pdf/22/c8/JCB_201304143.PMC3857477.pdf
"60:137– 170. http://dx.doi.org/10.1007/978-94-007-4186-7_ 7 Shiotsu, T., A. Yamamoto, S. Kagawa, T. Tamaki, Y .",Non-OADS,/arxiv_data1/oa_pdf/22/c8/JCB_201304143.PMC3857477.pdf
"http://dx.doi   .org/10.1291/hypres.18.19 7 Smutny, M., H.L.",OADS,/arxiv_data1/oa_pdf/22/c8/JCB_201304143.PMC3857477.pdf
"http://dx.doi   .org/10.1038/ncb207 2 Takai, Y ., J. Miyoshi, W. Ikeda, and H. Ogita.",OADS,/arxiv_data1/oa_pdf/22/c8/JCB_201304143.PMC3857477.pdf
"http://dx.doi.org/10.1038/nrm245 7 Takeichi, M. 2011.",OADS,/arxiv_data1/oa_pdf/22/c8/JCB_201304143.PMC3857477.pdf
"http://dx.doi.org/10.1016/j.devcel.2011.06.00 2 Tang, V .W., and W.M.",OADS,/arxiv_data1/oa_pdf/22/c8/JCB_201304143.PMC3857477.pdf
"196:115– 130. http://dx.doi.org/10.1083/jcb.20110311 6 Tang, V .W., and D.A.",OADS,/arxiv_data1/oa_pdf/22/c8/JCB_201304143.PMC3857477.pdf
"http://dx.doi.org/10.1016/S0006-   3495(03)74975- 3 Tsukita, S., and S. Tsukita.",OADS,/arxiv_data1/oa_pdf/22/c8/JCB_201304143.PMC3857477.pdf
"http://dx.doi.org/10.1083/jcb.108.1.3 1 Tunggal, J.A., I. Helfrich, A. Schmitz, H. Schwarz, D. Günzel, M. Fromm, R.  Kemler, T. Krieg, and C.M.",OADS,/arxiv_data1/oa_pdf/22/c8/JCB_201304143.PMC3857477.pdf
"http://dx.doi.org/10.1038/sj.emboj.760060 5 van Duijn, T.J., E.C.",OADS,/arxiv_data1/oa_pdf/22/c8/JCB_201304143.PMC3857477.pdf
"http://dx.doi.org/10.1074/jbc.M109   .09948 1 Vasioukhin, V ., C. Bauer, M. Yin, and E. Fuchs.",OADS,/arxiv_data1/oa_pdf/22/c8/JCB_201304143.PMC3857477.pdf
"100:209– 219. http://dx.doi.org/10.1016/S0092-8674(00)81559- 7 Verma, S., A.M. Shewan, J.A.",OADS,/arxiv_data1/oa_pdf/22/c8/JCB_201304143.PMC3857477.pdf
"279:34062– 34070. http://dx.doi.org/10.1074/jbc.M40481420 0 Verma, S., S.P.",OADS,/arxiv_data1/oa_pdf/22/c8/JCB_201304143.PMC3857477.pdf
"120:2366– 2377. http://dx.doi.org/10.1242/jcs.00433 3 Ghosh, M., X.",Non-OADS,/arxiv_data1/oa_pdf/22/c8/JCB_201304143.PMC3857477.pdf
"http://dx.doi.org/10.1126/   science.109456 1 Gomez, G.A., R.W.",Non-OADS,/arxiv_data1/oa_pdf/22/c8/JCB_201304143.PMC3857477.pdf
"21:499– 505. http://dx.doi.org/10.1016/j.tcb.2011.05.00 6 Hernandez-Valladares, M., T. Kim, B. Kannan, A. Tung, A.H. Aguda, M.  Larsson, J.A.",OADS,/arxiv_data1/oa_pdf/22/c8/JCB_201304143.PMC3857477.pdf
"http://dx.doi.org/10   .1038/nsmb.179 2 Huber, T.B., C. Kwoh, H. Wu, K. Asanuma, M. Gödel, B. Hartleben, K.J.",Non-OADS,/arxiv_data1/oa_pdf/22/c8/JCB_201304143.PMC3857477.pdf
"http://dx.doi.org/10.1002/(SICI)1097-4652(199711)173:2<147::AID-   JCP13>3.0.CO;2- D Johnson, R.I., M.J. Seppa, and R.L.",OADS,/arxiv_data1/oa_pdf/22/c8/JCB_201304143.PMC3857477.pdf
"http://dx.doi.org/10   .1083/jcb.20070610 8 Johnson, R.I., A. Sedgwick, C. D’Souza-Schorey, and R.L.",Non-OADS,/arxiv_data1/oa_pdf/22/c8/JCB_201304143.PMC3857477.pdf
"http://dx.doi.org/10.1091/mbc.E11-04-030 5 Kametani, Y., and M. Takeichi.",OADS,/arxiv_data1/oa_pdf/22/c8/JCB_201304143.PMC3857477.pdf
"http://dx.doi.org/10.1038/ncb152 0 Kim, J.M., H. Wu, G. Green, C.A.",OADS,/arxiv_data1/oa_pdf/22/c8/JCB_201304143.PMC3857477.pdf
"http://dx.doi   .org/10.1126/science.108106 8 Kinoshita, Y., and F.G. Knox.",OADS,/arxiv_data1/oa_pdf/22/c8/JCB_201304143.PMC3857477.pdf
"http://dx.doi.org/10.1161/01.RES   .64.5.101 3 Kovacs, E.M., M. Goodwin, R.G.",OADS,/arxiv_data1/oa_pdf/22/c8/JCB_201304143.PMC3857477.pdf
"http://dx.doi.org/10.1016/S0960-   9822(02)00661- 9 Kovacs, E.M., S. Verma, R.G.",OADS,/arxiv_data1/oa_pdf/22/c8/JCB_201304143.PMC3857477.pdf
"http://dx.doi.org/10.1038/ncb229 0 Lambert, M., D. Choquet, and R.M.",Non-OADS,/arxiv_data1/oa_pdf/22/c8/JCB_201304143.PMC3857477.pdf
"http://dx.doi.org/10.1083/jcb.20010710 4 Leckband, D.E., Q. le Duc, N. Wang, and J. de Rooij.",OADS,/arxiv_data1/oa_pdf/22/c8/JCB_201304143.PMC3857477.pdf
"http://dx.doi.org/10.1074/jbc.M00662420 0 Löwik, M.M., P.J.",OADS,/arxiv_data1/oa_pdf/22/c8/JCB_201304143.PMC3857477.pdf
"http://dx.doi.org/10   .1038/sj.ki.500246 9 Lynch, D.K., S.C. Winata, R.J. Lyons, W.E.",Non-OADS,/arxiv_data1/oa_pdf/22/c8/JCB_201304143.PMC3857477.pdf
"http://dx.doi.org/10.1074/jbc.M21140720 0 Maciver, S.K., B.J.",Non-OADS,/arxiv_data1/oa_pdf/22/c8/JCB_201304143.PMC3857477.pdf
http://dx.doi   .org/10.1046/j.1432-1327.1998.2560388.,Non-OADS,/arxiv_data1/oa_pdf/22/c8/JCB_201304143.PMC3857477.pdf
"http://dx.doi.org/10.1091/   mbc.E12-08-057 4 Wang, W., R. Eddy, and J. Condeelis.",OADS,/arxiv_data1/oa_pdf/22/c8/JCB_201304143.PMC3857477.pdf
"http://dx.doi   .org/10.1038/nrc214 8 Wong, V., and B.M.",OADS,/arxiv_data1/oa_pdf/22/c8/JCB_201304143.PMC3857477.pdf
"http://dx.doi.org/10.1083/   jcb.136.2.39 9 Yaddanapudi, S., M.M.",Non-OADS,/arxiv_data1/oa_pdf/22/c8/JCB_201304143.PMC3857477.pdf
"http://dx.doi.org/10.1172/JCI5855 2 Yamashiro, S., D.S.",OADS,/arxiv_data1/oa_pdf/22/c8/JCB_201304143.PMC3857477.pdf
"http://dx.doi.org/10.1002/cm.2103 1 Yonemura, S., Y .",OADS,/arxiv_data1/oa_pdf/22/c8/JCB_201304143.PMC3857477.pdf
"http://dx.doi.org/10.1038/ncb205 5 Zhang, J., M. Betson, J. Erasmus, K. Zeikos, M. Bailly, L.P. Cramer, and V .M.",Non-OADS,/arxiv_data1/oa_pdf/22/c8/JCB_201304143.PMC3857477.pdf
"http://dx.doi   .org/10.1242/jcs.0263 9 Zhao, J., S. Bruck, S. Cemerski, L. Zhang, B. Butler, A. Dani, J.A.",OADS,/arxiv_data1/oa_pdf/22/c8/JCB_201304143.PMC3857477.pdf
33:38– 47. http://dx.doi.org/10.1128/MCB.00734-1 2,Non-OADS,/arxiv_data1/oa_pdf/22/c8/JCB_201304143.PMC3857477.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/fd/b7/JCB_201308001.PMC3857478.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/fd/b7/JCB_201308001.PMC3857478.pdf
Online supplemental material is  available at http://www.jcb.org/cgi/content/full/jcb.201308001/DC1.,Non-OADS,/arxiv_data1/oa_pdf/fd/b7/JCB_201308001.PMC3857478.pdf
Additional data are available in the JCB DataViewer at http://dx.doi   .org/10.1083/jcb.201308001.dv.,OADS,/arxiv_data1/oa_pdf/fd/b7/JCB_201308001.PMC3857478.pdf
"http://dx.doi.org/10.1083/jcb.128.5.87 9 Allan, V.J., and R.D.",OADS,/arxiv_data1/oa_pdf/fd/b7/JCB_201308001.PMC3857478.pdf
"http://dx.doi.org/10.1083/jcb.113.2.34 7Demembranated sperm preparation Sperm chromatin was prepared as described previously (Murray, 1991).",Non-OADS,/arxiv_data1/oa_pdf/fd/b7/JCB_201308001.PMC3857478.pdf
"http://dx.doi   .org/10.1006/jmbi.2000.431 5 Lane, J.D., and V.J.",OADS,/arxiv_data1/oa_pdf/fd/b7/JCB_201308001.PMC3857478.pdf
"http://dx.doi   .org/10.1091/mbc.10.6.190 9 Liu, T.Y., X. Bian, S. Sun, X. Hu, R.W.",OADS,/arxiv_data1/oa_pdf/fd/b7/JCB_201308001.PMC3857478.pdf
"http://dx.doi.org/10.1083/jcb.123.3.50 1 Lu, L., M.S.",OADS,/arxiv_data1/oa_pdf/fd/b7/JCB_201308001.PMC3857478.pdf
"http://dx.doi.org/10.1091/mbc.E09-04-032 7 Lu, L., M.S.",Non-OADS,/arxiv_data1/oa_pdf/fd/b7/JCB_201308001.PMC3857478.pdf
"http://dx.doi.org/10   .1083/jcb.20101206 3 Maresca, T.J., and R. Heald.",OADS,/arxiv_data1/oa_pdf/fd/b7/JCB_201308001.PMC3857478.pdf
"http://dx.doi.org/10.1007/978-1-59745-000-3_3 3 Mitchison, T.J., P. Nguyen, M. Coughlin, and A.C. Groen.",Non-OADS,/arxiv_data1/oa_pdf/fd/b7/JCB_201308001.PMC3857478.pdf
"http://dx.doi   .org/10.1091/mbc.E12-12-085 0 Morrison, E.E., B.N.",Non-OADS,/arxiv_data1/oa_pdf/fd/b7/JCB_201308001.PMC3857478.pdf
"http://dx.doi.org/10.1038/   sj.onc.120224 7 Murray, A.W.",Non-OADS,/arxiv_data1/oa_pdf/fd/b7/JCB_201308001.PMC3857478.pdf
"http://dx.doi.org/10.1038/339280a 0 Newmeyer, D.D., and K.L.",OADS,/arxiv_data1/oa_pdf/fd/b7/JCB_201308001.PMC3857478.pdf
"http://dx.doi   .org/10.1016/S0091-679X(08)60299- X Niclas, J., V.J.",OADS,/arxiv_data1/oa_pdf/fd/b7/JCB_201308001.PMC3857478.pdf
"http://dx.doi.org/10.1083/jcb.133.3.58 5 Niethammer, P., H.Y.",OADS,/arxiv_data1/oa_pdf/fd/b7/JCB_201308001.PMC3857478.pdf
"http://dx.doi.org/10.1016/j.cub.2008.03.03 8 Orso, G., D. Pendin, S. Liu, J. Tosetto, T.J. Moss, J.E.",OADS,/arxiv_data1/oa_pdf/fd/b7/JCB_201308001.PMC3857478.pdf
"http://dx.doi.org/10.1038/nature0828 0 Petry, S., C. Pugieux, F.J. Nédélec, and R.D.",OADS,/arxiv_data1/oa_pdf/fd/b7/JCB_201308001.PMC3857478.pdf
"http://dx.doi.org/10.1091/mbc.E04-08-072 6 Puhka, M., H. Vihinen, M. Joensuu, and E. Jokitalo.",OADS,/arxiv_data1/oa_pdf/fd/b7/JCB_201308001.PMC3857478.pdf
"http://dx.doi.org/10.1083/jcb.20070511 2 Puhka, M., M. Joensuu, H. Vihinen, I. Belevich, and E. Jokitalo.",OADS,/arxiv_data1/oa_pdf/fd/b7/JCB_201308001.PMC3857478.pdf
"http://dx.doi.org/10.1091/mbc.E10-12-095 0 Reck-Peterson, S.L., A. Yildiz, A.P.",Non-OADS,/arxiv_data1/oa_pdf/fd/b7/JCB_201308001.PMC3857478.pdf
"http://dx.doi.org/10.1016/   j.cell.2006.05.04 6 Ross, J.L., K. Wallace, H. Shuman, Y.E.",OADS,/arxiv_data1/oa_pdf/fd/b7/JCB_201308001.PMC3857478.pdf
"http://dx.doi.org/10.1038/ncb142 1 Shibata, Y., C. Voss, J.M.",OADS,/arxiv_data1/oa_pdf/fd/b7/JCB_201308001.PMC3857478.pdf
"http://dx.doi.org/10.1038/ncb163 6 Audhya, A., A. Desai, and K. Oegema.",Non-OADS,/arxiv_data1/oa_pdf/fd/b7/JCB_201308001.PMC3857478.pdf
"http://dx.doi   .org/10.1083/jcb.20070113 9 Baur, T., K. Ramadan, A. Schlundt, J. Kartenbeck, and H.H.",Non-OADS,/arxiv_data1/oa_pdf/fd/b7/JCB_201308001.PMC3857478.pdf
"http://dx.doi   .org/10.1242/jcs.01018 1 Bian, X., R.W.",Non-OADS,/arxiv_data1/oa_pdf/fd/b7/JCB_201308001.PMC3857478.pdf
"http://dx.doi.org/   10.1073/pnas.110164310 8 Byrnes, L.J., and H. Sondermann.",OADS,/arxiv_data1/oa_pdf/fd/b7/JCB_201308001.PMC3857478.pdf
"http://dx.doi.org/10.1073/   pnas.101279210 8 Chan, R.C., and D.I.",OADS,/arxiv_data1/oa_pdf/fd/b7/JCB_201308001.PMC3857478.pdf
"322:289– 300. http://dx.doi.org/10.1007/978-1-59745-000-3_2 0 Chen, S., P. Novick, and S. Ferro-Novick.",Non-OADS,/arxiv_data1/oa_pdf/fd/b7/JCB_201308001.PMC3857478.pdf
"http://dx.doi.org/10.1016/j.ceb   .2013.02.00 6 Collas, P., and D. Poccia.",OADS,/arxiv_data1/oa_pdf/fd/b7/JCB_201308001.PMC3857478.pdf
"http://dx.doi.org/10.1016/   S0091-679X(08)61991- 3 Dreier, L., and T.A.",OADS,/arxiv_data1/oa_pdf/fd/b7/JCB_201308001.PMC3857478.pdf
"http://dx.doi.org/10.1083/   jcb.148.5.88 3 Du, Y., S. Ferro-Novick, and P. Novick.",OADS,/arxiv_data1/oa_pdf/fd/b7/JCB_201308001.PMC3857478.pdf
"http://dx.doi   .org/10.1242/jcs.0128 6 English, A.R., and G.K. Voeltz.",Non-OADS,/arxiv_data1/oa_pdf/fd/b7/JCB_201308001.PMC3857478.pdf
"http://dx.doi.org/10.1101/cshperspect.a01322 7 English, A.R., and G.K. Voeltz.",OADS,/arxiv_data1/oa_pdf/fd/b7/JCB_201308001.PMC3857478.pdf
"http://dx.doi.org/10   .1038/ncb264 7 Friedman, J.R., B.M.",Non-OADS,/arxiv_data1/oa_pdf/fd/b7/JCB_201308001.PMC3857478.pdf
"http://dx.doi.org/   10.1083/jcb.20091102 4 Goyal, U., and C. Blackstone.",Non-OADS,/arxiv_data1/oa_pdf/fd/b7/JCB_201308001.PMC3857478.pdf
"http://dx.doi.org/10.1016/j.bbamcr.2013.04.00 9 Grigoriev, I., S.M.",OADS,/arxiv_data1/oa_pdf/fd/b7/JCB_201308001.PMC3857478.pdf
"http://dx.doi   .org/10.1016/j.cub.2007.12.05 0 Hetzer, M., D. Bilbao-Cortés, T.C.",OADS,/arxiv_data1/oa_pdf/fd/b7/JCB_201308001.PMC3857478.pdf
"http://dx.doi.org/10.1016/S1097-2765(00)80266- X Hu, J., Y. Shibata, P.P.",OADS,/arxiv_data1/oa_pdf/fd/b7/JCB_201308001.PMC3857478.pdf
"http://dx.doi.org/10.1016/0076-   6879(91)96041- O Juwana, J.P., P. Henderikx, A. Mischo, A. Wadle, N. Fadle, K. Gerlach, J.W.",Non-OADS,/arxiv_data1/oa_pdf/fd/b7/JCB_201308001.PMC3857478.pdf
"81:275– 284. http://dx.doi.org/10.1002/(SICI)1097-0215(19990412)81:2<275:: AID-IJC18>3.0.CO;2- Z King, S.J., C.L.",OADS,/arxiv_data1/oa_pdf/fd/b7/JCB_201308001.PMC3857478.pdf
http://dx.doi.org/10.1091/mbc.E03-01-002 5,Non-OADS,/arxiv_data1/oa_pdf/fd/b7/JCB_201308001.PMC3857478.pdf
"283:18892– 18904. http://dx.doi.org/10.1074/jbc.M80098620 0 Shibata, Y., J. Hu, M.M.",OADS,/arxiv_data1/oa_pdf/fd/b7/JCB_201308001.PMC3857478.pdf
"25:329– 354. http://dx.doi.org/10.1146/annurev.cellbio.042308.11332 4 Shibata, Y., T. Shemesh, W.A.",OADS,/arxiv_data1/oa_pdf/fd/b7/JCB_201308001.PMC3857478.pdf
"http://dx.doi.org/10.1016/j.cell.2010.11.00 7 Simon, I., M. Zerial, and R.S.",OADS,/arxiv_data1/oa_pdf/fd/b7/JCB_201308001.PMC3857478.pdf
"271:20470– 20478. http://dx.doi.org/10.1074/jbc.271.34.2047 0 Smyth, J.T., A.M. Beg, S. Wu, J.W.",Non-OADS,/arxiv_data1/oa_pdf/fd/b7/JCB_201308001.PMC3857478.pdf
"http://dx.doi   .org/10.1016/j.cub.2012.05.05 7 Steffen, W., S. Karki, K.T.",OADS,/arxiv_data1/oa_pdf/fd/b7/JCB_201308001.PMC3857478.pdf
"http://dx.doi.org/10.1083/jcb.103.4.155 7 Tirnauer, J.S., E. O’Toole, L. Berrueta, B.E.",Non-OADS,/arxiv_data1/oa_pdf/fd/b7/JCB_201308001.PMC3857478.pdf
"http://dx.doi.org/10.1083/jcb.145.5.99 3 Voeltz, G.K., W.A.",OADS,/arxiv_data1/oa_pdf/fd/b7/JCB_201308001.PMC3857478.pdf
"http://dx.doi.org/10.1016/j.cell.2005.11.04 7 Waterman-Storer, C.M., and E.D.",OADS,/arxiv_data1/oa_pdf/fd/b7/JCB_201308001.PMC3857478.pdf
"http://dx.doi.org/10.1016/   S0960-9822(98)70321- 5 Waterman-Storer, C.M., J. Gregory, S.F.",OADS,/arxiv_data1/oa_pdf/fd/b7/JCB_201308001.PMC3857478.pdf
"http://dx.doi.org/10.1083/jcb.130.5.116 1 Williams, R.C.",Non-OADS,/arxiv_data1/oa_pdf/fd/b7/JCB_201308001.PMC3857478.pdf
"http://dx.doi.org/10.1016/0076-6879(82)   85038- 6 Wedlich-Söldner, R., I. Schulz, A. Straube, and G. Steinberg.",OADS,/arxiv_data1/oa_pdf/fd/b7/JCB_201308001.PMC3857478.pdf
"http://dx.doi.org/10.1091/mbc.01-10-047 5 Wiese, C., M.W.",Non-OADS,/arxiv_data1/oa_pdf/fd/b7/JCB_201308001.PMC3857478.pdf
http://dx.doi   .org/10.1242/jcs.04196 2,Non-OADS,/arxiv_data1/oa_pdf/fd/b7/JCB_201308001.PMC3857478.pdf
This article is distributed under the terms of an Attribution–Noncommercial– Share Alike–No Mirror Sites license for the first six months after the publication date (see  http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/da/be/JCB_201309038.PMC3857480.pdf
"After six months it is available under a Creative Commons  License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at  http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/da/be/JCB_201309038.PMC3857480.pdf
Online  supplemental material is available at http://www.jcb.org/cgi/content/ full/jcb.201309038/DC1.,Non-OADS,/arxiv_data1/oa_pdf/da/be/JCB_201309038.PMC3857480.pdf
Additional data are available in the JCB Data - Viewer at http://dx.doi.org/10.1083/jcb.201309038.dv.,OADS,/arxiv_data1/oa_pdf/da/be/JCB_201309038.PMC3857480.pdf
"1:7. http://dx.doi.org/10.1186/1472-6750-1- 7 Arquint, C., K.F.",Non-OADS,/arxiv_data1/oa_pdf/da/be/JCB_201309038.PMC3857480.pdf
"http://dx.doi.org/10.1242/jcs.09988 7 Barr, A.R., J.V.",Non-OADS,/arxiv_data1/oa_pdf/da/be/JCB_201309038.PMC3857480.pdf
"http://dx.doi.org/10.1083/jcb.20091216 3 Basto, R., J. Lau, T. Vinogradova, A. Gardiol, C.G.",Non-OADS,/arxiv_data1/oa_pdf/da/be/JCB_201309038.PMC3857480.pdf
"http://dx.doi.org/10.1016/   j.cub.2005.11.04 2 Bobinnec, Y., A. Khodjakov, L.M.",OADS,/arxiv_data1/oa_pdf/da/be/JCB_201309038.PMC3857480.pdf
"http://dx.doi.org/10.1038/nmeth96 8 Castiel, A., M.M.",OADS,/arxiv_data1/oa_pdf/da/be/JCB_201309038.PMC3857480.pdf
"http://dx.doi.org/10.1242/jcs.07973 1 Cimini, D., L.A. Cameron, and E.D.",OADS,/arxiv_data1/oa_pdf/da/be/JCB_201309038.PMC3857480.pdf
"http://dx.doi.org/10.1016/j.cub.2004.11.02 9 Cizmecioglu, O., M. Arnold, R. Bahtz, F. Settele, L. Ehret, U. Haselmann-Weiss,  C. Antony, and I. Hoffmann.",Non-OADS,/arxiv_data1/oa_pdf/da/be/JCB_201309038.PMC3857480.pdf
"http://dx.doi.org/10.1016/j.yexcr .2006   .06.00 8 Magidson, V., C.B.",OADS,/arxiv_data1/oa_pdf/da/be/JCB_201309038.PMC3857480.pdf
"http://dx.doi   .org/10.1016/j.cell.2011.07.01 2 Mahmood, S., W. Ahmad, and M.J. Hassan.",OADS,/arxiv_data1/oa_pdf/da/be/JCB_201309038.PMC3857480.pdf
"6:39. http://dx.doi.org/   10.1186/1750-1172-6-3 9 Maniotis, A., and M. Schliwa.",Non-OADS,/arxiv_data1/oa_pdf/da/be/JCB_201309038.PMC3857480.pdf
"http://dx.doi.org/10.1016/0092-8674(91)90524- 3 Mennella, V., B. Keszthelyi, K.L.",OADS,/arxiv_data1/oa_pdf/da/be/JCB_201309038.PMC3857480.pdf
"http://dx.doi.org/   10.1038/ncb259 7 Meunier, S., and I. Vernos.",OADS,/arxiv_data1/oa_pdf/da/be/JCB_201309038.PMC3857480.pdf
"http://dx.doi.org/10.1091/mbc.E09-01-001 1 Pfaff, K.L., C.T.",Non-OADS,/arxiv_data1/oa_pdf/da/be/JCB_201309038.PMC3857480.pdf
"http://dx.doi.org/10   .1128/MCB.00175-0 7 Pfau, S.J., and A. Amon.",Non-OADS,/arxiv_data1/oa_pdf/da/be/JCB_201309038.PMC3857480.pdf
"http://dx.doi.org/   10.1038/embor.2012.6 5 Silkworth, W.T., I.K.",Non-OADS,/arxiv_data1/oa_pdf/da/be/JCB_201309038.PMC3857480.pdf
"http://dx.doi.org/10.1371/journal.pone.000656 4 Silkworth, W.T., I.K.",Non-OADS,/arxiv_data1/oa_pdf/da/be/JCB_201309038.PMC3857480.pdf
"http://dx.doi.org/10.1091/mbc.E11-02-009 5 Sir, J.H., A.R.",Non-OADS,/arxiv_data1/oa_pdf/da/be/JCB_201309038.PMC3857480.pdf
"http://dx.doi.org/10.1038/ng.97 1 Sonnen, K.F., L. Schermelleh, H. Leonhardt, and E.A.",Non-OADS,/arxiv_data1/oa_pdf/da/be/JCB_201309038.PMC3857480.pdf
"http://dx.doi.org/10.1242/bio   .2012233 7 Stevens, N.R., J. Dobbelaere, K. Brunk, A. Franz, and J.W.",OADS,/arxiv_data1/oa_pdf/da/be/JCB_201309038.PMC3857480.pdf
"http://dx.doi.org/10.1083/jcb.20091001 6 Stevens, N.R., H. Roque, and J.W.",OADS,/arxiv_data1/oa_pdf/da/be/JCB_201309038.PMC3857480.pdf
"http://dx.doi.org/10.1016/j.devcel.2010.11.01 0 Tang, C.J., S.Y.",OADS,/arxiv_data1/oa_pdf/da/be/JCB_201309038.PMC3857480.pdf
"http://dx.doi.org/10.1038/emboj.2011.37 8 Thompson, S.L., and D.A.",OADS,/arxiv_data1/oa_pdf/da/be/JCB_201309038.PMC3857480.pdf
"180:665– 672. http://dx.doi.org/10.1083/jcb.20071202 9 Thompson, S.L., and D.A.",OADS,/arxiv_data1/oa_pdf/da/be/JCB_201309038.PMC3857480.pdf
"20:1666– 1671. http://dx.doi.org/10.1016/j.cub.2010.08.01 8 Vulprecht, J., A. David, A. Tibelius, A. Castiel, G. Konotop, F. Liu, F. Bestvater,  M.S.",Non-OADS,/arxiv_data1/oa_pdf/da/be/JCB_201309038.PMC3857480.pdf
"http://dx.doi.org/10.1242/jcs.10410 9 Zamora, I., and W.F.",Non-OADS,/arxiv_data1/oa_pdf/da/be/JCB_201309038.PMC3857480.pdf
3:15. http://dx.doi.org/10.1186/   1741-7007-3-1 5of Plk4 and CPAP to the centrosome.,Non-OADS,/arxiv_data1/oa_pdf/da/be/JCB_201309038.PMC3857480.pdf
"482:53– 58. http://dx.doi.org/10.1038/nature1080 2 Debec, A., C. Détraves, C. Montmory, G. Géraud, and M. Wright.",OADS,/arxiv_data1/oa_pdf/da/be/JCB_201309038.PMC3857480.pdf
"http://dx.doi.org/10.1016/j.tcb   .2005.04.00 8 Duncan, T., and J.G.",OADS,/arxiv_data1/oa_pdf/da/be/JCB_201309038.PMC3857480.pdf
"http://dx.doi.org/10.1007/s10577-011-9205- 8 Dzhindzhev, N.S., Q.D.",OADS,/arxiv_data1/oa_pdf/da/be/JCB_201309038.PMC3857480.pdf
"http://dx.doi.org/10.1038/nature0944 5 Fu, J., and D.M.",OADS,/arxiv_data1/oa_pdf/da/be/JCB_201309038.PMC3857480.pdf
"2:120104. http://dx.doi   .org/10.1098/rsob.12010 4 Ganem, N.J., S.A. Godinho, and D. Pellman.",Non-OADS,/arxiv_data1/oa_pdf/da/be/JCB_201309038.PMC3857480.pdf
"http://dx.doi.org/10.1038/nrm337 3 Gregan, J., S. Polakova, L. Zhang, I.M.",OADS,/arxiv_data1/oa_pdf/da/be/JCB_201309038.PMC3857480.pdf
"http://dx.doi.org/10.1016/j.tcb.2011.01.00 3 Hatch, E.M., A. Kulukian, A.J.",OADS,/arxiv_data1/oa_pdf/da/be/JCB_201309038.PMC3857480.pdf
"http://dx.doi.org/10.1083/jcb.20100604 9 Hinchcliffe, E.H., F.J. Miller, M. Cham, A. Khodjakov, and G. Sluder.",OADS,/arxiv_data1/oa_pdf/da/be/JCB_201309038.PMC3857480.pdf
"http://dx.doi.org/10   .1126/science.105686 6 Hornick, J.E., C.C.",OADS,/arxiv_data1/oa_pdf/da/be/JCB_201309038.PMC3857480.pdf
"http://dx.doi   .org/10.1016/j.cub.2011.02.04 9 Izraeli, S., L.A. Lowe, V.L.",OADS,/arxiv_data1/oa_pdf/da/be/JCB_201309038.PMC3857480.pdf
"http://dx.doi   .org/10.1126/science.121021 4 Kanda, T., K.F.",OADS,/arxiv_data1/oa_pdf/da/be/JCB_201309038.PMC3857480.pdf
"http://dx.doi.org/10.1016/S0960-   9822(98)70156- 3 Khodjakov, A., R.W.",OADS,/arxiv_data1/oa_pdf/da/be/JCB_201309038.PMC3857480.pdf
"10:59– 67. http://dx.doi.org/10.1016/S0960-9822(99)00276- 6 Kitajima, T.S., M. Ohsugi, and J. Ellenberg.",OADS,/arxiv_data1/oa_pdf/da/be/JCB_201309038.PMC3857480.pdf
"http://dx.doi.org/10.1016/j.cell.2011.07.03 1 Kleylein-Sohn, J., J. Westendorf, M. Le Clech, R. Habedanck, Y.D.",OADS,/arxiv_data1/oa_pdf/da/be/JCB_201309038.PMC3857480.pdf
"http://dx.doi.org/10.1016/j.devcel.2007.07.00 2 Klingseisen, A., and A.P.",OADS,/arxiv_data1/oa_pdf/da/be/JCB_201309038.PMC3857480.pdf
"http://dx.doi   .org/10.1101/gad.16903 7 Kubo, A., H. Sasaki, A. Yuba-Kubo, S. Tsukita, and N. Shiina.",OADS,/arxiv_data1/oa_pdf/da/be/JCB_201309038.PMC3857480.pdf
"147:969– 980. http://dx.doi.org/10.1083/jcb.147.5.96 9 Lawo, S., M. Hasegan, G.D. Gupta, and L. Pelletier.",OADS,/arxiv_data1/oa_pdf/da/be/JCB_201309038.PMC3857480.pdf
"http://dx.doi.org/10.1038/ncb259 1 Lecland, N., A. Debec, A. Delmas, S. Moutinho-Pereira, N. Malmanche, A.  Bouissou, C. Dupré, A. Jourdan, B. Raynaud-Messina, H. Maiato, and   A. Guichet.",Non-OADS,/arxiv_data1/oa_pdf/da/be/JCB_201309038.PMC3857480.pdf
http://dx.doi.org/10.1242/bio.2013332 7,Non-OADS,/arxiv_data1/oa_pdf/da/be/JCB_201309038.PMC3857480.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/d8/a1/JCB_201305050.PMC3857483.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/d8/a1/JCB_201305050.PMC3857483.pdf
"http://dx.doi.org/10   .1016/j.cell.2004.07.01 1 Kerosuo, L., and M. Bronner-Fraser.",OADS,/arxiv_data1/oa_pdf/d8/a1/JCB_201305050.PMC3857483.pdf
"http://dx.doi.org/10.1016/j.semcdb.2012.03.01 0 Kuphal, S., and A.K.",OADS,/arxiv_data1/oa_pdf/d8/a1/JCB_201305050.PMC3857483.pdf
"http://dx.doi.org/10.1038/sj.onc.120950 8 Lander, R., K. Nordin, and C. LaBonne.",OADS,/arxiv_data1/oa_pdf/d8/a1/JCB_201305050.PMC3857483.pdf
"http://dx.doi.org/10.1083/jcb.20101208 5 Lander, R., T. Nasr, S.D.",OADS,/arxiv_data1/oa_pdf/d8/a1/JCB_201305050.PMC3857483.pdf
"4:1542. http://dx.doi.org/10.1038/ncomms254 3 Lencinas, A., D.C. Chhun, K.P.",Non-OADS,/arxiv_data1/oa_pdf/d8/a1/JCB_201305050.PMC3857483.pdf
"http://dx.doi.org/10   .1242/dmm.01059 5 Murray, S.A., K.F.",Non-OADS,/arxiv_data1/oa_pdf/d8/a1/JCB_201305050.PMC3857483.pdf
"134:1789– 1797. http://dx.doi.org/10.1242/dev.0283 7 Nakagawa, S., and M. Takeichi.",OADS,/arxiv_data1/oa_pdf/d8/a1/JCB_201305050.PMC3857483.pdf
"http://dx.doi   .org/10.1146/annurev-cellbio-092910-15403 6 Nieto, M.A., M.G.",OADS,/arxiv_data1/oa_pdf/d8/a1/JCB_201305050.PMC3857483.pdf
"http://dx.doi.org/10.1126/science.751344 3 Nitta, K.R., S. Takahashi, Y .",OADS,/arxiv_data1/oa_pdf/d8/a1/JCB_201305050.PMC3857483.pdf
"http://dx.doi.org/10.1387/ijdb.062252k n Sánchez-Tilló, E., Y .",Non-OADS,/arxiv_data1/oa_pdf/d8/a1/JCB_201305050.PMC3857483.pdf
"http://dx.doi.org/10.1007/s00018-012-1122- 2 Sauka-Spengler, T., and M. Barembaum.",OADS,/arxiv_data1/oa_pdf/d8/a1/JCB_201305050.PMC3857483.pdf
"http://dx.doi.org/10.1016/j.devcel.2007.08.00 5 Sheng, G., M. dos Reis, and C.D.",OADS,/arxiv_data1/oa_pdf/d8/a1/JCB_201305050.PMC3857483.pdf
"http://dx.doi.org/10.1016/S0092-8674(03)00927- 9 Shiau, C.E., and M. Bronner-Fraser.",OADS,/arxiv_data1/oa_pdf/d8/a1/JCB_201305050.PMC3857483.pdf
"http://dx.doi.org/10.1242/   dev.03435 5 Shoval, I., A. Ludwig, and C. Kalcheim.",Non-OADS,/arxiv_data1/oa_pdf/d8/a1/JCB_201305050.PMC3857483.pdf
"http://dx.doi.org/10.1242/dev.0274 2 Sivertsen, S., R. Hadar, S. Elloul, L. Vintman, C. Bedrossian, R. Reich, and B.  Davidson.",Non-OADS,/arxiv_data1/oa_pdf/d8/a1/JCB_201305050.PMC3857483.pdf
"http://dx.doi   .org/10.1016/j.lungcan.2006.08.01 0 Strobl-Mazzulla, P.H., and M.E.",OADS,/arxiv_data1/oa_pdf/d8/a1/JCB_201305050.PMC3857483.pdf
"http://dx.doi.org/10.1083/jcb.20120309 8 Theveneau, E., L. Marchant, S. Kuriyama, M. Gull, B. Moepps, M. Parsons, and R.  Mayor.",OADS,/arxiv_data1/oa_pdf/d8/a1/JCB_201305050.PMC3857483.pdf
"http://dx.doi.org/10.1016/j.devcel.2010.06.01 2 Thiery, J.P., H. Acloque, R.Y .",OADS,/arxiv_data1/oa_pdf/d8/a1/JCB_201305050.PMC3857483.pdf
"http://dx.doi.org/10.1016/S0925-4773(00)00318- X van Grunsven, L.A., V .",OADS,/arxiv_data1/oa_pdf/d8/a1/JCB_201305050.PMC3857483.pdf
Online supplemental material is  available at http://www.jcb.org/cgi/content/full/jcb.201305050/DC1.,Non-OADS,/arxiv_data1/oa_pdf/d8/a1/JCB_201305050.PMC3857483.pdf
"http://dx.doi.org/10.1016/S0091-679X(08)00209- 4 Akitaya, T., and M. Bronner-Fraser.",OADS,/arxiv_data1/oa_pdf/d8/a1/JCB_201305050.PMC3857483.pdf
"http://dx.doi.org/10.1002/aja.100194010 3 Bildsoe, H., D.A.",OADS,/arxiv_data1/oa_pdf/d8/a1/JCB_201305050.PMC3857483.pdf
"http://dx.doi.org/10.1016/j.ydbio.2012.12.00 4 Bothe, I., M.U.",OADS,/arxiv_data1/oa_pdf/d8/a1/JCB_201305050.PMC3857483.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d8/a1/JCB_201305050.PMC3857483.pdf
"EMBO Rep.  11:670– 677. http://dx.doi.org/10.1038/embor.2010.11 7 Chen, Y.T., P.O.",OADS,/arxiv_data1/oa_pdf/d8/a1/JCB_201305050.PMC3857483.pdf
"http://dx.doi.org/10.1002/dvg.2033 2 Chen, Z.F., and R.R.",OADS,/arxiv_data1/oa_pdf/d8/a1/JCB_201305050.PMC3857483.pdf
"http://dx.doi   .org/10.1101/gad.9.6.68 6 Cheung, M., M.C.",OADS,/arxiv_data1/oa_pdf/d8/a1/JCB_201305050.PMC3857483.pdf
"http://dx.doi.org/10   .1016/j.devcel.2004.12.01 0 Chui, M.H.",OADS,/arxiv_data1/oa_pdf/d8/a1/JCB_201305050.PMC3857483.pdf
"http://dx.doi.org/10.1002/ijc.2774 5 Coles, E.G., L.A. Taneyhill, and M. Bronner-Fraser.",Non-OADS,/arxiv_data1/oa_pdf/d8/a1/JCB_201305050.PMC3857483.pdf
"312:533– 544. http://dx.doi.org/10.1016/j.ydbio.2007.09.05 6 Comijn, J., G. Berx, P .",OADS,/arxiv_data1/oa_pdf/d8/a1/JCB_201305050.PMC3857483.pdf
"http://dx.doi.org/10   .1016/S1097-2765(01)00260- X Dady, A., C. Blavet, and J.L.",OADS,/arxiv_data1/oa_pdf/d8/a1/JCB_201305050.PMC3857483.pdf
"http://dx.doi.org/10.1002/dvdy.2381 3 Delalande, J.M., M.E.",Non-OADS,/arxiv_data1/oa_pdf/d8/a1/JCB_201305050.PMC3857483.pdf
"http://dx.doi.org/10.1002/dvdy.2148 5 Eisaki, A., H. Kuroda, A. Fukui, and M. Asashima.",OADS,/arxiv_data1/oa_pdf/d8/a1/JCB_201305050.PMC3857483.pdf
"271:151– 157. http://dx.doi.org/10.1006/bbrc.2000.254 5 Ellis, A.L., Z. Wang, X. Yu, and J.E.",OADS,/arxiv_data1/oa_pdf/d8/a1/JCB_201305050.PMC3857483.pdf
"http://dx.doi   .org/10.1128/JVI.02706-0 9 Gottardi, C.J., E. Wong, and B.M.",Non-OADS,/arxiv_data1/oa_pdf/d8/a1/JCB_201305050.PMC3857483.pdf
http://dx.doi.org/10   .1083/jcb.153.5.104 9,Non-OADS,/arxiv_data1/oa_pdf/d8/a1/JCB_201305050.PMC3857483.pdf
"http://dx.doi.org/10.1016/j.ydbio.2007.02.04 5 Verschueren, K., J.E.",OADS,/arxiv_data1/oa_pdf/d8/a1/JCB_201305050.PMC3857483.pdf
"http://dx.doi.org/10.1074/jbc.274.29.2048 9 V oiculescu, O., C. Papanayotou, and C.D.",Non-OADS,/arxiv_data1/oa_pdf/d8/a1/JCB_201305050.PMC3857483.pdf
"3:419– 426. http://dx.doi.org/10.1038/nprot.2008.1 0 Wakamatsu, N., Y .",Non-OADS,/arxiv_data1/oa_pdf/d8/a1/JCB_201305050.PMC3857483.pdf
"http://dx.doi.org/10.1038/8686 0 Zhang, C., and M.W.",OADS,/arxiv_data1/oa_pdf/d8/a1/JCB_201305050.PMC3857483.pdf
http://dx.doi   .org/10.1016/j.ydbio.2009.04.01 6,OADS,/arxiv_data1/oa_pdf/d8/a1/JCB_201305050.PMC3857483.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/6a/c9/JCB_201307181.PMC3857485.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/6a/c9/JCB_201307181.PMC3857485.pdf
Online supplemental material is available at http://www.jcb.org/cgi/   content/full/jcb.201307181/DC1.,Non-OADS,/arxiv_data1/oa_pdf/6a/c9/JCB_201307181.PMC3857485.pdf
Additional data are available in the  JCB DataViewer at http://dx.doi.org/10.1083/jcb.201307181.dv.,OADS,/arxiv_data1/oa_pdf/6a/c9/JCB_201307181.PMC3857485.pdf
"http://dx.doi.org/10.1038/3500312 0 Bao, Z., Z. Zhao, T.J. Boyle, J.I.",Non-OADS,/arxiv_data1/oa_pdf/6a/c9/JCB_201307181.PMC3857485.pdf
"http://dx.doi.org/10.1016/j.ydbio.2008.02.05 4 Bupp, J.M., A.E.",OADS,/arxiv_data1/oa_pdf/6a/c9/JCB_201307181.PMC3857485.pdf
"http://dx.doi   .org/10.1083/jcb.20070604 0 Cheng, C., L. Shtessel, M.M.",OADS,/arxiv_data1/oa_pdf/6a/c9/JCB_201307181.PMC3857485.pdf
"32:3383– 3391. http://dx.doi.org/10.1093/nar/gkh66 1 Chung, H.M., C. Shea, S. Fields, R.N.",OADS,/arxiv_data1/oa_pdf/6a/c9/JCB_201307181.PMC3857485.pdf
"http://dx.doi.org/10.1016/j   .celrep.2012.11.01 9 Dechat, T., K. Pfleghaar, K. Sengupta, T. Shimi, D.K.",OADS,/arxiv_data1/oa_pdf/6a/c9/JCB_201307181.PMC3857485.pdf
"http://dx.doi.org/10.1101/gad.165270 8 de Lange, T. 2009.",Non-OADS,/arxiv_data1/oa_pdf/6a/c9/JCB_201307181.PMC3857485.pdf
"http://dx.doi.org/10.1126/science.117063 3 Draskovic, I., N. Arnoult, V. Steiner, S. Bacchetti, P. Lomonte, and A. Londoño- Vallejo.",Non-OADS,/arxiv_data1/oa_pdf/6a/c9/JCB_201307181.PMC3857485.pdf
"http://dx.doi.org/10.1371/journal.pbio.100128 7 Ebrahimi, H., and A.D. Donaldson.",Non-OADS,/arxiv_data1/oa_pdf/6a/c9/JCB_201307181.PMC3857485.pdf
"http://dx.doi.org/10.1016/   0092-8674(93)90388- 7 Penkner, A., L. Tang, M. Novatchkova, M. Ladurner, A. Fridkin, Y.  Gruenbaum, D. Schweizer, J. Loidl, and V. Jantsch.",OADS,/arxiv_data1/oa_pdf/6a/c9/JCB_201307181.PMC3857485.pdf
"http://dx.doi.org/10   .1016/j.devcel.2007.05.00 4 Potts, P.R., and H. Yu.",OADS,/arxiv_data1/oa_pdf/6a/c9/JCB_201307181.PMC3857485.pdf
"http://dx.doi.org/10.1038/   nsmb125 9 Raices, M., R.E.",OADS,/arxiv_data1/oa_pdf/6a/c9/JCB_201307181.PMC3857485.pdf
"132:745– 757. http://dx.doi.org/10.1016/j.cell.2007.12.03 9 Rawlins, D.J., and P.J.",OADS,/arxiv_data1/oa_pdf/6a/c9/JCB_201307181.PMC3857485.pdf
http://dx.doi   .org/10.1111/j.1365-2818.1990.tb02949.,Non-OADS,/arxiv_data1/oa_pdf/6a/c9/JCB_201307181.PMC3857485.pdf
"http://dx.doi   .org/10.1101/gad.178750 9 Shtessel, L., M.R.",OADS,/arxiv_data1/oa_pdf/6a/c9/JCB_201307181.PMC3857485.pdf
"http://dx.doi.org/10.1534/   g3.112.00444 0 Starr, D.A.",Non-OADS,/arxiv_data1/oa_pdf/6a/c9/JCB_201307181.PMC3857485.pdf
"http://dx.doi.org/10.1242/jcs   .03762 2 Szostak, J.W., and E.H. Blackburn.",Non-OADS,/arxiv_data1/oa_pdf/6a/c9/JCB_201307181.PMC3857485.pdf
"http://dx.doi.org/10.1016/0092-   8674(82)90109- X Taddei, A., G. Van Houwe, S. Nagai, I. Erb, E. van Nimwegen, and S.M.",OADS,/arxiv_data1/oa_pdf/6a/c9/JCB_201307181.PMC3857485.pdf
"http://dx.doi.org/10.1101/gr.083881.10 8 Timmons, L., D.L.",Non-OADS,/arxiv_data1/oa_pdf/6a/c9/JCB_201307181.PMC3857485.pdf
"http://dx.doi.org/10 .1016/   S0378-1119(00)00579- 5 Towbin, B.D., C. González-Aguilera, R. Sack, D. Gaidatzis, V. Kalck, P.  Meister, P. Askjaer, and S.M.",OADS,/arxiv_data1/oa_pdf/6a/c9/JCB_201307181.PMC3857485.pdf
"http://dx.doi.org/10.1016/j.cell.2012.06.05 1 Vannier, J.B., V. Pavicic-Kaltenbrunner, M.I.",OADS,/arxiv_data1/oa_pdf/6a/c9/JCB_201307181.PMC3857485.pdf
"http://dx.doi   .org/10.1016/j.cell.2012.03.03 0 Wellinger, R.J., A.J.",OADS,/arxiv_data1/oa_pdf/6a/c9/JCB_201307181.PMC3857485.pdf
"http://dx.doi.org/10.1101/   gad.11.21.280 1 Yeager, T.R., A.A. Neumann, A. Englezou, L.I.",OADS,/arxiv_data1/oa_pdf/6a/c9/JCB_201307181.PMC3857485.pdf
"http://dx.doi.org/10   .1101/gad.48620 8 Ferreira, H.C., B. Luke, H. Schober, V. Kalck, J. Lingner, and S.M.",Non-OADS,/arxiv_data1/oa_pdf/6a/c9/JCB_201307181.PMC3857485.pdf
"http://dx.doi.org/10.1038/ncb226 3 Funabiki, H., I. Hagan, S. Uzawa, and M. Yanagida.",OADS,/arxiv_data1/oa_pdf/6a/c9/JCB_201307181.PMC3857485.pdf
"http://dx.doi.org/10.1083/   jcb.121.5.96 1 Garvik, B., M. Carson, and L. Hartwell.",OADS,/arxiv_data1/oa_pdf/6a/c9/JCB_201307181.PMC3857485.pdf
"http://dx.doi.org/10.1038/emboj.2009.19 6 Gotta, M., T. Laroche, A. Formenton, L. Maillet, H. Scherthan, and S.M.",Non-OADS,/arxiv_data1/oa_pdf/6a/c9/JCB_201307181.PMC3857485.pdf
"http://dx.doi.org/10.1083/jcb.134.6.134 9 Hagelstrom, R.T., K.B.",OADS,/arxiv_data1/oa_pdf/6a/c9/JCB_201307181.PMC3857485.pdf
"http://dx.doi.org/10.1038/nbt.158 7 Horn, H.F., Z. Brownstein, D.R.",OADS,/arxiv_data1/oa_pdf/6a/c9/JCB_201307181.PMC3857485.pdf
"http://dx.doi.org/10.1172/JCI6691 1 Jegou, T., I. Chung, G. Heuvelman, M. Wachsmuth, S.M.",Non-OADS,/arxiv_data1/oa_pdf/6a/c9/JCB_201307181.PMC3857485.pdf
"http://dx.doi   .org/10.1091/mbc.E08-02-010 8 Lackner, D.H., M. Raices, H. Maruyama, C. Haggblom, and J. Karlseder.",OADS,/arxiv_data1/oa_pdf/6a/c9/JCB_201307181.PMC3857485.pdf
"http://dx.doi   .org/10.1038/emboj.2012.6 1 Laroche, T., S.G. Martin, M. Gotta, H.C. Gorham, F.E.",Non-OADS,/arxiv_data1/oa_pdf/6a/c9/JCB_201307181.PMC3857485.pdf
"http://dx.doi.org/10   .1016/S0960-9822(98)70252- 0 Liu, T., A. Rechtsteiner, T.A.",OADS,/arxiv_data1/oa_pdf/6a/c9/JCB_201307181.PMC3857485.pdf
"http://dx.doi.org/10.1101/gr.115519.11 0 Lowden, M.R., B. Meier, T.W.",Non-OADS,/arxiv_data1/oa_pdf/6a/c9/JCB_201307181.PMC3857485.pdf
"http://dx.doi   .org/10.1534/genetics.108.08992 0 Marshall, W.F., A.F.",Non-OADS,/arxiv_data1/oa_pdf/6a/c9/JCB_201307181.PMC3857485.pdf
"http://dx.doi.org/10.1091/mbc.7.5.82 5 Mattout, A., B.L.",Non-OADS,/arxiv_data1/oa_pdf/6a/c9/JCB_201307181.PMC3857485.pdf
"http://dx.doi   .org/10.1016/j.cub.2011.08.03 0 Meier, B., I. Clejan, Y. Liu, M. Lowden, A. Gartner, J. Hodgkin, and S. Ahmed.",OADS,/arxiv_data1/oa_pdf/6a/c9/JCB_201307181.PMC3857485.pdf
"http://dx.doi.org/10.1371/journal.pgen.002001 8 Meister, P., L.R.",Non-OADS,/arxiv_data1/oa_pdf/6a/c9/JCB_201307181.PMC3857485.pdf
"http://dx.doi.org/10.1016/S0076-6879(10)70021- 5 Meister, P., B.D.",OADS,/arxiv_data1/oa_pdf/6a/c9/JCB_201307181.PMC3857485.pdf
"http://dx.doi.org/10.1101/gad.55961 0 Nagai, S., P. Heun, and S.M.",OADS,/arxiv_data1/oa_pdf/6a/c9/JCB_201307181.PMC3857485.pdf
"http://dx.doi   .org/10.2217/epi.09.4 9 Nagele, R.G., A.Q.",Non-OADS,/arxiv_data1/oa_pdf/6a/c9/JCB_201307181.PMC3857485.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/e0/50/JCB_201305109.PMC3857486.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/e0/50/JCB_201305109.PMC3857486.pdf
"http://dx.doi.org/10   .1016/S1534-5807(02)00258- 7 Conduit, P.T., and J.W.",OADS,/arxiv_data1/oa_pdf/e0/50/JCB_201305109.PMC3857486.pdf
"http://dx.doi.org/10.1016/j.cub.2010.11.05 5 Conduit, P.T., K. Brunk, J. Dobbelaere, C.I.",OADS,/arxiv_data1/oa_pdf/e0/50/JCB_201305109.PMC3857486.pdf
"http://dx.doi   .org/10.1016/j.cub.2010.11.01 1 D’Angiolella, V ., V .",OADS,/arxiv_data1/oa_pdf/e0/50/JCB_201305109.PMC3857486.pdf
"http://dx.doi.org/10.1038/nature0914 0 Delgehyr, N., H. Rangone, J. Fu, G. Mao, B. Tom, M.G.",Non-OADS,/arxiv_data1/oa_pdf/e0/50/JCB_201305109.PMC3857486.pdf
"http://dx.doi.org/10.1016/j.cub.2012.01.04 6 Dix, C.I., and J.W.",OADS,/arxiv_data1/oa_pdf/e0/50/JCB_201305109.PMC3857486.pdf
"17:1759– 1764. http://dx.doi.org/10.1016/j.cub.2007.08.06 5 Dobbelaere, J., F. Josué, S. Suijkerbuijk, B. Baum, N. Tapon, and J. Raff.",Non-OADS,/arxiv_data1/oa_pdf/e0/50/JCB_201305109.PMC3857486.pdf
"http://dx.doi.org/   10.1371/journal.pbio.006022 4 Fu, J., and D.M.",OADS,/arxiv_data1/oa_pdf/e0/50/JCB_201305109.PMC3857486.pdf
"2:120104. http://dx.doi   .org/10.1098/rsob.12010 4 Goetz, S.C., K.F.",Non-OADS,/arxiv_data1/oa_pdf/e0/50/JCB_201305109.PMC3857486.pdf
"http://dx.doi.org/10.1016/j.cell.2012.10.01 0 González, C., G. Tavosanis, and C. Mollinari.",OADS,/arxiv_data1/oa_pdf/e0/50/JCB_201305109.PMC3857486.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e0/50/JCB_201305109.PMC3857486.pdf
"http://dx.doi.org/10.1093/emboj/18.8.218 4 Kleylein-Sohn, J., J. Westendorf, M. Le Clech, R. Habedanck, Y .-D. Stierhof,  and E.A.",Non-OADS,/arxiv_data1/oa_pdf/e0/50/JCB_201305109.PMC3857486.pdf
"http://dx.doi.org/10.1016/j.devcel.2007.07.00 2 Kobayashi, T., W.Y .",OADS,/arxiv_data1/oa_pdf/e0/50/JCB_201305109.PMC3857486.pdf
"http://dx.doi.org/10.1016/   j.cell.2011.04.02 8 Kohlmaier, G., J. Loncarek, X. Meng, B.F. McEwen, M.M.",OADS,/arxiv_data1/oa_pdf/e0/50/JCB_201305109.PMC3857486.pdf
"http://dx.doi.org/10.1016/   j.cub.2009.05.01 8 Kremer, J.R.J., D.N.D.",OADS,/arxiv_data1/oa_pdf/e0/50/JCB_201305109.PMC3857486.pdf
"http://dx.doi.org/10.1006/jsbi.1996.001 3 Lee, H.S., J.A.",OADS,/arxiv_data1/oa_pdf/e0/50/JCB_201305109.PMC3857486.pdf
"http://dx.doi.org/10.1038/nature1194 1 Lucas, E.P., and J.W.",OADS,/arxiv_data1/oa_pdf/e0/50/JCB_201305109.PMC3857486.pdf
"http://dx.doi.org/10.1083/jcb.20070408 1 Martinez-Campos, M., R. Basto, J. Baker, M. Kernan, and J.W.",OADS,/arxiv_data1/oa_pdf/e0/50/JCB_201305109.PMC3857486.pdf
"http://dx.doi.org/10.1083/jcb.20040213 0 Mastronarde, D.N.",OADS,/arxiv_data1/oa_pdf/e0/50/JCB_201305109.PMC3857486.pdf
"http://dx.doi.org/10.1016/j.jsb.2005.07.00 7 Nigg, E.A., and J.W.",OADS,/arxiv_data1/oa_pdf/e0/50/JCB_201305109.PMC3857486.pdf
"http://dx.doi.org/10.1016/j.cell.2009.10.03 6 Peel, N., N.R.",OADS,/arxiv_data1/oa_pdf/e0/50/JCB_201305109.PMC3857486.pdf
"http://dx.doi.org/10.1016/j.cub   .2007.04.03 6Measuring PCM size To quantify PCM size, Z-stacks (0.2-µm steps, spanning the entire centro - some volume) of WT or CP110 brain cells in prometaphase to metaphase  stained for Asl, Cnn, and DNA were acquired using the Fluoview confocal  microscope (Olympus) described above.",OADS,/arxiv_data1/oa_pdf/e0/50/JCB_201305109.PMC3857486.pdf
"http://dx.doi.org/10.1016/j.devcel.2010.05.01 7 Basto, R., J. Lau, T. Vinogradova, A. Gardiol, C.G.",OADS,/arxiv_data1/oa_pdf/e0/50/JCB_201305109.PMC3857486.pdf
"http://dx.doi.org/10.1016/j.cell.2008.05.03 9 Baumbach, J., M.P.",OADS,/arxiv_data1/oa_pdf/e0/50/JCB_201305109.PMC3857486.pdf
"http://dx.doi.org/10.1242/bio.2012223 8 Bettencourt-Dias, M., F. Hildebrandt, D. Pellman, G. Woods, and S.A. Godinho.",Non-OADS,/arxiv_data1/oa_pdf/e0/50/JCB_201305109.PMC3857486.pdf
"27:307– 315. http://dx.doi.org/10.1016/j.tig.2011.05.00 4 Cao, J., Y .",OADS,/arxiv_data1/oa_pdf/e0/50/JCB_201305109.PMC3857486.pdf
"http://dx.doi.org/10.1038/ncb251 2 Carvalho-Santos, Z.Z., P.P.",Non-OADS,/arxiv_data1/oa_pdf/e0/50/JCB_201305109.PMC3857486.pdf
http://dx.doi.org/10.1016/j.devcel.2012.06.00 1,OADS,/arxiv_data1/oa_pdf/e0/50/JCB_201305109.PMC3857486.pdf
"http://dx.doi.org/10.1083/jcb.20020303 5 Roque, H., A. Wainman, J. Richens, K. Kozyrska, A. Franz, and J.W.",OADS,/arxiv_data1/oa_pdf/e0/50/JCB_201305109.PMC3857486.pdf
"http://dx.doi.org/10   .1016/j.cub.2009.05.01 6 Sonnen, K.F., L. Schermelleh, H. Leonhardt, and E.A.",OADS,/arxiv_data1/oa_pdf/e0/50/JCB_201305109.PMC3857486.pdf
"http://dx.doi.org/10.1242/   bio.2012233 7 Spektor, A., W.Y .",OADS,/arxiv_data1/oa_pdf/e0/50/JCB_201305109.PMC3857486.pdf
"http://dx.doi.org/10   .1016/j.cell.2007.06.02 7 Stevens, N.R., J. Dobbelaere, A. Wainman, F. Gergely, and J.W.",OADS,/arxiv_data1/oa_pdf/e0/50/JCB_201305109.PMC3857486.pdf
"http://dx.doi   .org/10.1083/jcb.20090503 1 Stevens, N.R., H. Roque, and J.W.",OADS,/arxiv_data1/oa_pdf/e0/50/JCB_201305109.PMC3857486.pdf
"http://dx.doi.org/10.1016/j.devcel.2010.11.01 0 Stevens, N.R., J. Dobbelaere, K. Brunk, A. Franz, and J.W.",OADS,/arxiv_data1/oa_pdf/e0/50/JCB_201305109.PMC3857486.pdf
"http://dx.doi.org/10.1083/jcb.20091001 6 Tang, C.-J.C., R.-H. Fu, K.-S. Wu, W.-B.",OADS,/arxiv_data1/oa_pdf/e0/50/JCB_201305109.PMC3857486.pdf
"http://dx.doi.org/10.1038/ncb188 9 Tsang, W.Y ., A. Spektor, D.J.",Non-OADS,/arxiv_data1/oa_pdf/e0/50/JCB_201305109.PMC3857486.pdf
"http://dx.doi.org/10.1091/mbc.E06-04-037 1 Tsang, W.Y ., C. Bossard, H. Khanna, J. Peränen, A. Swaroop, V .",Non-OADS,/arxiv_data1/oa_pdf/e0/50/JCB_201305109.PMC3857486.pdf
"http://dx.doi.org/10.1016/j.devcel.2008.07.00 4 Tsang, W.Y ., A. Spektor, S. Vijayakumar, B.R.",OADS,/arxiv_data1/oa_pdf/e0/50/JCB_201305109.PMC3857486.pdf
http://dx.doi.org/10.1016/j.devcel.2009.03.00 4,OADS,/arxiv_data1/oa_pdf/e0/50/JCB_201305109.PMC3857486.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/be/41/JCB_201305027.PMC3857487.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/be/41/JCB_201305027.PMC3857487.pdf
"http://dx.doi.org/10.1101/sqb.2010.75.05 0 Bender, M.A., R. Byron, T. Ragoczy, A.",Non-OADS,/arxiv_data1/oa_pdf/be/41/JCB_201305027.PMC3857487.pdf
"http://dx.doi.org/10.1182/blood-2006-04-01443 1 Bian, Q., and A.S. Belmont.",Non-OADS,/arxiv_data1/oa_pdf/be/41/JCB_201305027.PMC3857487.pdf
"http://dx.doi.org/10.1093/nar/gkq17 8 Brown, K.E., S.S.",OADS,/arxiv_data1/oa_pdf/be/41/JCB_201305027.PMC3857487.pdf
"http://dx.doi.org/10.1016/   S1097-2765(00)80311- 1 Brown, K.E., S. Amoils, J.M.",OADS,/arxiv_data1/oa_pdf/be/41/JCB_201305027.PMC3857487.pdf
"http://dx.doi.org/10.1038/3507857 7 Cope, N.F., P. Fraser, and C.H.",Non-OADS,/arxiv_data1/oa_pdf/be/41/JCB_201305027.PMC3857487.pdf
"11:204. http://dx.doi.org/10.1186/   gb-2010-11-3-20 4 Driscoll, M.C., C.S.",Non-OADS,/arxiv_data1/oa_pdf/be/41/JCB_201305027.PMC3857487.pdf
"http://dx.doi.org/10.1016/j.jmb.2006.09.07 2 Finlan, L.E., D. Sproul, I. Thomson, S. Boyle, E. Kerr, P. Perry, B. Ylstra, J.R.  Chubb, and W.A.",OADS,/arxiv_data1/oa_pdf/be/41/JCB_201305027.PMC3857487.pdf
"http://dx.doi.org/10.1371/journal.pgen.100003 9 Francastel, C., W. Magis, and M. Groudine.",Non-OADS,/arxiv_data1/oa_pdf/be/41/JCB_201305027.PMC3857487.pdf
"http://dx.doi   .org/10.1128/MCB.00208-0 7 Guelen, L., L. Pagie, E. Brasset, W. Meuleman, M.B.",Non-OADS,/arxiv_data1/oa_pdf/be/41/JCB_201305027.PMC3857487.pdf
"http://dx.doi   .org/10.1038/nature0694 7 Hahm, K., B.S.",OADS,/arxiv_data1/oa_pdf/be/41/JCB_201305027.PMC3857487.pdf
"http://dx.doi   .org/10.1101/gad.12.6.78 2 Hepperger, C., A. Mannes, J. Merz, J. Peters, and S. Dietzel.",OADS,/arxiv_data1/oa_pdf/be/41/JCB_201305027.PMC3857487.pdf
"http://dx.doi.org/10.1007/s00412-008-0168- 2 Hu, Y ., I. Kireev, M.J. Plutz, N. Ashourian, and A.S. Belmont.",Non-OADS,/arxiv_data1/oa_pdf/be/41/JCB_201305027.PMC3857487.pdf
"http://dx.doi.org/10.1083/jcb   .20080919 6 Kind, J., L. Pagie, H. Ortabozkoyun, S. Boyle, S.S. de Vries, H. Janssen, M.  Amendola, L.D.",Non-OADS,/arxiv_data1/oa_pdf/be/41/JCB_201305027.PMC3857487.pdf
"http://dx.doi.org/10.1016/j.cell.2013.02.02 8 Kohwi, M., J.R. Lupton, S.L.",OADS,/arxiv_data1/oa_pdf/be/41/JCB_201305027.PMC3857487.pdf
Online  supplemental material is available at http://www.jcb.org/cgi/content/ full/jcb.201305027/DC1.,Non-OADS,/arxiv_data1/oa_pdf/be/41/JCB_201305027.PMC3857487.pdf
Additional data are available in the JCB Data - Viewer at http://dx.doi.org/10.1083/jcb.201305027.dv.,OADS,/arxiv_data1/oa_pdf/be/41/JCB_201305027.PMC3857487.pdf
"http://dx.doi   .org/10.1016/S0091-679X(08)60986- 3 Andrulis, E.D., A.M. Neiman, D.C. Zappulla, and R. Sternglanz.",OADS,/arxiv_data1/oa_pdf/be/41/JCB_201305027.PMC3857487.pdf
"http://dx.doi.org/10.1038/2910 0 Bailey, T.L., and C. Elkan.",Non-OADS,/arxiv_data1/oa_pdf/be/41/JCB_201305027.PMC3857487.pdf
"http://dx.doi   .org/10.1016/j.molcel.2007.01.01 7 Kumaran, R.I., and D.L.",OADS,/arxiv_data1/oa_pdf/be/41/JCB_201305027.PMC3857487.pdf
"http://dx.doi.org/10.1083/jcb.20070606 0 Meldi, L., and J.H.",OADS,/arxiv_data1/oa_pdf/be/41/JCB_201305027.PMC3857487.pdf
"http://dx.doi.org/10.1016/j.tcb.2011.08.00 1 Palstra, R.J., B. Tolhuis, E. Splinter, R. Nijmeijer, F. Grosveld, and W. de Laat.",OADS,/arxiv_data1/oa_pdf/be/41/JCB_201305027.PMC3857487.pdf
"http://dx.doi.org/10.1038/ng124 4 Peric-Hupkes, D., and B. van Steensel.",OADS,/arxiv_data1/oa_pdf/be/41/JCB_201305027.PMC3857487.pdf
"http://dx.doi.org/10.1101/sqb.2010.75.01 4 Peters, A.H., S. Kubicek, K. Mechtler, R.J. O’Sullivan, A.A. Derijck, L.  Perez-Burgos, A. Kohlmaier, S. Opravil, M. Tachibana, Y. Shinkai,   et al.",Non-OADS,/arxiv_data1/oa_pdf/be/41/JCB_201305027.PMC3857487.pdf
"http://dx.doi   .org/10.1016/S1097-2765(03)00477- 5 Ragoczy, T., M.A.",OADS,/arxiv_data1/oa_pdf/be/41/JCB_201305027.PMC3857487.pdf
"http://dx.doi.org/10.1101/gad.141950 6 Reddy, K.L., J.M.",OADS,/arxiv_data1/oa_pdf/be/41/JCB_201305027.PMC3857487.pdf
"http://dx.doi.org/10.1038/nature0672 7 Robinett, C.C., A.",OADS,/arxiv_data1/oa_pdf/be/41/JCB_201305027.PMC3857487.pdf
"http://dx.doi.org/10.1083/jcb.135.6.168 5 Shevelyov, Y .Y ., and D.I.",Non-OADS,/arxiv_data1/oa_pdf/be/41/JCB_201305027.PMC3857487.pdf
"http://dx.doi   .org/10.1083/jcb.20091216 7 Strukov, Y .G., and A.S. Belmont.",Non-OADS,/arxiv_data1/oa_pdf/be/41/JCB_201305027.PMC3857487.pdf
"150:934– 947. http://dx.doi.org/10.1016/j.cell.2012.06.05 1 Tumbar, T., G. Sudlow, and A.S. Belmont.",OADS,/arxiv_data1/oa_pdf/be/41/JCB_201305027.PMC3857487.pdf
"http://dx.doi.org/10.1083/jcb.145.7.134 1 Vedadi, M., D. Barsyte-Lovejoy, F. Liu, S. Rival-Gervier, A. Allali-Hassani,  V .",Non-OADS,/arxiv_data1/oa_pdf/be/41/JCB_201305027.PMC3857487.pdf
"http://dx.doi   .org/10.1038/nchembio.59 9 Warming, S., N. Costantino, D.L.",Non-OADS,/arxiv_data1/oa_pdf/be/41/JCB_201305027.PMC3857487.pdf
"http://dx.doi.org/10.1093/nar/gni03 5 Williams, R.R., V .",OADS,/arxiv_data1/oa_pdf/be/41/JCB_201305027.PMC3857487.pdf
"http://dx.doi.org/10.1242/jcs.0272 7 Wu, R., A.V .",OADS,/arxiv_data1/oa_pdf/be/41/JCB_201305027.PMC3857487.pdf
"http://dx.doi.org/10.1091/mbc   .E04-11-099 7 Yao, J., R.D.",Non-OADS,/arxiv_data1/oa_pdf/be/41/JCB_201305027.PMC3857487.pdf
"25:569– 580. http://dx.doi.org/10.1101/gad.202141 1 Zhao, R., M.S.",Non-OADS,/arxiv_data1/oa_pdf/be/41/JCB_201305027.PMC3857487.pdf
"http://dx.doi   .org/10.1016/j.gde.2009.02.00 7 Zullo, J.M., I.A.",OADS,/arxiv_data1/oa_pdf/be/41/JCB_201305027.PMC3857487.pdf
"Although different models have been pro - posed, there is still no clear picture of how these three  components cooperate to initiate endocytosis, which may  indicate that there is some flexibility underlying this im - portant event.From uncertain beginnings: Initiation mechanisms of  clathrin-mediated endocytosis Camilla Godlee and Marko Kaksonen Cell Biology and Biophysics Unit, EMBL Heidelberg, 69117 Heidelberg, Germany © 2013 Godlee and Kaksonen  This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).",Non-OADS,/arxiv_data1/oa_pdf/eb/43/JCB_201307100.PMC3857488.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/eb/43/JCB_201307100.PMC3857488.pdf
"http://dx.doi   .org/10.1038/ncb235 1 Ferguson, S.S.G., W.E.",Non-OADS,/arxiv_data1/oa_pdf/eb/43/JCB_201307100.PMC3857488.pdf
"http://dx.doi   .org/10.1126/science.291.5506.105 1 Ford, M.G.J., I.G.",OADS,/arxiv_data1/oa_pdf/eb/43/JCB_201307100.PMC3857488.pdf
"http://dx.doi.org/10.1038/nature0102 0 Garrenton, L.S., C.J.",OADS,/arxiv_data1/oa_pdf/eb/43/JCB_201307100.PMC3857488.pdf
"http://dx.doi.org/10.1073/   pnas.100581710 7 Henne, W.M., E. Boucrot, M. Meinecke, E. Evergren, Y .",OADS,/arxiv_data1/oa_pdf/eb/43/JCB_201307100.PMC3857488.pdf
"http://dx.doi.org/10   .1126/science.118846 2 Hinrichsen, L., J. Harborth, L. Andrees, K. Weber, and E.J.",OADS,/arxiv_data1/oa_pdf/eb/43/JCB_201307100.PMC3857488.pdf
"http://dx.doi.org/10.1074/jbc   .M30729020 0 Howard, J.P., J.L.",Non-OADS,/arxiv_data1/oa_pdf/eb/43/JCB_201307100.PMC3857488.pdf
"http://dx.doi.org/10.1083/jcb.20011002 7 Huang, K.M., K. D’Hondt, H. Riezman, and S.K.",OADS,/arxiv_data1/oa_pdf/eb/43/JCB_201307100.PMC3857488.pdf
"http://dx.doi.org/10.1093/   emboj/18.14.389 7 Huang, F., A. Khvorova, W. Marshall, and A. Sorkin.",Non-OADS,/arxiv_data1/oa_pdf/eb/43/JCB_201307100.PMC3857488.pdf
"http://dx.doi.org/10.1074/jbc   .C40004620 0 Idevall-Hagren, O., E.J.",OADS,/arxiv_data1/oa_pdf/eb/43/JCB_201307100.PMC3857488.pdf
"http://dx.doi.org/10.1016/   j.cell.2010.05.00 6 Johannessen, L.E., N.M. Pedersen, K.W.",OADS,/arxiv_data1/oa_pdf/eb/43/JCB_201307100.PMC3857488.pdf
"http://dx.doi.org/10.1128/MCB   .26.2.389-401.200 6 Jost, M., F. Simpson, J.M.",OADS,/arxiv_data1/oa_pdf/eb/43/JCB_201307100.PMC3857488.pdf
"http://dx.doi.org/10.1016/   S0960-9822(98)00022- 0 Kaksonen, M., C.P.",OADS,/arxiv_data1/oa_pdf/eb/43/JCB_201307100.PMC3857488.pdf
"http://dx.doi.org/10.1016/j.cell.2005.09.02 4 Keyel, P.A., S.K.",OADS,/arxiv_data1/oa_pdf/eb/43/JCB_201307100.PMC3857488.pdf
"17:4300– 4317. http://dx.doi.org/10.1091/mbc.E06-05-042 1 Kirchhausen, T. 2012.",Non-OADS,/arxiv_data1/oa_pdf/eb/43/JCB_201307100.PMC3857488.pdf
"http://dx.doi.org/10.1083/   jcb.20070103 0 Kukulski, W., M. Schorb, M. Kaksonen, and J.A.G.",OADS,/arxiv_data1/oa_pdf/eb/43/JCB_201307100.PMC3857488.pdf
"http://dx.doi.org/10.1016/j.cell   .2012.05.04 6 Lakadamyali, M., M.J. Rust, and X. Zhuang.",OADS,/arxiv_data1/oa_pdf/eb/43/JCB_201307100.PMC3857488.pdf
"http://dx.doi.org/10.1016/j.cell.2005.12.03 8References Abe, N., T. Inoue, T. Galvez, L. Klein, and T. Meyer.",OADS,/arxiv_data1/oa_pdf/eb/43/JCB_201307100.PMC3857488.pdf
"http://dx.doi.org/10.1242/jcs.02079 2 Aguet, F., C.N.",Non-OADS,/arxiv_data1/oa_pdf/eb/43/JCB_201307100.PMC3857488.pdf
"http://dx.doi.org/10.1091/mbc.E10-05-042 1 Antonescu, C.N., F. Aguet, G. Danuser, and S.L.",Non-OADS,/arxiv_data1/oa_pdf/eb/43/JCB_201307100.PMC3857488.pdf
"http://dx.doi.org/10.1091/mbc   .E11-04-036 2 Beattie, E.C., C.L.",Non-OADS,/arxiv_data1/oa_pdf/eb/43/JCB_201307100.PMC3857488.pdf
"http://dx.doi.org/10.1534/genetics.111.13288 6 Boucrot, E., S. Saffarian, R. Massol, T. Kirchhausen, and M. Ehrlich.",Non-OADS,/arxiv_data1/oa_pdf/eb/43/JCB_201307100.PMC3857488.pdf
"http://dx.doi.org/10.1016/j.yexcr.2006.09.02 5 Boucrot, E., S. Saffarian, R. Zhang, and T. Kirchhausen.",OADS,/arxiv_data1/oa_pdf/eb/43/JCB_201307100.PMC3857488.pdf
"http://dx.doi.org/10   .1371/journal.pone.001059 7 Carroll, S.Y ., P.C.",Non-OADS,/arxiv_data1/oa_pdf/eb/43/JCB_201307100.PMC3857488.pdf
"http://dx.doi.org/10.1016/j.devcel.2009.08.00 6 Carroll, S.Y ., H.E.M.",OADS,/arxiv_data1/oa_pdf/eb/43/JCB_201307100.PMC3857488.pdf
"http://dx.doi.org/10.1091/mbc.E11-02-010 8 Cocucci, E., F. Aguet, S. Boulant, and T. Kirchhausen.",Non-OADS,/arxiv_data1/oa_pdf/eb/43/JCB_201307100.PMC3857488.pdf
"http://dx.doi.org/10   .1016/j.cell.2012.05.04 7 Collins, B.M., A.J.",OADS,/arxiv_data1/oa_pdf/eb/43/JCB_201307100.PMC3857488.pdf
"http://dx.doi.org/10.1016/S0092-8674(02)00735- 3 Conner, S.D., and S.L.",OADS,/arxiv_data1/oa_pdf/eb/43/JCB_201307100.PMC3857488.pdf
"http://dx.doi   .org/10.1083/jcb.20030406 9 Connolly, J.L., S.A. Green, and L.A. Greene.",Non-OADS,/arxiv_data1/oa_pdf/eb/43/JCB_201307100.PMC3857488.pdf
"http://dx.doi.org/10.1083/jcb.90.1.17 6 Cureton, D.K., R.H. Massol, S. Saffarian, T.L.",Non-OADS,/arxiv_data1/oa_pdf/eb/43/JCB_201307100.PMC3857488.pdf
"http://dx.doi.org/10.1371/journal.ppat.100039 4 Cureton, D.K., C.E.",Non-OADS,/arxiv_data1/oa_pdf/eb/43/JCB_201307100.PMC3857488.pdf
"http://dx.doi.org/10.1128/JVI.07194-1 1 Dannhauser, P.N., and E.J.",OADS,/arxiv_data1/oa_pdf/eb/43/JCB_201307100.PMC3857488.pdf
"http://dx.doi.org/10.1038/ncb247 8 Diril, M.K., M. Wienisch, N. Jung, J. Klingauf, and V .",Non-OADS,/arxiv_data1/oa_pdf/eb/43/JCB_201307100.PMC3857488.pdf
"http://dx.doi.org/10.1016/   j.devcel.2005.12.01 1 Doyon, J.B., B. Zeitler, J. Cheng, A.T. Cheng, J.M.",OADS,/arxiv_data1/oa_pdf/eb/43/JCB_201307100.PMC3857488.pdf
"http://dx.doi.org/10.1038/ncb217 5 Ehrlich, M., W. Boll, A.",Non-OADS,/arxiv_data1/oa_pdf/eb/43/JCB_201307100.PMC3857488.pdf
"http://dx.doi.org/10.1016/   j.cell.2004.08.01 7 Fairn, G.D., M. Hermansson, P. Somerharju, and S. Grinstein.",OADS,/arxiv_data1/oa_pdf/eb/43/JCB_201307100.PMC3857488.pdf
"http://dx.doi.org/10.1091/mbc.E12-07-055 0 Stachowiak, J.C., E.M. Schmid, C.J.",Non-OADS,/arxiv_data1/oa_pdf/eb/43/JCB_201307100.PMC3857488.pdf
"http://dx.doi   .org/10.1038/ncb256 1 Stimpson, H.E.M., C.P.",Non-OADS,/arxiv_data1/oa_pdf/eb/43/JCB_201307100.PMC3857488.pdf
"http://dx.doi   .org/10.1091/mbc.E09-05-042 9 Sun, Y ., and D.G.",OADS,/arxiv_data1/oa_pdf/eb/43/JCB_201307100.PMC3857488.pdf
"http://dx.doi.org/10.1242/jcs.11574 1 Taylor, M.J., D. Perrais, and C.J.",OADS,/arxiv_data1/oa_pdf/eb/43/JCB_201307100.PMC3857488.pdf
"http://dx.doi.org/10.1371/journal.pbio.100060 4 Toshima, J.Y ., J. Toshima, M. Kaksonen, A.C. Martin, D.S.",OADS,/arxiv_data1/oa_pdf/eb/43/JCB_201307100.PMC3857488.pdf
"http://dx.doi.org/   10.1073/pnas.060104210 3 Toshima, J.Y ., J. Nakanishi, K. Mizuno, J. Toshima, and D.G.",OADS,/arxiv_data1/oa_pdf/eb/43/JCB_201307100.PMC3857488.pdf
"http://dx.doi   .org/10.1091/mbc.E09-07-054 1 Traub, L.M.",Non-OADS,/arxiv_data1/oa_pdf/eb/43/JCB_201307100.PMC3857488.pdf
"http://dx.doi .org/10   .1038/nrm275 1 Umasankar, P .K., S. Sanker, J.R. Thieman, S. Chakraborty, B. Wendland, M. Tsang,  and L.M.",Non-OADS,/arxiv_data1/oa_pdf/eb/43/JCB_201307100.PMC3857488.pdf
"http://dx.doi.org/10.1038/ncb247 3 van der Schaar, H.M., M.J. Rust, C. Chen, H. van der Ende-Metselaar, J.  Wilschut, X. Zhuang, and J.M.",OADS,/arxiv_data1/oa_pdf/eb/43/JCB_201307100.PMC3857488.pdf
"http://dx.doi.org/10.1371/journal.ppat.100024 4 Vernay, A., S. Schaub, I. Guillas, M. Bassilana, and R.A. Arkowitz.",Non-OADS,/arxiv_data1/oa_pdf/eb/43/JCB_201307100.PMC3857488.pdf
"http://dx.doi.org/10   .1083/jcb.20120309 9 Warren, R.A., F.A.",Non-OADS,/arxiv_data1/oa_pdf/eb/43/JCB_201307100.PMC3857488.pdf
"http://dx.doi.org/10.1016/   S0092-8674(00)80578- 4 Yeung, B.G., H.L.",OADS,/arxiv_data1/oa_pdf/eb/43/JCB_201307100.PMC3857488.pdf
"http://dx.doi   .org/10.1091/mbc.10.11.364 3 Yeung, T., G.E.",OADS,/arxiv_data1/oa_pdf/eb/43/JCB_201307100.PMC3857488.pdf
"http://dx.doi.org/10.1126/science.115206 6 Zimmerberg, J., and M.M.",OADS,/arxiv_data1/oa_pdf/eb/43/JCB_201307100.PMC3857488.pdf
"http://dx.doi   .org/10.1038/nrm178 4 Zoncu, R., R.M.",OADS,/arxiv_data1/oa_pdf/eb/43/JCB_201307100.PMC3857488.pdf
"http://dx.doi.org/10   .1073/pnas.061173310 4Liu, A.P., F. Aguet, G. Danuser, and S.L.",Non-OADS,/arxiv_data1/oa_pdf/eb/43/JCB_201307100.PMC3857488.pdf
"http://dx.doi.org/10.1083/jcb.20100811 7 Loerke, D., M. Mettlen, D. Yarar, K. Jaqaman, H. Jaqaman, G. Danuser, and S.L.",Non-OADS,/arxiv_data1/oa_pdf/eb/43/JCB_201307100.PMC3857488.pdf
"http://dx.doi.org/10.1371/journal.pbio.100005 7 Maldonado-Báez, L., and B. Wendland.",OADS,/arxiv_data1/oa_pdf/eb/43/JCB_201307100.PMC3857488.pdf
"http://dx.doi   .org/10.1016/j.tcb.2006.08.00 1 Malecz, N., P.C.",OADS,/arxiv_data1/oa_pdf/eb/43/JCB_201307100.PMC3857488.pdf
"http://dx.doi.org/10   .1016/S0960-9822(00)00778- 8 Maurer, M.E., and J.A.",OADS,/arxiv_data1/oa_pdf/eb/43/JCB_201307100.PMC3857488.pdf
"http://dx.doi.org/10.1242/jcs.0321 7 Meloty-Kapella, L., B. Shergill, J. Kuon, E. Botvinick, and G. Weinmaster.",Non-OADS,/arxiv_data1/oa_pdf/eb/43/JCB_201307100.PMC3857488.pdf
"http://dx.doi   .org/10.1016/j.devcel.2012.04.00 5 Mettlen, M., D. Loerke, D. Yarar, G. Danuser, and S.L.",OADS,/arxiv_data1/oa_pdf/eb/43/JCB_201307100.PMC3857488.pdf
"http://dx.doi.org/10.1083/jcb.20090807 8 Miller, S.E., D.A.",OADS,/arxiv_data1/oa_pdf/eb/43/JCB_201307100.PMC3857488.pdf
"http://dx.doi.org/10.1016/j.cell.2011.10.03 8 Mitsunari, T., F. Nakatsu, N. Shioda, P.E.",OADS,/arxiv_data1/oa_pdf/eb/43/JCB_201307100.PMC3857488.pdf
"http://dx.doi.org/10   .1128/MCB.25.21.9318-9323.200 5 Motley, A., N.A.",OADS,/arxiv_data1/oa_pdf/eb/43/JCB_201307100.PMC3857488.pdf
"http://dx.doi.org/10.1083/jcb.20030514 5 Murthy, V .N., and P. De Camilli.",Non-OADS,/arxiv_data1/oa_pdf/eb/43/JCB_201307100.PMC3857488.pdf
"http://dx.doi.org/10.1146/annurev   .neuro.26.041002.13144 5 Nunez, D., C. Antonescu, M. Mettlen, A. Liu, S.L.",Non-OADS,/arxiv_data1/oa_pdf/eb/43/JCB_201307100.PMC3857488.pdf
12:1868– 1878. http://dx.doi.org/10.1111/j.1600-0854.2011.01273.,Non-OADS,/arxiv_data1/oa_pdf/eb/43/JCB_201307100.PMC3857488.pdf
"http://dx.doi.org/10.1016/j.cell   .2006.08.03 5 Rappoport, J.Z., and S.M.",OADS,/arxiv_data1/oa_pdf/eb/43/JCB_201307100.PMC3857488.pdf
"http://dx.doi.org/10.1242/jcs.04003 0 Reider, A., S.L.",OADS,/arxiv_data1/oa_pdf/eb/43/JCB_201307100.PMC3857488.pdf
"http://dx.doi.org/10.1038/emboj.2009.24 8 Rust, M.J., M. Lakadamyali, F. Zhang, and X. Zhuang.",OADS,/arxiv_data1/oa_pdf/eb/43/JCB_201307100.PMC3857488.pdf
"http://dx.doi.org/10.1038/nsmb76 9 Santini, F., I. Gaidarov, and J.H.",Non-OADS,/arxiv_data1/oa_pdf/eb/43/JCB_201307100.PMC3857488.pdf
"http://dx.doi.org/10.1083/jcb.20011013 2 Santolini, E., C. Puri, A.E.",OADS,/arxiv_data1/oa_pdf/eb/43/JCB_201307100.PMC3857488.pdf
"151:1345– 1352. http://dx.doi.org/10.1083/jcb.151.6.134 5 Scott, M.G.H., A. Benmerah, O. Muntaner, and S. Marullo.",Non-OADS,/arxiv_data1/oa_pdf/eb/43/JCB_201307100.PMC3857488.pdf
"http://dx.doi.org/10.1074/ jbc.M10658620 0 Shim, J., and J. Lee.",OADS,/arxiv_data1/oa_pdf/eb/43/JCB_201307100.PMC3857488.pdf
This article is distributed under the terms of an Attribution–Noncommercial– Share Alike–No Mirror Sites license for the first six months after the publication date (see  http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/f0/1d/JCB_201308173.PMC3857489.pdf
"After six months it is available under a Creative Commons  License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at  http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/f0/1d/JCB_201308173.PMC3857489.pdf
"http://dx.doi.org/10.1126/   science.110800 3 Delamarre, L., R. Couture, I. Mellman, and E.S.",OADS,/arxiv_data1/oa_pdf/f0/1d/JCB_201308173.PMC3857489.pdf
"http://dx.doi.org/10.1084/jem.2005244 2 Dengjel, J., M. Høyer-Hansen, M.O.",OADS,/arxiv_data1/oa_pdf/f0/1d/JCB_201308173.PMC3857489.pdf
"http://dx.doi.org/10.1074/mcp.M111   .01403 5 Florey, O., S.E.",Non-OADS,/arxiv_data1/oa_pdf/f0/1d/JCB_201308173.PMC3857489.pdf
"http://dx.doi.org/10.1038/ncb236 3 Fonteneau, J.F., M. Larsson, S. Somersan, C. Sanders, C. Münz, W.W. Kwok, N.  Bhardwaj, and F. Jotereau.",Non-OADS,/arxiv_data1/oa_pdf/f0/1d/JCB_201308173.PMC3857489.pdf
"http://dx.doi.org/10.1016/j.chom.2009.09.00 5 Henault, J., J. Martinez, J.M.",OADS,/arxiv_data1/oa_pdf/f0/1d/JCB_201308173.PMC3857489.pdf
"http://dx.doi.org/10.1016/j.immuni   .2012.09.01 4 Huang, J., V. Canadien, G.Y.",OADS,/arxiv_data1/oa_pdf/f0/1d/JCB_201308173.PMC3857489.pdf
"http://dx.doi.org/10   .1007/s00018-011-0834- z Lee, H.K., L.M.",Non-OADS,/arxiv_data1/oa_pdf/f0/1d/JCB_201308173.PMC3857489.pdf
"http://dx.doi.org/10.1016/j.immuni.2009.12.00 6 Levine, B., N. Mizushima, and H.W.",OADS,/arxiv_data1/oa_pdf/f0/1d/JCB_201308173.PMC3857489.pdf
"http://dx.doi.org/10.1038/   nature0978 2 Ma, J., C. Becker, C.A.",OADS,/arxiv_data1/oa_pdf/f0/1d/JCB_201308173.PMC3857489.pdf
"http://dx.doi.org/10.1074/jbc.M112   .38281 2 Martinez, J., J. Almendinger, A. Oberst, R. Ness, C.P.",OADS,/arxiv_data1/oa_pdf/f0/1d/JCB_201308173.PMC3857489.pdf
"http://dx.doi.org/10.1146/annurev.immunol.021908.13253 7 Randow, F., and C. Münz.",OADS,/arxiv_data1/oa_pdf/f0/1d/JCB_201308173.PMC3857489.pdf
"http://dx.doi.org/   10.1038/nature0642 1 Savina, A., C. Jancic, S. Hugues, P. Guermonprez, P. Vargas, I.C.",Non-OADS,/arxiv_data1/oa_pdf/f0/1d/JCB_201308173.PMC3857489.pdf
"http://dx.doi   .org/10.1016/j.cell.2006.05.03 517 h at 100,000 g at 6°C.",OADS,/arxiv_data1/oa_pdf/f0/1d/JCB_201308173.PMC3857489.pdf
Online supplemental material is available at  http://www.jcb.org/cgi/content/full/jcb.201308173/DC1.,Non-OADS,/arxiv_data1/oa_pdf/f0/1d/JCB_201308173.PMC3857489.pdf
Additional  data are available in the JCB DataViewer at http://dx.doi.org/10.1083/ jcb.201308173.dv.,OADS,/arxiv_data1/oa_pdf/f0/1d/JCB_201308173.PMC3857489.pdf
"http://dx.doi.org/10.1007/978-1-60761-421-0_2 5 Schmid, D., M. Pypaert, and C. Münz.",Non-OADS,/arxiv_data1/oa_pdf/f0/1d/JCB_201308173.PMC3857489.pdf
"http://dx.doi   .org/10.1016/j.immuni.2006.10.01 8 Seger, R.A. 2010.",OADS,/arxiv_data1/oa_pdf/f0/1d/JCB_201308173.PMC3857489.pdf
"http://dx.doi.org/   10.1146/annurev-biochem-052709-09455 2 Zuber, C., M.J. Spiro, B. Guhl, R.G.",OADS,/arxiv_data1/oa_pdf/f0/1d/JCB_201308173.PMC3857489.pdf
http://dx.doi.org/10.1091/mbc.11.12.422 7,Non-OADS,/arxiv_data1/oa_pdf/f0/1d/JCB_201308173.PMC3857489.pdf
"5: 497-502, October 2013   http://dx.doi.org/ 10.3347/kjp.2013.51.5.497 ▣ORIGINAL ARTICLE Identification of Atg8 Isoform in Encysting Acanthamoeba Eun-Kyung Moon1, Yeonchul Hong1, Dong-Il Chung1 and Hyun-Hee Kong2,* 1Department of Parasitology, Kyungpook National University School of Medicine, Daegu 700-422, Korea;   2Department of Parasitology, Dong-A University College of Medicine, Busan 602-714, Korea Abstract:  Autophagy-related protein 8 (Atg8) is an essential component of autophagy formation and encystment of cyst- forming parasites, and some protozoa, such as, Acanthamoeba , Entamoeba , and Dictyostelium , have been reported to  possess a type of Atg8.",OADS,/arxiv_data1/oa_pdf/49/0f/kjp-51-497.PMC3857495.pdf
"*Corresponding author (hhkong@dau.ac.kr) © 2013, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/49/0f/kjp-51-497.PMC3857495.pdf
Clustal W (http://www.ch.embnet.org/sofrware/Clust - alW.html) was used to produce the alignment.,OADS,/arxiv_data1/oa_pdf/49/0f/kjp-51-497.PMC3857495.pdf
"5: 503-510, October 2013   http://dx.doi.org/ 10.3347/kjp.2013.51.5.503 ▣ORIGINAL ARTICLE A Rapid Diagnostic Test for Toxoplasmosis using  Recombinant Antigenic N-terminal Half of SAG1 Linked  with Intrinsically Unstructured Domain of GRA2 Protein Kyoung Ju Song1,†, Zhaoshou Yang1,†, Chom-Kyu Chong2, Jin-Soo Kim2, Kyung Chan Lee2, Tong-Soo Kim3   and Ho-Woo Nam1,* 1Department of Parasitology, Catholic Institute of Parasitic Disease, College of Medicine, Catholic University of Korea, Seoul 137-701, Korea; 2Asan  Biotech Institute, Asan Pharm Co Ltd, Kiheung 445-813, Korea; 3Department of Parasitology, Inha University School of Medicine,   Incheon 400-712, Korea Abstract:  Toxoplasma gondii  is an apicomplexan parasite with a broad host range of most warm-blooded mammals in - cluding humans, of which one-thirds of the human population has been infected worldwide which can cause congenital  defects, abortion, and neonatal complications.",Non-OADS,/arxiv_data1/oa_pdf/41/03/kjp-51-503.PMC3857496.pdf
"*Corresponding author (howoo@catholic.ac.kr) © 2013, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/41/03/kjp-51-503.PMC3857496.pdf
"5: 511-517, October 2013  http://dx.doi.org/ 10.3347/kjp.2013.51.5.511 ▣ORIGINAL ARTICLE Phylogenetic Analysis of Ruminant Theileria  spp.",Non-OADS,/arxiv_data1/oa_pdf/22/c6/kjp-51-511.PMC3857497.pdf
"*Corresponding authors (vectorparasit@126.com; yinhong@caas.net.cn) © 2013, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/22/c6/kjp-51-511.PMC3857497.pdf
"5: 519-524, October 2013   http://dx.doi.org/ 10.3347/kjp.2013.51.5.519 ▣ORIGINAL ARTICLE Breast-Feeding Protects Infantile Diarrhea Caused by  Intestinal Protozoan Infections Ekhlas Hamed Abdel-Hafeez1,*, Usama Salah Belal1, Manal Zaki Mohamed Abdellatif1,   Koji Naoi2 and Kazumi Norose3 1Department of Parasitology, Faculty of Medicine, Minia University, Minia, 61519, Egypt; 2Medical Corporation Kohitsujikai, Chiba, 275-0026, Japan;  3Department of Infection and Host Defense, Graduate School of Medicine, Chiba University, Chiba, 260-8670, Japan Abstract:  This study investigated the effect of breast-feeding in protection against protozoan infection in infants with per - sistent diarrhea.",Non-OADS,/arxiv_data1/oa_pdf/39/89/kjp-51-519.PMC3857498.pdf
"*Corresponding author (ekhlasha@yahoo.com) © 2013, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/39/89/kjp-51-519.PMC3857498.pdf
"5: 525-530, October 2013  http://dx.doi.org/ 10.3347/kjp.2013.51.5.525 ▣ORIGINAL ARTICLE Comparison of Functional Gene Annotation of Toxascaris  leonina  and Toxocara canis  using CLC Genomics  Workbench Ki Uk Kim1,†, Sang Kyun Park2,3,†, Shin Ae Kang2,3, Mi Kyung Park2,3, Min Kyoung Cho2, Ho-jin Jung4,   Kyung-Yun Kim4 and Hak Sun Yu2,3,*  1Department of Internal Medicine, and 2Department of Parasitology, School of Medicine, Pusan National University, Yangsan 626-870, Korea;  3Immunoregulatory Therapeutics Group in Brain Busan 21 Project, Yangsan 626-870, Korea; 4Insilicogen, Inc., Venture Valley, Suwon 441-813, Korea  Abstract:  The ascarids, Toxocara canis  and Toxascaris leonina , are probably the most common gastrointestinal helminths  encountered in dogs.",Non-OADS,/arxiv_data1/oa_pdf/a7/17/kjp-51-525.PMC3857499.pdf
"*Corresponding author (hsyu@pusan.ac.kr) © 2013, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a7/17/kjp-51-525.PMC3857499.pdf
"The ontology  covers 3 domains; cellular component (parts of a cell or its ex - tracellular environment), molecular function (elemental activ - ities of a gene product at the molecular level, such as binding  or catalysis), and biological process (operations or sets of mo - lecular events with a defined beginning and end, pertinent to  functioning of integrated living units: cells, tissues, organs, and  organisms) (http://www.geneontology.org).",OADS,/arxiv_data1/oa_pdf/a7/17/kjp-51-525.PMC3857499.pdf
"Results of GO analysis of 2 organ - isms were compared to each other, and to those of C. elegans   in AmiGO (http://amigo.geneontology.org).",OADS,/arxiv_data1/oa_pdf/a7/17/kjp-51-525.PMC3857499.pdf
"5: 531-536, October 2013   http://dx.doi.org/ 10.3347/kjp.2013.51.5.531 ▣ORIGINAL ARTICLE Tetrathyridia of Mesocestoides lineatus  in Chinese Snakes  and Their Adults Recovered from Experimental Animals Shin-Hyeong Cho1, Tong-Soo Kim2, Yoon Kong3, Byoung-Kuk Na4 and Woon-Mok Sohn4,* 1Division of Malaria and Parasitic Diseases, National Institute of Health, Centers for Disease Control and Prevention, Osong 363-951, Korea;  2Department of Parasitology and Inha Research Institute for Medical Sciences, Inha University College of Medicine, Incheon 400-712, Korea;  3Department of Molecular Parasitology, College of Medicine, Sungkyunkwan University, Suwon 440-746, Korea;   4Department of Parasitology and Institute of Health Sciences, Gyeongsang National University School of Medicine, Jinju 660-751, Korea Abstract:  Morphological characteristics of Mesocestoides lineatus  tetrathyridia collected from Chinese snakes and their  adults recovered from experimental animals were studied.",OADS,/arxiv_data1/oa_pdf/a0/1d/kjp-51-531.PMC3857500.pdf
"*Corresponding author (wmsohn@gnu.ac.kr) © 2013, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a0/1d/kjp-51-531.PMC3857500.pdf
"5: 537-544, October 2013  http://dx.doi.org/ 10.3347/kjp.2013.51.5.537 ▣ORIGINAL ARTICLE Histopathological Changes in Tissues of Bithynia  siamensis  goniomphalos  Incubated in Crude Extracts   of Camellia Seed and Mangosteen Pericarp  Ratchadawan Aukkanimart1,2, Thidarut Boonmars1,2,3,*, Somchai Pinlaor1,2, Smarn Tesana1, Surasit Aunpromma4,  Chantana Booyarat5, Pranee Sriraj1,2, Porntip Laummaunwai2 and Wiyada Punjaruk6 1Department of Parasitology, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand; 2Liver Fluke and Cholangiocarcinoma  Research Center, Khon Kaen University, Khon Kaen 40002, Thailand; 3Research and Diagnostic Center for Emerging Infectious Diseases, Khon  Kaen University, Khon Kaen 40002, Thailand; 4Faculty of Veterinary Medicine, Khon Kaen University, Khon Kaen 40002, Thailand; 5Faculty of  Pharmacology, Khon Kaen University, Khon Kaen 40002, Thailand; 6Faculty of Physiology, Khon Kaen University, Khon Kaen 40002, Thailand Abstract:  The present study was performed to observe histopathological changes in tissues of Bithynia siamensis  goni- omphalos  (Gastropoda, Bithyniidae) incubated in crude extract solutions of camellia ( Camellia oleifera ) seed and mango - steen ( Garcinia mangostana ) pericarp, and furthermore to estimate the molluscicidal effects of 2 plant substances.",Non-OADS,/arxiv_data1/oa_pdf/19/a8/kjp-51-537.PMC3857501.pdf
"*Corresponding author (bthida@kku.ac.th) © 2013, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/19/a8/kjp-51-537.PMC3857501.pdf
"5: 545-549, October 2013  http://dx.doi.org/ 10.3347/kjp.2013.51.5.545 ▣CASE REPORT An Autochthonous Case of Canine Visceral Leishmaniasis  in Korea Dong Ha Bhang1,†, Ul Soo Choi6,†, Hyun Jeong Kim5, Kyoung-Oh Cho5, Sung-Shik Shin5, Hee-Jeong Youn2,4,   Cheol-Yong Hwang1,4,* and Hwa-Young Youn1,3,4,* 1Department of Veterinary Internal Medicine, 2Veterinary Parasitology, 3BK21 Program for Veterinary Science, and 4KRF Zoonotic Disease Priority  Research Institute, College of Veterinary Medicine, Seoul National University, Seoul 151-742, Korea; 5College of Veterinary Medicine, Chonnam  National University, Gwangju 500-757, Korea; 6Department of Veterinary Clinical Pathology and Bio-Safety Research Institute, College of Veterinary  Medicine, Chonbuk National University, Jeonju 561-756, Korea Abstract:  A 12-year-old spayed female mixed-bred dog presented with nasal bleeding of 2 days duration and a skin nod - ule in the left flank.",Non-OADS,/arxiv_data1/oa_pdf/0e/1f/kjp-51-545.PMC3857502.pdf
"*Corresponding author (cyhwang@snu.ac.kr; hyyoun@snu.ac.kr) © 2013, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0e/1f/kjp-51-545.PMC3857502.pdf
"5: 551-555, October 2013  http://dx.doi.org/ 10.3347/kjp.2013.51.5.551 ▣CASE REPORT A Case of Vivax Malaria Complicated by Adult Respiratory  Distress Syndrome and Successful Management with  Extracorporeal Membrane Oxygenation Hyun-Jung Lee1, Ji-Hyeon Baek1, Myoung-Hun Chae1, Hoyeon Joo1, Jin-Soo Lee1,*, Moon-Hyun Chung1,   Yun-Kyu Park2 and Joung-Teak Kim3 1Department of Internal Medicine; 2Department of Parasitology; 3Department of Thoracic and Cardiovascular Surgery, Inha University School of  Medicine, Incheon 400-712, Korea  Abstract:  Complicated malaria is mainly caused by Plasmodium falciparum , but, increasingly, Plasmodium vivax  is also  being reported as a cause.",Non-OADS,/arxiv_data1/oa_pdf/70/31/kjp-51-551.PMC3857503.pdf
"*Corresponding author (ljinsoo@inha.ac.kr) © 2013, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/70/31/kjp-51-551.PMC3857503.pdf
"5: 557-562, October 2013  http://dx.doi.org/ 10.3347/kjp.2013.51.5.557 ▣CASE REPORT A Case of Plasmodium ovale wallikeri  Infection in a  Chinese Worker Returning from West Africa Yuchun Li, Guangze Wang, Dingwei Sun, Feng Meng, Shigan Lin, Ximin Hu * and Shanqing Wang * Parasitic Diseases Department, Hainan Provincial Center for Disease Control and Prevention, Haikou, Hainan 570203, P .",Non-OADS,/arxiv_data1/oa_pdf/b2/ee/kjp-51-557.PMC3857504.pdf
"*Corresponding authors (wangsqkevin@hotmail.com; huximin372@sohu.com) © 2013, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b2/ee/kjp-51-557.PMC3857504.pdf
The phylogeny tree was constructed using the neighbor-join - ing method in MEGA 3 (http://www.megasoftware.net).,OADS,/arxiv_data1/oa_pdf/b2/ee/kjp-51-557.PMC3857504.pdf
China Action Plan for Malaria Elimination (http://www.moh.gov.,Non-OADS,/arxiv_data1/oa_pdf/b2/ee/kjp-51-557.PMC3857504.pdf
"5: 563-567, October 2013  http://dx.doi.org/ 10.3347/kjp.2013.51.5.563 ▣CASE REPORT Molecular Diagnosis of an Ocular Toxocariasis Patient in  Vietnam Nguyen Van De1,*, Nguyen Vu Trung2, Le Van Duyet2 and Jong-Yil Chai3 1Department of Parasitology, Hanoi Medical University, Hanoi, Vietnam; 2National Hospital of Tropical Diseases, Hanoi, Vietnam;   3Department of Parasitology and Tropical Medicine, Seoul National University College of Medicine, Seoul 110-799, Korea  Abstract:  An ocular Toxocara canis  infection is reported for the first time in Vietnam.",Non-OADS,/arxiv_data1/oa_pdf/64/4b/kjp-51-563.PMC3857505.pdf
"*Corresponding author (ngvdeyhn@gmail.com) © 2013, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/64/4b/kjp-51-563.PMC3857505.pdf
JN61- 7989.1 (http://www.ncbi.nlm.nih.gov/nuccore/JN617989.1).,Non-OADS,/arxiv_data1/oa_pdf/64/4b/kjp-51-563.PMC3857505.pdf
GenBank: AB1 100  32.1  (http://www.ncbi.nlm.nih.gov/nuccore/AB1 10032.1).,OADS,/arxiv_data1/oa_pdf/64/4b/kjp-51-563.PMC3857505.pdf
Y09489.1 (http://www.ncbi.nlm.,Non-OADS,/arxiv_data1/oa_pdf/64/4b/kjp-51-563.PMC3857505.pdf
"5: 569-572, October 2013  http://dx.doi.org/ 10.3347/kjp.2013.51.5.569 ▣CASE REPORT A Case of Human Pulmonary Dirofilariasis in a 48-Year-Old  Korean Man Hyo Jae Kang1, Young Sik Park1, Chang-Hoon Lee1, Sang-Min Lee1, Jae-Joon Yim1, Chul-Gyu Yoo1,   Young Whan Kim1, Sung Koo Han1, Jong-Yil Chai2 and Jinwoo Lee1,* 1Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine and Lung Institute, Seoul National University College of  Medicine, Seoul 110-744, Korea; 2Department of Parasitology and Tropical Medicine, Seoul National University College of Medicine,   Seoul 110-799, Korea Abstract:  Dirofilariasis is a rare disease in humans.",Non-OADS,/arxiv_data1/oa_pdf/31/11/kjp-51-569.PMC3857506.pdf
"*Corresponding author (realrain7@gmail.com) © 2013, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/31/11/kjp-51-569.PMC3857506.pdf
"5: 573-577, October 2013  http://dx.doi.org/ 10.3347/kjp.2013.51.5.573 ▣BRIEF COMMUNICATION Detection of Acute Toxoplasmosis in Pigs Using Loop- Mediated Isothermal Amplification and Quantitative PCR Yanhua Wang1,*, Guangxiang Wang1, Delin Zhang2,*, Hong Yin3,* and Meng Wang1 1State Key Laboratory of Veterinary Etiological Biology, 2Key Laboratory of Veterinary Parasitology of Gansu Province, 3Key Laboratory of Veterinary  Public Health of the Ministry of Agriculture, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou 730046, China Abstract:  A loop-mediated isothermal amplification (LAMP) assay allows rapid diagnosis of Toxoplasma gondii infection.",Non-OADS,/arxiv_data1/oa_pdf/0d/04/kjp-51-573.PMC3857507.pdf
"* Corresponding authors (wangyh061001@163.com; zhangdl2005@163.com;  yinhong@caas.net.cn) © 2013, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0d/04/kjp-51-573.PMC3857507.pdf
"5: 579-581, October 2013  http://dx.doi.org/ 10.3347/kjp.2013.51.5.579 ▣BRIEF COMMUNICATION Seroprevalence of Toxoplasma gondii  Infection in Police  Dogs in Shenyang, Northeastern China Cheng-Wu Liu1,†, Na Yang2,†,*, Jian-Bin He2, Ming-Yang Mu2, Min Yang1, Ning Sun1 and Hong-Kui Li3 1Shenyang Police Dog Technical College, Shenyang, Liaoning Province 110034, China; 2College of Animal Science and Veterinary Medicine,  Shenyang Agricultural University, Shenyang, Liaoning Province 110866, China; 3Liaoning Center for Animal Disease Control and Prevention,  Shenyang, Liaoning Province 110164, China Abstract:  In recent years, worldwide surveys of Toxoplasma gondii  infection in dogs have been reported.",Non-OADS,/arxiv_data1/oa_pdf/53/19/kjp-51-579.PMC3857508.pdf
"*Corresponding author (dayangna@163.com) © 2013, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/53/19/kjp-51-579.PMC3857508.pdf
"5: 583-588, October 2013  http://dx.doi.org/ 10.3347/kjp.2013.51.5.583 ▣BRIEF COMMUNICATION Alteration of Cytokine Production during Visceral Larva  Migrans by Toxascaris leonina  in Mice Shin Ae Kang, Mi-Kyung Park, Min Kyoung Cho and Hak Sun Yu *  Department of Parasitology, School of Medicine, Pusan National University, and Immunoregulatory Therapeutics Group in Brain Busan 21 Project,  Yangsan 626-870, Korea  Abstract:  To determine alteration of immune responses during visceral larva migrans (VLM) caused by Toxascaris leonina   at several time points, we experimentally infected mice with embryonated eggs of T. leonina  and measured T-helper (Th)  cell-related serial cytokine production after infection.",Non-OADS,/arxiv_data1/oa_pdf/ad/c8/kjp-51-583.PMC3857509.pdf
"*Corresponding author (hsyu@pusan.ac.kr) © 2013, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ad/c8/kjp-51-583.PMC3857509.pdf
"5: 589-594, October 2013  http://dx.doi.org/ 10.3347/kjp.2013.51.5.589 ▣BRIEF COMMUNICATION STAT6 Expression and IL-13 Production in Association  with Goblet Cell Hyperplasia and Worm Expulsion of  Gymnophalloides seoi  from C57BL/6 Mice Jin-Joo Lee1,†, Donghee Kim2,†, Kyoung-Ho Pyo1, Min-Ki Kim1, Hyo-Jin Kim1, Jong-Yil Chai1 and Eun-Hee Shin1,3,* 1Department of Parasitology and Tropical Medicine, Seoul National University College of Medicine, and Institute of Endemic Diseases, Seoul National  University Medical Research Center, Seoul 110-799, Korea; 2Seoul National University Gang-Nam Hospital, Seoul 135-984, Korea; 3Seoul National  University Bundang Hospital, Seongnam 463-707, Korea Abstract:  In intestinal helminth infections, Th2 immune respones are generally associated with mucin secretion for worm  expulsion from the host intestine.",Non-OADS,/arxiv_data1/oa_pdf/e7/e7/kjp-51-589.PMC3857510.pdf
"© 2013, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e7/e7/kjp-51-589.PMC3857510.pdf
"5: 595-597, October 2013  http://dx.doi.org/ 10.3347/kjp.2013.51.5.595 ▣BRIEF COMMUNICATION Serological and Molecular Characteristics of the First  Korean Case of Echinococcus multilocularis Jin-Sook Jeong1, Sang-Young Han2, Young-Hoon Kim3, Yasuhito Sako4, Tetsuya Yanagida4, Akira Ito4,*   and Jong-Yil Chai5,* Departments of 1Pathology, 2Internal Medicine, 3General Surgery, Dong-A University College of Medicine, Busan 602-714, Korea; 4Department of  Parasitology, Asahikawa Medical University, Asahikawa, Hokkaido 078-8510, Japan; 5Department of Parasitology and Tropical Medicine, Seoul  National University College of Medicine, Seoul 110-799, Korea Abstract:  In December 2011, we reported an autochthonous case of Echinococcus multilocularis  infection in a 42-year- old woman in Korea.",Non-OADS,/arxiv_data1/oa_pdf/c8/ac/kjp-51-595.PMC3857511.pdf
"*Corresponding authors (cjy@snu.ac.kr; akiraito@asahikawa-med.ac.jp) © 2013, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c8/ac/kjp-51-595.PMC3857511.pdf
"5: 599-602, October 2013  http://dx.doi.org/ 10.3347/kjp.2013.51.5.599 ▣BRIEF COMMUNICATION Human Neurocysticercosis Case and an Endemic Focus  of Taenia solium  in Lao PDR  Hyeong-Kyu Jeon1, Tai-Soon Yong2, Woon-Mok Sohn3, Jong-Yil Chai4, Duk-Young Min5, Han-Jong Rim6,  Bounnaloth Insisiengmay7 and Keeseon S. Eom1,* 1Department of Parasitology and Medical Research Institute, Chungbuk National University School of Medicine, Cheongju 361-763, Korea;  2Department of Environmental Medical Biology, Yonsei University College of Medicine, Seoul 120-752, Korea; 3Department of Parasitology and  Institute of Health Sciences, Gyeongsang National University School of Medicine, Jinju 660-751, Korea; 4Department of Parasitology and Tropical  Medicine, Seoul National University College of Medicine, Seoul 110-799 Korea; 5Department of Microbiology and Immunology, Eulji University  College of Medicine, Daejeon 301-746, Korea; 6Department of Parasitology, Korea University College of Medicine, Seoul 130-705, Korea;  7Department of Preventive Medicine, Ministry of Healthcare, Lao PDR Abstract:  A male patient with neurocysticercosis was identified in Montai Village, Xay District, Oudomxay Province, Lao  PDR in February 2004.",Non-OADS,/arxiv_data1/oa_pdf/1c/d3/kjp-51-599.PMC3857512.pdf
"*Corresponding author (kseom@chungbuk.ac.kr) © 2013, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1c/d3/kjp-51-599.PMC3857512.pdf
"5: 603-606, October 2013  http://dx.doi.org/ 10.3347/kjp.2013.51.5.603 ▣BRIEF COMMUNICATION Intestinal Parasites among Wild Rodents in Northern  Gangwon-do, Korea Young-Il Lee1, Hee-Jang Pyeon1 and Min Seo2,* Departments of 1Anatomy, 2Parasitology, College of Medicine, Dankook University, Cheonan 330-714, Korea Abstract:  To determine geographical patterns of natural parasite infections among wild rodents, a total of 46 wild rodents  from 3 different localities in northern Gangwon-do (Province), Korea were examined for intestinal parasite infections.",OADS,/arxiv_data1/oa_pdf/42/70/kjp-51-603.PMC3857513.pdf
"*Corresponding author (bbbenji@naver.com) © 2013, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/42/70/kjp-51-603.PMC3857513.pdf
http://www.R-project.org .,Non-OADS,/arxiv_data1/oa_pdf/03/f3/10661_2013_Article_3372.PMC3857523.pdf
"3Seehttp://ethicsandtechnology.eu/socialresponsibility/index.php (last accessed: November 1, 2011).1516 N. Doorn, J. O. Kroesen 123",Non-OADS,/arxiv_data1/oa_pdf/0a/f8/11948_2011_Article_9335.PMC3857546.pdf
",http://www.cancer.",Non-OADS,/arxiv_data1/oa_pdf/0c/08/srep03466.PMC3857567.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3466 | DOI: 10.1038/srep03466 8",Non-OADS,/arxiv_data1/oa_pdf/0c/08/srep03466.PMC3857567.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/2f/4b/srep03465.PMC3857568.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3465 | DOI: 10.1038/srep03465 7",Non-OADS,/arxiv_data1/oa_pdf/2f/4b/srep03465.PMC3857568.pdf
Scale invariance in political science: http://www.people.fas.harvard.,Non-OADS,/arxiv_data1/oa_pdf/fc/27/srep03463.PMC3857569.pdf
"& Deckert, P. Tracing the motivations and antecedent behaviors of lone-actor terrorism: http://www.icst.psu.edu/docs/3.ExecSum/ ICST.LoneActor.ExecSumm.pdf (Date of access: 07-25-2013).",Non-OADS,/arxiv_data1/oa_pdf/fc/27/srep03463.PMC3857569.pdf
Available at http://intelreport.mandiant.com/Mandiant_APT1_Report.pdf (Date of access: 3- 19-2013).,OADS,/arxiv_data1/oa_pdf/fc/27/srep03463.PMC3857569.pdf
"The Government Office for Science, London: http://www.bis.gov.uk/foresight/our-work/projects/published-projects/computer- trading (Date of access: 07-24-2013).",Non-OADS,/arxiv_data1/oa_pdf/fc/27/srep03463.PMC3857569.pdf
wrote the paper but all authors participated in associateddiscussions.Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/fc/27/srep03463.PMC3857569.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3463 | DOI: 10.1038/srep03463 6",Non-OADS,/arxiv_data1/oa_pdf/fc/27/srep03463.PMC3857569.pdf
wrote the manuscript.Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/60/00/srep03462.PMC3857570.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3462 | DOI: 10.1038/srep03462 8",Non-OADS,/arxiv_data1/oa_pdf/60/00/srep03462.PMC3857570.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3458 | DOI: 10.1038/srep03458 11",Non-OADS,/arxiv_data1/oa_pdf/4a/e4/srep03458.PMC3857571.pdf
"CORUM complex enrichment analysis .The protein complex annotations for human dataset were downloaded from CORUM database30(http://mips.gsf.de/genre/ proj/corum/index.html), which contained manually curated and experimentally verified protein complex annotations.",OADS,/arxiv_data1/oa_pdf/39/70/srep03460.PMC3857574.pdf
Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/39/70/srep03460.PMC3857574.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3460 | DOI: 10.1038/srep03460 7",Non-OADS,/arxiv_data1/oa_pdf/39/70/srep03460.PMC3857574.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3464 | DOI: 10.1038/srep03464 6",Non-OADS,/arxiv_data1/oa_pdf/4d/a3/srep03464.PMC3857576.pdf
Published  by  Elsevier  B.V.   http://dx.doi.org/10.1016/j.ehb.2013.05.004Open access under CC BY-NC-SA license.,Non-OADS,/arxiv_data1/oa_pdf/4a/9e/main.PMC3857590.pdf
The online version of this article is published within an Open Access environment subject to the conditions of the Creative Commons Attribution-NonCommercial-ShareAlike licence <http://creativecommons.org/licenses/by-nc-sa/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/c1/34/S0950268813000770a.PMC3857592.pdf
Questionnaire The survey questionnaire was adapted from the enhanced sporadic enteric disease case questionnairethat had been previously developed and used for thesystematic follow-up of reported cases of gastrointesti- nal illness in ROW (http://www.phac-aspc.gc.ca/ c-enternet/publications-eng.php).,OADS,/arxiv_data1/oa_pdf/c1/34/S0950268813000770a.PMC3857592.pdf
Published by Elsevier Ltd. http://dx.doi.org/10.1016/j.jbtep.2013.07.011J.,Non-OADS,/arxiv_data1/oa_pdf/1f/7e/main.PMC3857594.pdf
Published by Elsevier Ltd. http://dx.doi.org/10.1016/j.beem.2013.10.003Best Practice & Research Clinical Endocrinology & Metabolism 27 (2013) 745 –762 Open access under CC BY-NC-ND license.,Non-OADS,/arxiv_data1/oa_pdf/8e/21/main.PMC3857600.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/8e/21/main.PMC3857600.pdf
"Journal of Clinical Endocrinology and Metabolism Published online before print August 12, 2013, http://dx.doi.org/10.1210/jc.2013-2215 .",Non-OADS,/arxiv_data1/oa_pdf/8e/21/main.PMC3857600.pdf
Development  contributes  to changes in  white  matter  and  gray  matter  development  and 1878-9293 © 2013 Elsevier Ltd.  http://dx.doi.org/10.1016/j.dcn.2013.09.001Open access under CC BY-NC-ND license.,Non-OADS,/arxiv_data1/oa_pdf/ed/98/main.PMC3857610.pdf
"Data  underwent  standard  preprocessing  steps including slice-timing  correction,  realignment  of  func- tional data  (mcﬂirt,  http://www.fmrib.ox.ac.uk/fsl/)  and thresholding to  exclude  non-brain  voxels  from  subse- quent analysis.",Non-OADS,/arxiv_data1/oa_pdf/ed/98/main.PMC3857610.pdf
"10  (9),  659–669, http://dx.doi.org/10.1038/nrn2667.",Non-OADS,/arxiv_data1/oa_pdf/ed/98/main.PMC3857610.pdf
"http://informahealthcare.com/dre ISSN 0963-8288 print/ISSN 1464-5165 online Disabil Rehabil, 2013; 35(25): 2123–2131 !2013 Informa UK Ltd. DOI: 10.3109/09638288.2013.771705 RESEARCH PAPER The assessment of weight status in children and young people attending a spina bifida outpatient clinic: a retrospective medical record review Amy C. McPherson1, Judy Anne Swift2, Emily Yung3, Julia Lyons4, and Paige Church4 1Bloorview Research Institute, Dalla Lana School of Public Health, Toronto, ON, Canada,2Division of Nutritional Sciences, University of Nottingham, Nottingham, UK,3Bloorview Research Institute, Toronto, ON, Canada, and4Holland Bloorview Kids Rehabilitation Hospital, Toronto, ON, Canada Abstract Purpose : Children with disabilities are two to three times more likely to become overweight or obese than typically developing children.",Non-OADS,/arxiv_data1/oa_pdf/cd/cd/DRE-35-2123.PMC3857675.pdf
Available from: http://www.spinabifidaassociation.org/site/c.liKWL7PLLrF/ b.2700287/k.C25F/Obesity.htm 2009 [last accessed 28 Jan 2011].,Non-OADS,/arxiv_data1/oa_pdf/cd/cd/DRE-35-2123.PMC3857675.pdf
"Obesity: guidance on the prevention, identification, assessment and manage-ment of overweight and obesity in adults and children; 2006.Available from: http://www.nice.org.uk/nicemedia/pdf/CG43NICEGuideline.pdf [last accessed 12 Jul 2012].",Non-OADS,/arxiv_data1/oa_pdf/cd/cd/DRE-35-2123.PMC3857675.pdf
Published by Elsevier B.V. http://dx.doi.org/10.1016/j.cognition.2013.08.008⇑Corresponding author.,Non-OADS,/arxiv_data1/oa_pdf/ec/fb/main.PMC3857687.pdf
"Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.How to cite this article: Ramos, D. et al.",Non-OADS,/arxiv_data1/oa_pdf/18/e6/srep03445.PMC3857860.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3445 | DOI: 10.1038/srep03445 7",Non-OADS,/arxiv_data1/oa_pdf/18/e6/srep03445.PMC3857860.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3435 | DOI: 10.1038/srep03435 8",Non-OADS,/arxiv_data1/oa_pdf/e1/52/srep03435.PMC3857861.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2013  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseSeptember 2013 |  79  | e50757 | Page 1 of 8Video Article Profiling the Triacylglyceride Contents in Bat Integumentary Lipids by Preparative Thin Layer Chromatography and MALDI-TOF Mass Spectrometry Evan L. Pannkuk1, Thomas S. Risch2, Brett J. Savary3 1Graduate Program of Environmental Science, Arkansas State University 2Department of Biological Sciences, Arkansas State University 3Arkansas Biosciences Institute and College of Agriculture and Technology, Arkansas State University Correspondence to: Brett J. Savary at bsavary@astate.edu URL: http://www.jove.com/video/50757 DOI: doi:10.3791/50757 Keywords: Chemistry, Issue 79, Molecular Biology, Biochemistry, Genetics, Anatomy, Physiology, Eukaryota, Bacterial Infections and Mycoses, Pathological Conditions, Signs and Symptoms, Diagnosis, Life Sciences (General), Triacylglyceride, Plagiopatagium, Integument, Sebaceous gland, White-Nose Syndrome, Matrix-Assisted Laser-desorption/Ionization Time-of-Flight Mass Spectrometry, Thin-Layer Chromatography, animal model Date Published: 9/5/2013 Citation: Pannkuk, E.L., Risch, T.S., Savary, B.J.",Non-OADS,/arxiv_data1/oa_pdf/a9/e5/jove-79-50757.PMC3857882.pdf
"Video Link The video component of this article can be found at http://www.jove.com/video/50757/ Introduction Mammalian integumentary tissues include the epidermis, keratinous structures ( e.g.",Non-OADS,/arxiv_data1/oa_pdf/a9/e5/jove-79-50757.PMC3857882.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2013  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseSeptember 2013 |  79  | e50579 | Page 1 of 17Video Article Test Samples for Optimizing STORM Super-Resolution Microscopy Daniel J. Metcalf1, Rebecca Edwards1, Neelam Kumarswami1, Alex E. Knight1 1Analytical Science Division, National Physical Laboratory Correspondence to: Daniel J. Metcalf at daniel.metcalf@nikon.co.uk URL: http://www.jove.com/video/50579 DOI: doi:10.3791/50579 Keywords: Molecular Biology, Issue 79, Genetics, Bioengineering, Biomedical Engineering, Biophysics, Basic Protocols, HeLa Cells, Actin Cytoskeleton, Coated Vesicles, Receptor, Epidermal Growth Factor, Actins, Fluorescence, Endocytosis, Microscopy, STORM, super-resolution microscopy, nanoscopy, cell biology, fluorescence microscopy, test samples, resolution, actin filaments, fiducial markers, epidermal growth factor, cell, imaging Date Published: 9/6/2013 Citation: Metcalf, D.J., Edwards, R., Kumarswami, N., Knight, A.E.",Non-OADS,/arxiv_data1/oa_pdf/97/91/jove-79-50579.PMC3857894.pdf
"Video Link The video component of this article can be found at http://www.jove.com/video/50579/ Introduction Recently a range of optical microscopy techniques have been developed, typically referred to as super-resolution microscopy or nanoscopy, which can bypass the diffraction limit and generate images with resolutions of 100 nm or better 1,2 .",Non-OADS,/arxiv_data1/oa_pdf/97/91/jove-79-50579.PMC3857894.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/53/66/ddt404.PMC3857948.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2013  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseSeptember 2013 |  79  | e50635 | Page 1 of 7Video Article Matrix-assisted Laser Desorption/Ionization Time of Flight (MALDI-TOF) Mass Spectrometric Analysis of Intact Proteins Larger than 100 kDa Luca Signor1, Elisabetta Boeri Erba1 1Institute of Structural Biology ""J.P. Ebel"", UMR5075, Commissariat à L'Energie Atomique et aux Energies Alternatives (CEA), Centre National de la Recherche Scientifique (CNRS), Université J. Fourier Correspondence to: Elisabetta Boeri Erba at eboerierba@googlemail.com URL: http://www.jove.com/video/50635 DOI: doi:10.3791/50635 Keywords: Chemistry, Issue 79, Chemistry Techniques, Analytical, Mass Spectrometry, Analytic Sample Preparation Methods, biochemistry, Analysis of intact proteins, mass spectrometry, matrix-assisted laser desorption ionization, time of flight, sample preparation Date Published: 9/9/2013 Citation: Signor, L., Boeri Erba, E. Matrix-assisted Laser Desorption/Ionization Time of Flight (MALDI-TOF) Mass Spectrometric Analysis of Intact Proteins Larger than 100 kDa.",Non-OADS,/arxiv_data1/oa_pdf/cb/d8/jove-79-50635.PMC3857990.pdf
"Overall, we provide information necessary to a novice for analysing intact proteins larger than 100 kDa by MALDI-MS. Video Link The video component of this article can be found at http://www.jove.com/video/50635/ Introduction Structural biology relies on the production of high quality proteins 1 and therefore needs to be coupled with efficient and reliable techniques for protein analysis 2,3.",Non-OADS,/arxiv_data1/oa_pdf/cb/d8/jove-79-50635.PMC3857990.pdf
To viewplease visit the journal online (http://dx.doi.org/10.1136/ archdischild-2012-302778).,Non-OADS,/arxiv_data1/oa_pdf/9c/48/archdischild-2012-302778.PMC3858016.pdf
Table 1 Characteristics of study participants All (N=1434) White British boys (N=314) Pakistani boys (N=383) White British girls (N=328) Pakistani girls (N=409) Birth weight (kg) Mean (SD) 3.22 (0.55) 3.38 (0.59) 3.19 (0.52) 3.26 (0.57) 3.08 (0.51)z Score (SD)* −0.22 (1.21) 0.00 (1.26) −0.38 (1.12) −0.00 (1.28) −0.40 (1.16) Weight at 2 years (kg) † Mean (SD) 12.45 (1.54) 12.75 (1.50) 12.81 (1.45) 12.16 (1.41) 12.16 (1.66)z Score (SD)* 0.32 (1.01) 0.29 (1.01) 0.33 (1.02) 0.34 (0.98) 0.32 (1.04) Length at 2 years (cm) † Mean (SD) 86.6 (3.4) 87.3 (3.6) 87.3 (3.1) 85.4 (3.4) 86.4 (3.2)z Score (SD)* −0.04 (1.04) −0.06 (1.14) −0.07 (1.00) −0.20 (1.04) 0.11 (1.00) % Smoked during pregnancy 18.1 37.3 3.9 33.8 3.9% Preterm birth 5.4 7.0 4.4 5.5 4.9Mean maternal height cm (SD) 161.4 (6.4) 164.1 (6.1) 159.7 (5.7) 163.9 (6.2) 159.0 (5.9) *z Score calculated using the WHO growth standards (http://www.who.int/childgrowth/en/).,Non-OADS,/arxiv_data1/oa_pdf/9c/48/archdischild-2012-302778.PMC3858016.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Cameron N, Demerath E. Critical periods in human growth: relationships to chronic disease.",Non-OADS,/arxiv_data1/oa_pdf/9c/48/archdischild-2012-302778.PMC3858016.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b0/1f/copd-8-621.PMC3858025.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2013:8 621–629International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  621OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S5285 4standardized evaluation of lung congestion   during COPD exacerbation better identifies  patients at risk of dying arne Didrik høiseth1 T orbjørn Omland1 Bo Daniel Karlsson2 Pål h Brekke1 Vidar søyseth1 1Cardiothoracic research group,   Division of Medicine, akershus  University hospital and Institute  of Clinical Medicine, University of  Oslo, Oslo, norway; 2Department  of radiology, akershus University  hospital, lørenskog, norway Correspondence: arne Didrik høiseth   akershus University hospital and  Institute of Clinical Medicine, University  of Oslo, 1478 lørenskog, Oslo, norway   Tel +47 679 68800   email a.d.hoiseth@medisin.uio.n oBackground:  Congestive heart failure is underdiagnosed in patients with chronic obstructive  pulmonary disease (COPD).",Non-OADS,/arxiv_data1/oa_pdf/b0/1f/copd-8-621.PMC3858025.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-copd-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/b0/1f/copd-8-621.PMC3858025.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/b0/1f/copd-8-621.PMC3858025.pdf
Available from: http://www.who.int/classifications/icd/en/.,OADS,/arxiv_data1/oa_pdf/b0/1f/copd-8-621.PMC3858025.pdf
Available from:  http://www.goldcopd ..org/.,Non-OADS,/arxiv_data1/oa_pdf/b0/1f/copd-8-621.PMC3858025.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/2c/29/copd-8-631.PMC3858026.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2013:8 631–639International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  631OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S5255 7hospital readmissions following initiation   of nebulized arformoterol tartrate or nebulized  short-acting beta-agonists among inpatients  treated for COPD Vamsi Bollu1 Frank r ernst2 John Karafilidis1 Krithika rajagopalan1 scott B robinson2 sidney s Braman3 1sunovion Pharmaceuticals, Inc.,   Marlborough, M a, 2Premier healthcare  alliance, Charlotte, nC, 3The Icahn  school of Medicine at Mount sinai,   new Y ork, nY, Usa Correspondence: Vamsi Bollu   sunovion Pharmaceuticals, Inc.,  84 Waterford Drive, Marlborough,   Ma 01752, Usa   Tel +1 508 357 7704   Fax +1 508 357 7662   email v amsi.bollu@sunovion.co mBackground:  Inpatient admissions for chronic obstructive pulmonary disease (COPD) represent  a significant economic burden, accounting for over half of direct medical costs.",Non-OADS,/arxiv_data1/oa_pdf/2c/29/copd-8-631.PMC3858026.pdf
"Available from: http://www.nhlbi.nih.gov/resources/docs/cht-book.ht m.  Accessed August 1, 2013.",Non-OADS,/arxiv_data1/oa_pdf/2c/29/copd-8-631.PMC3858026.pdf
"Available from:  http://www.medpac.gov/documents/jun07_entirereport.pd f. Accessed   August 1, 2013.",OADS,/arxiv_data1/oa_pdf/2c/29/copd-8-631.PMC3858026.pdf
"Available from: http://www.gpo.gov/fdsys/pkg/PLAW-  111publ148/pdf/PLAW-111publ148.pd f. Accessed August 1, 2013.",Non-OADS,/arxiv_data1/oa_pdf/2c/29/copd-8-631.PMC3858026.pdf
"Available from: http://www.goldcopd.org/guidelines- global-strategy-for-diagnosis-management.htm l. Accessed August 1,  2013.",Non-OADS,/arxiv_data1/oa_pdf/2c/29/copd-8-631.PMC3858026.pdf
"Available from: http://www.gpo.gov/fdsys/ pkg/PLAW-104publ191/html/PLAW-104publ191.ht m. Accessed   September 19, 2012.",Non-OADS,/arxiv_data1/oa_pdf/2c/29/copd-8-631.PMC3858026.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-copd-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/2c/29/copd-8-631.PMC3858026.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/2c/29/copd-8-631.PMC3858026.pdf
"Treatment Outcomes of Advanced Stage  Malignant Melanoma in Hand and Foot after  Amputation in Korean Patients Kyujin Cho, MD, Sung Taek Jung, MD Department of Orthopaedics, Chonnam National University Hospital, Gwangju, KoreaOriginal Article    Clinics in Orthopedic Surgery 2013;5:314-320   •  http://dx.doi.org/10.4055/cios.2013.5.4.314 Received May 9, 2012; Accepted January 14, 2013 Correspondence to: Sung Taek Jung, MD Department of Orthopaedics, Chonnam National University Hospital, 42  Jebong-ro, Dong-gu, Gwangju 501-757, Korea Tel: +82-62-220-6336, Fax: +82-62-220-7681 E-mail: stjung@jnu.ac.krMalignant melanoma is a class of malignant tumors de - rived from neural crest cells.",Non-OADS,/arxiv_data1/oa_pdf/03/19/cios-5-314.PMC3858086.pdf
"It is  generally believed that melanomas arising in acral loca - tions are initially diagnosed at a more advanced stage and  that this may account for its grave prognosis.9) To confirm  this, we reviewed our experience in the management of  Copyright © 2013 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/03/19/cios-5-314.PMC3858086.pdf
"Biologic Fixation through Bridge Plating for  Comminuted Shaft Fracture of the Clavicle:  Technical Aspects and Prospective Clinical  Experience with a Minimum   of 12-Month Follow-up Gu Hee Jung, MD, Chang-Min Park, MD *, Jae-Do Kim, MD Departments of Orthopaedic Surgery and *Trauma Surgery, Kosin University Gospel Hospital, Busan, KoreaTechnical Note    Clinics in Orthopedic Surgery 2013;5:327-333   •  http://dx.doi.org/10.4055/cios.2013.5.4.327 Received July 7, 2012; Accepted June 10, 2013 Correspondence to: Gu Hee Jung, MD Department of Orthopaedic Surgery, Kosin University Gospel Hospital,  262 Gamcheon-ro, Seo-gu, Busan 602-702, Korea Tel: +82-51-990-6229, Fax: +82-51-243-0181 E-mail: jyujin2001@kosin.ac.krTraditionally, midshaft clavicle fractures have been con - sidered to be injuries that rarely require open reduction.",Non-OADS,/arxiv_data1/oa_pdf/38/a8/cios-5-327.PMC3858087.pdf
"In addition, the  operative intervention has gradually increased due to an  increased incidence of complex fracture patterns following  Copyright © 2013 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/38/a8/cios-5-327.PMC3858087.pdf
"The Effect of Zoledronic Acid on the Volume of  the Fusion-Mass in Lumbar Spinal Fusion Y e-Soo Park, MD, Hong-Sik Kim, MD, Seung-Wook Baek, MD, Dong-Yi Kong, MD, Jeong-Ah Ryu, MD * Departments of Orthopaedic Surgery and *Radiology, Guri Hospital, Hanyang University College of Medicine, Guri, KoreaOriginal Article    Clinics in Orthopedic Surgery 2013;5:292-297   •  http://dx.doi.org/10.4055/cios.2013.5.4.292 Received January 21, 2013; Accepted April 9, 2013 Correspondence to: Ye-Soo Park, MD Department of Orthopaedic Surgery, Guri Hospital, Hanyang University  College of Medicine, 153 Gyungchoon-ro, Guri 471-701, Korea Tel: +82-31-560-2316, Fax: +82-31-557-8781 E-mail: hyparkys@hanyang.ac.krSpinal lumbar fusion surgery, a relatively common surgi - cal procedure, frequently utilizes bone grafts.",Non-OADS,/arxiv_data1/oa_pdf/e1/00/cios-5-292.PMC3858088.pdf
"Most previous studies used animal models  and found that bisphosphonate shows negative effects on  spinal fusion consolidation, with dose-dependent effects  on fusion rates and graft incorporation,7-10) However, stud - ies of distraction osteogenesis, which uses bolus dosing  of nitrogen-containing bisphosphonates, have shown sig - nificant increases in callus volume, mineral content, and  strength in treated animals, even in the presence of stress  Copyright © 2013 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e1/00/cios-5-292.PMC3858088.pdf
"Sexual Activity after Total Hip Replacement in  Korean Patients: How They Do, What They Want,  and How to Improve Byung-Ho Y oon, MD, Kyung-Hag Lee, MD, Serae Noh, RN,   Y ong-Chan Ha, MD *, Y oung-Kyun Lee, MD, Kyung-Hoi Koo, MD Department of Orthopedic Surgery, Seoul National University Bundang Hospital, Seongnam,   *Department of Orthopaedic Surgery, Chung-Ang University College of Medicine, Seoul, KoreaOriginal Article    Clinics in Orthopedic Surgery 2013;5:269-277   •  http://dx.doi.org/10.4055/cios.2013.5.4.269 Received February 2, 2013; Accepted April 29, 2013 Correspondence to: Yong-Chan Ha, MD  Department of Orthopaedic Surgery, Chung-Ang University College of  Medicine, 102 Heukseok-ro, Dongjak-gu, Seoul 156-755, Korea Tel: +82-2-6299-1577, Fax: +82-2-822-1710 E-mail: hayongch@naver.comSexual activity is an integral part of the quality of life and  affects it.1,2) A dysfunction in sexual activity is known to be  strongly associated with physical and emotional dissatis - faction and depression.3) Studies on sexual activity after total hip replacement  have reported that the adverse effects of arthritis of the hip Background: Concerns of patients on sexual activity after total hip arthroplasty have not been well studied in Asian patients.",Non-OADS,/arxiv_data1/oa_pdf/3c/54/cios-5-269.PMC3858089.pdf
"(2) What are the changes in sexual activity after THR in  Copyright © 2013 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3c/54/cios-5-269.PMC3858089.pdf
"Glomus Tumor of Hoffa’s Fat Pad and Its  Management by Arthroscopic Excision Sharad Prabhakar, MS *, Mandeep Singh Dhillon, MS *, Rakesh Kumar Vasishtha, MD†, Kamal Bali, MS *,‡ Departments of *Orthopaedics and †Histopathology, Postgraduate Institute of Medical Education and Research, Chandigarh, India,  ‡Department of Orthopaedics, London Health Sciences Center, London, ON, CanadaCase Report    Clinics in Orthopedic Surgery 2013;5:334-337   •  http://dx.doi.org/10.4055/cios.2013.5.4.334 Received January 20, 2011; Accepted April 11, 2011 Correspondence to: Kamal Bali, MS Department of Orthopaedics, London Health Sciences Center, University  Hospital London, 339 Windermere Rd London, ON N6G 2V4, Canada Tel: +1-2263767242, Fax: +91-172-2744401 E-mail: kamalpgi@gmail.com A glomus tumor is a rare benign hamartoma arising from  a neuromyoarterial glomus body.1) Glomus tumors ac - count for only 1.6% of soft tissue tumors occurring in the  extremities.2) These tumors are typically found in the sub - ungual region, but several case reports of glomus tumors  around the knee have been published.3) These tumors  have been reported in subcutaneous tissue,4) the patellar  ligament5) and beneath the plica synovialis in the knee.3)  There is only one previous case report describing a glomus  tumor in Hoffa’s fat pad,6) which was managed by open  excision.",Non-OADS,/arxiv_data1/oa_pdf/78/8d/cios-5-334.PMC3858090.pdf
"Copyright © 2013 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/78/8d/cios-5-334.PMC3858090.pdf
"Comparison of Complete Distal Release of  the Medial Collateral Ligament and Medial  Epicondylar Osteotomy during Ligament  Balancing in Varus Knee Total Knee Arthroplasty Jae Ang Sim, MD, Y ong Seuk Lee, MD, Ji Hoon Kwak, MD,   Sang Hoon Y ang, MD, Kwang Hui Kim, MD, Beom Koo Lee, MD  Department of Orthopedic Surgery, Gil Medical Center, Gachon University, Incheon, Korea Original Article    Clinics in Orthopedic Surgery 2013;5:287-291   •  http://dx.doi.org/10.4055/cios.2013.5.4.287 Received March 19, 2012; Accepted March 15, 2013 Correspondence to: Beom Koo Lee, MD  Department of Orthopedic Surgery, Gachon University Gil Hospital, 1198  Kuwol-dong, Namdong-gu, Incheon 405-760, Korea Tel: +82-32-460-3384, Fax: +82-32-468-5437 E-mail: bklee@gilhospital.comThe acquisition of proper soft tissue balance is one of the  crucial factors for preventing long-term failure and obtain - ing successful treatment outcomes of total knee arthro - plasty (TKA).1) The soft tissue is composed of not only a  pathological contracture of the medial soft tissue but also  the attenuation or laxity of the lateral soft tissue in a varus  knee due to degenerative arthritis.",Non-OADS,/arxiv_data1/oa_pdf/d5/f6/cios-5-287.PMC3858091.pdf
"Copyright © 2013 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d5/f6/cios-5-287.PMC3858091.pdf
"Clinical and Radiological Evaluation after  Arthroscopic Rotator Cuff Repair Using Suture  Bridge Technique Kwang Won Lee, MD, Dong Wook Seo, MD *, Kyoung Wan Bae, MD, Won Sik Choy, MD  Department of Orthopedic Surgery, Eulji University College of Medicine, Daejeon,   *Department of Orthopedic Surgery, Gongju Medical Center, Gongju, KoreaOriginal Article    Clinics in Orthopedic Surgery 2013;5:306-313   •  http://dx.doi.org/10.4055/cios.2013.5.4.306 Received May 29, 2012; Accepted February 27, 2013 Correspondence to: Dong Wook Seo, MD Department of Orthopedic Surgery, Gongju Medical Center, 130 Ungjin-ro,  Gongju 314-050, Korea Tel: +82-41-850-5245, Fax: +82-41-850-5275 E-mail: Seodongwook@doctor.korea.comArthroscopic rotator cuff repair is a currently popular  treatment.",Non-OADS,/arxiv_data1/oa_pdf/b4/42/cios-5-306.PMC3858092.pdf
"Double-row technique has a higher  load to failure and a lower frequency of gap formation  Copyright © 2013 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b4/42/cios-5-306.PMC3858092.pdf
"Uncommon Indications for Reverse   Total Shoulder Arthroplasty Y oon Suk Hyun, MD, Gazi Huri, MD, Nickolas G. Garbis, MD, Edward G. McFarland, MD Division of Shoulder Surgery, Department of Orthopaedic Surgery, The Johns Hopkins University, Baltimore, MD, USAReview Article    Clinics in Orthopedic Surgery 2013;5:243-255   •  http://dx.doi.org/10.4055/cios.2013.5.4.243 Received February 2, 2013; Accepted February 19, 2013 Correspondence to: Edward G. McFarland, MD Department of Orthopaedic Surgery, The Johns Hopkins University/ Johns Hopkins Bayview Medical Center, 4940 Eastern Avenue, #A665,  Baltimore, MD 21224-2780, USA Tel: +1-4105505440, Fax: +1-4105502899 E-mail: ehenze1@jhmi.eduReverse total shoulder arthroplasty (rTSA) was originally  created to address the complex problem of rotator cuff  arthropathy.",Non-OADS,/arxiv_data1/oa_pdf/c9/1a/cios-5-243.PMC3858093.pdf
"Copyright © 2013 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c9/1a/cios-5-243.PMC3858093.pdf
"Posterior Cruciate Ligament:   Focus on Conflicting Issues Y ong Seuk Lee, MD, Y oung Bok Jung, MD * Department of Orthopaedic Surgery, Gachon University School of Medicine, Gil Hospital, Incheon,   *Department of Orthopaedic Surgery, Hyundae General Hospital, Namyangju, KoreaReview Article    Clinics in Orthopedic Surgery 2013;5:256-262   •  http://dx.doi.org/10.4055/cios.2013.5.4.256 Received September 13, 2012; Accepted October 29, 2012 Correspondence to: Young Bok Jung, MD Department of Orthopaedic Surgery, Hyundae General Hospital, Janghyeon- ri, Jinjeop-eup, Namyangju 472-865, Korea Tel: +82-70-4135-1949, Fax: +82-31-572-1462 E-mail: jungyb2000@paran.comDespite advances in knowledge of the basic science of the  posterior cruciate ligament (PCL), there are still some  controversies and challenging areas in orthopedic practice.",Non-OADS,/arxiv_data1/oa_pdf/69/38/cios-5-256.PMC3858094.pdf
"Race and Amis22) conducted the first  biomechanical comparison between isometric single and  double bundle reconstruction; their results showed over - Copyright © 2013 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/69/38/cios-5-256.PMC3858094.pdf
"Biomechanical Comparison of an Intramedullary  and Extramedullary Free-Tissue   Graft Reconstruction of the Acromioclavicular  Joint Complex Rishi Garg, MD *,†, Gregory J. Adamson, MD *,†, Pooya Javidan, MD *, Thay Q. Lee, PhD * *Orthopaedic Biomechanics Laboratory, Long Beach VA Healthcare System and University of California, Irvine, CA,  †Congress Medical Associates, Pasadena, CA, USAOriginal Article    Clinics in Orthopedic Surgery 2013;5:298-305   •  http://dx.doi.org/10.4055/cios.2013.5.4.298 Received October 15, 2012; Accepted February 27, 2013 Correspondence to: Gregory J. Adamson, MD Congress Medical Associates, 800 S Raymond Ave, Pasadena, CA 91105,  USA Tel: +1-626-396-1206, Fax: +1-626-95-5715 E-mail: rishigargmd@gmail.comBackground: Several different surgical techniques have been described to address the coracoclavicular (CC) ligaments in acro - mioclavicular (AC) joint injuries.",Non-OADS,/arxiv_data1/oa_pdf/26/7c/cios-5-298.PMC3858095.pdf
"Copyright © 2013 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/26/7c/cios-5-298.PMC3858095.pdf
"Treatment Outcomes of Open Pelvic Fractures  Associated with Extensive Perineal Injuries Ebrahim Ghayem Hasankhani, MD, Farzad Omidi-Kashani, MD Orthopedic Department, Orthopedic Research Center, Imam Reza Hospital, Mashhad University of Medical Sciences, Mashhad, Iran Original Article    Clinics in Orthopedic Surgery 2013;5:263-268   •  http://dx.doi.org/10.4055/cios.2013.5.4.263 Received March 17, 2013; Accepted May 10, 2013 Correspondence to: Farzad Omidi-Kashani, MD Orthopedic Department, Orthopedic Research Center, Imam Reza Hospital,  Imam Reza Square, Mashhad University of Medical Sciences, Mashhad  9197918868, Iran Tel: +98-511-7646500, Fax: +98-511-8417453 E-mail: omidif@mums.ac.irPelvic fractures due to high-energy trauma are associated  with life threatening injuries and high rates of mortality.1)  Numerous studies have demonstrated that extensive blood  loss is the main cause of death in patients with pelvic frac - tures.2-4) Type of the fracture according to Y oung-Burgess  classification5) and presence of associated devastating soft  tissue injuries affect transfusion requirement and mortal - ity rate.3)Background: The main causes of death in patients with open pelviperineal injuries are uncontrollable bleeding and pelvic sepsis.",Non-OADS,/arxiv_data1/oa_pdf/70/53/cios-5-263.PMC3858096.pdf
"Keywords:  Open fracture, Perineal injury, Pelvic fracture  Despite advances taken to prevent accidents, initial  resuscitation, intensive care management, and modern  fracture stabilization techniques, the mortality rate of pel - vic fractures is still high.6) Open fractures compared with  closed fractures are associated with higher rates of mor - bidity and mortality and the latter approaches to 50% due  to the additional risk of hemorrhage and multiple system  organ failure.4,7) Risk factors that are commonly cited for  mortality in peculiar fractures include an Injury Severity  Score (ISS)8) of > 25, a triage-revised trauma score of < 8,  > 65 years of age, < 100 mmHg initial systolic blood pres - sure, < 8 Glasgow Coma Scale (GCS), blood transfusion  of > 10 units in the first 24 hours, and colloid infusion of  > 6 L in the first 24 hours.9) These fractures are more likely to need blood trans - fusion and be unstable vertically or rotationally.10) The  Copyright © 2013 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/70/53/cios-5-263.PMC3858096.pdf
"Locking Compression Plate in Musculoskeletal  Oncology ‘a Friend in Need’ Masood Umer, MBBS, Kashif Abbas, MBBS *, Shahid Khan, MBBS, Haroon ur Rashid, MBBS Section of Orthopaedic Surgery, Department of Orthopaedic Surgery, The Aga Khan University Hospital, Karachi,   *Department of Orthopaedic Surgery, Islam Medical and Dental College, Siakot, PakistanOriginal Article    Clinics in Orthopedic Surgery 2013;5:321-326   •  http://dx.doi.org/10.4055/cios.2013.5.4.321 Received September 3, 2012; Accepted April 1, 2013 Correspondence to: Kashif Abbas, MBBS Department of Orthopaedic Surgery, Islam Medical and Dental College,  Pasrur Road, Sialkot, Pakistan Tel: +92-42-58969092, Fax: +92-42-35774391 E-mail: kashah_pk@yahoo.comIn Pakistan, musculoskeletal oncology is yet to develop as  an individual orthopedic subspeciality.",Non-OADS,/arxiv_data1/oa_pdf/b7/69/cios-5-321.PMC3858097.pdf
"Its ability to offer a fixed angle construct in the  locking-hole reduces the toggle between the plate and  Copyright © 2013 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b7/69/cios-5-321.PMC3858097.pdf
"Copyright © 2013 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a1/b6/cios-5-338.PMC3858098.pdf
"2006;14(3):253-8. http://dx.doi.org/10.4055/cios.2013.5.4.338Received February 15, 2013; Accepted April 29, 2013 Correspondence to: Paritosh Gogna, MS Department of Orthopaedics Paraplegia and Rehabilitation, Pandit  Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences,  2/11-J UH Medical Enclave, Rohtak, Haryana 124001, India Tel: +91-8607773555 E-mail: paritosh.gogna@gmail.com Jihyeung Kim, Kyungpyo Nam, Seung Hwan Rhee, Jong  Won Won, Hyuk-Soo Han, Seung-Baik Kang, Reply: First, we are very grateful for your interest in our study  and valuable comments.",Non-OADS,/arxiv_data1/oa_pdf/a1/b6/cios-5-338.PMC3858098.pdf
"2006;14(3):253-8. http://dx.doi.org/10.4055/cios.2013.5.4.339Correspondence to: Seung-Baik Kang, MD Department of Orthopedic Surgery, Seoul Metropolitan Government  Seoul National University Boramae Medical Center, 20 Boramae-ro 5-gil,  Dongjak-gu, Seoul 156-707, Korea Tel: +82-2-870-2313, Fax: +82-2-870-3866, E-mail: ossbkang@snu.ac.kr",Non-OADS,/arxiv_data1/oa_pdf/a1/b6/cios-5-338.PMC3858098.pdf
"Remnant Preservation is Helpful to Obtain Good  Clinical Results in Posterior Cruciate Ligament  Reconstruction: Comparison of Clinical Results   of Three Techniques Sang Hak Lee, MD, Y oung Bok Jung, MD *, Han-Jun Lee, MD†,  Ho Joong Jung, MD†, Seong Hwan Kim, MD† Center for Joint Diseases and Rheumatism, Kyung Hee University Hospital at Gangdong, Seoul,  *Department of Orthopaedic Surgery, Joint Center, Hyundae General Hospital, Namyangju,  †Department of Orthopaedic Surgery, Chung-Ang University School of Medicine, Seoul, Korea Original Article    Clinics in Orthopedic Surgery 2013;5:278-286   •  http://dx.doi.org/10.4055/cios.2013.5.4.278 Received January 16, 2012; Accepted February 6, 2013 Correspondence to: Young Bok Jung, MD Department of Orthopaedic Surgery, Joint Center, Hyundae General  Hospital, 21 Bonghyeon-ro, Jinjeop-eup, Namyangju 472-865, Korea  Tel: +82-31-574-9119, Fax: +82-2-822-1710, E-mail: jungyb2000@paran.",Non-OADS,/arxiv_data1/oa_pdf/71/ca/cios-5-278.PMC3858099.pdf
"Consequently, arthroscopic PCL reconstructions  have increased, which has been facilitated by the aware - ness of the pathogenesis, clinical diagnostic skills, and  development of arthroscopic instruments and surgical  Copyright © 2013 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/71/ca/cios-5-278.PMC3858099.pdf
"Consisting  of polymethyl methacrylate microspheres of 30-40 µm with CASE REPORThttp://dx.doi.org/10.5125/jkaoms.2013.39.4.193 pISSN 2234-7550 ·eISSN 2234-5930 Tae-Geon Kwon Department of Oral and Maxillofacial Surgery, School of Dentistry, Kyungpook  National University, 680 Gukchaebosang-ro, Jung-gu, Daegu 700-842, Korea TEL: +82-53-600-7551   FAX: +82-53-426-5365 E-mail: kwondk@knu.ac.kr     This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CC Copyright ⃆ 2013 The Korean Association of Oral and Maxillofacial Surgeons.",Non-OADS,/arxiv_data1/oa_pdf/ac/2b/jkaoms-39-193.PMC3858123.pdf
"On the contrary, the mandibular  anterior fragment is depressed by muscles such as digastric,  geniohyoid, and mylohyoid1.CASE REPORThttp://dx.doi.org/10.5125/jkaoms.2013.39.4.188 pISSN 2234-7550 ·eISSN 2234-5930 Hyun Seok Department of Oral and Maxillofacial Surgery, College of Dentistry, Gang- neung-Wonju National University, 7 Jukheon-gil, Gangneung 210-702, Korea TEL: +82-33-640-3139   FAX: +82-33-640-3113 E-mail: sok8585@hanmail.net    This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CC Copyright ⃆ 2013 The Korean Association of Oral and Maxillofacial Surgeons.",Non-OADS,/arxiv_data1/oa_pdf/b2/da/jkaoms-39-188.PMC3858124.pdf
"In particular,  the maxillary anterior is very important aesthetically, and CLINICAL ANALYSIShttp://dx.doi.org/10.5125/jkaoms.2013.39.4.156 pISSN 2234-7550 ·eISSN 2234-5930    This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CC Copyright ⃆ 2013 The Korean Association of Oral and Maxillofacial Surgeons.",Non-OADS,/arxiv_data1/oa_pdf/db/fe/jkaoms-39-156.PMC3858125.pdf
"According to Delamaire et al.4, diabetic patients were more CLINICAL ANALYSIShttp://dx.doi.org/10.5125/jkaoms.2013.39.4.175 pISSN 2234-7550 ·eISSN 2234-5930 Hee-Kyun Oh Department of Oral and Maxillofacial Surgery, Dental Science Research  Institute, School of Dentistry, Chonnam National University, 33 Yongbong-ro,  Buk-gu, Gwangju 500-757, Korea TEL: +82-62-220-5436   FAX: +82-62-220-5437 E-mail: cnuh.oms@gmail.com    This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CC Copyright ⃆ 2013 The Korean Association of Oral and Maxillofacial Surgeons.",Non-OADS,/arxiv_data1/oa_pdf/d9/3d/jkaoms-39-175.PMC3858126.pdf
"Before correction Jung-Tae Lee1*, Jae-Whan Jung2*, Jae-Yong Choi2, Tae-Geon Kwon1     1Department of Oral and Maxillofacial Surgery, School of Dentistry, Kyungpook National University,  2Department of Biochemistry, Kyungpook National University School of Medicine , Daegu, Korea  After correction Jung-Tae Lee1*, Jae-Hwan Jeong2*, Je-Yong Choi2, Tae-Geon Kwon1     1Department of Oral and Maxillofacial Surgery, School of Dentistry, Kyungpook National University,  2Department of Biochemistry & Cell Biology, School of Medicine, Kyungpook National University , Daegu, Korea    This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which  permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.CCCORRECTIONhttp://dx.doi.org/10.5125/jkaoms.2013.39.4.200 pISSN 2234-7550 ·eISSN 2234-5930 Copyright ⃆ 2013 The Korean Association of Oral and Maxillofacial Surgeons.",Non-OADS,/arxiv_data1/oa_pdf/9f/f2/jkaoms-39-200.PMC3858127.pdf
"Hematopoietic  stem cells (HSCs) have been reported to be able to make  skeletal muscle1,2, cardiac muscle3,4, and liver5 because  they can differentiate into adipocytes1, condrocytes6,7, ORIGINAL ARTICLEhttp://dx.doi.org/10.5125/jkaoms.2013.39.4.150 pISSN 2234-7550 ·eISSN 2234-5930 Je-Uk Park  Department of Oral and Maxillofacial Surgery, The Catholic University of  Korea, Seoul St. Mary’s Hospital, 222 Banpo-daero, Seocho-gu, Seoul 137-701,  Korea TEL: +82-2-2258-6291   FAX: +82-2-537-2374 E-mail: jupark@catholic.ac.kr    This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CC Copyright ⃆ 2013 The Korean Association of Oral and Maxillofacial Surgeons.",Non-OADS,/arxiv_data1/oa_pdf/aa/c5/jkaoms-39-150.PMC3858128.pdf
"As the most widely used method for diagnosing facial asy- mmetries and maxillofacial deformities, cephalic radiography  is effective in making plans for orthodontic treatment and  orthognathic surgery and evaluating the postoperative results5-9.CLINICAL ANALYSIShttp://dx.doi.org/10.5125/jkaoms.2013.39.4.168 pISSN 2234-7550 ·eISSN 2234-5930 Eun-Ja Kim Department of Oral and Maxillofacial Surgery, Wonkwang University Dental  Hospital, 895 Muwang-ro, Iksan 570-711, Korea TEL: +82-63-859-2921   FAX: +82-63-857-4002 E-mail: mistej@naver.com    This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CC Copyright ⃆ 2013 The Korean Association of Oral and Maxillofacial Surgeons.",Non-OADS,/arxiv_data1/oa_pdf/23/6b/jkaoms-39-168.PMC3858129.pdf
"In the early stage, machined surface  implants using pure titanium were reported to have achieved CLINICAL ANALYSIShttp://dx.doi.org/10.5125/jkaoms.2013.39.4.161 pISSN 2234-7550 ·eISSN 2234-5930 Ji-Hyun Bae Department of Conservative Dentistry, Section of Dentistry, Seoul National  University Bundang Hospital, 82 Gumi-ro 173beon-gil, Bundang-gu, Seongnam  463-707, Korea TEL: +82-31-787-7541   FAX: +82-31-787-4068 E-mail: kyk0505@snubh.org    This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CC Copyright ⃆ 2013 The Korean Association of Oral and Maxillofacial Surgeons.",Non-OADS,/arxiv_data1/oa_pdf/9f/73/jkaoms-39-161.PMC3858130.pdf
"In 2005, the World Health Organiza- tion reclassified OKC as “keratocystic odontogenic tumor ” CASE REPORThttp://dx.doi.org/10.5125/jkaoms.2013.39.4.182 pISSN 2234-7550 ·eISSN 2234-5930 Bong-Wook Park  Department of Oral and Maxillofacial Surgery, Institute of Health Science,  Gyeonsang National University School of Medicine, 79 Gangnam-ro, Jinju 660- 702, Korea TEL: +82-55-750-8263   FAX: +82-55-761-7024 E-mail: parkbw@gnu.ac.kr    This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CC Copyright ⃆ 2013 The Korean Association of Oral and Maxillofacial Surgeons.",Non-OADS,/arxiv_data1/oa_pdf/4d/9b/jkaoms-39-182.PMC3858131.pdf
Because	big	EDITORIALhttp://dx.doi.org/10.5125/jkaoms.2013.39.4.149 pISSN 2234-7550 ·eISSN 2234-5930,Non-OADS,/arxiv_data1/oa_pdf/61/0d/jkaoms-39-149.PMC3858132.pdf
"Impressions	of	the	patient’s	teeth	are	used	to	create	a	dental	TECHNICAL NOTEhttp://dx.doi.org/10.5125/jkaoms.2013.39.4.197 pISSN 2234-7550 ·eISSN 2234-5930 Sang-Hoon Kang Department of Oral and Maxillofacial Surgery, National Health Insurance  Service Ilsan Hospital, 100 Ilsan-ro, Ilsandong-gu, Goyang 410-719, Korea TEL: +82-31-900-0267   FAX: +82-31-900-0343 E-mail: omfs1ksh@hanmail.net    This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CC Copyright ⃆ 2013 The Korean Association of Oral and Maxillofacial Surgeons.",Non-OADS,/arxiv_data1/oa_pdf/d8/9f/jkaoms-39-197.PMC3858133.pdf
"Nasal obstruction or congestion with  noisy breathing, headache, odontalgia, sinusitis with low- grade fever and unilateral facial swelling, maxillary pain, CASE REPORThttp://dx.doi.org/10.5125/jkaoms.2013.39.5.246 pISSN 2234-7550 ·eISSN 2234-5930 Woong Nam Department of Oral and Maxillofacial Surgery, College of Dentistry, Yonsei  University, 50, Yonsei-ro, Seodaemoon-gu, Seoul 120-752, Korea TEL: +82-2-2228-2971   FAX: +82-2227-8022 E-mail: omsnam@yuhs.ac    This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CC Copyright ⃆ 2013 The Korean Association of Oral and Maxillofacial Surgeons.",Non-OADS,/arxiv_data1/oa_pdf/e6/1d/jkaoms-39-246.PMC3858134.pdf
"Actually,	needle	breakage	has	not	been	reported	to	cause	se- vere	complications	such	as	damage	to	important	anatomical	CASE REPORThttp://dx.doi.org/10.5125/jkaoms.2013.39.5.251 pISSN 2234-7550 ·eISSN 2234-5930 Seong-Yong Moon Department of Oral and Maxillofacial Surgery, School of Dentistry, Chosun  University, 309, Pilmun-daero, Dong-gu, Gwangju 501-759, Korea  TEL: +82-62-220-3817   FAX: +82-62-228-7316 E-mail: msygood@chosun.ac.kr    This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CC Copyright ⃆ 2013 The Korean Association of Oral and Maxillofacial Surgeons.",Non-OADS,/arxiv_data1/oa_pdf/b5/0d/jkaoms-39-251.PMC3858135.pdf
"We	report	a	case	of	mandibular	third	molar	located	in	the	 pterygomandibular	space	that	seems	to	have	been	displaced	 by	neither	cyst	nor	tumor.CASE REPORThttp://dx.doi.org/10.5125/jkaoms.2013.39.5.242 pISSN 2234-7550 ·eISSN 2234-5930 Hoon Myoung Department of Oral and Maxillofacial Surgery, Dental Research Institute, Seoul  National University, 101, Daehak-ro, Jongno-gu, Seoul 110-749, Korea  TEL: +82-2-2072-3059   FAX: +82-2-766-4948 E-mail: myoungh@snu.ac.kr    This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CC Copyright ⃆ 2013 The Korean Association of Oral and Maxillofacial Surgeons.",Non-OADS,/arxiv_data1/oa_pdf/8f/7b/jkaoms-39-242.PMC3858136.pdf
"Therefore,	cell	therapy	product	is	called	 personalized	medicine	compared	to	the	medicine	with	mass	EDITORIALhttp://dx.doi.org/10.5125/jkaoms.2013.39.5.201 pISSN 2234-7550 ·eISSN 2234-5930",Non-OADS,/arxiv_data1/oa_pdf/8d/73/jkaoms-39-201.PMC3858137.pdf
Available 	from:	http://www.cancer.org/treatment/ treatmentsandsideeffects/complementaryandalternativemedicine/ pharmacologicalandbiologicaltreatment/cell-therapy.,Non-OADS,/arxiv_data1/oa_pdf/8d/73/jkaoms-39-201.PMC3858137.pdf
"In this paper, we present an unusual case of lateral  dislocation of the intact mandibular condyle with symphy- sis fracture and describe a method of reduction using bone-CASE REPORThttp://dx.doi.org/10.5125/jkaoms.2013.39.5.238 pISSN 2234-7550 ·eISSN 2234-5930 Hyung Jun Kim  Department of Oral and Maxillofacial Surgery, College of Dentistry, Yonsei  University, 50, Yonsei-ro, Seodaemun-gu, Seoul 120-752, Korea  TEL: +82-82-2-2228-3132   FAX: +82-2-2227-8022 E-mail: kimoms@yuhs.ac    This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CC Copyright ⃆ 2013 The Korean Association of Oral and Maxillofacial Surgeons.",Non-OADS,/arxiv_data1/oa_pdf/42/80/jkaoms-39-238.PMC3858138.pdf
"Poor prognosis ORIGINAL ARTICLEhttp://dx.doi.org/10.5125/jkaoms.2013.39.5.224 pISSN 2234-7550 ·eISSN 2234-5930 Jin-Wook Kim Department of Oral and Maxillofacial Surgery, School of Dentistry, Kyungpook  National University, 2177, Dalgubeol-daero, Jung-gu, Daegu 700-412, Korea  TEL: +82-53-426-5365   FAX: +82-53-600-7575 E-mail: vocaleo@knu.ac.kr    This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CC Copyright ⃆ 2013 The Korean Association of Oral and Maxillofacial Surgeons.",Non-OADS,/arxiv_data1/oa_pdf/bd/b0/jkaoms-39-224.PMC3858139.pdf
"Variation Statistics The evolution of human society has been generally accom-REVIEW ARTICLEhttp://dx.doi.org/10.5125/jkaoms.2013.39.5.203 pISSN 2234-7550 ·eISSN 2234-5930 Yong-Geun Choi Biostatistics, Graduate School of Clinical Dentistry, Korea University, 73,  Inchon-ro, Seongbuk-gu, Seoul 136-705, Korea TEL: +82-2-3394-7555   FAX: +82-2-3394-6875 E-mail: mosby1@naver.com    This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CC Copyright ⃆ 2013 The Korean Association of Oral and Maxillofacial Surgeons.",Non-OADS,/arxiv_data1/oa_pdf/1e/cb/jkaoms-39-203.PMC3858140.pdf
"Unexpected fracture or split with buccal fracture of the ORIGINAL ARTICLEhttp://dx.doi.org/10.5125/jkaoms.2013.39.5.217 pISSN 2234-7550 ·eISSN 2234-5930 Soon Jung Hwang Department of Oral and Maxillofacial Surgery, School of Dentistry, Seoul  National University, 101, Daehak-ro, Jongno-gu, Seoul 110-768, Korea TEL: +82-2-2072-3061   FAX: +82-2-766-4948 E-mail: sjhwang@snu.ac.kr    This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CC Copyright ⃆ 2013 The Korean Association of Oral and Maxillofacial Surgeons.",Non-OADS,/arxiv_data1/oa_pdf/ff/88/jkaoms-39-217.PMC3858141.pdf
Image J is freely available from the NIH Web site  (http://rsb.info.nih.gov/ij) bundled with Java.,OADS,/arxiv_data1/oa_pdf/ff/88/jkaoms-39-217.PMC3858141.pdf
"In Korea, nu- merous epidemiological studies on TMD have been reported CLINICAL ANALYSIShttp://dx.doi.org/10.5125/jkaoms.2013.39.5.231 pISSN 2234-7550 ·eISSN 2234-5930 Su-Gwan Kim Department of Oral and Maxillofacial Surgery, School of Dentistry, Chosun  University, 309, Pilmun-daero, Dong-gu, Gwangju 501-759, Korea TEL: +82-62-220-3815   FAX: +82-62-228-7316 E-mail: sgckim@chosun.ac.kr    This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CC Copyright ⃆ 2013 The Korean Association of Oral and Maxillofacial Surgeons.",Non-OADS,/arxiv_data1/oa_pdf/19/74/jkaoms-39-231.PMC3858142.pdf
"Since 2000s, about 615,000 ORIGINAL ARTICLEhttp://dx.doi.org/10.5125/jkaoms.2013.39.5.207 pISSN 2234-7550 ·eISSN 2234-5930 Uk-Kyu Kim Department of Oral and Maxillofacial Surgery, School of Dentistry, Pusan  National University, 49, Busandaehak-ro, Mulgeum-eup, Yangsan 626-870,  Korea TEL: +82-55-360-5112   FAX: +82-55-360-5104 E-mail: kuksjs@pusan.ac.kr    This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CC Copyright ⃆ 2013 The Korean Association of Oral and Maxillofacial Surgeons.",Non-OADS,/arxiv_data1/oa_pdf/5c/30/jkaoms-39-207.PMC3858143.pdf
"Once called a “forgotten disease,” this syndrome CASE REPORThttp://dx.doi.org/10.5125/jkaoms.2013.39.2.85 pISSN 2234-7550 ·eISSN 2234-5930 Jin-Young Choi Department of Oral and Maxillofacial Surgery, Dental Research Institute,  School of Dentistry, Seoul National University, 101 Daehak-ro, Jongno-gu,  Seoul 110-749, Korea TEL: +82-2-2072-3393   FAX: +82-2-762-4735 E-mail: jinychoi@snu.ac.kr    This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CC Copyright ⃆ 2013 The Korean Association of Oral and Maxillofacial Surgeons.",Non-OADS,/arxiv_data1/oa_pdf/e3/20/jkaoms-39-85.PMC3858144.pdf
"Stem cell can self-renew by differentiating   repeatedly; it has multi-lineage differentiation capability  with which it can morph into a cell with a certain function REVIEW ARTICLEhttp://dx.doi.org/10.5125/jkaoms.2013.39.2.55 pISSN 2234-7550 ·eISSN 2234-5930 Sun-Jong Kim Department of Oral and Maxillofacial Surgery, Ewha Womans University  Mokdong Hospital, Ewha Womans University School of Medicine, 1071  Anyangcheon-ro, Yangcheon-gu, Seoul 158-710, Korea TEL: +82-2-2650-5041   FAX: +82-2-2650-5764 E-mail: sjsj7777@ewha.ac.kr This study was supported by a grant of the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (A110848).",Non-OADS,/arxiv_data1/oa_pdf/ec/3e/jkaoms-39-55.PMC3858145.pdf
"This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CC Copyright ⃆ 2013 The Korean Association of Oral and Maxillofacial Surgeons.",Non-OADS,/arxiv_data1/oa_pdf/ec/3e/jkaoms-39-55.PMC3858145.pdf
"Since FOBMD is occasionally included in the differential  diagnosis of radiolucent lesions of the jaws, knowledge of the  radiographic, clinical, and histopathological characteristics  in association with accurate examination are mandatory to  distinguish it from other most common intrabony defect  lesions such as odontogenic cysts or traumatic bone cyst  (TBC), aneuris mal bone cyst, central giant cell granuloma,  CASE REPORThttp://dx.doi.org/10.5125/jkaoms.2013.39.2.94 pISSN 2234-7550 ·eISSN 2234-5930 Hyeon-Min Kim Department of Oral and Maxillofacial Surgery, Gachon University Gil Medical  Center, 1198 Kuwol-dong, Namdong-gu, Incheon 405-760, Korea TEL: +82-32-460-3373   FAX: +82-32-460-3102 E-mail: umincw@gilhospital.com    This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CC Copyright ⃆ 2013 The Korean Association of Oral and Maxillofacial Surgeons.",Non-OADS,/arxiv_data1/oa_pdf/2a/5e/jkaoms-39-94.PMC3858146.pdf
"However, EDITORIALhttp://dx.doi.org/10.5125/jkaoms.2013.39.2.41 pISSN 2234-7550 ·eISSN 2234-5930",Non-OADS,/arxiv_data1/oa_pdf/10/f8/jkaoms-39-41.PMC3858147.pdf
"Furthermore, REVIEW ARTICLEhttp://dx.doi.org/10.5125/jkaoms.2013.39.2.43 pISSN 2234-7550 ·eISSN 2234-5930 Joo L. Ong Department of Biomedical Engineering, University of Texas at San Antonio,  One UTSA Circle, AET 1.102, San Antonio, Texas 78249, USA TEL: +1-210-458-7084   FAX: +1-210-458-7007 E-mail: anson.ong@utsa.edu    This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CC Copyright ⃆ 2013 The Korean Association of Oral and Maxillofacial Surgeons.",Non-OADS,/arxiv_data1/oa_pdf/82/58/jkaoms-39-43.PMC3858148.pdf
Available from: http://www.biomet.com/biologics/timesh.cfm.,Non-OADS,/arxiv_data1/oa_pdf/82/58/jkaoms-39-43.PMC3858148.pdf
Available from: http://www.polypid.,Non-OADS,/arxiv_data1/oa_pdf/82/58/jkaoms-39-43.PMC3858148.pdf
Available from: http://www.stryker.com/en-us/ GSDAMRetirement/index.htmstellent/groups/public/documents/ web_prod/023526.pdf.,Non-OADS,/arxiv_data1/oa_pdf/82/58/jkaoms-39-43.PMC3858148.pdf
Available  from: http://www.synthes.com/sites/intl/Products/Biomaterials/ Trauma/Pages/Norian_SRS.aspx.,OADS,/arxiv_data1/oa_pdf/82/58/jkaoms-39-43.PMC3858148.pdf
Available from: http://www.synthes.com/MediaBin/International%20 DATA/036.000.886.pdf.,Non-OADS,/arxiv_data1/oa_pdf/82/58/jkaoms-39-43.PMC3858148.pdf
Available from: http://www.lorenzsurgical.com/product.,Non-OADS,/arxiv_data1/oa_pdf/82/58/jkaoms-39-43.PMC3858148.pdf
php?item=24&cat=9;%20http://www.lorenzsurgical.com/ downloads/LOR-7013-MimixBro%20(m)-FINAL.pdf.,OADS,/arxiv_data1/oa_pdf/82/58/jkaoms-39-43.PMC3858148.pdf
Available from: http://www.zimmer.com/en-US/hcp/surgical/ product/palacos-bone-cements.jspx.,Non-OADS,/arxiv_data1/oa_pdf/82/58/jkaoms-39-43.PMC3858148.pdf
Available from: http://www.novabone.com/NB/ novabone_works.html.,Non-OADS,/arxiv_data1/oa_pdf/82/58/jkaoms-39-43.PMC3858148.pdf
Available from: http://www.osteosymbionics.,Non-OADS,/arxiv_data1/oa_pdf/82/58/jkaoms-39-43.PMC3858148.pdf
Available from: http://www.bonalive.com/.,Non-OADS,/arxiv_data1/oa_pdf/82/58/jkaoms-39-43.PMC3858148.pdf
"ORIGINAL ARTICLEhttp://dx.doi.org/10.5125/jkaoms.2013.39.2.71 pISSN 2234-7550 ·eISSN 2234-5930 Jongrak Hong Department of Oral and Maxillofacial Surgery, Samsung Medical Center,  Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul  135-710, Korea TEL: +82-2-3410-2420   FAX: +82-2-3410-0038 E-mail: hongjr@skku.edu    This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CC This study was supported by Samsung Medical Center (grant no.",Non-OADS,/arxiv_data1/oa_pdf/4f/d2/jkaoms-39-71.PMC3858149.pdf
"For the adequate  restoration of the masticatory function under posterior  occlusal load, the use of implants with sufficient length and  Ji-Hyun Bae Subdivision of Medical Statistics, Department of Conservative Dentistry, Seoul  National University Bundang Hospital, 82 Gumi-ro 173beon-gil, Bundang-gu,  Seongnam 463-707, Korea TEL: +82-31-787-2780   FAX: +82-31-787-4068 E-mail: beigeh@snubh.org     This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CCORIGINAL ARTICLEhttp://dx.doi.org/10.5125/jkaoms.2013.39.2.77 pISSN 2234-7550 ·eISSN 2234-5930 Copyright ⃆ 2013 The Korean Association of Oral and Maxillofacial Surgeons.",Non-OADS,/arxiv_data1/oa_pdf/1f/81/jkaoms-39-77.PMC3858150.pdf
"Therefore, various surgical reconstructions have been develo- ped for functional restoration, which sometimes results in  the morbidity of the unnecessary donor site and long-term ORIGINAL ARTICLEhttp://dx.doi.org/10.5125/jkaoms.2013.39.2.63 pISSN 2234-7550 ·eISSN 2234-5930 In Ho Cha Department of Oral and Maxillofacial Surgery, Yonsei University College of  Dentistry, 50 Yonsei-ro, Seodaemun-gu, Seoul 120-752, Korea TEL: +82-2-2228-3140   FAX: +82-2-364-0992 E-mail: cha8764@yuhs.ac     This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CC Copyright ⃆ 2013 The Korean Association of Oral and Maxillofacial Surgeons.",Non-OADS,/arxiv_data1/oa_pdf/3e/bf/jkaoms-39-63.PMC3858151.pdf
"Case Report  On June 11, 2010, an 11-month-old infant was brought CASE REPORThttp://dx.doi.org/10.5125/jkaoms.2013.39.2.90 pISSN 2234-7550 ·eISSN 2234-5930 Seung-Il Song Department of Dentistry, Ajou University School of Medicine, 206 WorldCup- ro, Yeongtong-gu, Suwon 443-749, Korea TEL: +82-31-219-5328   FAX: +82-31-219-5329 E-mail: seungilsong@daum.net    This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CC Copyright ⃆ 2013 The Korean Association of Oral and Maxillofacial Surgeons.",Non-OADS,/arxiv_data1/oa_pdf/7e/ea/jkaoms-39-90.PMC3858152.pdf
"However, as most patients with head and neck  tumours often have medical comorbidities a proper and  critical preoperative assessment of the risk of postoperative  complications is essential before such patients are selected for  André M. Eckardt Department of Cranio-Maxillofacial Surgery, Faculty of Dentistry, Hannover  Medical University, Carl-Neuberg-Strasse 1, 30625 Hannover, Germany  TEL: +49-511-532-4879   FAX: +49-511-532-8879 E-mail: eckardt.andre@mh-hannover.de    This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CCREVIEW ARTICLEhttp://dx.doi.org/10.5125/jkaoms.2013.39.1.3 pISSN 2234-7550 ·eISSN 2234-5930 Copyright ⃆ 2013 The Korean Association of Oral and Maxillofacial Surgeons.",Non-OADS,/arxiv_data1/oa_pdf/a2/9f/jkaoms-39-3.PMC3858153.pdf
"Radiopaque tumors  Chul-Hwan Kim Department of Oral and Maxillofacial Surgery, School of Dentistry, Dankook  University, 119 Dandae-ro, Dongnam-gu, Cheonan 330-714, Korea TEL: +82-41-550-1996   FAX: +82-41-551-8988 E-mail: kimchoms@dankook.ac.kr    This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CCCASE REPORThttp://dx.doi.org/10.5125/jkaoms.2013.39.1.35 pISSN 2234-7550 ·eISSN 2234-5930 Copyright ⃆ 2013 The Korean Association of Oral and Maxillofacial Surgeons.",Non-OADS,/arxiv_data1/oa_pdf/0b/7b/jkaoms-39-35.PMC3858154.pdf
"Tae-Geon Kwon Department of Oral and Maxillofacial Surgery, School of Dentistry, Kyungpook  National University, 2175 Dalgubeol-daero, Jung-gu, Daegu 700-705, Korea  TEL: +82-53-600-7574   FAX: +82-53-426-5365 E-mail: kwondk@knu.ac.kr    This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CCCASE REPORThttp://dx.doi.org/10.5125/jkaoms.2013.39.1.27 pISSN 2234-7550 ·eISSN 2234-5930 Copyright ⃆ 2013 The Korean Association of Oral and Maxillofacial Surgeons.",Non-OADS,/arxiv_data1/oa_pdf/01/98/jkaoms-39-27.PMC3858155.pdf
"Surgical treatments include arthrocentesis, arthroscope,  Chul-Hoon Kim Department of Oral and Maxillofacial Surgery, School of Medicine, Dong-A   University, 26 Daesingongwon-ro, Seo-gu, Busan 602-715, Korea TEL: +82-51-240-5475   FAX: +82-51-241-5475 E-mail: bbp2000@hanmail.net    This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CCCLINICAL ANALYSIShttp://dx.doi.org/10.5125/jkaoms.2013.39.1.14 pISSN 2234-7550 ·eISSN 2234-5930 Copyright ⃆ 2013 The Korean Association of Oral and Maxillofacial Surgeons.",Non-OADS,/arxiv_data1/oa_pdf/f1/fa/jkaoms-39-14.PMC3858156.pdf
EDITORIALhttp://dx.doi.org/10.5125/jkaoms.2013.39.1.1 pISSN 2234-7550 ·eISSN 2234-5930,OADS,/arxiv_data1/oa_pdf/80/70/jkaoms-39-1.PMC3858157.pdf
"7]CLINICAL ANALYSIShttp://dx.doi.org/10.5125/jkaoms.2013.39.1.21 pISSN 2234-7550 ·eISSN 2234-5930 ensure favorable appearance with less shrinkage compared  to STSG and less postoperative pain and discomfort of the  donor site; on the other hand, the survival rate is lower than  STSG, with FTSG having a limitation in terms of skin size;  hence the possible difficulty in repairing huge defects.",Non-OADS,/arxiv_data1/oa_pdf/d6/87/jkaoms-39-21.PMC3858158.pdf
"FTSG can  In-Ho Cha Department of Oral and Maxillofacial Surgery, College of Dentistry, Yonsei  University, 50 Yonsei-ro, Seodaemun-gu, Seoul 120-752, Korea TEL: +82-2-2228-3140   FAX: +82-2-2227-7825 E-mail: cha8764@yuhs.ac    This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CC *This study was supported by a faculty research grant of Yonsei University College of Dentistry for 2008 (6-2008-0061).Copyright ⃆ 2013 The Korean Association of Oral and Maxillofacial Surgeons.",Non-OADS,/arxiv_data1/oa_pdf/d6/87/jkaoms-39-21.PMC3858158.pdf
"Introduction The injection of relatively high doses of bisphosphonate  (BP) into malignant tumor patients is known to increase  the incidence of bisphosphonate-related osteonecrosis of  the jaw (BRONJ), whereas the injection of BP in as much  as the amount used to treat osteoporosis hardly causes  Tae-Geon Kwon Department of Oral and Maxillofacial Surgery, School of Dentistry, Kyungpook  National University, 2177 Dalgubeol-daero, Jung-gu, Daegu 700-412, Korea TEL: +82-53-600-7551   FAX: +82-53-426-5365 E-mail: kwondk@knu.ac.kr    This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CCORIGINAL ARTICLEhttp://dx.doi.org/10.5125/jkaoms.2013.39.1.9 pISSN 2234-7550 ·eISSN 2234-5930 Copyright ⃆ 2013 The Korean Association of Oral and Maxillofacial Surgeons.",Non-OADS,/arxiv_data1/oa_pdf/94/79/jkaoms-39-9.PMC3858159.pdf
Available from: http://knhanes.cdc.go.kr.,Non-OADS,/arxiv_data1/oa_pdf/94/79/jkaoms-39-9.PMC3858159.pdf
"The use of self-inflating hydrogel tissue expander (Cylinder  Dental, Osmed GmbH, Ilmenau, Germany) prior to the  vertical augmentation of resorbed edentulous ridges may  reduce the mean incidence of post-operative graft exposition  from 25% to 4%, increasing the mean vertical bone gain from  approximately 4.0 mm to 7.5 mm compared to augmentations  Sun-Jong Kim Department of Oral and Maxillofacial Surgery, Ewha Womans University  Mokdong Hospital, 1071, Anyangcheon-ro, Yangcheon-gu, Seoul 158-710, Korea TEL: +82-2-2650-5631   FAX: +82-2-2650-5764 E-mail: sjsj7777@ewha.ac.kr    This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CCCASE REPORThttp://dx.doi.org/10.5125/jkaoms.2013.39.1.31 pISSN 2234-7550 ·eISSN 2234-5930 Copyright ⃆ 2013 The Korean Association of Oral and Maxillofacial Surgeons.",Non-OADS,/arxiv_data1/oa_pdf/d3/2e/jkaoms-39-31.PMC3858160.pdf
Dental	implant	diagnosis	and	 treatment	have	been	revolutionized	by	recent	advances	in	EDITORIALhttp://dx.doi.org/10.5125/jkaoms.2013.39.3.101 pISSN 2234-7550 ·eISSN 2234-5930,Non-OADS,/arxiv_data1/oa_pdf/11/0d/jkaoms-39-101.PMC3858163.pdf
"Clinicians	REVIEW ARTICLEhttp://dx.doi.org/10.5125/jkaoms.2013.39.3.103 pISSN 2234-7550 ·eISSN 2234-5930 In-Woong Um Korea Tooth Bank/Seoul In Dental Clinic, Gooahm Building 3rd ﬂoor, Nonhyun-  dong 249-11, Gang nam-gu, Seoul 135-832, Korea TEL: +82-2-548-2055   FAX: +82-2-548-2228 E-mail: h-bmp@hanmail.net    This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CC Copyright ⃆ 2013 The Korean Association of Oral and Maxillofacial Surgeons.",Non-OADS,/arxiv_data1/oa_pdf/31/a2/jkaoms-39-103.PMC3858164.pdf
"CASE REPORThttp://dx.doi.org/10.5125/jkaoms.2013.39.3.139 pISSN 2234-7550 ·eISSN 2234-5930 Jongrak Hong Department of Oral and Maxillofacial Surgery, Samsung Medical Center, Sung- kyunkwan University School of Medicine, 50 Irwon-ro, Gangnam-gu, Seoul  135-710, Korea TEL: +82-2-3410-2420   FAX: +82-2-3410-0038 E-mail: hongjr@skku.edu    This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CC Copyright ⃆ 2013 The Korean Association of Oral and Maxillofacial Surgeons.",Non-OADS,/arxiv_data1/oa_pdf/8f/6c/jkaoms-39-139.PMC3858165.pdf
"Note, however, that the optimization of  gene delivery to bone marrow stromal cells (BMSCs) from  mammalian cells had limited efficiencies.ORIGINAL ARTICLEhttp://dx.doi.org/10.5125/jkaoms.2013.39.3.112 pISSN 2234-7550 ·eISSN 2234-5930 Tae-Geon Kwon  Center for Orthognathic Surgery, Department of Oral and Maxillofacial  Surgery, School of Dentistry, Kyungpook National University, 2177 Dalgubeol- daero, Jung-gu, Daegu 700-412, Korea TEL: +82-53-600-7574   FAX: +82-53-426-5365 E-mail: kwondk@knu.ac.kr    This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CC Copyright ⃆ 2013 The Korean Association of Oral and Maxillofacial Surgeons.",Non-OADS,/arxiv_data1/oa_pdf/fa/d4/jkaoms-39-112.PMC3858166.pdf
"Introduction One of the distressing complications of implant placement  is damage to the inferior alveolar nerve (IAN).Various ORIGINAL ARTICLEhttp://dx.doi.org/10.5125/jkaoms.2013.39.3.127 pISSN 2234-7550 ·eISSN 2234-5930 Jong-Ho Lee Department of Oral and Maxillofacial Surgery, School of Dentistry, Seoul  National University, 101 Daehak-ro, Jongno-gu, Seoul 110-749, Korea TEL: +82-2-2072-2630   FAX: +82-2-766-4948 E-mail: leejongh@snu.ac.kr    This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CC Copyright ⃆ 2013 The Korean Association of Oral and Maxillofacial Surgeons.",Non-OADS,/arxiv_data1/oa_pdf/2e/02/jkaoms-39-127.PMC3858167.pdf
"CASE REPORThttp://dx.doi.org/10.5125/jkaoms.2013.39.3.134 pISSN 2234-7550 ·eISSN 2234-5930 Ho Lee Department of Oral and Maxillofacial Surgery, Section of Dentistry, SMG-SNU  Boramae Medical Center, 20 Boramae-ro 5-gil, Dongj ak-gu, Seoul 156-849,   Korea TEL: +82-2-870-2496   FAX: +82-2-831-0714 E-mail: neo0224@gmail.com     This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CC Copyright ⃆ 2013 The Korean Association of Oral and Maxillofacial Surgeons.",Non-OADS,/arxiv_data1/oa_pdf/2a/89/jkaoms-39-134.PMC3858168.pdf
"Its	primary	causes	include:	 implant	placement	in	erroneous	sites	and	at	an	improper	CASE REPORThttp://dx.doi.org/10.5125/jkaoms.2013.39.3.144 pISSN 2234-7550 ·eISSN 2234-5930 Su-Gwan Kim Department of Oral and Maxillofacial Surgery, School of Dentistry, Chosun  University, 309 Pilmun-daero, Dong-gu, Gwangju 501-759, Korea  TEL: +82-62-220-3815   FAX: +82-62-228-7316 E-mail: sgckim@chosun.ac.kr    This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CC Copyright ⃆ 2013 The Korean Association of Oral and Maxillofacial Surgeons.",Non-OADS,/arxiv_data1/oa_pdf/82/94/jkaoms-39-144.PMC3858169.pdf
"Introduction Bone grafting started to be applied to the pneumatized  maxillary sinus in blade implant placement in the late 1970s  after grafting in the maxillary sinus was performed by Boyne  with the intention of bone augmentation for the first time in ORIGINAL ARTICLEhttp://dx.doi.org/10.5125/jkaoms.2013.39.3.120 pISSN 2234-7550 ·eISSN 2234-5930 Jeong Keun Lee Division of Oral and Maxillofacial Surgery, Department of Dentistry, Ajou  University School of Medicine, 206 WorldCup-ro, Yeongtong-gu, Suwon 443- 749, Korea TEL: +82-31-219-5328   FAX: +82-31-219-5329 E-mail: arcady@ajou.ac.kr    This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CC Copyright ⃆ 2013 The Korean Association of Oral and Maxillofacial Surgeons.",Non-OADS,/arxiv_data1/oa_pdf/40/d8/jkaoms-39-120.PMC3858170.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/ by-nc-nd/3.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and  that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/da/4e/kft194.PMC3858188.pdf
Available at: http://www.rivm.nl/ en/Library/Scientific/Reports/2012/oktober/Risk_assessment_of_tobacco_ additives_and_smoke_components_a_method_proposal .,Non-OADS,/arxiv_data1/oa_pdf/da/4e/kft194.PMC3858188.pdf
Available at: http://echa.europa.eu/documents/10162/6434698/orats_final_  rar_buta-1_3-diene_en.pdf .,Non-OADS,/arxiv_data1/oa_pdf/da/4e/kft194.PMC3858188.pdf
"Available at:  http://oehha.ca.gov/air/toxic_contaminants/html/1,3-Butadiene.htm .",Non-OADS,/arxiv_data1/oa_pdf/da/4e/kft194.PMC3858188.pdf
Available at: http://www.epa.gov/iris/sup- docs/butasup.pdf .,OADS,/arxiv_data1/oa_pdf/da/4e/kft194.PMC3858188.pdf
Available at: http://www.who.int/ fctc/guidelines/Decisions9and10.pdf .,Non-OADS,/arxiv_data1/oa_pdf/da/4e/kft194.PMC3858188.pdf
Available at: http://www.who.int/fctc/en/ .,OADS,/arxiv_data1/oa_pdf/da/4e/kft194.PMC3858188.pdf
"International Agency for Research on Cancer (IARC) Monographs  on the Evaluation of Carcinogenic Risks to Humans, 1,3-Butadiene, Ethylene  Oxide and Vinyl Halides (Vinyl Fluoride, Vinyl Chloride and Vinyl Bromide)  97, http://monographs.iarc.fr/ENG/Monographs/vol97/mono97.pdf .IRIS (2013).",Non-OADS,/arxiv_data1/oa_pdf/da/4e/kft194.PMC3858188.pdf
Available at: http://www.epa.,OADS,/arxiv_data1/oa_pdf/da/4e/kft194.PMC3858188.pdf
Available at: http://ntp.niehs.nih.gov/ .,Non-OADS,/arxiv_data1/oa_pdf/da/4e/kft194.PMC3858188.pdf
Available at: http://www.rivm.nl/ toevoegingentabaksproducten/products.html .,Non-OADS,/arxiv_data1/oa_pdf/da/4e/kft194.PMC3858188.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/),  which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a7/c5/kft197.PMC3858191.pdf
"To assess the DILI potential of registered drugs within the data set, infor - mation on hepatic ADRs in FDA-approved drug labels was obtained from DailyMed (http://dailymed.nlm.nih.gov/), and the DILI potential was classified using the method of Chen et al.",OADS,/arxiv_data1/oa_pdf/a7/c5/kft197.PMC3858191.pdf
"cDILI groups for the 182 drugs according to FDA labeling sections BW, WP, and AR as described and published by DailyMed (http://dailymed.nlm.nih.gov/).TABLE 2—Continued BSEP Inhibition ClassaCompound (n = 250)TA Transport (% of control) DILI (n = 182) GroupcAverage SEM Significanceb338",Non-OADS,/arxiv_data1/oa_pdf/a7/c5/kft197.PMC3858191.pdf
"TABLE 3 Accumulation of TA in SCHH Treated With Compounds With Different Effects in the Vesicle Assay (Inhibitors or noninhibitors) and  DILI Potential (BW/WP or Ar/nM) DILIaBSEP InhibitionbTOTALAccc   (% of control)ICAccd   (% of control)BILEAcce   (% of control) Average SEM Average SEM Average SEM BW/WP Yes Cyclosporine A 16.6 0.7 45.3 1.9 4.5 2.6 BW/WP Yes Ritonavir 27.3 2.1 70.7 1.6 16.0 9.2 BW/WP Yes Rosiglitazone 21.0 3.0 54.5 3.7 14.6 8.5 BW/WP Yes Troglitazone 14.0 0.6 30.4 1.9 8.9 0.7 AR/NM Yes Mifepristone 78.9 7.7 132.9 11.1 61.0 7.9 AR/NM Yes Isradipine 57.2 4.7 74.4 6.6 51.5 6.2 AR/NM Yes Budesonide 78.0 7.6 72.9 4.6 79.6 9.2 AR/NM Yes Glyburide 54.1 1.1 72.3 5.6 46.7 3.7 BW/WP No Valproic acid 89.1 6.0 101.4 10.1 81.3 9.8 BW/WP No Flutamide 100.2 5.9 106.6 8.5 96.1 9.5 BW/WP No Zidovudine 98.0 4.7 104.2 16.9 96.0 16.2 AR/NM No Omeprazole 86.1 1.6 92.4 7.1 83.6 6.6 AR/NM No Cimetidine 81.5 1.7 91.8 6.0 77.5 5.3 AR/NM No Haloperidol 102.3 7.5 113.3 7.7 98.0 9.8 AR/NM No Chlorpromazine 99.1 5.3 104.3 10.1 95.4 10.6 aDILI groups according to FDA labeling sections BW, WP, and AR as described and published by DailyMed (http://dailymed.nlm.nih.gov/).",Non-OADS,/arxiv_data1/oa_pdf/a7/c5/kft197.PMC3858191.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which  permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/aa/53/kft200.PMC3858192.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/),  which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/60/36/kft212.PMC3858196.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/),  which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/68/3c/kft213.PMC3858197.pdf
"Individual values  obtained were analyzed for AUC0→t by trapezoidal method using PK Functions  for Microsoft Excel (PK Functions for Microsoft Excel, Joel I. Usansky, Ph.D.,  Atul Desai, M.S., and Diane Tang-Liu, Ph.D., Department of Pharmacokinetics  and Drug Metabolism, Allergan, Irvine, California; http://www.boomer.org/ pkin/soft.html ), a method previously used by other investigators ( Beringer  et  al.",OADS,/arxiv_data1/oa_pdf/68/3c/kft213.PMC3858197.pdf
Accessed at: http://search.oecd.org/officialdocuments/ displaydocumentpdf/?cote=ENV/JM/MONO(2013)10&doclanguage=en .,Non-OADS,/arxiv_data1/oa_pdf/68/3c/kft213.PMC3858197.pdf
Available at: http://www.regulations.gov/#!documentDetail;D=EPA-HQ- OPPT-2013-0171-0002 .,OADS,/arxiv_data1/oa_pdf/68/3c/kft213.PMC3858197.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/),  which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/76/3f/kft218.PMC3858200.pdf
Available at: http://www.novachem.com/ExWeb%20Documents/joffre/ Ethyl11.pdf .,Non-OADS,/arxiv_data1/oa_pdf/76/3f/kft218.PMC3858200.pdf
Available  at: http://www.frontlineservices.com.au/Frontline_Services/Fruit_ripening_ gas_-_ethylene.html .,Non-OADS,/arxiv_data1/oa_pdf/76/3f/kft218.PMC3858200.pdf
Available at:  http://www.novachem.com/ExWeb%20Documents/responsible-care/ ETHYLENERP.pdf .,Non-OADS,/arxiv_data1/oa_pdf/76/3f/kft218.PMC3858200.pdf
"Answers to this question might be brought by the determination of both protein–protein and protein–RNA interaction networks of PPR proteins and the bio - chemical characterization of complexes involving PPR proteins.Pentatricopeptide repeat proteins A set of modular RNA-specific binders massively   used for organelle gene expression Philippe Giegé institute for plant molecular biology ( iBMP-C nrs ), University of s trasbourg Correspondence to: Philippe Giegé ; Email: philippe.giege@ibmp.cnrs.unistra.fr Submitted: 08/07/2013; Accepted: 08/07/2013 http://dx.doi.org/10.4161/10.4161/rna.26081",Non-OADS,/arxiv_data1/oa_pdf/a5/2d/rna-10-1417.PMC3858423.pdf
Plant Mol Biol  2000; 42:603-13; PMID:10809006; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a5/2d/rna-10-1417.PMC3858423.pdf
Plant Cell 2004; 16:2089-103; PMID:15269332; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a5/2d/rna-10-1417.PMC3858423.pdf
Trends Plant Sci 2008; 13:663-70; PMID:19004664;  http://dx.doi.org/10.1016/j.tplants.2008.10.001 5.,OADS,/arxiv_data1/oa_pdf/a5/2d/rna-10-1417.PMC3858423.pdf
Biochemistry (Mosc) 2011; 76:924- 31; PMID:22022966; http://dx.doi.org/10.1134/S0006297911080086 7.,Non-OADS,/arxiv_data1/oa_pdf/a5/2d/rna-10-1417.PMC3858423.pdf
Cell 2008; 135:462- 74; PMID:18984158; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/a5/2d/rna-10-1417.PMC3858423.pdf
Nat Struct Mol Biol 2010; 17:740-4;  PMID:20473316; http://dx.doi.org/10.1038/ nsmb.1812 9.,OADS,/arxiv_data1/oa_pdf/a5/2d/rna-10-1417.PMC3858423.pdf
PLoS One 2013; 8:e57286;  PMID:23472078; http://dx.doi.org/10.1371/journal.pone.005728611.,Non-OADS,/arxiv_data1/oa_pdf/a5/2d/rna-10-1417.PMC3858423.pdf
PLoS One 2013; 8:e65343; PMID:23762347; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a5/2d/rna-10-1417.PMC3858423.pdf
Cell 2002; 110:501-12; PMID:12202039;  http://dx.doi.org/10.1016/S0092-8674(02)00873-5 14.,OADS,/arxiv_data1/oa_pdf/a5/2d/rna-10-1417.PMC3858423.pdf
Science 2009; 326:1509-12; PMID:19933107;  http://dx.doi.org/10.1126/science.1178811,Non-OADS,/arxiv_data1/oa_pdf/a5/2d/rna-10-1417.PMC3858423.pdf
"www.landesbioscience.com RNA Biology 1419RNA Biology 10:9, 1419–1425; September 2013; © 2013 Landes Bioscience PoiNt-of-View PoiNt-of-View Keywords:  chloroplast, mitochondria,  plant, PPR, RNA editing Abbreviations:  NSR, nucleotide-spec - ifying residue; PPR, pentatricopeptide  repeat Submitted: 03/01/2013Revised: 05/02/2013Accepted: 05/02/2013http://dx.doi.org/10.4161/rna.24908 *Correspondence to: Takahiro Nakamura;   Email: tnaka@agr.kyushu-u.ac.jpC-to-U RNA editing has been widely  observed in organellar RNAs in  terrestrial plants.",Non-OADS,/arxiv_data1/oa_pdf/69/8c/rna-10-1419.PMC3858424.pdf
"Based on the  assumption that functionally related genes will be co-expressed (e.g., for chloroplast gene expression), co-regulated PPR genes were surveyed in the ATTED-II gene co- expression database (http://atted.jp/).",OADS,/arxiv_data1/oa_pdf/69/8c/rna-10-1419.PMC3858424.pdf
( A) Hierarchical clustering of PPR genes based on  the co-expression profile in A tteD-ii (http://atted.jp/).,OADS,/arxiv_data1/oa_pdf/69/8c/rna-10-1419.PMC3858424.pdf
the NSRs were converted into a probability matrix that indicated the de - coded nucleotide frequency according to the PPR code.30 the probability matrix was also shown by logo (http://weblogo.threeplusone.com/create.cgi).,OADS,/arxiv_data1/oa_pdf/69/8c/rna-10-1419.PMC3858424.pdf
Nucleic Acids Res  2008; 36:311-8; PMID:18032432; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/69/8c/rna-10-1419.PMC3858424.pdf
Nature 2005; 433:326-30; PMID:15662426; http://dx.doi.org/10.1038/nature03229 16.,OADS,/arxiv_data1/oa_pdf/69/8c/rna-10-1419.PMC3858424.pdf
J Biol Chem 2006; 281:37661-7; PMID:17015439;  http://dx.doi.org/10.1074/jbc.M608184200 17.,OADS,/arxiv_data1/oa_pdf/69/8c/rna-10-1419.PMC3858424.pdf
Proc Natl Acad Sci USA 2007; 104:8178-83; PMID:17483454; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/69/8c/rna-10-1419.PMC3858424.pdf
Plant Cell 2009; 21:146-56; PMID:19182104; http://dx.doi.org/10.1105/tpc.108.064667 19.,OADS,/arxiv_data1/oa_pdf/69/8c/rna-10-1419.PMC3858424.pdf
Plant Cell  2004; 16:2089-103; PMID:15269332; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/69/8c/rna-10-1419.PMC3858424.pdf
Plant Cell Physiol 2012; 53:1171- 9; PMID:22576772; http://dx.doi.org/10.1093/pcp/ pcs069 21.,Non-OADS,/arxiv_data1/oa_pdf/69/8c/rna-10-1419.PMC3858424.pdf
Plant Cell 2009; 21:558-67; PMID:19252080; http://dx.doi.org/10.1105/ tpc.108.064535 24.,OADS,/arxiv_data1/oa_pdf/69/8c/rna-10-1419.PMC3858424.pdf
Nat Protoc 2012; 7:1931- 45; PMID:23037308; http://dx.doi.org/10.1038/ nprot.2012.117 25.,Non-OADS,/arxiv_data1/oa_pdf/69/8c/rna-10-1419.PMC3858424.pdf
Plant Mol Biol 2013; 81:337-46; PMID:23288601;  http://dx.doi.org/10.1007/s11103-012-0003-2 26.,OADS,/arxiv_data1/oa_pdf/69/8c/rna-10-1419.PMC3858424.pdf
FEBS Lett  2011; 585:700-4; PMID:21281638; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/69/8c/rna-10-1419.PMC3858424.pdf
Annu Rev Plant Biol  2010; 61:125-55; PMID:20192740; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/69/8c/rna-10-1419.PMC3858424.pdf
Trends Biochem Sci 2005; 30:97-105;  PMID:15691655; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/69/8c/rna-10-1419.PMC3858424.pdf
Cell Mol Life Sci  2011; 68:567-86; PMID:20938709; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/69/8c/rna-10-1419.PMC3858424.pdf
Adv Protein Chem Struct Biol 2012; 86:193- 224; PMID:22243585; http://dx.doi.org/10.1016/ B978-0-12-386497-0.00006-2 6.,OADS,/arxiv_data1/oa_pdf/69/8c/rna-10-1419.PMC3858424.pdf
Biochemistry (Mosc)  2011; 76:924-31; PMID:22022966; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/69/8c/rna-10-1419.PMC3858424.pdf
Nucleic Acids Res 2004; 32:4137-44;  PMID:15295040; http://dx.doi.org/10.1093/nar/ gkh763 11.,OADS,/arxiv_data1/oa_pdf/69/8c/rna-10-1419.PMC3858424.pdf
EMBO J 2001; 20:1144-52; PMID:11230137;  http://dx.doi.org/10.1093/emboj/20.5.1144 12.,Non-OADS,/arxiv_data1/oa_pdf/69/8c/rna-10-1419.PMC3858424.pdf
Proc Natl Acad Sci USA 2012; 109:5104- 9; PMID:22411807; http://dx.doi.org/10.1073/ pnas.1202452109 47.,OADS,/arxiv_data1/oa_pdf/69/8c/rna-10-1419.PMC3858424.pdf
J Exp Bot 2012; 63:5301-10;  PMID:22821940; http://dx.doi.org/10.1093/jxb/ ers188 49.,OADS,/arxiv_data1/oa_pdf/69/8c/rna-10-1419.PMC3858424.pdf
Plant  Cell Physiol 2007; 48:322-31; PMID:17213228;  http://dx.doi.org/10.1093/pcp/pcm005 50.,Non-OADS,/arxiv_data1/oa_pdf/69/8c/rna-10-1419.PMC3858424.pdf
Plant J 2012; 70:432-44; PMID:22248025; http://dx.doi.org/10.1111/j.1365- 313X.2011.04883.x 51.,OADS,/arxiv_data1/oa_pdf/69/8c/rna-10-1419.PMC3858424.pdf
Plant Physiol 2012; 158:1610-27;  PMID:22345507; http://dx.doi.org/10.1104/ pp.111.192351 52.,Non-OADS,/arxiv_data1/oa_pdf/69/8c/rna-10-1419.PMC3858424.pdf
IUBMB Life 2012; 64:120-5; PMID:22162179; http://dx.doi.org/10.1002/iub.581 53.,Non-OADS,/arxiv_data1/oa_pdf/69/8c/rna-10-1419.PMC3858424.pdf
New Phytol  2011; 191:37-47; PMID:21557747; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/69/8c/rna-10-1419.PMC3858424.pdf
Plant Cell 2012; 24:3684- 94; PMID:23001034; http://dx.doi.org/10.1105/ tpc.112.099507 38.,OADS,/arxiv_data1/oa_pdf/69/8c/rna-10-1419.PMC3858424.pdf
RNA 2009; 15:1142- 53; PMID:19395655; http://dx.doi.org/10.1261/ rna.1533909 39.,OADS,/arxiv_data1/oa_pdf/69/8c/rna-10-1419.PMC3858424.pdf
Plant J 2009; 59:1011-23; PMID:19500301; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/69/8c/rna-10-1419.PMC3858424.pdf
Plant Mol Biol 2010; 73:309-23;  PMID:20143129; http://dx.doi.org/10.1007/s11103- 010-9616-5 41.,OADS,/arxiv_data1/oa_pdf/69/8c/rna-10-1419.PMC3858424.pdf
Plant J 2009; 59:738-49;  PMID:19453459; http://dx.doi.org/10.1111/j.1365- 313X.2009.03909.x 42.,OADS,/arxiv_data1/oa_pdf/69/8c/rna-10-1419.PMC3858424.pdf
Nucleic Acids Res 2012; 40:5052-64;  PMID:22362750; http://dx.doi.org/10.1093/nar/gks164 43.,OADS,/arxiv_data1/oa_pdf/69/8c/rna-10-1419.PMC3858424.pdf
J Biol Chem 2011; 286:21361-71;  PMID:21504904; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/69/8c/rna-10-1419.PMC3858424.pdf
Plant J 2010; 62:560-70; PMID:20163555;  http://dx.doi.org/10.1111/j.1365-313X.2010.04175.x 45.,OADS,/arxiv_data1/oa_pdf/69/8c/rna-10-1419.PMC3858424.pdf
Plant J 2012; 72:450-60; PMID:22747551; http://dx.doi.org/10.1111/j.1365- 313X.2012.05091.x27.,OADS,/arxiv_data1/oa_pdf/69/8c/rna-10-1419.PMC3858424.pdf
J Biol Chem 2012; 287:38064- 72; PMID:22977245; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/69/8c/rna-10-1419.PMC3858424.pdf
Plant J 2012; 71:836-49; PMID:22540321; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/69/8c/rna-10-1419.PMC3858424.pdf
PLoS One  2013; 8:e57286; PMID:23472078; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/69/8c/rna-10-1419.PMC3858424.pdf
PLoS Genet 2012; 8:e1002910; PMID:22916040;  http://dx.doi.org/10.1371/journal.pgen.1002910 32.,OADS,/arxiv_data1/oa_pdf/69/8c/rna-10-1419.PMC3858424.pdf
Nucleic Acids Res  2012; 40:2712-23; PMID:22127869; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/69/8c/rna-10-1419.PMC3858424.pdf
Plant Physiol 2009; 150:1260- 71; PMID:19448041; http://dx.doi.org/10.1104/ pp.109.136812 35.,Non-OADS,/arxiv_data1/oa_pdf/69/8c/rna-10-1419.PMC3858424.pdf
FEBS Lett 2007; 581:4132-8;  PMID:17707818; http://dx.doi.org/10.1016/j.febs - let.2007.07.075 36.,OADS,/arxiv_data1/oa_pdf/69/8c/rna-10-1419.PMC3858424.pdf
FEBS Lett 2008;  582:4163-8; PMID:19041647; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/69/8c/rna-10-1419.PMC3858424.pdf
"3,7 The latter is critically linked to function as these proteins  *Correspondence to: Zofia MA Chrzanowska-Lightowlers;   Email: zofia.chrzanowska-lightowlers@ncl.ac.ukSubmitted: 02/22/2013; Revised: 04/10/2013; Accepted: 04/22/2013http://dx.doi.org/10.4161/rna.24770Pentatricopeptide repeat (PPR) proteins constitute a large family  of RNA-binding proteins that contain a canonical 35 residue repeat motif.",Non-OADS,/arxiv_data1/oa_pdf/a4/16/rna-10-1433.PMC3858426.pdf
Plant Cell 2004; 16:2089- 103; PMID:15269332; http://dx.doi.org/10.1105/ tpc.104.022236.,OADS,/arxiv_data1/oa_pdf/a4/16/rna-10-1433.PMC3858426.pdf
New Phytol 2011; 191:37- 47; PMID:21557747; http://dx.doi.org/10.1111/j.1469-8137.2011.03746.x.,Non-OADS,/arxiv_data1/oa_pdf/a4/16/rna-10-1433.PMC3858426.pdf
Biochem Soc Trans 2007; 35:1643- 7; PMID:18031283; http://dx.doi.org/10.1042/ BST0351643.,OADS,/arxiv_data1/oa_pdf/a4/16/rna-10-1433.PMC3858426.pdf
Trends Plant Sci 2008; 13:663-70; PMID:19004664;  http://dx.doi.org/10.1016/j.tplants.2008.10.001.,OADS,/arxiv_data1/oa_pdf/a4/16/rna-10-1433.PMC3858426.pdf
Proc Natl Acad Sci USA 2011; 108:1723- 8; PMID:21220331; http://dx.doi.org/10.1073/ pnas.1007667108.10.,OADS,/arxiv_data1/oa_pdf/a4/16/rna-10-1433.PMC3858426.pdf
J Theor Biol 1967; 14:255-74; PMID:11541392; http://dx.doi.org/10.1016/0022-5193(67)90079-3.,OADS,/arxiv_data1/oa_pdf/a4/16/rna-10-1433.PMC3858426.pdf
Proc Biol Sci 1996; 263:1053-9; PMID:8805838; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a4/16/rna-10-1433.PMC3858426.pdf
Mol Biol Evol  2010; 27:1436-48; PMID:20118192; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a4/16/rna-10-1433.PMC3858426.pdf
Nature  1981; 290:457-65; PMID:7219534; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a4/16/rna-10-1433.PMC3858426.pdf
Cell 1981; 25:793-803; PMID:6269758;  http://dx.doi.org/10.1016/0092-8674(81)90187-2.,OADS,/arxiv_data1/oa_pdf/a4/16/rna-10-1433.PMC3858426.pdf
Am J Hum Genet  2001; 68:145-53; PMID:11115380; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a4/16/rna-10-1433.PMC3858426.pdf
J Mol Evol 2001; 53:430-5; PMID:11675602;  http://dx.doi.org/10.1007/s002390010232.,OADS,/arxiv_data1/oa_pdf/a4/16/rna-10-1433.PMC3858426.pdf
Biochem  J 2008; 416:e5-6; PMID:18939947; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a4/16/rna-10-1433.PMC3858426.pdf
Proc Natl Acad Sci USA 2003; 100:605- 10; PMID:12529507; http://dx.doi.org/10.1073/ pnas.242716699.,OADS,/arxiv_data1/oa_pdf/a4/16/rna-10-1433.PMC3858426.pdf
Biochem  J 2004; 382:331-6; PMID:15139850; http://dx.doi.org/10.1042/BJ20040469.,OADS,/arxiv_data1/oa_pdf/a4/16/rna-10-1433.PMC3858426.pdf
J Med Genet 2011;  48:183-9; PMID:21266382; http://dx.doi.org/10.1136/ jmg.2010.081976.,Non-OADS,/arxiv_data1/oa_pdf/a4/16/rna-10-1433.PMC3858426.pdf
J Biol Chem  2010; 285:13742-7; PMID:20220140; http://dx.doi.org/10.1074/jbc.M109.098400.,OADS,/arxiv_data1/oa_pdf/a4/16/rna-10-1433.PMC3858426.pdf
Biochem J 2012; 441:275-83; PMID:21880015;  http://dx.doi.org/10.1042/BJ20110985.,OADS,/arxiv_data1/oa_pdf/a4/16/rna-10-1433.PMC3858426.pdf
Eur J Cancer 2012; 48:2462- 73; PMID:22326293; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/a4/16/rna-10-1433.PMC3858426.pdf
Nucleic Acids Res 2009; 37:5859- 67; PMID:19651879; http://dx.doi.org/10.1093/nar/ gkp627.,Non-OADS,/arxiv_data1/oa_pdf/a4/16/rna-10-1433.PMC3858426.pdf
Cell Cycle 2011; 10:2904- 16; PMID:21857155; http://dx.doi.org/10.4161/ cc.10.17.17060.,OADS,/arxiv_data1/oa_pdf/a4/16/rna-10-1433.PMC3858426.pdf
PLoS  One 2011; 6:e23112; PMID:21826230; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a4/16/rna-10-1433.PMC3858426.pdf
J Autoimmun 2012; 38:369-80; PMID:22560840;  http://dx.doi.org/10.1016/j.jaut.2012.03.004.,OADS,/arxiv_data1/oa_pdf/a4/16/rna-10-1433.PMC3858426.pdf
Mitochondrion 2003; 2:277-91;  PMID:16120328; http://dx.doi.org/10.1016/S1567- 7249(03)00005-9.,OADS,/arxiv_data1/oa_pdf/a4/16/rna-10-1433.PMC3858426.pdf
Biochim Biophys Acta 2011; 1814:1779- 84; PMID:22015679; http://dx.doi.org/10.1016/j.bba- pap.2011.09.013.,OADS,/arxiv_data1/oa_pdf/a4/16/rna-10-1433.PMC3858426.pdf
Cell Metab 2013; 17:399-410; PMID:23473034; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/a4/16/rna-10-1433.PMC3858426.pdf
Cell 2008; 135:462- 74; PMID:18984158; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/a4/16/rna-10-1433.PMC3858426.pdf
Cell 1980; 22:393- 403; PMID:7448867; http://dx.doi.org/10.1016/0092- 8674(80)90350-5.,OADS,/arxiv_data1/oa_pdf/a4/16/rna-10-1433.PMC3858426.pdf
Cell 2010; 142:456-67; PMID:20691904;  http://dx.doi.org/10.1016/j.cell.2010.06.035.,OADS,/arxiv_data1/oa_pdf/a4/16/rna-10-1433.PMC3858426.pdf
Nat Struct Mol  Biol 2010; 17:740-4; PMID:20473316; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a4/16/rna-10-1433.PMC3858426.pdf
Nat Commun 2013;  4:1353; PMID:23322041; http://dx.doi.org/10.1038/ ncomms2358.42.,OADS,/arxiv_data1/oa_pdf/a4/16/rna-10-1433.PMC3858426.pdf
EMBO J 2009; 28:1087- 98; PMID:19262567; http://dx.doi.org/10.1038/ emboj.2009.53.,Non-OADS,/arxiv_data1/oa_pdf/a4/16/rna-10-1433.PMC3858426.pdf
J Neurosci Res 2013; 91:494-505; PMID:23361976; http://dx.doi.org/10.1002/jnr.23189.,Non-OADS,/arxiv_data1/oa_pdf/a4/16/rna-10-1433.PMC3858426.pdf
Hum Mol Genet 1997; 6:615-25; PMID:9097968;  http://dx.doi.org/10.1093/hmg/6.4.615.,Non-OADS,/arxiv_data1/oa_pdf/a4/16/rna-10-1433.PMC3858426.pdf
Proc Natl Acad Sci USA 1985; 82:351- 5; PMID:2982153; http://dx.doi.org/10.1073/ pnas.82.2.351.,OADS,/arxiv_data1/oa_pdf/a4/16/rna-10-1433.PMC3858426.pdf
Nature 2011; 478:269- 73; PMID:21947009; http://dx.doi.org/10.1038/ nature10435.,Non-OADS,/arxiv_data1/oa_pdf/a4/16/rna-10-1433.PMC3858426.pdf
Nucleic Acids  Res 2011; 39:4284-99; PMID:21278163; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a4/16/rna-10-1433.PMC3858426.pdf
J Biol Chem 2007; 282:12610-8; PMID:17337445; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/a4/16/rna-10-1433.PMC3858426.pdf
Nucleic Acids Res  2013; 41:2479-88; PMID:23303773; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a4/16/rna-10-1433.PMC3858426.pdf
Isr J Chem 2010; 50:45-59; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a4/16/rna-10-1433.PMC3858426.pdf
FEBS Lett  2012; 586:3555-61; PMID:22841715; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a4/16/rna-10-1433.PMC3858426.pdf
Cell 2003; 115:97-108; PMID:14532006; http://dx.doi.org/10.1016/S0092- 8674(03)00762-1.,OADS,/arxiv_data1/oa_pdf/a4/16/rna-10-1433.PMC3858426.pdf
Biochem Biophys  Res Commun 2010; 398:759-64; PMID:20633537;  http://dx.doi.org/10.1016/j.bbrc.2010.07.019.,OADS,/arxiv_data1/oa_pdf/a4/16/rna-10-1433.PMC3858426.pdf
Biochim Biophys Acta 2012; 1819:1008- 16; PMID:22051507; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/a4/16/rna-10-1433.PMC3858426.pdf
EMBO J 2012; 31:443- 56; PMID:22045337; http://dx.doi.org/10.1038/emboj.2011.392.,Non-OADS,/arxiv_data1/oa_pdf/a4/16/rna-10-1433.PMC3858426.pdf
Nucleic Acids Res 2012; 40:8033- 47; PMID:22661577; http://dx.doi.org/10.1093/nar/ gks506.,OADS,/arxiv_data1/oa_pdf/a4/16/rna-10-1433.PMC3858426.pdf
Biochemistry 2010; 49:7467-73; PMID:20677761;  http://dx.doi.org/10.1021/bi1008479.,Non-OADS,/arxiv_data1/oa_pdf/a4/16/rna-10-1433.PMC3858426.pdf
Mol Biol Cell 2010; 21:1315-23; PMID:20200222; http://dx.doi.org/10.1091/mbc.E10- 01-0047.,Non-OADS,/arxiv_data1/oa_pdf/a4/16/rna-10-1433.PMC3858426.pdf
Mol  Cell 2006; 22:657-68; PMID:16762838; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a4/16/rna-10-1433.PMC3858426.pdf
Genes Dev  2006; 20:2996-3009; PMID:17050673; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a4/16/rna-10-1433.PMC3858426.pdf
EMBO J 2010; 29:1116- 25; PMID:20186120; http://dx.doi.org/10.1038/emboj.2010.14.,OADS,/arxiv_data1/oa_pdf/a4/16/rna-10-1433.PMC3858426.pdf
Nucleic Acids Res 2012; 40:6109-21; PMID:22453275;  http://dx.doi.org/10.1093/nar/gks266.,OADS,/arxiv_data1/oa_pdf/a4/16/rna-10-1433.PMC3858426.pdf
"However, studies  *Correspondence to: Mamoru Sugita; Email: sugita@gene.nagoya-u.ac.jp Submitted: 02/21/2013; Revised: 04/10/2013; Accepted: 04/22/2013http://dx.doi.org/10.4161/rna.24772Pentatricopeptide repeat (PPR) proteins are widespread in  eukaryotes and in particular, include several hundred members in land plants.",Non-OADS,/arxiv_data1/oa_pdf/d8/87/rna-10-1439.PMC3858427.pdf
"The genome database was updated (The Physcomitrella patens   resource COSMOSS, http://www.cosmoss.org/) and two addi - tional PPR proteins were identified and designated PpPPR_104 and PpPPR_105.",OADS,/arxiv_data1/oa_pdf/d8/87/rna-10-1439.PMC3858427.pdf
Plant J 2012; 70:271-8; PMID:22117821; http://dx.doi.org/10.1111/j.1365-313X.2011.04869.x.,OADS,/arxiv_data1/oa_pdf/d8/87/rna-10-1439.PMC3858427.pdf
Plant Biol (Stuttg)  2005; 7:228-37; PMID:15912442; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d8/87/rna-10-1439.PMC3858427.pdf
Science  1994; 265:615-21; PMID:8036511; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d8/87/rna-10-1439.PMC3858427.pdf
Trends Biochem Sci 1999; 24:298-300;  PMID:10431172; http://dx.doi.org/10.1016/S0968- 0004(99)01419-X.,OADS,/arxiv_data1/oa_pdf/d8/87/rna-10-1439.PMC3858427.pdf
Trends Biochem Sci 1997; 22:12-3; PMID:9020585;  http://dx.doi.org/10.1016/S0968-0004(96)30046-7.5.,OADS,/arxiv_data1/oa_pdf/d8/87/rna-10-1439.PMC3858427.pdf
Adv Bot Res 2012; 63:253-313; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d8/87/rna-10-1439.PMC3858427.pdf
Annu Rev Plant Biol 2006; 57:497-520;  PMID:16669772; http://dx.doi.org/10.1146/annurev.arplant.57.032905.105338.,OADS,/arxiv_data1/oa_pdf/d8/87/rna-10-1439.PMC3858427.pdf
Science 2008; 319:64-9; PMID:18079367;  http://dx.doi.org/10.1126/science.1150646.,OADS,/arxiv_data1/oa_pdf/d8/87/rna-10-1439.PMC3858427.pdf
Gene 2004; 343:305- 11; PMID:15588585; http://dx.doi.org/10.1016/j.gene.2004.09.015.,OADS,/arxiv_data1/oa_pdf/d8/87/rna-10-1439.PMC3858427.pdf
J Biol Chem  2007; 282:10773-82; PMID:17283080; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d8/87/rna-10-1439.PMC3858427.pdf
Plant Cell 2004; 16:2089- 103; PMID:15269332; http://dx.doi.org/10.1105/ tpc.104.022236.,OADS,/arxiv_data1/oa_pdf/d8/87/rna-10-1439.PMC3858427.pdf
Science 2011; 332:960- 3; PMID:21551031; http://dx.doi.org/10.1126/sci-ence.1203810.,OADS,/arxiv_data1/oa_pdf/d8/87/rna-10-1439.PMC3858427.pdf
"Trends Plant Sci 2008; 13:663-70; PMID:19004664; http://dx.doi.org/10.1016/j.tplants.2008.10.001.In contrast, PpPPR_43 protein is not involved in RNA editing,  but is required for group II intron splicing of the mitochon - drial cox1 transcript.10 The DYW domain of PpPPR_43 is dis - tinct from the other nine DYW domains of Physcomitrella  PPR  proteins.",Non-OADS,/arxiv_data1/oa_pdf/d8/87/rna-10-1439.PMC3858427.pdf
Plant Cell 2012; 24:3684- 94; PMID:23001034; http://dx.doi.org/10.1105/tpc.112.099507.,OADS,/arxiv_data1/oa_pdf/d8/87/rna-10-1439.PMC3858427.pdf
Proc Natl Acad Sci USA  2013; 110:E1169-78; PMID:23487777; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d8/87/rna-10-1439.PMC3858427.pdf
Biochim Biophys Acta  2002; 1576:346-9; PMID:12084583; http://dx.doi.org/10.1016/S0167-4781(02)00346-9.,OADS,/arxiv_data1/oa_pdf/d8/87/rna-10-1439.PMC3858427.pdf
J Plant Physiol 2004; 161:113-5;  PMID:15002671; http://dx.doi.org/10.1078/0176- 1617-01220.,Non-OADS,/arxiv_data1/oa_pdf/d8/87/rna-10-1439.PMC3858427.pdf
Plant  J 2003; 36:541-9; PMID:14617084; http://dx.doi.org/10.1046/j.1365-313X.2003.01900.x.,OADS,/arxiv_data1/oa_pdf/d8/87/rna-10-1439.PMC3858427.pdf
FEBS Lett 2007; 581:4132-8; PMID:17707818; http://dx.doi.org/10.1016/j.febslet.2007.07.075.,OADS,/arxiv_data1/oa_pdf/d8/87/rna-10-1439.PMC3858427.pdf
FEBS Lett 2008; 582:4163-8; PMID:19041647; http://dx.doi.org/10.1016/j.febs- let.2008.11.017.,OADS,/arxiv_data1/oa_pdf/d8/87/rna-10-1439.PMC3858427.pdf
Plant Cell  2009; 21:146-56; PMID:19182104; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d8/87/rna-10-1439.PMC3858427.pdf
Prog Biophys Mol Biol 1985; 45:1- 56; PMID:3881803; http://dx.doi.org/10.1016/0079- 6107(85)90004-5.,OADS,/arxiv_data1/oa_pdf/d8/87/rna-10-1439.PMC3858427.pdf
Mol Plant 2010; 3:691- 705; PMID:20603383; http://dx.doi.org/10.1093/mp/ ssq025.,OADS,/arxiv_data1/oa_pdf/d8/87/rna-10-1439.PMC3858427.pdf
Plant Physiol 2010; 154:1588- 601; PMID:20935174; http://dx.doi.org/10.1104/ pp.110.164111.,Non-OADS,/arxiv_data1/oa_pdf/d8/87/rna-10-1439.PMC3858427.pdf
Plant J 2011; 67:370-80;  PMID:21466601; http://dx.doi.org/10.1111/j.1365- 313X.2011.04600.x.,OADS,/arxiv_data1/oa_pdf/d8/87/rna-10-1439.PMC3858427.pdf
Mol Biol Evol 2008; 25:1405- 14; PMID:18400790; http://dx.doi.org/10.1093/mol- bev/msn084.,Non-OADS,/arxiv_data1/oa_pdf/d8/87/rna-10-1439.PMC3858427.pdf
Mol Genet Genomics 2009; 281:473-81; PMID:19169711;  http://dx.doi.org/10.1007/s00438-009-0424-z.,OADS,/arxiv_data1/oa_pdf/d8/87/rna-10-1439.PMC3858427.pdf
Plant J 2010; 62:560-70; PMID:20163555;  http://dx.doi.org/10.1111/j.1365-313X.2010.04175.x.,OADS,/arxiv_data1/oa_pdf/d8/87/rna-10-1439.PMC3858427.pdf
Plant Cell Physiol 2010; 51:1942-9; PMID:20837503;  http://dx.doi.org/10.1093/pcp/pcq142.,OADS,/arxiv_data1/oa_pdf/d8/87/rna-10-1439.PMC3858427.pdf
FEBS Lett 2011; 585:2367-71; PMID:21708151; http://dx.doi.org/10.1016/j.febs- let.2011.06.009.,OADS,/arxiv_data1/oa_pdf/d8/87/rna-10-1439.PMC3858427.pdf
Plant Signal Behav 2010; 5:727- 9; PMID:20383068; http://dx.doi.org/10.4161/ psb.5.6.11664.,OADS,/arxiv_data1/oa_pdf/d8/87/rna-10-1439.PMC3858427.pdf
BMC Evol  Biol 2012; 12:66; http://dx.doi.org/10.1186/1471- 2148-12-66; PMID:22583633.,Non-OADS,/arxiv_data1/oa_pdf/d8/87/rna-10-1439.PMC3858427.pdf
Plant Cell 2009; 21:3686-99; PMID:19934379; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d8/87/rna-10-1439.PMC3858427.pdf
New Phytol 2011; 191:37-47; PMID:21557747; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d8/87/rna-10-1439.PMC3858427.pdf
Plant Physiol 2011; 155:1678- 89; PMID:21139083; http://dx.doi.org/10.1104/ pp.110.168120.,Non-OADS,/arxiv_data1/oa_pdf/d8/87/rna-10-1439.PMC3858427.pdf
Plant Physiol 2012; 158:156-89; PMID:22065420;  http://dx.doi.org/10.1104/pp.111.188474.,Non-OADS,/arxiv_data1/oa_pdf/d8/87/rna-10-1439.PMC3858427.pdf
Front Plant  Sci 2012; 3:207; PMID:22973286; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d8/87/rna-10-1439.PMC3858427.pdf
Plant Cell 2006; 18:2650-63; PMID:17041147;  http://dx.doi.org/10.1105/tpc.106.046110.,OADS,/arxiv_data1/oa_pdf/d8/87/rna-10-1439.PMC3858427.pdf
Mol Cell Biol 2008; 28:5337- 47; PMID:18591259; http://dx.doi.org/10.1128/ MCB.00563-08.,Non-OADS,/arxiv_data1/oa_pdf/d8/87/rna-10-1439.PMC3858427.pdf
Plant Cell 2010; 22:234-48;  PMID:20097872; http://dx.doi.org/10.1105/tpc.109.066266.,OADS,/arxiv_data1/oa_pdf/d8/87/rna-10-1439.PMC3858427.pdf
BMC Genomics 2009; 10:200; PMID:19400948; http://dx.doi.org/10.1186/1471- 2164-10-200.,OADS,/arxiv_data1/oa_pdf/d8/87/rna-10-1439.PMC3858427.pdf
Science 2007; 316:715-9; PMID:17395793;  http://dx.doi.org/10.1126/science.,OADS,/arxiv_data1/oa_pdf/d8/87/rna-10-1439.PMC3858427.pdf
Plant Cell 2006; 18:176- 97; PMID:16326926; http://dx.doi.org/10.1105/ tpc.105.036392.,OADS,/arxiv_data1/oa_pdf/d8/87/rna-10-1439.PMC3858427.pdf
Nat Struct Mol  Biol 2010; 17:740-4; PMID:20473316; http://dx.doi.org/10.1038/nsmb.1812.,OADS,/arxiv_data1/oa_pdf/d8/87/rna-10-1439.PMC3858427.pdf
FEBS J 2009; 276:5860-9; PMID:19740105; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d8/87/rna-10-1439.PMC3858427.pdf
8 The characterization of PPR proteins has also  *Correspondence to: Peter A Gegenheimer; Email: pgegen@ku.edu;  Philippe Giegé; Email: philippe.giege@ibmp-cnrs.unistra.frSubmitted: 03/28/2013; Revised: 06/03/2013; Accepted: 06/04/2013http://dx.doi.org/10.4161/rna.25273A fast growing number of studies identify pentatricopeptide  repeat (PPR) proteins as major players in gene expression processes.,Non-OADS,/arxiv_data1/oa_pdf/cd/55/rna-10-1457.PMC3858429.pdf
Trends Plant Sci 2008; 13:663-70; PMID:19004664;  http://dx.doi.org/10.1016/j.tplants.2008.10.001 2.,OADS,/arxiv_data1/oa_pdf/cd/55/rna-10-1457.PMC3858429.pdf
Plant Cell 2004; 16:2089- 103; PMID:15269332; http://dx.doi.org/10.1105/ tpc.104.022236 4.,OADS,/arxiv_data1/oa_pdf/cd/55/rna-10-1457.PMC3858429.pdf
Nature 2011; 478:269-73; PMID:21947009; http://dx.doi.org/10.1038/ nature10435 5.,Non-OADS,/arxiv_data1/oa_pdf/cd/55/rna-10-1457.PMC3858429.pdf
Genes Dev 2012; 26:1005-9; PMID:22588715;  http://dx.doi.org/10.1101/gad.193581.112 6.,Non-OADS,/arxiv_data1/oa_pdf/cd/55/rna-10-1457.PMC3858429.pdf
New Phytol  2011; 191:37-47; PMID:21557747; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/cd/55/rna-10-1457.PMC3858429.pdf
Cell Cycle 2009; 8:1650-3; PMID:19411849; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/cd/55/rna-10-1457.PMC3858429.pdf
RNA 2010; 16:1725- 47; PMID:20627997; http://dx.doi.org/10.1261/ rna.2214510 12.,OADS,/arxiv_data1/oa_pdf/cd/55/rna-10-1457.PMC3858429.pdf
Cell 1983; 35:849- 57; PMID:6197186; http://dx.doi.org/10.1016/0092-8674(83)90117-4 14.,OADS,/arxiv_data1/oa_pdf/cd/55/rna-10-1457.PMC3858429.pdf
Gene  1993; 135:33-6; PMID:8276275; http://dx.doi.org/10.1016/0378-1119(93)90046-6 15.,OADS,/arxiv_data1/oa_pdf/cd/55/rna-10-1457.PMC3858429.pdf
Altman S. A view of RNase P. Mol Biosyst 2007;  3:604-7; PMID:17700860; http://dx.doi.org/10.1039/ b707850c 16.,OADS,/arxiv_data1/oa_pdf/cd/55/rna-10-1457.PMC3858429.pdf
Trends Biochem  Sci 2006; 31:333-41; PMID:16679018; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/cd/55/rna-10-1457.PMC3858429.pdf
Proc Natl Acad Sci USA 2005; 102:11284- 9; PMID:16061811; http://dx.doi.org/10.1073/ pnas.050527110218.,OADS,/arxiv_data1/oa_pdf/cd/55/rna-10-1457.PMC3858429.pdf
Nucleic Acids Res 2012; 40:10384-93;  PMID:22904083; http://dx.doi.org/10.1093/nar/ gks744 20.,Non-OADS,/arxiv_data1/oa_pdf/cd/55/rna-10-1457.PMC3858429.pdf
RNA  2003; 9:1073-83; PMID:12923256; http://dx.doi.org/10.1261/rna.5880403 21.,OADS,/arxiv_data1/oa_pdf/cd/55/rna-10-1457.PMC3858429.pdf
Trends Genet 2003; 19:561- 9; PMID:14550630; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/cd/55/rna-10-1457.PMC3858429.pdf
RNA Biol 2009;  6:40-2; PMID:19106627; http://dx.doi.org/10.4161/ rna.6.1.7566 23.,OADS,/arxiv_data1/oa_pdf/cd/55/rna-10-1457.PMC3858429.pdf
Cell 1983; 35:815-28; PMID:6652686; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/cd/55/rna-10-1457.PMC3858429.pdf
Nat Struct Mol  Biol 2010; 17:740-4; PMID:20473316; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/cd/55/rna-10-1457.PMC3858429.pdf
Genes Dev 2012; 26:1022- 7; PMID:22549728; http://dx.doi.org/10.1101/ gad.189514.112 63.,OADS,/arxiv_data1/oa_pdf/cd/55/rna-10-1457.PMC3858429.pdf
Cell Rep 2012; 2:19- 25; PMID:22840392; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/cd/55/rna-10-1457.PMC3858429.pdf
Mol  Genet Genomics 2011; 286:359-69; PMID:21987179; http://dx.doi.org/10.1007/s00438-011-0651-y 65.,OADS,/arxiv_data1/oa_pdf/cd/55/rna-10-1457.PMC3858429.pdf
Chembiochem  2012; 13:2270-6; PMID:22976545; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/cd/55/rna-10-1457.PMC3858429.pdf
RNA Biol  2013; 10: In press; PMID:23595059; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/cd/55/rna-10-1457.PMC3858429.pdf
Nucleic Acids Res 2007; 35:3676- 92; PMID:17488843; http://dx.doi.org/10.1093/nar/ gkm270 69.,OADS,/arxiv_data1/oa_pdf/cd/55/rna-10-1457.PMC3858429.pdf
Int Rev Cytol 2005; 247:165-221;  PMID:16344113; http://dx.doi.org/10.1016/S0074- 7696(05)47004-7 70.,OADS,/arxiv_data1/oa_pdf/cd/55/rna-10-1457.PMC3858429.pdf
J Mol  Biol 1991; 221:1-5; PMID:1717693; http://dx.doi.org/10.1016/0022-2836(91)80194-Y 71.,OADS,/arxiv_data1/oa_pdf/cd/55/rna-10-1457.PMC3858429.pdf
Proc Natl Acad Sci USA 1995; 92:5822-6;  PMID:7597035; http://dx.doi.org/10.1073/ pnas.92.13.5822 72.,OADS,/arxiv_data1/oa_pdf/cd/55/rna-10-1457.PMC3858429.pdf
Science 1987; 238:527- 30; PMID:2443980; http://dx.doi.org/10.1126/sci- ence.2443980 74.,OADS,/arxiv_data1/oa_pdf/cd/55/rna-10-1457.PMC3858429.pdf
Genes Dev 1994; 8:3021- 31; PMID:8001821; http://dx.doi.org/10.1101/ gad.8.24.302143.,OADS,/arxiv_data1/oa_pdf/cd/55/rna-10-1457.PMC3858429.pdf
Methods Enzymol 2001; 341:56-77; PMID:11582805;  http://dx.doi.org/10.1016/S0076-6879(01)41145-1 44.,OADS,/arxiv_data1/oa_pdf/cd/55/rna-10-1457.PMC3858429.pdf
Biochem Biophys Res Commun 1998; 247:234-41; PMID:9642109; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/cd/55/rna-10-1457.PMC3858429.pdf
"Thomas BC, Chamberlain J, Engelke DR,  Gegenheimer P. Evidence for an RNA-based cata-lytic mechanism in eukaryotic nuclear ribonuclease P.  RNA 2000; 6:554-62; PMID:10786846; http://dx.doi.",OADS,/arxiv_data1/oa_pdf/cd/55/rna-10-1457.PMC3858429.pdf
Gene 1989; 82:63- 4; PMID:2479591; http://dx.doi.org/10.1016/0378- 1119(89)90030-9 54.,OADS,/arxiv_data1/oa_pdf/cd/55/rna-10-1457.PMC3858429.pdf
Mol Biochem Parasitol 2001; 115:109-17;  PMID:11377745; http://dx.doi.org/10.1016/S0166- 6851(01)00273-0 55.,OADS,/arxiv_data1/oa_pdf/cd/55/rna-10-1457.PMC3858429.pdf
Cell 2008; 135:462- 74; PMID:18984158; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/cd/55/rna-10-1457.PMC3858429.pdf
Nucleic Acids Res 2012; 40:11583- 93; PMID:23042678; http://dx.doi.org/10.1093/nar/ gks910 57.,OADS,/arxiv_data1/oa_pdf/cd/55/rna-10-1457.PMC3858429.pdf
RNA  2008; 14:1930-41; PMID:18669444; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/cd/55/rna-10-1457.PMC3858429.pdf
Cell 2010; 142:456-67; PMID:20691904;  http://dx.doi.org/10.1016/j.cell.2010.06.035 59.,OADS,/arxiv_data1/oa_pdf/cd/55/rna-10-1457.PMC3858429.pdf
Biochim Biophys Acta 2012;  1819:1017-26; PMID:22137969; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/cd/55/rna-10-1457.PMC3858429.pdf
J Mol Biol 1996; 257:43-52; PMID:8632458; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/cd/55/rna-10-1457.PMC3858429.pdf
FEBS Lett 1999;  442:7-10; PMID:9923593; http://dx.doi.org/10.1016/ S0014-5793(98)01621-4 31.,OADS,/arxiv_data1/oa_pdf/cd/55/rna-10-1457.PMC3858429.pdf
RNA  2006; 12:1661-70; PMID:16894220; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/cd/55/rna-10-1457.PMC3858429.pdf
Proc Natl Acad Sci USA  1992; 89:9875-9; PMID:1409716; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/cd/55/rna-10-1457.PMC3858429.pdf
"Puranam RS, Attardi G. The RNase P associated with HeLa cell mitochondria contains an essential  RNA component identical in sequence to that of  the nuclear RNase P. Mol Cell Biol 2001; 21:548- 61; PMID:11134342; http://dx.doi.org/10.1128/MCB.21.2.548-561.2001 38.",Non-OADS,/arxiv_data1/oa_pdf/cd/55/rna-10-1457.PMC3858429.pdf
J Biol  Chem 1995; 270:12885-91; PMID:7759547; http://dx.doi.org/10.1074/jbc.270.21.12885 39.,Non-OADS,/arxiv_data1/oa_pdf/cd/55/rna-10-1457.PMC3858429.pdf
FEBS Lett 1987; 215:132-6; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/cd/55/rna-10-1457.PMC3858429.pdf
Nucleic Acids Res 1990; 18:6625- 31; PMID:2123540; http://dx.doi.org/10.1093/ nar/18.22.6625 42.,OADS,/arxiv_data1/oa_pdf/cd/55/rna-10-1457.PMC3858429.pdf
J Mol Biol 2012; 422:204-14; PMID:22626870;  http://dx.doi.org/10.1016/j.jmb.2012.05.020 90.,OADS,/arxiv_data1/oa_pdf/cd/55/rna-10-1457.PMC3858429.pdf
Proc Natl Acad Sci USA  1993; 90:6498-502; PMID:8341661; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/cd/55/rna-10-1457.PMC3858429.pdf
RNA 2000; 6:545- 53; PMID:10786845; http://dx.doi.org/10.1017/ S1355838200991465 92.,OADS,/arxiv_data1/oa_pdf/cd/55/rna-10-1457.PMC3858429.pdf
PLoS One 2013; 8:e57286;  PMID:23472078; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/cd/55/rna-10-1457.PMC3858429.pdf
Bioinformatics  2006; 22:195-201; PMID:16301204; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/cd/55/rna-10-1457.PMC3858429.pdf
EMBO J 2006; 25:5117-25; PMID:17053788;  http://dx.doi.org/10.1038/sj.emboj.7601377 83.,Non-OADS,/arxiv_data1/oa_pdf/cd/55/rna-10-1457.PMC3858429.pdf
Nucleic Acids Res  2012; 40:6957-65; PMID:22561375; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/cd/55/rna-10-1457.PMC3858429.pdf
J Biol Chem 1997; 272:28531- 8; PMID:9353315; http://dx.doi.org/10.1074/ jbc.272.45.28531 85.,OADS,/arxiv_data1/oa_pdf/cd/55/rna-10-1457.PMC3858429.pdf
Biochemistry  1998; 37:2393-400; PMID:9485387; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/cd/55/rna-10-1457.PMC3858429.pdf
Proc Natl Acad Sci USA 2003; 100:13213- 8; PMID:14585931; http://dx.doi.org/10.1073/ pnas.2235589100 76.,OADS,/arxiv_data1/oa_pdf/cd/55/rna-10-1457.PMC3858429.pdf
Plant dicistronic tRNA-snoRNA genes:  a new mode of expression of the small nucleolar RNAs  processed by RNase Z. EMBO J 2003; 22:621-32;  PMID:12554662; http://dx.doi.org/10.1093/emboj/ cdg040 77.,Non-OADS,/arxiv_data1/oa_pdf/cd/55/rna-10-1457.PMC3858429.pdf
FEBS Lett  2010; 584:448-54; PMID:19900443; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/cd/55/rna-10-1457.PMC3858429.pdf
Structure 2012; 20:397- 405; PMID:22404999; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/cd/55/rna-10-1457.PMC3858429.pdf
"3,5,6 PPR proteins are defined by the presence of tandem repeats of  degenerate 31–36 amino acid motifs and can be classified based  *Correspondence to: Katharine A Howell; Email: kate.howell@uwa.edu.au Submitted: 06/18/2013; Revised: 08/15/2013; Accepted: 08/16/2013http://dx.doi.org/10.4161/rna.26172A small subset of the large pentatricopeptide repeat (PPR)  protein family in higher plants contain a C-terminal small MutS-related (SMR) domain.",Non-OADS,/arxiv_data1/oa_pdf/94/25/rna-10-1501.PMC3858433.pdf
"Mutant phenotype descriptions are based on manual curation of the literature and, where available, seedling phenotype descriptions from the maize photosynthetic mutant library 61 (PML; http://pml.uoregon.edu/photosyntheticml.html).",Non-OADS,/arxiv_data1/oa_pdf/94/25/rna-10-1501.PMC3858433.pdf
Mol Biol Evol 2008; 25:1120-8; PMID:18343892; http://dx.doi.org/10.1093/molbev/ msn057 3.,Non-OADS,/arxiv_data1/oa_pdf/94/25/rna-10-1501.PMC3858433.pdf
Trends Plant Sci 2008; 13:663-70; PMID:19004664;  http://dx.doi.org/10.1016/j.tplants.2008.10.001 4.,OADS,/arxiv_data1/oa_pdf/94/25/rna-10-1501.PMC3858433.pdf
New Phytol  2011; 191:37-47; PMID:21557747; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/94/25/rna-10-1501.PMC3858433.pdf
Biochem Soc Trans 2007; 35:1643- 7; PMID:18031283; http://dx.doi.org/10.1042/ BST0351643 6.,OADS,/arxiv_data1/oa_pdf/94/25/rna-10-1501.PMC3858433.pdf
Plant Cell  2004; 16:2089-103; PMID:15269332; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/94/25/rna-10-1501.PMC3858433.pdf
Science 2007; 316:715-9;  PMID:17395793; http://dx.doi.org/10.1126/science.,OADS,/arxiv_data1/oa_pdf/94/25/rna-10-1501.PMC3858433.pdf
Mutat Res 2010; 694:20-30; PMID:20833188;  http://dx.doi.org/10.1016/j.mrfmmm.2010.08.0099.,OADS,/arxiv_data1/oa_pdf/94/25/rna-10-1501.PMC3858433.pdf
Trends Biochem Sci 1999; 24:298-300; PMID:10431172; http://dx.doi.org/10.1016/S0968- 0004(99)01419-X 10.,OADS,/arxiv_data1/oa_pdf/94/25/rna-10-1501.PMC3858433.pdf
Mol Biol Int  2011; 2011:691735; PMID:22091410; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/94/25/rna-10-1501.PMC3858433.pdf
Plant J  2012; 72:547-58; PMID:22708543; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/94/25/rna-10-1501.PMC3858433.pdf
Eukaryot Cell 2011; 10:856- 68; PMID:21622904; http://dx.doi.org/10.1128/ EC.00326-10 40.,Non-OADS,/arxiv_data1/oa_pdf/94/25/rna-10-1501.PMC3858433.pdf
Science  2009; 324:1724-6; PMID:19556510; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/94/25/rna-10-1501.PMC3858433.pdf
FEBS Lett 2011; 585:809-13; PMID:21315716;  http://dx.doi.org/10.1016/j.febslet.2011.02.007 42.,OADS,/arxiv_data1/oa_pdf/94/25/rna-10-1501.PMC3858433.pdf
J  Struct Biol 2011; 174:282-9; PMID:21276852; http://dx.doi.org/10.1016/j.jsb.2011.01.008 43.,OADS,/arxiv_data1/oa_pdf/94/25/rna-10-1501.PMC3858433.pdf
J Mol Biol 2008; 383:1156- 70; PMID:18804481; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/94/25/rna-10-1501.PMC3858433.pdf
Nucleic Acids Res  2012; 40:3106-16; PMID:22139936; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/94/25/rna-10-1501.PMC3858433.pdf
Nucleic Acids Res 2004; 32(Database  issue):D115-9; PMID:14681372; http://dx.doi.org/10.1093/nar/gkh131 48.,OADS,/arxiv_data1/oa_pdf/94/25/rna-10-1501.PMC3858433.pdf
Nucleic Acids Res  2012; 40(Database issue):D306-12; PMID:22096229;  http://dx.doi.org/10.1093/nar/gkr948 49.,OADS,/arxiv_data1/oa_pdf/94/25/rna-10-1501.PMC3858433.pdf
BMC Bioinformatics  2007; 8:2; PMID:17199898; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/94/25/rna-10-1501.PMC3858433.pdf
Cell  Res 2009; 19:271-3; PMID:19153597; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/94/25/rna-10-1501.PMC3858433.pdf
Nucleic Acids  Res 2004; 32:1792-7; PMID:15034147; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/94/25/rna-10-1501.PMC3858433.pdf
Syst Biol 2012; 61:539-42; PMID:22357727;  http://dx.doi.org/10.1093/sysbio/sys02925.,OADS,/arxiv_data1/oa_pdf/94/25/rna-10-1501.PMC3858433.pdf
Plant Physiol 2010; 154:1588- 601; PMID:20935174; http://dx.doi.org/10.1104/ pp.110.164111 26.,Non-OADS,/arxiv_data1/oa_pdf/94/25/rna-10-1501.PMC3858433.pdf
J Plant Res 2013; 126:403-14;  PMID:23076438; http://dx.doi.org/10.1007/s10265-012-0527-1 27.,OADS,/arxiv_data1/oa_pdf/94/25/rna-10-1501.PMC3858433.pdf
Cell 1993; 74:787-99; PMID:7690685; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/94/25/rna-10-1501.PMC3858433.pdf
Plant Physiol  1996; 112:1465-9; PMID:8972595; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/94/25/rna-10-1501.PMC3858433.pdf
Plant  J 2004; 40:672-85; PMID:15546351; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/94/25/rna-10-1501.PMC3858433.pdf
Front Plant Sci 2012;  3:135; PMID:22723802; http://dx.doi.org/10.3389/ fpls.2012.00135 32.,OADS,/arxiv_data1/oa_pdf/94/25/rna-10-1501.PMC3858433.pdf
Front Plant  Sci 2013; 4:14; PMID:23407626; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/94/25/rna-10-1501.PMC3858433.pdf
Plant J 2008; 56:590-602; PMID:18657233;  http://dx.doi.org/10.1111/j.1365-313X.2008.03634.x 35.,OADS,/arxiv_data1/oa_pdf/94/25/rna-10-1501.PMC3858433.pdf
Plant  J 2000; 22:303-13; PMID:10849347; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/94/25/rna-10-1501.PMC3858433.pdf
Plant Cell 2013; 25:2265- 75; PMID:23735295; http://dx.doi.org/10.1105/ tpc.113.111567 37.,OADS,/arxiv_data1/oa_pdf/94/25/rna-10-1501.PMC3858433.pdf
J Eukaryot Microbiol 1999; 46:347-66; PMID:18092388; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/94/25/rna-10-1501.PMC3858433.pdf
Plant Physiol 2011; 157:1342- 62; PMID:21908688; http://dx.doi.org/10.1104/ pp.111.183129 14.,Non-OADS,/arxiv_data1/oa_pdf/94/25/rna-10-1501.PMC3858433.pdf
Plant Physiol 2012; 158:1610-27; PMID:22345507; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/94/25/rna-10-1501.PMC3858433.pdf
PLoS One 2011; 6:e28398; PMID:22164284; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/94/25/rna-10-1501.PMC3858433.pdf
Mol Cell Proteomics 2010; 9:1594-615;  PMID:20423899; http://dx.doi.org/10.1074/mcp.,OADS,/arxiv_data1/oa_pdf/94/25/rna-10-1501.PMC3858433.pdf
J Proteome Res  2013; 12:491-504; PMID:23198870; http://dx.doi.org/10.1021/pr300952g 18.,Non-OADS,/arxiv_data1/oa_pdf/94/25/rna-10-1501.PMC3858433.pdf
Plant Physiol  2012; 158:156-89; PMID:22065420; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/94/25/rna-10-1501.PMC3858433.pdf
Plant Cell 2006; 18:176- 97; PMID:16326926; http://dx.doi.org/10.1105/ tpc.105.036392 20.,OADS,/arxiv_data1/oa_pdf/94/25/rna-10-1501.PMC3858433.pdf
Plant Cell 2012;  24:3060-73; PMID:22797472; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/94/25/rna-10-1501.PMC3858433.pdf
Mol  Cell Proteomics 2010; 9:1063-84; PMID:20061580;  http://dx.doi.org/10.1074/mcp.M900325-MCP200 22.,OADS,/arxiv_data1/oa_pdf/94/25/rna-10-1501.PMC3858433.pdf
Mol Syst Biol 2012;  8:606; PMID:22929616; http://dx.doi.org/10.1038/ msb.2012.39 23.,Non-OADS,/arxiv_data1/oa_pdf/94/25/rna-10-1501.PMC3858433.pdf
Plant Physiol 2010; 152:1219-50; PMID:20089766;  http://dx.doi.org/10.1104/pp.109.152694 24.,Non-OADS,/arxiv_data1/oa_pdf/94/25/rna-10-1501.PMC3858433.pdf
Plant Cell 2009; 21:1669- 92; PMID:19525416; http://dx.doi.org/10.1105/ tpc.108.063784,OADS,/arxiv_data1/oa_pdf/94/25/rna-10-1501.PMC3858433.pdf
Nucleic Acids Res 2013; 41(Database issue):D1185-91;  PMID:23180787; http://dx.doi.org/10.1093/nar/ gks1151 61.,OADS,/arxiv_data1/oa_pdf/94/25/rna-10-1501.PMC3858433.pdf
Trends Plant Sci 2004; 9:293-301; PMID:15165561;  http://dx.doi.org/10.1016/j.tplants.2004.04.00158.,OADS,/arxiv_data1/oa_pdf/94/25/rna-10-1501.PMC3858433.pdf
Curr Biol 2004; 14:354-62; PMID:15028209;  http://dx.doi.org/10.1016/j.cub.2004.02.039 59.,OADS,/arxiv_data1/oa_pdf/94/25/rna-10-1501.PMC3858433.pdf
PLoS One 2008; 3:e1994;  PMID:18431481; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/94/25/rna-10-1501.PMC3858433.pdf
Biometrika 1995; 82:711-32; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/94/25/rna-10-1501.PMC3858433.pdf
Syst  Biol 2012; 61:170-3; PMID:21963610; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/94/25/rna-10-1501.PMC3858433.pdf
Mol Biol Evol 2008; 25:1253-6; PMID:18397919;  http://dx.doi.org/10.1093/molbev/msn083 57.,Non-OADS,/arxiv_data1/oa_pdf/94/25/rna-10-1501.PMC3858433.pdf
Proteomics 2004; 4:1581- 90; PMID:15174128; http://dx.doi.org/10.1002/ pmic.200300776,OADS,/arxiv_data1/oa_pdf/94/25/rna-10-1501.PMC3858433.pdf
"Do not distribute.www.landesbioscience.com  RNA Biology  1557RNA Biology 10:9, 1557–1575; S eptember 2013; © 2013 Landes Bioscience ReSeARch  p A pe R ReSeARch  p A pe R *Correspondence to: Claire Lurin; Email: lurin@evry.inra.fr Submitted: 03/29/2013; Revised: 08/11/2013; Accepted: 08/12/2013http://dx.doi.org/10.4161/rna.26128Introduction Plant nuclear genomes code for more than 99% of the 25  0 00– 30  0 00 proteins required to build plant cells and tissues.1 These  proteins are addressed to various cell compartments to ensure  specific cellular processes.",Non-OADS,/arxiv_data1/oa_pdf/64/f9/rna-10-1557.PMC3858439.pdf
(2)  ppR d omains were recovered from FLAGdb++ v5 (http://urgv.evry.inra.fr/projects/FLAGdb++/ hT ML/index.shtml) and from manually  curated published evidences.,OADS,/arxiv_data1/oa_pdf/64/f9/rna-10-1557.PMC3858439.pdf
(7) Data of  ppR  em bryo defective mutants ( eM B) was obtained from SeedGenes database (http://www.seedgenes.org/index.html)  and manually curated mutants from published studies.,OADS,/arxiv_data1/oa_pdf/64/f9/rna-10-1557.PMC3858439.pdf
"Subcellular  localization prediction of the PPR proteins were performed using TargetP server (http://www.cbs.dtu.dk/services/TargetP/) (ver - sion 1.01 was used when we initiated this work to select the 166 PPRs and version 1.1 was used when we built Tables 1 and 2 ),  Predotar v1.03 (http://urgi.versailles.inra.fr/predotar/predotar.html), iPSORT (http://ipsort.hgc.jp/), Loctree (https://www.rostlab.org/owiki/index.php/Loctree), Multiloc (http://abi.inf.uni-tuebingen.de/Services/MultiLoc/), and AtSubP (http://bioinfo3.noble.org/AtSubP/?dowhat=About) software using default setting.",OADS,/arxiv_data1/oa_pdf/64/f9/rna-10-1557.PMC3858439.pdf
"Proteomic data was recovered from published proteomic references and subcellular proteome databases: PPDB (Plant Proteome Database http://ppdb.tc.cornell.edu/), 43  SUBA3 (Subcellular location database for Arabidopsis proteins http://suba.plantenergy.uwa.edu.au/), 5 and AT_CHLORO  (http://www.grenoble.prabi.fr/at_chloro/).42 Subcellular localization of proteins.",OADS,/arxiv_data1/oa_pdf/64/f9/rna-10-1557.PMC3858439.pdf
Nature 2000; 408:796-815; PMID:11130711; http://dx.doi.org/10.1038/35048692 2.,Non-OADS,/arxiv_data1/oa_pdf/64/f9/rna-10-1557.PMC3858439.pdf
Curr Opin Genet Dev 1999; 9:678-87; PMID:10607615; http://dx.doi.org/10.1016/S0959-437X(99)00030-1 3.,OADS,/arxiv_data1/oa_pdf/64/f9/rna-10-1557.PMC3858439.pdf
Nat Genet 1997; 15:57-61; PMID:8988169; http://dx.doi.org/10.1038/ng0197-57 4.,Non-OADS,/arxiv_data1/oa_pdf/64/f9/rna-10-1557.PMC3858439.pdf
DNA Res 1999; 6:283-90; PMID:10574454; http://dx.doi.org/10.1093/dnares/6.5.283 5.,OADS,/arxiv_data1/oa_pdf/64/f9/rna-10-1557.PMC3858439.pdf
Nucleic Acids Res 2013; 41(Database issue):D1185-91; PMID:23180787; http://dx.doi.org/10.1093/nar/gks1151 6.,OADS,/arxiv_data1/oa_pdf/64/f9/rna-10-1557.PMC3858439.pdf
Biochim Biophys Acta 2013; 1833:304-13; PMID:22406071; http://dx.doi.org/10.1016/j.bbam - cr.2012.02.015 7.,OADS,/arxiv_data1/oa_pdf/64/f9/rna-10-1557.PMC3858439.pdf
Science 2013; 339:571-4; PMID:23372012; http://dx.doi.org/10.1126/sci-ence.1229262 8.,OADS,/arxiv_data1/oa_pdf/64/f9/rna-10-1557.PMC3858439.pdf
Nat Rev Mol Cell Biol 2011; 12:48-59; PMID:21139638; http://dx.doi.org/10.1038/nrm3027 9.,OADS,/arxiv_data1/oa_pdf/64/f9/rna-10-1557.PMC3858439.pdf
"Philos Trans R Soc Lond B Biol Sci 2003; 358:181-8, discussion 188-9; PMID:12594926; http://dx.doi.org/10.1098/rstb.2002.1179 1 0.",Non-OADS,/arxiv_data1/oa_pdf/64/f9/rna-10-1557.PMC3858439.pdf
Trends Plant Sci 2008; 13:663-70; PMID:19004664; http://dx.doi.org/10.1016/j.tplants.2008.10.001 11.,OADS,/arxiv_data1/oa_pdf/64/f9/rna-10-1557.PMC3858439.pdf
Plant Cell 2004; 16:2089-103; PMID:15269332; http://dx.doi.org/10.1105/tpc.104.022236 12.,OADS,/arxiv_data1/oa_pdf/64/f9/rna-10-1557.PMC3858439.pdf
Mol Biol Evol 2008; 25:1120-8; PMID:18343892; http://dx.doi.org/10.1093/molbev/msn057 13.,Non-OADS,/arxiv_data1/oa_pdf/64/f9/rna-10-1557.PMC3858439.pdf
Science 2011; 332:960-3; PMID:21551031; http://dx.doi.org/10.1126/sci-ence.1203810 14.,OADS,/arxiv_data1/oa_pdf/64/f9/rna-10-1557.PMC3858439.pdf
New Phytol 2011; 191:37-47; PMID:21557747; http://dx.doi.org/10.1111/j.1469-8137.2011.03746.x15.,Non-OADS,/arxiv_data1/oa_pdf/64/f9/rna-10-1557.PMC3858439.pdf
Mol Plant 2010; 3:691-705; PMID:20603383; http://dx.doi.org/10.1093/mp/ssq025 16.,OADS,/arxiv_data1/oa_pdf/64/f9/rna-10-1557.PMC3858439.pdf
PLoS Genet 2012; 8:e1002910; PMID:22916040; http://dx.doi.org/10.1371/journal.pgen.1002910 17.,OADS,/arxiv_data1/oa_pdf/64/f9/rna-10-1557.PMC3858439.pdf
PLoS One 2013; 8:e57286; PMID:23472078; http://dx.doi.org/10.1371/journal.pone.0057286 18.,Non-OADS,/arxiv_data1/oa_pdf/64/f9/rna-10-1557.PMC3858439.pdf
Nature 2005; 433:326-30; PMID:15662426; http://dx.doi.org/10.1038/nature03229 19.,Non-OADS,/arxiv_data1/oa_pdf/64/f9/rna-10-1557.PMC3858439.pdf
"Plant Cell 2009; 21:558-67; PMID:19252080; http://dx.doi.org/10.1105/tpc.108.064535 20.  de Longevialle AF, Meyer EH, Andrés C, Taylor NL, Lurin C, Millar AH, Small ID.",OADS,/arxiv_data1/oa_pdf/64/f9/rna-10-1557.PMC3858439.pdf
"Plant Cell 2007; 19:3256-65; PMID:17965268; http://dx.doi.org/10.1105/tpc.107.054841 21.  de Longevia lle AF, Hendrickson L, Taylor NL,  Delannoy E, Lurin C, Badger M, Millar AH, Small I.",OADS,/arxiv_data1/oa_pdf/64/f9/rna-10-1557.PMC3858439.pdf
Plant J 2008; 56:157-68; PMID:18557832; http://dx.doi.org/10.1111/j.1365-313X.2008.03581.x 22.,OADS,/arxiv_data1/oa_pdf/64/f9/rna-10-1557.PMC3858439.pdf
Plant Cell 2005; 17:2791-804; PMID:16141451; http://dx.doi.org/10.1105/tpc.105.034454 23.,OADS,/arxiv_data1/oa_pdf/64/f9/rna-10-1557.PMC3858439.pdf
J Mol Biol  2008; 375:626-36; PMID:18054044; http://dx.doi.org/10.1016/j.jmb.2007.11.011 24.,OADS,/arxiv_data1/oa_pdf/64/f9/rna-10-1557.PMC3858439.pdf
Plant Physiol 2012; 158:1115-29; PMID:22247268; http://dx.doi.org/10.1104/pp.111.192393 25.,Non-OADS,/arxiv_data1/oa_pdf/64/f9/rna-10-1557.PMC3858439.pdf
PLoS One 2011; 6:e28398; PMID:22164284; http://dx.doi.org/10.1371/journal.pone.0028398 26.,Non-OADS,/arxiv_data1/oa_pdf/64/f9/rna-10-1557.PMC3858439.pdf
Genes Dev 2012; 26:1022-7; PMID:22549728; http://dx.doi.org/10.1101/gad.189514.112 27.,OADS,/arxiv_data1/oa_pdf/64/f9/rna-10-1557.PMC3858439.pdf
Plant Cell 2006; 18:815-30; PMID:16489121; http://dx.doi.org/10.1105/tpc.105.039495 28.,OADS,/arxiv_data1/oa_pdf/64/f9/rna-10-1557.PMC3858439.pdf
Plant Cell 2011; 23:730-40; PMID:21297037; http://dx.doi.org/10.1105/tpc.110.08163829.,OADS,/arxiv_data1/oa_pdf/64/f9/rna-10-1557.PMC3858439.pdf
PLoS Biol 2007; 5:e117; PMID:17456005; http://dx.doi.org/10.1371/journal.pbio.0050117 3  0.,Non-OADS,/arxiv_data1/oa_pdf/64/f9/rna-10-1557.PMC3858439.pdf
PLoS Genet 2011; 7:e1002324; PMID:22022283; http://dx.doi.org/10.1371/journal.pgen.1002324 31.,Non-OADS,/arxiv_data1/oa_pdf/64/f9/rna-10-1557.PMC3858439.pdf
Nat Protoc 2007; 2:953-71; PMID:17446895; http://dx.doi.org/10.1038/nprot.2007.131 32.,Non-OADS,/arxiv_data1/oa_pdf/64/f9/rna-10-1557.PMC3858439.pdf
Proteomics 2004; 4:1581-90;   PMID:15174128; http://dx.doi.org/10.1002/pmic.200300776 33.,OADS,/arxiv_data1/oa_pdf/64/f9/rna-10-1557.PMC3858439.pdf
FEBS Lett 1988; 235:173-7; PMID:3402595; http://dx.doi.org/10.1016/0014-5793(88)81257-2 34.,OADS,/arxiv_data1/oa_pdf/64/f9/rna-10-1557.PMC3858439.pdf
J Bioenerg Biomembr 1997; 29:19-27; PMID:9067798; http://dx.doi.org/10.1023/A:1022403604273 35.,Non-OADS,/arxiv_data1/oa_pdf/64/f9/rna-10-1557.PMC3858439.pdf
J Biol Chem 1996; 271:21226-30; PMID:8702895; http://dx.doi.org/10.1074/jbc.271.35.21226 36.,OADS,/arxiv_data1/oa_pdf/64/f9/rna-10-1557.PMC3858439.pdf
Plant Physiol 2009; 150:1272-85; PMID:19474214; http://dx.doi.org/10.1104/pp.109.137885 37.,Non-OADS,/arxiv_data1/oa_pdf/64/f9/rna-10-1557.PMC3858439.pdf
J Mol Biol 2010; 402:510-23; PMID:20688079; http://dx.doi.org/10.1016/j.jmb.2010.07.052 38.,OADS,/arxiv_data1/oa_pdf/64/f9/rna-10-1557.PMC3858439.pdf
Bioinformatics 2002; 18:298-305; PMID:11847077; http://dx.doi.org/10.1093/bioinfor-matics/18.2.298 39.,OADS,/arxiv_data1/oa_pdf/64/f9/rna-10-1557.PMC3858439.pdf
J Mol Biol   2005; 348:85-100; PMID:15808855; http://dx.doi.org/10.1016/j.jmb.2005.02.025 40.,OADS,/arxiv_data1/oa_pdf/64/f9/rna-10-1557.PMC3858439.pdf
Bioinformatics 2006; 22:1158-65; PMID:16428265; http://dx.doi.org/10.1093/bioinformatics/btl002 41.,OADS,/arxiv_data1/oa_pdf/64/f9/rna-10-1557.PMC3858439.pdf
Plant Physiol 2010; 154:36-54; PMID:20647376; http://dx.doi.org/10.1104/pp.110.156851 42.,Non-OADS,/arxiv_data1/oa_pdf/64/f9/rna-10-1557.PMC3858439.pdf
Mol Cell Proteomics 2010; 9:1063-84; PMID:20061580; http://dx.doi.org/10.1074/mcp.M900325-MCP200,OADS,/arxiv_data1/oa_pdf/64/f9/rna-10-1557.PMC3858439.pdf
Plant Cell 2012; 24:676-91; PMID:22319053; http://dx.doi.org/10.1105/tpc.111.091074 70.,OADS,/arxiv_data1/oa_pdf/64/f9/rna-10-1557.PMC3858439.pdf
Plant J 2012; 71:836-49; PMID:22540321; http://dx.doi.org/10.1111/j.1365-313X.2012.05036.x 71.,OADS,/arxiv_data1/oa_pdf/64/f9/rna-10-1557.PMC3858439.pdf
Plant J 2013; 74:935-45; PMID:23521509; http://dx.doi.org/10.1111/tpj.12180 72.,OADS,/arxiv_data1/oa_pdf/64/f9/rna-10-1557.PMC3858439.pdf
Plant Cell 2004; 16:241-56; PMID:14671022; http://dx.doi.org/10.1105/tpc.016055 73.,OADS,/arxiv_data1/oa_pdf/64/f9/rna-10-1557.PMC3858439.pdf
Curr Biol 2004; 14:354-62; PMID:15028209; http://dx.doi.org/10.1016/j.cub.2004.02.039 74.,OADS,/arxiv_data1/oa_pdf/64/f9/rna-10-1557.PMC3858439.pdf
Plant Physiol 2011; 157:587-98; PMID:21841088; http://dx.doi.org/10.1104/pp.111.182352 75.,Non-OADS,/arxiv_data1/oa_pdf/64/f9/rna-10-1557.PMC3858439.pdf
J Biol Chem 2004; 279:49367-83; PMID:15322131; http://dx.doi.org/10.1074/jbc.M406763200 76.,OADS,/arxiv_data1/oa_pdf/64/f9/rna-10-1557.PMC3858439.pdf
PLoS One 2008; 3:e1994; PMID:18431481; http://dx.doi.org/10.1371/journal.pone.0001994 77.,Non-OADS,/arxiv_data1/oa_pdf/64/f9/rna-10-1557.PMC3858439.pdf
J Exp Bot 2012; 63:5301-10; PMID:22821940; http://dx.doi.org/10.1093/jxb/ers188 78.,OADS,/arxiv_data1/oa_pdf/64/f9/rna-10-1557.PMC3858439.pdf
Plant J 2010; 61:456-66; PMID:19929879; http://dx.doi.org/10.1111/j.1365-313X.2009.04082.x 79.,OADS,/arxiv_data1/oa_pdf/64/f9/rna-10-1557.PMC3858439.pdf
Plant J 2010; 61:446-55; PMID:19919573; http://dx.doi.org/10.1111/j.1365-313X.2009.04076.x 80.,OADS,/arxiv_data1/oa_pdf/64/f9/rna-10-1557.PMC3858439.pdf
Biochim Biophys Acta 2013; 1833:253-9; PMID:22683762; http://dx.doi.org/10.1016/j.bbamcr.2012.05.029 81.,OADS,/arxiv_data1/oa_pdf/64/f9/rna-10-1557.PMC3858439.pdf
Plant Physiol 2013; 161:644-62; PMID:23257241; http://dx.doi.org/10.1104/pp.112.21099756.,Non-OADS,/arxiv_data1/oa_pdf/64/f9/rna-10-1557.PMC3858439.pdf
Proteomics 2011; 11:1780-8; PMID:21433285; http://dx.doi.org/10.1002/pmic.201000648 57.,OADS,/arxiv_data1/oa_pdf/64/f9/rna-10-1557.PMC3858439.pdf
Plant Physiol 2011; 157:1342-62; PMID:21908688; http://dx.doi.org/10.1104/pp.111.183129 58.,Non-OADS,/arxiv_data1/oa_pdf/64/f9/rna-10-1557.PMC3858439.pdf
Nat Struct Mol Biol 2010; 17:740-4; PMID:20473316; http://dx.doi.org/10.1038/nsmb.1812 59.,OADS,/arxiv_data1/oa_pdf/64/f9/rna-10-1557.PMC3858439.pdf
Plant Physiol 2012; 158:156-89; PMID:22065420; http://dx.doi.org/10.1104/pp.111.188474 60.,Non-OADS,/arxiv_data1/oa_pdf/64/f9/rna-10-1557.PMC3858439.pdf
Plant J 2003; 36:541-9; PMID:14617084; http://dx.doi.org/10.1046/j.1365-313X.2003.01900.x 61.,OADS,/arxiv_data1/oa_pdf/64/f9/rna-10-1557.PMC3858439.pdf
Plant Cell 2003; 15:1480-95; PMID:12782738; http://dx.doi.org/10.1105/tpc.010397 62.,OADS,/arxiv_data1/oa_pdf/64/f9/rna-10-1557.PMC3858439.pdf
Plant Cell 2006; 18:2650-63; PMID:17041147; http://dx.doi.org/10.1105/tpc.106.046110 63.,OADS,/arxiv_data1/oa_pdf/64/f9/rna-10-1557.PMC3858439.pdf
Plant Cell 2007; 19:196-210; PMID:17259266; http://dx.doi.org/10.1105/tpc.105.039594 64.,OADS,/arxiv_data1/oa_pdf/64/f9/rna-10-1557.PMC3858439.pdf
Plant Physiol 2009; 150:1260-71; PMID:19448041; http://dx.doi.org/10.1104/pp.109.136812 65.,Non-OADS,/arxiv_data1/oa_pdf/64/f9/rna-10-1557.PMC3858439.pdf
Plant Cell 2009; 21:146-56; PMID:19182104; http://dx.doi.org/10.1105/tpc.108.064667 66.,OADS,/arxiv_data1/oa_pdf/64/f9/rna-10-1557.PMC3858439.pdf
Plant Physiol 2011; 156:2053-68; PMID:21653783; http://dx.doi.org/10.1104/pp.111.177501 67.,Non-OADS,/arxiv_data1/oa_pdf/64/f9/rna-10-1557.PMC3858439.pdf
Plant Physiol 2010; 152:939-47; PMID:20018598; http://dx.doi.org/10.1104/pp.109.151175 68.,Non-OADS,/arxiv_data1/oa_pdf/64/f9/rna-10-1557.PMC3858439.pdf
Plant Cell 2009; 21:3686-99; PMID:19934379; http://dx.doi.org/10.1105/tpc.109.07147243.,OADS,/arxiv_data1/oa_pdf/64/f9/rna-10-1557.PMC3858439.pdf
Nucleic Acids Res 2009; 37(Database issue):D969-74; PMID:18832363; http://dx.doi.org/10.1093/nar/gkn654 44.,OADS,/arxiv_data1/oa_pdf/64/f9/rna-10-1557.PMC3858439.pdf
Plant Physiol 2009; 149:719-34; PMID:19010998; http://dx.doi.org/10.1104/pp.108.131300 45.,Non-OADS,/arxiv_data1/oa_pdf/64/f9/rna-10-1557.PMC3858439.pdf
J Proteome Res 2013; 12:491-504; PMID:23198870; http://dx.doi.org/10.1021/pr300952g 46.,Non-OADS,/arxiv_data1/oa_pdf/64/f9/rna-10-1557.PMC3858439.pdf
Proteomics 2012; 12:1024-38; PMID:22522809; http://dx.doi.org/10.1002/pmic.201100413 47.,OADS,/arxiv_data1/oa_pdf/64/f9/rna-10-1557.PMC3858439.pdf
J Proteome Res 2011; 10:1571-82; PMID:21166475; http://dx.doi.org/10.1021/pr1009433 48.,Non-OADS,/arxiv_data1/oa_pdf/64/f9/rna-10-1557.PMC3858439.pdf
Mol Biol Cell 2005; 16:260-9; PMID:15496452; http://dx.doi.org/10.1091/mbc.E04-09-0791 49.,Non-OADS,/arxiv_data1/oa_pdf/64/f9/rna-10-1557.PMC3858439.pdf
Plant Cell Physiol 2013; 54:622-33; PMID:23396599; http://dx.doi.org/10.1093/pcp/pct031 50.,Non-OADS,/arxiv_data1/oa_pdf/64/f9/rna-10-1557.PMC3858439.pdf
Plant Cell Physiol 2004; 45:1543-56; PMID:15574830; http://dx.doi.org/10.1093/pcp/pch209 51.,Non-OADS,/arxiv_data1/oa_pdf/64/f9/rna-10-1557.PMC3858439.pdf
Mol Cell Proteomics 2007; 6:394-412; PMID:17151019; http://dx.doi.org/10.1074/mcp.M600250-MCP200 52.,OADS,/arxiv_data1/oa_pdf/64/f9/rna-10-1557.PMC3858439.pdf
J Biol Chem 2010; 285:39140-9; PMID:20843791; http://dx.doi.org/10.1074/jbc.M110.160531 53.,OADS,/arxiv_data1/oa_pdf/64/f9/rna-10-1557.PMC3858439.pdf
Plant Cell Physiol 2012; 53:543-54; PMID:22318864; http://dx.doi.org/10.1093/pcp/pcs010 54.,Non-OADS,/arxiv_data1/oa_pdf/64/f9/rna-10-1557.PMC3858439.pdf
J Proteome Res 2009; 8:2752-67; PMID:19334764; http://dx.doi.org/10.1021/pr801044y 55.,Non-OADS,/arxiv_data1/oa_pdf/64/f9/rna-10-1557.PMC3858439.pdf
Proteomics 2004; 4:397-406; PMID:14760709; http://dx.doi.org/10.1002/pmic.200300607,OADS,/arxiv_data1/oa_pdf/64/f9/rna-10-1557.PMC3858439.pdf
Trends Plant Sci 2009; 14:194- 9; PMID:19285907; http://dx.doi.org/10.1016/j.tplants.2009.01.005 88.,OADS,/arxiv_data1/oa_pdf/64/f9/rna-10-1557.PMC3858439.pdf
Plant Mol Biol 2000; 42:819-32; PMID:10890530; http://dx.doi.org/10.1023/A:1006496308160 89.,OADS,/arxiv_data1/oa_pdf/64/f9/rna-10-1557.PMC3858439.pdf
Plant Mol Biol 2005; 58:421-33; PMID:16021404; http://dx.doi.org/10.1007/s11103-005-5702-5 85.,OADS,/arxiv_data1/oa_pdf/64/f9/rna-10-1557.PMC3858439.pdf
Biochim Biophys Acta 2011; 1808:1012-20; PMID:20637721; http://dx.doi.org/10.1016/j.bbamem.2010.07.004 86.,OADS,/arxiv_data1/oa_pdf/64/f9/rna-10-1557.PMC3858439.pdf
Front Plant Sci 2012; 3:221; PMID:23056004; http://dx.doi.org/10.3389/fpls.2012.0022182.,OADS,/arxiv_data1/oa_pdf/64/f9/rna-10-1557.PMC3858439.pdf
J Biol Chem 2011; 286:21361-71; PMID:21504904; http://dx.doi.org/10.1074/jbc.M111.230516 83.,OADS,/arxiv_data1/oa_pdf/64/f9/rna-10-1557.PMC3858439.pdf
This is an open- access article distributed under the terms of the Creative Commons Licens e (http://creativecommons.org/  licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/f8/4d/ijbsv09p1079.PMC3858581.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/1e/c4/ijbsv09p1089.PMC3858582.pdf
"The image file was inverted; co n- sequentially spots were digitized using ScanAlyze  software (Ve rsion 2.51; http://rana.lbl.gov/   EisenSoftware.htm), and normalized by subtracting  the background as the average intensity value of 3 spots containing plasmid DNA (PUC18).",OADS,/arxiv_data1/oa_pdf/1e/c4/ijbsv09p1089.PMC3858582.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/39/73/ijbsv09p1099.PMC3858583.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/  licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/5d/c5/ijbsv09p1121.PMC3858585.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/4b/e1/ijbsv09p1134.PMC3858586.pdf
The application can be downloaded from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/d7/bc/SJA-7-365.PMC3858682.pdf
"7, Issue 4, October-December 2013  Saudi Journal of AnaesthesiaThe survey was distributed via the commercially available  “Survey Monkey” software  (www.surveymonkey.com)  to all practicing anesthesiologists in Saudi Arabia, who  are physically attending the bi- annual meetings of  the   Saudi Anaesthetic Association, via email and/or an  electronic invitation message sent to the members of  the Triple M (Morbidity Mortality Meeting (MMM)) anesthesia Yahoo group (http://health.groups.yahoo.com/group/ Triple M).",Non-OADS,/arxiv_data1/oa_pdf/39/d1/SJA-7-367.PMC3858683.pdf
2. http://www.asra.com/Newsletters/Feb_09.pdf [last assessed  on 2013 Feb 14].,Non-OADS,/arxiv_data1/oa_pdf/20/1d/SJA-7-371.PMC3858684.pdf
The application can be downloaded from http://itunes.apple.com/us/app/medknow-journals/id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/ab/7e/SJA-7-373.PMC3858685.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/0e/d2/SJA-7-387.PMC3858687.pdf
available from: http://www.icmr.nic.in/ ijmr/2009/november/1125.,Non-OADS,/arxiv_data1/oa_pdf/ec/57/SJA-7-427.PMC3858694.pdf
Start a QR-code reading software (see list of free applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR-code printed in the journal.,Non-OADS,/arxiv_data1/oa_pdf/7c/b0/SJA-7-464.PMC3858701.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.,Non-OADS,/arxiv_data1/oa_pdf/7c/b0/SJA-7-464.PMC3858701.pdf
E-mail: sukhminder_bajwa2001@yahoo.com ReFeRenceS 1. available from: http://sciencewatch.com/grr/india/.,Non-OADS,/arxiv_data1/oa_pdf/97/e4/SJA-7-477.PMC3858706.pdf
3. available from: http://archive.sciencewatch.com/dr/ cou/2011/11decall/.,Non-OADS,/arxiv_data1/oa_pdf/97/e4/SJA-7-477.PMC3858706.pdf
4. available from: http://archive.sciencewatch.com/dr/ cou/2012/12janallgraphs/.,Non-OADS,/arxiv_data1/oa_pdf/97/e4/SJA-7-477.PMC3858706.pdf
The application can be downloaded  from http://itunes.apple.com/us/app/medknow-journals/id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/9c/fa/DRJ-10-602.PMC3858733.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/6a/37/DRJ-10-609.PMC3858734.pdf
The application can be downloaded  from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/a0/81/DRJ-10-630.PMC3858738.pdf
"Rescue efforts were complicated by heavy snow in the  area (http://en.wikipedia.org/wik/Iran_Air_Flight_277).A 25-year-old female crash victim with multiple head  injuries (skull fracture and two fractures in mandible),  leg injuries (broken left leg), abdominal injuries  (ruptured liver), spinal fractures, head contusion in  left temporal lobe (CT scan revealed edema and  hematoma) and other injuries was referred to Urmia  Imam Khomeini Education and Treatment Center and  was incubated for 2 weeks until her homodynamic,  low blood pressure and pneumonia got under control.",Non-OADS,/arxiv_data1/oa_pdf/a3/53/DRJ-10-678.PMC3858746.pdf
http://www.R-project.org.,Non-OADS,/arxiv_data1/oa_pdf/fa/53/srep03471.PMC3858787.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/fa/53/srep03471.PMC3858787.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3471 | DOI: 10.1038/srep03471 8",Non-OADS,/arxiv_data1/oa_pdf/fa/53/srep03471.PMC3858787.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3473 | DOI: 10.1038/srep03473 4",Non-OADS,/arxiv_data1/oa_pdf/55/0a/srep03473.PMC3858788.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3478 | DOI: 10.1038/srep03478 6",Non-OADS,/arxiv_data1/oa_pdf/cd/b5/srep03478.PMC3858789.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3479 | DOI: 10.1038/srep03479 5",Non-OADS,/arxiv_data1/oa_pdf/a4/2d/srep03479.PMC3858790.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3480 | DOI: 10.1038/srep03480 5",Non-OADS,/arxiv_data1/oa_pdf/6a/a0/srep03480.PMC3858791.pdf
"ensembl.org/index.html]) databases were used to search for available mouse genesequences to design primers using Primer3Plus [http://www.bioinformatics.nl/cgi- bin/primer3plus/primer3plus.cgi], taking into account possible secondary structures using Mfold [http://mfold.rna.albany.edu/?q 5mfold]) and the specificity of the Figure 6 |Schematic representation of the mouse TrpRS gene.",OADS,/arxiv_data1/oa_pdf/e6/ae/srep03477.PMC3858792.pdf
primers using BLAST [http://blast.ncbi.nlm.nih.gov/]).,OADS,/arxiv_data1/oa_pdf/e6/ae/srep03477.PMC3858792.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3477 | DOI: 10.1038/srep03477 7",Non-OADS,/arxiv_data1/oa_pdf/e6/ae/srep03477.PMC3858792.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/20/04/srep03475.PMC3858794.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3475 | DOI: 10.1038/srep03475 5",Non-OADS,/arxiv_data1/oa_pdf/20/04/srep03475.PMC3858794.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/6e/d5/srep03481.PMC3858796.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3481 | DOI: 10.1038/srep03481 5",Non-OADS,/arxiv_data1/oa_pdf/6e/d5/srep03481.PMC3858796.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreportsCompeting financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/b7/b2/srep03472.PMC3858797.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3472 | DOI: 10.1038/srep03472 7",Non-OADS,/arxiv_data1/oa_pdf/b7/b2/srep03472.PMC3858797.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/7b/bd/srep03474.PMC3858798.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3474 | DOI: 10.1038/srep03474 13",Non-OADS,/arxiv_data1/oa_pdf/7b/bd/srep03474.PMC3858798.pdf
"Surgical Neurology International Surgical Neurology International Editor Antonio A. F. DeSalles,  MD University of California, Los Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :   http://www.surgicalneurologyint.comSNI: Stereotactic, a supplement to Surgical Neurology International S411Minimally invasive management of adult craniopharyngiomas: An  analysis of our series and review of literature Gazanfar Rahmathulla1,2, Gene H. Barnett1 Departments of Neurosurgery, 1 The Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center, Neurological and Taussig Cancer Institutes, Cleveland Clinic,  Cleveland, Ohio, United States, 2Mayo Clinic, Jacksonville, Florida E-mail: Gazanfar Rahmathulla - rahmathulla.gazanfar@mayo.edu; *Gene H. Barnett - barnetg@ccf.org *Corresponding author Received: 14 March 13  Accepted: 08 May 13  Published: 20 November 13   Abstract Background:  Craniopharyngiomas (CPs) are slow growing tumors with an  incidence of between 1.2% and 4.6%, having a bimodal age distribution typically peaking in childhood and in adults between 45 and 60 years.",Non-OADS,/arxiv_data1/oa_pdf/57/d1/SNI-4-411.PMC3858800.pdf
"Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2013/4/7/411/121612 Copyright: © 2012 Rahmathulla G. This is an open-access article distributed under the terms of the Creative Commons Attribution  License, which permits unrestricted use,  distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/57/d1/SNI-4-411.PMC3858800.pdf
"Surgical Neurology International Editor Antonio A. F. DeSalles,  MD University of California,  Los Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Stereotactic, a supplement to Surgical Neurology International S422Clinical functional anatomy of the pterygopalatine ganglion,  cephalgia and related dysautonomias: A review Seyed Ali Khonsary, Quanfeng Ma, Pablo Villablanca1, Josh Emerson, Dennis Malkasian Department of Neurosurgery, Skull Base Laboratory, 1Department of Radiological Sciences, UCLA School of Medicine, Los Angeles, CA 90036, USA E‑mail: *Seyed Ali Khonsary ‑ akhon@ucla.edu; Quanfeng Ma ‑ quanfeng.ma@gmail.com; Pablo Villablanca ‑ pvillablanca@mednet.ucla.edu;   Josh Emerson ‑ jemerson@mednet.ucla.edu; Dennis Malkasian ‑ dennis.malkasian@sbcglobal.net   *Corresponding author Received: 14 February 13 Accepted: 21 October 13 Published: 20 November 13 Access this article  online Website: www.surgicalneurologyint.com DOI:   10.4103/2152-7806.121628 Quick Response Code: Abstract The purpose of this article is to explain the anatomy of the pterygopalatine  ganglion (PPG), its location in the pterygopalatine fossa (PPF) in the skull, and  the relationship it has to the Vidian nerve terminal branches and the fifth cranial  nerve.",Non-OADS,/arxiv_data1/oa_pdf/df/93/SNI-4-422.PMC3858801.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2013/4/7/422/121628 Copyright: © 2013 Khonsary SA.,Non-OADS,/arxiv_data1/oa_pdf/df/93/SNI-4-422.PMC3858801.pdf
"Surgical Neurology International Surgical Neurology International Editor Antonio A. F. DeSalles,  MD University of California, Los Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :   http://www.surgicalneurologyint.comSNI: Stereotactic, a supplement to Surgical Neurology International S429Stereotactic radiosurgery for the treatment of Glomus Jugulare  Tumors Emerson Magno de Andrade, José Reginaldo Brito, Susana Dias Mario, Suely Maymone de Melo,  Salomon Benabou Stereotactic Radiosurgery Service, Hospital Bandeirantes, São Paulo-SP , Brazil E-mail: *Emerson Magno de Andrade - emersonmagno@hotmail.com; José Reginaldo Brito - jrnbrito@gmail.com; Susana Dias Mario - sd .mario@uol.com.br;  Suely Maymone de Melo - suelymmm@ig.com.br; Salomon Benabou - neurorad@t erra.com.br Received: 10 June 13 Accepted: 13 August 13 Published: 20 November 13 Abstract Background:  The glomus jugulare tumor is a slowly growing benign neoplasm  originating from neural crest.",Non-OADS,/arxiv_data1/oa_pdf/34/f5/SNI-4-429.PMC3858802.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2013/4/7/429/121629 Copyright: © 2013 de Andrade EM.,Non-OADS,/arxiv_data1/oa_pdf/34/f5/SNI-4-429.PMC3858802.pdf
"Surgical Neurology International Surgical Neurology International Editor Antonio A. F. DeSalles,  MD University of California, Los Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :   http://www.surgicalneurologyint.comSNI: Stereotactic, a supplement to Surgical Neurology International S436Stereotactic radiosurgery boost to the resection cavity for cerebral  metastases: Report of overall survival, complications, and corticosteroid protocol Robert G. Kellogg, David C. Straus, Mehee Choi1, Thymur A. Chaudhry2, Aidnag Z. Diaz3,  Lorenzo F .",Non-OADS,/arxiv_data1/oa_pdf/cb/76/SNI-4-436.PMC3858803.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2013/4/7/436/121632 Copyright: © 2013 Kellogg RG.,Non-OADS,/arxiv_data1/oa_pdf/cb/76/SNI-4-436.PMC3858803.pdf
"Surgical Neurology International Surgical Neurology International Editor Antonio A. F. DeSalles,  MD University of California, Los Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :   http://www.surgicalneurologyint.comSNI: Stereotactic, a supplement to Surgical Neurology International S443Neuropsychological effects of deep brain stimulation for  Parkinson’s disease Ali Harati, Thomas Müller1 Neurosurgical Department, Klinikum Dortmund, 1Department for Neurology, St. Joseph-Krankenhaus Berlin-Weißensee, Germany E-mail: *Ali Harati - ali.harati@klinikumdo.de; Thomas Müller - th.mueller@alexius.de *Corresponding author Received: 14 June 13 Accepted: 21 August 13 Published: 20 November 13 Abstract Background:  Putative changes of cognition after deep brain stimulation (DBS)  in patients with Parkinson’s disease (PD) are a matter of debate.",Non-OADS,/arxiv_data1/oa_pdf/05/83/SNI-4-443.PMC3858804.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2013/4/7/443/121637 Copyright: © 2013 Harati A.,Non-OADS,/arxiv_data1/oa_pdf/05/83/SNI-4-443.PMC3858804.pdf
"Surgical Neurology International Surgical Neurology International Editor Antonio A. F. DeSalles,  MD University of California, Los Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :   http://www.surgicalneurologyint.comSNI: Stereotactic, a supplement to Surgical Neurology International S448Image guided surgery in the management of craniocerebral  gunshot injuries Tarek Elserry, Hesham Anwer, Ignatius Ngene Esene Department of Neurosurgery, Faculty of Medicine, Ain Shams University, Cairo, Egypt E-mail: *Tarek Elserry - elserry@yahoo.com; Hesham Anwer - hishambando@yahoo.com; Ignatius Ngene Esene - esenengene@yahoo.co.uk *Corresponding author Received: 16 March 13  Accepted: 06 September 13  Published: 20 November 13 Abstract Background: A craniocerebral trauma caused by ﬁ rearms is a complex injury  with high morbidity and mortality.",Non-OADS,/arxiv_data1/oa_pdf/fb/da/SNI-4-448.PMC3858805.pdf
"Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2013/4/7/448/121642 Copyright: © 2013 Elserry T. This is an open-access article distributed under the terms of the Creative Commons Attribution Lic ense, which permits unrestricted use, distribution,  and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/fb/da/SNI-4-448.PMC3858805.pdf
"Surgical Neurology International Surgical Neurology International Editor Antonio A. F. DeSalles,  MD University of California, Los Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :   http://www.surgicalneurologyint.comSNI: Stereotactic, a supplement to Surgical Neurology International S455Management of trigeminal neuralgia in sclerosteosis Emerson Magno de Andrade, André Beer-Furlan, Kleber Paiva Duarte, Erich Talamoni Fonoff,  Manoel Jacobsen Teixeira Division of Functional Neurosurgery - Department of Neurosurgery, University of São Paulo Medical School (FMUSP); São Paulo, Br azil E-mail: *Emerson Magno de Andrade - emersonmagno@hotmail.com; André Beer-Furlan - beerfurlan@uol.com.br; Kleber Paiva Duarte - kleberduarte@uol.com.br;  Erich Talamoni Fonoff - fonoffet@usp.br; Manoel Jacobsen T eixeira - manoeljacobsen@gmail.com*Corresponding author Received: 16 June 13  Accepted: 14 September 13  Published: 20 November 13 Abstract Background: Sclerosteosis is a rare bone disorder characterized by a progressive  craniotubular hyperostosis.",Non-OADS,/arxiv_data1/oa_pdf/ff/f5/SNI-4-455.PMC3858807.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2013/4/7/455/121644 Copyright: © 2013 de Andrade EM.,Non-OADS,/arxiv_data1/oa_pdf/ff/f5/SNI-4-455.PMC3858807.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3470 | DOI: 10.1038/srep03470 11",Non-OADS,/arxiv_data1/oa_pdf/fb/7c/srep03470.PMC3858860.pdf
"164 http://j-stroke.orgCopyright © 2013  Korean Stroke Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/00/7e/jos-15-164.PMC3859000.pdf
Keywords CT perfusion; ischemic stroke; Perfusion pattern; Case studyReviewJournal of Stroke  2013;15( 3):164- 173 http://dx.doi.org/10.5853/jos.2013.15.3.164 Introduction Cerebral perfusion refers to the capillary or tissue level of  blood flow.,Non-OADS,/arxiv_data1/oa_pdf/00/7e/jos-15-164.PMC3859000.pdf
3 / September 2013 http://dx.doi.org/10.5853/jos.2013.15.3.164 http://j-stroke.org  165restored promptly.,Non-OADS,/arxiv_data1/oa_pdf/00/7e/jos-15-164.PMC3859000.pdf
Perfusion Patterns of Ischemic Stroke on CTP http://dx.doi.org/10.5853/jos.2013.15.3.164 166 http://j-stroke.orgFigure 2.,Non-OADS,/arxiv_data1/oa_pdf/00/7e/jos-15-164.PMC3859000.pdf
3 / September 2013 http://dx.doi.org/10.5853/jos.2013.15.3.164 http://j-stroke.org  167Figure 3.,OADS,/arxiv_data1/oa_pdf/00/7e/jos-15-164.PMC3859000.pdf
Perfusion Patterns of Ischemic Stroke on CTP http://dx.doi.org/10.5853/jos.2013.15.3.164 168 http://j-stroke.orgtional selection.,Non-OADS,/arxiv_data1/oa_pdf/00/7e/jos-15-164.PMC3859000.pdf
3 / September 2013 http://dx.doi.org/10.5853/jos.2013.15.3.164 http://j-stroke.org  169Figure 5.,Non-OADS,/arxiv_data1/oa_pdf/00/7e/jos-15-164.PMC3859000.pdf
Perfusion Patterns of Ischemic Stroke on CTP http://dx.doi.org/10.5853/jos.2013.15.3.164 170 http://j-stroke.orgFigure 6.,Non-OADS,/arxiv_data1/oa_pdf/00/7e/jos-15-164.PMC3859000.pdf
"3 / September 2013 http://dx.doi.org/10.5853/jos.2013.15.3.164 http://j-stroke.org  171scanner.20,21 Although this has only been addressed in case re - ports so far,24,25 based on our experience, we can not only iden - tify patients with posterior circulation ischemia but also we may  be able to identify the presence of a favorable penumbral pat - tern.",Non-OADS,/arxiv_data1/oa_pdf/00/7e/jos-15-164.PMC3859000.pdf
Perfusion Patterns of Ischemic Stroke on CTP http://dx.doi.org/10.5853/jos.2013.15.3.164 172 http://j-stroke.orgFigure 8.,Non-OADS,/arxiv_data1/oa_pdf/00/7e/jos-15-164.PMC3859000.pdf
"3 / September 2013 http://dx.doi.org/10.5853/jos.2013.15.3.164 http://j-stroke.org  173ume, cerebral oxygen extraction fraction and cerebral metabol - ic rate of oxygen measured by positron emission tomography  with 15O-labelled carbon dioxide or water, carbon monoxide  and oxygen: a multicentre study in Japan.",OADS,/arxiv_data1/oa_pdf/00/7e/jos-15-164.PMC3859000.pdf
"Copyright © 2013  Korean Stroke Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fd/5a/jos-15-127.PMC3859001.pdf
pISSN: 2287-6391 • eISSN: 2287-6405 http://j-stroke.org  127JoS now linked to PMCEditorialJournal of Stroke  2013;15( 3):127 http://dx.doi.org/10.5853/jos.2013.15.3.127 Recent advances in information technology (IT) have drasti - cally changed our life style.,Non-OADS,/arxiv_data1/oa_pdf/fd/5a/jos-15-127.PMC3859001.pdf
"174 http://j-stroke.orgCopyright © 2013  Korean Stroke Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/94/93/jos-15-174.PMC3859002.pdf
"Keywords Stroke; Robot-assisted therapy; Motor disorder; RehabilitationReviewJournal of Stroke  2013;15( 3):174- 181 http://dx.doi.org/10.5853/jos.2013.15.3.174 Introduction Stroke is a common, serious, and disabling health-care prob - lem throughout the world.1 In particular, in Korea, which is very  rapidly changing into an “ Aging Society,” the incidence of stroke  has increased, albeit gradually, during the last few decades.2 On  the other hand, the mortality rate from stroke has declined over  time,2 resulting in an increased prevalence of stroke in Korea.",Non-OADS,/arxiv_data1/oa_pdf/94/93/jos-15-174.PMC3859002.pdf
"3 / September 2013 http://dx.doi.org/10.5853/jos.2013.15.3.174 http://j-stroke.org  175ment in functional outcome after stroke.5 Therefore, one im - portant goal of rehabilitation of stroke patients is the effective  use of neuroplasticity for functional recovery.",Non-OADS,/arxiv_data1/oa_pdf/94/93/jos-15-174.PMC3859002.pdf
"Robot-assisted therapy http://dx.doi.org/10.5853/jos.2013.15.3.174 176 http://j-stroke.orggait training alone.15,16,18-20 This means that the addition of ro - bot-assisted therapy with end-effector-type devices to conven - tional physiotherapy can be recommended for use in patients  with subacute stroke.",Non-OADS,/arxiv_data1/oa_pdf/94/93/jos-15-174.PMC3859002.pdf
"3 / September 2013 http://dx.doi.org/10.5853/jos.2013.15.3.174 http://j-stroke.org  177stroke reported that patients who received conventional therapy  alone showed little improvement, whereas patients who re - ceived robotic training plus conventional therapy continued to  improve in the latter half of the inpatient rehabilitation period.",OADS,/arxiv_data1/oa_pdf/94/93/jos-15-174.PMC3859002.pdf
Robot-assisted therapy http://dx.doi.org/10.5853/jos.2013.15.3.174 178 http://j-stroke.orgstudies may be needed to draw a definite conclusion about the  effect of robot-assisted training on ADL in patients with chronic  stroke.,Non-OADS,/arxiv_data1/oa_pdf/94/93/jos-15-174.PMC3859002.pdf
3 / September 2013 http://dx.doi.org/10.5853/jos.2013.15.3.174 http://j-stroke.org  179made an effort to analyze the effects of different types of robotic  devices on upper limb and hand motor function as well as gait  function.,OADS,/arxiv_data1/oa_pdf/94/93/jos-15-174.PMC3859002.pdf
Robot-assisted therapy http://dx.doi.org/10.5853/jos.2013.15.3.174 180 http://j-stroke.orgRoth HR.,Non-OADS,/arxiv_data1/oa_pdf/94/93/jos-15-174.PMC3859002.pdf
3 / September 2013 http://dx.doi.org/10.5853/jos.2013.15.3.174 http://j-stroke.org  181bot-assisted reaching exercise promotes arm movement recov - ery in chronic hemiparetic stroke: a randomized controlled pi - lot study.,Non-OADS,/arxiv_data1/oa_pdf/94/93/jos-15-174.PMC3859002.pdf
"Copyright © 2013  Korean Stroke Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1a/0e/jos-15-153.PMC3859003.pdf
"pISSN: 2287-6391 • eISSN: 2287-6405 http://j-stroke.org  153Cerebral Microbleeds: Their Associated Factors,  Radiologic Findings, and Clinical Implications Beom Joon Kim,a Seung-Hoon Leeb aDepartment of Neurology and Cerebrovascular Center, Seoul National University Bundang Hospital, Seongnam, Korea bDepartment of Neurology, Seoul National University Hospital, Seoul, Korea Correspondence:  Seung-Hoon Lee Department of Neurology, Seoul National  University Hospital, 101 Daehak-ro,  Jongno-gu, Seoul 110-744, Korea Tel: +82-2-2072-1014 Fax: +82-2-3672-7553 E-mail: sb0516@snu.ac.kr Received: July 28, 2013 Revised: August 29, 2013 Accepted: September 9, 2013 The authors have no financial conflicts of  interest.Cerebral microbleeds (CMBs) are tiny, round dark-signal lesions that are most often detected  on gradient-echo MR images.",Non-OADS,/arxiv_data1/oa_pdf/1a/0e/jos-15-153.PMC3859003.pdf
"Keywords Cerebral microbleed; Ischemic stroke; Intracerebral hemorrhage; Antithrombotics;  Gradient-echo MRIReviewJournal of Stroke  2013;15( 3):153- 163 http://dx.doi.org/10.5853/jos.2013.15.3.153 Introduction The term cerebral microbleed (CMB) refers to small, round  dark-signal lesions detected by T2*-weighted or gradient-echo  (GRE) magnetic resonance imaging (MRI).1 CMBs were intro - duced to stroke physicians in the late 1990s and early 2000s af - ter development of MRI techniques sensitive to paramagnetic  effects.2 The clinical significance of CMBs has been actively in - vestigated, especially in the stroke field and more recently in  studies on cognitive impairment and aging.3 Histological inves - tigation has shown that CMBs are tiny foci containing hemo - siderin-laden macrophages and abnormal microvessels showing  fibrohyalinosis.4,5 Clinical cases with frank symptoms caused by  CMBs are uncommon.",Non-OADS,/arxiv_data1/oa_pdf/1a/0e/jos-15-153.PMC3859003.pdf
Cerebral Microbleeds http://dx.doi.org/10.5853/jos.2013.15.3.153 154 http://j-stroke.orgVisualization and detection of cerebral  microbleeds GRE sequences are more sensitive to susceptibility effects  than are classical MRI sequences.,Non-OADS,/arxiv_data1/oa_pdf/1a/0e/jos-15-153.PMC3859003.pdf
"3 / September 2013 http://dx.doi.org/10.5853/jos.2013.15.3.153 http://j-stroke.org  155agreement values, are necessary for clinical and radiologic re - search studies.",Non-OADS,/arxiv_data1/oa_pdf/1a/0e/jos-15-153.PMC3859003.pdf
Cerebral Microbleeds http://dx.doi.org/10.5853/jos.2013.15.3.153 156 http://j-stroke.orgTable 1.,Non-OADS,/arxiv_data1/oa_pdf/1a/0e/jos-15-153.PMC3859003.pdf
3 / September 2013 http://dx.doi.org/10.5853/jos.2013.15.3.153 http://j-stroke.org  157Figure 3.,Non-OADS,/arxiv_data1/oa_pdf/1a/0e/jos-15-153.PMC3859003.pdf
Cerebral Microbleeds http://dx.doi.org/10.5853/jos.2013.15.3.153 158 http://j-stroke.orgFigure 4.,Non-OADS,/arxiv_data1/oa_pdf/1a/0e/jos-15-153.PMC3859003.pdf
3 / September 2013 http://dx.doi.org/10.5853/jos.2013.15.3.153 http://j-stroke.org  159The increased likelihood of cerebral hemorrhage associated  with the presence of CMBs may allow prediction of hemor - rhagic transformation after ischemic stroke.,Non-OADS,/arxiv_data1/oa_pdf/1a/0e/jos-15-153.PMC3859003.pdf
"Cerebral Microbleeds http://dx.doi.org/10.5853/jos.2013.15.3.153 160 http://j-stroke.orgR, et al.",OADS,/arxiv_data1/oa_pdf/1a/0e/jos-15-153.PMC3859003.pdf
3 / September 2013 http://dx.doi.org/10.5853/jos.2013.15.3.153 http://j-stroke.org  16132.,OADS,/arxiv_data1/oa_pdf/1a/0e/jos-15-153.PMC3859003.pdf
Cerebral Microbleeds http://dx.doi.org/10.5853/jos.2013.15.3.153 162 http://j-stroke.orgsion and cerebral amyloid angiopathy.,Non-OADS,/arxiv_data1/oa_pdf/1a/0e/jos-15-153.PMC3859003.pdf
"3 / September 2013 http://dx.doi.org/10.5853/jos.2013.15.3.153 http://j-stroke.org  163clinically and radiologically, independently of white matter le - sions.",OADS,/arxiv_data1/oa_pdf/1a/0e/jos-15-153.PMC3859003.pdf
"128 http://j-stroke.orgCopyright © 2013  Korean Stroke Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f2/18/jos-15-128.PMC3859004.pdf
"Keywords Stroke; India; Epidemiology; Incidence; Stroke unit; RehabilitationReviewJournal of Stroke  2013;15( 3):128- 134 http://dx.doi.org/10.5853/jos.2013.15.3.128 Introduction Stroke is becoming an important cause of premature death  and disability in low-income and middle-income countries like  India, largely driven by demographic changes and enhanced by  the increasing prevalence of the key modifiable risk factors.",Non-OADS,/arxiv_data1/oa_pdf/f2/18/jos-15-128.PMC3859004.pdf
"3 / September 2013 http://dx.doi.org/10.5853/jos.2013.15.3.128 http://j-stroke.org  129search terms used were ‘Stroke in India’ , ‘Stroke epidemiology’ ,  ‘Stroke burden’ , ‘Stroke and India’ , ‘Stroke care in India’ , etc.",Non-OADS,/arxiv_data1/oa_pdf/f2/18/jos-15-128.PMC3859004.pdf
Stroke Epidemiology and Care Services in India http://dx.doi.org/10.5853/jos.2013.15.3.128 130 http://j-stroke.orgfirst-ever stroke admitted to hospitals has been estimated to be  aged 40 years or less.,Non-OADS,/arxiv_data1/oa_pdf/f2/18/jos-15-128.PMC3859004.pdf
3 / September 2013 http://dx.doi.org/10.5853/jos.2013.15.3.128 http://j-stroke.org  131risk factors (more than 3) were significantly more in rural popu - lation than in urban population.,OADS,/arxiv_data1/oa_pdf/f2/18/jos-15-128.PMC3859004.pdf
"Stroke Epidemiology and Care Services in India http://dx.doi.org/10.5853/jos.2013.15.3.128 132 http://j-stroke.org140/100,000 person-years (95% CI: 132.90 to 147.09) and the  age-adjusted incidence rate was 181.67/100,000 person-years  (95% CI: 172.44 to 190.89) (Unpublished data).",Non-OADS,/arxiv_data1/oa_pdf/f2/18/jos-15-128.PMC3859004.pdf
3 / September 2013 http://dx.doi.org/10.5853/jos.2013.15.3.128 http://j-stroke.org  133Rehabilitation In India the rehabilitation is mainly centred on physiothera - pists.,Non-OADS,/arxiv_data1/oa_pdf/f2/18/jos-15-128.PMC3859004.pdf
Stroke Epidemiology and Care Services in India http://dx.doi.org/10.5853/jos.2013.15.3.128 134 http://j-stroke.orgpopulation of Calcutta--and epidemiological study.,Non-OADS,/arxiv_data1/oa_pdf/f2/18/jos-15-128.PMC3859004.pdf
8. http://www.sancd.org/Updated%20Stroke%20Fact%20sheet  %202012.pdf: stroke fact sheet India.,Non-OADS,/arxiv_data1/oa_pdf/f2/18/jos-15-128.PMC3859004.pdf
"182 http://j-stroke.orgCopyright © 2013  Korean Stroke Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/96/2a/jos-15-182.PMC3859005.pdf
"Keywords Thrombolysis; Recurrence; Acute ischemic stroke; OutcomeOriginal ArticleJournal of Stroke  2013;15( 3):182- 188 http://dx.doi.org/10.5853/jos.2013.15.3.182 Introduction The possibility of repeated thrombolysis has increased be - cause of the widespread use of thrombolytic treatments, an im - proved chance of survival after thrombolytic treatment, and an  increase in life expectancy.1,2 In myocardial infarction and pul - monary embolism, repeated thrombolytic therapy using intra - venous recombinant tissue plasminogen activator (rt-PA) has been reported to be safe and effective.3-5 However, repeated  thrombolytic therapy in patients with acute ischemic stroke is  rarely reported, and almost all previous reports were of patients  who received intravenous rt-PA.2,6-8 Only 1 case report detailed  a successful endovascular treatment for recurrent basilar artery  occlusions.9 Recently, multimodal thrombolytic therapy, which  includes intravenous and intra-arterial thrombolytic drugs and  mechanical thrombectomy, has been introduced and is fre -",Non-OADS,/arxiv_data1/oa_pdf/96/2a/jos-15-182.PMC3859005.pdf
"3 / September 2013 http://dx.doi.org/10.5853/jos.2013.15.3.182 http://j-stroke.org  183quently used by stroke teams.10-13 The goals of this study are to  1) identify how frequently repeated thrombolytic treatments  are performed since the existence of multimodal thrombolytic  treatments, and 2) characterize the safety and outcome of re - peated thrombolytic therapy in patients with acute ischemic  stroke.",Non-OADS,/arxiv_data1/oa_pdf/96/2a/jos-15-182.PMC3859005.pdf
Repeated Thrombolytic Therapy in Ischemic Stroke http://dx.doi.org/10.5853/jos.2013.15.3.182 184 http://j-stroke.orgarteries as the first ischemic strokes.,Non-OADS,/arxiv_data1/oa_pdf/96/2a/jos-15-182.PMC3859005.pdf
3 / September 2013 http://dx.doi.org/10.5853/jos.2013.15.3.182 http://j-stroke.org  185different between patients with single and repeated treatments.,Non-OADS,/arxiv_data1/oa_pdf/96/2a/jos-15-182.PMC3859005.pdf
"Repeated Thrombolytic Therapy in Ischemic Stroke http://dx.doi.org/10.5853/jos.2013.15.3.182 186 http://j-stroke.orged administration of streptokinase is not recommended because  of its antigenicity.29 Although rt-PA and urokinase are endoge - nous proteins and are considered non-antigenic, several studies  have reported the development of antibodies against rt-PA and  allergic reactions after rt-PA administrations.30-32 Furthermore,  activation of fibrinolysis may facilitate anaphylactoid reactions.33  Previous reports did not show any immunological reactions in  patients who were given repeated treatments.2 Although we did  not check titers of antibodies, our 5 patients who received re - peated treatments with rt-PA or urokinase did not show any  symptoms or signs of an immunological reaction.",Non-OADS,/arxiv_data1/oa_pdf/96/2a/jos-15-182.PMC3859005.pdf
3 / September 2013 http://dx.doi.org/10.5853/jos.2013.15.3.182 http://j-stroke.org  187ly treated with repeated intravascular procedures.,Non-OADS,/arxiv_data1/oa_pdf/96/2a/jos-15-182.PMC3859005.pdf
Repeated Thrombolytic Therapy in Ischemic Stroke http://dx.doi.org/10.5853/jos.2013.15.3.182 188 http://j-stroke.orgMuir KW.,Non-OADS,/arxiv_data1/oa_pdf/96/2a/jos-15-182.PMC3859005.pdf
"144 http://j-stroke.orgCopyright © 2013  Korean Stroke Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/02/41/jos-15-144.PMC3859006.pdf
"Keywords Cardioembolic stroke; Atrial fibrillation; CHADS 2; New oral anticoagulants; Pre - vention; ReviewReviewJournal of Stroke  2013;15( 3):144- 152 http://dx.doi.org/10.5853/jos.2013.15.3.144 Introduction Cardioembolic stroke, which is an important subtype of isch - emic stroke, involves a large infarct volume and multiple vascu - lar territories.",Non-OADS,/arxiv_data1/oa_pdf/02/41/jos-15-144.PMC3859006.pdf
"3 / September 2013 http://dx.doi.org/10.5853/jos.2013.15.3.144 http://j-stroke.org  145fibrillation is the highest in those older than 80 years.25 The im - portance of atrial fibrillation in ischemic stroke will further in - crease in Korean society, which is rapidly aging.",Non-OADS,/arxiv_data1/oa_pdf/02/41/jos-15-144.PMC3859006.pdf
"Stroke and Atrial Fibrillation  http://dx.doi.org/10.5853/jos.2013.15.3.144 146 http://j-stroke.orgbe useful in predicting the recurrence of stroke in patients with  stroke associated with NVAF.40,42 Furthermore, it was recently  reported that the CHADS 2 score can be used to predict the pro - gnosis of stroke associated with NVAF (Figure 2).43,44  Emergence of new anticoagulants  Warfarin, a vitamin K antagonist, was the only oral anticoagu - lant available for a long time.",Non-OADS,/arxiv_data1/oa_pdf/02/41/jos-15-144.PMC3859006.pdf
"3 / September 2013 http://dx.doi.org/10.5853/jos.2013.15.3.144 http://j-stroke.org  147rate was significantly lower and the GI bleeding rate was not  significantly different in the apixaban group.49 Hemorrhagic  stroke rates related to receiving warfarin were higher in Asian  patients than in non-Asian patients, but hemorrhagic stroke  rates were significantly reduced by dabigatran in both Asian and  non-Asian patients compared with individuals receiving warfa - rin.54 In non-hemorrhagic adverse events, approximately 10%  of the patients in the dabigatran group complained of severe  dyspepsia and approximately 21% of them discontinued the  drugs.",Non-OADS,/arxiv_data1/oa_pdf/02/41/jos-15-144.PMC3859006.pdf
Stroke and Atrial Fibrillation  http://dx.doi.org/10.5853/jos.2013.15.3.144 148 http://j-stroke.orgrenal function.,Non-OADS,/arxiv_data1/oa_pdf/02/41/jos-15-144.PMC3859006.pdf
"3 / September 2013 http://dx.doi.org/10.5853/jos.2013.15.3.144 http://j-stroke.org  149about ischemic stroke associated with NVAF.91 Ischemic stroke  related to NVAF has been more prevalent, as life expectancy is  increasing worldwide, and disease burden is also increasing  steeply.",Non-OADS,/arxiv_data1/oa_pdf/02/41/jos-15-144.PMC3859006.pdf
Stroke and Atrial Fibrillation  http://dx.doi.org/10.5853/jos.2013.15.3.144 150 http://j-stroke.orgof Patients with Atrial Fibrillation).,Non-OADS,/arxiv_data1/oa_pdf/02/41/jos-15-144.PMC3859006.pdf
3 / September 2013 http://dx.doi.org/10.5853/jos.2013.15.3.144 http://j-stroke.org  151the RE-LY trial.,OADS,/arxiv_data1/oa_pdf/02/41/jos-15-144.PMC3859006.pdf
Stroke and Atrial Fibrillation  http://dx.doi.org/10.5853/jos.2013.15.3.144 152 http://j-stroke.orgcet 2009;374:534-542.,Non-OADS,/arxiv_data1/oa_pdf/02/41/jos-15-144.PMC3859006.pdf
"Copyright © 2013  Korean Stroke Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2c/db/jos-15-135.PMC3859007.pdf
"pISSN: 2287-6391 • eISSN: 2287-6405 http://j-stroke.org  135Facilitating Stroke Management using Modern  Information Technology Hyo Suk Nam,a Eunjeong Park,b,c Ji Hoe Heoa  aDepartment of Neurology, Y onsei University College of Medicine, Seoul, Korea bWireless Health Institute, University of California Los Angeles (UCLA), Los Angeles, United States cEmbedded Software Research Center, Ewha Woman’s University, Seoul, Korea Correspondence:  Ji Hoe Heo Department of Neurology, Yonsei  University College of Medicine,   50 Yonsei-ro, Seodaemun-gu,   Seoul 120-752, Korea Tel: +82-2-2228-1605 Fax: +82-2-393-0705 E-mail: jhheo@yuhs.ac Received: July 25, 2013 Revised: September 8, 2013 Accepted: September 9, 2013 The authors are grateful to Mr. Dong-Su  Jang (Yonsei University College of Medicine)  for providing the illustration.",Non-OADS,/arxiv_data1/oa_pdf/2c/db/jos-15-135.PMC3859007.pdf
Keywords Stroke; Information technology; Mobile health; TelemedicineReviewJournal of Stroke  2013;15( 3):135- 143 http://dx.doi.org/10.5853/jos.2013.15.3.135 Introduction T reatment of stroke requires specialized processes that are ex - pediently provided.,Non-OADS,/arxiv_data1/oa_pdf/2c/db/jos-15-135.PMC3859007.pdf
"Stroke Management using Information Technology http://dx.doi.org/10.5853/jos.2013.15.3.135 136 http://j-stroke.orginformation more readily accessible, assist in diagnosis and mon - itoring, provide decision support, and enhance implementation  of guidelines and recommendations.2  Health-related use of the internet is increasing.",Non-OADS,/arxiv_data1/oa_pdf/2c/db/jos-15-135.PMC3859007.pdf
"3 / September 2013 http://dx.doi.org/10.5853/jos.2013.15.3.135 http://j-stroke.org  137device-based telemedicine.16,17 Mobile telemedicine systems  can be freely used while at work and home as well as while trav - eling via a wireless internet service and a smartphone.",OADS,/arxiv_data1/oa_pdf/2c/db/jos-15-135.PMC3859007.pdf
"Stroke Management using Information Technology http://dx.doi.org/10.5853/jos.2013.15.3.135 138 http://j-stroke.orgminutes (median difference of 41 minutes, P< 0.0001).",Non-OADS,/arxiv_data1/oa_pdf/2c/db/jos-15-135.PMC3859007.pdf
"3 / September 2013 http://dx.doi.org/10.5853/jos.2013.15.3.135 http://j-stroke.org  139care providers to improve multidisciplinary care delivery and  patient care quality.41 Mobile devices as supplementary tools  for neurologic examination and decision  making A mobile-device-supported neurological examination Portable mobile devices have been used to easily administer  neurological examinations, including measuring visual acuity  and color vision.42 Because mobile devices have rich multitouch  user interfaces and built-in accelerometers,42 these features might  be useful for assessing patients’ neurologic deficits.",Non-OADS,/arxiv_data1/oa_pdf/2c/db/jos-15-135.PMC3859007.pdf
Stroke Management using Information Technology http://dx.doi.org/10.5853/jos.2013.15.3.135 140 http://j-stroke.orgdisplayed on the screen.,Non-OADS,/arxiv_data1/oa_pdf/2c/db/jos-15-135.PMC3859007.pdf
"3 / September 2013 http://dx.doi.org/10.5853/jos.2013.15.3.135 http://j-stroke.org  141ment, and remote monitoring.68 Lifestyle applications can help  manage weight control, diet and cooking, and exercise.",Non-OADS,/arxiv_data1/oa_pdf/2c/db/jos-15-135.PMC3859007.pdf
http://www.index.go.kr/egams/stts/jsp/potal/stts/PO_STTS_  IdxMain.jsp?idx_cd=1346.,OADS,/arxiv_data1/oa_pdf/2c/db/jos-15-135.PMC3859007.pdf
http://www.who.int/goe/pub - lications/goe_mhealth_web.pdf.,Non-OADS,/arxiv_data1/oa_pdf/2c/db/jos-15-135.PMC3859007.pdf
500 million people will be using mobile health  apps by 2015. http://www.computerworld.com/s/article/919  6823/500_million_people_will_be_using_mobile_health_ apps_by_2015.,Non-OADS,/arxiv_data1/oa_pdf/2c/db/jos-15-135.PMC3859007.pdf
Stroke Management using Information Technology http://dx.doi.org/10.5853/jos.2013.15.3.135 142 http://j-stroke.org21.,Non-OADS,/arxiv_data1/oa_pdf/2c/db/jos-15-135.PMC3859007.pdf
https://itunes.apple.com/ us/app/ipronator/id471884445?mt=8.,Non-OADS,/arxiv_data1/oa_pdf/2c/db/jos-15-135.PMC3859007.pdf
3 / September 2013 http://dx.doi.org/10.5853/jos.2013.15.3.135 http://j-stroke.org  143T rial of Org 10172 in Acute Stroke T reatment.,Non-OADS,/arxiv_data1/oa_pdf/2c/db/jos-15-135.PMC3859007.pdf
https://itunes.apple.com/us/ app/iclass/id397133435?mt=8.,Non-OADS,/arxiv_data1/oa_pdf/2c/db/jos-15-135.PMC3859007.pdf
https://itunes.apple.com/us/app/noejoljung-jin - lyojichim/id409056109?mt=8.,Non-OADS,/arxiv_data1/oa_pdf/2c/db/jos-15-135.PMC3859007.pdf
Keywords: Hysterectomy; Laparoscopy; Suture techniqueOriginal  Article Obstet Gynecol Sci 2013;56(6):389-399 http://dx.doi.org/10.5468/ogs.2013.56.6.389 pISSN 2287-8572  · eISSN 2287-8580,Non-OADS,/arxiv_data1/oa_pdf/c3/f6/ogs-56-389.PMC3859010.pdf
"Keywords: Bleomycin, etoposide, and cisplatin regimen; Chemotherapy, Omentum; Yolk sac tumorCase Report Obstet Gynecol Sci 2013;56(6):412-415 http://dx.doi.org/10.5468/ogs.2013.56.6.412 pISSN 2287-8572  · eISSN 2287-8580",Non-OADS,/arxiv_data1/oa_pdf/d3/ed/ogs-56-412.PMC3859011.pdf
Keywords: Adrenocortical adenoma; Adrenalectomy; Cushing syndrome; Oligohydramnios; PregnancyCase Report Obstet Gynecol Sci 2013;56(6):400-403 http://dx.doi.org/10.5468/ogs.2013.56.6.400 pISSN 2287-8572  · eISSN 2287-8580,Non-OADS,/arxiv_data1/oa_pdf/fa/69/ogs-56-400.PMC3859012.pdf
Keywords: Hepatitis A; Pregnancy; Pregnancy complicationsOriginal Article Obstet Gynecol Sci 2013;56(6):368-374 http://dx.doi.org/10.5468/ogs.2013.56.6.368 pISSN 2287-8572  · eISSN 2287-8580,Non-OADS,/arxiv_data1/oa_pdf/cb/4b/ogs-56-368.PMC3859013.pdf
"However,  recent reports from the Korea Centers for Disease Control  and Prevention show that there has been a sharp increase  in incidence of HAV infection from 317 cases in 2002 to  13,111 cases in 2009 (http://www.cdc.go.kr/kcdchome/jsp/ home/main/Main.jsp) (Fig.",Non-OADS,/arxiv_data1/oa_pdf/cb/4b/ogs-56-368.PMC3859013.pdf
Keywords: Colon cancer; Endometrial cancer; Lynch syndromeCase Report Obstet Gynecol Sci 2013;56(6):408-411 http://dx.doi.org/10.5468/ogs.2013.56.6.408 pISSN 2287-8572  · eISSN 2287-8580,Non-OADS,/arxiv_data1/oa_pdf/c7/af/ogs-56-408.PMC3859014.pdf
Keywords: Angiopoietin-2; Ovary; Vascular endothelial growth factor A; VitrificationOriginal  Article Obstet Gynecol Sci 2013;56(6):382-388 http://dx.doi.org/10.5468/ogs.2013.56.6.382 pISSN 2287-8572  · eISSN 2287-8580,Non-OADS,/arxiv_data1/oa_pdf/a7/e7/ogs-56-382.PMC3859015.pdf
Keywords:   Cervical cancer; Small cell carcinoma; Syndrome of inappropriate antidiuretic hormone secretionCase Report Obstet Gynecol Sci 2013;56(6):420-425 http://dx.doi.org/10.5468/ogs.2013.56.6.420 pISSN 2287-8572  · eISSN 2287-8580,Non-OADS,/arxiv_data1/oa_pdf/36/55/ogs-56-420.PMC3859016.pdf
Keywords: Chemoradiotherapy; Metastasis; Vaginal NeoplasmsCase Report Obstet Gynecol Sci 2013;56(6):416-419 http://dx.doi.org/10.5468/ogs.2013.56.6.416 pISSN 2287-8572  · eISSN 2287-8580,Non-OADS,/arxiv_data1/oa_pdf/b1/ee/ogs-56-416.PMC3859017.pdf
"Keywords: Laparoscopic myomectomy, Laparotomic myomectomy, Myomectomy, Obstetric outcomeOriginal  Article Obstet Gynecol Sci 2013;56(6):375-381 http://dx.doi.org/10.5468/ogs.2013.56.6.375 pISSN 2287-8572  · eISSN 2287-8580",Non-OADS,/arxiv_data1/oa_pdf/42/ab/ogs-56-375.PMC3859018.pdf
Keywords: Broad ligament; Ectopic pregnancy; Ultrasonography Case Report Obstet Gynecol Sci 2013;56(6):404-407 http://dx.doi.org/10.5468/ogs.2013.56.6.404 pISSN 2287-8572  · eISSN 2287-8580,Non-OADS,/arxiv_data1/oa_pdf/d5/e0/ogs-56-404.PMC3859019.pdf
http://dx.doi.org/10.1002/jcu.22010.,Non-OADS,/arxiv_data1/oa_pdf/d5/e0/ogs-56-404.PMC3859019.pdf
Copyright © 2013 Korean Society of Obstetrics and Gynecology Review Obstet Gynecol Sci 2013;56(6):353-361 http://dx.doi.org/10.5468/ogs.2013.56.6.353 pISSN 2287-8572  · eISSN 2287-8580,Non-OADS,/arxiv_data1/oa_pdf/df/b5/ogs-56-353.PMC3859020.pdf
Supplementary material can be found via  http://ogscience.org/src/sm/ogs-56-353-s001.pdf.,Non-OADS,/arxiv_data1/oa_pdf/df/b5/ogs-56-353.PMC3859020.pdf
Supplementary material can be found via  http://ogscience.org/src/sm/ogs-56-353-s002.pdf.,Non-OADS,/arxiv_data1/oa_pdf/df/b5/ogs-56-353.PMC3859020.pdf
Keywords: Neonatal outcome; Resident; Staff; Vacuum delivery; Vaginal delivery Original  Article Obstet Gynecol Sci 2013;56(6):362-367 http://dx.doi.org/10.5468/ogs.2013.56.6.362 pISSN 2287-8572  · eISSN 2287-8580,Non-OADS,/arxiv_data1/oa_pdf/a6/52/ogs-56-362.PMC3859021.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e1/78/awt277.PMC3859221.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/10/4c/awt300.PMC3859226.pdf
Availability The Leishmania (Leishmania) amazonensis Genome Database is available at the URL http://www.lge.ibi.,OADS,/arxiv_data1/oa_pdf/56/f7/dst031.PMC3859324.pdf
"First published online July 16, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 580-588, http://dx.doi.org/10.1590/1414-431X20133161 ISSN 1414-431X Braz J Med Biol Res 46(7) 2013 www.bjournal.com.br",Non-OADS,/arxiv_data1/oa_pdf/00/46/1414-431X-bjmbr-46-07-580.PMC3859329.pdf
"First published online July 27, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 614-622, http://dx.doi.org/10.1590/1414-431X20133032 ISSN 1414-431X Braz J Med Biol Res 46(7) 2013 www.bjournal.com.br",Non-OADS,/arxiv_data1/oa_pdf/12/27/1414-431X-bjmbr-46-07-614.PMC3859330.pdf
"The sequences were aligned by ClustalW, an online program used for multiple sequence alignment (http://www.genome.jp/ tools/clustalw/).",OADS,/arxiv_data1/oa_pdf/12/27/1414-431X-bjmbr-46-07-614.PMC3859330.pdf
"First published online July 30, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 567-573, http://dx.doi.org/10.1590/1414-431X20132339 ISSN 1414-431X www.bjournal.com.br Braz J Med Biol Res 46(7) 2013",Non-OADS,/arxiv_data1/oa_pdf/e8/bf/1414-431X-bjmbr-46-07-567.PMC3859331.pdf
"First published online July 22, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 589-600, http://dx.doi.org/10.1590/1414-431X20132859 ISSN 1414-431X www.bjournal.com.br Braz J Med Biol Res 46(7) 2013",Non-OADS,/arxiv_data1/oa_pdf/f6/e5/1414-431X-bjmbr-46-07-589.PMC3859332.pdf
"First published online July 22, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 623-628, http://dx.doi.org/10.1590/1414-431X20133103 ISSN 1414-431X www.bjournal.com.br Braz J Med Biol Res 46(7) 2013",Non-OADS,/arxiv_data1/oa_pdf/b4/f0/1414-431X-bjmbr-46-07-623.PMC3859333.pdf
"First published online July 16, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 607-613, http://dx.doi.org/10.1590/1414-431X20132817 ISSN 1414-431X www.bjournal.com.br Braz J Med Biol Res 46(7) 2013",Non-OADS,/arxiv_data1/oa_pdf/a9/3d/1414-431X-bjmbr-46-07-607.PMC3859334.pdf
"First published online July 31, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 574-579, http://dx.doi.org/10.1590/1414-431X20132900 ISSN 1414-431X Braz J Med Biol Res 46(7) 2013 www.bjournal.com.br",Non-OADS,/arxiv_data1/oa_pdf/95/a4/1414-431X-bjmbr-46-07-574.PMC3859335.pdf
"First published online July 30, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 629-633, http://dx.doi.org/10.1590/1414-431X20132832 ISSN 1414-431X www.bjournal.com.br Braz J Med Biol Res 46(7) 2013",Non-OADS,/arxiv_data1/oa_pdf/c9/01/1414-431X-bjmbr-46-07-629.PMC3859336.pdf
"First published online July 16, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 601-606, http://dx.doi.org/10.1590/1414-431X20132894 ISSN 1414-431X Short Communication www.bjournal.com.br Braz J Med Biol Res 46(7) 2013",Non-OADS,/arxiv_data1/oa_pdf/da/4a/1414-431X-bjmbr-46-07-601.PMC3859337.pdf
"First published online July 22, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 634-642, http://dx.doi.org/10.1590/1414-431X20132647 ISSN 1414-431X Braz J Med Biol Res 46(7) 2013 www.bjournal.com.br",Non-OADS,/arxiv_data1/oa_pdf/bd/ba/1414-431X-bjmbr-46-07-634.PMC3859338.pdf
"First published online July 16, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 559-566, http://dx.doi.org/10.1590/1414-431X20132455 ISSN 1414-431X www.bjournal.com.br Braz J Med Biol Res 46(7) 2013",Non-OADS,/arxiv_data1/oa_pdf/a5/2c/1414-431X-bjmbr-46-07-559.PMC3859339.pdf
"First published online July 16, 2013.Brazilian Journal of Medical and Biological Research (2013) 46: 555-558, http://dx.doi.org/10.1590/1414-431X20133054 ISSN 1414-431X www.bjournal.com.br Braz J Med Biol Res 46(7) 2013",Non-OADS,/arxiv_data1/oa_pdf/5b/be/1414-431X-bjmbr-46-07-555.PMC3859340.pdf
Information on the SSR ma rkers and their annealing temperatures was obtained fro m the National BioResource Project (NBRP) KOMUGI web si te (http://www.shigen.nig.,OADS,/arxiv_data1/oa_pdf/3d/03/63_374.PMC3859348.pdf
"http://statgen.ncs u.edu/qtlcart/WQTLCart.htm Welsh,  J.R., D.L.",OADS,/arxiv_data1/oa_pdf/3d/03/63_374.PMC3859348.pdf
Information on SSR markers an d the annealing temperature used for each was obtained fro m the National BioResource Project (NBRP) KOMUGI web si te (http://www.shigen.nig.,OADS,/arxiv_data1/oa_pdf/a9/5d/63_423.PMC3859354.pdf
http://statgen.ncs u.edu/qtlcart/WQTLCart.htm.,OADS,/arxiv_data1/oa_pdf/a9/5d/63_423.PMC3859354.pdf
Here we present the B arley Gene Expression D atabase (bex-db: http://barleyflc.dna .affrc.go.jp/bexdb/index.html) as  a repository of transcrip- tome data including the sequences and the expression pr ofiles of barley genes resulting from microarray anal- ysis.,OADS,/arxiv_data1/oa_pdf/1a/f3/63_430.PMC3859355.pdf
"Introduction Among the major cereal crops, barley ( Hordeum vulgare ) is ranked fourth in worldwide production behind wheat, riceand maize (http://faostat.fao.o rg).",Non-OADS,/arxiv_data1/oa_pdf/1a/f3/63_430.PMC3859355.pdf
Nucleotide sequences Information for construc tion and sequencing of 12 ‘Haruna Nijo’ cDNA libraries is available on the top page (Project Summary) of bex-db (http://barleyflc.dna.affrc.go.,OADS,/arxiv_data1/oa_pdf/1a/f3/63_430.PMC3859355.pdf
On the basi s of their sequence similarity analyzed using the EST clustering programs of TGICL(http://compbio.dfci.harvard.,OADS,/arxiv_data1/oa_pdf/1a/f3/63_430.PMC3859355.pdf
"We also constr ucted 22,148 contig clusters (EST_CL),  basing  on the information  of paired  ends (http://barleyflc.dna.affrc.go.j p/bexdb/pages/help/clustering _method.html), to be displayed in a “Cluster viewer”.",OADS,/arxiv_data1/oa_pdf/1a/f3/63_430.PMC3859355.pdf
"A list of the top 100 genes (probes) with pos- itively or negatively correlate d expression patterns to each other was created for each microarray dataset.Mapping of FLcDNAs onto the barley genome A genome browser to display the annotation data of bar- ley genes reported by IBSC has already been developedwithin a database, EnsemblPlant s (http://plants.ensembl.org/ Hordeum_vulgare/Info/Index/).",OADS,/arxiv_data1/oa_pdf/1a/f3/63_430.PMC3859355.pdf
After masking for repeats by the software tool CENSOR  (http://www.girinst.org/ downloads/software/censor/) with mipsREdat_9.0p_Poaceae_TEs as described previously (Nussbaumer et al.,OADS,/arxiv_data1/oa_pdf/1a/f3/63_430.PMC3859355.pdf
Clone order The barley FLcDNAs clones are available for distribution by the National Institute of Agrobi ological Sciences by sending a request to the NIAS DNA Bank (http://www.dna.affrc.go.jp/distribution/).,Non-OADS,/arxiv_data1/oa_pdf/1a/f3/63_430.PMC3859355.pdf
"http://www.artinthepicture.com/paintings/Paul_Klee/Siblings/   Lambert, J. H. (1760).",Non-OADS,/arxiv_data1/oa_pdf/d5/e2/i-perception-4-299.PMC3859547.pdf
For more information visit http://www.anato- mie1.uniklinikum-jena.de/Mitarbeiter/Dr_+G_+Leichsenring.html  and http:// www.personperception.uni-jena.de/ .,Non-OADS,/arxiv_data1/oa_pdf/8b/b6/i-perception-4-303.PMC3859548.pdf
uni-jena.de/svw/Allgpsy1/index.html  and http://www.personperception.uni- jena.de/ .,Non-OADS,/arxiv_data1/oa_pdf/8b/b6/i-perception-4-303.PMC3859548.pdf
For more information visit http://www.anatomie1.uniklinikum-jena.de/ Forschung_Research/AG+Redies.html,Non-OADS,/arxiv_data1/oa_pdf/8b/b6/i-perception-4-303.PMC3859548.pdf
"However, subsequently in 2012, an amateur scientist Val Watham in the United Kingdom won the prize in a BBC radio pro-gram, demonstrating that the common belief is true in an experiment of watching videos of people walking with horizontally or vertically striped clothes (http://www.bbc.co.uk/radio4/features/sywtbas/finalists/stripes/ ), with the supervision of Thompson himself.",Non-OADS,/arxiv_data1/oa_pdf/d4/6d/i-perception-4-347.PMC3859551.pdf
http://www.cognitionandculture.net/home/blog/13-ophelias-blog/804-fast-lemons-and-intuitive-beliefs.,Non-OADS,/arxiv_data1/oa_pdf/c7/c0/i-perception-4-365.PMC3859554.pdf
"The Edge, EDGE Annual Question 2012: http://edge.org/annual-question, at http://www.edge.org/responses/what-is-your-favorite-deep-elegant-or-beautiful-explanation  Smith, L. B., & Sera, M. D. (1992).",Non-OADS,/arxiv_data1/oa_pdf/c7/c0/i-perception-4-365.PMC3859554.pdf
"We used four stimulus objects  having the 3D shapes shown in Figure 1: Dragon, Buddha, and Bunny from the Stanford 3D Scanning  Repository (http://graphics.stanford.edu/data/3Dscanrep/), and Skull from the LightWave Object con-tent.",Non-OADS,/arxiv_data1/oa_pdf/a8/94/i-perception-4-407.PMC3859557.pdf
The full text of these instructions is available at   http://nwkpsych.rutgers.edu/~alan/dlinstructions ).,Non-OADS,/arxiv_data1/oa_pdf/6a/f2/i-perception-4-437.PMC3859559.pdf
"The clips were excerpts taken from different parts of the same video sequence (downloaded from http://www.3dtv.at/movies/Oldtim - ers_en.aspx) and, thus, except for motion and scene content, were relatively similar to each other in terms of image features such as saturation and sharpness.",Non-OADS,/arxiv_data1/oa_pdf/cf/0a/i-perception-4-456.PMC3859560.pdf
http://www.daysyn.com/Day2004Trends.pdf.,Non-OADS,/arxiv_data1/oa_pdf/11/ec/i-perception-4-239.PMC3859567.pdf
"2.2  Stimuli The stimulus material was derived from a standard definition (720  576 pixels, 25 fps) recording of  a solo Bharatanatyam dance performed in appropriate costumes by a semi-professional Indian dancer  of 6 min and 26 s (see A V example in Movie 1 or at http://pacoweb.psy.gla.ac.uk/watchingdance , and  Figure 1 for an illustration of all three conditions).",Non-OADS,/arxiv_data1/oa_pdf/96/d3/i-perception-4-265.PMC3859570.pdf
"However, FECD genetic studies have primarily  focused on patients with European ancestry from the United Molecular Vision  2013; 19:2508-2516 <http://www.molvis.org/molvis/v 19/2508 > Received 14 January 2013 | Accepted 10 December 2013 | Published 12 December 2013© 2013 Molecular Vision 2508Genetic screen of African Americans with Fuchs endothelial  corneal dystrophy Mollie A. Minear,1 Yi-Ju Li,1,2 Jacqueline Rimmler,1 Elmer Balajonda,3 Shera Watson,1 R. Rand Allingham,3  Michael A. Hauser,1 Gordon K. Klintworth,3,4 Natalie A. Afshari,5 Simon G. Gregory1 (The last two authors contributed equally to this work.)",Non-OADS,/arxiv_data1/oa_pdf/10/e7/mv-v19-2508.PMC3859630.pdf
"Molecular Vision  2013; 19:2508-2516 <http://www.molvis.org/molvis/v 19/2508 > © 2013 Molecular Vision  2509Kingdom, the United States, and Australia as well as a small  number of Asian populations from China, India, Japan, and  Korea.",Non-OADS,/arxiv_data1/oa_pdf/10/e7/mv-v19-2508.PMC3859630.pdf
Molecular Vision  2013; 19:2508-2516 <http://www.molvis.org/molvis/v 19/2508 > © 2013 Molecular Vision  2510all PCR amplifications used 30 ng input genomic DNA per  primer pair.,Non-OADS,/arxiv_data1/oa_pdf/10/e7/mv-v19-2508.PMC3859630.pdf
Molecular Vision  2013; 19:2508-2516 <http://www.molvis.org/molvis/v 19/2508 > © 2013 Molecular Vision  2511Table  1.,Non-OADS,/arxiv_data1/oa_pdf/10/e7/mv-v19-2508.PMC3859630.pdf
"Molecular Vision  2013; 19:2508-2516 <http://www.molvis.org/molvis/v 19/2508 > © 2013 Molecular Vision  2512in African Americans in the EVS database, and only p.R158R  and p.D886D were not detected in European Americans  (Appendix 5).",OADS,/arxiv_data1/oa_pdf/10/e7/mv-v19-2508.PMC3859630.pdf
Molecular Vision  2013; 19:2508-2516 <http://www.molvis.org/molvis/v 19/2508 > © 2013 Molecular Vision  2513with this variant; the African American woman was a hetero - zygous carrier.,Non-OADS,/arxiv_data1/oa_pdf/10/e7/mv-v19-2508.PMC3859630.pdf
"Molecular Vision  2013; 19:2508-2516 <http://www.molvis.org/molvis/v 19/2508 > © 2013 Molecular Vision  2514indicate that any effect conferred by these genes is likely to  be small, just as it seems to be in Europeans and Asians with  FECD.",Non-OADS,/arxiv_data1/oa_pdf/10/e7/mv-v19-2508.PMC3859630.pdf
Molecular Vision  2013; 19:2508-2516 <http://www.molvis.org/molvis/v 19/2508 > © 2013 Molecular Vision  25155.,Non-OADS,/arxiv_data1/oa_pdf/10/e7/mv-v19-2508.PMC3859630.pdf
Molecular Vision  2013; 19:2508-2516 <http://www.molvis.org/molvis/v 19/2508 > © 2013 Molecular Vision  2516in late-onset Fuchs endothelial corneal dystrophy.,Non-OADS,/arxiv_data1/oa_pdf/10/e7/mv-v19-2508.PMC3859630.pdf
Available from: http://evs.gs.washington.edu/EVS/ 38.,Non-OADS,/arxiv_data1/oa_pdf/10/e7/mv-v19-2508.PMC3859630.pdf
To viewplease visit the journal online (http://dx.doi.org/10.1136/jech- 2012-201891).,Non-OADS,/arxiv_data1/oa_pdf/e3/4d/jech-2012-201891.PMC3859677.pdf
Data requests are made to the BiB executive using the form available from the study website http://www.borninbradford.nhs.uk (please click on ‘Science and Research ’to access the form).,Non-OADS,/arxiv_data1/oa_pdf/e3/4d/jech-2012-201891.PMC3859677.pdf
See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 United Nations Children ’s Fund WHO.,Non-OADS,/arxiv_data1/oa_pdf/e3/4d/jech-2012-201891.PMC3859677.pdf
"Sincerely,   Ro nald Ellis PhD, Editor-in-Chief     Ev a M. Riedmann PhD, Acquisitions EditorLetter from the Editor ronald Ellis1,* and Eva M. rie dmann2 1senior Vice President r&d a nd chi ef tec hnology offic er; nas Vax, Ltd.; nes s Ziona, Israel; 2acquisitions Editor; Landes Bioscience; Vienna, aus tria *Correspondence to: Ronald Ellis; Email: rellis@landesbioscience.com Submitted: 1/22/13; Accepted: 1/22/13http://dx.doi.org/10.4161/hv.24055",Non-OADS,/arxiv_data1/oa_pdf/db/61/hvi-9-227.PMC3859738.pdf
"Do not distribute.www.landesbioscience.com  Human Vaccines & Immunotherapeutics  265Human Vaccines & Immunotherapeutics 9:2, 265–274; February 2013; © 2013 Landes Bioscience Commentary Commentary Keywords:  mRNA, dendritic cell,  immunotherapy, cancer Submitted: 10/17/12Accepted: 10/25/12http://dx.doi.org/10.4161/hv.22661 *Correspondence to: Karine Breckpot;   Email: kbreckpo@vub.ac.beTwo decades ago, mRNA became the  focus of research in molecular medi - cine and was proposed as an active phar - maceutical ingredient for the therapy of cancer.",Non-OADS,/arxiv_data1/oa_pdf/d7/14/hvi-9-265.PMC3859745.pdf
Eur J Immunol 1993; 23:1719-22; PMID:8325342; http://dx.doi.org/10.1002/eji.1830230749.,Non-OADS,/arxiv_data1/oa_pdf/d7/14/hvi-9-265.PMC3859745.pdf
Nature 1992; 356:152-4; PMID:1545867; http://dx.doi.org/10.1038/356152a0.,OADS,/arxiv_data1/oa_pdf/d7/14/hvi-9-265.PMC3859745.pdf
J Exp Med 1996; 184:465-72; PMID:8760800; http://dx.doi.org/10.1084/jem.184.2.465.,Non-OADS,/arxiv_data1/oa_pdf/d7/14/hvi-9-265.PMC3859745.pdf
Gene Ther 2003; 10:367-74; PMID:12601391; http://dx.doi.org/10.1038/sj.gt.3301901.,OADS,/arxiv_data1/oa_pdf/d7/14/hvi-9-265.PMC3859745.pdf
Biomaterials 2011; 32:9128-35; PMID:21868088; http://dx.doi.org/10.1016/j.biomaterials.2011.08.024.,OADS,/arxiv_data1/oa_pdf/d7/14/hvi-9-265.PMC3859745.pdf
Cancer Invest 2003; 21:341-9; PMID:12901279; http://dx.doi.org/10.1081/CNV-120018224.,Non-OADS,/arxiv_data1/oa_pdf/d7/14/hvi-9-265.PMC3859745.pdf
J Immunol Methods 2012; 377:23-36; PMID:22269772; http://dx.doi.org/10.1016/j.jim.2011.12.010.,Non-OADS,/arxiv_data1/oa_pdf/d7/14/hvi-9-265.PMC3859745.pdf
Nat Med 2004; 10:475-80; PMID:15122249; http://dx.doi.org/10.1038/nm1039.,OADS,/arxiv_data1/oa_pdf/d7/14/hvi-9-265.PMC3859745.pdf
Crit Rev Oncol Hematol 2008; 66:118-34; PMID:18262431; http://dx.doi.org/10.1016/j.critrevonc.2007.12.007.,Non-OADS,/arxiv_data1/oa_pdf/d7/14/hvi-9-265.PMC3859745.pdf
Immunol Rev 2007; 219:118-42; PMID:17850486; http://dx.doi.org/10.1111/j.1600-065X.2007.00551.x.10.,Non-OADS,/arxiv_data1/oa_pdf/d7/14/hvi-9-265.PMC3859745.pdf
Annu Rev Immunol 2012; 30:1-22; PMID:22136168; http://dx.doi.org/10.1146/annurev-immunol-100311-102839.,Non-OADS,/arxiv_data1/oa_pdf/d7/14/hvi-9-265.PMC3859745.pdf
Immunol Rev 2004; 199:251-63; PMID:15233739; http://dx.doi.org/10.1111/j.0105-2896.2004.00139.x.,Non-OADS,/arxiv_data1/oa_pdf/d7/14/hvi-9-265.PMC3859745.pdf
Cancer Gene Ther 2002; 9:787-97; PMID:12189529; http://dx.doi.org/10.1038/sj.cgt.7700499.,Non-OADS,/arxiv_data1/oa_pdf/d7/14/hvi-9-265.PMC3859745.pdf
J Immunol Methods 2002; 264:135-51; PMID:12191517; http://dx.doi.org/10.1016/S0022-1759(02)00099-6.,Non-OADS,/arxiv_data1/oa_pdf/d7/14/hvi-9-265.PMC3859745.pdf
Cancer Gene Ther 2003; 10:696-706; PMID:12944989; http://dx.doi.org/10.1038/sj.cgt.7700622.,Non-OADS,/arxiv_data1/oa_pdf/d7/14/hvi-9-265.PMC3859745.pdf
Methods Mol Biol 2008; 423:155-63; PMID:18370196; http://dx.doi.org/10.1007/978-1-59745-194-9_10.,Non-OADS,/arxiv_data1/oa_pdf/d7/14/hvi-9-265.PMC3859745.pdf
Gene Ther 2005; 12:772-82; PMID:15750615; http://dx.doi.org/10.1038/sj.gt.3302471.,OADS,/arxiv_data1/oa_pdf/d7/14/hvi-9-265.PMC3859745.pdf
Mol Ther 2004; 10:768-79; PMID:15451461; http://dx.doi.org/10.1016/j.ymthe.2004.07.017.,OADS,/arxiv_data1/oa_pdf/d7/14/hvi-9-265.PMC3859745.pdf
Blood 2006; 108:4009-17; PMID:16940422; http://dx.doi.org/10.1182/blood-2006-04-015024.,Non-OADS,/arxiv_data1/oa_pdf/d7/14/hvi-9-265.PMC3859745.pdf
PLoS One 2011; 6:e17596; PMID:21408612; http://dx.doi.org/10.1371/journal.pone.0017596.,Non-OADS,/arxiv_data1/oa_pdf/d7/14/hvi-9-265.PMC3859745.pdf
Mol Ther 2012; 20:1063-74; PMID:22371843; http://dx.doi.org/10.1038/mt.2012.11.,OADS,/arxiv_data1/oa_pdf/d7/14/hvi-9-265.PMC3859745.pdf
Cancer Immunol Immunother 2011; 60:809-18; PMID:21365467; http://dx.doi.org/10.1007/s00262-011-0991-9.,Non-OADS,/arxiv_data1/oa_pdf/d7/14/hvi-9-265.PMC3859745.pdf
Curr Opin Immunol  2011; 23:399-406; PMID:21497074; http://dx.doi.org/10.1016/j.coi.2011.03.007.,OADS,/arxiv_data1/oa_pdf/d7/14/hvi-9-265.PMC3859745.pdf
Immunotherapy 2011; 3:605-7; PMID:21554090; http://dx.doi.org/10.2217/imt.11.28.,Non-OADS,/arxiv_data1/oa_pdf/d7/14/hvi-9-265.PMC3859745.pdf
Expert  Opin Biol Ther 2004; 4:1285-94; PMID:15268662; http://dx.doi.org/10.1517/14712598.4.8.1285.,OADS,/arxiv_data1/oa_pdf/d7/14/hvi-9-265.PMC3859745.pdf
J Biomed Biotechnol 2010; 2010:623687; PMID:20625504; http://dx.doi.org/10.1155/2010/623687.,Non-OADS,/arxiv_data1/oa_pdf/d7/14/hvi-9-265.PMC3859745.pdf
Vaccine 2012; 30:4414-8; PMID:22546329; http://dx.doi.org/10.1016/j.vac - cine.2012.04.060.,Non-OADS,/arxiv_data1/oa_pdf/d7/14/hvi-9-265.PMC3859745.pdf
J Gene Med 2004; 6:1175-88; PMID:15468193; http://dx.doi.org/10.1002/jgm.615.,OADS,/arxiv_data1/oa_pdf/d7/14/hvi-9-265.PMC3859745.pdf
Trends Immunol 2002; 23:445- 9; PMID:12200066; http://dx.doi.org/10.1016/S1471-4906(02)02281-0.,OADS,/arxiv_data1/oa_pdf/d7/14/hvi-9-265.PMC3859745.pdf
J Cell Mol Med 2008; 12:690-700; PMID:18419605; http://dx.doi.org/10.1111/j.1582-4934.2007.00084.x.,OADS,/arxiv_data1/oa_pdf/d7/14/hvi-9-265.PMC3859745.pdf
Immunol Lett 2005; 99:8-11; PMID:15894104; http://dx.doi.org/10.1016/j.imlet.2005.01.011.,OADS,/arxiv_data1/oa_pdf/d7/14/hvi-9-265.PMC3859745.pdf
Eur J Immunol 1997; 27:3135-42; PMID:9464798; http://dx.doi.org/10.1002/eji.1830271209.,Non-OADS,/arxiv_data1/oa_pdf/d7/14/hvi-9-265.PMC3859745.pdf
Blood 2002; 100:1354-61; PMID:12149218; http://dx.doi.org/10.1182/blood-2001-11-0017.,Non-OADS,/arxiv_data1/oa_pdf/d7/14/hvi-9-265.PMC3859745.pdf
Blood 2001; 97:3466-9; PMID:11369638; http://dx.doi.org/10.1182/blood.V97.11.3466.,Non-OADS,/arxiv_data1/oa_pdf/d7/14/hvi-9-265.PMC3859745.pdf
Blood 2006; 108:2655-61; PMID:16763205; http://dx.doi.org/10.1182/blood-2006-03-011353.,Non-OADS,/arxiv_data1/oa_pdf/d7/14/hvi-9-265.PMC3859745.pdf
Cancer Res 2004; 64:5934-7; PMID:15342370; http://dx.doi.org/10.1158/0008-5472.CAN-04-1261.,Non-OADS,/arxiv_data1/oa_pdf/d7/14/hvi-9-265.PMC3859745.pdf
Nat Immunol 2005; 6:769-76; PMID:15995707; http://dx.doi.org/10.1038/ni1223.,Non-OADS,/arxiv_data1/oa_pdf/d7/14/hvi-9-265.PMC3859745.pdf
Nat Immunol 2004; 5:508-15; PMID:15064759; http://dx.doi.org/10.1038/ni1059.,Non-OADS,/arxiv_data1/oa_pdf/d7/14/hvi-9-265.PMC3859745.pdf
Gene Ther 2006; 13:1027-36; PMID:16511519; http://dx.doi.org/10.1038/sj.gt.3302750.,OADS,/arxiv_data1/oa_pdf/d7/14/hvi-9-265.PMC3859745.pdf
Mol Ther 2008; 16:1170-80; PMID:18431362; http://dx.doi.org/10.1038/mt.2008.77.,OADS,/arxiv_data1/oa_pdf/d7/14/hvi-9-265.PMC3859745.pdf
Clin Cancer Res 2009; 15:3366-75; PMID:19417017; http://dx.doi.org/10.1158/1078-0432.CCR-08-2982.50.,Non-OADS,/arxiv_data1/oa_pdf/d7/14/hvi-9-265.PMC3859745.pdf
Cancer 2005; 103:1280-91; PMID:15693021; http://dx.doi.org/10.1002/cncr.20911.,Non-OADS,/arxiv_data1/oa_pdf/d7/14/hvi-9-265.PMC3859745.pdf
J Clin Invest 2005; 115:3623-33; PMID:16308572; http://dx.doi.org/10.1172/JCI25947.,Non-OADS,/arxiv_data1/oa_pdf/d7/14/hvi-9-265.PMC3859745.pdf
Br J Cancer 2005; 93:749-56; PMID:16136047; http://dx.doi.org/10.1038/sj.bjc.6602761.,Non-OADS,/arxiv_data1/oa_pdf/d7/14/hvi-9-265.PMC3859745.pdf
Cancer Gene Ther 2006; 13:905-18; PMID:16710345; http://dx.doi.org/10.1038/sj.cgt.7700961.,Non-OADS,/arxiv_data1/oa_pdf/d7/14/hvi-9-265.PMC3859745.pdf
Cancer Immunol Immunother 2007; 56:659-75; PMID:16947019; http://dx.doi.org/10.1007/s00262-006-0222-y.,Non-OADS,/arxiv_data1/oa_pdf/d7/14/hvi-9-265.PMC3859745.pdf
J Immunother 2011; 34:448-56; PMID:21577140; http://dx.doi.org/10.1097/CJI.0b013e31821dcb31.,Non-OADS,/arxiv_data1/oa_pdf/d7/14/hvi-9-265.PMC3859745.pdf
Cancer Immunol Immunother 2012; 61:1033-43; PMID:22159452; http://dx.doi.org/10.1007/s00262-011-1176-2.,Non-OADS,/arxiv_data1/oa_pdf/d7/14/hvi-9-265.PMC3859745.pdf
Clin Cancer Res 2012; 18:5460-70; PMID:22896657; http://dx.doi.org/10.1158/1078-0432.CCR-11-3368.,Non-OADS,/arxiv_data1/oa_pdf/d7/14/hvi-9-265.PMC3859745.pdf
Int J Cancer 2001; 93:243-51; PMID:11410873; http://dx.doi.org/10.1002/ijc.1323.,Non-OADS,/arxiv_data1/oa_pdf/d7/14/hvi-9-265.PMC3859745.pdf
Cancer Immunol Immunother 2007; 56:1513-37; PMID:17503040; http://dx.doi.org/10.1007/s00262-007-0334-z.,Non-OADS,/arxiv_data1/oa_pdf/d7/14/hvi-9-265.PMC3859745.pdf
Cancer Immunol Immunother 2010; 59:1573-82; PMID:20204387; http://dx.doi.org/10.1007/s00262-010-0833-1.,Non-OADS,/arxiv_data1/oa_pdf/d7/14/hvi-9-265.PMC3859745.pdf
Eur J Immunol 2005; 35:2452-8; PMID:15997468; http://dx.doi.org/10.1002/eji.200526069.,Non-OADS,/arxiv_data1/oa_pdf/d7/14/hvi-9-265.PMC3859745.pdf
J Exp Med 2005; 202:425-35; PMID:16061729; http://dx.doi.org/10.1084/jem.20041961.,Non-OADS,/arxiv_data1/oa_pdf/d7/14/hvi-9-265.PMC3859745.pdf
Clin Dev Immunol 2008; 2008:106321; PMID:19190769; http://dx.doi.org/10.1155/2008/106321.,Non-OADS,/arxiv_data1/oa_pdf/d7/14/hvi-9-265.PMC3859745.pdf
Eur J Immunol 2003; 33:1052-62; PMID:12672071; http://dx.doi.org/10.1002/eji.200323676.,Non-OADS,/arxiv_data1/oa_pdf/d7/14/hvi-9-265.PMC3859745.pdf
Clin Cancer Res 2004; 10:7466-74; PMID :15569976 ; http://dx.doi.org/10.1158/1078-0432.CCR-04-0684.,Non-OADS,/arxiv_data1/oa_pdf/d7/14/hvi-9-265.PMC3859745.pdf
J Exp Med 2007; 204:1441-51; PMID:17535975; http://dx.doi.org/10.1084/jem.20070021.,Non-OADS,/arxiv_data1/oa_pdf/d7/14/hvi-9-265.PMC3859745.pdf
Blood 2012; PMID:22966165; http://dx.doi.org/10.1182/blood-2012-06-435941.,Non-OADS,/arxiv_data1/oa_pdf/d7/14/hvi-9-265.PMC3859745.pdf
Neuro Oncol 2004; 6:236-46; PMID:15279716; http://dx.doi.org/10.1215/S1152851703000668.,Non-OADS,/arxiv_data1/oa_pdf/d7/14/hvi-9-265.PMC3859745.pdf
J Immunother 2011; 34:1-15; PMID:21150709; http://dx.doi.org/10.1097/CJI.0b013e3181f7dbe8.,Non-OADS,/arxiv_data1/oa_pdf/d7/14/hvi-9-265.PMC3859745.pdf
Cancer Res 2011; 71:6132-42; PMID:21816907; http://dx.doi.org/10.1158/0008-5472.CAN-11-0291.,Non-OADS,/arxiv_data1/oa_pdf/d7/14/hvi-9-265.PMC3859745.pdf
Immunity 2005; 23:165-75; PMID:16111635; http://dx.doi.org/10.1016/j.immuni.2005.06.008.,OADS,/arxiv_data1/oa_pdf/d7/14/hvi-9-265.PMC3859745.pdf
Eur J Immunol 2004; 34:537-47; PMID:14768059; http://dx.doi.org/10.1002/eji.200324198.,Non-OADS,/arxiv_data1/oa_pdf/d7/14/hvi-9-265.PMC3859745.pdf
Eur J Immunol 2005; 35:1557-66; PMID:15832293; http://dx.doi.org/10.1002/eji.200425656.,Non-OADS,/arxiv_data1/oa_pdf/d7/14/hvi-9-265.PMC3859745.pdf
Science 2004; 303:1529-31; PMID:14976261; http://dx.doi.org/10.1126/science.1093616.,OADS,/arxiv_data1/oa_pdf/d7/14/hvi-9-265.PMC3859745.pdf
Science 2004; 303:1526-9; PMID:14976262; http://dx.doi.org/10.1126/science.1093620.,OADS,/arxiv_data1/oa_pdf/d7/14/hvi-9-265.PMC3859745.pdf
J Biol Chem 2004; 279:12542-50; PMID:14729660; http://dx.doi.org/10.1074/jbc.M310175200.,OADS,/arxiv_data1/oa_pdf/d7/14/hvi-9-265.PMC3859745.pdf
Nature 2001; 413:732-8; PMID:11607032; http://dx.doi.org/10.1038/35099560.,OADS,/arxiv_data1/oa_pdf/d7/14/hvi-9-265.PMC3859745.pdf
Gene Ther 2011; 18:702-8; PMID:21368901; http://dx.doi.org/10.1038/gt.2011.17.,OADS,/arxiv_data1/oa_pdf/d7/14/hvi-9-265.PMC3859745.pdf
Eur J Cancer 1977; 13:439-40; PMID:872860; http://dx.doi.org/10.1016/0014-2964(77)90099-8.,Non-OADS,/arxiv_data1/oa_pdf/d7/14/hvi-9-265.PMC3859745.pdf
Methods Enzymol 1983; 93:3-12; PMID:6346012; http://dx.doi.org/10.1016/S0076-6879(83)93031-8.,OADS,/arxiv_data1/oa_pdf/d7/14/hvi-9-265.PMC3859745.pdf
J Immunol Methods 1987; 99:67-75; PMID:3571992; http://dx.doi.org/10.1016/0022-1759(87)90033-0.,Non-OADS,/arxiv_data1/oa_pdf/d7/14/hvi-9-265.PMC3859745.pdf
Int Arch Allergy Immunol 2009; 150:59-65; PMID:19339803; http://dx.doi.org/10.1159/000210381.89.,Non-OADS,/arxiv_data1/oa_pdf/d7/14/hvi-9-265.PMC3859745.pdf
J Leukoc Biol 2007; 82:861-8; PMID:17634280; http://dx.doi.org/10.1189/jlb.0307167.,Non-OADS,/arxiv_data1/oa_pdf/d7/14/hvi-9-265.PMC3859745.pdf
J Exp Med 2002; 195:1289-302; PMID:12021309; http://dx.doi.org/10.1084/jem.20020161.,Non-OADS,/arxiv_data1/oa_pdf/d7/14/hvi-9-265.PMC3859745.pdf
J Exp Med 2000; 192:1685-96; PMID:11120766; http://dx.doi.org/10.1084/jem.192.12.1685.,Non-OADS,/arxiv_data1/oa_pdf/d7/14/hvi-9-265.PMC3859745.pdf
Cancer Res 2010; 70:9031-40; PMID:21045153; http://dx.doi.org/10.1158/0008-5472.CAN-10-0699.,Non-OADS,/arxiv_data1/oa_pdf/d7/14/hvi-9-265.PMC3859745.pdf
Cancer Res 2012; 72:1661-71; PMID:22337996; http://dx.doi.org/10.1158/0008-5472.CAN-11-2957.,Non-OADS,/arxiv_data1/oa_pdf/d7/14/hvi-9-265.PMC3859745.pdf
Curr Opin Hematol 2000; 7:168-73; PMID:10786654; http://dx.doi.org/10.1097/00062752-200005000-00007.,Non-OADS,/arxiv_data1/oa_pdf/d7/14/hvi-9-265.PMC3859745.pdf
Cancer Res 2011; 71:6132-42; PMID:21816907; http://dx.doi.org/10.1158/0008-5472.CAN-11-0291.,Non-OADS,/arxiv_data1/oa_pdf/d7/14/hvi-9-265.PMC3859745.pdf
Eur J Immunol 2000; 30:1-7; PMID:10602021; http://dx.doi.org/10.1002/1521-4141(200001)30:1<1::AID-IMMU1>3.0.CO;2-#.,Non-OADS,/arxiv_data1/oa_pdf/d7/14/hvi-9-265.PMC3859745.pdf
J Invest Dermatol 2000; 114:632-6; PMID:10733665; http://dx.doi.org/10.1046/j.1523-1747.2000.00929.x.,Non-OADS,/arxiv_data1/oa_pdf/d7/14/hvi-9-265.PMC3859745.pdf
Cell Mol Life Sci 2004; 61:2418-24; PMID:15378210; http://dx.doi.org/10.1007/s00018-004-4255-0.,OADS,/arxiv_data1/oa_pdf/d7/14/hvi-9-265.PMC3859745.pdf
Eur J Immunol 2006; 36:2807-16; PMID:17013976; http://dx.doi.org/10.1002/eji.200635910.75.,Non-OADS,/arxiv_data1/oa_pdf/d7/14/hvi-9-265.PMC3859745.pdf
Curr Opin Immunol 2005; 17:275-81; PMID:15886117; http://dx.doi.org/10.1016/j.coi.2005.04.004.,OADS,/arxiv_data1/oa_pdf/d7/14/hvi-9-265.PMC3859745.pdf
Cancer Immunol Immunother 2012; 61:1033-43; PMID:22159452; http://dx.doi.org/10.1007/s00262-011-1176-2.,Non-OADS,/arxiv_data1/oa_pdf/d7/14/hvi-9-265.PMC3859745.pdf
Melanoma Res 2011; 21:152-9; PMID:21317818; http://dx.doi.org/10.1097/CMR.0b013e328343ece0.,Non-OADS,/arxiv_data1/oa_pdf/d7/14/hvi-9-265.PMC3859745.pdf
Clin Cancer Res 2009; 15:2531-40; PMID:19318472; http://dx.doi.org/10.1158/1078-0432.CCR-08-2729.,Non-OADS,/arxiv_data1/oa_pdf/d7/14/hvi-9-265.PMC3859745.pdf
Cancer Res 2009; 69:2927-34; PMID:19318559; http://dx.doi.org/10.1158/0008-5472.CAN-08-3920.,Non-OADS,/arxiv_data1/oa_pdf/d7/14/hvi-9-265.PMC3859745.pdf
Clin Cancer Res 2011; 17:5725-35; PMID:21771874; http://dx.doi.org/10.1158/1078-0432.CCR-11-1261.,Non-OADS,/arxiv_data1/oa_pdf/d7/14/hvi-9-265.PMC3859745.pdf
Science 1990; 247:1465-8; PMID:1690918; http://dx.doi.org/10.1126/sci - ence.1690918.,OADS,/arxiv_data1/oa_pdf/d7/14/hvi-9-265.PMC3859745.pdf
Nature 1998; 392:245-52; PMID:9521319; http://dx.doi.org/10.1038/32588.,Non-OADS,/arxiv_data1/oa_pdf/d7/14/hvi-9-265.PMC3859745.pdf
Immunol Rev 1997; 156:199-209; PMID:9176709; http://dx.doi.org/10.1111/j.1600-065X.1997.tb00969.x.,Non-OADS,/arxiv_data1/oa_pdf/d7/14/hvi-9-265.PMC3859745.pdf
Mol Ther 2011; 19:990-9; PMID:21189474; http://dx.doi.org/10.1038/mt.2010.289.,OADS,/arxiv_data1/oa_pdf/d7/14/hvi-9-265.PMC3859745.pdf
2011; Available from: http://www.curevac.,Non-OADS,/arxiv_data1/oa_pdf/d7/14/hvi-9-265.PMC3859745.pdf
2011; Available from: http://www.curevac.de/pdf/201106_ASCO_PCA_final.pdf.122.,Non-OADS,/arxiv_data1/oa_pdf/d7/14/hvi-9-265.PMC3859745.pdf
Cancer 2003; 98:144-54; PMID:12833467; http://dx.doi.org/10.1002/cncr.11462.,Non-OADS,/arxiv_data1/oa_pdf/d7/14/hvi-9-265.PMC3859745.pdf
Clin Cancer Res 2006; 12:5801-8; PMID:17020987; http://dx.doi.org/10.1158/1078-0432.CCR-05-2421.,Non-OADS,/arxiv_data1/oa_pdf/d7/14/hvi-9-265.PMC3859745.pdf
J Immunother 2008; 31:180-8; PMID:18481387; http://dx.doi.org/10.1097/CJI.0b013e31815ce501.,Non-OADS,/arxiv_data1/oa_pdf/d7/14/hvi-9-265.PMC3859745.pdf
J Immunother 2009; 32:498-507; PMID:19609242; http://dx.doi.org/10.1097/CJI.0b013e3181a00068.117.,Non-OADS,/arxiv_data1/oa_pdf/d7/14/hvi-9-265.PMC3859745.pdf
Curr Opin Allergy Clin Immunol 2009; 9:537-43; PMID:19680119; http://dx.doi.org/10.1097/ACI.0b013e3283310ff7.,Non-OADS,/arxiv_data1/oa_pdf/d7/14/hvi-9-265.PMC3859745.pdf
Clin Cancer Res 2012; 18:336-41; PMID:22142824; http://dx.doi.org/10.1158/1078-0432.CCR-11-2323.,Non-OADS,/arxiv_data1/oa_pdf/d7/14/hvi-9-265.PMC3859745.pdf
Clin Cancer Res 2009; 15:4986-92; PMID:19622576; http://dx.doi.org/10.1158/1078-0432.CCR-08-3240.,Non-OADS,/arxiv_data1/oa_pdf/d7/14/hvi-9-265.PMC3859745.pdf
Mol Ther 2010; 18:651-9; PMID:19935776; http://dx.doi.org/10.1038/mt.2009.275.,OADS,/arxiv_data1/oa_pdf/d7/14/hvi-9-265.PMC3859745.pdf
"Human Vaccines & Immunotherapeutics 9:2, 294–299; February 2013; © 2013 Landes Bioscience Commentary 294 Human Vaccines & Immunotherapeutics Volume 9 Issue 2Keywords:  human safety, pharmaceutical  product development, drugs, biologicals,  antidotes, antibody-mediated immunity, antipeptide antibodies, peptide-based vaccines Submitted: 11/01/12Accepted: 11/12/12http://dx.doi.org/10.4161/hv.22858 Correspondence to: Salvador Eugenio C. Caoili;  Email: badong@post.upm.edu.phIf new scientific knowledge is to be  more efficiently generated and applied  toward the advancement of health,  human safety must be more effectively  addressed in the conduct of research.",Non-OADS,/arxiv_data1/oa_pdf/7b/1d/hvi-9-294.PMC3859750.pdf
J Biomed Biotechnol 2010; 2010; PMID:20706613;  http://dx.doi.org/10.1155/2010/961752.,OADS,/arxiv_data1/oa_pdf/7b/1d/hvi-9-294.PMC3859750.pdf
Immunotherapy 2010; 2:575- 82; PMID:20636010; http://dx.doi.org/10.2217/ imt.10.29.,Non-OADS,/arxiv_data1/oa_pdf/7b/1d/hvi-9-294.PMC3859750.pdf
Postgrad Med J  1993; 69:337-9; PMID:8346128; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7b/1d/hvi-9-294.PMC3859750.pdf
J Toxicol Clin Toxicol  2003; 41:309-15; PMID:12807314; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/7b/1d/hvi-9-294.PMC3859750.pdf
Nat Immunol  2012; 13:21-8; PMID:22179281; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7b/1d/hvi-9-294.PMC3859750.pdf
Nat Rev Microbiol  2010; 8:656-67; PMID:20694027; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/7b/1d/hvi-9-294.PMC3859750.pdf
Bioessays 2011; 33:803-9; PMID:22006823; http://dx.doi.org/10.1002/ bies.201100093.,Non-OADS,/arxiv_data1/oa_pdf/7b/1d/hvi-9-294.PMC3859750.pdf
Lancet Infect Dis  2010; 10:712-22; PMID:20883967; http://dx.doi.org/10.1016/S1473-3099(10)70166-3.,Non-OADS,/arxiv_data1/oa_pdf/7b/1d/hvi-9-294.PMC3859750.pdf
Emerg Infect Dis 2010; 16:1023-4; PMID:20507764; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/7b/1d/hvi-9-294.PMC3859750.pdf
Vaccine  2008; 26:6189-99; PMID:18852005; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7b/1d/hvi-9-294.PMC3859750.pdf
Methods  Mol Biol 2010; 657:93-108; PMID:20602209;  http://dx.doi.org/10.1007/978-1-60761-783-9_7.,Non-OADS,/arxiv_data1/oa_pdf/7b/1d/hvi-9-294.PMC3859750.pdf
Proteins 1993; 15:113-20; PMID:8441749; http://dx.doi.org/10.1002/ prot.340150203.,OADS,/arxiv_data1/oa_pdf/7b/1d/hvi-9-294.PMC3859750.pdf
Hum Vaccin  2011; 7:795-7; PMID:21445008; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7b/1d/hvi-9-294.PMC3859750.pdf
Croat Med  J 2012; 53:301-3; PMID:22911520; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/7b/1d/hvi-9-294.PMC3859750.pdf
Hum Immunol  2012; 73:859-66; PMID:22504410; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7b/1d/hvi-9-294.PMC3859750.pdf
"Cad Saude Publica 2001; 17(Suppl):7-22, discussion  23-36; PMID:11426254; http://dx.doi.org/10.1590/ S0102-311X2001000700002.",Non-OADS,/arxiv_data1/oa_pdf/7b/1d/hvi-9-294.PMC3859750.pdf
J  Biol Syst 2006; 14:65-90; http://dx.doi.org/10.1142/ S0218339006001726.,OADS,/arxiv_data1/oa_pdf/7b/1d/hvi-9-294.PMC3859750.pdf
Curr Genomics 2008; 9:69-79; PMID:19440447;  http://dx.doi.org/10.2174/138920208784139546.,OADS,/arxiv_data1/oa_pdf/7b/1d/hvi-9-294.PMC3859750.pdf
Curr Genomics  2009; 10:102-9; PMID:19794882; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/7b/1d/hvi-9-294.PMC3859750.pdf
Annu Rev Anthropol  1998; 27:247-71; http://dx.doi.org/10.1146/annurev.,Non-OADS,/arxiv_data1/oa_pdf/7b/1d/hvi-9-294.PMC3859750.pdf
Open Public Health J 2008; 1:8-16;  PMID:20072707; http://dx.doi.org/10.2174/187494 4500801010008.,Non-OADS,/arxiv_data1/oa_pdf/7b/1d/hvi-9-294.PMC3859750.pdf
BMC Med Ethics 2012; 13:16;  PMID:22769234; http://dx.doi.org/10.1186/1472- 6939-13-16.,Non-OADS,/arxiv_data1/oa_pdf/7b/1d/hvi-9-294.PMC3859750.pdf
Future Med Chem 2009; 1:1375- 80; PMID:21426052; http://dx.doi.org/10.4155/ fmc.09.117.,Non-OADS,/arxiv_data1/oa_pdf/7b/1d/hvi-9-294.PMC3859750.pdf
Trop Med Int Health 2006; 11:1075-81;  PMID:16827708; http://dx.doi.org/10.1111/j.1365- 3156.2006.01659.x.41.,Non-OADS,/arxiv_data1/oa_pdf/7b/1d/hvi-9-294.PMC3859750.pdf
Toxicol Sci 2011; 120(Suppl 1):S49-75; PMID:21059794;  http://dx.doi.org/10.1093/toxsci/kfq338.,OADS,/arxiv_data1/oa_pdf/7b/1d/hvi-9-294.PMC3859750.pdf
Nat Rev Cancer  2006; 6:714-27; PMID:16929325; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7b/1d/hvi-9-294.PMC3859750.pdf
Hum Vaccin  2011; 7:574-5; PMID:21422821; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7b/1d/hvi-9-294.PMC3859750.pdf
Adv Bioinforma 2012; 346765; PMID:23209458; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/7b/1d/hvi-9-294.PMC3859750.pdf
"www.landesbioscience.com Human Vaccines & Immunotherapeutics 339Human Vaccines & Immunotherapeutics 9:2, 339–348; February 2012; © 2012 Landes Bioscience ReseaR cH papeR ReseaR cH papeR *Correspondence to: Waldely Oliveira Dias; Email: waldely@butantan.gov.br Submitted: 08/10/12; Revised: 11/01/12; Accepted: 11/11/12http://dx.doi.org/10.4161/hv.22847Introduction Whooping cough or pertussis is an infectious disease of the  upper respiratory tract caused by the Gram-negative coccobacil - lus Bordetella pertussis  and a major cause of childhood morbidity  and mortality.",Non-OADS,/arxiv_data1/oa_pdf/8a/09/hvi-9-339.PMC3859757.pdf
Lancet 2010; 375:1969-87; PMID:20466419; http://dx.doi.org/10.1016/S0140- 6736(10)60549-1.,OADS,/arxiv_data1/oa_pdf/8a/09/hvi-9-339.PMC3859757.pdf
Pediatr Infect Dis J 2003; 22:22-7; PMID:12544404;  http://dx.doi.org/10.1097/00006454-200301000- 00009.,OADS,/arxiv_data1/oa_pdf/8a/09/hvi-9-339.PMC3859757.pdf
Pediatrics 2003; 112:405-6;  PMID:12897292; http://dx.doi.org/10.1542/ peds.112.2.405.,Non-OADS,/arxiv_data1/oa_pdf/8a/09/hvi-9-339.PMC3859757.pdf
Clin Infect Dis 1999;  28(Suppl 2):S112-7; PMID:10447028; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8a/09/hvi-9-339.PMC3859757.pdf
Pediatrics 1999; 104:1381-3;  PMID:10585991; http://dx.doi.org/10.1542/ peds.104.6.1381.6.,Non-OADS,/arxiv_data1/oa_pdf/8a/09/hvi-9-339.PMC3859757.pdf
N Engl J Med 1996; 334:349- 55; PMID:8538705; http://dx.doi.org/10.1056/NEJM199602083340602.,Non-OADS,/arxiv_data1/oa_pdf/8a/09/hvi-9-339.PMC3859757.pdf
Lancet 1984;  1:122-6; PMID:6140441; http://dx.doi.org/10.1016/ S0140-6736(84)90061-8.,OADS,/arxiv_data1/oa_pdf/8a/09/hvi-9-339.PMC3859757.pdf
Vaccine 2008; 26:5883- 7; PMID:18775463; http://dx.doi.org/10.1016/j.vac- cine.2008.07.105.,Non-OADS,/arxiv_data1/oa_pdf/8a/09/hvi-9-339.PMC3859757.pdf
Vaccine 2011; 29:2355-6;  PMID:21129396; http://dx.doi.org/10.1016/j.vac- cine.2010.11.059.11.,Non-OADS,/arxiv_data1/oa_pdf/8a/09/hvi-9-339.PMC3859757.pdf
"Immunogenicity, reactogenicity and consistency of pro- duction of a Brazilian combined vaccine against diph- theria, tetanus, pertussis and Haemophilus influenzae type b. Mem Inst Oswaldo Cruz 2008; 103:711-8;  PMID:19057823; http://dx.doi.org/10.1590/S0074- 02762008000700014.",Non-OADS,/arxiv_data1/oa_pdf/8a/09/hvi-9-339.PMC3859757.pdf
Microbes Infect 2007; 9:1096- 103; PMID:17644385; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/8a/09/hvi-9-339.PMC3859757.pdf
J Biol  Stand 1986; 14:57-65; PMID:2870067; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8a/09/hvi-9-339.PMC3859757.pdf
Vaccine 2009; 27:4219- 24; PMID:19393709; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/8a/09/hvi-9-339.PMC3859757.pdf
J Lipid Res 2007; 48:2419- 27; PMID:17703058; http://dx.doi.org/10.1194/jlr.,OADS,/arxiv_data1/oa_pdf/8a/09/hvi-9-339.PMC3859757.pdf
Infect Immun 2002; 70:3521-8;  PMID:12065491; http://dx.doi.org/10.1128/IAI.70.7.3521-3528.2002.,Non-OADS,/arxiv_data1/oa_pdf/8a/09/hvi-9-339.PMC3859757.pdf
Microbes Infect 2001; 3:655-77; PMID:11445452;  http://dx.doi.org/10.1016/S1286-4579(01)01421-6.,Non-OADS,/arxiv_data1/oa_pdf/8a/09/hvi-9-339.PMC3859757.pdf
Immunology 1998; 93:1-10; PMID:9536112;  http://dx.doi.org/10.1046/j.1365-2567.1998.00401.x.,Non-OADS,/arxiv_data1/oa_pdf/8a/09/hvi-9-339.PMC3859757.pdf
J Biol Stand 1989; 17:249-58;  PMID:2477374; http://dx.doi.org/10.1016/0092- 1157(89)90017-6.,OADS,/arxiv_data1/oa_pdf/8a/09/hvi-9-339.PMC3859757.pdf
J Biol Stand 1988;  16:299-309; PMID:2904442; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8a/09/hvi-9-339.PMC3859757.pdf
Vaccine 2008; 26:899-906; PMID:18207288; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/8a/09/hvi-9-339.PMC3859757.pdf
Clin Vaccine Immunol  2009; 16:544-50; PMID:19261771; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8a/09/hvi-9-339.PMC3859757.pdf
Lab Anim 2009; 43:155- 64; PMID:19116295; http://dx.doi.org/10.1258/ la.2008.007134.,OADS,/arxiv_data1/oa_pdf/8a/09/hvi-9-339.PMC3859757.pdf
PLoS Pathog 2006; 2:e65; PMID:16839199; http://dx.doi.org/10.1371/journal.ppat.0020065.,Non-OADS,/arxiv_data1/oa_pdf/8a/09/hvi-9-339.PMC3859757.pdf
J Exp Med 2000; 191:1841- 52; PMID:10839801; http://dx.doi.org/10.1084/ jem.191.11.1841.,Non-OADS,/arxiv_data1/oa_pdf/8a/09/hvi-9-339.PMC3859757.pdf
Mem Inst Oswaldo Cruz  2002; 97:909-13; PMID:12386721; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8a/09/hvi-9-339.PMC3859757.pdf
Braz J Med Biol Res 2007; 40:69-76; PMID:17224998; http://dx.doi.org/10.1590/S0100- 879X2007000100009.,Non-OADS,/arxiv_data1/oa_pdf/8a/09/hvi-9-339.PMC3859757.pdf
Rev Inst Med T rop Sao Paulo 2009; 51:131-4;  PMID:19551286; http://dx.doi.org/10.1590/S0036- 46652009000300002.,Non-OADS,/arxiv_data1/oa_pdf/8a/09/hvi-9-339.PMC3859757.pdf
Clin Vaccine Immunol 2007; 14:821- 9; PMID:17494641; http://dx.doi.org/10.1128/ CVI.00074-07.,Non-OADS,/arxiv_data1/oa_pdf/8a/09/hvi-9-339.PMC3859757.pdf
"Do not distribute.Human Vaccines & Immunotherapeutics 9:2, 362–374; February 2013; © 2013 Landes Bioscience 362  Human  Vaccines & Immunotherapeutics  V olume 9 Issue 2*Correspondence to: Dace Zavadska; Email: dzavadska@apollo.lv Submitted: 09/11/12; Revised: 10/27/12; Accepted: 11/03/12http://dx.doi.org/10.4161/hv.22766Recommendations for tick-borne encephalitis  vaccination from the Central European  Vaccination Awareness Group (CEVAG) Dace Zavadska,1,* Ioana Anca,2 Francis André,3 Mustafa Bakir,4 Roman Chlibek,5 Milan Č ižman,6 Inga Ivaskeviciene,7   Atanas Mangarov,8 Zsófia Mészner,9 Marko Pokorn,6 Roman Prymula,5,10 Darko Richter,11 Nuran Salman,12 Pavol Šimurka,13   Eda Tamm,14 Goran Tešović,15 Ingrid Urbancikova16 and Vytautas Usonis7 1Department of Pediatrics; Riga Stradins University; Riga, Latvia; 2Carol Davila University of Medicine and Pharmacy; Institute for Mother and Child Care; Bucharest, Romania;  3Consultant; Chaumont-Gistoux, Belgium; 4Department of Pediatrics; Division of Pediatric Infectious Diseases; Marmara University School of Medicine; Istanbul, Turkey;  5Faculty of Military Health Sciences; University of Defence; Hradec Kralove, Czech Republic; 6Department of Infectious Diseases; University Medical Centre; Ljubljana, Slovenia;  7Faculty of Medicine; Vilnius University Clinic of Children’s Diseases; Vilnius, Lithuania; 8Infectious Diseases Hospital; Sofia, Bulgaria; 9National Institute of Child Health;  Budapest, Hungary; 10University Hospital; Hradec Kralove, Czech Republic; 11Department of Pediatrics; University Hospital Center; Zagreb, Croatia; 12Division of Infectious  Disease and Clinical Microbiology; University of Istanbul; Istanbul Turkey; 13Pediatric Clinic; Faculty Hospital; University of Trencin; Trenčín, Slovakia; 14Children’s Clinic of  Tartu University Hospital; Tartu, Estonia; 15Paediatric Infectious Diseases Department; University of Zagreb School of Medicine; Zagreb, Croatia; 16Department of Paediatric  Infectious Diseases; Children’s Faculty Hospital; Košice, Slovakia Keywords:  tick-borne encephalitis, TBE vaccination, recommendations, CEVAG, Central Europe Introduction Tick-borne encephalitis (TBE) is a pathogenic human infec - tion caused by the TBE virus (TBEV), a flavivirus, which  is transmitted by infected ticks and by unpasteurized dairy products from infected cows, goats, or sheep.",Non-OADS,/arxiv_data1/oa_pdf/e7/f1/hvi-9-362.PMC3859759.pdf
"The aim of this review is to reinforce existing knowledge  of TBE burden, highlighting the current situation in Central European Vaccination Awareness Group (CEVAG; http://www.cevag.org/) countries and how CEVAG perceives TBE risk, and developing a formal CEVAG guidance statement on TBE vac - cination.",Non-OADS,/arxiv_data1/oa_pdf/e7/f1/hvi-9-362.PMC3859759.pdf
Available at: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=2495 (last accessed October 2012).,Non-OADS,/arxiv_data1/oa_pdf/e7/f1/hvi-9-362.PMC3859759.pdf
Clin Infect Dis 2002; 35:650-8; PMID:12203160; http://dx.doi.org/10.1086/342059.,OADS,/arxiv_data1/oa_pdf/e7/f1/hvi-9-362.PMC3859759.pdf
Available at: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=2494 (last accessed October 2012).,Non-OADS,/arxiv_data1/oa_pdf/e7/f1/hvi-9-362.PMC3859759.pdf
Available at:  http://www.ulac.lt/ (last accessed April 2012).,Non-OADS,/arxiv_data1/oa_pdf/e7/f1/hvi-9-362.PMC3859759.pdf
Available at: http://ecdc.europa.eu/ (last accessed January 2012).,Non-OADS,/arxiv_data1/oa_pdf/e7/f1/hvi-9-362.PMC3859759.pdf
Available at:  http://www.epis.sk/ (last accessed July 2012).,Non-OADS,/arxiv_data1/oa_pdf/e7/f1/hvi-9-362.PMC3859759.pdf
Vaccine 2011; 29:5178-83; PMID:21620916; http://dx.doi.org/10.1016/j.vaccine.2011.05.033.,Non-OADS,/arxiv_data1/oa_pdf/e7/f1/hvi-9-362.PMC3859759.pdf
Zoonoses Public Health 2011; 58:220-7; PMID:20604912; http://dx.doi.org/10.1111/j.1863-2378.2010.01342.x.,Non-OADS,/arxiv_data1/oa_pdf/e7/f1/hvi-9-362.PMC3859759.pdf
Vaccine 2003; 21(Suppl 1):S50-5; PMID:12628814; http://dx.doi.org/10.1016/S0264-410X(02)00813-7.,Non-OADS,/arxiv_data1/oa_pdf/e7/f1/hvi-9-362.PMC3859759.pdf
Intervirology 2012; 55:194-200; PMID:21325791; http://dx.doi.org/10.1159/000324023.,Non-OADS,/arxiv_data1/oa_pdf/e7/f1/hvi-9-362.PMC3859759.pdf
Eur J Public Health 2012; 22:182-6; PMID:21398380; http://dx.doi.org/10.1093/eurpub/ckr018.,Non-OADS,/arxiv_data1/oa_pdf/e7/f1/hvi-9-362.PMC3859759.pdf
Available at: http://www.who.int/ith/ITH2010.pdf (last accessed February 2012).,Non-OADS,/arxiv_data1/oa_pdf/e7/f1/hvi-9-362.PMC3859759.pdf
Vaccine 2012; 30:6301-6; PMID:22885012; http://dx.doi.org/10.1016/j.vaccine.2012.07.083.,Non-OADS,/arxiv_data1/oa_pdf/e7/f1/hvi-9-362.PMC3859759.pdf
Hum Vaccin 2009; 5:551-6; PMID:19430202; http://dx.doi.org/10.4161/hv.5.8.8571.18.,Non-OADS,/arxiv_data1/oa_pdf/e7/f1/hvi-9-362.PMC3859759.pdf
Available at: http://ecdc.europa.eu/en/healthtop-ics/spotlight/spotlight_tickborne/pages/situation_in_european_countries.aspx (last accessed April 2012).,Non-OADS,/arxiv_data1/oa_pdf/e7/f1/hvi-9-362.PMC3859759.pdf
Available at: http://www.lic.gov.lv/docs/268/2009-dok/12_09_II.pdf (last accessed March 2012).,Non-OADS,/arxiv_data1/oa_pdf/e7/f1/hvi-9-362.PMC3859759.pdf
Available at: http://www.uvzsr.sk (last accessed April 2012).,Non-OADS,/arxiv_data1/oa_pdf/e7/f1/hvi-9-362.PMC3859759.pdf
Zentralbl Bakteriol 1999; 289:540-7; PMID:10652720; http://dx.doi.org/10.1016/S0934-8840(99)80007-3.,Non-OADS,/arxiv_data1/oa_pdf/e7/f1/hvi-9-362.PMC3859759.pdf
Available at: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=2493 (last accessed October 2012).,Non-OADS,/arxiv_data1/oa_pdf/e7/f1/hvi-9-362.PMC3859759.pdf
J Med Virol 2004; 74:580-8; PMID:15484275; http://dx.doi.org/10.1002/jmv.20224.,Non-OADS,/arxiv_data1/oa_pdf/e7/f1/hvi-9-362.PMC3859759.pdf
Available at: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=2740 (last accessed October 2012).,Non-OADS,/arxiv_data1/oa_pdf/e7/f1/hvi-9-362.PMC3859759.pdf
Available at: http://www.oek.hu (last accessed July 2012).,Non-OADS,/arxiv_data1/oa_pdf/e7/f1/hvi-9-362.PMC3859759.pdf
J Virol Methods 2010; 163:481-5; PMID:19836419; http://dx.doi.org/10.1016/j.jviromet.2009.10.003.,OADS,/arxiv_data1/oa_pdf/e7/f1/hvi-9-362.PMC3859759.pdf
Available at: http://www.eurosur-veillance.org/ViewArticle.aspx?ArticleId=20128 (last accessed October 2012).References 1.,Non-OADS,/arxiv_data1/oa_pdf/e7/f1/hvi-9-362.PMC3859759.pdf
Available at: http://www.who.int/immunization/sage/6_TBE_backgr_18_Mar_net_apr_2011.pdf (last accessed May 2012).,Non-OADS,/arxiv_data1/oa_pdf/e7/f1/hvi-9-362.PMC3859759.pdf
Available at: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=18848 (last accessed October 2012).,Non-OADS,/arxiv_data1/oa_pdf/e7/f1/hvi-9-362.PMC3859759.pdf
Ticks Tick Borne Dis 2011; 2:2-15; PMID:21771531; http://dx.doi.org/10.1016/j.ttbdis.2010.10.007.,OADS,/arxiv_data1/oa_pdf/e7/f1/hvi-9-362.PMC3859759.pdf
Available at: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=18916 (last accessed October 2012).,Non-OADS,/arxiv_data1/oa_pdf/e7/f1/hvi-9-362.PMC3859759.pdf
Vector Borne Zoonotic Dis 2011; 11:659-64; PMID:21028962; http://dx.doi.org/10.1089/vbz.2010.0054.,OADS,/arxiv_data1/oa_pdf/e7/f1/hvi-9-362.PMC3859759.pdf
Vector Borne Zoonotic Dis 2012; 12:236-42; PMID:22022821; http://dx.doi.org/10.1089/vbz.2011.0728.,Non-OADS,/arxiv_data1/oa_pdf/e7/f1/hvi-9-362.PMC3859759.pdf
Antiviral Res 2003; 57:129-46; PMID:12615309; http://dx.doi.org/10.1016/S0166-3542(02)00206-1.,Non-OADS,/arxiv_data1/oa_pdf/e7/f1/hvi-9-362.PMC3859759.pdf
Vaccine 2003; 21(Suppl 1):S11-8; PMID:12628810; http://dx.doi.org/10.1016/S0264-410X(02)00811-3.,Non-OADS,/arxiv_data1/oa_pdf/e7/f1/hvi-9-362.PMC3859759.pdf
Vaccine 2010; 28:7396-400; PMID:20854899; http://dx.doi.org/10.1016/j.vaccine.2010.09.003.,Non-OADS,/arxiv_data1/oa_pdf/e7/f1/hvi-9-362.PMC3859759.pdf
Lancet 2008; 371:1861-71; PMID:18514730; http://dx.doi.org/10.1016/S0140-6736(08)60800-4.,Non-OADS,/arxiv_data1/oa_pdf/e7/f1/hvi-9-362.PMC3859759.pdf
"Infect Dis Clin  North Am 2008; 22:561-75, x; PMID:18755391; http://dx.doi.org/10.1016/j.idc.2008.03.013.",OADS,/arxiv_data1/oa_pdf/e7/f1/hvi-9-362.PMC3859759.pdf
Clin Infect Dis 1999; 28:882-90; PMID:10825054; http://dx.doi.org/10.1086/515195.,Non-OADS,/arxiv_data1/oa_pdf/e7/f1/hvi-9-362.PMC3859759.pdf
Vaccine 2011; 29:4556-64; PMID:21549781; http://dx.doi.org/10.1016/j.vac-cine.2011.04.061.,Non-OADS,/arxiv_data1/oa_pdf/e7/f1/hvi-9-362.PMC3859759.pdf
Available at: http://www.eurosurveil-lance.org/ViewArticle.aspx?ArticleId=19976 (last accessed May 2012).,Non-OADS,/arxiv_data1/oa_pdf/e7/f1/hvi-9-362.PMC3859759.pdf
http://www.terviseamet.ee/ fileadmin/dok/Nakkushaigused/statistika/2010/Epid_ulevaade_2010.pdf (last accessed April 2012).,OADS,/arxiv_data1/oa_pdf/e7/f1/hvi-9-362.PMC3859759.pdf
Expert Rev Vaccines  2006; 5:461-6; PMID:16989626; http://dx.doi.org/10.1586/14760584.5.4.461.,Non-OADS,/arxiv_data1/oa_pdf/e7/f1/hvi-9-362.PMC3859759.pdf
T ravel Med Infect Dis 2008; 6:331-41; PMID:18984477; http://dx.doi.org/10.1016/j.tmaid.2008.06.011.,Non-OADS,/arxiv_data1/oa_pdf/e7/f1/hvi-9-362.PMC3859759.pdf
Annu Rev Immunol 2011; 29:587-619; PMID:21219187; http://dx.doi.org/10.1146/annurev-immunol-031210-101315.60.,Non-OADS,/arxiv_data1/oa_pdf/e7/f1/hvi-9-362.PMC3859759.pdf
PLoS One 2007; 2:e500; PMID:17551580; http://dx.doi.org/10.1371/journal.pone.0000500.,OADS,/arxiv_data1/oa_pdf/e7/f1/hvi-9-362.PMC3859759.pdf
Int J Med Microbiol 2008; 298(Suppl.1):S301-4; http://dx.doi.org/10.1016/j.ijmm.2008.01.002.,OADS,/arxiv_data1/oa_pdf/e7/f1/hvi-9-362.PMC3859759.pdf
Hum Vaccin  Immunother 2012; 8:736-42; PMID:22699436; http://dx.doi.org/10.4161/hv.20058.55.,Non-OADS,/arxiv_data1/oa_pdf/e7/f1/hvi-9-362.PMC3859759.pdf
Vaccine 2004; 23:427-34; PMID:15530690; http://dx.doi.org/10.1016/j.vaccine.2004.07.002.,Non-OADS,/arxiv_data1/oa_pdf/e7/f1/hvi-9-362.PMC3859759.pdf
Vaccine 2010; 28:2827-31; PMID:20167301; http://dx.doi.org/10.1016/j.vaccine.2010.02.001.,Non-OADS,/arxiv_data1/oa_pdf/e7/f1/hvi-9-362.PMC3859759.pdf
Vaccine 2007; 25:7559-67; PMID:17869389; http://dx.doi.org/10.1016/j.vaccine.2007.08.024.,Non-OADS,/arxiv_data1/oa_pdf/e7/f1/hvi-9-362.PMC3859759.pdf
Available at: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19606 (last accessed October 2012).,Non-OADS,/arxiv_data1/oa_pdf/e7/f1/hvi-9-362.PMC3859759.pdf
Vet Parasitol 2010; 167:92-4; PMID:19833440; http://dx.doi.org/10.1016/j.vetpar.2009.09.011.,OADS,/arxiv_data1/oa_pdf/e7/f1/hvi-9-362.PMC3859759.pdf
"Do not distribute.Human Vaccines & Immunotherapeutics 9:2, 382–388; February 2013; © 2013 Landes Bioscience Resea Rc H p ape R 382 Human Vaccines & Immunotherapeutics  V olume 9 Issue 2*Correspondence to: Alassane Dicko; Email: adicko@mrtcbko.org Submitted: 07/30/12; Revised: 10/19/12; Accepted: 10/27/12http://dx.doi.org/10.4161/hv.22692Introduction Globally, approximately 1.6 million children under 5 years of  age die from pneumonia annually, and nearly half of pneumonia-related deaths occur in sub-Saharan Africa.",Non-OADS,/arxiv_data1/oa_pdf/19/e6/hvi-9-382.PMC3859761.pdf
Lancet 2010; 375:1969-87; PMID:20466419; http://dx.doi.org/10.1016/S0140-6736(10)60549-1.,OADS,/arxiv_data1/oa_pdf/19/e6/hvi-9-382.PMC3859761.pdf
2010 [http://www.vaccineamc.org/updatemar23_10.html] 3.,Non-OADS,/arxiv_data1/oa_pdf/19/e6/hvi-9-382.PMC3859761.pdf
PLoS Med 2010; 7:10; http://dx.doi.org/10.1371/journal.pmed.1000348.,OADS,/arxiv_data1/oa_pdf/19/e6/hvi-9-382.PMC3859761.pdf
Vaccine 2008; 26:3719-26; PMID:18514974; http://dx.doi.org/10.1016/j.vac-cine.2008.04.066.,Non-OADS,/arxiv_data1/oa_pdf/19/e6/hvi-9-382.PMC3859761.pdf
Vaccine 2011; 29:3372-3; PMID:21396901; http://dx.doi.org/10.1016/j.vac-cine.2011.02.089.8.,Non-OADS,/arxiv_data1/oa_pdf/19/e6/hvi-9-382.PMC3859761.pdf
Clin Microbiol Infect 2010; 16:402-10; PMID:20132251; http://dx.doi.org/10.1111/j.1469-0691.2010.03182.x.,Non-OADS,/arxiv_data1/oa_pdf/19/e6/hvi-9-382.PMC3859761.pdf
Lancet 2006; 368:1495-502; PMID:17071283; http://dx.doi.org/10.1016/S0140-6736(06)69637-2.,Non-OADS,/arxiv_data1/oa_pdf/19/e6/hvi-9-382.PMC3859761.pdf
BMC Public Health 2011; 11:882-93; PMID:22112189; http://dx.doi.org/10.1186/1471-2458-11-882.,Non-OADS,/arxiv_data1/oa_pdf/19/e6/hvi-9-382.PMC3859761.pdf
Pediatr Infect Dis J 2009; 28(Suppl):S109-18; PMID:19325447; http://dx.doi.org/10.1097/INF .0b013e318199f62d.,Non-OADS,/arxiv_data1/oa_pdf/19/e6/hvi-9-382.PMC3859761.pdf
Pediatr Infect Dis J 2009; 28(Suppl):S77-88; PMID:19325450; http://dx.doi.org/10.1097/INF .0b013e318199f609.,Non-OADS,/arxiv_data1/oa_pdf/19/e6/hvi-9-382.PMC3859761.pdf
Pediatr Infect Dis J 2009; 28(Suppl):S97-108; PMID:19325452; http://dx.doi.org/10.1097/INF .0b013e318199f61b.14.,Non-OADS,/arxiv_data1/oa_pdf/19/e6/hvi-9-382.PMC3859761.pdf
Pediatr Infect Dis J 2009; 28:e276-82; PMID:20118683; http://dx.doi.org/10.1097/INF .0b013e3181b48ca3.,OADS,/arxiv_data1/oa_pdf/19/e6/hvi-9-382.PMC3859761.pdf
Lancet 2009; 374:1339-50; PMID:19837254; http://dx.doi.org/10.1016/S0140-6736(09)61208-3.,Non-OADS,/arxiv_data1/oa_pdf/19/e6/hvi-9-382.PMC3859761.pdf
Pediatr Infect Dis J 2010; 29:e47-56; PMID:20508478; http://dx.doi.org/10.1097/INF .0b013e3181dffabf.,OADS,/arxiv_data1/oa_pdf/19/e6/hvi-9-382.PMC3859761.pdf
Pediatr Infect Dis J 2011; 30:69-72; PMID:20980933; http://dx.doi.org/10.1097/INF .0b013e3181f2da06.,OADS,/arxiv_data1/oa_pdf/19/e6/hvi-9-382.PMC3859761.pdf
Hum Vaccin 2011; 7:511-22; PMID:21441782; http://dx.doi.org/10.4161/hv.7.5.14634.,Non-OADS,/arxiv_data1/oa_pdf/19/e6/hvi-9-382.PMC3859761.pdf
Clin Vaccine Immunol 2006; 13:356-60; PMID:16522777; http://dx.doi.org/10.1128/CVI.13.3.356-360.2006.,Non-OADS,/arxiv_data1/oa_pdf/19/e6/hvi-9-382.PMC3859761.pdf
Clin Vaccine Immunol 2010; 17:134-42; PMID:19889940; http://dx.doi.org/10.1128/CVI.00289-09.,Non-OADS,/arxiv_data1/oa_pdf/19/e6/hvi-9-382.PMC3859761.pdf
Hum Vaccin 2005; 1:112-7; PMID:17012870; http://dx.doi.org/10.4161/hv.1.3.1848.,Non-OADS,/arxiv_data1/oa_pdf/19/e6/hvi-9-382.PMC3859761.pdf
Pediatr Infect Dis J 2009; 28(Suppl):S89-96; PMID:19325451; http://dx.doi.org/10.1097/INF .0b013e318199f901.,Non-OADS,/arxiv_data1/oa_pdf/19/e6/hvi-9-382.PMC3859761.pdf
Pediatr Infect Dis J 2011; 30:e235-43; PMID:21817957; http://dx.doi.org/10.1097/INF .0b013e31822a8541.,OADS,/arxiv_data1/oa_pdf/19/e6/hvi-9-382.PMC3859761.pdf
Lancet 2006; 367:740-8; PMID:16517274; http://dx.doi.org/10.1016/S0140-6736(06)68304-9.,OADS,/arxiv_data1/oa_pdf/19/e6/hvi-9-382.PMC3859761.pdf
BMC Pediatr 2010; 10:4; PMID:20122261; http://dx.doi.org/10.1186/1471-2431-10-4.,OADS,/arxiv_data1/oa_pdf/19/e6/hvi-9-382.PMC3859761.pdf
Vaccine 2012; 30:6416-20; PMID:22921290; http://dx.doi.org/10.1016/j.vaccine.2012.08.017.,Non-OADS,/arxiv_data1/oa_pdf/19/e6/hvi-9-382.PMC3859761.pdf
Vaccine 1998; 16:921-7; PMID:9682338; http://dx.doi.org/10.1016/S0264-410X(97)00303-4.,Non-OADS,/arxiv_data1/oa_pdf/19/e6/hvi-9-382.PMC3859761.pdf
"Human Vaccines & Immunotherapeutics 9:2, 420–429; February 2013; © 2013 Landes Bioscience ReseaR cH papeR 420 Human Vaccines & Immunotherapeutics Volume 9 Issue 2*Correspondence to: Joan Joseph; Email: jjoseph@clinic.ub.es Submitted: 08/29/12; Revised: 10/31/12; Accepted: 11/10/12http://dx.doi.org/10.4161/hv.22903Introduction According to the UNAIDS World AIDS Day Report for 2011,  at the end of 2010 an estimated 34 million people were living with HIV worldwide and 2.7 million individuals became newly infected with the virus in 2010.",Non-OADS,/arxiv_data1/oa_pdf/96/8a/hvi-9-420.PMC3859767.pdf
Available: http://www.unaids.org/en/ media/unaids/contentassets/documents/unaidspubli- cation/2011/JC2216_WorldAIDSday_report_2011_ en.pdf.,Non-OADS,/arxiv_data1/oa_pdf/96/8a/hvi-9-420.PMC3859767.pdf
Am J Public Health 2001; 91:1377- 9; PMID:11527761; http://dx.doi.org/10.2105/ AJPH.91.9.1377.,Non-OADS,/arxiv_data1/oa_pdf/96/8a/hvi-9-420.PMC3859767.pdf
BMC Infect Dis 2011; 11:283;  PMID:22023776; http://dx.doi.org/10.1186/1471- 2334-11-283.,Non-OADS,/arxiv_data1/oa_pdf/96/8a/hvi-9-420.PMC3859767.pdf
AIDS Care 2011; 23:1430-47; PMID:21722022;  http://dx.doi.org/10.1080/09540121.2011.555750.,Non-OADS,/arxiv_data1/oa_pdf/96/8a/hvi-9-420.PMC3859767.pdf
Vaccine 2011; 29:5850-9; PMID:21740947; http://dx.doi.org/10.1016/j.vaccine.2011.06.055.,Non-OADS,/arxiv_data1/oa_pdf/96/8a/hvi-9-420.PMC3859767.pdf
Am J Epidemiol  2001; 153:619-27; PMID:11282787; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/96/8a/hvi-9-420.PMC3859767.pdf
J Acquir Immune  Defic Syndr 2005; 39:359-64; PMID:15980699;  http://dx.doi.org/10.1097/01.qai.0000152039.88422.,Non-OADS,/arxiv_data1/oa_pdf/96/8a/hvi-9-420.PMC3859767.pdf
J Acquir Immune Defic Syndr  2004; 36:721-5; PMID:15167291; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/96/8a/hvi-9-420.PMC3859767.pdf
AIDS Care 2006; 18:569-73; PMID:16831784;  http://dx.doi.org/10.1080/09540120500274976.,Non-OADS,/arxiv_data1/oa_pdf/96/8a/hvi-9-420.PMC3859767.pdf
J Cardiopulm Rehabil 2003; 23:269-80; PMID:12894001; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/96/8a/hvi-9-420.PMC3859767.pdf
AIDS Res Hum Retroviruses  2009; 25:217-24; PMID:19239362; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/96/8a/hvi-9-420.PMC3859767.pdf
Int J STD AIDS  2005; 16:314-7; PMID:15899086; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/96/8a/hvi-9-420.PMC3859767.pdf
J Acquir Immune Defic Syndr Hum Retrovirol  1997; 16:108-15; PMID:9358105; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/96/8a/hvi-9-420.PMC3859767.pdf
J Acquir Immune  Defic Syndr 2004; 36:604-12; PMID:15097304;  http://dx.doi.org/10.1097/00126334-200405010- 00009.,Non-OADS,/arxiv_data1/oa_pdf/96/8a/hvi-9-420.PMC3859767.pdf
J Assoc Nurses  AIDS Care 2007; 18:51-63; PMID:17662924; http://dx.doi.org/10.1016/j.jana.2007.05.002.,Non-OADS,/arxiv_data1/oa_pdf/96/8a/hvi-9-420.PMC3859767.pdf
J Acquir Immune Defic Syndr 2005; 39:499- 501; PMID:16010176; http://dx.doi.org/10.1097/01.,Non-OADS,/arxiv_data1/oa_pdf/96/8a/hvi-9-420.PMC3859767.pdf
AIDS Behav 2005; 9:301-9; PMID:16088366;  http://dx.doi.org/10.1007/s10461-005-9004-3.,Non-OADS,/arxiv_data1/oa_pdf/96/8a/hvi-9-420.PMC3859767.pdf
J Acquir Immune Defic Syndr 2008;  48:82-9; PMID:18391750; http://dx.doi.org/10.1097/QAI.0b013e31817236ab.,Non-OADS,/arxiv_data1/oa_pdf/96/8a/hvi-9-420.PMC3859767.pdf
J Adolesc Health 2011; 49:42-6;  PMID:21700155; http://dx.doi.org/10.1016/j.jado- health.2010.10.009.,Non-OADS,/arxiv_data1/oa_pdf/96/8a/hvi-9-420.PMC3859767.pdf
AIDS 1998; 12:785-93; PMID:9619811; http://dx.doi.org/10.1097/00002030-199807000- 00015.,Non-OADS,/arxiv_data1/oa_pdf/96/8a/hvi-9-420.PMC3859767.pdf
J Am Diet Assoc  2004; 104:70-5; PMID:14702587; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/96/8a/hvi-9-420.PMC3859767.pdf
Appl Nurs Res 2004; 17:55-60; PMID:14991556; http://dx.doi.org/10.1016/j.apnr.2003.12.002.,OADS,/arxiv_data1/oa_pdf/96/8a/hvi-9-420.PMC3859767.pdf
J Urban Health 2000; 77:425- 37; PMID:10976615; http://dx.doi.org/10.1007/ BF02386751.,Non-OADS,/arxiv_data1/oa_pdf/96/8a/hvi-9-420.PMC3859767.pdf
Psychol Health Med 2012; 17:223-34;  PMID:22250925; http://dx.doi.org/10.1080/1354850 6.2011.608803.,Non-OADS,/arxiv_data1/oa_pdf/96/8a/hvi-9-420.PMC3859767.pdf
AIDS Behav 2010; 14:607-17;  PMID:19037720; http://dx.doi.org/10.1007/s10461-008-9486-x.,Non-OADS,/arxiv_data1/oa_pdf/96/8a/hvi-9-420.PMC3859767.pdf
AIDS  1995; 9:1079-83; PMID:8527082; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/96/8a/hvi-9-420.PMC3859767.pdf
Vaccine 2011; 29:1991-6; PMID:21241735;  http://dx.doi.org/10.1016/j.vaccine.2010.12.043.,Non-OADS,/arxiv_data1/oa_pdf/96/8a/hvi-9-420.PMC3859767.pdf
"Journal of  Preventive Medicine  & Public Health 293 Copyright © 2013  The Korean Society for Preventive MedicineJournal of  Preventive Medicine  & Public Health PB Copyright © 2013  The Korean Society for Preventive MedicineJ Prev Med Public Health 2013;46:293-299   •  http://dx.doi.org/10.3961/jpmph.2013.46.6.293 The Economic Burden of Epilepsy in Korea, 2010 Jaehun Jung1, Hye-Young Seo2, Young Ae Kim2, In-Hwan Oh3, Yo Han Lee1, Seok-Jun Yoon1 1Department of Preventive Medicine, Korea University College of Medicine, Seoul; 2Graduate School of Public Health, Korea University, Seoul;   3Department of Preventive Medicine, Kyung Hee University College of Medicine, Seoul, KoreaOriginal Article Objectives: The purposes of this study were to evaluate the prevalence of epilepsy and to estimate the cost of epilepsy in Korea, 2010.",Non-OADS,/arxiv_data1/oa_pdf/72/04/jpmph-46-293.PMC3859850.pdf
"Key words:  Epilepsy, Cost of illness, Prevalence Received:  April 15, 2013; Accepted:  September 16, 2013 Corresponding author:  Seok-Jun Yoon, MD, PhD 145 Anam-ro, Seongbuk-gu, Seoul 136-701, Korea Tel: +82-2920-6412, Fax: +82-2920-7220   E-mail : yoonsj02@korea.ac.kr This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.INTRODUCTION The International League Against Epilepsy and the Interna - tional Bureau for Epilepsy defined epilepsy as a disease of brain  featured by a state causing at least one epileptic seizure con - tinuously and its neurobiological, cognitive, psychological, and  social results [1].",Non-OADS,/arxiv_data1/oa_pdf/72/04/jpmph-46-293.PMC3859850.pdf
Available from: http://www.khp.re.kr/english/ about_01.jsp.,Non-OADS,/arxiv_data1/oa_pdf/72/04/jpmph-46-293.PMC3859850.pdf
Available from: http://laborstat.molab.go.kr/newWeb/intro/ sub1/sub01_02.jsp.,Non-OADS,/arxiv_data1/oa_pdf/72/04/jpmph-46-293.PMC3859850.pdf
Available from: http://kosis.kr/statistic - sList/statisticsList_01List.jsp?vwcd =MT_ZTITLE&parentId =A.,OADS,/arxiv_data1/oa_pdf/72/04/jpmph-46-293.PMC3859850.pdf
Available from: http://apps.who.int/classifica - tions/icd10/browse/2010/en.,OADS,/arxiv_data1/oa_pdf/72/04/jpmph-46-293.PMC3859850.pdf
"Journal of  Preventive Medicine  & Public Health 300 Copyright © 2013  The Korean Society for Preventive MedicineJ Prev Med Public Health 2013;46:300-308   •  http://dx.doi.org/10.3961/jpmph.2013.46.6.300 Determinants of Health Care Expenditures and the Con - tribution of Associated Factors: 16 Cities and Provinces in  Korea, 2003-2010  Kimyoung Han1, Minho Cho2, Kihong Chun1,2 1Department of Preventive Medicine and Public Health, Ajou University School of Medicine, Suwon; 2Graduate School of Public Health,   Ajou University, Suwon, KoreaOriginal Article Objectives: The purpose of this study was to classify determinants of cost increases into two categories, negotiable factors and non- negotiable factors, in order to identify the determinants of health care expenditure increases and to clarify the contribution of associ - ated factors selected based on a literature review.",Non-OADS,/arxiv_data1/oa_pdf/01/ca/jpmph-46-300.PMC3859851.pdf
"Key words:  Health care costs, Medical care costs, Public policy, Health resources Received:  July 10, 2013; Accepted:  September 9, 2013 Corresponding author:  Kihong Chun, MD, PhD 206 World cup-ro, Yeongtong-gu, Suwon 443-721, Korea Tel: +82-31-219-5082 , Fax: +82-31-219-5084   E-mail : ajoujkh@ajou.ac.kr This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.INTRODUCTION Since the introduction of the National Health Insurance sys - tem 20 years ago, health care expenditures in Korea have been  drastically increasing every year.",Non-OADS,/arxiv_data1/oa_pdf/01/ca/jpmph-46-300.PMC3859851.pdf
"Journal of  Preventive Medicine  & Public Health 309 Copyright © 2013  The Korean Society for Preventive MedicineJ Prev Med Public Health 2013;46:309-318   •  http://dx.doi.org/10.3961/jpmph.2013.46.6.309 Cancer Incidence in Korean Vietnam Veterans During  1992-2003: The Korean Veterans Health Study Sang-Wook Yi Department of Preventive Medicine and Public Health, Kwandong University College of Medicine, Gangneung, KoreaOriginal Article Objectives: The aim of this study was to investigate the association between Vietnam experience including exposure to military her - bicides and cancer incidence in Korean Vietnam War veterans.",Non-OADS,/arxiv_data1/oa_pdf/a8/be/jpmph-46-309.PMC3859852.pdf
"Key words:  Neoplasms, Cohort studies, Incidence, Korea, Veterans, Vietnam War  Received:  July 23, 2013; Accepted:  September 23, 2013 Corresponding author:  Sang-Wook Yi, MD, PhD 24 Beomil-ro 579beon-gil, Gangneung 210-701, Korea Tel: +82-33-649-7468, Fax: +82-33-641-1074   E-mail : flyhigh@kd.ac.kr This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.INTRODUCTION During the Vietnam War, between 1961 and 1971, the US  and allied forces sprayed herbicides for military purposes [1].",Non-OADS,/arxiv_data1/oa_pdf/a8/be/jpmph-46-309.PMC3859852.pdf
Available from: http://monographs.iarc.fr/ENG/Classification.,Non-OADS,/arxiv_data1/oa_pdf/a8/be/jpmph-46-309.PMC3859852.pdf
"Journal of  Preventive Medicine  & Public Health 319 Copyright © 2013  The Korean Society for Preventive MedicineJ Prev Med Public Health 2013;46:319-328   •  http://dx.doi.org/10.3961/jpmph.2013.46.6.319 Cardiovascular Health Metrics and All-cause and   Cardiovascular Disease Mortality Among Middle-aged  Men in Korea: The Seoul Male Cohort Study Ji Young Kim1, Young-Jin Ko1, Chul Woo Rhee1, Byung-Joo Park1,2, Dong-Hyun Kim3, Jong-Myon Bae4,   Myung-Hee Shin5, Moo-Song Lee6, Zhong Min Li7, Yoon-Ok Ahn1,8  1Department of Preventive Medicine, Seoul National University College of Medicine, Seoul; 2Korea Institute of Drug Safety and Risk Management,  Seoul; 3Department of Social Medicine, Hallym University College of Medicine, Chuncheon; 4Department of Preventive Medicine, Cheju National   University College of Medicine, Jeju; 5Department of Social and Preventive Medicine, Sungkyunkwan University School of Medicine, Suwon;   6Department of Preventive Medicine, Ulsan University College of Medicine, Seoul, Korea; 7Department of Epidemiology and Statistics, School of  Public Health Sciences, Jilin University, Changchun, China; 8Korean Foundation for Cancer Research, Seoul, KoreaOriginal Article Objectives: This study estimated the association of cardiovascular health behaviors with the risk of all-cause and cardiovascular dis - ease (CVD) mortality in middle-aged men in Korea.",Non-OADS,/arxiv_data1/oa_pdf/b9/94/jpmph-46-319.PMC3859853.pdf
"Key words:  Cardiovascular diseases, Cohort studies, Cox proportional hazards models, Life style, Mortality Received:  June 28, 2013; Accepted:  October 4, 2013 Corresponding author:  Yoon-Ok Ahn, MD, PhD 103 Daehak-ro, Jongno-gu, Seoul 110-799, Korea Tel: +82-2-740-8322, Fax: +82-2-747-4830   E-mail : yoahn@snu.ac.kr This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.INTRODUCTION The leading causes of death globally are non-communicable  diseases (NCD) including cardiovascular disease (CVD), cancer,  diabetes, and chronic respiratory disease, which accounted for  63% of 57 million deaths total worldwide in 2008.",Non-OADS,/arxiv_data1/oa_pdf/b9/94/jpmph-46-319.PMC3859853.pdf
Available from: http://www.who.int/gho/pub - lications/world_health_statistics/EN_WHS2012_Full.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b9/94/jpmph-46-319.PMC3859853.pdf
Available from:  http://www.cdc.go.kr/CDC/notice/CdcKrIntro0504.jsp?,Non-OADS,/arxiv_data1/oa_pdf/b9/94/jpmph-46-319.PMC3859853.pdf
Available from: http://www.hsph.harvard.,Non-OADS,/arxiv_data1/oa_pdf/b9/94/jpmph-46-319.PMC3859853.pdf
"Journal of  Preventive Medicine  & Public Health 329 Copyright © 2013  The Korean Society for Preventive MedicineJournal of  Preventive Medicine  & Public Health PB Copyright © 2013  The Korean Society for Preventive MedicineJ Prev Med Public Health 2013;46:329-335   •  http://dx.doi.org/10.3961/jpmph.2013.46.6.329 Relationship Between Current Sleep Duration and Past  Suicidal Ideation or Attempt Among Korean Adolescents  Sung-In Jang1,2, Kwang-Sig Lee1,2, Eun-Cheol Park1,2  1Department of Preventive Medicine, Yonsei University College of Medicine, Seoul; 2Health Services Research Institute, Yonsei University College of  Medicine, Seoul, Korea Original Article Objectives: To comprehensively examine the relationship between current sleep duration and past suicidal idea or attempt among  Korean adolescents.",Non-OADS,/arxiv_data1/oa_pdf/ee/d9/jpmph-46-329.PMC3859854.pdf
"Key words:  Suicidal ideation, Suicidal attempt, Sleep duration, Depressed mood, Adolescent, Korea  Received:  May 22, 2013; Accepted:  October 4, 2013 Corresponding author:  Kwang-Sig Lee, PhD 50 Yonsei-ro, Seodaemun-gu, Seoul 120-752, Korea  Tel: +82-2-2228-1876, Fax: +82-2-392-8133   E-mail : ecophy@yuhs.ac This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.INTRODUCTION  Suicide has become a major issue for adolescent health in  the past decade [1,2].",Non-OADS,/arxiv_data1/oa_pdf/ee/d9/jpmph-46-329.PMC3859854.pdf
"METHODS  Data  The data used for this study came from the 2009 Korea Youth  Risk Behavior Web-based Survey (KYRBWS) conducted by the  Korea Ministry of Education, Science and Technology, the Korea  Ministry of Health and Welfare, and the Korea Center for Dis - ease Control and Prevention (KCDC) (http://yhs.cdc.go.kr).",OADS,/arxiv_data1/oa_pdf/ee/d9/jpmph-46-329.PMC3859854.pdf
"Journal of  Preventive Medicine  & Public Health 336 Copyright © 2013  The Korean Society for Preventive MedicineJ Prev Med Public Health 2013;46:336-345   •  http://dx.doi.org/10.3961/jpmph.2013.46.6.336 Social Network Characteristics and Body Mass Index in an  Elderly Korean Population Won Joon Lee1, Yoosik Youm2, Yumie Rhee3, Yeong-Ran Park4, Sang Hui Chu5, Hyeon Chang Kim1 1Department of Preventive Medicine, Yonsei University College of Medicine, Seoul; 2Department of Sociology, Yonsei University College of Social   Sciences, Seoul; 3Department of Internal Medicine, Yonsei University College of Medicine, Seoul; 4Division of Silver Industry, Kangnam University,  Yongin; 5Department of Clinical Nursing Science, Yonsei University College of Nursing, Seoul, KoreaOriginal Article Objectives: Research has shown that obesity appears to spread through social ties.",Non-OADS,/arxiv_data1/oa_pdf/7b/a4/jpmph-46-336.PMC3859855.pdf
"Key words:  Aged, Body mass index, Social support  Received:  May 24, 2013; Accepted:  October 17, 2013 Corresponding author:  Yoosik Youm, PhD  50 Yonsei-ro, Seodaemun-gu, Seoul 120-752, Korea Tel: +82-2-2123-2431, Fax: +82-2-123-2420   E-mail : yoosik@yonsei.ac.kr This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.INTRODUCTION The study of the effects of social networks on health rose to  the surface in the 1970s through pioneers such as Cassel, Cobb, pISSN 1975-8375 eISSN 2233-4521  and Berkman, who theorized or proved empirically that social  networks could affect mortality [1-6].",Non-OADS,/arxiv_data1/oa_pdf/7b/a4/jpmph-46-336.PMC3859855.pdf
"Journal of  Preventive Medicine  & Public Health 346 Copyright © 2013  The Korean Society for Preventive MedicineJ Prev Med Public Health 2013;46:346-352   •  http://dx.doi.org/10.3961/jpmph.2013.46.6.346 Association of Selected Medical Conditions With Breast  Cancer Risk in Korea Sun Jae Jung1,2, Minkyo Song1,3, Ji-Yeob Choi2,3, Nan Song2, Sue Kyung Park1-3, Keun-Young Yoo1, Daehee Kang1-3 1Department of Preventive Medicine, Seoul National University College of Medicine, Seoul; 2Cancer Research Institute, Seoul National University   College of Medicine, Seoul; 3Department of Biomedical Sciences, Seoul National University Graduate School, Seoul, KoreaOriginal Article Objectives: To estimate the effect of medical conditions in the population of Korea on breast cancer risk in a case-control study.",Non-OADS,/arxiv_data1/oa_pdf/f5/a0/jpmph-46-346.PMC3859856.pdf
"Key words:  Breast neoplasms, Diabetes mellitus, Hypertension, Ovarian diseases, Menopause Received:  August 1, 2013; Accepted:  October 17, 2013 Corresponding author:  Daehee Kang, MD, PhD 103 Daehak-ro, Jongno-gu, Seoul 110-799, Korea Tel: +82-2-740-8001, Fax: +82-2-747-4830   E-mail : dhkang@snu.ac.kr This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.INTRODUCTION Breast cancer is the second most common cancer among  Korean women [1].",Non-OADS,/arxiv_data1/oa_pdf/f5/a0/jpmph-46-346.PMC3859856.pdf
"Journal of  Preventive Medicine  & Public Health 353 Copyright © 2013  The Korean Society for Preventive MedicineJournal of  Preventive Medicine  & Public Health PB Copyright © 2013  The Korean Society for Preventive MedicineJ Prev Med Public Health 2013;46:353-359   •  http://dx.doi.org/10.3961/jpmph.2013.46.6.353 A Trend Analysis of the Prevalence, Awareness,   Treatment, and Control of Hypertension by Age Group Jong Youn Moon, Kwan Jun Park, Young Hwangbo, Mee Ri Lee, Byoung In Yoo, Jong Hye Won, Yoon Hyung Park Department of Preventive Medicine, Soonchunhyang University College of Medicine, Cheonan, KoreaOriginal Article Objectives: We examined the trends in prevalence, awareness, treatment, and control of hypertension in Korea as a basis for improv - ing hypertension control programs.",Non-OADS,/arxiv_data1/oa_pdf/fa/8a/jpmph-46-353.PMC3859857.pdf
"Key words:  Prevalence, Awareness, Therapeutics, Prevention & control, Hypertension, Korean National Health and Nutrition Examina - tion Survey Received:  September 27, 2013; Accepted:  October 21, 2013 Corresponding author:  Yoon Hyung Park, MD, PhD 31 Suncheonhyang 6-gil, Dongnam-gu, Cheonan 330-930, Korea Tel: +82-41-570-2483, Fax: +82-41-575-2406   E-mail : parky@sch.ac.kr This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.INTRODUCTION The prevalence of cardiovascular disease (CVD) has been  continuously increasing due to population aging, and changes  in consumption and lifestyle patterns [1].",Non-OADS,/arxiv_data1/oa_pdf/fa/8a/jpmph-46-353.PMC3859857.pdf
Available from: http://kostat.go.kr/portal/korea/kor_nw/2/6/2/ index.board?bmode =read&aSeq =260046.,OADS,/arxiv_data1/oa_pdf/fa/8a/jpmph-46-353.PMC3859857.pdf
Available from: http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/fa/8a/jpmph-46-353.PMC3859857.pdf
"459 http://dx.doi.org/10.3345/kjp.2013.56.11.459The promotion of mental health and the pre ­ vention of mental health problems in child and  adolescent Sun Mi Cho, PhD, Yun Mi Shin, MD Department of Psychiatry, Ajou University School of Medicine, Suwon, Korea Improving mental health and reducing the burden of mental illness are complementary strategies  which, along with the treatment and rehabilitation of people with mental disorders, significantly improve  population health and well-being.",Non-OADS,/arxiv_data1/oa_pdf/de/2d/kjped-56-459.PMC3859877.pdf
"Key words: Mental health, Primary prevention, Child, AdolescentCorresponding author: Yunmi Shin, MD Department of Psychiatry, Ajou University School of Medicine, 206 World cup-ro, Yeongtong-gu, Suwon 443-721, KoreaTel: +82-31-219-5180Fax: +82-31-219-5179E-mail: ymshin@ajou.ac.kr Received: 21 April 2013 Accepted: 27 August 2013 Copyright © 2013 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Review article  Korean J Pediatr 2013;56(11):459 ­464 http://dx.doi.org/10.3345/kjp.2013.56.11.459 pISSN 1738 ­1061•eISSN 2092 ­7258 Korean J Pediatr Introduction  The mental health needs of children and adolescents within Korea and all over the  worldwide have received increasing attention in recent years1).",Non-OADS,/arxiv_data1/oa_pdf/de/2d/kjped-56-459.PMC3859877.pdf
http://dx.doi.org/10.3345/kjp.2013.56.11.459Choi SM and Shin YM  • Prevention mental health problems 4601.,Non-OADS,/arxiv_data1/oa_pdf/de/2d/kjped-56-459.PMC3859877.pdf
461 http://dx.doi.org/10.3345/kjp.2013.56.11.459Korean J Pediatr 2013;56(11):459-464 2.,Non-OADS,/arxiv_data1/oa_pdf/de/2d/kjped-56-459.PMC3859877.pdf
"http://dx.doi.org/10.3345/kjp.2013.56.11.459Choi SM and Shin YM  • Prevention mental health problems 4621) Specific mental disorders occur at specific stages of a  child and adolescent’s development, screening programs and  interventions for such disorders can be targeted to the stage  at which they are most likely to appear; 2) there is a high de - gree of continuity between child and adolescent disorders into adulthood, early intervention could prevent or reduce the  likelihood of long-term impairment; 3) effective interventions  can reduce the burden of mental health disorders on the  indi vidual and the family; 4) the majority of children and  adolescents who do not receive treatment may experience  significant negative outcomes.",Non-OADS,/arxiv_data1/oa_pdf/de/2d/kjped-56-459.PMC3859877.pdf
463 http://dx.doi.org/10.3345/kjp.2013.56.11.459Korean J Pediatr 2013;56(11):459-464 the screening instruments and to interpret the results.,OADS,/arxiv_data1/oa_pdf/de/2d/kjped-56-459.PMC3859877.pdf
http://dx.doi.org/10.3345/kjp.2013.56.11.459Choi SM and Shin YM  • Prevention mental health problems 46419.,Non-OADS,/arxiv_data1/oa_pdf/de/2d/kjped-56-459.PMC3859877.pdf
"465 http://dx.doi.org/10.3345/kjp.2013.56.11.459Prevalence of rotavirus genotypes in South Korea  in 1989–2009: implications for a nationwide  rotavirus vaccine program Van Thai Than, Wonyong Kim, PhD Department of Microbiology, Research Center for Medical Sciences, Chung-Ang University College of Medicine, Seoul, Korea The epidemiology of human group A rotavirus was analyzed by examining genotypic data acquired from  1989 to 2009 in South Korea.",Non-OADS,/arxiv_data1/oa_pdf/df/e4/kjped-56-465.PMC3859878.pdf
"Key words: Rotavirus, G type, P type, Nationwide vaccine programCorresponding author: Wonyong Kim, PhD Department of Microbiology, Chung-Ang University College of Medicine, 84 Heukseok-ro, Dongjak-gu, Seoul 156-861, KoreaTel: +82-2-820-5685Fax: +82-2-822-5685E-mail: kimwy@cau.ac.kr Received: 23 April 2013 Accepted: 18 August 2013 Copyright © 2013 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Review article  Korean J Pediatr 2013;56(11):465-473 http://dx.doi.org/10.3345/kjp.2013.56.11.465 pISSN 1738-1061•eISSN 2092-7258 Korean J Pediatr Introduction Rotavirus is the most c ommon causal agent of acute diarrhea among children  worldwide and is transmitted between individuals via the fecal-oral route1).",Non-OADS,/arxiv_data1/oa_pdf/df/e4/kjped-56-465.PMC3859878.pdf
http://dx.doi.org/10.3345/kjp.2013.56.11.465Than VT and Kim W  • Rotavirus genotype prevalence 466samples.,Non-OADS,/arxiv_data1/oa_pdf/df/e4/kjped-56-465.PMC3859878.pdf
The first  search retrieved published studies from the PubMed-NCBI  database (http://www.ncbi.nlm.nih.gov).,OADS,/arxiv_data1/oa_pdf/df/e4/kjped-56-465.PMC3859878.pdf
"This search used  the terms “human,” “rotavirus,” and “Korea.” The second  search, which retrieved published articles from the KoreaMed  database (http://koreamed.org/SearchBasic.php), used the terms  “rotavirus” and “human.” Both searches focused on hospitalized  children and outpatients who had been hospitalized with acute  gastroenteritis.",Non-OADS,/arxiv_data1/oa_pdf/df/e4/kjped-56-465.PMC3859878.pdf
467 http://dx.doi.org/10.3345/kjp.2013.56.11.465Korean J Pediatr 2013;56(11):465-473 6.,Non-OADS,/arxiv_data1/oa_pdf/df/e4/kjped-56-465.PMC3859878.pdf
http://dx.doi.org/10.3345/kjp.2013.56.11.465Than VT and Kim W  • Rotavirus genotype prevalence 468in 198358).,Non-OADS,/arxiv_data1/oa_pdf/df/e4/kjped-56-465.PMC3859878.pdf
"469 http://dx.doi.org/10.3345/kjp.2013.56.11.465Korean J Pediatr 2013;56(11):465-473 responsible for 7.4% to 39% of rural infections51-54,56,59); however,  the rate of infection was much lower, only 1% to 3%, in urban  hospitals41,48-50,60).",Non-OADS,/arxiv_data1/oa_pdf/df/e4/kjped-56-465.PMC3859878.pdf
http://dx.doi.org/10.3345/kjp.2013.56.11.465Than VT and Kim W  • Rotavirus genotype prevalence 4703.,Non-OADS,/arxiv_data1/oa_pdf/df/e4/kjped-56-465.PMC3859878.pdf
471 http://dx.doi.org/10.3345/kjp.2013.56.11.465Korean J Pediatr 2013;56(11):465-473 to estimate the epidemiological importance of these genotypes  owing to limited analyses (Table 1).,Non-OADS,/arxiv_data1/oa_pdf/df/e4/kjped-56-465.PMC3859878.pdf
Supplementary materials Supplementary Table 1 can be found via http://kjp.or.kr/ upload/2013600040-supp.pdf.,Non-OADS,/arxiv_data1/oa_pdf/df/e4/kjped-56-465.PMC3859878.pdf
http://dx.doi.org/10.3345/kjp.2013.56.11.465Than VT and Kim W  • Rotavirus genotype prevalence 47227.,Non-OADS,/arxiv_data1/oa_pdf/df/e4/kjped-56-465.PMC3859878.pdf
473 http://dx.doi.org/10.3345/kjp.2013.56.11.465Korean J Pediatr 2013;56(11):465-473 Germany.,Non-OADS,/arxiv_data1/oa_pdf/df/e4/kjped-56-465.PMC3859878.pdf
"Tae-Jung Sung, MD Department of Pediatrics, Hallym University Kangnam Sacred Heart Hospital, Seoul, Korea Corresponding author: Tae-Jung Sung, MD Department of Pediatrics, Hallym University Kangnam Sacred Heart Hospital, 1 Singil-ro, Yeongdeungpo-gu, Seoul 150-950, Korea Tel: +82-2-829-5148Fax: +82-2-829-4469E-mail: neosung@hallym.or.kr  Received: 27 August, 2013 Accepted: 9 October, 2013 Copyright © 2013 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Editorial Korean J Pediatr 2013;56(11):474-476 http://dx.doi.org/10.3345/kjp.2013.56.11.474 pISSN 1738-1061•eISSN 2092-7258 Korean J Pediatr Recently, birth of premature babies and low birth weight babies has been increasing  and survival rate of very low birth weight babies even under 500 g not to mention under  1,000 g is remarkably enhanced thanks to the development of neonatology.",Non-OADS,/arxiv_data1/oa_pdf/a3/56/kjped-56-474.PMC3859879.pdf
475 http://dx.doi.org/10.3345/kjp.2013.56.11.474Korean J Pediatr 2013;56(11):474-476 as totally different serovars according to hybridization and  wonder if studies investigating difference among serovars are  meaningless8).,Non-OADS,/arxiv_data1/oa_pdf/a3/56/kjped-56-474.PMC3859879.pdf
http://dx.doi.org/10.3345/kjp.2013.56.11.474Sung TJ  • Ureaplasma Urealyticum or Ureaplasma Parvum  476relationship with cytokines should be studied further in the  future.,Non-OADS,/arxiv_data1/oa_pdf/a3/56/kjped-56-474.PMC3859879.pdf
"477 http://dx.doi.org/10.3345/kjp.2013.56.11.477Serological investigation of Ureaplasma urealy­ ticum  in Korean preterm infants  Ho Seon Eun, MD, Soon Min Lee, MD, Min Soo Park, MD, Kook In Park, MD, Ran Namgung, MD, Chul Lee, MD Department of Pediatrics, Severance Children’s Hospital, Yonsei University College of Medicine, Seoul, Korea  Purpose:  Ureaplasma  colonization is related with perinatal complications in preterm infants.",Non-OADS,/arxiv_data1/oa_pdf/b6/5f/kjped-56-477.PMC3859880.pdf
"Key words: Ureaplasma urealyticum , Serovar, Bronchopulmonary dysplasiaCorresponding author: Min Soo Park, MD Departments of Pediatrics and Clinical Pharma - cology, Severance Children’s Hospital, Yonsei University College of Medicine, 50 Yonsei-ro, Seodaemun-gu, Seoul 120-752, KoreaTel: +82-2-2228-0400Fax: +82-2-313-4614E-mail: minspark@yuhs.ac Received: 9 April 2013 Revised: 24 May 2013Accepted: 13 June 2013 Copyright © 2013 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Original article  Korean J Pediatr 2013;56(11):477 ­481 http://dx.doi.org/10.3345/kjp.2013.56.11.477 pISSN 1738 ­1061•eISSN 2092 ­7258 Korean J Pediatr Introduction Ureaplasma  colonization has been associated with pregnancy complications, neonatal  morbidities, and perinatal death1).",Non-OADS,/arxiv_data1/oa_pdf/b6/5f/kjped-56-477.PMC3859880.pdf
"http://dx.doi.org/10.3345/kjp.2013.56.11.477Eun HS, et al.",OADS,/arxiv_data1/oa_pdf/b6/5f/kjped-56-477.PMC3859880.pdf
479 http://dx.doi.org/10.3345/kjp.2013.56.11.477Korean J Pediatr 2013;56(11):477-481 Results A total of 344 preterm infants less than 34 weeks gestation  were enrolled and all endotracheal and gastric aspirates were  analyzed by culture and PCR.,Non-OADS,/arxiv_data1/oa_pdf/b6/5f/kjped-56-477.PMC3859880.pdf
"http://dx.doi.org/10.3345/kjp.2013.56.11.477Eun HS, et al.",OADS,/arxiv_data1/oa_pdf/b6/5f/kjped-56-477.PMC3859880.pdf
481 http://dx.doi.org/10.3345/kjp.2013.56.11.477Korean J Pediatr 2013;56(11):477-481 References  1.,Non-OADS,/arxiv_data1/oa_pdf/b6/5f/kjped-56-477.PMC3859880.pdf
"482 http://dx.doi.org/10.3345/kjp.2013.56.11.482The effect of rhinovirus on airway inflammation  in a murine asthma model  Eugene Kim, MD, Huisu Lee, Hyun Sook Kim, Sulmui Won, Eu Kyoung Lee, MD, Hwan Soo Kim, MD, Kyongwon Bang, Yoon Hong  Chun, MD, Jong-Seo Yoon, MD, Hyun Hee Kim, MD, Jin Tack Kim, MD, Joon Sung Lee, MD Department of Pediatrics, The Catholic University of Korea College of Medicine, Seoul, Korea Purpose: The aim of the present study was to investigate the differences in lower airway inflammatory  immune responses, including cellular responses and responses in terms of inflammatory mediators in  bronchoalveolar lavage fluid (BALF) and the airway, to rhinovirus (RV) infection on asthma exacerbation  by comparing a control and a murine asthma model, with or without RV infection.",Non-OADS,/arxiv_data1/oa_pdf/42/eb/kjped-56-482.PMC3859881.pdf
"Key words: Immune response, Rhinovirus, Asthma, ExacerbationCorresponding author: Hyun Hee Kim, MD Department of Pediatrics, Bucheon St. Mary’s Hospital, The Catholic University of Korea College of Medicine, 327 Sosa-ro 327beon-gil, Wonmi-gu, Bucheon 420-717, Korea Tel: +82-32-340-7046Fax: +82-32-340-2314E-mail: hhkped@catholic.ac.kr Received: 29 May 2013 Revised: 20 July 2013Accepted: 21 August 2013 Copyright © 2013 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Original article  Korean J Pediatr 2013;56(11):482-489 http://dx.doi.org/10.3345/kjp.2013.56.11.482 pISSN 1738-1061•eISSN 2092-7258 Korean J Pediatr Introduction Rhinovirus (RV) is a common cause of asthma exacerbation.",Non-OADS,/arxiv_data1/oa_pdf/42/eb/kjped-56-482.PMC3859881.pdf
"483 http://dx.doi.org/10.3345/kjp.2013.56.11.482Korean J Pediatr 2013;56(11):482-489 has been widely sampled for these studies, which have shown  that this sample can provide information regarding the cellular  and molecular process involved in asthma4).",OADS,/arxiv_data1/oa_pdf/42/eb/kjped-56-482.PMC3859881.pdf
"http://dx.doi.org/10.3345/kjp.2013.56.11.482Kim E, et al.",OADS,/arxiv_data1/oa_pdf/42/eb/kjped-56-482.PMC3859881.pdf
485 http://dx.doi.org/10.3345/kjp.2013.56.11.482Korean J Pediatr 2013;56(11):482-489 showed a higher eosinophil count compared with RV infected  PBS mice ( P=0.046) (Fig.,Non-OADS,/arxiv_data1/oa_pdf/42/eb/kjped-56-482.PMC3859881.pdf
"http://dx.doi.org/10.3345/kjp.2013.56.11.482Kim E, et al.",OADS,/arxiv_data1/oa_pdf/42/eb/kjped-56-482.PMC3859881.pdf
"487 http://dx.doi.org/10.3345/kjp.2013.56.11.482Korean J Pediatr 2013;56(11):482-489 IL-6, IL-1 β, and TNF- α than those in RV infected PBS mice (all  P=0.009) (Fig.",Non-OADS,/arxiv_data1/oa_pdf/42/eb/kjped-56-482.PMC3859881.pdf
"http://dx.doi.org/10.3345/kjp.2013.56.11.482Kim E, et al.",OADS,/arxiv_data1/oa_pdf/42/eb/kjped-56-482.PMC3859881.pdf
489 http://dx.doi.org/10.3345/kjp.2013.56.11.482Korean J Pediatr 2013;56(11):482-489 with airway eosinophil infiltration.,Non-OADS,/arxiv_data1/oa_pdf/42/eb/kjped-56-482.PMC3859881.pdf
"490 http://dx.doi.org/10.3345/kjp.2013.56.11.490Evaluation of risk for graft-versus-host disease  in children who receive less than the full doses of mini-dose methotrexate for graft-versus-host disease prophylaxis in allogeneic hematopoietic stem cell transplantation Sook Kyung Yum, MD, Hye-Yoon Choi, MD, Jae Wook Lee, MD, PhD, Pil-Sang Jang, MD, PhD, Nack-Gyun Chung, MD, PhD, Dae- Chul Jeong, MD, PhD, Bin Cho, MD, PhD, Hack-Ki Kim, MD, PhD Department of Pediatrics, The Catholic University of Korea College of Medicine, Seoul, Korea Purpose:  The use of cyclosporine and mini-dose methotrexate (MTX) is a common strategy for graft- versus-host disease (GVHD) prophylaxis in allogeneic transplants.",Non-OADS,/arxiv_data1/oa_pdf/1a/d3/kjped-56-490.PMC3859882.pdf
"Key words: Methotrexate, Graft-versus-host disease, ProphylaxisCorresponding author: Bin Cho, MD, PhD Department of Pediatrics, Seoul St. Mary’s Hos - pital, The Catholic University of Korea College of Medicine, 222 Banpo-daero, Seocho-gu, Seoul 137-701, KoreaTel: +82-2-2258-6187Fax: +82-2-537-4544E-mail: chobinkr@catholic.ac.kr Received: 2 September 2013 Revised: 4 October 2013Accepted: 8 October 2013 Copyright © 2013 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Original article  Korean J Pediatr 2013;56(11):490-495 http://dx.doi.org/10.3345/kjp.2013.56.11.490 pISSN 1738-1061•eISSN 2092-7258 Korean J Pediatr Introduction Both acute and chronic graft-versus-host disease (GVHD) are significant complications  that may occur in children who receive allogeneic hematopoietic stem cell transplantation  (HSCT), although the overall incidence is lower than found in the adult patient  population1,2).",Non-OADS,/arxiv_data1/oa_pdf/1a/d3/kjped-56-490.PMC3859882.pdf
"491 http://dx.doi.org/10.3345/kjp.2013.56.11.490Korean J Pediatr 2013;56(11):490-495 Since its initial introduction in 1986, a combination of cyclo - sporine (CsA) and mini-dose methotrexate (MTX) has become an  important means of GVHD prophylaxis3,4).",Non-OADS,/arxiv_data1/oa_pdf/1a/d3/kjped-56-490.PMC3859882.pdf
"http://dx.doi.org/10.3345/kjp.2013.56.11.490Yum SK, et al.",OADS,/arxiv_data1/oa_pdf/1a/d3/kjped-56-490.PMC3859882.pdf
"493 http://dx.doi.org/10.3345/kjp.2013.56.11.490Korean J Pediatr 2013;56(11):490-495 7.8% ±2.7% (8/103), including 6 patients with grade III and 2  pa tients with grade IV acute GVHD.",Non-OADS,/arxiv_data1/oa_pdf/1a/d3/kjped-56-490.PMC3859882.pdf
"http://dx.doi.org/10.3345/kjp.2013.56.11.490Yum SK, et al.",OADS,/arxiv_data1/oa_pdf/1a/d3/kjped-56-490.PMC3859882.pdf
495 http://dx.doi.org/10.3345/kjp.2013.56.11.490Korean J Pediatr 2013;56(11):490-495 cyclosporin A as graft-versus-host disease prophylaxis in patients  with beta thalassemia major undergoing allogeneic blood and marrow transplantation.,Non-OADS,/arxiv_data1/oa_pdf/1a/d3/kjped-56-490.PMC3859882.pdf
"496 http://dx.doi.org/10.3345/kjp.2013.56.11.496Liver abscess due to  Klebsiella pneumoniae  in  a healthy 12-year-old boy  Da Hye Yoon, MD, Yeon Jin Jeon, MD, E Young Bae, MD, Dae Chul Jeong, MD, Jin Han Kang, MD Department of Pediatrics, The Catholic University of Korea College of Medicine, Seoul, Korea Pyogenic liver abscess (PLA) is rare in healthy children.",Non-OADS,/arxiv_data1/oa_pdf/22/7b/kjped-56-496.PMC3859883.pdf
"Key words: Pyogenic liver abscess, Drainage, Antibiotics, Klebsiella pneumoniae  Corresponding author: Jin Han Kang, MD Department of Pediatrics, Seoul St. Mary's Hospital, The Catholic University of Korea College of Medicine, 222 Banpo ­daero, Seocho ­gu, Seoul 137 ­701, Korea Tel: +82 ­2­2258 ­6183 Fax: +82 ­2­537­4544 E­mail: kjhan@catholic.ac.kr Received: 6 December, 2012Revised: 11 March, 2013Accepted: 15 April, 2013 Copyright © 2013 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Case report Korean J Pediatr 2013;56(11):496-499 http://dx.doi.org/10.3345/kjp.2013.56.11.496 pISSN 1738-1061•eISSN 2092-7258 Korean J Pediatr Introduction  Pyogenic liver abscess (PLA) occurs most frequently in persons with immunodeficiency,  certain genetic disorders, infections of the skin or abdominal cavity and protein-calorie  malnutrition1,2).",Non-OADS,/arxiv_data1/oa_pdf/22/7b/kjped-56-496.PMC3859883.pdf
"497 http://dx.doi.org/10.3345/kjp.2013.56.11.496Korean J Pediatr 2013;56(11):496-499 270,000/mm3.",OADS,/arxiv_data1/oa_pdf/22/7b/kjped-56-496.PMC3859883.pdf
"http://dx.doi.org/10.3345/kjp.2013.56.11.496Yoon DH, et al.",OADS,/arxiv_data1/oa_pdf/22/7b/kjped-56-496.PMC3859883.pdf
499 http://dx.doi.org/10.3345/kjp.2013.56.11.496Korean J Pediatr 2013;56(11):496-499  7.,Non-OADS,/arxiv_data1/oa_pdf/22/7b/kjped-56-496.PMC3859883.pdf
"500 http://dx.doi.org/10.3345/kjp.2013.56.11.500Stroke after percutaneous transhepatic variceal  obliteration of esophageal varix in Caroli syndrome  Yoo Min Lee, MD1,2, Yoon Lee, MD1, Yon Ho Choe, MD, PhD1 1Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, 2Kyung Hee University Graduate School of Medicine,  Seoul, Korea  Here we present the case of an 11-year-old female patient diagnosed with Caroli syndrome, who  had refractory esophageal varices.",Non-OADS,/arxiv_data1/oa_pdf/0f/a5/kjped-56-500.PMC3859884.pdf
"Key words: Percutaneous transhepatic obliteration, Embolization, Esophageal varix, Caroli diseaseCorresponding author: Yon Ho Choe, MD, PhD Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 135-710, KoreaTel: +82-2-3410-3527Fax: +82-2-3410-0043E-mail: i101016@skku.edu Received: 12 December, 2012 Revised: 20 February, 2013Accepted: 3 May, 2013 Copyright © 2013 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Case report Korean J Pediatr 2013;56(11):500-504 http://dx.doi.org/10.3345/kjp.2013.56.11.500 pISSN 1738-1061•eISSN 2092-7258 Korean J Pediatr Introduction Percutaneous transhepatic variceal obliteration (PTVO) was introduced in 1974 as a  treatment for bleeding esophageal varices can be used for patients who continue to bleed  despite of medical therapy for inoperable recurrent variceal bleeding1).",Non-OADS,/arxiv_data1/oa_pdf/0f/a5/kjped-56-500.PMC3859884.pdf
501 http://dx.doi.org/10.3345/kjp.2013.56.11.500Korean J Pediatr 2013;56(11):500-504 esophageal variceal bleeding in spite of conventional treatments.,Non-OADS,/arxiv_data1/oa_pdf/0f/a5/kjped-56-500.PMC3859884.pdf
"http://dx.doi.org/10.3345/kjp.2013.56.11.500Lee YM, et al.",OADS,/arxiv_data1/oa_pdf/0f/a5/kjped-56-500.PMC3859884.pdf
"503 http://dx.doi.org/10.3345/kjp.2013.56.11.500Korean J Pediatr 2013;56(11):500-504 therapy including the early use of portal pressure-reducing drugs  such as somatostatin, octreotide, and terlipressin, and EVL has  become the first-line treatment in the management of acute  variceal bleeding9).",Non-OADS,/arxiv_data1/oa_pdf/0f/a5/kjped-56-500.PMC3859884.pdf
"http://dx.doi.org/10.3345/kjp.2013.56.11.500Lee YM, et al.",OADS,/arxiv_data1/oa_pdf/0f/a5/kjped-56-500.PMC3859884.pdf
1;http://dl.dropboxusercontent.com/u/ 9744348/Scenario_template.pdf ).,Non-OADS,/arxiv_data1/oa_pdf/f7/71/10745_2013_Article_9601.PMC3859889.pdf
2The scenarios for the GBR and its fishing and tourism industries are available in full at http://dl.dropboxusercontent.com/u/9744348/ Limits_to_CCA_in_the_GBR.pdf .Fig.,Non-OADS,/arxiv_data1/oa_pdf/f7/71/10745_2013_Article_9601.PMC3859889.pdf
Available from: http://www.ehp.qld.gov.au/coastalplan/pdf/ qcp-web.pdf [accessed 20.03.13].,OADS,/arxiv_data1/oa_pdf/f7/71/10745_2013_Article_9601.PMC3859889.pdf
"http://www.globalcarbonproject.org/ carbonbudget/index.htm G r a h a m ,N .A .J .",Non-OADS,/arxiv_data1/oa_pdf/f7/71/10745_2013_Article_9601.PMC3859889.pdf
Available from:/ http://www.gbrmpa.gov.au/our-partners/ tourism-industry/tackling-climate-change [accessed 20.03.13].,Non-OADS,/arxiv_data1/oa_pdf/f7/71/10745_2013_Article_9601.PMC3859889.pdf
"Accessed 29 May 2011. http://www.climatechange.qld.gov.au/whatsbeingdone/ climatechangestrategy/impactsonqueenslandsregions.html Robins, J.",OADS,/arxiv_data1/oa_pdf/f7/71/10745_2013_Article_9601.PMC3859889.pdf
http://www.saugeenojibway.,Non-OADS,/arxiv_data1/oa_pdf/10/fe/10745_2013_Article_9568.PMC3859892.pdf
http://www.ceaa-acee.gc.ca/default.asp?lang=Enandn= 7F3C6AF0-1 65pp.,Non-OADS,/arxiv_data1/oa_pdf/10/fe/10745_2013_Article_9568.PMC3859892.pdf
Tremor Other Hyperkin et Mov 2013; 3: http://tremorjournal.org/article/view/201 * To whom correspondence should be addressed.,Non-OADS,/arxiv_data1/oa_pdf/10/d5/tre-03-201-4686-1.PMC3859893.pdf
"1,2 Although some patients have been reported with infarcts in the pons, substantia nigra, centrum semiovale, frontal subcortex, striatum, corona radiata, internal capsule, and basal ganglia,3the saccadic gazeFreely available online Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services1",Non-OADS,/arxiv_data1/oa_pdf/10/d5/tre-03-201-4686-1.PMC3859893.pdf
"Table 1.Cases of Progressive Supranuclear Palsy-like Syndrome After Aortic Surgery Case Age/ GenderProcedure Complications Initial Signs and Symptoms Later symptoms Time CourseMRI findings 1 25/M AVR and resection of infected graftGraft infection Vision difficulty Dysarthria, dysphagia, unsteady gait2 months Small T2/FLAIR hyperintensity in splenium of corpus collosum and another in frontal lobe 2 53/M AAA repair and repair dissecting descending aortic aneurysmDescending aortic aneurysm dissection following initialrepairDysarthria, dysphagia, gait ImbalanceAnarthria, further gait imbalance6 weeks Right occipital infarct 3 156/M Resection of AA and AVRSNGP, mild gait unstability, dysarthriaMarked unsteady gait, dysarthria, SNGPAfter 3-4 monthsWNL 4145/F Resection of acute aortic dissectionSNGP, transient memory deficitsMarked unsteady gait, dysarthria, SNGPAfter 2 monthsWNL 5152/M Resection of acute aortic dissectionSNGP, unsteady gaitMarked unsteady gait, SNGP, dysarthria,dysphagia, severalpartial seizures3-4 monthsSubtle T2 signal abnormality mesialtemporal lobes 6 144/M Resection of AA, AVRSNGP Unsteady gait, dysarthria, dysphagia, SNGP, dystonicpharyngeal movementsSeveral weeksMRI WNL, MRA with mild anomalous irregularities ofMCA 7 157/M Repair AV and ascending aortaSNGP Unsteady gait, SNGP, dysarthria5 months Tiny lacunar infarct caudate head 8150/M AAA repair and AVRSNGP, unsteady gaitSNGP, unsteady gait, dysarthria2 months Head CT old R cerebral infarct 9145/F Resection of AAA, AVRMild dysarthria and dysphagia, probable SNGPDysarthria, dysphagia, drooling, gait unst, SNGP2 months WNL 10265/M AA repair Hypotension Dysarthria, dysphagiaReduced vertical gaze and gait instability6 months Hypoxic-ischemic bilateral striopallidal lesions 11464/M AAA repair and AVRSNGP, balance difficulty, dysarthriaNot provided 2 years None performed, CT WNL 12441/F Repair of patent ductus arteriosisSNGP, dysarthria, gait difficultyProgessive gait difficulty5 years MRI WNL, MRA narrow P1 segment of L PCA 13444/F Several repairs of aortic dissection andAVRSNGP, dysphagia Not provided 10 years Periventricular small vessel changes, MRAnarrow P1 segment ofPCANandipati S, Rucker JC, Frucht SJ Supranuclear Palsy-like Syndrome Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services2",Non-OADS,/arxiv_data1/oa_pdf/10/d5/tre-03-201-4686-1.PMC3859893.pdf
"MRI5Magnetic Resonance Imaging, AAA 5ascending aortic aneurysm, AA 5aortic aneurysm, AVR 5aortic valve replacement, SNGP 5supranuclear gaze palsy, WNL 5within normal limits, MRA 5Magnetic Resonance Angiogram, CT 5Computer Tomography.Supranuclear Palsy-like Syndrome Nandipati S, Rucker JC, Frucht SJ Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services3",Non-OADS,/arxiv_data1/oa_pdf/10/d5/tre-03-201-4686-1.PMC3859893.pdf
"Neurology 2004; 62:971–973, doi: http://dx.doi.org/10.1212/01.WNL.0000115170.40838.9B.",Non-OADS,/arxiv_data1/oa_pdf/10/d5/tre-03-201-4686-1.PMC3859893.pdf
"2.Kim HT, Shields S, Bhatia K, Quinn N. Progressive supranuclear palsy- like phenotype associated with bilateral hypoxic-ischemic striatopallidal lesions.Move Disord 2005;20:755–757, doi: http://dx.doi.org/10.1002/mds.20407.",OADS,/arxiv_data1/oa_pdf/10/d5/tre-03-201-4686-1.PMC3859893.pdf
"Ann Neurol 2008;63:355–365, doi: http://dx.doi.org/10.1002/ana.21201.",Non-OADS,/arxiv_data1/oa_pdf/10/d5/tre-03-201-4686-1.PMC3859893.pdf
"Semin Ophthalm 2007;22:33–34, doi: http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/10/d5/tre-03-201-4686-1.PMC3859893.pdf
"Mild facial masking and dystonia arealso present.Nandipati S, Rucker JC, Frucht SJ Supranuclear Palsy-like Syndrome Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services4",Non-OADS,/arxiv_data1/oa_pdf/10/d5/tre-03-201-4686-1.PMC3859893.pdf
URL [ http://www.R-project.org ] Ramsey J (2011) Polyploidy and ecological adaptation in wild yarrow.,Non-OADS,/arxiv_data1/oa_pdf/70/62/35_2011_Article_91.PMC3859894.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER TFII-I and DBC1 in cell cycle and DNA repair 3048 www.bjcancer.com | DOI:10.1038/bjc.2013.532,Non-OADS,/arxiv_data1/oa_pdf/cd/51/bjc2013532a.PMC3859932.pdf
Available from http://globocan.iarc.fr.,Non-OADS,/arxiv_data1/oa_pdf/06/26/bjc2013624a.PMC3859935.pdf
For image analysis the freeware ImageJ v1.33 down- loaded from the NIH website (http://rsb.info.nih.gov/ij) and for statistical analysis the GraphPad Prism were used.,OADS,/arxiv_data1/oa_pdf/90/18/bjc2013646a.PMC3859937.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER AGO2 in malignant melanoma 3124 www.bjcancer.com | DOI:10.1038/bjc.2013.646,Non-OADS,/arxiv_data1/oa_pdf/90/18/bjc2013646a.PMC3859937.pdf
"The microarray data were deposited in NCBI’s Gene Expression Omnibus (GEO) public database (http://www.ncbi.nlm.nih.gov/g eo/; Gene Expression Omnibus accession number, GSE47764).Cell culture and transfections.",OADS,/arxiv_data1/oa_pdf/87/6b/bjc2013655a.PMC3859942.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER miR-200b/c in cholangiocarcinoma cells 3104 www.bjcancer.com | DOI:10.1038/bjc.2013.655,Non-OADS,/arxiv_data1/oa_pdf/87/6b/bjc2013655a.PMC3859942.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Optimal TNM staging system for NPC BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2013.659 2997,Non-OADS,/arxiv_data1/oa_pdf/2d/c5/bjc2013659a.PMC3859943.pdf
National Comprehensive Cancer NetworkWebsite http://www.nccn.org/professionals/physician_gls/pdf/head-and-neck.pdf.,Non-OADS,/arxiv_data1/oa_pdf/8a/c6/bjc2013668a.PMC3859947.pdf
Hardy–Weinberg equilibrium (HWE) was examined by using online analytical tools (http://ihg.gsf.de).,OADS,/arxiv_data1/oa_pdf/59/b3/bjc2013669a.PMC3859948.pdf
"A test of the proportional hazards, a required assumption of Cox regression, was performed for e ach covariate and globally using the Breslow method in R (http://www.r-project.org/).",OADS,/arxiv_data1/oa_pdf/59/b3/bjc2013669a.PMC3859948.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Role of GSTM3 on the risk and prognosis of RCC BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2013.669 3115,Non-OADS,/arxiv_data1/oa_pdf/59/b3/bjc2013669a.PMC3859948.pdf
"To view a copy of this license, visit http://creativecommon- s.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER EndoPredict identifies late distant metastases 2964 www.bjcancer.com | DOI:10.1038/bjc.2013.671",Non-OADS,/arxiv_data1/oa_pdf/f4/8a/bjc2013671a.PMC3859949.pdf
Available at: http://eccamsterdam2013.ecco-org.eu/Scientific-Programme/Abstract-search.,Non-OADS,/arxiv_data1/oa_pdf/0c/2a/bjc2013677a.PMC3859950.pdf
Definition of rehabilitation http://www.who.int/topics/ rehabilitation.,Non-OADS,/arxiv_data1/oa_pdf/16/79/bjc2013679a.PMC3859951.pdf
org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Induction of bone metastasis in mouse PCa by FT 3022 www.bjcancer.com | DOI:10.1038/bjc.2013.690,Non-OADS,/arxiv_data1/oa_pdf/50/53/bjc2013690a.PMC3859952.pdf
"244161 to J.P.C.-G.and R.I.-P. (http://force-project.eu), Canon Foundation to R.I.-P. CONABIO to G.H-P.(GM005), and CONACyT to L.A.-F. (160230).",Non-OADS,/arxiv_data1/oa_pdf/cf/32/srep03486.PMC3860008.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/cf/32/srep03486.PMC3860008.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3486 | DOI: 10.1038/srep03486 5",Non-OADS,/arxiv_data1/oa_pdf/cf/32/srep03486.PMC3860008.pdf
"Voxel-based morphometry (VBM) .The brain images were analyzed using voxel- based morphometry in SPM8 (Wellcome Department of Imaging NeuroscienceGroup, London, UK; http://www.fil.ion.ucl.ac.uk/spm), using the VBM8 toolbox (http://dbm.neuro.uni-jena.de/vbm.html).",OADS,/arxiv_data1/oa_pdf/5c/dd/srep03457.PMC3860009.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3457 | DOI: 10.1038/srep03457 6",Non-OADS,/arxiv_data1/oa_pdf/5c/dd/srep03457.PMC3860009.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/17/76/srep03490.PMC3860011.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3490 | DOI: 10.1038/srep03490 5",Non-OADS,/arxiv_data1/oa_pdf/17/76/srep03490.PMC3860011.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3488 | DOI: 10.1038/srep03488 3",Non-OADS,/arxiv_data1/oa_pdf/4f/75/srep03488.PMC3860012.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/6a/60/srep03484.PMC3860013.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3484 | DOI: 10.1038/srep03484 7",Non-OADS,/arxiv_data1/oa_pdf/6a/60/srep03484.PMC3860013.pdf
http://dx.doi.org/10.1016/j.ijscr.2013.08.020,OADS,/arxiv_data1/oa_pdf/f0/6d/main.PMC3860016.pdf
2012.  http://emedicine.medscape.com/ 3.,Non-OADS,/arxiv_data1/oa_pdf/f0/6d/main.PMC3860016.pdf
http://dx.doi.org/10.1016/j.ijscr.2013.10.009,OADS,/arxiv_data1/oa_pdf/3d/1b/main.PMC3860017.pdf
http://dx.doi.org/10.1016/j.ijscr.2013.08.026,OADS,/arxiv_data1/oa_pdf/0e/8a/main.PMC3860020.pdf
http://dx.doi.org/10.1016/j.ijscr.2013.07.035,OADS,/arxiv_data1/oa_pdf/c3/e6/main.PMC3860021.pdf
http://dx.doi.org/10.1016/j.ijscr.2013.10.002,OADS,/arxiv_data1/oa_pdf/c2/56/main.PMC3860022.pdf
http://dx.doi.org/10.1016/j.ijscr.2013.10.003,OADS,/arxiv_data1/oa_pdf/8f/e0/main.PMC3860023.pdf
http://dx.doi.org/10.1016/j.ijscr.2013.07.038,OADS,/arxiv_data1/oa_pdf/49/19/main.PMC3860024.pdf
http://dx.doi.org/10.1016/j.ijscr.2013.11.001,OADS,/arxiv_data1/oa_pdf/06/c7/main.PMC3860025.pdf
"J  Med  Case  Rep  2009; 3:9326, http://dx.doi.org/10.1186/1752-1947-3-9326 .",Non-OADS,/arxiv_data1/oa_pdf/06/c7/main.PMC3860025.pdf
http://dx.doi.org/10.1016/j.ijscr.2013.09.013,OADS,/arxiv_data1/oa_pdf/6d/4c/main.PMC3860026.pdf
http://dx.doi.org/10.1016/j.ijscr.2013.09.014,OADS,/arxiv_data1/oa_pdf/4b/b8/main.PMC3860027.pdf
http://dx.doi.org/10.1016/j.ijscr.2013.09.004,OADS,/arxiv_data1/oa_pdf/0e/18/main.PMC3860028.pdf
http://dx.doi.org/10.1016/j.ijscr.2013.10.012,OADS,/arxiv_data1/oa_pdf/fc/4a/main.PMC3860029.pdf
http://dx.doi.org/10.1016/j.ijscr.2013.10.007,OADS,/arxiv_data1/oa_pdf/29/76/main.PMC3860031.pdf
http://dx.doi.org/10.1016/j.ijscr.2013.09.017,OADS,/arxiv_data1/oa_pdf/21/8b/main.PMC3860033.pdf
http://dx.doi.org/10.1016/j.ijscr.2013.09.018,OADS,/arxiv_data1/oa_pdf/a6/a5/main.PMC3860034.pdf
http://dx.doi.org/10.1016/j.ijscr.2013.07.036,OADS,/arxiv_data1/oa_pdf/03/91/main.PMC3860035.pdf
http://dx.doi.org/10.1016/j.ijscr.2013.09.015,OADS,/arxiv_data1/oa_pdf/68/f1/main.PMC3860036.pdf
http://dx.doi.org/10.1016/j.ijscr.2013.10.019,OADS,/arxiv_data1/oa_pdf/68/cc/main.PMC3860037.pdf
http://dx.doi.org/10.1016/j.ijscr.2013.06.022,OADS,/arxiv_data1/oa_pdf/5f/37/main.PMC3860039.pdf
http://dx.doi.org/10.1016/j.ijscr.2013.09.007,OADS,/arxiv_data1/oa_pdf/d3/4f/main.PMC3860041.pdf
http://dx.doi.org/10.1016/j.ijscr.2013.08.025,OADS,/arxiv_data1/oa_pdf/ba/77/main.PMC3860043.pdf
http://dx.doi.org/10.1016/j.ijscr.2013.09.009,OADS,/arxiv_data1/oa_pdf/25/88/main.PMC3860045.pdf
"Case  Rep  Radiol 2011; 2011 :592124, http://dx.doi.org/10.1155/2011/592124 .",Non-OADS,/arxiv_data1/oa_pdf/25/88/main.PMC3860045.pdf
http://dx.doi.org/10.1016/j.ijscr.2013.09.008,OADS,/arxiv_data1/oa_pdf/9a/ba/main.PMC3860047.pdf
http://dx.doi.org/10.1016/j.ijscr.2013.08.023,OADS,/arxiv_data1/oa_pdf/5e/0f/main.PMC3860048.pdf
http://dx.doi.org/10.1016/j.ijscr.2013.08.021,OADS,/arxiv_data1/oa_pdf/f0/85/main.PMC3860050.pdf
http://dx.doi.org/10.1016/j.ijscr.2013.10.008,OADS,/arxiv_data1/oa_pdf/b3/69/main.PMC3860051.pdf
Ltd(http://www.diversityarrays.com/) (DArT markers).,OADS,/arxiv_data1/oa_pdf/ca/9e/hdy201316a.PMC3860161.pdf
The LigandRNA program is available free of charge as a web server at http://ligandrna.genesilico.pl.,OADS,/arxiv_data1/oa_pdf/79/78/1605.PMC3860260.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.039834.113.,OADS,/arxiv_data1/oa_pdf/79/78/1605.PMC3860260.pdf
"This article, published in RNA , is available under a Creative Commons License (Attribution-NonCommercial 3.0 Unported),as described at http://creativecommons.org/licenses/by-nc/3.0/.BIOINFORMATICS RNA 19:1605 –1616; Published by Cold Spring Harbor Laboratory Press for the RNA Society 1605",Non-OADS,/arxiv_data1/oa_pdf/79/78/1605.PMC3860260.pdf
LigandRNA is relatively fast and can be accessed via a freely available web server at http://ligandrna.genesilico.pl/ and athttp://ligandrna.biol.amu.edu.pl.,OADS,/arxiv_data1/oa_pdf/79/78/1605.PMC3860260.pdf
SUPPLEMENTAL MATERIAL Supplemental material is available for this article at http://ligandrna.genesilico.pl/site_media/supplementary/supp_mat.pdf.,Non-OADS,/arxiv_data1/oa_pdf/79/78/1605.PMC3860260.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.040808.113.© 2013 Lu et al.,OADS,/arxiv_data1/oa_pdf/a1/f8/1815.PMC3860261.pdf
"After 12 months, it is availableunder a Creative Commons License (Attribution-NonCommercial 3.0Unported), as described at http://creativecommons.org/licenses/by-nc/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/a1/f8/1815.PMC3860261.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/5d/14/srep03411.PMC3860288.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3411 | DOI: 10.1038/srep03411 6",Non-OADS,/arxiv_data1/oa_pdf/5d/14/srep03411.PMC3860288.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/80/fe/cpaa-5-001.PMC3860356.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Pharmacology: Advances and Applications 2013:5 1–3Clinical Pharmacology: Advances and Applications Dove press submit your manuscript | www.dovepress.co m Dove press  1EditoriAlopen access to scientific and medical research open Access Full text Article http: //dx.doi.org/10.2147/CPAA.S5561 3Special issue of clinical pharmacology: advances  and applications in new protein therapeutics  modulating tumor immunity Arthur E Frankel department of internal Medicine,   Simmons Comprehensive Cancer  Center, the University of texas  Southwestern Medical Center,    dallas, tX, USA Correspondence: Arthur E Frankel   department of internal Medicine,  Simmons Comprehensive Cancer   Center, 2201 inwood rd, dallas,   tX 75235, USA   Email arthur.frankel@utsouthwestern.",Non-OADS,/arxiv_data1/oa_pdf/80/fe/cpaa-5-001.PMC3860356.pdf
"Clinical Pharmacology: Advances and Applications Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-pharmacology-advances-and-applications-journa lClinical Pharmacology: Advances and Applications is an international,  peer-reviewed, open access journal publishing original research, reports,  reviews and commentaries on all areas of drug experience in humans.",Non-OADS,/arxiv_data1/oa_pdf/80/fe/cpaa-5-001.PMC3860356.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/80/fe/cpaa-5-001.PMC3860356.pdf
"Bandura’s Teacher Self-Efﬁcacy Scale (TSES) Bandura’s Teacher Self-Efﬁcacy Scale ( http://people.ehe.ohio-state.edu/ahoy/ﬁles/ 2009/02/bandura-instr.pdf ) is a 30 item efﬁcacy measure written in interrogative rather than declarative statements, afﬁxed to a nine point scale anchored at ﬁvepoints (‘‘nothing,’’ ‘‘very little,’’ ‘‘some inﬂuence,’’ ‘‘quite a bit,’’ and ‘‘a greatdeal’’) (Fig.",Non-OADS,/arxiv_data1/oa_pdf/89/84/10972_2013_Article_9351.PMC3860844.pdf
"The National Science Education Standards (National Research Council 1996 ), as well as the newer Framework for K-12 Science Education (National Research Council 2011 ) which have inﬂuenced the Next Generation Science Standards ( 2012 ;http://www.next genscience.org/ ), speak of overarching themes, themes that cut across grade level and discipline—perhaps these are the areas to which science teacher self-efﬁcacy mea-sures could be pointing.",Non-OADS,/arxiv_data1/oa_pdf/89/84/10972_2013_Article_9351.PMC3860844.pdf
Retrieved from http://people.ehe.osu.edu/ahoy/ .,Non-OADS,/arxiv_data1/oa_pdf/89/84/10972_2013_Article_9351.PMC3860844.pdf
Retrieved from http://www.nextgenscience.org/ .,Non-OADS,/arxiv_data1/oa_pdf/89/84/10972_2013_Article_9351.PMC3860844.pdf
"Retrieved from http://www.rasch.org/rmt/rmt94k.htm (April, 26, 2013).",Non-OADS,/arxiv_data1/oa_pdf/89/84/10972_2013_Article_9351.PMC3860844.pdf
Two months after publication this  article is available to the public under an Attribution–Noncommercial–Share Alike  3.0 Unported Creative Commons License (http://creativecommons.org/licenses/ by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/9d/4e/3775.PMC3861075.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/29/5b/3776.PMC3861076.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/33/34/3787.PMC3861077.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/f9/68/3805.PMC3861078.pdf
"Primers were designed using Primer3 (http://frodo.wi   .mit.edu/) and were blasted to check specificity (primers: HDAC2  forward [F], 5 ′-ttggcctttctgagctgatt-3 ′; HDAC2 reverse [R],  5′-agagggtctctgccactgaa-3 ′; HDAC4 F, 5 ′-gctctcccagctctcca - gca-3′; HDAC4 R, 5 ′-gttgtgagctgctgctgcaccgt-3 ′;HDAC5 F,  5′-tgagaggcaggcccttcagt-3 ′; HDAC5 R, 5 ′-cctccagtgccactc - ccaac-3′; GATA4 F, 5 ′-ggctcccagagattcttcct-3 ′; GATA4 R, 5 ′-ctct- gctacggccagtaagg-3 ′; β-MHC F, 5 ′-accaagcagccacgccagta3 ′; β- MHC R, 5 ′-tgctttgcctttgcccttgt-3 ′; Inpp5f F, 5 ′-aacttgggaaaggc - ctgg-3′; Inpp5f R, 5 ′-catggagctgcggatctt-3 ′; α–smooth muscle  actin ( ACTA1 ), 5′-tcgcgaccttactgactacctg-3 ′, 5′-gcttctctttgat - gtcgcgc-3 ′; GAPDH F, 5 ′-ccacagtcc atgccatca-3 ′; GAPDH R,  5′-ggatgaccttgcccacag-3 ′).",Non-OADS,/arxiv_data1/oa_pdf/f9/68/3805.PMC3861078.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/17/8b/3819.PMC3861079.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/a8/38/3832.PMC3861080.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported Cre - ative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/2f/3b/3842.PMC3861081.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/f4/17/3857.PMC3861082.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/9e/73/3869.PMC3861083.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/28/7a/3881.PMC3861084.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/d3/40/3896.PMC3861085.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/e9/56/3909.PMC3861086.pdf
"The Microscope Simulator 2.0.0 software program  (CISMM UNC-Chapel Hill; http://cismm.cs.unc.edu/downloads;  Quammen et al., 2008) was used to generate geometrical cylinder  models with length, inner diameter, and outer diameter.",OADS,/arxiv_data1/oa_pdf/e9/56/3909.PMC3861086.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/75/32/3920.PMC3861087.pdf
"We used the Oval Profile  Plot plug-in (http://rsbweb.nih.gov/ij/plugins/oval-profile.html) of  ImageJ to create intensity profiles along the NE and determined the  aggregation index, expressed as the percentage deviation from a  uniform distribution and measured as the positive integral of mea - sured intensity from the mean intensity.",OADS,/arxiv_data1/oa_pdf/75/32/3920.PMC3861087.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/87/68/3939.PMC3861088.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/57/9a/3945.PMC3861089.pdf
"The seminiferous  *Correspondence to: C Yan Cheng; Email: Y-Cheng@popcbr.rockefeller.edu Submitted: 03/28/2013; Revised: 05/27/2013; Accepted: 06/08/2013http://dx.doi.org/10.4161/spermatogenesis.25385During spermatogenesis, spermatogonia (2n, diploid) un - dergo a series of mitotic divisions as well as differentiation to  become spermatocytes, which enter meiosis I to be followed  by meiosis II to form round spermatids (1n, haploid), and then  differentiate into spermatozoa (1n, haploid) via spermiogenesis.",Non-OADS,/arxiv_data1/oa_pdf/e5/df/spmg-3-e25385.PMC3861170.pdf
Reproduction 2006; 132:673-80; PMID:17071768; http://dx.doi.org/10.1530/rep.1.01081 4.,Non-OADS,/arxiv_data1/oa_pdf/e5/df/spmg-3-e25385.PMC3861170.pdf
Pharmacol  Rev 2012; 64:16-64; PMID:22039149; http://dx.doi.org/10.1124/pr.110.002790 5.,Non-OADS,/arxiv_data1/oa_pdf/e5/df/spmg-3-e25385.PMC3861170.pdf
Prog Histochem  Cytochem 2011; 46:49-127; PMID:21705043; http://dx.doi.org/10.1016/j.proghi.2011.05.001 6.,OADS,/arxiv_data1/oa_pdf/e5/df/spmg-3-e25385.PMC3861170.pdf
Adv Exp Med Biol 2008; 636:212-33; PMID:19856170; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e5/df/spmg-3-e25385.PMC3861170.pdf
Adv Exp Med Biol 2008; 636:186-211;  PMID:19856169; http://dx.doi.org/10.1007/978-0- 387-09597-4_11 10.,Non-OADS,/arxiv_data1/oa_pdf/e5/df/spmg-3-e25385.PMC3861170.pdf
Tissue Cell 1977; 9:475- 98; PMID:929577; http://dx.doi.org/10.1016/0040-8166(77)90007-6 13.,OADS,/arxiv_data1/oa_pdf/e5/df/spmg-3-e25385.PMC3861170.pdf
Anat Rec 1978; 190:99-111; PMID:626419; http://dx.doi.org/10.1002/ ar.1091900109 14.,Non-OADS,/arxiv_data1/oa_pdf/e5/df/spmg-3-e25385.PMC3861170.pdf
Am J Anat 1979; 155:259-79; PMID:474448;  http://dx.doi.org/10.1002/aja.1001550208 15.,Non-OADS,/arxiv_data1/oa_pdf/e5/df/spmg-3-e25385.PMC3861170.pdf
Anat Rec 1976; 185:259-78; PMID:937734;  http://dx.doi.org/10.1002/ar.1091850302 16.,Non-OADS,/arxiv_data1/oa_pdf/e5/df/spmg-3-e25385.PMC3861170.pdf
J Androl 2005; 26:354-9; PMID:15867003;  http://dx.doi.org/10.2164/jandrol.04142 17.,OADS,/arxiv_data1/oa_pdf/e5/df/spmg-3-e25385.PMC3861170.pdf
The consequences of actin disruption at Sertoli ectoplasmic  specialization sites facing spermatids after in vivo expo- sure of rat testis to cytochalasin D. Biol Reprod 1988;  39:105-18; PMID:3207792; http://dx.doi.org/10.1095/ biolreprod39.1.105 18.,Non-OADS,/arxiv_data1/oa_pdf/e5/df/spmg-3-e25385.PMC3861170.pdf
Adv Exp Med  Biol 2008; 636:1-15; PMID:19856159; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e5/df/spmg-3-e25385.PMC3861170.pdf
Pharmacol Rev 2008; 60:146-80; PMID:18483144; http://dx.doi.org/10.1124/pr.107.07105 20.,Non-OADS,/arxiv_data1/oa_pdf/e5/df/spmg-3-e25385.PMC3861170.pdf
Spermatogenesis 2011; 1:14-35; PMID:21866274; http://dx.doi.org/10.4161/spmg.1.1.14525 21.,Non-OADS,/arxiv_data1/oa_pdf/e5/df/spmg-3-e25385.PMC3861170.pdf
Nat Rev Endocrinol  2010; 6:380-95; PMID:20571538; http://dx.doi.org/10.1038/nrendo.2010.71 22.,Non-OADS,/arxiv_data1/oa_pdf/e5/df/spmg-3-e25385.PMC3861170.pdf
Mol Endocrinol 1989; 3:110-6; PMID:2915644; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e5/df/spmg-3-e25385.PMC3861170.pdf
Endocrinology 2003; 144:2141-63; PMID:12697723; http://dx.doi.org/10.1210/en.2002- 221035 24.,Non-OADS,/arxiv_data1/oa_pdf/e5/df/spmg-3-e25385.PMC3861170.pdf
Biochem Biophys Res Commun 1993;  190:140-7; PMID:8422239; http://dx.doi.org/10.1006/ bbrc.1993.1022 25.,OADS,/arxiv_data1/oa_pdf/e5/df/spmg-3-e25385.PMC3861170.pdf
DNA Cell Biol 1993; 12:823-30; PMID:7692878; http://dx.doi.org/10.1089/dna.1993.12.823 26.,OADS,/arxiv_data1/oa_pdf/e5/df/spmg-3-e25385.PMC3861170.pdf
Biol Reprod 2001; 64:396- 407; PMID:11133699; http://dx.doi.org/10.1095/biol- reprod64.1.396 28.,OADS,/arxiv_data1/oa_pdf/e5/df/spmg-3-e25385.PMC3861170.pdf
Int Rev Cell Mol Biol 2011; 288:185-225;  PMID:21482413; http://dx.doi.org/10.1016/B978-0- 12-386041-5.00005-4 29.,OADS,/arxiv_data1/oa_pdf/e5/df/spmg-3-e25385.PMC3861170.pdf
Bioessays  2004; 26:978-92; PMID:15351968; http://dx.doi.org/10.1002/bies.20099 32.,Non-OADS,/arxiv_data1/oa_pdf/e5/df/spmg-3-e25385.PMC3861170.pdf
J Endocrinol 2006; 190:759-70; PMID:17003277;  http://dx.doi.org/10.1677/joe.1.06867 33.,Non-OADS,/arxiv_data1/oa_pdf/e5/df/spmg-3-e25385.PMC3861170.pdf
Proc Natl Acad Sci USA 2012; 109:12562- 7; PMID:22797892; http://dx.doi.org/10.1073/ pnas.1202316109 34.,OADS,/arxiv_data1/oa_pdf/e5/df/spmg-3-e25385.PMC3861170.pdf
Trends Cell  Biol 1998; 8:151-7; PMID:9695829; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e5/df/spmg-3-e25385.PMC3861170.pdf
Pharmacol  Rev 2008; 60:261-310; PMID:18922965; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e5/df/spmg-3-e25385.PMC3861170.pdf
Curr Opin Cell Biol 2009; 21:676- 83; PMID:19525103; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e5/df/spmg-3-e25385.PMC3861170.pdf
Mol Endocrinol  2010; 24:2114-25; PMID:20880986; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e5/df/spmg-3-e25385.PMC3861170.pdf
Anticancer Agents Med Chem 2011;  11:993-1002; PMID:22023045; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e5/df/spmg-3-e25385.PMC3861170.pdf
Anticancer Agents Med Chem  2011; 11:638-42; PMID:21787276; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e5/df/spmg-3-e25385.PMC3861170.pdf
Curr Opin Cell Biol 2012; 24:569- 81; PMID:22819514; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e5/df/spmg-3-e25385.PMC3861170.pdf
Onco Targets Ther 2010; 3:83-97;  PMID:20616959; http://dx.doi.org/10.2147/OTT.,OADS,/arxiv_data1/oa_pdf/e5/df/spmg-3-e25385.PMC3861170.pdf
Biochem  J 2005; 391:359-70; PMID:15975092; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e5/df/spmg-3-e25385.PMC3861170.pdf
Cell 2003; 114:469-82;  PMID:12941275; http://dx.doi.org/10.1016/S0092-8674(03)00605-6 49.,OADS,/arxiv_data1/oa_pdf/e5/df/spmg-3-e25385.PMC3861170.pdf
Spermatogenesis 2011; 1:73-86; PMID:21866278;  http://dx.doi.org/10.4161/spmg.1.1.15452 50.,Non-OADS,/arxiv_data1/oa_pdf/e5/df/spmg-3-e25385.PMC3861170.pdf
J Biol Chem 2005; 280:25029-47; PMID:15870075;  http://dx.doi.org/10.1074/jbc.M501049200,OADS,/arxiv_data1/oa_pdf/e5/df/spmg-3-e25385.PMC3861170.pdf
J Cell Biol 1999; 145:605-18; PMID:10225960; http://dx.doi.org/10.1083/ jcb.145.3.605 79.,OADS,/arxiv_data1/oa_pdf/e5/df/spmg-3-e25385.PMC3861170.pdf
Spermatogenesis  2013; 3:e25465; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e5/df/spmg-3-e25385.PMC3861170.pdf
Nat Communs 2012; 3:1185; http://dx.doi.org/10.1038/ncomms2171 81.,OADS,/arxiv_data1/oa_pdf/e5/df/spmg-3-e25385.PMC3861170.pdf
Biol Reprod 2010; 82:516-27; PMID:19828778; http://dx.doi.org/10.1095/biolre- prod.109.080374 83.,OADS,/arxiv_data1/oa_pdf/e5/df/spmg-3-e25385.PMC3861170.pdf
Biol Reprod 2011; 85:1091-3;  PMID:21900678; http://dx.doi.org/10.1095/biolre- prod.111.095976 84.,OADS,/arxiv_data1/oa_pdf/e5/df/spmg-3-e25385.PMC3861170.pdf
Trends Mol Med 2013;  In press; PMID:23643465; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e5/df/spmg-3-e25385.PMC3861170.pdf
Endocrinology 2003; 144:1139-42;  PMID:12639893; http://dx.doi.org/10.1210/en.2002-0211 86.,Non-OADS,/arxiv_data1/oa_pdf/e5/df/spmg-3-e25385.PMC3861170.pdf
J Cell  Sci 2004; 117:783-98; PMID:14734653; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e5/df/spmg-3-e25385.PMC3861170.pdf
FASEB J 2013; 27:464-77; PMID:23073828; http://dx.doi.org/10.1096/fj.12-212514 88.,OADS,/arxiv_data1/oa_pdf/e5/df/spmg-3-e25385.PMC3861170.pdf
Int J Biochem Cell Biol 2011; 43:651- 65; PMID:21256972; http://dx.doi.org/10.1016/j.bio- cel.2011.01.00864.,OADS,/arxiv_data1/oa_pdf/e5/df/spmg-3-e25385.PMC3861170.pdf
Endocrinology 2009; 150:3336-44;  PMID:19213829; http://dx.doi.org/10.1210/en.2008- 1741 67.,Non-OADS,/arxiv_data1/oa_pdf/e5/df/spmg-3-e25385.PMC3861170.pdf
Proc Natl Acad Sci USA 2009; 106:9298- 303; PMID:19470647; http://dx.doi.org/10.1073/ pnas.0813113106 68.,OADS,/arxiv_data1/oa_pdf/e5/df/spmg-3-e25385.PMC3861170.pdf
Biol  Reprod 2013; 88:59; PMID:23325809; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e5/df/spmg-3-e25385.PMC3861170.pdf
Am J Anat  1952; 90:167-215; PMID:14923625; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e5/df/spmg-3-e25385.PMC3861170.pdf
Am J Anat 1963; 112:35-51; PMID:14021715;  http://dx.doi.org/10.1002/aja.1001120103 72.,Non-OADS,/arxiv_data1/oa_pdf/e5/df/spmg-3-e25385.PMC3861170.pdf
Int Rev Cell Mol Biol  2009; 278:309-53; PMID:19815182; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e5/df/spmg-3-e25385.PMC3861170.pdf
Proc Natl Acad Sci USA  2008; 105:8950-5; PMID:18579774; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e5/df/spmg-3-e25385.PMC3861170.pdf
J Biol Chem 2006; 281:17286- 303; PMID:16608848; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/e5/df/spmg-3-e25385.PMC3861170.pdf
Biol Reprod 2004; 70:945-64; PMID:14645107; http://dx.doi.org/10.1095/biolre- prod.103.02360651.,OADS,/arxiv_data1/oa_pdf/e5/df/spmg-3-e25385.PMC3861170.pdf
Biochem  J 2011; 435:553-62; PMID:21486226; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e5/df/spmg-3-e25385.PMC3861170.pdf
Spermatogenesis  2011; 1:99-104; PMID:22319657; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e5/df/spmg-3-e25385.PMC3861170.pdf
Spermatogenesis 2011;  1:291-7; PMID:22332112; http://dx.doi.org/10.4161/ spmg.1.4.18393 54.,Non-OADS,/arxiv_data1/oa_pdf/e5/df/spmg-3-e25385.PMC3861170.pdf
Int Rev Cell Mol Biol  2013; 303:319-55; PMID:23445814; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e5/df/spmg-3-e25385.PMC3861170.pdf
FASEB J 2009; 23:2555-67; PMID:19293393; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e5/df/spmg-3-e25385.PMC3861170.pdf
Endocrinology 2013; 154:1907-20; PMID:23546604;  http://dx.doi.org/10.1210/en.2012-2269 57.,Non-OADS,/arxiv_data1/oa_pdf/e5/df/spmg-3-e25385.PMC3861170.pdf
Proc Natl Acad Sci USA  2010; 107:11411-6; PMID:20534520; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e5/df/spmg-3-e25385.PMC3861170.pdf
Am J Physiol Endocrinol Metab  2013; 304:E145-59; PMID:23169788; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e5/df/spmg-3-e25385.PMC3861170.pdf
Int Rev Cytol  1985; 94:177-211; PMID:3894273; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e5/df/spmg-3-e25385.PMC3861170.pdf
Endocr Rev 2004; 25:747-806;  PMID:15466940; http://dx.doi.org/10.1210/er.2003- 0022,Non-OADS,/arxiv_data1/oa_pdf/e5/df/spmg-3-e25385.PMC3861170.pdf
" REPORT www.landesbioscience.com Spermatogenesis e25733-1Spermatogenesis 3:3, e25733; July/August/September 2013; © 2013 Landes BioscienceREPORT *Correspondence to: A Wayne Vogl; Email: vogl@mail.ubc.ca Submitted: 05/23/2013; Revised: 07/10/2013; Accepted: 07/11/2013http://dx.doi.org/10.4161/spermatogenesis.25733Introduction In the seminiferous epithelium of the mammalian testis, a dra - matic turnover of intercellular junctions occurs during spermato - genesis.",Non-OADS,/arxiv_data1/oa_pdf/34/6a/spmg-3-e25733.PMC3861171.pdf
J Cell Biol 1983; 96:1491- 6; PMID:6841456; http://dx.doi.org/10.1083/ jcb.96.5.1491 30.,Non-OADS,/arxiv_data1/oa_pdf/34/6a/spmg-3-e25733.PMC3861171.pdf
Anat Rec 1999; 254:418-28; PMID:10096674;  http://dx.doi.org/10.1002/(SICI)1097- 0185(19990301)254:3<418::AID-AR13>3.0.CO;2-C 31.,OADS,/arxiv_data1/oa_pdf/34/6a/spmg-3-e25733.PMC3861171.pdf
J Mol Biol 1987;  198:515-31; PMID:3430617; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/34/6a/spmg-3-e25733.PMC3861171.pdf
Curr Opin Cell Biol 2008; 20:235- 41; PMID:18337078; http://dx.doi.org/10.1016/j.ceb.2008.01.005 33.,OADS,/arxiv_data1/oa_pdf/34/6a/spmg-3-e25733.PMC3861171.pdf
J Cell Mol Med 2010; 14(6B):1569-93;  PMID:19656240; http://dx.doi.org/10.1111/j.1582- 4934.2009.00868.x 34.,Non-OADS,/arxiv_data1/oa_pdf/34/6a/spmg-3-e25733.PMC3861171.pdf
Differentiation  1989; 41:216-22; PMID:2612769; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/34/6a/spmg-3-e25733.PMC3861171.pdf
Biol Reprod 1985; 32:1143-56;  PMID:2410039; http://dx.doi.org/10.1095/biolre- prod32.5.1143 40.,OADS,/arxiv_data1/oa_pdf/34/6a/spmg-3-e25733.PMC3861171.pdf
Histochem  Cell Biol 2011; 136:543-55; PMID:21915674; http://dx.doi.org/10.1007/s00418-011-0856-5 41.,Non-OADS,/arxiv_data1/oa_pdf/34/6a/spmg-3-e25733.PMC3861171.pdf
Microb Pathog 2012; 52:149-56;  PMID:22197999; http://dx.doi.org/10.1016/j.mic- path.2011.12.00114.,OADS,/arxiv_data1/oa_pdf/34/6a/spmg-3-e25733.PMC3861171.pdf
Biol Reprod 2004; 71:548-59; PMID:15084482;  http://dx.doi.org/10.1095/biolreprod.104.028803 15.,OADS,/arxiv_data1/oa_pdf/34/6a/spmg-3-e25733.PMC3861171.pdf
Biol Reprod 2009; 80:162-74; PMID:18799754;  http://dx.doi.org/10.1095/biolreprod.108.070623 16.,Non-OADS,/arxiv_data1/oa_pdf/34/6a/spmg-3-e25733.PMC3861171.pdf
Biol Open 2012;  1:1-9; PMID:23213360; http://dx.doi.org/10.1242/ bio.20122519 17.,OADS,/arxiv_data1/oa_pdf/34/6a/spmg-3-e25733.PMC3861171.pdf
Reproduction 2012; 143:347-57; PMID:22157319; http://dx.doi.org/10.1530/REP-11- 0317 18.,Non-OADS,/arxiv_data1/oa_pdf/34/6a/spmg-3-e25733.PMC3861171.pdf
Biol Reprod 2013; 88:60; PMID:23303684;  http://dx.doi.org/10.1095/biolreprod.112.104851 19.,OADS,/arxiv_data1/oa_pdf/34/6a/spmg-3-e25733.PMC3861171.pdf
Endocrinology 2009; 150:1861-9;  PMID:19095743; http://dx.doi.org/10.1210/en.2008- 1232 20.,Non-OADS,/arxiv_data1/oa_pdf/34/6a/spmg-3-e25733.PMC3861171.pdf
J Cell Physiol 2007; 210:644-54;  PMID:17133358; http://dx.doi.org/10.1002/ jcp.20855 21.,OADS,/arxiv_data1/oa_pdf/34/6a/spmg-3-e25733.PMC3861171.pdf
Biol Reprod 2004; 70:805- 12; PMID:14627549; http://dx.doi.org/10.1095/biol- reprod.103.022723 22.,OADS,/arxiv_data1/oa_pdf/34/6a/spmg-3-e25733.PMC3861171.pdf
Cell Motil Cytoskeleton 2008; 65:614- 25; PMID:18553359; http://dx.doi.org/10.1002/ cm.20287 24.,Non-OADS,/arxiv_data1/oa_pdf/34/6a/spmg-3-e25733.PMC3861171.pdf
Anat Rec (Hoboken)  2012; 295:201-7; PMID:22190417; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/34/6a/spmg-3-e25733.PMC3861171.pdf
PLoS One 2010; 5:e9406; PMID:20195380;  http://dx.doi.org/10.1371/journal.pone.0009406 26.,Non-OADS,/arxiv_data1/oa_pdf/34/6a/spmg-3-e25733.PMC3861171.pdf
Spermatogenesis 2011; 1:14- 35; PMID:21866274; http://dx.doi.org/10.4161/ spmg.1.1.14525 3.,Non-OADS,/arxiv_data1/oa_pdf/34/6a/spmg-3-e25733.PMC3861171.pdf
Am J  Anat 1977; 148:313-28; PMID:857632; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/34/6a/spmg-3-e25733.PMC3861171.pdf
Science 2012; 338:798- 802; PMID:22997133; http://dx.doi.org/10.1126/sci- ence.1219969 5.,OADS,/arxiv_data1/oa_pdf/34/6a/spmg-3-e25733.PMC3861171.pdf
Anat Rec 1976; 185:259-78; PMID:937734;  http://dx.doi.org/10.1002/ar.1091850302 6.,Non-OADS,/arxiv_data1/oa_pdf/34/6a/spmg-3-e25733.PMC3861171.pdf
Biol Reprod  2009; 80:153-61; PMID:18799755; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/34/6a/spmg-3-e25733.PMC3861171.pdf
Anat Rec 1979; 194:213-32; PMID:464323;  http://dx.doi.org/10.1002/ar.1091940204 8.,Non-OADS,/arxiv_data1/oa_pdf/34/6a/spmg-3-e25733.PMC3861171.pdf
Am J Anat 1979; 155:259- 79; PMID:474448; http://dx.doi.org/10.1002/ aja.1001550208 9.,Non-OADS,/arxiv_data1/oa_pdf/34/6a/spmg-3-e25733.PMC3861171.pdf
Int Rev Cell Mol Biol  2013; 303:319-55; PMID:23445814; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/34/6a/spmg-3-e25733.PMC3861171.pdf
J Cell Biol 2000; 150:377-89; PMID:10908579; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/34/6a/spmg-3-e25733.PMC3861171.pdf
Curr Opin Cell Biol 2010; 22:513- 8; PMID:20538447; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/34/6a/spmg-3-e25733.PMC3861171.pdf
PLoS Biol  2011; 9:e1000604; PMID:21445324; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/34/6a/spmg-3-e25733.PMC3861171.pdf
Nat Cell Biol 2010; 12:902-8;  PMID:20729836; http://dx.doi.org/10.1038/ncb2094,OADS,/arxiv_data1/oa_pdf/34/6a/spmg-3-e25733.PMC3861171.pdf
"C Yan Cheng* and Dolores D Mruk The Mary M. Wohlford Laboratory for Male Contraceptive Research; Center for Biomedical Research; The Population Council; New York, NY USA *Correspondence to: C Yan Cheng; Email: ccheng@mail.rockefeller.edu Submitted: 06/13/2013; Accepted: 06/13/2013http://dx.doi.org/10.4161/spmg.25888Figure 1.",Non-OADS,/arxiv_data1/oa_pdf/ba/66/spmg-3-e25888.PMC3861172.pdf
"This figure  was prepared based on data at: http://www.prb.org/DataFinder/Topic/Rankings.aspx?ind=35 us - ing the Filters of “All Methods, 2008, Percent.” Only eight selected countries are shown, and six of the most widely used contraceptives and/or practices are presented.",Non-OADS,/arxiv_data1/oa_pdf/ba/66/spmg-3-e25888.PMC3861172.pdf
"(http://www.asianews.it/news-en/As-a-result-of-forced- sterilisations,-4.6-million-women-can-no-longer-have- children-in-India-28182.html).",Non-OADS,/arxiv_data1/oa_pdf/ba/66/spmg-3-e25888.PMC3861172.pdf
"24 Correspondence to: Hsiao Chang Chan; Email: hsiaocchan@cuhk.edu.hk Submitted: 08/18/2013; Accepted: 08/20/2013http://dx.doi.org/10.4161/spmg.26228Letter from the editor CFTR and male fertility—Impact beyond cystic fibrosis Hsiao Chang  Chan Epithelial Cell Biology r esearch Center, s chool of Biomedical s ciences; Faculty of Medicine; t he Chinese University of Hong Kong; Hong Kong, P r China",Non-OADS,/arxiv_data1/oa_pdf/8a/68/spmg-3-e26228.PMC3861173.pdf
Science 1989; 245:1066-73; PMID:2475911 ;  http://dx.doi.org/10.1126/science.2475911 2.,Non-OADS,/arxiv_data1/oa_pdf/8a/68/spmg-3-e26228.PMC3861173.pdf
Science  1989; 245:1059-65;  PMID:2772657 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8a/68/spmg-3-e26228.PMC3861173.pdf
Science 1989; 245:1073-80; PMID:2570460 ;  http://dx.doi.org/10.1126/science.2570460 4.,Non-OADS,/arxiv_data1/oa_pdf/8a/68/spmg-3-e26228.PMC3861173.pdf
Cell 1992; 68:809-18;  PMID:1371239 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8a/68/spmg-3-e26228.PMC3861173.pdf
J Physiol 2009;  587:2187-95;  PMID :19015188 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8a/68/spmg-3-e26228.PMC3861173.pdf
N Engl J Med 1972; 287:586- 9; PMID:5055208 ; http://dx.doi.org/10.1056/ NEJM197209212871204 8.,OADS,/arxiv_data1/oa_pdf/8a/68/spmg-3-e26228.PMC3861173.pdf
N Engl J Med  1968; 279:65-9;  PMID:5657013 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8a/68/spmg-3-e26228.PMC3861173.pdf
Andrologia 2000; 32:71-83;  PMID:10755189 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8a/68/spmg-3-e26228.PMC3861173.pdf
Hum Reprod Update  2012; 18:703-13;  PMID:22709980 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8a/68/spmg-3-e26228.PMC3861173.pdf
Nat Cell Biol 2003; 5:902-6; PMID:14515130 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8a/68/spmg-3-e26228.PMC3861173.pdf
Proc Natl Acad Sci U S A 2007; 104:9816-21; PMID:17519339 ; http://dx.doi.org/10.1073/ pnas.0609253104 17.,OADS,/arxiv_data1/oa_pdf/8a/68/spmg-3-e26228.PMC3861173.pdf
Hum Reprod 2012; 27:2585-97;  PMID:22777528 ;  http://dx.doi.org/10.1093/humrep/des254 21.,OADS,/arxiv_data1/oa_pdf/8a/68/spmg-3-e26228.PMC3861173.pdf
Philos Trans R Soc Lond B Biol Sci  2010; 365:1621-35;  PMID:20403874 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8a/68/spmg-3-e26228.PMC3861173.pdf
"Oncogene 2013; 32:2282-91, e1-7;  PMID:22797075 ; http://dx.doi.",OADS,/arxiv_data1/oa_pdf/8a/68/spmg-3-e26228.PMC3861173.pdf
Biochim Biophys Acta  2013; 1833:2961-9;  PMID:23916755 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8a/68/spmg-3-e26228.PMC3861173.pdf
Spermatogenesis 2012; 2:264-72; PMID:23248767 ;  http://dx.doi.org/10.4161/spmg.22014 25.,Non-OADS,/arxiv_data1/oa_pdf/8a/68/spmg-3-e26228.PMC3861173.pdf
Nat Genet 1993; 3:157-64; PMID:7684647 ;  http://dx.doi.org/10.1038/ng0293-157,OADS,/arxiv_data1/oa_pdf/8a/68/spmg-3-e26228.PMC3861173.pdf
"13 Among the ginsen - osides, Rg1 has been found for NO production in endothelial cells by glucocorticoid receptor (GR)-dependent, non-genomic *Correspondence to: Alice ST Wong; Email: awong1@hku.hk Submitted: 09/04/2013; Accepted: 09/05/2013http://dx.doi.org/10.4161/spmg.26391Ginseng and male reproductive function Kar w ah Leung and Alice ST w ong* School of Biological Sciences; University of Hong Kong; Hong Kong, PR China Keywords:  ginseng, ginsenosides, sexual behavior, sperm, spermatogenesis, steroid receptor Abbreviations: ACh, acetylcholine; AR, androgen receptor; cGMP, cyclic guanosine monophosphate; CREM, cAMP-responsive  element modulator; CP, cyclophosphamide; DA, dopamine; ER, estrogen receptor; GABA, gamma-aminobutyric acid; GDNF,  glial cell-derived neurotrophic factor; GR, glucocorticoid receptor;LH, luteinizing hormone; NO, nitric oxide; NOS, nitric oxide  synthase; PR, progesterone receptor; ZEA, zearalenone Ginseng is often referred to as the King of all herbs, and is  found to be a promising agent to improve general well-being.",Non-OADS,/arxiv_data1/oa_pdf/5d/68/spmg-3-e26391.PMC3861174.pdf
PLoS Med 2012; 9:e1001356;  PMID:23271957; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/5d/68/spmg-3-e26391.PMC3861174.pdf
Fertil Steril  2010; 93:2169-74;  PMID:20338559 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5d/68/spmg-3-e26391.PMC3861174.pdf
Aust N Z J  Obstet Gynaecol 2007; 47:145-9; PMID:17355306 ;  http://dx.doi.org/10.1111/j.1479-828X.2007.00702.x 6.,Non-OADS,/arxiv_data1/oa_pdf/5d/68/spmg-3-e26391.PMC3861174.pdf
Br J Clin Pharmacol 2008;  66:444-50;  PMID:18754850 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5d/68/spmg-3-e26391.PMC3861174.pdf
"J Urol 2002; 168:2070-3; PMID:12394711 ; http://dx.doi.org/10.1016/ S0022-5347(05)64298-X 8. de Andrade E, de Mesquita AA, Claro JdeA, de Andrade PM, Ortiz V, Paranhos M, Srougi M. Study of the efficacy of Korean Red Ginseng in the  treatment of erectile dysfunction.",OADS,/arxiv_data1/oa_pdf/5d/68/spmg-3-e26391.PMC3861174.pdf
Asian J Androl  2007; 9:241-4;  PMID:16855773 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5d/68/spmg-3-e26391.PMC3861174.pdf
J Urol 1999; 162:1508-11; PMID:10492246 ;  http://dx.doi.org/10.1016/S0022-5347(05)68349-8 10.,OADS,/arxiv_data1/oa_pdf/5d/68/spmg-3-e26391.PMC3861174.pdf
Br J Pharmacol 1995; 115:15-8; PMID:7647970 ;  http://dx.doi.org/10.1111/j.1476-5381.1995.,Non-OADS,/arxiv_data1/oa_pdf/5d/68/spmg-3-e26391.PMC3861174.pdf
Ann N Y Acad Sci 2002;  962:372-7;  PMID:12076988 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5d/68/spmg-3-e26391.PMC3861174.pdf
Pharmacol Ther 2005; 106:233-66;  PMID:15866322 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5d/68/spmg-3-e26391.PMC3861174.pdf
FEBS Lett 2006; 580:3211-6; PMID:16696977 ;  http://dx.doi.org/10.1016/j.febslet.2006.04.08015.,OADS,/arxiv_data1/oa_pdf/5d/68/spmg-3-e26391.PMC3861174.pdf
Am J Chin Med (Gard City N Y) 1976; 4:163-8; PMID:937239 ; http://dx.doi.org/10.1142/ S0192415X76000202 17.,Non-OADS,/arxiv_data1/oa_pdf/5d/68/spmg-3-e26391.PMC3861174.pdf
Physiol Behav  1998; 64:445-50;  PMID:9761217 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5d/68/spmg-3-e26391.PMC3861174.pdf
Methods Find Exp  Clin Pharmacol 1998; 20:59-64; PMID:9575484 ;  http://dx.doi.org/10.1358/mf.1998.20.1.485633 19.,Non-OADS,/arxiv_data1/oa_pdf/5d/68/spmg-3-e26391.PMC3861174.pdf
Arch Androl 1982; 8:261-3;  PMID:7202345 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5d/68/spmg-3-e26391.PMC3861174.pdf
Acta Pharmacol Sin 2013; 34:214-20; PMID:23202798 ; http://dx.doi.org/10.1038/ aps.2012.147 25.,Non-OADS,/arxiv_data1/oa_pdf/5d/68/spmg-3-e26391.PMC3861174.pdf
Neurochem Int 1992; 21:1-5; PMID:1338897 ;  http://dx.doi.org/10.1016/0197-0186(92)90061-U 26.,OADS,/arxiv_data1/oa_pdf/5d/68/spmg-3-e26391.PMC3861174.pdf
J Ethnopharmacol 1998; 62:215- 22; PMID:9849631 ; http://dx.doi.org/10.1016/ S0378-8741(98)00066-X 27.,Non-OADS,/arxiv_data1/oa_pdf/5d/68/spmg-3-e26391.PMC3861174.pdf
Fertil Steril 2007;  88:1000-2;  PMID:17418830 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5d/68/spmg-3-e26391.PMC3861174.pdf
Science 2000; 287:1489-93; PMID:10688798 ;  http://dx.doi.org/10.1126/science.287.5457.1489 33. de Rooij DG.,OADS,/arxiv_data1/oa_pdf/5d/68/spmg-3-e26391.PMC3861174.pdf
Reproduction 2001; 121:347-54; PMID:11226060 ; http://dx.doi.org/10.1530/ rep.0.1210347 34.,Non-OADS,/arxiv_data1/oa_pdf/5d/68/spmg-3-e26391.PMC3861174.pdf
Int J Androl 2001;  24:126-35;  PMID:11380701 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5d/68/spmg-3-e26391.PMC3861174.pdf
Mol Hum Reprod 2004; 10:129-35; PMID:14742698 ;  http://dx.doi.org/10.1093/molehr/gah012 36.,OADS,/arxiv_data1/oa_pdf/5d/68/spmg-3-e26391.PMC3861174.pdf
Am J Chin Med 1999; 27:123- 8; PMID:10354824 ; http://dx.doi.org/10.1142/ S0192415X9900015X38.,Non-OADS,/arxiv_data1/oa_pdf/5d/68/spmg-3-e26391.PMC3861174.pdf
Am J Chin Med 2001; 29:155-60;  PMID:11321473 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5d/68/spmg-3-e26391.PMC3861174.pdf
Mol Reprod Dev 2007; 74:497-501; PMID:17013883 ;  http://dx.doi.org/10.1002/mrd.20583 41.,OADS,/arxiv_data1/oa_pdf/5d/68/spmg-3-e26391.PMC3861174.pdf
J Emb Trans  2013;   http://dx.doi.org/10.12750/JET.2013.28.1.63   43.,Non-OADS,/arxiv_data1/oa_pdf/5d/68/spmg-3-e26391.PMC3861174.pdf
Reprod Med Biol 2007; 6:99-108; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5d/68/spmg-3-e26391.PMC3861174.pdf
"Clin J Oncol Nurs 2002; 6:175-6, 180; PMID:11998614 ; http://dx.doi.org/10.1188/02.",OADS,/arxiv_data1/oa_pdf/5d/68/spmg-3-e26391.PMC3861174.pdf
Int J Radiat Oncol Biol Phys 1984;  10 :1551-4 ;  PMID:6090360 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5d/68/spmg-3-e26391.PMC3861174.pdf
Biol Pharm Bull 2003; 26:308- 12; PMID:12612438 ; http://dx.doi.org/10.1248/ bpb.26.308 48.,Non-OADS,/arxiv_data1/oa_pdf/5d/68/spmg-3-e26391.PMC3861174.pdf
J Ginseng Res 2011; 35:294-300;  PMID:23717072 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5d/68/spmg-3-e26391.PMC3861174.pdf
Diabetes Spectrum 2004; 17:4225-30;  http://dx.doi.org/10.2337/diaspect.17.4.225 50.,Non-OADS,/arxiv_data1/oa_pdf/5d/68/spmg-3-e26391.PMC3861174.pdf
Endocr Regul 2011; 45:139-48;  PMID:21793626 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5d/68/spmg-3-e26391.PMC3861174.pdf
Urology  2005; 65:611-5;  PMID:15780402 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5d/68/spmg-3-e26391.PMC3861174.pdf
Diabetes Care 1995; 18:1373-5; PMID:8721940 ;  http://dx.doi.org/10.2337/diacare.18.10.1373 53.,Non-OADS,/arxiv_data1/oa_pdf/5d/68/spmg-3-e26391.PMC3861174.pdf
Asian J Androl 2013; 15:395- 9; PMID:23377529 ; http://dx.doi.org/10.1038/ aja.2012.15954.,Non-OADS,/arxiv_data1/oa_pdf/5d/68/spmg-3-e26391.PMC3861174.pdf
Food Chem Toxicol  2007; 45:2237-44;  PMID:17624648 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5d/68/spmg-3-e26391.PMC3861174.pdf
Hum Reprod 2005; 20:3481-7; PMID:16123086 ; http://dx.doi.org/10.1093/ humrep/dei267 57.,OADS,/arxiv_data1/oa_pdf/5d/68/spmg-3-e26391.PMC3861174.pdf
J Urol 2013; 189:2243- 7; PMID:23201383 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/5d/68/spmg-3-e26391.PMC3861174.pdf
Mol Pharmacol 2006; 70:1916-24;  PMID:16985185 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5d/68/spmg-3-e26391.PMC3861174.pdf
Biochem Biophys Res Commun 2007; 353:764- 9; PMID:17196933 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/5d/68/spmg-3-e26391.PMC3861174.pdf
J Sex Med  2012; 9:1681-96;  PMID:22512993 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5d/68/spmg-3-e26391.PMC3861174.pdf
Horm Behav  1997; 32:176-83;  PMID:9454668 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5d/68/spmg-3-e26391.PMC3861174.pdf
Proc Natl Acad Sci U S A 1993; 90:11162-6; PMID:8248223 ; http://dx.doi.org/10.1073/ pnas.90.23.11162 63.,OADS,/arxiv_data1/oa_pdf/5d/68/spmg-3-e26391.PMC3861174.pdf
J Clin Endocrinol Metab 2004; 89:3510- 5; PMID:15240639 ; http://dx.doi.org/10.1210/ jc.2003-031823 64.,Non-OADS,/arxiv_data1/oa_pdf/5d/68/spmg-3-e26391.PMC3861174.pdf
J Clin Endocrinol Metab  2002; 87:3691-5;  PMID:12161497 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5d/68/spmg-3-e26391.PMC3861174.pdf
Jpn J Cancer  Res 1996; 87:357-62; PMID:8641966 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5d/68/spmg-3-e26391.PMC3861174.pdf
J Steroid Biochem Mol Biol 2003; 84:463-8;  PMID:12732291 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5d/68/spmg-3-e26391.PMC3861174.pdf
Contraception 1977; 15:163-74 ;  PMID:837690 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5d/68/spmg-3-e26391.PMC3861174.pdf
Arch Androl  1979; 3:23-9;  PMID:485657 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5d/68/spmg-3-e26391.PMC3861174.pdf
Int J Androl  1981; 4:1-17;  PMID:7203688 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5d/68/spmg-3-e26391.PMC3861174.pdf
Biochem Biophys Res Commun 1981; 100:840-6; PMID:7271785 ; http://dx.doi.org/10.1016/ S0006-291X(81)80250-171.,OADS,/arxiv_data1/oa_pdf/5d/68/spmg-3-e26391.PMC3861174.pdf
Biol Reprod 2002; 67:1327- 36; PMID:12297552 ; http://dx.doi.org/10.1095/ biolreprod67.4.1327 72.,OADS,/arxiv_data1/oa_pdf/5d/68/spmg-3-e26391.PMC3861174.pdf
Mol Cell  Endocrinol 2000; 161:31-5;  PMID:10773388 ;  http://dx.doi.org/10.1016/S0303-7207(99)00220-8 73.,OADS,/arxiv_data1/oa_pdf/5d/68/spmg-3-e26391.PMC3861174.pdf
Andrologia 2008; 40:146-51; PMID:18477200 ;  http://dx.doi.org/10.1111/j.1439-0272.2007.00814.x 74.,Non-OADS,/arxiv_data1/oa_pdf/5d/68/spmg-3-e26391.PMC3861174.pdf
Contraception 1981; 23:527-41;  PMID:6793300 ;  http://dx.doi.org/10.1016/0010-7824(81)90080-977.,Non-OADS,/arxiv_data1/oa_pdf/5d/68/spmg-3-e26391.PMC3861174.pdf
Biol Reprod 1999; 60:908- 13; PMID:10084965 ; http://dx.doi.org/10.1095/ biolreprod60.4.908 78.,OADS,/arxiv_data1/oa_pdf/5d/68/spmg-3-e26391.PMC3861174.pdf
Reproduction 2010; 140:453-64; PMID:20562298 ;  http://dx.doi.org/10.1530/REP-10-0168 79.,Non-OADS,/arxiv_data1/oa_pdf/5d/68/spmg-3-e26391.PMC3861174.pdf
J Endocrinol 1995; 144:13-8;  PMID:7891014 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5d/68/spmg-3-e26391.PMC3861174.pdf
Reproduction 2012; 143:297-307; PMID:22143972 ; http://dx.doi.org/10.1530/ REP-11-0326,Non-OADS,/arxiv_data1/oa_pdf/5d/68/spmg-3-e26391.PMC3861174.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b5/10/cia-9-001.PMC3861292.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2014:9 1–8Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S4135 6Managing hypercholesterolemia and preventing  cardiovascular events in elderly and younger  Chinese adults: focus on rosuvastatin Zhen wang Junbo Ge Department of Cardiology,    Zhongshan Hospital, Shanghai,    People’s Republic of China Correspondence: Junbo Ge   Department of Cardiology, Shanghai  Institute of Cardiovascular Diseases,  Zhongshan Hospital, Fudan University,  180 Fenglin Road, Shanghai 200032,  People’s Republic of China   Tel +86 21 640 41909 ext 2745   email ge.junbo@zs-hospital.sh.c nAbstract:  Coronary heart disease (CHD) is the leading cause of death worldwide.",Non-OADS,/arxiv_data1/oa_pdf/b5/10/cia-9-001.PMC3861292.pdf
Available from: http://www.who.int/mediacentre/ factsheets/fs310/en /.,Non-OADS,/arxiv_data1/oa_pdf/b5/10/cia-9-001.PMC3861292.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treat - ments intended to prevent or delay the onset of maladaptive correlates  of aging in human beings.",Non-OADS,/arxiv_data1/oa_pdf/b5/10/cia-9-001.PMC3861292.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/b5/10/cia-9-001.PMC3861292.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/50/3a/ccid-6-317.PMC3861293.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical, Cosmetic and Investigational Dermatology 2013:6 317–323Clinical, Cosmetic and Investigational Dermatology Dove press submit your manuscript | www.dovepress.co m Dove press  317OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CCID.S5195 8Investigation of age-related decline of microfibril- associated glycoprotein-1 in human skin through  immunohistochemistry study Qian Zheng siming Chen Ying Chen John lyga Russell Wyborski Uma santhanam Global Research and Development,   avon Products Inc., suffern, new Y ork,   Usa Correspondence: Qian Zheng   New Technology – Bioscience, Global  research and Development Center,   avon Products Inc., suffern, new York,  nY 10901, Usa   Tel +1 845 369 2624   Fax +1 845 369 2405   email qian.zheng@avon.co mAbstract:  During aging, the reduction of elastic and collagen fibers in dermis can lead to  skin atrophy, fragility, and aged appearance, such as increased facial wrinkling and sagging.",Non-OADS,/arxiv_data1/oa_pdf/50/3a/ccid-6-317.PMC3861293.pdf
"Clinical, Cosmetic and Investigational Dermatology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-cosmetic-and-investigational-dermatology-journa lClinical, Cosmetic and Investigational Dermatology is an interna - tional, peer-reviewed, open access, online journal that focuses on  the latest clinical and experimental research in all aspects of skin  disease and cosmetic interventions.",Non-OADS,/arxiv_data1/oa_pdf/50/3a/ccid-6-317.PMC3861293.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/50/3a/ccid-6-317.PMC3861293.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/38/b1/btt-8-001.PMC3861294.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpBiologics: Targets and Therapy 2014:8 1–12Biologics: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/BTT .S3547 5Non-tumor necrosis factor-based biologic  therapies for rheumatoid arthritis: present,   future, and insights into pathogenesis Filipe Seguro Paula1 José Delgado Alves1,2 1immunomediated Systemic Diseases  Unit, Department of Medicine 4,   Fernando Fonseca Hospital, Amadora,   2Center for the Study of Chronic  Diseases, Department of  Pharmacology, Faculty of Medical  Sciences, Lisbon, Portugal Correspondence: José Delgado Alves   Serviço de Medicina 4, Hospital Prof   Dr Fernando Fonseca, iC19,   2720-276 Amadora, Portugal   Tel +35 12 1434 5510   email jose.alves@fcm.unl.p tAbstract:  The way rheumatoid arthritis is treated has changed dramatically with the introduction  of anti-tumor necrosis factor (anti-TNF) biologics.",Non-OADS,/arxiv_data1/oa_pdf/38/b1/btt-8-001.PMC3861294.pdf
"Biologics: Targets & Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/biologics-targets--therapy-journa lBiologics: Targets & Therapy is an international, peer-reviewed journal  focusing on the patho-physiological rationale for and clinical applica - tion of Biologic agents in the management of autoimmune diseases,  cancers or other pathologies where a molecular target can be identified.",Non-OADS,/arxiv_data1/oa_pdf/38/b1/btt-8-001.PMC3861294.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/38/b1/btt-8-001.PMC3861294.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/79/c8/cia-9-015.PMC3861295.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2014:9 15–16Clinical Interventions in Aging This article was published in the following Dove Press journal:  Clinical Interventions in Aging 6 December 2013Dove press submit your manuscript | www.dovepress.co m Dove press  15LeTTeropen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S5442 6Number of times this article has been viewedOptimal treatment of actinic keratosis Gary Goldenberg Mount Sinai School of Medicine,    New Y ork, NY, USA Correspondence: Gary Goldenberg   Mount Sinai School of Medicine,   1428 Madison Ave, New Y ork,   NY 10029, USA   T el +1 917 209 9940   email garygoldenbergmd@gmail.co mDear editor We read with interest the review by Uhlenhake on treatments for actinic keratosis  (AK).1 The author presents a summary of the various AK treatment options used to  reduce the risk of progression to invasive squamous cell carcinoma.",Non-OADS,/arxiv_data1/oa_pdf/79/c8/cia-9-015.PMC3861295.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treat - ments intended to prevent or delay the onset of maladaptive correlates  of aging in human beings.",Non-OADS,/arxiv_data1/oa_pdf/79/c8/cia-9-015.PMC3861295.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/79/c8/cia-9-015.PMC3861295.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f1/a1/cia-8-1617.PMC3861296.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2013:8 1617–1624Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1617RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S3594 1High-grade glioma in elderly patients:   can the oncogeriatrician help?,Non-OADS,/arxiv_data1/oa_pdf/f1/a1/cia-8-1617.PMC3861296.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treat - ments intended to prevent or delay the onset of maladaptive correlates  of aging in human beings.",Non-OADS,/arxiv_data1/oa_pdf/f1/a1/cia-8-1617.PMC3861296.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/f1/a1/cia-8-1617.PMC3861296.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3 .0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e0/0a/dkt344.PMC3861333.pdf
"Version 3.1, 2013. http://www.eucast.org/clinical_breakpoints/ (13 July 2013, date last accessed).10US FDA.",Non-OADS,/arxiv_data1/oa_pdf/e0/0a/dkt344.PMC3861333.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f6/98/aft077.PMC3861334.pdf
"BritishGeriatrics Society, available online at http://www.bgs.org.uk/ index.php?option=com_content&view=article&id=1907:cqc-report-too-many-failing-hospitals&catid=6:prindex&Itemid=99(18 June 2012, date last accesssed).7.Bebbington A, Darton R, Bartholomew R, Netten A.",Non-OADS,/arxiv_data1/oa_pdf/f6/98/aft077.PMC3861334.pdf
"1675,Personal Social Services Research Unit, University of Kent atCanterbury, available online at http://www.pssru.ac.uk/pdf/ dp1675.pdf (4 May 2011, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/f6/98/aft077.PMC3861334.pdf
"nationalarchives.gov.uk/20130314010347/http://research.dwp.gov.uk/asd/asd5/rrep159.pdf (8 July 2013, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/f6/98/aft077.PMC3861334.pdf
"PhD thesis, University ofNottingham, 2012. available online at http://etheses.nottingham.",Non-OADS,/arxiv_data1/oa_pdf/f6/98/aft077.PMC3861334.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4a/f7/aft087.PMC3861335.pdf
"We ’ve Been Listening, Have You Been Learning?, London, 2011. http://patients-association.com/ Portals/0/Public/Files/Research%20Publications/We've%20been%20listening,%20have%20you%20been%20learning.pdf .",Non-OADS,/arxiv_data1/oa_pdf/4a/f7/aft087.PMC3861335.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4d/a5/aft123.PMC3861338.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4d/a5/aft123.PMC3861338.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a8/6b/imcrj-6-091.PMC3861361.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Medical Case Reports Journal 2013:6 91–93International Medical Case Reports Journal Dove press submit your manuscript | www.dovepress.co m Dove press  91Case Repo Rtopen access to scientific and medical research open access Full text article http: //dx.doi.org/10.2147/IMCRJ.S5201 5Neurological syndrome in an HIV-prevention  trial participant randomized to daily tenofovir  disoproxil fumarate (300 mg) and emtricitabine  (200 mg) in Bondo, Kenya Fredrick owino1 Justin Mandala2 Julie ambia3 Kawango agot1 Lut Van Damme2 1Impact Research and Development  organization, Kisumu, Kenya;   2Department of Global Health,   population, and Nutrition, FHI 360,   Washington, DC, Usa; 3KaVI-Institute  of Clinical Research, University of  Nairobi, Nairobi, Kenya Correspondence: Justin Mandala   FHI 360, 1825 Connecticut ave,  Washington, DC 20009, Usa   tel +1 202 884 8319   Fax +1 202 884 8400   email jmandala@fhi360.or gAbstract:  Side effects of antiretroviral drug use by HIV -positive patients have been  extensively  studied; however, there are limited data on the side effects of antiretroviral drugs used as an HIV  prophylaxis among healthy, HIV -negative individuals.",Non-OADS,/arxiv_data1/oa_pdf/a8/6b/imcrj-6-091.PMC3861361.pdf
"International Medical Case Reports Journal Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-medical-case-reports-journal-journa lThe International Medical Case Reports Journal is an international,  peer-reviewed open-access journal publishing original case reports  from all medical specialties.",Non-OADS,/arxiv_data1/oa_pdf/a8/6b/imcrj-6-091.PMC3861361.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/a8/6b/imcrj-6-091.PMC3861361.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/84/c9/cpaa-5-177.PMC3861362.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Pharmacology: Advances and Applications 2013:5 177–184Clinical Pharmacology: Advances and Applications Dove press submit your manuscript | www.dovepress.co m Dove press  177OriginAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CPAA.S5198 1single- and multiple-dose pharmacokinetics,  pharmacodynamics, and safety of apixaban   in healthy Chinese subjects Yimin Cui1 Yan song2 Jessie Wang2 Zhigang Yu2 Alan schuster2 Yu Chen Barrett2 Charles Frost2 1Peking University First hospital,   Beijing, People’s republic of China;   2Bristol-Myers squibb, Princeton,    nJ, UsA Correspondence: Charles Frost   Bristol-Myers squibb (e12–16),   route 206 and Province line road,  Princeton, nJ 08543, UsA   Tel +1 609 252 3552   Fax +1 609 252 6313   email c harles.frost@bms.co mBackground:  The pharmacokinetics (PK), pharmacodynamics (PD), and safety of apixaban  were assessed in healthy Chinese subjects in this randomized, placebo-controlled, double-blind,  single-sequence, single- and multiple-dose study.",Non-OADS,/arxiv_data1/oa_pdf/84/c9/cpaa-5-177.PMC3861362.pdf
"Available from: http://www.ich.org/fileadmin/ Public_Web_Site/ICH_Products/Guidelines/Efficacy/E5_R1/Step4/ E5_R1__Guideline.pd f. Accessed October 3, 2013.",Non-OADS,/arxiv_data1/oa_pdf/84/c9/cpaa-5-177.PMC3861362.pdf
"Clinical Pharmacology: Advances and Applications Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-pharmacology-advances-and-applications-journa lClinical Pharmacology: Advances and Applications is an international,  peer-reviewed, open access journal publishing original research, reports,  reviews and commentaries on all areas of drug experience in humans.",Non-OADS,/arxiv_data1/oa_pdf/84/c9/cpaa-5-177.PMC3861362.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/84/c9/cpaa-5-177.PMC3861362.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/3f/a7/tcrm-9-477.PMC3861363.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2013:9 477–482Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  477Case seRiesopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S5263 0Treatment of bisphosphonate related  osteonecrosis following root canal therapy   at the 1-year follow-up: report of two cases Figen Kaptan1 Meric Karapinar Kazandag1 Ufuk iseri2 1Yeditepe University, Faculty  of Dentistry, Department of  endodontics, 2Department of  Prosthodontics, istanbul, T urkey Correspondence: Meric Karapinar  Kazandag   Yeditepe University, Faculty of Dentistry,  Department of Endodontics, Bag ˇdat cad  No 238 Goztepe, 34728, istanbul, Turkey   Tel +90 532 647 3469   email mkarapinar@yahoo.co mAbstract:  The objective of this report was to use topical gaseous ozone as an adjunct to  conventional treatment methods and to describe the multidisciplinary management of bisphosphonate  associated bone necrosis, which developed following endodontic treatment.",Non-OADS,/arxiv_data1/oa_pdf/3f/a7/tcrm-9-477.PMC3861363.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/3f/a7/tcrm-9-477.PMC3861363.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/3f/a7/tcrm-9-477.PMC3861363.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/cc/fa/tcrm-9-469.PMC3861364.pdf
Permissions beyond the scope of the License are administered by Dove Medical Press Ltd.  Information on how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2013:9 469–475Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  469Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TCRM.S5021 2Video abstract Point your Smar tPhone at the code abo ve.,Non-OADS,/arxiv_data1/oa_pdf/cc/fa/tcrm-9-469.PMC3861364.pdf
"Or use: http://dvpr.es/GX94j KGabapentin enacarbil extended release   for the treatment of postherpetic neuralgia   in adults Ben M Thomas1 Paul Farquhar-Smith2 1Chelsea westminster Hospital,   London, UK; 2Department of  Anaesthetics, The Royal Marsden NHS  Foundation Trust, London, UK Correspondence: Paul Farquhar-Smith   Department of Anaesthetics, The Royal  Marsden NHS Foundation Trust,   Fulham Road, London, Sw3 6JJ, UK   Tel +44 207 352 8171 ext 2727   Fax +44 207 808 2726   email paul.farquhar-smith@rmh.nhs.u kAbstract:  The development of biomedical technology is allowing refinement of drug therapies  in order to improve medication profiles and benefit patients.",Non-OADS,/arxiv_data1/oa_pdf/cc/fa/tcrm-9-469.PMC3861364.pdf
Available from: http://labeling.pfizer.,Non-OADS,/arxiv_data1/oa_pdf/cc/fa/tcrm-9-469.PMC3861364.pdf
"Available from:  http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/ GabapentinEnacarbilHorizantDrugMonograph.pd f. Accessed May 21,  2013.",Non-OADS,/arxiv_data1/oa_pdf/cc/fa/tcrm-9-469.PMC3861364.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/cc/fa/tcrm-9-469.PMC3861364.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/cc/fa/tcrm-9-469.PMC3861364.pdf
"Available from: http://www.accessdata.fda.gov/ drugsatfda_docs/label/2011/021446s026,022488s00 5lbl.pdf.",Non-OADS,/arxiv_data1/oa_pdf/cc/fa/tcrm-9-469.PMC3861364.pdf
"In particular,  it is important to discriminate between squamous cell carci -REVIEW http://dx.doi.org/10.4046/trd.2013.75.5.181 ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2013;75:181-187 181Address for correspondence: Chi Young Jung, M.D., Ph.D. Department of Internal Medicine, Keimyung University School of  Medicine, 56 Dalseong-ro, Jung-gu, Daegu 700-712, Korea Phone:  82-53-250-8095, Fax: 82-53-250-7434 E-mail: jcy2475@dsmc.or.kr Received:  Aug. 21, 2013 Revised:  Aug. 28, 2013 Accepted:  Sep. 4, 2013 cc It is identical to the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0/).",Non-OADS,/arxiv_data1/oa_pdf/87/18/trd-75-181.PMC3861373.pdf
"Biopsy and mutation detection strategies in NSCLC http://dx.doi.org/10.4046/trd.2013.75.5.181  183 www.e-trd.orgas a marker of squamous cell carcinoma8,9,11,12.",Non-OADS,/arxiv_data1/oa_pdf/87/18/trd-75-181.PMC3861373.pdf
Biopsy and mutation detection strategies in NSCLC http://dx.doi.org/10.4046/trd.2013.75.5.181  185 www.e-trd.orgequate tissue samples for diagnosis are not obtained for all  patients with lung cancer.,Non-OADS,/arxiv_data1/oa_pdf/87/18/trd-75-181.PMC3861373.pdf
Available from: http://www.nccn.org/professionals/physi - cian_gls/f_guidelines.asp#nscl.,Non-OADS,/arxiv_data1/oa_pdf/87/18/trd-75-181.PMC3861373.pdf
Biopsy and mutation detection strategies in NSCLC http://dx.doi.org/10.4046/trd.2013.75.5.181  187 www.e-trd.orgthe pathology and molecular biology of advanced non-small  cell lung cancer.,Non-OADS,/arxiv_data1/oa_pdf/87/18/trd-75-181.PMC3861373.pdf
"The activation of EGFR stimulates REVIEW http://dx.doi.org/10.4046/trd.2013.75.5.188 ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2013;75:188-198 188Address for correspondence: Sei-Hoon Yang, M.D., Ph.D. Department of Internal Medicine, Wonkwang University College of  Medicine, 460 Iksan-daero, Iksan 570-974, Korea Phone:  82-63-859-2582, Fax: 82-63-855-2025 E-mail: yshpul@wku.ac.kr Received:  Jul.",Non-OADS,/arxiv_data1/oa_pdf/28/2e/trd-75-188.PMC3861374.pdf
"26, 2013 Accepted:  Aug. 20, 2013 cc It is identical to the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0/).",Non-OADS,/arxiv_data1/oa_pdf/28/2e/trd-75-188.PMC3861374.pdf
"Molecular basis of drug resistance http://dx.doi.org/10.4046/trd.2013.75.5.188  189 www.e-trd.orgtreatment (Figure 1)5,6.",Non-OADS,/arxiv_data1/oa_pdf/28/2e/trd-75-188.PMC3861374.pdf
"Molecular basis of drug resistance http://dx.doi.org/10.4046/trd.2013.75.5.188  191 www.e-trd.org2) Amplification of the MET oncogene: Another  mechanism by which patients develop acquired resistance  to EGFR inhibition occurs via the amplification of the MET  oncogene26,27.",Non-OADS,/arxiv_data1/oa_pdf/28/2e/trd-75-188.PMC3861374.pdf
"Molecular basis of drug resistance http://dx.doi.org/10.4046/trd.2013.75.5.188  193 www.e-trd.org(1) Met inhibitors (crizotinib, heat shock protein 90  [HSP90]):  The concomitant inhibition of MET and EGFR us - ing the monoclonal antiboby MetMab and erlotinib proved to  beefficacious in a phase II trial and early clinical trials of small- molecule inhibitors of MET given with EGFR inhibitors are  now currently underway (Figure 5).",Non-OADS,/arxiv_data1/oa_pdf/28/2e/trd-75-188.PMC3861374.pdf
Molecular basis of drug resistance http://dx.doi.org/10.4046/trd.2013.75.5.188  195 www.e-trd.orgwere found.,OADS,/arxiv_data1/oa_pdf/28/2e/trd-75-188.PMC3861374.pdf
Molecular basis of drug resistance http://dx.doi.org/10.4046/trd.2013.75.5.188  197 www.e-trd.orgTransl Med 2011;3:75ra26.,Non-OADS,/arxiv_data1/oa_pdf/28/2e/trd-75-188.PMC3861374.pdf
"All rights reserved.ORIGINAL ARTICLEhttp://dx.doi.org/10.4046/trd.2013.75.5.199 ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2013;75:199-204 199Address for correspondence: Won-Jung Koh, M.D.",Non-OADS,/arxiv_data1/oa_pdf/d1/30/trd-75-199.PMC3861375.pdf
"22, 2013 cc It is identical to the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0/).",Non-OADS,/arxiv_data1/oa_pdf/d1/30/trd-75-199.PMC3861375.pdf
"Increasing NTM isolation in South Korea http://dx.doi.org/10.4046/trd.2013.75.5.199  201 www.e-trd.orgwhich increased steadily to 1,459 in 2011 (Table 1).",OADS,/arxiv_data1/oa_pdf/d1/30/trd-75-199.PMC3861375.pdf
Increasing NTM isolation in South Korea http://dx.doi.org/10.4046/trd.2013.75.5.199  203 www.e-trd.orgute to the increase of NTM isolates in Korea.,Non-OADS,/arxiv_data1/oa_pdf/d1/30/trd-75-199.PMC3861375.pdf
http://dx.doi.org/10.1183/09031936.00149212.,Non-OADS,/arxiv_data1/oa_pdf/d1/30/trd-75-199.PMC3861375.pdf
"All rights reserved.ORIGINAL ARTICLEhttp://dx.doi.org/10.4046/trd.2013.75.5.205 ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2013;75:205-209 205Address for correspondence: Choong Jae Lee, Ph.D. Department of Pharmacology, Chungnam National University College  of Medicine, 266 Munhwa-ro, Jung-gu, Daejeon 301-747, Korea Phone:  82-42-580-8255, Fax: 82-42-585-6627 E-mail: LCJ123@cnu.ac.kr *Jiho Ryu and Hyun Jae Lee contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/e0/5f/trd-75-205.PMC3861376.pdf
"Received:  Sep. 11, 2013 Revised:  Oct. 10, 2013 Accepted:  Oct. 15, 2013 cc It is identical to the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0/).",Non-OADS,/arxiv_data1/oa_pdf/e0/5f/trd-75-205.PMC3861376.pdf
Prunetin and NF- κB pathway http://dx.doi.org/10.4046/trd.2013.75.5.205  207 www.e-trd.orgGCT TT A CG-3’ .,Non-OADS,/arxiv_data1/oa_pdf/e0/5f/trd-75-205.PMC3861376.pdf
Prunetin and NF- κB pathway http://dx.doi.org/10.4046/trd.2013.75.5.205  209 www.e-trd.orgin the cytoplasm as an inactive state.,Non-OADS,/arxiv_data1/oa_pdf/e0/5f/trd-75-205.PMC3861376.pdf
"All rights reserved.Introduction Superior vena cava syndrome (SVCS) usually occurs either  by the extrinsic compression of malignant tumors invading  the mediastinum or fibrosing mediastinitis, or by the de novo CASE REPORThttp://dx.doi.org/10.4046/trd.2013.75.5.210 ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2013;75:210-213 210Address for correspondence: Doh Hyung Kim, M.D., Ph.D. Division of Pulmonology and Allergy, Department of Internal Medicine,  Dankook University College of Medicine, 119 Dandae-ro, Dongnam-gu,  Cheonan 330-997, Korea Phone:  82-41-550-3870, Fax: 82-41-556-3256 E-mail: kimdh@dankook.ac.kr Received:  Aug. 30, 2012 Revised:  Sep. 13, 2012 Accepted:  Oct. 23, 2012 cc It is identical to the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0/).",Non-OADS,/arxiv_data1/oa_pdf/1d/20/trd-75-210.PMC3861377.pdf
Unusual superior vena cava syndrome by an invasive thymoma http://dx.doi.org/10.4046/trd.2013.75.5.210  211 www.e-trd.orgfering from facial edema and dyspnea for 1 week.,Non-OADS,/arxiv_data1/oa_pdf/1d/20/trd-75-210.PMC3861377.pdf
"Unusual superior vena cava syndrome by an invasive thymoma http://dx.doi.org/10.4046/trd.2013.75.5.210  213 www.e-trd.orgstudies, thymomas were classified into low risk (type A, AB,  and B1) and high risk (type B2, B3, and C) thymomas based  on the World Health Organization (WHO) histological clas - sification12.",Non-OADS,/arxiv_data1/oa_pdf/1d/20/trd-75-210.PMC3861377.pdf
"Spontaneous regression (SR) CASE REPORThttp://dx.doi.org/10.4046/trd.2013.75.5.214 ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2013;75:214-217 214Address for correspondence: Seon Cheol Park, M.D.",Non-OADS,/arxiv_data1/oa_pdf/bb/26/trd-75-214.PMC3861378.pdf
"11, 2013 Accepted:  Aug. 22, 2013 cc It is identical to the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0/).",Non-OADS,/arxiv_data1/oa_pdf/bb/26/trd-75-214.PMC3861378.pdf
"Spontaneous regression of non-small cell lung cancer http://dx.doi.org/10.4046/trd.2013.75.5.214  215 www.e-trd.orglymph node enlargements with increased FDG uptake in the  hilar, subcarinal, paratracheal, subaortic, prevascular and su - praclavicular areas (Figure 3).",Non-OADS,/arxiv_data1/oa_pdf/bb/26/trd-75-214.PMC3861378.pdf
Spontaneous regression of non-small cell lung cancer http://dx.doi.org/10.4046/trd.2013.75.5.214  217 www.e-trd.orgReferences 1.,Non-OADS,/arxiv_data1/oa_pdf/bb/26/trd-75-214.PMC3861378.pdf
"The majority of these  cases occurred in immunocompromised patients3-7 or before CASE REPORThttp://dx.doi.org/10.4046/trd.2013.75.5.218 ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2013;75:218-221 218Address for correspondence: Doosoo Jeon, M.D.",Non-OADS,/arxiv_data1/oa_pdf/9b/f7/trd-75-218.PMC3861379.pdf
"19, 2012 cc It is identical to the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0/).",Non-OADS,/arxiv_data1/oa_pdf/9b/f7/trd-75-218.PMC3861379.pdf
"Spontaneous rupture in splenic TB http://dx.doi.org/10.4046/trd.2013.75.5.218  219 www.e-trd.orgof blood sugar, blood urea, and serum creatinine, were within  normal limits.",Non-OADS,/arxiv_data1/oa_pdf/9b/f7/trd-75-218.PMC3861379.pdf
Spontaneous rupture in splenic TB http://dx.doi.org/10.4046/trd.2013.75.5.218  221 www.e-trd.orgreaction as well as 10 weeks of antituberculous theapy prior to  the splenectomy.,Non-OADS,/arxiv_data1/oa_pdf/9b/f7/trd-75-218.PMC3861379.pdf
"In 1937, Burke1 described first case of “vanishing lungs” in a  35-year-old man who experienced progressive dyspnea, re -CASE REPORThttp://dx.doi.org/10.4046/trd.2013.75.5.222 ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2013;75:222-224 222Address for correspondence: Deog Kyeom Kim, M.D., Ph.D. Department of Internal Medicine, Seoul Metropolitan Government  Seoul National University Boramae Medical Center, 20 Boramae-ro 5-gil,  Dongjak-gu, Seoul 156-707, Korea Phone:  82-2-870-2228, Fax: 82-2-831-0714 E-mail: kimdkmd@snu.ac.kr Received:  Jul.",Non-OADS,/arxiv_data1/oa_pdf/28/a2/trd-75-222.PMC3861380.pdf
"20, 2013 Revised:  Aug. 23, 2013 Accepted:  Aug. 26, 2013 cc It is identical to the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0/).",Non-OADS,/arxiv_data1/oa_pdf/28/a2/trd-75-222.PMC3861380.pdf
Giant bullae in young adult http://dx.doi.org/10.4046/trd.2013.75.5.222  223 www.e-trd.orgdicted).,Non-OADS,/arxiv_data1/oa_pdf/28/a2/trd-75-222.PMC3861380.pdf
This article is dist ributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cs hlp.org/site/misc/ terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/d6/42/2513.PMC3861665.pdf
"After six months, it is available under a Cr eative Commons License (Attribution- NonCommercial 3.0 Unporte d), as described at http://creativecommons.org/ licenses/by-nc/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/d6/42/2513.PMC3861665.pdf
6Corresponding author E-mail david_pellman@dfci.harvard.edu Article is online at http://www.genesdev.,Non-OADS,/arxiv_data1/oa_pdf/d6/42/2513.PMC3861665.pdf
Modeling breakage–fusion–bridge cycles as a sto-chastic paper folding process.http://arxiv.org/abs/1211.2356.,Non-OADS,/arxiv_data1/oa_pdf/d6/42/2513.PMC3861665.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/00/b2/2531.PMC3861666.pdf
8Corresponding author E-mail bclurman@fhcrc.org Article is online at http://www.genesde v.org/cgi/doi/10.1101/gad.229195.113.,Non-OADS,/arxiv_data1/oa_pdf/00/b2/2531.PMC3861666.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cs hlp.org/site/misc/ terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/c8/e5/2537.PMC3861667.pdf
"After six months, it is available under a Cr eative Commons License (Attribution- NonCommercial 3.0 Unporte d), as described at http://creativecommons.org/ licenses/by-nc/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/c8/e5/2537.PMC3861667.pdf
7Corresponding author E-mail lopes@imcr.uzh.ch Article is online at http://www.genesde v.org/cgi/doi/10.1101/gad.226373.113.,Non-OADS,/arxiv_data1/oa_pdf/c8/e5/2537.PMC3861667.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue pub-lication date (see http://genesdev.cshlp.,Non-OADS,/arxiv_data1/oa_pdf/1e/7d/2543.PMC3861668.pdf
"After six months, it is available under a Creative Commons License (Attribution- NonCommercial 3.0 Unported), as descr ibed at http://creativecommons.org/ licenses/by-nc/3.0/.9Present address: Department of Genetics, Yale University School of Medicine, New Haven, CT 06520, USA.",Non-OADS,/arxiv_data1/oa_pdf/1e/7d/2543.PMC3861668.pdf
10Corresponding authors E-mail haber@helix.mgh.harvard.edu E-mail s.diederichs@dkfz-heidelberg.de Article is online at http://www.genesdev.org/cgi/doi/10.1101/gad.224170.,Non-OADS,/arxiv_data1/oa_pdf/1e/7d/2543.PMC3861668.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/7e/58/2549.PMC3861669.pdf
7Corresponding author E-mail julie.soutourina@cea.fr Article is online at http://www.genesdev.,Non-OADS,/arxiv_data1/oa_pdf/7e/58/2549.PMC3861669.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cs hlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/f6/b0/2563.PMC3861670.pdf
"After six months, it is available under a Creative Commons License (Attribution- NonCommercial 3.0 Unported), as desc ribed at http://creativecommons.org/ licenses/by-nc/3.0/.3Corresponding author E-mail mhebrok@diabetes.ucsf.edu Article is online at http://www.genesdev.",Non-OADS,/arxiv_data1/oa_pdf/f6/b0/2563.PMC3861670.pdf
Array qualities were analyzed using the affyPLM package in R/Bioconductor and RMA Express software (http://rmaexpress.bmbolstad.com).,OADS,/arxiv_data1/oa_pdf/f6/b0/2563.PMC3861670.pdf
org/licenses/by-nc/3.0/.7Corresponding author E-mail ralf.adams@mpi-muenster.mpg.de Article is online at http://www.genesde v.org/cgi/doi/10.1101/gad.224089.113.,Non-OADS,/arxiv_data1/oa_pdf/80/46/2576.PMC3861671.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/e6/e3/2590.PMC3861672.pdf
7Corresponding author E-mail delevin@bu.edu Article is online at http://www.genesde v.org/cgi/doi/10.1101/gad.229310.113.,Non-OADS,/arxiv_data1/oa_pdf/e6/e3/2590.PMC3861672.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/f0/d0/2602.PMC3861673.pdf
"After six months, it is available under a Creative Commons License (Attribution- NonCommercial 3.0 Unported), as desc ribed at http://creativecommons.org/ licenses/by-nc/3.0/.6These authors contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/f0/d0/2602.PMC3861673.pdf
8Corresponding author E-mail jerry.pelletier@mcgill.ca Article is online at http://www.genesde v.org/cgi/doi/10.1101/gad.227132.113.,Non-OADS,/arxiv_data1/oa_pdf/f0/d0/2602.PMC3861673.pdf
( B) Predicted secondary structure (http://rna.tbi.,Non-OADS,/arxiv_data1/oa_pdf/f0/d0/2602.PMC3861673.pdf
Materials and methods Vector design The wild-type Cas9 gene sequence from S. pyogenes was mam- malian codon-optimized using an online tool (http://www.encorbio.com/protocols/Codon.htm) and synthesized by GenScript intopUC57 (pUC57/Cas9) (Supplemental Fig.,OADS,/arxiv_data1/oa_pdf/f0/d0/2602.PMC3861673.pdf
Full-length Cas9 variants were transferred from pUC57 (NcoI [Klenow-repaired]–EcoRV fragment]) intoLeGo-iG (StuI–BsrGI [Klenow-repaired]) (http://www.lentigo-vectors.de/vectors.htm) to generate pLC (Fig.,OADS,/arxiv_data1/oa_pdf/f0/d0/2602.PMC3861673.pdf
Cell culture and lentiviral/retroviral infections All retroviral packaging was performed using ecotropic Phoenix cells according to established protocols (http://www.stanford.edu/group/nolan/retroviral_systems/retsys.html).,OADS,/arxiv_data1/oa_pdf/f0/d0/2602.PMC3861673.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/d0/26/srep03497.PMC3861796.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3497 | DOI: 10.1038/srep03497 6",Non-OADS,/arxiv_data1/oa_pdf/d0/26/srep03497.PMC3861796.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3412 | DOI: 10.1038/srep03412 7",Non-OADS,/arxiv_data1/oa_pdf/c5/9a/srep03412.PMC3861797.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3453 | DOI: 10.1038/srep03453 8",Non-OADS,/arxiv_data1/oa_pdf/a5/5a/srep03453.PMC3861798.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/81/58/srep03448.PMC3861799.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3448 | DOI: 10.1038/srep03448 7",Non-OADS,/arxiv_data1/oa_pdf/81/58/srep03448.PMC3861799.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/30/bb/srep03446.PMC3861800.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3446 | DOI: 10.1038/srep03446 4",Non-OADS,/arxiv_data1/oa_pdf/30/bb/srep03446.PMC3861800.pdf
Local realignment around indels and base quality score recalibration were performed using the Genome Analysis Tool Kit (GATK) software and duplicate reads removed using Picard (http://picard.sourceforge.net).,OADS,/arxiv_data1/oa_pdf/f8/46/srep03494.PMC3861801.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: G.M.,Non-OADS,/arxiv_data1/oa_pdf/f8/46/srep03494.PMC3861801.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3494 | DOI: 10.1038/srep03494 10",Non-OADS,/arxiv_data1/oa_pdf/f8/46/srep03494.PMC3861801.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/be/a8/srep03495.PMC3861802.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3495 | DOI: 10.1038/srep03495 6",Non-OADS,/arxiv_data1/oa_pdf/be/a8/srep03495.PMC3861802.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/f9/06/srep03492.PMC3861804.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3492 | DOI: 10.1038/srep03492 9",Non-OADS,/arxiv_data1/oa_pdf/f9/06/srep03492.PMC3861804.pdf
The paper is accessible at http://www.iccfd.org/iccfd7/ proceedings.html.,Non-OADS,/arxiv_data1/oa_pdf/cc/57/srep03455.PMC3861805.pdf
"The National Hurricane Center web site: http://www.nhc.noaa.gov, last accessed on the 5th of March 2013.",OADS,/arxiv_data1/oa_pdf/cc/57/srep03455.PMC3861805.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3455 | DOI: 10.1038/srep03455 7",Non-OADS,/arxiv_data1/oa_pdf/cc/57/srep03455.PMC3861805.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3493 | DOI: 10.1038/srep03493 8",Non-OADS,/arxiv_data1/oa_pdf/39/8b/srep03493.PMC3861846.pdf
Statistical Analysis   R (http://www.r-project.org/) was used for all statistical ana lyses.,OADS,/arxiv_data1/oa_pdf/2d/23/nne-0003-0113.PMC3861847.pdf
http://clinicaltrials.gov .,Non-OADS,/arxiv_data1/oa_pdf/dd/e5/cro-0006-0579.PMC3861854.pdf
http://clinicaltrials.gov .,Non-OADS,/arxiv_data1/oa_pdf/dd/e5/cro-0006-0579.PMC3861854.pdf
http://clinicaltrials.gov .,Non-OADS,/arxiv_data1/oa_pdf/dd/e5/cro-0006-0579.PMC3861854.pdf
http://clinicaltrials.gov .,Non-OADS,/arxiv_data1/oa_pdf/dd/e5/cro-0006-0579.PMC3861854.pdf
"This is an open access article, published  under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/2.5).",Non-OADS,/arxiv_data1/oa_pdf/1f/53/JVR-04-031.PMC3861878.pdf
[8] http://www.ncbi.nlm.nih.,Non-OADS,/arxiv_data1/oa_pdf/79/ac/CG-14-388.PMC3861890.pdf
"gov/mesh/68015415?ordinalpos=1&itool =EntrezSystem2.PEntrez.Mesh.Mesh_ResultsPanel.Mesh_RVDoc Sum (Accessed June 1, 2013)  [9] http://www.outcomes-umassmed.org/grace/ (Accessed June 1,  2013)  [10] Fox, K.A.",OADS,/arxiv_data1/oa_pdf/79/ac/CG-14-388.PMC3861890.pdf
The IMEx is an international collaboration between a group of major public interaction data providers who have agreed  to share literature-curation efforts and make a nonredundant  set of PPI available in a single search interface on a common website (http://www.imexconsortium.org/) [8].,OADS,/arxiv_data1/oa_pdf/05/d8/CG-14-397.PMC3861891.pdf
"The Most Popular Repository (Which Have More Than 1000 Citations According to Google Scolar at the Time of Writing  this Manuscript, May 2013) on the PPI, for Detailed Description About These Repository Refer to the Text  Acronym Organisms Number of  Interactions Curated to  IMEx/MIMIx  standards IMEx  Partner Accept  submis- sion in  PSI-MI  format Avail- ability PSIC- QUIC  service Last  Content  Update URL References  BioGrid   (IMEx partner) Model organisms  279409 IMEx Yes   (Observer)No Free to  aca- demic  users Yes 2013 http:// www.thebiogrid.org [30-32]  BIND/BOND  (IMEx partner) H. sapiens,  S.cerevisiae,  M. musculus,  H. pylori 198,905 No Yes   (Inactiv) Yes  (submis- sion by  email) Free to  all  users Yes 2004 http://download.baderlab.org/ BINDTranslation/ [21, 33-35]  DIP/ LiveDIP  (IMEx partner) Model organisms  73268 IMEx Yes  (Active) Yes  (submis- sion by  email) Free to  aca- demic  users Yes 2005 http://dip.doe-mbi.ucla.edu [36-40]  HPRD Human 30,047 No No Yes  (submis- sion by  email) Free to  aca- demic  users No 2009 http:// www.hprd.org [24-26, 41]  IntAct   (IMEx partner) Model organisms  290,891 IMEx/MIMIx Yes  (Active) Yes  (submis- sion by  web- based  tool) Free to  all  users Yes 2011 http:// www.ebi.ac.uk/intact/ [28, 29, 42, 43]   MINT   (IMEx partner) Model organisms  241458 IMEx Yes  (Active) Yes  (submis- sion by  email) Free to  all  users Yes 2011 http://mint.bio.uniroma2.it/mint [22, 23, 43, 44]     Table 2.",Non-OADS,/arxiv_data1/oa_pdf/05/d8/CG-14-397.PMC3861891.pdf
"The Popularity of Tools Range from One Star to Five Stars Based on the  Numbers of Corresponding Publications’ Citations (According to Google Scholar at the Time of Writing this Manuscript,  May 2013): One Star Means Less than 50 Citations; Two Stars Mean Between 50 and 100 Citations; Three Stars Mean Between 100 and 200 Citations; Four Stars Mean Between 200 and 500 Citations, and Four Stars Mean Greater Than 500 Citations  Acronym Description OS Availability Popularity Stand- alone/Web- based/Plug-in URL and References  APID ( Cancer  Research  Center ) (Agile Protein Interac- tion DataAnalyzer) it’s  an interactive web-tool  that allow exploration  and analysis of protein- protein interaction Lin/Mac/Win Free *** Web-based http://bioinfow.dep.usal.es/apid/index.htm  [147]  BiNoM It developed to facilitate  the manipulation of  biological networks  represented in standard  systems biology for- mats (SBML, SBGN,  BioPAX) and to carry  out studies on the net- work structure.",OADS,/arxiv_data1/oa_pdf/05/d8/CG-14-397.PMC3861891.pdf
"Lin/Mac/Win Free ** Cytoscape  plug-in https://binom.curie.fr/ [148]  BioLayout BioLayout is a tool for  visualization and clus- tering of biological  networks in both 3D  and 2D, it is compatible  with Cytoscape.",OADS,/arxiv_data1/oa_pdf/05/d8/CG-14-397.PMC3861891.pdf
Lin/Mac/Win Free * Stand-alone http://www.biola yout.org.,Non-OADS,/arxiv_data1/oa_pdf/05/d8/CG-14-397.PMC3861891.pdf
"Lin/Mac/Win Free * Cytoscape  plug-in http://www.pat hogenomics.ca/cerebral/  [151]  Cytoscape A powerful interactive  open source network  visualization tool Lin/Mac/Win Free ***** Stand-alone http://cytoscapeweb.cytoscape.org/ [144,  146]  InterProSurf  (University of  Texas Medical  Branch)  wWeb server for pre- dicting the functional  sites on a protein sur- face Lin/Mac/Win Free * Web-based http://curie.utmb.edu/prosurf.html [152]",OADS,/arxiv_data1/oa_pdf/05/d8/CG-14-397.PMC3861891.pdf
Acronym Description OS Availability Popularity Stand- alone/Web- based/Plug-in URL and References  InterViewer  (Inha Univer- sity) Produces a molecular  interaction network of  good qua lity wit hout  computing force be- tween every pair of  nodes Win Free * Stand-alone http://interviewer.inha.ac.kr/ [153]  iSPOT (Uni- versita di  Roma)  SPOT (Sequence Pre- diction Of Target) infer  the peptide binding  specificity of any mem- ber of a family of pro- tein binding domains.,OADS,/arxiv_data1/oa_pdf/05/d8/CG-14-397.PMC3861891.pdf
Lin/Mac/Win Free * Web-based http://cbm.bio.uniroma2.it/ispot/ [154]  MCODE It finds clusters (highly  interconnected regions)  in a network.,OADS,/arxiv_data1/oa_pdf/05/d8/CG-14-397.PMC3861891.pdf
It can also  be used to lay out any  graph that requires  stratification according  to some characteristic  and thus can be used by  researchers in a variety  of fields Lin/Mac/Win Free ***** Cytoscape  plug-in http://baderlab.org/Software/MCODE [155]  Medusa An powerful interactive  tool for visualization  and clustering analysis  of biological networks.,OADS,/arxiv_data1/oa_pdf/05/d8/CG-14-397.PMC3861891.pdf
Lin/Mac/Win Free ** Web-based http://pipe.scs.fsu.edu/meta-ppisp.html  [157]  NAViGaTOR  (University of  Toronto) Software package for  visualizing and analyz- ing protein-protein  interaction networks Lin/Mac/Win Free ** Stand-alone http://ophid.utoronto.ca/navigator/ [158]  NOXclass  (Max-Planck- Institut für  Informatik)  A classifier identifying  protein-protein interac- tion types implemented  using a SVM algorithm.,OADS,/arxiv_data1/oa_pdf/05/d8/CG-14-397.PMC3861891.pdf
"Lin/Mac/Win Free *** Web-based http://noxclass.bioinf.mpi-inf.mpg.de/ [159]  Osprey a A tool for visualiza- tion and manipulation  of complex interaction  networks Lin/Mac/Win Free (regis- teration is  needed) **** Stand-alone http://biodata.mshri.on.ca/osprey/servlet/Ind ex [160]  Pajek is a standalone applica- tion, iIt can use for  analyzing large net- works with up to mil- lion of nodes and verti- ces.",OADS,/arxiv_data1/oa_pdf/05/d8/CG-14-397.PMC3861891.pdf
"Win Free ***** Stand-alone http://vlado.fmf.uni- lj.si/pub/networks/pajek/ [161, 162]",Non-OADS,/arxiv_data1/oa_pdf/05/d8/CG-14-397.PMC3861891.pdf
"Lin/Mac/Win Free * Web-based http://www.scowlp.org/scowlp/ [164, 165]  UVCLUSTER Iterative cluster analysis  of protein interaction  data.",OADS,/arxiv_data1/oa_pdf/05/d8/CG-14-397.PMC3861891.pdf
Lin/Win Free for  academic  users (ful- fillment of  software  license  agreement  is needed) *** Stand-alone http://www.uv.es/genomica/UVCLUSTER/  [166]  VisANT It designed specifically  for the integrative vis- ual data-mining of  multi-scale Bio- Network/Pathways.,OADS,/arxiv_data1/oa_pdf/05/d8/CG-14-397.PMC3861891.pdf
"Lin/Mac/Win Free ** Cytoscape  plug-in http://visant.bu.edu/ [167]    interaction networks is one of the central problems of sys- tems biology, the results of such researches are crucial for a  better understanding of the evolution of living systems and could be used for protein interaction and function prediction.",OADS,/arxiv_data1/oa_pdf/05/d8/CG-14-397.PMC3861891.pdf
To viewplease visit the journal online(http://dx.doi.org/10.1136/ amiajnl-2013-001922).,OADS,/arxiv_data1/oa_pdf/78/1d/amiajnl-2013-001922.PMC3861922.pdf
"W e have made our code available via GitHub (github.org) and MATLAB Central (http://www.mathworks.com/matlabcentral), and veri ﬁcation via national efforts like the eMERGE network or OMOP would be bene ﬁcial.In summary, correlating EHR variables with healthcare process events produced sensible grouping of variables, butappeared to be highly sensitive to the manner in which the vari-ables were collected.",Non-OADS,/arxiv_data1/oa_pdf/78/1d/amiajnl-2013-001922.PMC3861922.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Blumenthal D, Tavenner M. The “meaningful use ”regulation for electronic health records.",Non-OADS,/arxiv_data1/oa_pdf/78/1d/amiajnl-2013-001922.PMC3861922.pdf
To viewplease visit the journal online (http://dx.doi.org/10.1136/ amiajnl-2013-001962).,OADS,/arxiv_data1/oa_pdf/07/aa/amiajnl-2013-001962.PMC3861926.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Bhuiya FA, Pitts SR, McCaig LF.",Non-OADS,/arxiv_data1/oa_pdf/07/aa/amiajnl-2013-001962.PMC3861926.pdf
"http://www.nlm.nih.gov/research/umls/knowledge_sources/metathesaurus/ index.html 27 Friedman C, Hripcsak G. Evaluating natural language processors in the clinical domain.",OADS,/arxiv_data1/oa_pdf/07/aa/amiajnl-2013-001962.PMC3861926.pdf
To view please visit the journal online (http://dx.doi.org/10.1136/amiajnl-2013-001999).,Non-OADS,/arxiv_data1/oa_pdf/53/a8/amiajnl-2013-001999.PMC3861927.pdf
These updated algorithms are publicly available on PheKB (http://www.phekb.org/phenotype/multiple-sclerosis-demonstration-project).,Non-OADS,/arxiv_data1/oa_pdf/53/a8/amiajnl-2013-001999.PMC3861927.pdf
"While many studies have identi ﬁed individuals serving as cases and controls for disease status from EMR, 11 12 72 8this is Table 1 Counts of individuals selected by case algorithms Algorithm No of samples PPV* (%) PPV †(%) Definitive type 1 3975 96 96 Definitive type 2 85 64 79Possible type 1 1315 16 64Possible type 2 414 72 86Total 5789 –– Algorithm details are available at http://www.phekb.org/phenotype/multiple-sclerosis-demon stration-project.",Non-OADS,/arxiv_data1/oa_pdf/53/a8/amiajnl-2013-001999.PMC3861927.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Ritchie MD, Denny JC, Crawford DC, et al.",Non-OADS,/arxiv_data1/oa_pdf/53/a8/amiajnl-2013-001999.PMC3861927.pdf
To view please visit the journal online (http://dx.doi.org/10.1136/amiajnl-2013-001827).,Non-OADS,/arxiv_data1/oa_pdf/ee/9e/amiajnl-2013-001827.PMC3861931.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Allison MA, Ho E, Denenberg JO, et al.",Non-OADS,/arxiv_data1/oa_pdf/ee/9e/amiajnl-2013-001827.PMC3861931.pdf
Available from UR L: http://www.scielo.br/aob.,Non-OADS,/arxiv_data1/oa_pdf/7e/81/aob-20-334.PMC3861950.pdf
Available from URL: http://www.scielo.br/aob.,Non-OADS,/arxiv_data1/oa_pdf/7a/87/aob-20-343.PMC3861951.pdf
Available from URL: http://www.scielo.br/aob.,Non-OADS,/arxiv_data1/oa_pdf/13/ae/aob-20-317.PMC3861952.pdf
Available from  URL: http://www.scielo.br/aob.,Non-OADS,/arxiv_data1/oa_pdf/e2/f1/aob-20-324.PMC3861953.pdf
Available from URL: http://www.scielo.br/aob.,Non-OADS,/arxiv_data1/oa_pdf/12/4f/aob-20-351.PMC3861954.pdf
Avai lable from  URL: http://www.scielo.br/aob.,Non-OADS,/arxiv_data1/oa_pdf/8e/09/aob-20-356.PMC3861955.pdf
Available from URL: http://www.scielo.br/aob.,Non-OADS,/arxiv_data1/oa_pdf/9a/f6/aob-20-329.PMC3861956.pdf
Available  from URL: http://www.scielo.br/aob.,Non-OADS,/arxiv_data1/oa_pdf/11/1b/aob-20-367.PMC3861957.pdf
Available from URL: http://www.scielo.br/aob.,Non-OADS,/arxiv_data1/oa_pdf/93/a3/aob-20-372.PMC3861958.pdf
Avail able from URL: http://www.scielo.br/aob.,Non-OADS,/arxiv_data1/oa_pdf/0a/87/aob-20-346.PMC3861960.pdf
Available from URL: http://www.scielo.br/aob.,Non-OADS,/arxiv_data1/oa_pdf/da/e9/aob-21-109.PMC3861961.pdf
Disponível em: URL: http://www.unicamp.br/unicamp/unicamp_hoje/jornalPDF/234pag04.pdf.,Non-OADS,/arxiv_data1/oa_pdf/da/e9/aob-21-109.PMC3861961.pdf
Available from URL: http://www.scielo.br/aob.,Non-OADS,/arxiv_data1/oa_pdf/18/2e/aob-21-080.PMC3861962.pdf
Available from URL: http://www.scielo.br/aob.ABSTRACT Objective: To investigate the influence of low intensity laser  irradiation on the regeneration of the fibular nerve of rats after  crush injury.,Non-OADS,/arxiv_data1/oa_pdf/b0/af/aob-21-092.PMC3861963.pdf
Available from URL: http://www.scielo.br/aob.ABSTRACT Objectives: To evaluate the effects of monosialoganglioside  (GM1) administered transdermally with laser in the recovery  of spinal cord injury in rats.,Non-OADS,/arxiv_data1/oa_pdf/be/73/aob-21-087.PMC3861964.pdf
Available from URL: http://www.scielo.br/aob.,Non-OADS,/arxiv_data1/oa_pdf/c6/37/aob-21-116.PMC3861965.pdf
Available from URL: http://www.scielo.br/aob.,Non-OADS,/arxiv_data1/oa_pdf/a1/fe/aob-21-076.PMC3861966.pdf
Available from URL: http://www.scielo.br/aob.,Non-OADS,/arxiv_data1/oa_pdf/7c/ae/aob-21-103.PMC3861967.pdf
"Available from URL: http://www.scielo.br/aob.ABSTRACT Osteoarthritis (OA), the most common form of joint disease,  affects mainly the hips, knees, hands and feet, leading to severe  disability and loss of quality of life, particularly in the elderly  population.",Non-OADS,/arxiv_data1/oa_pdf/a7/63/aob-21-120.PMC3861968.pdf
Disponível em: http://www.ibge.gov.br/home/ estatistica/populacao /projecao_da_populacao/2008/projecao.pdf .,Non-OADS,/arxiv_data1/oa_pdf/a7/63/aob-21-120.PMC3861968.pdf
Available from URL: http://www.scielo.br/aob.ABSTRACT Objectives: To evaluate the correlation between radiographic  parameters and functional assessments of patients with osteo - arthritis of the shoulder who underwent shoulder arthroplasty and to describe the functional outcomes of this procedure in our  institution.,Non-OADS,/arxiv_data1/oa_pdf/08/0f/aob-21-098.PMC3861969.pdf
Available from URL: http://www.scielo.br/aob.ABSTRACT Objective: To report the results of medium-term follow-up  after deploying Arthrosurface-HemiCap in patients with  diagnosis of Hállux Rigidus (HR) .,Non-OADS,/arxiv_data1/oa_pdf/89/fb/aob-21-071.PMC3861970.pdf
Available from URL: http://www.scielo.br/aob.,Non-OADS,/arxiv_data1/oa_pdf/0c/9f/aob-21-170.PMC3861992.pdf
Available from URL: http://www.scielo.br/aob.,Non-OADS,/arxiv_data1/oa_pdf/57/37/aob-21-159.PMC3861993.pdf
Available from URL: http://www.scielo.br/aob.,Non-OADS,/arxiv_data1/oa_pdf/2e/75/aob-21-167.PMC3861994.pdf
"Available from URL: http://www.scielo.br/aob.ABSTRACT Objective: Evaluate the probable relationship among plantar  arch, lumbar curvature, and low back pain.",Non-OADS,/arxiv_data1/oa_pdf/e6/69/aob-21-135.PMC3861995.pdf
Available from URL: http://www.scielo.br/aob.,Non-OADS,/arxiv_data1/oa_pdf/dc/d0/aob-21-144.PMC3861996.pdf
Available from  URL: http://www.scielo.br/aob.,Non-OADS,/arxiv_data1/oa_pdf/34/4c/aob-21-150.PMC3861997.pdf
"With consents from family members, allografts were origi - nally obtained from donation of deceased individuals who were tested for hepatitis B and syphilis and were processed  according to American Academy of Orthopedic Surgeons re - commendations ( http://www.aaos.org/news/aaosnow/may11/ research7.asp ).",Non-OADS,/arxiv_data1/oa_pdf/34/4c/aob-21-150.PMC3861997.pdf
Available from URL: http://www.scielo.br/aob.,Non-OADS,/arxiv_data1/oa_pdf/ea/2a/aob-21-163.PMC3861998.pdf
Available from URL: http://www.scielo.br/aob.,Non-OADS,/arxiv_data1/oa_pdf/14/9f/aob-21-175.PMC3861999.pdf
Available from URL: http://www.scielo.br/aob.,Non-OADS,/arxiv_data1/oa_pdf/ab/e4/aob-21-139.PMC3862000.pdf
Available from URL: http://www.scielo.br/aob.,Non-OADS,/arxiv_data1/oa_pdf/c4/92/aob-21-155.PMC3862001.pdf
Available from URL: http://www.scielo.br/aob.AbstrAct Objective: To present our experiences of treating talar malunions  and nonunions.,Non-OADS,/arxiv_data1/oa_pdf/c6/54/aob-21-226.PMC3862002.pdf
Available from URL: http://www.scielo.br/aob.,Non-OADS,/arxiv_data1/oa_pdf/57/46/aob-21-223.PMC3862003.pdf
2000;2(1).Disponivel em http://www.revistas.ufg.br/index.php/fen/article/ view/674/752.,Non-OADS,/arxiv_data1/oa_pdf/57/46/aob-21-223.PMC3862003.pdf
Disponível em http://www.censo2010.ibge.gov.br/resulta-dos.,Non-OADS,/arxiv_data1/oa_pdf/57/46/aob-21-223.PMC3862003.pdf
Available from URL:  http://www.scielo.br/aob.,Non-OADS,/arxiv_data1/oa_pdf/11/f3/aob-21-213.PMC3862004.pdf
Available from URL: http://www.scielo.br/aob.AbstrAct Objective: Evaluate the static positioning of the scapula on  the rib cage in healthy subjects by means of clinical and radiographic evaluation to assess inter-examiner reliability of clinical examination and verify the reliability of this evaluation  method compared to the radiographic examination.,Non-OADS,/arxiv_data1/oa_pdf/dc/9a/aob-21-208.PMC3862005.pdf
Available from URL: http://www.scielo.br/aob.,Non-OADS,/arxiv_data1/oa_pdf/cf/b8/aob-21-219.PMC3862006.pdf
Available from URL: http://www.scielo.br/aob.ABSTRACT Objective: T o use the tomographic analysis of C1 and C2  vertebrae to assess the possibility of using Magerl’s technique  in patients with rheumatoid arthritis.,Non-OADS,/arxiv_data1/oa_pdf/b7/05/aob-21-195.PMC3862007.pdf
Available from URL: http://www.scielo.br/aob.,Non-OADS,/arxiv_data1/oa_pdf/3e/1b/aob-21-233.PMC3862008.pdf
"Available from URL: http://www.scielo.br/aob.ABSTRACT Objective: As patellofemoral pain syndrome (PFPS) is a  common disorder characterized by multifactorial etiology  and whose the most prevalent symptom is a diffuse pain,  usually located on the retropatellar region, however, it also shows signs and symptoms that can be related as ex - cessive subtalar pronation, external tibial torsion, patellar displacement alterations, painful range of motion of the  knee, pain in the patellar borders, muscular tightness and  changes in quadriceps angle (Q Angle), the objective of this work was to determine the frequency of these signs  and symptoms associated to a previous knee pain ques - tionnaire.",Non-OADS,/arxiv_data1/oa_pdf/28/b0/aob-21-198.PMC3862009.pdf
Available from URL: http://www.scielo.br/aob.,Non-OADS,/arxiv_data1/oa_pdf/1b/cc/aob-21-202.PMC3862010.pdf
Available from URL: http://www.scielo.br/aob.ABSTRACT Objectives: To describe the profile of patients treated in the  trauma and orthopedics nursing of a trauma care referral public hospital of in the state of Bahia.,OADS,/arxiv_data1/oa_pdf/c8/e1/aob-21-191.PMC3862011.pdf
Disponível em:<http://www.datasus.gov.br>.,OADS,/arxiv_data1/oa_pdf/c8/e1/aob-21-191.PMC3862011.pdf
Available from URL: http://www.scielo.br/aob.ABSTRACT Objective: To carry out a biomechanical study among four tech - niques for fixation of four-part humeral head fractures.,Non-OADS,/arxiv_data1/oa_pdf/81/fe/aob-21-34.PMC3862012.pdf
Available from URL: http://www.scielo.br/aob.ABSTRACT  Objective: To analyze the possible effects of low-intensity  ultrasound on induced tibia fracture of rats in a dose commonly  used in physical therapy treatments.,Non-OADS,/arxiv_data1/oa_pdf/98/25/aob-21-18.PMC3862013.pdf
Available from URL: http://www.scielo.br/aob.ABSTRACT Objective: To evaluate the efficacy of a new method of pro - visional preoperative immobilization for patients with trans - trochanteric femoral fractures.,Non-OADS,/arxiv_data1/oa_pdf/22/04/aob-21-40.PMC3862016.pdf
"Available from URL: http://www.scielo.br/aob.ABSTRACT Objective: T o assess whether viscosupplementation with  hyaluronic acid in patients with severe hemophilic arthropathy  associated with triamcinolone after washing with saline improves  joint pain, stiffness, function and quality of life.",Non-OADS,/arxiv_data1/oa_pdf/9b/40/aob-21-12.PMC3862017.pdf
Available  from URL: http://www.scielo.br/aob.,Non-OADS,/arxiv_data1/oa_pdf/59/1f/aob-21-43.PMC3862018.pdf
Available from  URL: http://www.scielo.br/aob.ABSTRACT Objective: To determine intra and interobserver agreement of  the grading system for femoral cementation in hip arthroplasty proposed by Barrack.,Non-OADS,/arxiv_data1/oa_pdf/bf/43/aob-21-30.PMC3862019.pdf
"Available  from URL: http://www.scielo.br/aob.ABSTRACT Patellofemoral dysfunction is a fairly common deficiency  among young individuals that primarily affects females and  may be characterized by pain, swelling and retropatellar  crepitation.",Non-OADS,/arxiv_data1/oa_pdf/bd/d9/aob-21-52.PMC3862020.pdf
Available from URL: http://www.scielo.br/aob.,Non-OADS,/arxiv_data1/oa_pdf/af/6a/aob-21-46.PMC3862021.pdf
Available from URL: http://www.scielo.br/aob.ABSTRACT Objective: To show our experience with press-fit cementless  stem and metaphyseal fixation with cement in a selected series of patients who underwent revision total knee arthro - plasty.,Non-OADS,/arxiv_data1/oa_pdf/2b/98/aob-21-23.PMC3862022.pdf
"http://informahealthcare.com/jmf ISSN: 1476-7058 (print), 1476-4954 (electronic) J Matern Fetal Neonatal Med, 2014; 27(1): 7–13 !2014 Informa UK Ltd. DOI: 10.3109/14767058.2013.799650 ORIGINAL ARTICLE A randomized trial comparing perinatal outcomes using insulin detemir or neutral protamine Hagedorn in type 1 diabetes Moshe Hod1, Elisabeth R. Mathiesen2,3,4, Lois Jovanovic ˇ5, David R. McCance6, Marina Ivanisevic7, Santiago Dura ´n-Garcia8, Lise Brøndsted9, Avideh Nazeri9, and Peter Damm2,4,10 1Helen Schneider Women’s Hospital, Rabin Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel,2Center for Pregnant Women with Diabetes, Rigshospitalet,3Department of Endocrinology, and4Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark,5Sansum Diabetes Research Institute, Santa Barbara, CA, USA,6Metabolic Unit, Royal Victoria Hospital, Belfast, UK,7Department of Obstetrics and Gynecology, University Hospital of Zagreb, Zagreb, Croatia,8Catedra de Endocrinologia, Unidad de Diabetes y Embarazo, Hospital Universitario de Valme, Seville, Spain,9Novo Nordisk A/S, Søborg, Denmark, and10Department of Obstetrics, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark Abstract Objective : This randomized controlled trial aimed to compare the efficacy and safety of insulin detemir (IDet) with neutral protamine Hagedorn (NPH), both with insulin aspart, in pregnant women with type 1 diabetes.",Non-OADS,/arxiv_data1/oa_pdf/08/0c/JMF-27-7.PMC3862070.pdf
Available from: http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021536s037lbl.pdf [last accessed 1 Oct 2012].,Non-OADS,/arxiv_data1/oa_pdf/08/0c/JMF-27-7.PMC3862070.pdf
Available from: http://www.ema.europa.eu/docs/en_GB/ document_library/EPAR_-_Product_Information/human/000528/ WC500036662.pdf [last accessed 1 Oct 2012].DOI: 10.3109/14767058.2013.799650 IDet versus NPH in pregnancy 13,Non-OADS,/arxiv_data1/oa_pdf/08/0c/JMF-27-7.PMC3862070.pdf
"http://informahealthcare.com/dre ISSN 0963-8288 print/ISSN 1464-5165 online Disabil Rehabil, 2013; 35(26): 2221–2226 !2013 Informa UK Ltd. DOI: 10.3109/09638288.2013.774440 RESEARCH PAPER A comparison of two-coloured filter systems for treating visual reading difficulties Roger Hall1, Nicola Ray2, Priscilla Harries3, and John Stein2 1Mentoring Plus, Bath, Somerset, England, UK,2Department of Physiology, Anatomy & Genetics, Oxford University, Parks Road, Oxford, UK, and 3School of Health Sciences and Social Care, Brunel University, Uxbridge, Middlesex, UK Abstract Purpose : Visual disturbances that make it difficult to read text are often termed ‘‘visual stress’’.",Non-OADS,/arxiv_data1/oa_pdf/55/5d/DRE-35-2221.PMC3862071.pdf
Available from: http://www.bdadyslexia.org.uk/about-dyslexia/further-information/eyes-and-dyslexia.html [last accessed22 Feb 2012].,Non-OADS,/arxiv_data1/oa_pdf/55/5d/DRE-35-2221.PMC3862071.pdf
Available from: http://www.goodschoolsguide.co.uk/help-and-advice/special-needs-advice/types-of-sen/sensory-difficulties/201/visual-stress [lastaccessed 1 Dec 2012].,Non-OADS,/arxiv_data1/oa_pdf/55/5d/DRE-35-2221.PMC3862071.pdf
Available from: http://www.harrisdyslexia.com [last accessed 22 Feb 2012].,Non-OADS,/arxiv_data1/oa_pdf/55/5d/DRE-35-2221.PMC3862071.pdf
"http://dx.doi.org/10.1016/j.curtheres.2013.03.001☆This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which per- mits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.",OADS,/arxiv_data1/oa_pdf/1c/2a/main.PMC3862192.pdf
"http://dx.doi.org/10.1016/j.curtheres.2012.12.003$This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which permits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/78/90/main.PMC3862193.pdf
"http://dx.doi.org/10.1016/j.curtheres.2012.12.005$This is an open-access article distributed under the terms of the Creative Commons Attribution–NonCommercial–No Derivative Works License, which permits non–commercial use, distribution, and reproduction in any medium,provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/b7/28/main.PMC3862197.pdf
http://dx.doi.org/10.1016/j.gynor.2013.05.006,OADS,/arxiv_data1/oa_pdf/b4/ba/main.PMC3862214.pdf
http://dx.doi.org/10.1016/j.gynor.2013.09.002 Contents lists available at ScienceDirect Gynecologic Oncology Reports journal homepage: www.elsevier.com/locate/gynor,Non-OADS,/arxiv_data1/oa_pdf/d1/f6/main.PMC3862215.pdf
http://dx.doi.org/10.1097/PAT.0b013e32835f2264 (Apr).,Non-OADS,/arxiv_data1/oa_pdf/d1/f6/main.PMC3862215.pdf
http://dx.doi.org/10.1016/j.gynor.2013.06.001,OADS,/arxiv_data1/oa_pdf/6a/51/main.PMC3862220.pdf
http://dx.doi.org/10.1016/j.gynor.2013.03.001 Contents lists available at SciVerse ScienceDirect Gynecologic Oncology Reports journal homepage: www.elsevier.com/locate/gynor,Non-OADS,/arxiv_data1/oa_pdf/8e/d8/main.PMC3862222.pdf
http://dx.doi.org/10.1016/j.gynor.2013.07.008 Contents lists available at ScienceDirect Gynecologic Oncology Reports journal homepage: www.elsevier.com/locate/gynor,Non-OADS,/arxiv_data1/oa_pdf/78/a3/main.PMC3862223.pdf
http://dx.doi.org/10.1016/j.gynor.2013.02.003 Contents lists available at SciVerse ScienceDirect Gynecologic Oncology Reports journal homepage: www.elsevier.com/locate/gynor,Non-OADS,/arxiv_data1/oa_pdf/ad/44/main.PMC3862225.pdf
http://dx.doi.org/10.1016/j.gynor.2013.02.004 Contents lists available at SciVerse ScienceDirect Gynecologic Oncology Reports journal homepage: www.elsevier.com/locate/gynor,Non-OADS,/arxiv_data1/oa_pdf/ed/e1/main.PMC3862227.pdf
http://dx.doi.org/10.1016/j.gynor.2013.07.006 Contents lists available at ScienceDirect Gynecologic Oncology Reports journal homepage: www.elsevier.com/locate/gynor,Non-OADS,/arxiv_data1/oa_pdf/25/85/main.PMC3862229.pdf
http://dx.doi.org/10.1016/j.gynor.2013.05.005,OADS,/arxiv_data1/oa_pdf/67/e9/main.PMC3862230.pdf
http://dx.doi.org/10.1016/j.gynor.2013.07.005 Contents lists available at ScienceDirect Gynecologic Oncology Reports journal homepage: www.elsevier.com/locate/gynor,Non-OADS,/arxiv_data1/oa_pdf/23/2f/main.PMC3862231.pdf
http://dx.doi.org/10.1016/j.gynor.2013.05.003,OADS,/arxiv_data1/oa_pdf/b7/03/main.PMC3862232.pdf
http://dx.doi.org/10.1016/j.gynor.2013.05.004,OADS,/arxiv_data1/oa_pdf/cd/c6/main.PMC3862234.pdf
http://dx.doi.org/10.1016/j.gynor.2013.06.002,OADS,/arxiv_data1/oa_pdf/3f/8e/main.PMC3862235.pdf
http://dx.doi.org/10.1016/j.gynor.2013.01.006 Contents lists available at SciVerse ScienceDirect Gynecologic Oncology Reports journal homepage: www.elsevier.com/locate/gynor,Non-OADS,/arxiv_data1/oa_pdf/fd/35/main.PMC3862236.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Cerebral Cortex January 2014;24:1 –16 doi:10.1093/cercor/bhs208Advance Access publication September 25, 2012",Non-OADS,/arxiv_data1/oa_pdf/e2/18/bhs208.PMC3862261.pdf
ThisisanOpenAccessarticledistributedunderthetermsoftheCreativeCommonsAttributionNon-CommercialLicense(http://creativecommons.org/licenses/by-nc/.,Non-OADS,/arxiv_data1/oa_pdf/cc/d0/bhs270.PMC3862262.pdf
Surface-based atlas datasets are accessible athttp://sumsdb.wustl.edu/sums/ directory.do?id=8287442&dir_name= MARKOV_CC12 .,OADS,/arxiv_data1/oa_pdf/cc/d0/bhs270.PMC3862262.pdf
Supplementary Material Supplementary material can be found at: http://www.cercor.,Non-OADS,/arxiv_data1/oa_pdf/cc/d0/bhs270.PMC3862262.pdf
http://www.ncbi.nlm.nih.gov/pubmed/22366334 [Epub ahead of print].,Non-OADS,/arxiv_data1/oa_pdf/cc/d0/bhs270.PMC3862262.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Cerebral Cortex January 2014;24:81 –97 doi:10.1093/cercor/bhs287Advance Access publication October 4, 2012",Non-OADS,/arxiv_data1/oa_pdf/a0/70/bhs287.PMC3862266.pdf
"Power spectra of ECoGs were calculated with fre- quency resolutions of 0.25 and 2.0 Hz for SWA and cortical activation, respectively, using the MATLAB (MathWorks) toolbox Neurospec 2.0 (http://www.neurospec.org ).",OADS,/arxiv_data1/oa_pdf/a0/70/bhs287.PMC3862266.pdf
Supplementary Material Supplementary material can be found at: http://www.cercor.oxford- journals.org/ Funding This work was supported by the Medical Research Council UK (award U138197109) and Parkinson ’s UK (grant number G-0806).,Non-OADS,/arxiv_data1/oa_pdf/a0/70/bhs287.PMC3862266.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non- commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c8/c4/bhs293.PMC3862267.pdf
Supplementary Material Supplementary material can be found at: http://www.cercor.,Non-OADS,/arxiv_data1/oa_pdf/c8/c4/bhs293.PMC3862267.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non- commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/96/95/bhs296.PMC3862268.pdf
Supplementary Material Supplementary material can be found at: http://www.cercor.,Non-OADS,/arxiv_data1/oa_pdf/96/95/bhs296.PMC3862268.pdf
http://dx.doi.org/10.1016/j.gynor.2013.07.002,OADS,/arxiv_data1/oa_pdf/52/74/main.PMC3862295.pdf
http://dx.doi.org/10.1016/j.gynor.2013.06.004,OADS,/arxiv_data1/oa_pdf/48/9b/main.PMC3862301.pdf
http://dx.doi.org/10.1016/j.gynor.2013.02.007 Contents lists available at SciVerse ScienceDirect Gynecologic Oncology Reports journal homepage: www.elsevier.com/locate/gynor,Non-OADS,/arxiv_data1/oa_pdf/72/47/main.PMC3862303.pdf
http://dx.doi.org/10.1016/j.gynor.2013.07.001,OADS,/arxiv_data1/oa_pdf/98/42/main.PMC3862305.pdf
http://dx.doi.org/10.1016/j.gynor.2013.04.002 Contents lists available at SciVerse ScienceDirect Gynecologic Oncology Reports journal homepage: www.elsevier.com/locate/gynor,Non-OADS,/arxiv_data1/oa_pdf/e0/15/main.PMC3862306.pdf
http://dx.doi.org/10.1016/j.gynor.2013.07.007 Contents lists available at ScienceDirect Gynecologic Oncology Reports journal homepage: www.elsevier.com/locate/gynor,Non-OADS,/arxiv_data1/oa_pdf/1d/ae/main.PMC3862308.pdf
http://dx.doi.org/10.1016/j.gynor.2013.07.003 Contents lists available at ScienceDirect Gynecologic Oncology Reports journal homepage: www.elsevier.com/locate/gynor,Non-OADS,/arxiv_data1/oa_pdf/96/d8/main.PMC3862309.pdf
http://dx.doi.org/10.1016/j.gynor.2013.06.005,OADS,/arxiv_data1/oa_pdf/40/b2/main.PMC3862313.pdf
http://dx.doi.org/10.1016/j.gynor.2013.05.001 Contents lists available at ScienceDirect Gynecologic Oncology Reports journal homepage: www.elsevier.com/locate/gynor,Non-OADS,/arxiv_data1/oa_pdf/14/8a/main.PMC3862319.pdf
http://dx.doi.org/10.1016/j.gynor.2013.02.001 Contents lists available at SciVerse ScienceDirect Gynecologic Oncology Reports journal homepage: www.elsevier.com/locate/gynor,Non-OADS,/arxiv_data1/oa_pdf/79/95/main.PMC3862320.pdf
http://dx.doi.org/10.1016/j.gynor.2013.01.005 Contents lists available at SciVerse ScienceDirect Gynecologic Oncology Reports journal homepage: www.elsevier.com/locate/gynor,Non-OADS,/arxiv_data1/oa_pdf/5a/84/main.PMC3862321.pdf
http://dx.doi.org/10.1016/j.gynor.2013.02.005 Contents lists available at SciVerse ScienceDirect Gynecologic Oncology Reports journal homepage: www.elsevier.com/locate/gynor,Non-OADS,/arxiv_data1/oa_pdf/29/20/main.PMC3862322.pdf
http://dx.doi.org/10.1016/j.gynor.2013.02.002 Contents lists available at SciVerse ScienceDirect Gynecologic Oncology Reports journal homepage: www.elsevier.com/locate/gynor,Non-OADS,/arxiv_data1/oa_pdf/63/7a/main.PMC3862329.pdf
http://dx.doi.org/10.1016/j.gynor.2013.04.004 Contents lists available at SciVerse ScienceDirect Gynecologic Oncology Reports journal homepage: www.elsevier.com/locate/gynor,Non-OADS,/arxiv_data1/oa_pdf/d5/44/main.PMC3862332.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/08/50/ijn-8-4705.PMC3862391.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/08/50/ijn-8-4705.PMC3862391.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/08/50/ijn-8-4705.PMC3862391.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/1f/65/ijn-8-4703.PMC3862392.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/1f/65/ijn-8-4703.PMC3862392.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/1f/65/ijn-8-4703.PMC3862392.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ae/13/ijn-8-4673.PMC3862393.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2013:8 4673–4676International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  4673Letteropen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/IJN.S5371 2Are calcifying microvesicles another analogous  substructure of calcifying nanoparticles?,Non-OADS,/arxiv_data1/oa_pdf/ae/13/ijn-8-4673.PMC3862393.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/ae/13/ijn-8-4673.PMC3862393.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ae/13/ijn-8-4673.PMC3862393.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/91/f1/ndt-9-1899.PMC3862394.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2013:9 1899–1905Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1899OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S4872 2salivary alpha-amylase and cortisol responsiveness  following electrically stimulated physical stress   in bipolar disorder patients Y oshihiro Tanaka Y oshihiro Maruyama Y oshinobu ishitobi aimi Kawano T omoko ando rie ikeda ayako inoue Junko imanaga shizuko Okamoto Masayuki Kanehisa Taiga Ninomiya Jusen Tsuru Jotaro akiyoshi Department of Neuropsychiatry,   Faculty of Medicine, Oita University,   hasama-Machi, Oita, Japan correspondence: Jotaro akiyoshi   Department of Neuropsychiatry, Faculty  of Medicine, Oita University, hasama- Machi, Oita 879-5593, Japan   Tel +81 97 586 5823   Fax +81 97 549 3583   email akiyoshi@oita-u.ac.j pBackground:  Bipolar disorder (BP) is often associated with a change in hypothalamus– pituitary–adrenal axis function change due to chronic stress.",Non-OADS,/arxiv_data1/oa_pdf/91/f1/ndt-9-1899.PMC3862394.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing  on concise rapid reporting of clinical or pre-clinical studies on a  range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/91/f1/ndt-9-1899.PMC3862394.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/91/f1/ndt-9-1899.PMC3862394.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/da/7f/clep-5-475.PMC3862395.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Epidemiology 2013:5 475–481Clinical Epidemiology Dove press submit your manuscript | www.dovepress.co m Dove press  475Original rEsEarChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CLEP .S5342 0Estimating the prevalence of atrial fibrillation   in a general population using validated   electronic health data Johannes Norberg svante Bäckström Jan-håkan Jansson lars Johansson Department of Public Health   and Clinical Medicine, Umeå   University, Umeå, sweden Correspondence: lars Johansson   Department of Medicine,   skellefteå County hospital,   93186 skellefteå, sweden   T el +46 91 077 1493   Email lars.johansson@vll.s eBackground:  The purpose of this study was to determine the prevalence of atrial fibrillation  (AF) in the general population and to validate an administrative diagnosis register, ie, the  National Patient Register (NPR), and an electrocardiography (ECG) database in estimating  disease prevalence.",Non-OADS,/arxiv_data1/oa_pdf/da/7f/clep-5-475.PMC3862395.pdf
Available from:  http://www.scb.se/Pages/SSD/SSD_TreeView.aspx?id=34047 8.,OADS,/arxiv_data1/oa_pdf/da/7f/clep-5-475.PMC3862395.pdf
"Clinical Epidemiology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-epidemiology-journa lClinical Epidemiology is an international, peer-reviewed, open access  journal focusing on disease and drug epidemiology, identification of  risk factors and screening procedures to develop optimal preventative  initiatives and programs.",Non-OADS,/arxiv_data1/oa_pdf/da/7f/clep-5-475.PMC3862395.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d7/40/imcrj-6-099.PMC3862396.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Medical Case Reports Journal 2013:6 99–105International Medical Case Reports Journal Dove press submit your manuscript | www.dovepress.co m Dove press  99Case Repo Rtopen access to scientific and medical research open access Full text article http: //dx.doi.org/10.2147/IMCRJ.S5124 0Lyme disease: case report of persistent Lyme  disease from pulaski County, Virginia James R palmieri1 scott King1 Matthew Case1 arben santo2 1Department of Microbiology,   Infectious and emerging Diseases,   2Department of pathology, edward  Via College of osteopathic Medicine,   Blacksburg, V a, Usa Correspondence: James R palmieri   Department of Microbiology, Infectious  and emerging Diseases, edward Via  College of osteopathic Medicine –  Virginia Campus, 2265 Kraft Drive,  Blacksburg, Va 24060, Usa   email jpalmieri@vcom.vt.ed uAbstract:  A 50-year-old woman from Pulaski, Virginia, presented to a local clinic with  headaches, fever, generalized joint pain, excessive thirst and fluid intake, and a progressing  rash on her back.",Non-OADS,/arxiv_data1/oa_pdf/d7/40/imcrj-6-099.PMC3862396.pdf
"Available from:  http://www.cdc.gov/lyme/stats/charts table s/casesbyyear.htm l. Accessed  November 5, 2013.",OADS,/arxiv_data1/oa_pdf/d7/40/imcrj-6-099.PMC3862396.pdf
"Available from: http://www.cdc.gov/lyme/stats/index.htm l. Accessed  November 5, 2013.",OADS,/arxiv_data1/oa_pdf/d7/40/imcrj-6-099.PMC3862396.pdf
"International Medical Case Reports Journal Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-medical-case-reports-journal-journa lThe International Medical Case Reports Journal is an international,  peer-reviewed open-access journal publishing original case reports  from all medical specialties.",Non-OADS,/arxiv_data1/oa_pdf/d7/40/imcrj-6-099.PMC3862396.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/d7/40/imcrj-6-099.PMC3862396.pdf
Available from: http://www.piercenet.com/files/TR0065-ELISA-guide.,Non-OADS,/arxiv_data1/oa_pdf/d7/40/imcrj-6-099.PMC3862396.pdf
Available from: http://www.rapidtest.com/index.php?i =Lyme-Disease- ELISA-kit&id=137&cat=1 6.,Non-OADS,/arxiv_data1/oa_pdf/d7/40/imcrj-6-099.PMC3862396.pdf
Available from: http://www.piercenet.com/ Objects/View.cfm?Type=Page&ID=03971E57-D4D0-4B97-971C- 0632E822453 5.,Non-OADS,/arxiv_data1/oa_pdf/d7/40/imcrj-6-099.PMC3862396.pdf
"Available from: http://mcdonald.ucdavis.edu/uploads/1/8/5/3/1853874/ promega_ecl_substrate.pd f. Accessed November 5, 2013.",Non-OADS,/arxiv_data1/oa_pdf/d7/40/imcrj-6-099.PMC3862396.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/71/09/copd-8-613.PMC3862397.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2013:8 613–619International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  613OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S5370 7Indacaterol therapy in moderate-to-severe  chronic obstructive pulmonary disease: findings   from a single-center primary care cohort Mukesh P Singh horsefair Practice group, sandy   Lane Health Centre, Rugeley, UK Correspondence: Mukesh P Singh   horsefair Practice group,   Keele University Medical School   Teaching Practice, Sandy Lane   health Centre, sandy lane,   Rugeley, Staffordshire WS15 2LB, UK   Tel +44 1889 582 244   email mps_67@yahoo.co mBackground:  Once-daily long-acting β2-agonists (LABAs) are an important treatment option,  either alone or in combination with other inhaled long-acting bronchodilators in the management  of chronic obstructive pulmonary disease (COPD).",Non-OADS,/arxiv_data1/oa_pdf/71/09/copd-8-613.PMC3862397.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-copd-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/71/09/copd-8-613.PMC3862397.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/71/09/copd-8-613.PMC3862397.pdf
Available  from: http://www.nice.org.uk/nicemedia/live/13029/49425/49425.pdf .,Non-OADS,/arxiv_data1/oa_pdf/71/09/copd-8-613.PMC3862397.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b1/d1/jaa-6-127.PMC3862399.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpJournal of Asthma and Allergy 2013:6 127–133Journal of Asthma and Allergy Dove press submit your manuscript | www.dovepress.co m Dove press  127OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JAA.S5380 15-grass pollen tablets achieve disease control  in patients with seasonal allergic rhinitis  unresponsive to drugs: a real-life study elide Anna Pastorello1 laura losappio1 stefania Milani2 giuseppina Manzotti3 Valentina Fanelli4 Valerio Pravettoni5 Fabio Agostinis6 Alberto Flores D’Arcais7 ilaria Dell’Albani8 Paola Puccinelli9 cristoforo incorvaia10 Franco Frati8 1Allergy and immunology Department,   niguarda hospital, Milan, 2Allergy  Department, san Marco general  hospital, Bergamo, 3Allergy  Department, Treviglio hospital,   Bergamo, 4Allergy Department,   italian institute for Auxology, Milan,   5clinical Allergy and immunology  Unit, Foundation irccs ca’ granda  Ospedale Maggiore Policlinico, Milan,   6Department of Pediatrics, riuniti  hospital, Bergamo, 7Department of  Pediatrics, legnano hospital, Milan,   8Medical and scientific Department,   stallergenes italy, Milan, 9regulatory  Department, stallergenes italy, Milan,   10Allergy/Pulmonary rehabilitation,   icP hospital, Milan, italy correspondence: Franco Frati   Medical and Scientific Department,  stallergenes italy, Viale certosa 2,   Milan 20155, italy   Tel +39 0233 4541   Fax +39 02 7005 8778   email ffrati@stallergenes.i tBackground:  An important subpopulation in allergic rhinitis is represented by patients with  severe form of disease that is not responsive to drug treatment.",Non-OADS,/arxiv_data1/oa_pdf/b1/d1/jaa-6-127.PMC3862399.pdf
"Journal of Asthma and Allergy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-asthma-and-allergy-journa lThe Journal of Asthma and Allergy is an international, peer-reviewed  open-access journal publishing original research, reports, editorials  and commentaries on the following topics: Asthma; Pulmonary physi - ology; Asthma related clinical health; Clinical immunology and the  immunological basis of disease; Pharmacological interventions and new therapies.",Non-OADS,/arxiv_data1/oa_pdf/b1/d1/jaa-6-127.PMC3862399.pdf
Visit http://www.dovepress.com/testimonials.ph p to read  real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b1/d1/jaa-6-127.PMC3862399.pdf
"http://dx.doi.org/10.1016/j.ijpddr.2013.05.001qThis is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike License, which permits non- commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.",OADS,/arxiv_data1/oa_pdf/6b/bd/main.PMC3862408.pdf
"Supplementary data Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.ijpddr.2013.05.",OADS,/arxiv_data1/oa_pdf/6b/bd/main.PMC3862408.pdf
"http://dx.doi.org/10.1016/j.ijpddr.2013.08.002Abbreviations: BSF, bloodstream form; EbS, 2-pheny l-12-benzisothiazol-3(2H)-one; EbSe, ebselen (2-phenyl-12-benzisoselenazol-3(2H)-one); G6-P, glucose-6-phosphate; G6PDH, glucose-6-phosphate d ehydrogenase; Gly3P, glycerol-3-phosphate; GK, glycerol kinase; HK, hexokinase; PF, procyclic form; rTbHK1, recombinant Trypanosoma brucei hexokinase 1; TbHK, T. brucei hexokinase.",OADS,/arxiv_data1/oa_pdf/b7/96/main.PMC3862409.pdf
"Supplementary data Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.ijpddr.2013.08.",OADS,/arxiv_data1/oa_pdf/b7/96/main.PMC3862409.pdf
"http://dx.doi.org/ jbc.M113.495101 Misset, O., Opperdoes, F.R., 1984.",Non-OADS,/arxiv_data1/oa_pdf/b7/96/main.PMC3862409.pdf
"The World Health Organization recently estimated that malaria causes about 240 million bouts of illness and around 0.86 million deaths annually ( http://www.who.int/ mediacentre/factsheets/fs094/en/print.html , world health organization malaria fact sheet No.",Non-OADS,/arxiv_data1/oa_pdf/2f/46/main.PMC3862410.pdf
"http://dx.doi.org/10.1016/j.ijpddr.2013.06.001Abbreviations: SL, synthetic lethal; P.,Plasmodium ; ADR, antimalarial drug resistance; SW, Smith–Waterman; GO, gene ontology; GOA, gene ontologyannotation; PDB, Protein Data Bank.",OADS,/arxiv_data1/oa_pdf/2f/46/main.PMC3862410.pdf
"The databases used include BioGRID (Biological General Repository for Interaction Datasets) (http://thebiogrid.org ) for yeast SL genes, KEGG SSDB (Kyoto Ency- clopedia of Genes and Genomes Sequence Similarity DataBase) (http://www.genome.jp/kegg ), KEGG OC (Ortholog Cluster) (http://www.genome.jp/tools/oc )(Nakaya et al., 2013 ), PlasmoDB Version 9.1 ( http://plasmodb.org ), and Gene DB ( http://www.ge- nedb.org ) for Plasmodium genes.",OADS,/arxiv_data1/oa_pdf/2f/46/main.PMC3862410.pdf
"A total of 4284 yeast SL genes were obtained from the BioGRID database (version 3.1.72, http://thebiogrid.org ).",OADS,/arxiv_data1/oa_pdf/2f/46/main.PMC3862410.pdf
"Supplementary data Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.ijpddr.2013.06.",OADS,/arxiv_data1/oa_pdf/2f/46/main.PMC3862410.pdf
"http://dx.doi.org/10.1016/j.ijpddr.2012.11.001qThis is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike License, which permits non-commercial use, distribution, and reproduction in any medium, provided theoriginal author and source are credited.",OADS,/arxiv_data1/oa_pdf/f6/d1/main.PMC3862411.pdf
"Animal procedures and management protocols were approved by the Ethics Commit- tee according to the Animal Welfare Policy (act 087/02) of the Faculty of Veterinary Medicine, Universidad Nacional del Centro de la Provincia de Buenos Aires (UNCPBA), Tandil, Argentina (http://www.vet.unicen.edu.ar ).",Non-OADS,/arxiv_data1/oa_pdf/f6/d1/main.PMC3862411.pdf
Real-time quantitative PCR H. contortus mRNA sequences of target and reference genes were obtained from the GenBank web site ( http://www.ncbi.nlm.,OADS,/arxiv_data1/oa_pdf/f6/d1/main.PMC3862411.pdf
http://dx.doi.org/10.1016/ j.vetpar.2012.09.021 .,OADS,/arxiv_data1/oa_pdf/f6/d1/main.PMC3862411.pdf
"http://dx.doi.org/10.1016/j.ijpddr.2013.04.002qThis is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike License, which permits non- commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.",OADS,/arxiv_data1/oa_pdf/5d/2b/main.PMC3862413.pdf
"http://dx.doi.org/10.1016/j.ijpddr.2013.06.002qThis is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which per- mits non-commercial use, distribution, and reproduction in any medium, providedthe original author and source are credited.",OADS,/arxiv_data1/oa_pdf/be/10/main.PMC3862419.pdf
http://dx.doi.org/10.1016/ j.vetpar.2010.03.006 .,OADS,/arxiv_data1/oa_pdf/be/10/main.PMC3862419.pdf
http://dx.doi.org/10.1016/j.vetpar.,OADS,/arxiv_data1/oa_pdf/be/10/main.PMC3862419.pdf
http://dx.doi.org/ 10.1136/vr.101077 .,Non-OADS,/arxiv_data1/oa_pdf/be/10/main.PMC3862419.pdf
"Techiongroup, 2013. http://www.techiongroup.co.nz/researchprojects_pages/ research.aspx .",Non-OADS,/arxiv_data1/oa_pdf/be/10/main.PMC3862419.pdf
"http://dx.doi.org/10.1016/j.ijpddr.2013.01.004qThis is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike License, which permits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.",OADS,/arxiv_data1/oa_pdf/bf/78/main.PMC3862423.pdf
"Supplementary data Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.ijpddr.2013.01.",OADS,/arxiv_data1/oa_pdf/bf/78/main.PMC3862423.pdf
"http://dx.doi.org/10.1016/j.ijpddr.2012.12.002Abbreviations: EF1-a, elongation factor 1 alpha; eIF-5A, translation initiation factor 5A; ENO2, enolase 2; GRA2, dense granule protein 2; GRA7, dense granuleprotein 7; G3PDH, glyceraldehyde-3-phosphate dehydrogenase; Hsp70, heat shockprotein 70; Hsp90, heat shock protein 90; MIC1, microneme protein 1; MIC2,microneme protein 2; PP2C, protein phosphatase 2C; ROP2, rhoptry protein 2; ROP9, rhoptry protein 9; small Hsp20, small heat shock protein 20; TgCDPK1, Toxoplasma gondii calcium-dependent protein kinase 1. qThis is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike License, which permits non- commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.",OADS,/arxiv_data1/oa_pdf/b2/ad/main.PMC3862439.pdf
Mascot searching was carried out on a local Mascot server against gene annotations from ToxoDB version 7.2 (http://toxodb.org/toxo/ ).,OADS,/arxiv_data1/oa_pdf/b2/ad/main.PMC3862439.pdf
"Supplementary data Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.ijpddr.2012.",OADS,/arxiv_data1/oa_pdf/b2/ad/main.PMC3862439.pdf
"http://dx.doi.org/10.1016/j.ijpddr.2013.08.001Abbreviations: SbIII, potassium antimonyl tartrate; WTS, Wild-type susceptible; SbR, SbIII-resistant; Lg, L.(V.)guyanensis ; Lb, L.(V.)braziliensis ; La, L.(L.) amazonensis ; Li, L.(L.)infantum ; MRPA, multidrug-resistance protein A; Pgp, phosphoglycoprotein; AQP1, aquaglyceroporin-1.",Non-OADS,/arxiv_data1/oa_pdf/cd/89/main.PMC3862441.pdf
The band intensities were analyzed using the software CP ATLAS 2.0 ( http://lazarsoftware.com/download.html ).,OADS,/arxiv_data1/oa_pdf/cd/89/main.PMC3862441.pdf
The intensity of bands was quantiﬁed using ImageJ ( http://rsbweb.nih.gov/ij/ ).,OADS,/arxiv_data1/oa_pdf/cd/89/main.PMC3862441.pdf
http://dx.doi.org/10.1371/ journal.pone.0035671 .,Non-OADS,/arxiv_data1/oa_pdf/cd/89/main.PMC3862441.pdf
"Med., 695382. http://dx.doi.org/10.1155/ 2011/695382 .",Non-OADS,/arxiv_data1/oa_pdf/cd/89/main.PMC3862441.pdf
http://dx.doi.org/10.1371/journal.pntd.,Non-OADS,/arxiv_data1/oa_pdf/cd/89/main.PMC3862441.pdf
Available at: < http://www.who.int/tdr/ diseases/leish/direction/en/ > (Last access 30.06.12).,Non-OADS,/arxiv_data1/oa_pdf/cd/89/main.PMC3862441.pdf
"The genomes of Toxoplasma ,Neospora , and Cryptosporidium en- code for calmodulin-domain protein kinase 1 (CDPK1) homologs (TGME49_101440, NCLIV_011980, and cgd3_920 in the EuPathDB http://eupathdb.org/eupathdb/ ) containing a glycine at the gate- keeper amino acid position.",Non-OADS,/arxiv_data1/oa_pdf/ca/5a/main.PMC3862444.pdf
"http://dx.doi.org/10.1016/j.ijpddr.2013.04.001qThis is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike License, which permits non- commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.",OADS,/arxiv_data1/oa_pdf/ca/5a/main.PMC3862444.pdf
"Reads were mapped to the T. gondii ME49 genome (ToxoDB http://toxodb.org/version 2008_07_23) using alignment software BWA ( Li et al., 2009 ).",OADS,/arxiv_data1/oa_pdf/ca/5a/main.PMC3862444.pdf
"Supplementary data Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.ijpddr.2013.",OADS,/arxiv_data1/oa_pdf/ca/5a/main.PMC3862444.pdf
http://dx.doi.org/10.1016/j.ijppaw.2012.11.003⇑Corresponding author.,OADS,/arxiv_data1/oa_pdf/39/92/main.PMC3862492.pdf
J. Parasitol.. http://dx.doi.org/10.1645/GE-3083.1.,Non-OADS,/arxiv_data1/oa_pdf/39/92/main.PMC3862492.pdf
"http://dx.doi.org/10.1016/j.ijppaw.2013.02.003⇑Corresponding author at: 180 E. Green St., Warnell School of Forestry and Natural Resources, University of Georgia, Athens, GA 30602, United States.",Non-OADS,/arxiv_data1/oa_pdf/dc/d3/main.PMC3862495.pdf
< http://www.iucnredlist.org > (Downloaded on 05 December 2012).,Non-OADS,/arxiv_data1/oa_pdf/dc/d3/main.PMC3862495.pdf
"http://dx.doi.org/10.1016/j.ijppaw.2013.05.003qThis is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike License, which permits n on-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.",OADS,/arxiv_data1/oa_pdf/9d/76/main.PMC3862498.pdf
< http://pediatrics.aappublications.org/ content/108/5/e93.full.html > (accessed 16.04.2013).,Non-OADS,/arxiv_data1/oa_pdf/9d/76/main.PMC3862498.pdf
http://dx.doi.org/10.1016/j.ijppaw.2013.02.005⇑Corresponding Author.,OADS,/arxiv_data1/oa_pdf/60/91/main.PMC3862500.pdf
"During this period, temperatures were 2.3 /C176C (2012) and 2.1 /C176C above average (Ranked summer regional temperatures table, http://www.ec.gc.ca/adsc- cmda/default.asp?lang=En&n=30EDCA67-1 , accessed 14.12.12).",OADS,/arxiv_data1/oa_pdf/60/91/main.PMC3862500.pdf
"http://dx.doi.org/10.1016/j.ijppaw.2012.11.002qThis is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike License, which permits non-commercial use, distribution, and reproduction in any medium, provided theoriginal author and source are credited.",OADS,/arxiv_data1/oa_pdf/c8/91/main.PMC3862501.pdf
"http://dx.doi.org/10.1016/j.ijppaw.2013.05.002qThis is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike License, which permits non-commercial use, distribution, and reproduction in any medium, provided theoriginal author and source are credited.",OADS,/arxiv_data1/oa_pdf/77/5a/main.PMC3862502.pdf
"For now, read the introduction of the ICZN and be familiar with the glossary ( http://iczn.org/ ).",Non-OADS,/arxiv_data1/oa_pdf/b9/2c/main.PMC3862503.pdf
"http://dx.doi.org/10.1016/j.ijppaw.2013.03.005⇑Address: McMaster Building B14, Faculty of Veterinary Science, University of Sydney, New South Wales 2006, Australia.",Non-OADS,/arxiv_data1/oa_pdf/b9/2c/main.PMC3862503.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/31/5d/ndt-9-1867.PMC3862505.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2013:9 1867–1872Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1867OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S5338 6sigma-1 receptor concentration in plasma   of patients with late-life depression:   a preliminary study hideyuki shimizu1 Minoru Takebayashi2 Masayuki Tani1 hiroaki Tanaka1 Bun Yamagata1 Kenzo Kurosawa1 hiroki Yamada1 Mitsugu hachisu3 Kazue hisaoka-Nakashima2 Mami Okada-Tsuchioka2 Masaru Mimura4 akira iwanami1 1Department of Neuropsychiatry,   showa University school of  Medicine, T okyo, Japan; 2Department  of Psychiatry and institute for  clinical research, National hospital  Organization Kure Medical center,   Kure, Japan; 3Department of clinical  Psychopharmacy, Pharmacy school,   showa University, T okyo, Japan;   4Department of Neuropsychiatry,   Keio University school of Medicine,   T okyo, Japan correspondence: Masayuki Tani   showa University school of Medicine,   6-11-11 Kita-Karasuyama,   setagaya-ku, T okyo, Japan 157-0061   T el +81 333 005 231   Fax +81 333 089 710   email tanimambo@hotmail.co.j pBackground:  Recently, the sigma-1 receptor has been shown to play a significant role in the  neural transmission of mood by regulating N-methyl-D-aspartate receptors.",Non-OADS,/arxiv_data1/oa_pdf/31/5d/ndt-9-1867.PMC3862505.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing  on concise rapid reporting of clinical or pre-clinical studies on a  range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/31/5d/ndt-9-1867.PMC3862505.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/31/5d/ndt-9-1867.PMC3862505.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/36/2c/dddt-7-1471.PMC3862506.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2013:7 1471–1479Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1471Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S4143 1Disease-modifying drugs in Alzheimer’s disease Laura Ghezzi elio Scarpini Daniela Galimberti Neurology Unit, Department of  Pathophysiology and Transplantation,   University of Milan, Fondazione Cà  Granda, iRCCS Ospedale Maggiore  Policlinico, Milan, italy Correspondence: Laura Ghezzi   Neurology Unit, Department of   Pathophysiology and Transplantation,   University of Milan, Fondazione Cà   Granda, iRCCS Ospedale Maggiore   Policlinico, via F Sforza 35,   Milan 20122, italy   Tel +39 2 5503 3847   Fax +39 2 5503 6580   email lauraghezzi@me.co mAbstract:  Alzheimer’ s disease (AD) is an age-dependent neurodegenerative disorder and  the most common cause of dementia.",Non-OADS,/arxiv_data1/oa_pdf/36/2c/dddt-7-1471.PMC3862506.pdf
Available from: http://www.clinicaltrials.,Non-OADS,/arxiv_data1/oa_pdf/36/2c/dddt-7-1471.PMC3862506.pdf
Available from:  http://www.clinicaltrials.gov/ct2/show/NCT01953601?term=MK- 8931&rank=3.,Non-OADS,/arxiv_data1/oa_pdf/36/2c/dddt-7-1471.PMC3862506.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/36/2c/dddt-7-1471.PMC3862506.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/36/2c/dddt-7-1471.PMC3862506.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ea/c7/jpr-6-791.PMC3862507.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpJournal of Pain Research 2013:6 791–801Journal of Pain Research Dove press submit your manuscript | www.dovepress.co m Dove press  791Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S4719 2Mitigating the risk of opioid abuse through a  balanced undergraduate pain medicine curriculum Patricia K Morley-Forster1,2  Joseph v Pergolizzi3–5 Robert Taylor Jr5  Robert A Axford-Gatley6  edward M Sellers7  1Department of Anesthesia and  Perioperative Medicine, University  of western Ontario, London, ON,   Canada; 2Outpatient Pain Clinic,   St Joseph’s Hospital, London, ON,   Canada; 3Department of Medicine,   Johns Hopkins University School  of Medicine, Baltimore, MD, USA;   4Department of Pharmacology,   Temple University School of  Medicine, Philadelphia, PA, USA;   5NeMA Research inc, Naples, FL,   USA; 6Clinical Content and editorial  Services, Complete Healthcare  Communications, inc, Chadds Ford,   PA, USA; 7DL Global Partners inc,   T oronto, ON, Canada Correspondence: Patricia K Morley- Forster   Medical Director, Outpatient Pain Clinic,  St Joseph’s Hospital, Room B3-628,   268 Grosvenor Street, London,   Ontario N6A 4v2, Canada   Tel +1 519 646 6000 (ext 65065)   email p at.morley-forster@sjhc.london.",Non-OADS,/arxiv_data1/oa_pdf/ea/c7/jpr-6-791.PMC3862507.pdf
"Available from: http://www.acgme.org/acgmeweb/Portals/0/PFAssets/ ProgramRequirements/sh_multiPainPR707.pd f. Accessed October 1,  2013.",OADS,/arxiv_data1/oa_pdf/ea/c7/jpr-6-791.PMC3862507.pdf
Available from: http://nationalpaincentre.mcmaster.ca/opioid /.,Non-OADS,/arxiv_data1/oa_pdf/ea/c7/jpr-6-791.PMC3862507.pdf
Available from: http://www.agencymeddirectors.,OADS,/arxiv_data1/oa_pdf/ea/c7/jpr-6-791.PMC3862507.pdf
"May 6, 2011. http://www.tampabay.com/ news/health/article1168138.ec e. Accessed October 22, 2013.",Non-OADS,/arxiv_data1/oa_pdf/ea/c7/jpr-6-791.PMC3862507.pdf
"Available from: http://www.fda.gov/Drugs/DrugSafety/ Postm arketDrugSafetyInformationforPatientsandProviders /ucm111350.ht m.  Accessed October 1, 2013.",Non-OADS,/arxiv_data1/oa_pdf/ea/c7/jpr-6-791.PMC3862507.pdf
"Journal of Pain Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-pain-research-journa lThe Journal of Pain Research is an international, peer-reviewed, open  access, online journal that welcomes laboratory and clinical findings  in the fields of pain research and the prevention and management  of pain.",Non-OADS,/arxiv_data1/oa_pdf/ea/c7/jpr-6-791.PMC3862507.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ea/c7/jpr-6-791.PMC3862507.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/24/92/ijn-8-4659.PMC3862508.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2013:8 4659–4671International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  4659OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S5192 7T umor targeting and imaging with dual-   peptide conjugated multifunctional   liposomal nanoparticles christine rangger1 anna helbok1 Jane sosabowski2 christian Kremser3 gottfried Koehler4 ruth Prassl5,6 Fritz andreae7 Irene J Virgolini1 elisabeth von guggenberg1 clemens Decristoforo1 1Department of Nuclear Medicine,   Innsbruck Medical University,   Innsbruck, austria; 2centre for  Molecular Oncology, Barts cancer  Institute, Queen Mary University of  london, london, UK; 3Department  of radiology, Innsbruck Medical  University, Innsbruck, 4Department  of computational and structural  Biology, Max Perutz laboratories,   University of Vienna, Wien, 5Institute  of Biophysics, Medical University  of graz, graz, 6ludwig Boltzmann  Institute for lung Vascular research,   7picheM research and Development,   graz, austria correspondence: clemens Decristoforo   Department of Nuclear Medicine,  Innsbruck Medical University,  anichstrasse 35,   a-6020 Innsbruck, austria   Tel +43 512 504 80951   Fax +43 512 504 6780951   email clemens.decristoforo@uki.a tBackground:  The significant progress in nanotechnology provides a wide spectrum of nanosized  material for various applications, including tumor targeting and molecular imaging.",Non-OADS,/arxiv_data1/oa_pdf/24/92/ijn-8-4659.PMC3862508.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/24/92/ijn-8-4659.PMC3862508.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/24/92/ijn-8-4659.PMC3862508.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/67/b0/ijn-8-4677.PMC3862509.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2013:8 4677–4687International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  4677OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S5126 2characterization, pharmacokinetics,   and hypoglycemic effect of berberine   loaded solid lipid nanoparticles Mei Xue Ming-xing Yang Wei Zhang Xiu-min li De-hong gao Zhi-min Ou Zhi-peng li su-huan liu Xue-jun li shu-yu Yang Xiamen Diabetes Institute, The  First affiliated hospital of Xiamen  University, Xiamen, People’s republic  of china correspondence: shu-yu Yang   Xiamen Diabetes Institute, The First  Affiliated Hospital of Xiamen University,  55 Zhenhai road, Xiamen, People’s  republic of china, 361003   Tel +86 592 213 7558   Fax +86 592 213 7559   email yang.shuyu@yahoo.com.c n    Xue-jun li   Xiamen Diabetes Institute, The First  Affiliated Hospital of Xiamen University,  55 Zhenhai road, Xiamen, People’s  republic of china, 361003   Tel +86 592 213 7610   Fax +86 592 213 7558   email lixuejun@yahoo.com.c nAbstract:  The high aqueous solubility, poor permeability, and absorption of berberine (BBR)  result in its low plasma level after oral administration, which greatly limits its clinical application.",Non-OADS,/arxiv_data1/oa_pdf/67/b0/ijn-8-4677.PMC3862509.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/67/b0/ijn-8-4677.PMC3862509.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/67/b0/ijn-8-4677.PMC3862509.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/77/f2/ndt-9-1889.PMC3862510.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2013:9 1889–1898Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1889OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S5405 1randomized, placebo-controlled, double-   blind study assessing the efficacy and safety   of paliperidone palmitate in asian patients   with schizophrenia Nagahide Takahashi1 Masayoshi Takahashi2 Takayuki saito3 Misuzu iizumi4 Yuki saito5 hiroko shimizu6 Taka Matsumura7 1clinical responsible Physicians  Department, clinical science  Division, 2clinical science initiative  Department, clinical science  Division, 3Project lead Department,   Project Development Division,   4Trial Management Department,   Japan clinical Operations Division,   5Biostatistics Department,   Quantitative science Division,   6clinical Pharmacology Department,   Quantitative science Division,   7clinical science Division, Janssen  Pharmaceuticals KK, T okyo, Japan correspondence: Nagahide Takahashi   clinical science Division,   Janssen Pharmaceuticals KK,   5-2 Nishi-kanda-3-tyome,   chiyoda-ku, T okyo 101-0065, Japan   T el +81 3 4411 5509   Fax +81 3 4411 5086   email ntakaha4@its.jnj.co mBackground:  This 13-week, double-blind study was conducted to confirm the efficacy and  safety of paliperidone palmitate (PP), at dosing regimens approved in other countries, in Asian  patients with schizophrenia.",Non-OADS,/arxiv_data1/oa_pdf/77/f2/ndt-9-1889.PMC3862510.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing  on concise rapid reporting of clinical or pre-clinical studies on a  range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/77/f2/ndt-9-1889.PMC3862510.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/77/f2/ndt-9-1889.PMC3862510.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/56/d5/cmar-5-401.PMC3862511.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpCancer Management and Research 2013:5 401–408Cancer Management and Research Dove press submit your manuscript | www.dovepress.co m Dove press  401ExpER t OpiniO nopen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/CMAR.S5225 6Daily baseline skin care in the prevention,   treatment, and supportive care of skin toxicity   in oncology patients: recommendations   from a multinational expert panel René-Jean Bensadoun1 phillipe Humbert2 Jean Krutman3 thomas Luger4 Raoul triller5 André Rougier6 Sophie Seite6 Brigitte Dreno7 1Department of Radiation Oncology,   CHU poitiers, poitiers Cedex,   2Department of Dermatology,   University Hospital of Besançon,   Besançon, France; 3iUF-Leibniz  Research institute for Environmental  Medicine, Heinrich-Heine University,   Düsseldorf, 4Department of  Dermatology, University of Münster,   Münster, Germany; 5Centre of  Dermatology, Hertford British  Hospital, Levallois-p erret, 6La Roche- posay Laboratoire pharmaceutique,   Asnières, 7Department of Cancero- Dermatology, Hôtel Dieu, CHU  nantes, France Correspondence: RJ Bensadoun   CHU de poitiers, Bp 577,   86021, poitiers, France   Email rene-jean.bensadoun@chu-poitiers.f rAbstract:  Skin reactions due to radiotherapy and chemotherapy are a significant problem for an  important number of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/56/d5/cmar-5-401.PMC3862511.pdf
"Cancer Management and Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/cancer-management-and-research-journa lCancer Management and Research is an international, peer-reviewed  open access journal focusing on cancer research and the optimal use of  preventative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/56/d5/cmar-5-401.PMC3862511.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/56/d5/cmar-5-401.PMC3862511.pdf
http://dx.doi.org/10.1016/j.ijppaw.2012.11.005qNucleotide sequence data reported in this paper are available in the GenBank database under the Accession numbers JQ867025–JQ867067.,OADS,/arxiv_data1/oa_pdf/7b/f7/main.PMC3862512.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/20/18/ndt-9-1873.PMC3862513.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2013:9 1873–1884Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1873Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S5218 822q11 deletion syndrome: a review   of the neuropsychiatric features   and their neurobiological basis Chiara Squarcione Maria Chiara T orti Fabio Di Fabio Massimo Biondi Department of Neurology and  Psychiatry, Sapienza University   of Rome, Rome, italy Correspondence: Chiara Squarcione   Department of Neurology and Psychiatry,  Sapienza University of Rome, viale  dell’Università 30, 00185 Rome, italy   Tel +39 06 4991 4539   email chiarasquarcione@hotmail.co mAbstract:  The 22q11.2 deletion syndrome (22q11DS) is caused by an autosomal dominant  microdeletion of chromosome 22 at the long arm (q) 11.2 band.",Non-OADS,/arxiv_data1/oa_pdf/20/18/ndt-9-1873.PMC3862513.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing  on concise rapid reporting of clinical or pre-clinical studies on a  range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/20/18/ndt-9-1873.PMC3862513.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/20/18/ndt-9-1873.PMC3862513.pdf
http://dx.doi.org/10.1016/j.ijppaw.2012.12.001⇑Corresponding author.,OADS,/arxiv_data1/oa_pdf/70/7f/main.PMC3862514.pdf
"http://dx.doi.org/10.1016/j.ijppaw.2013.04.003qThis is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike License, which permits non- commercial use, distribution, and reproduction in any medium, provided theoriginal author and source are credited.",OADS,/arxiv_data1/oa_pdf/f5/4b/main.PMC3862515.pdf
< http://www.physics.csbsju.edu/stats/ > (10.02.13).,Non-OADS,/arxiv_data1/oa_pdf/f5/4b/main.PMC3862515.pdf
"http://dx.doi.org/10.1016/j.ijppaw.2013.09.003qThis is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which per-mits non-commercial use, distribution, and reproduction in any medium, providedthe original author and source are credited.",OADS,/arxiv_data1/oa_pdf/9a/0c/main.PMC3862517.pdf
"http://dx.doi.org/10.1016/j.ijppaw.2012.11.001qThis is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike License, which permits non-commercial use, distribution, and reproduction in any medium, provided theoriginal author and source are credited.",OADS,/arxiv_data1/oa_pdf/de/2b/main.PMC3862518.pdf
"Red birds- of-paradise are endangered endemic Indonesian frugivorous passerines ( Worth et al., 1990 ,http://www.birdlife.org/datazone/ speciesfactsheet.php?id=5840 ).",Non-OADS,/arxiv_data1/oa_pdf/de/2b/main.PMC3862518.pdf
"Supplementary data Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.ijppaw.2012.",OADS,/arxiv_data1/oa_pdf/de/2b/main.PMC3862518.pdf
< http://www.iucnredlist.org > (accessed 03.2012).,Non-OADS,/arxiv_data1/oa_pdf/de/2b/main.PMC3862518.pdf
"http://dx.doi.org/10.1016/j.ijppaw.2013.09.008qThis is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which per-mits non-commercial use, distribution, and reproduction in any medium, providedthe original author and source are credited.",OADS,/arxiv_data1/oa_pdf/9b/1b/main.PMC3862519.pdf
The reference values (in parenthesis) were obtained from ISIS 2002 ( http://www.isis.org ).,OADS,/arxiv_data1/oa_pdf/9b/1b/main.PMC3862519.pdf
"The sequence obtained was aligned using BLASTN (Basic Local Alignment Search Tool) with sequences from the GenBank available at http://www.ncbi.nlm.nih.gov/blast/Blast.cgi (Altschul et al., 1997 ) and MalAvi available at http://mbio-serv2.mbioekol.lu.se/Malavi/ blast.html (Zhang et al., 2000 ).",OADS,/arxiv_data1/oa_pdf/9b/1b/main.PMC3862519.pdf
"However, in the MalAvi database, there is no record of occurrence of any haemosporidian parasites in the Egyptian goose (http://mbio-serv2.mbioekol.lu.se/Malavi/index.html ).",Non-OADS,/arxiv_data1/oa_pdf/9b/1b/main.PMC3862519.pdf
http://dx.doi.org/10.1016/j.ijppaw.2013.03.002⇑Corresponding author.,OADS,/arxiv_data1/oa_pdf/7e/66/main.PMC3862520.pdf
"Financial support This work was supported by the Faculty of Veterinary Medicine, University of Calgary, Alberta Innovates Health Solutions, and theCircumArctic Rangifer Monitoring and Assessment Network (CAR- MA, http://www.carmanetwork.com ), NSERC Canada International Polar Year Funding, and the Reindeer Research Program, University of Alaska, Fairbanks.",Non-OADS,/arxiv_data1/oa_pdf/7e/66/main.PMC3862520.pdf
"http://dx.doi.org/10.1016/j.ijppaw.2013.09.007qThis is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which per-mits non-commercial use, distribution, and reproduction in any medium, providedthe original author and source are credited.International Journal for Parasitology: Parasites and Wildlife 2 (2013) i Contents lists available at ScienceDirect International Journal for Parasitology: Parasites and Wildlife journal homepage: www.elsevier.com/locate/ijppaw",Non-OADS,/arxiv_data1/oa_pdf/b0/36/main.PMC3862521.pdf
http://dx.doi.org/10.1016/j.ijppaw.2013.03.004⇑Corresponding author.,OADS,/arxiv_data1/oa_pdf/38/66/main.PMC3862522.pdf
http://dx.doi.org/10.1016/j.ijppaw.2012.11.004⇑Corresponding author.,OADS,/arxiv_data1/oa_pdf/e4/3d/main.PMC3862524.pdf
Available at: < http://www.darwin.zoology.,Non-OADS,/arxiv_data1/oa_pdf/e4/3d/main.PMC3862524.pdf
"http://dx.doi.org/10.1016/j.ijppaw.2013.09.001qThis is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which p ermits non- commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/92/2c/main.PMC3862525.pdf
http://dx.doi.org/ 10.1016/j.tree.2013.06.002 .,OADS,/arxiv_data1/oa_pdf/92/2c/main.PMC3862525.pdf
http://dx.doi.org/10.1111/1365- 2656.12088 .,Non-OADS,/arxiv_data1/oa_pdf/92/2c/main.PMC3862525.pdf
http://dx.doi.org/10.1016/j.ijppaw.2013.02.004qNote: Nucleotide sequence data reported in this paper are available in the GenBank™.,OADS,/arxiv_data1/oa_pdf/af/29/main.PMC3862526.pdf
Int.. http://dx.doi.org/10.4061/2011/591980 .,OADS,/arxiv_data1/oa_pdf/af/29/main.PMC3862526.pdf
http://dx.doi.org/10.1016/j.ijppaw.2013.04.001⇑Corresponding author.,OADS,/arxiv_data1/oa_pdf/63/71/main.PMC3862527.pdf
Available online: <http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20420 >.,Non-OADS,/arxiv_data1/oa_pdf/63/71/main.PMC3862527.pdf
"http://dx.doi.org/10.1016/j.ijppaw.2013.05.004qThis is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike License, which permits non-commercial use, distribution, and reproduction in any medium, provided theoriginal author and source are credited.",OADS,/arxiv_data1/oa_pdf/9a/1c/main.PMC3862528.pdf
"Larval DNA was extracted and puriﬁed by DNA IQtm System kit (Promega, USA) according to the protocolof the European Reference Laboratory for Parasites (EURLP) for identiﬁcation of Trichinella muscle stage larvae at the species level (http://www.iss.it/binary/crlp/cont/PCR%20method%20WEB%20SI- TE.1177083731.pdf , 02/13/2012).",Non-OADS,/arxiv_data1/oa_pdf/9a/1c/main.PMC3862528.pdf
"This species has also been reported in wild boar: three times in Latvia and Estonia, and once in Lithuania and Fin- land ( http://www.iss.it/site/Trichinella/scripts/reso.asp , 02/27/ 2013).",Non-OADS,/arxiv_data1/oa_pdf/9a/1c/main.PMC3862528.pdf
http://dx.doi.org/10.1016/j.ijppaw.2013.02.002⇑Corresponding author.,OADS,/arxiv_data1/oa_pdf/a0/91/main.PMC3862529.pdf
"http://dx.doi.org/10.1016/j.ijppaw.2013.04.004qThis is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike License, which permits non-commercial use, distribution, and reproduction in any medium, provided theoriginal author and source are credited.",OADS,/arxiv_data1/oa_pdf/bf/40/main.PMC3862530.pdf
http://dx.doi.org/10.1016/j.ijppaw.2013.03.001⇑Corresponding author.,OADS,/arxiv_data1/oa_pdf/89/c4/main.PMC3862532.pdf
http://dx.doi.org/10.1071/WR12115.,Non-OADS,/arxiv_data1/oa_pdf/89/c4/main.PMC3862532.pdf
http://dx.doi.org/10.1016/j.ijppaw.2012.12.002⇑Corresponding author.,OADS,/arxiv_data1/oa_pdf/75/44/main.PMC3862533.pdf
"Supplementary data Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.ijppaw.2012.",OADS,/arxiv_data1/oa_pdf/75/44/main.PMC3862533.pdf
"http://dx.doi.org/10.1016/j.ijppaw.2012.11.006qThis is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-Share Alike License, which permits non-commercial use, distribution, and reproduction in any medium, provided theoriginal author and source are credited.",OADS,/arxiv_data1/oa_pdf/59/11/main.PMC3862534.pdf
Available from: < http://www.R-project.com >.,Non-OADS,/arxiv_data1/oa_pdf/59/11/main.PMC3862534.pdf
"http://dx.doi.org/10.1016/j.ijppaw.2013.04.005qThis is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike License, which permits non- commercial use, distribution, and reproduction in any medium, provided theoriginal author and source are credited.",OADS,/arxiv_data1/oa_pdf/87/e3/main.PMC3862535.pdf
"/C160These haplotypes had been previously reported in the MalAvi database ( Bensch et al., 2009 ) which is available online at http://mbio-serv2.mbioekol.lu.se/Malavi/ .",OADS,/arxiv_data1/oa_pdf/87/e3/main.PMC3862535.pdf
"http://dx.doi.org/10.1016/j.ijppaw.2013.03.003⇑Corresponding author Address: Institute of Parasitology, Biology Centre of the Academy of Sciences of the Czech Republic, Branišovská 31, 37005 C ˇeské Budeˇjovice, Czech Republic.",Non-OADS,/arxiv_data1/oa_pdf/17/11/main.PMC3862536.pdf
"Spores were mea- sured on digital images using ImageJ v.1 /C144p (Wayne Rasband, http://imagej.nih.gov/ij ) calibrated against a digital image of a grat- icule.",OADS,/arxiv_data1/oa_pdf/17/11/main.PMC3862536.pdf
"We acknowledge support from Mote Marine Laboratory which provided vehicles for ﬁeld work and lab- oratory equipment, and fund raising efforts from Addictive Fishing (http://www.addictiveﬁshing.com ) which also contributed to the project.",Non-OADS,/arxiv_data1/oa_pdf/17/11/main.PMC3862536.pdf
http://dx.doi.org/10.1016/j.ympev.2013.02.026 .,OADS,/arxiv_data1/oa_pdf/17/11/main.PMC3862536.pdf
Online at: < http://www.st.nmfs.noa.gov/st1/ commercial/ >.,Non-OADS,/arxiv_data1/oa_pdf/17/11/main.PMC3862536.pdf
"Tracer v1.4, < http://beast.bio.ed.ac.uk/Tracer >.",OADS,/arxiv_data1/oa_pdf/17/11/main.PMC3862536.pdf
"http://dx.doi.org/10.1016/j.ijppaw.2013.09.005qThis is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike License, which permits non-commercial use, distribution, and reproduction in any medium, provided theoriginal author and source are credited.",OADS,/arxiv_data1/oa_pdf/8e/ec/main.PMC3862537.pdf
Available from: <http://www.cse.csiro.au/ poptools>.,Non-OADS,/arxiv_data1/oa_pdf/8e/ec/main.PMC3862537.pdf
"http://dx.doi.org/10.1016/j.ijppaw.2013.05.001qThis is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike License, which permits non- commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.",OADS,/arxiv_data1/oa_pdf/17/a8/main.PMC3862538.pdf
Available from < http://www.eol.org >.,Non-OADS,/arxiv_data1/oa_pdf/17/a8/main.PMC3862538.pdf
Available from: < http://datathief.org/ >.,OADS,/arxiv_data1/oa_pdf/17/a8/main.PMC3862538.pdf
"http://dx.doi.org/10.1016/j.ijppaw.2013.06.001qThis is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike License, which permits non- commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.",OADS,/arxiv_data1/oa_pdf/f6/3f/main.PMC3862539.pdf
"http://dx.doi.org/10.1016/j.ijppaw.2012.11.007qThis is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-Share Alike License, which permits non-commercial use, distribution, and reproduction in any medium, provided theoriginal author and source are credited.",OADS,/arxiv_data1/oa_pdf/de/89/main.PMC3862541.pdf
"Sequencing was per- formed by Synergene Biotech GmbH, Biotech Center Zurich, Swit- zerland ( http://www.synergene-biotech.com ) with the primers Cest5 seqand Cest4 for Taenia spp.",OADS,/arxiv_data1/oa_pdf/de/89/main.PMC3862541.pdf
"Sequencing results were then compared with entries in the GenBank nucleotide database, using BLAST search ( http://www.blast.ncbi.nlm.nih.gov ).Since genotyping to determine individual wolves was not per- formed for these fecal samples, some of them may have originated from the same animal and, thus, the term occurrence rather than prevalence is used to describe the percentage of positives.",OADS,/arxiv_data1/oa_pdf/de/89/main.PMC3862541.pdf
Available online at: http://www.zoologia.hu/qp/qp.html.,Non-OADS,/arxiv_data1/oa_pdf/de/89/main.PMC3862541.pdf
"http://dx.doi.org/10.1016/j.ijppaw.2013.09.004qThis is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike License, which permits non-commercial use, distribution, and reproduction in any medium, provided theoriginal author and source are credited.",OADS,/arxiv_data1/oa_pdf/a8/88/main.PMC3862544.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/fa/48/jbm-4-149.PMC3862583.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpJournal of Blood Medicine 2013:4 149–159Journal of Blood Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  149Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JBM.S5467 1a common signaling pathway is activated   in erythroid cells expressing high levels of fetal  hemoglobin: a potential role for caMP-elevating  agents in β-globin disorders T ohru ikuta1 Yuichi Kuroyanagi1 nadine Odo1 siyang liu2 1Department of anesthesiology and  Perioperative Medicine, 2Department  of Physiology, Medical college of  georgia, georgia regents University,   augusta, ga, Usa correspondence: Tohru ikuta   Department of anesthesiology and  Perioperative Medicine, Medical college  of georgia, georgia regents University,  1120 15th street, BiW-2144,   augusta, ga 30912, Usa   Tel +1 706 721 3098   Fax +1 706 721 8752   email tikuta@gru.ed uBackground:  Although erythroid cells prepared from fetal liver, cord blood, or blood from  β-thalassemia patients are known to express fetal hemoglobin at high levels, the underlying  mechanisms remain elusive.",Non-OADS,/arxiv_data1/oa_pdf/fa/48/jbm-4-149.PMC3862583.pdf
"Journal of Blood Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/Journal-of-blood-medicine-journa lThe Journal of Blood Medicine is an international, peer-reviewed, open  access, online journal publishing laboratory, experimental and clinical aspects  of all topics pertaining to blood based medicine including but not limited to:  Transfusion Medicine; Blood collection, Donor issues, Transmittable diseases,  and Blood banking logistics; Immunohematology; Artificial and alternative blood based therapeutics; Hematology; Biotechnology/nanotechnology of  blood related medicine; Legal aspects of blood medicine; Historical perspec - tives.",Non-OADS,/arxiv_data1/oa_pdf/fa/48/jbm-4-149.PMC3862583.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/fa/48/jbm-4-149.PMC3862583.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ce/09/copd-9-001.PMC3862584.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2014:9 1–7International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/COPD.S2494 0New developments in the management   of COPD: clinical utility of indacaterol 75 µg Paschalis Steiropoulos1 Kostas Archontogeorgis1 evangelia Nena2 Demosthenes Bouros1 1Department of Pneumonology,   Medical School, Democritus  University of Thrace, Alexandroupolis,   Greece; 2Laboratory of Hygiene and  environmental Protection, Medical  School, Democritus University of  Thrace, Alexandroupolis, Greece Correspondence: Paschalis Steiropoulos   Department of Pneumonology,   Medical School, Democritus University of  Thrace, 68100 Alexandroupolis, Greece   Tel +30 2551 075 333   Fax +30 2551 076 106   email pstirop@med.duth.g rAbstract:  Chronic obstructive pulmonary disease (COPD) is a global health challenge and a  major cause of mortality worldwide.",Non-OADS,/arxiv_data1/oa_pdf/ce/09/copd-9-001.PMC3862584.pdf
Available from: http://www.goldcopd.org/uploads/users/files/ GOLD_Report_2013_Feb20.pdf .,OADS,/arxiv_data1/oa_pdf/ce/09/copd-9-001.PMC3862584.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-copd-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/ce/09/copd-9-001.PMC3862584.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ce/09/copd-9-001.PMC3862584.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/36/47/tcrm-9-505.PMC3862585.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2013:9 505–509Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  505Case seRiesopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S5455 8Colchicine intoxication: a report of two   suicide cases abdulsamet erden1 Hatice Karagoz1 Hasan Hüseyin Gümüscü1 samet Karahan1 Mustafa Basak1 Fatma aykas1 Kadir Bulut1 ali Cetinkaya1 Deniz avci1 Orhan Kürsat Poyrazoglu2 1internal Medicine Department,   2Gastroenterology Department,   Kayseri Training and Research  Hospital, Kayseri, T urkey Correspondence: samet Karahan   internal Medicine Department,   Kayseri Training and Research Hospital,   Kayseri Eg ˘itim Araştırma Hastanesi,   l˙ç Hastalıkları Klinig ˘i, 9 Blok 3,   Kat Kocasinan, Kayseri, Turkey   Tel +90 506 302 0036   email doktorsamet@yahoo.co mAbstract:  Colchicine, an old and well-known drug, is an alkaloid extracted from Colchicum  autumnale  and related species.",Non-OADS,/arxiv_data1/oa_pdf/36/47/tcrm-9-505.PMC3862585.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/36/47/tcrm-9-505.PMC3862585.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/36/47/tcrm-9-505.PMC3862585.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/71/c0/cpaa-5-185.PMC3862586.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Pharmacology: Advances and Applications 2013:5 185–192Clinical Pharmacology: Advances and Applications Dove press submit your manuscript | www.dovepress.co m Dove press  185OriginAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CPAA.S5315 1Cytochrome P450 3A4*22, PPAR- α, and ARNT   polymorphisms and clopidogrel response rolf P Kreutz1,2 Janelle Owens2 Yan Jin2 Perry nystrom2 Zeruesenay Desta2 Yvonne Kreutz2 Jeffrey A Breall1 lang li3 ChienWei Chiang3 richard J Kovacs1 David A Flockhart2 1Krannert institute of Cardiology,   2Division of Clinical Pharmacology,   indiana University school of Medicine,   3Center for Computational Biology  and Bioinformatics, indiana University  school of Medicine, indianapolis,   indiana, UsA Correspondence: rolf P Kreutz   Krannert institute of Cardiology,   indiana University school of Medicine,  1800 n Capitol Ave, Me-400,  indianapolis, in 46202, UsA   Tel +1 317 962 0561   Fax +1 317 962 0113   email rkreutz@iu.ed uAbstract:  Recent candidate gene studies using a human liver bank and in vivo validation in  healthy volunteers identified polymorphisms in cytochrome P450 (CYP) 3A4 gene (CYP3A4*22 ),  Ah-receptor nuclear translocator ( ARNT ), and peroxisome proliferator-activated receptor- α  (PP AR-α) genes that are associated with the CYP3A4 phenotype.",Non-OADS,/arxiv_data1/oa_pdf/71/c0/cpaa-5-185.PMC3862586.pdf
"Clinical Pharmacology: Advances and Applications Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-pharmacology-advances-and-applications-journa lClinical Pharmacology: Advances and Applications is an international,  peer-reviewed, open access journal publishing original research, reports,  reviews and commentaries on all areas of drug experience in humans.",Non-OADS,/arxiv_data1/oa_pdf/71/c0/cpaa-5-185.PMC3862586.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/71/c0/cpaa-5-185.PMC3862586.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/7c/e3/ppa-7-1213.PMC3862587.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2013:7 1213–1220Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  1213OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S5185 2Video abstract Point your Smar tPhone at the code abo ve.,Non-OADS,/arxiv_data1/oa_pdf/7c/e3/ppa-7-1213.PMC3862587.pdf
"Or use: http://dvpr.es/1iI4OR dThe influence of socioeconomic status on  women’s preferences for modern contraceptive  providers in nigeria: a multilevel choice modeling Olatunde Aremu school of health, sport, and  Bioscience, health studies Field,   University of east london, london,   United Kingdom correspondence: Olatunde Aremu   University of east london, romford road,  stratford, london, e15 4lZ,   United Kingdom   T el +44 77 6267 4797   Fax +44 20 8223 4965   email olatunde.aremu@yahoo.co m;  o.aremu@uel.ac.u kBackground:  Contraceptives are one of the most cost effective public health interventions.",Non-OADS,/arxiv_data1/oa_pdf/7c/e3/ppa-7-1213.PMC3862587.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal focusing on the growing importance of patient  preference and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/7c/e3/ppa-7-1213.PMC3862587.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/7c/e3/ppa-7-1213.PMC3862587.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/12/19/mder-7-001.PMC3862588.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpMedical Devices: Evidence and Research 2014:7 1–5Medical Devices: Evidence and Research Dove press submit your manuscript | www.dovepress.co m Dove press  1ORiginal REsEaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/MDER.S5403 8Benefits of monitoring patients with mobile  cardiac telemetry (McT) compared   with the Event or holter monitors Jean-Patrick Tsang Shunmugam Mohan Bayser Consulting, Skokie, IL, USA Correspondence: Jean-Patrick Tsang   Bayser Consulting, 4709 Golf Road –  Suite 803, Skokie, IL 60076, USA   Tel +1 847 920 1000   Fax +1 847 679 8285   Email bayser@bayser.co mIntroduction:  This research is meant to establish if a patient monitored with mobile cardiac  telemetry (MCT) sees different outcomes regarding diagnostic yield of arrhythmia, therapeutic  management through the use of antiarrhythmic drugs, and cardiovascular costs incurred in the  hospital setting when compared with more traditional monitoring devices, such as the Holter  or the Event monitor.",Non-OADS,/arxiv_data1/oa_pdf/12/19/mder-7-001.PMC3862588.pdf
Submit your manuscript here:  http://www.dovepress.com/medical-devices-evidence-and-research-journa l Medical Devices: Evidence and Research 2014:7submit your manuscript | www.dovepress.co m Dove press Dove press Dove pres s 5Benefits of mobile cardiac telemetry thank Joseph Capper and Michael Geldart with CardioNet  for partially defraying the cost of this study.,Non-OADS,/arxiv_data1/oa_pdf/12/19/mder-7-001.PMC3862588.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ed/64/ijgm-7-001.PMC3862589.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of General Medicine 2014:7 1–11International Journal of General Medicine This article was published in the following Dove Press journal:  International Journal of General Medicine 4 December 2013Dove press submit your manuscript | www.dovepress.co m Dove press  1RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJGM.S5564 9Does tight glycemic control improve outcomes   in pediatric patients undergoing surgery   and/or those with critical illness?,Non-OADS,/arxiv_data1/oa_pdf/ed/64/ijgm-7-001.PMC3862589.pdf
"International Journal of General Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-general-medicine-journa lThe International Journal of General Medicine is an international,  peer-reviewed open-access journal that focuses on general and internal  medicine, pathogenesis, epidemiology, diagnosis, monitoring and treat - ment protocols.",Non-OADS,/arxiv_data1/oa_pdf/ed/64/ijgm-7-001.PMC3862589.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ed/64/ijgm-7-001.PMC3862589.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/14/98/cia-9-009.PMC3862590.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2014:9 9–14Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  9OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S4832 5Prevalence of dementia in Al-Quseir city,   red sea governorate, egypt hamdy n  el Tallawy1 Wafaa M Farghly1 reda Badry1 Tarek A rageh1 ghaydaa A shehata1 n Abdel hakeem M2 Mohamed Abd el hamed1 Mohamed AM sayd3 Yasser hamed2 Mahmoud r Kandil1 1Department of n eurology,   2Department of neurology Faculty  of Medicine, Assiut University, Assiut  egypt; 3Department of neurology,   Faculty of Medicine, sohag University,   sohag, egypt Correspondence: reda Badry   Assiut University hospital, Department  of neurology, 71526 Assiut, egypt   email redaalbadry02@gmail.co mAbstract:  Dementia is one of the most important public health problems as a result of the rapid  increase in the number of elderly persons worldwide.",Non-OADS,/arxiv_data1/oa_pdf/14/98/cia-9-009.PMC3862590.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treat - ments intended to prevent or delay the onset of maladaptive correlates  of aging in human beings.",Non-OADS,/arxiv_data1/oa_pdf/14/98/cia-9-009.PMC3862590.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/14/98/cia-9-009.PMC3862590.pdf
Available from: http://www.msdiscovery.,Non-OADS,/arxiv_data1/oa_pdf/14/98/cia-9-009.PMC3862590.pdf
OncoImmunology 2013; 2:e26098; http://dx.doi.org/10.4161/onci.26098Is there a future for adoptive cell transfer   in melanoma patients?,Non-OADS,/arxiv_data1/oa_pdf/4e/43/onci-2-e26098.PMC3862631.pdf
Clin Cancer Res 2010; 16:2646-55; PMID:20406835 ; http://dx.doi.org/10.1158/1078- 0432.CCR-10-0041 2.,Non-OADS,/arxiv_data1/oa_pdf/4e/43/onci-2-e26098.PMC3862631.pdf
J Clin Oncol 2008; 26:5233-9; PMID:18809613 ;  http://dx.doi.org/10.1200/JCO.2008.16.5449 3.,Non-OADS,/arxiv_data1/oa_pdf/4e/43/onci-2-e26098.PMC3862631.pdf
J Clin Oncol 2013 ; 31:2152-9;  PMID:23650429 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/4e/43/onci-2-e26098.PMC3862631.pdf
Clin Cancer Res 2012; 18:6758-70; PMID:23032743 ; http://dx.doi.org/10.1158/1078- 0432.CCR-12-11775.,Non-OADS,/arxiv_data1/oa_pdf/4e/43/onci-2-e26098.PMC3862631.pdf
Clin Cancer Res 2011; 17:4550-7;  PMID:21498393 ; http://dx.doi.org/10.1158/1078- 0432.CCR-11-0116 6.,Non-OADS,/arxiv_data1/oa_pdf/4e/43/onci-2-e26098.PMC3862631.pdf
Clin  Cancer Res 2013; 19:4792-800  PMID:23690483 ;  http://dx.doi.org/10.1158/1078-0432.CCR-13-0380 7.,Non-OADS,/arxiv_data1/oa_pdf/4e/43/onci-2-e26098.PMC3862631.pdf
N Engl J Med 2011; 364:2507- 16; PMID:21639808 ; http://dx.doi.org/10.1056/ NEJMoa1103782 8.,OADS,/arxiv_data1/oa_pdf/4e/43/onci-2-e26098.PMC3862631.pdf
N Engl J Med 2010; 363:711-23;  PMID:20525992 ; http://dx.doi.org/10.1056/ NEJMoa10034669.,OADS,/arxiv_data1/oa_pdf/4e/43/onci-2-e26098.PMC3862631.pdf
J Immunother 2011; 34:212-20; PMID:21304398 ;  http://dx.doi.org/10.1097/CJI.0b013e318209c94c 10.,Non-OADS,/arxiv_data1/oa_pdf/4e/43/onci-2-e26098.PMC3862631.pdf
N Engl J Med  2013; 369:122-33;  PMID:23724867 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/4e/43/onci-2-e26098.PMC3862631.pdf
"OncoImmunology 2013; 2:e26295; http://dx.doi.org/10.4161/onci.26295The relationship between malignant   and tumor-associated cells provides a new strategy  for targeted diagnosis and therapy Xiaoling Lu†, Jian h e†, Xia Li†, and y ongxiang Zhao* Biological Targeting Diagonosis and Therapy r esearch Center; Guangxi Medical u niversity; Nanning, China †These authors contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/e9/4a/onci-2-e26295.PMC3862633.pdf
Cell  2013; 153:139-52; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e9/4a/onci-2-e26295.PMC3862633.pdf
Nature  2010 ; 468:824-8; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e9/4a/onci-2-e26295.PMC3862633.pdf
Proc Natl Acad Sci U S  A 2013 ; 110:270-5; PMID: 23248284; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e9/4a/onci-2-e26295.PMC3862633.pdf
Proc Natl Acad Sci U S A  2013 ; 110:8170 -5; PMID:23630281 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e9/4a/onci-2-e26295.PMC3862633.pdf
Nat Rev Cancer 2012 ;  12:265-77; http://dx.doi.org/10.1038/nrc3258 ;  PMID:22437871 6.,Non-OADS,/arxiv_data1/oa_pdf/e9/4a/onci-2-e26295.PMC3862633.pdf
Clin Cancer Res 2012 ;18:1751-9; PMID:  22275504; http://dx.doi.org/ 10.1158/ 1078-0432.,Non-OADS,/arxiv_data1/oa_pdf/e9/4a/onci-2-e26295.PMC3862633.pdf
Cancer Res 2012 ; 72:1353 -62;  http://dx.doi.org/10.1158/0008-5472.CAN-11-2526 ; PMID:22282654,Non-OADS,/arxiv_data1/oa_pdf/e9/4a/onci-2-e26295.PMC3862633.pdf
"OncoImmunology 2013; 2:e27025; http://dx.doi.org/10.4161/onci.27025Effects of conventional therapeutic interventions  on the number and function of regulatory T cells Mario r oselli1, Vittore c ereda1, Maria Giovanna di Bari2, Vincenzo Formica1, antonella s pila2, caroline Jochems3,  Benedetto Farsaci3, renee Donahue3, James L Gulley3,4, Jeffrey s chlom3,*,†, and Fiorella Guadagni2,† 1Medical Oncology; Department of Internal Medicine; Tor Vergata University c linical c enter; University of r ome Tor Vergata; r ome, Italy;   2Interinstitutional Multidisciplinary Biobank (BioBIM); Department of Laboratory Medicine and a dvanced Biotechnologies; I rccs s an r affaele Pisana; r ome, Italy;   3Laboratory of Tumor Immunology and Biology; c enter for c ancer r esearch; National c ancer Institute; National Institutes of h ealth; Bethesda, MD U sa;  4Medical Oncology Branch; c enter for c ancer r esearch; National c ancer Institute; National Institutes of h ealth; Bethesda, MD U sa †These authors contributed equally to this manuscript.",Non-OADS,/arxiv_data1/oa_pdf/d1/20/onci-2-e27025.PMC3862634.pdf
Supplemental Materials Supplemental materials may be found here:http://www.landesbioscience.com/journals/oncoimmunology/ article/27025/ References 1.,Non-OADS,/arxiv_data1/oa_pdf/d1/20/onci-2-e27025.PMC3862634.pdf
Nat Rev Cancer 2012; 12:298- 306;  PMID:22419253 ; http://dx.doi.org/10.1038/ nrc3245 .,Non-OADS,/arxiv_data1/oa_pdf/d1/20/onci-2-e27025.PMC3862634.pdf
Nat Rev Drug Discov 2012; 11:215- 33;  PMID:22301798 ; http://dx.doi.org/10.1038/ nrd3626 .,OADS,/arxiv_data1/oa_pdf/d1/20/onci-2-e27025.PMC3862634.pdf
J Transl Med 2012; 10:1;  PMID:22214470 ;  http://dx.doi.org/10.1186/1479-5876-10-1 .,Non-OADS,/arxiv_data1/oa_pdf/d1/20/onci-2-e27025.PMC3862634.pdf
Exp Biol Med (Maywood) 2011; 236:567-79;  PMID:21486861 ;  http://dx.doi.org/10.1258/ebm.2011.011007 .,Non-OADS,/arxiv_data1/oa_pdf/d1/20/onci-2-e27025.PMC3862634.pdf
Oncogene  2010; 29:482-91;  PMID :19881547 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d1/20/onci-2-e27025.PMC3862634.pdf
Semin Oncol  2012; 39:323-39;  PMID:22595055 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d1/20/onci-2-e27025.PMC3862634.pdf
J Exp Med 2006; 203:1259-71;  PMID:16636135 ; http://dx.doi.org/10.1084/ jem.20052494 .,Non-OADS,/arxiv_data1/oa_pdf/d1/20/onci-2-e27025.PMC3862634.pdf
J Immunother 2010; 33:991-8;  PMID:20948437 ;  http://dx.doi.org/10.1097/CJI.0b013e3181f4c208 .,Non-OADS,/arxiv_data1/oa_pdf/d1/20/onci-2-e27025.PMC3862634.pdf
J Clin Oncol 2009; 27:5911- 8;  PMID:19805669 ; http://dx.doi.org/10.1200/ JCO.2009.23.3494 .,Non-OADS,/arxiv_data1/oa_pdf/d1/20/onci-2-e27025.PMC3862634.pdf
Clin Cancer Res 2008; 14:6674-82;   PMID:18927310 ; http://dx.doi.org/10.1158/1078- 0432.CCR-07-5212 .,Non-OADS,/arxiv_data1/oa_pdf/d1/20/onci-2-e27025.PMC3862634.pdf
Cancer Res 2010; 70:3526-36;   PMID:20406969 ; http://dx.doi.org/10.1158/0008- 5472.CAN-09-3278 .,Non-OADS,/arxiv_data1/oa_pdf/d1/20/onci-2-e27025.PMC3862634.pdf
Clin Cancer Res 2009; 15:2148-57;   PMID:19276286 ; http://dx.doi.org/10.1158/1078- 0432.CCR-08-1332 .15.,Non-OADS,/arxiv_data1/oa_pdf/d1/20/onci-2-e27025.PMC3862634.pdf
Nat Rev Cancer 2012; 12:237-51;  PMID:22437869 ;  http://dx.doi.org/10.1038/nrc3237 .,Non-OADS,/arxiv_data1/oa_pdf/d1/20/onci-2-e27025.PMC3862634.pdf
J Natl Cancer Inst 2012;  104:599-613;  PMID:22395641 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d1/20/onci-2-e27025.PMC3862634.pdf
N Engl J Med 2010; 363:411-22;  PMID:20818862 ; http://dx.doi.org/10.1056/ NEJMoa1001294 .,OADS,/arxiv_data1/oa_pdf/d1/20/onci-2-e27025.PMC3862634.pdf
Immunol Rev  2006; 213:131-45;  PMID:16972901 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d1/20/onci-2-e27025.PMC3862634.pdf
J Immunother  2006; 29:233-40;  PMID:16699366 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d1/20/onci-2-e27025.PMC3862634.pdf
Nat Immunol 2012; 13:343- 51;  PMID:22430787 ; http://dx.doi.org/10.1038/ ni.2224 .,Non-OADS,/arxiv_data1/oa_pdf/d1/20/onci-2-e27025.PMC3862634.pdf
Clin Cancer Res 2012; 18:3022-9;  PMID:22510350 ;  http://dx.doi.org/10.1158/1078-0432.CCR-11-3216 .,Non-OADS,/arxiv_data1/oa_pdf/d1/20/onci-2-e27025.PMC3862634.pdf
J Clin Oncol 2006; 24:1169- 77;  PMID:16505437 ; http://dx.doi.org/10.1200/ JCO.2005.03.6830 .,Non-OADS,/arxiv_data1/oa_pdf/d1/20/onci-2-e27025.PMC3862634.pdf
Trends Immunol  2011; 32:19-25;  PMID:21067974 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d1/20/onci-2-e27025.PMC3862634.pdf
Clin Cancer Res 2007; 13:5256-61;   PMID:17875753 ; http://dx.doi.org/10.1158/1078- 0432.CCR-07-0892 .,Non-OADS,/arxiv_data1/oa_pdf/d1/20/onci-2-e27025.PMC3862634.pdf
Immunotherapy  2011; 3:77-96;  PMID:21174559 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d1/20/onci-2-e27025.PMC3862634.pdf
J Immunother 2001; 24:392-407; PMID:11696695 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d1/20/onci-2-e27025.PMC3862634.pdf
Nat Med 2007;  13:828-35;  PMID:17603493 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d1/20/onci-2-e27025.PMC3862634.pdf
J Immunol 2010;  184:3106-16;  PMID:20142361 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d1/20/onci-2-e27025.PMC3862634.pdf
J Immunol 2011; 186:3805- 7;  PMID:21422250 ; http://dx.doi.org/10.4049/ jimmunol.1100364 .,Non-OADS,/arxiv_data1/oa_pdf/d1/20/onci-2-e27025.PMC3862634.pdf
Cancer Immunol Immunother 2011; 60:197-206;  PMID:20976449 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d1/20/onci-2-e27025.PMC3862634.pdf
Cancer Immunol Immunother  2010; 59:663-74;  PMID:19890632 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d1/20/onci-2-e27025.PMC3862634.pdf
J Clin Oncol 2003; 21:1232-7;   PMID:12663709 ; http://dx.doi.org/10.1200/ JCO.2003.06.100 .,Non-OADS,/arxiv_data1/oa_pdf/d1/20/onci-2-e27025.PMC3862634.pdf
Int J Cancer 2012; 130:1948-59;  PMID:21633954 ;  http://dx.doi.org/10.1002/ijc.26219 .38.,Non-OADS,/arxiv_data1/oa_pdf/d1/20/onci-2-e27025.PMC3862634.pdf
Cancer Immunol Immunother  2011; 60:1227-42;  PMID:21544650 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d1/20/onci-2-e27025.PMC3862634.pdf
Immunity 2008; 28:870- 80;  PMID:18513999 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d1/20/onci-2-e27025.PMC3862634.pdf
FASEB J 2012;  26:2253-76;  PMID:22362896 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d1/20/onci-2-e27025.PMC3862634.pdf
http://www.can - cer.gov/clinicaltrials/search/view?cdrid=442407&ve rsion=HealthProfessional .,Non-OADS,/arxiv_data1/oa_pdf/d1/20/onci-2-e27025.PMC3862634.pdf
Clin  Cancer Res 2008; 14:1032-40;  PMID :18281535 ;  http://dx.doi.org/10.1158/1078-0432.CCR-07-2056 .,Non-OADS,/arxiv_data1/oa_pdf/d1/20/onci-2-e27025.PMC3862634.pdf
"OncoImmunology 2013; 2:e26097;http://dx.doi.org/10.4161/onci.26097New prospects   on the NKG2D/NKG2DL system for oncology evelyn Ullrich1,2,*, Joachim Koch2,3, adelheid Cerwenka4, and a lexander Steinle5 1Children’s Hospital; Department of Pediatric Hematology and Oncology; Goethe-University Frankfurt am Main; Frankfurt am Main, Germany;   2Center for Cell and Gene Therapy; Goethe University Frankfurt am Main; Frankfurt am Main, Germany; 3Institute for Biomedical r esearch; Georg-Speyer-Haus;   NK Cell Biology; Frankfurt am Main, Germany; 4German Cancer r esearch Center (DKFZ); Innate Immunity Group; Heidelberg, Germany;   5Institute for Molecular Medicine; Goethe-University Frankfurt am Main; Frankfurt am Main, Germany Keywords:  immune escape, MIC, NK cell, NKG2D, Rae, T cell, tumor immunology, ULBP The activating immunoreceptor NKG2D endows cytotoxic  lymphocytes with the capacity to recognize and eliminate  infected or malignant cells.",Non-OADS,/arxiv_data1/oa_pdf/13/01/onci-2-e26097.PMC3862635.pdf
Trends Immunol  2013; 34:182-91;  PMID:23414611 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/13/01/onci-2-e26097.PMC3862635.pdf
Annu Rev Immunol 2013 ; 31:413-41;  PMID:23298206 ; http://dx.doi.org/10.1146/ annurev-immunol-032712-095951 5.,Non-OADS,/arxiv_data1/oa_pdf/13/01/onci-2-e26097.PMC3862635.pdf
Oncogene  2008 ; 27:5944 -58;  PMID:18836475 ; http://dx.doi.org/10.1038/ onc.2008.272 6.,OADS,/arxiv_data1/oa_pdf/13/01/onci-2-e26097.PMC3862635.pdf
Oncogene  2008 ; 27:5932 - 43; PMID:18836474 ; http://dx.doi.org/10.1038/ onc.2008.267 7.,OADS,/arxiv_data1/oa_pdf/13/01/onci-2-e26097.PMC3862635.pdf
Nat Rev Immunol 2009 ; 9:568-80;  PMID:19629084 ; http://dx.doi.org/10.1038/ nri2604 8.,Non-OADS,/arxiv_data1/oa_pdf/13/01/onci-2-e26097.PMC3862635.pdf
Nat  Rev Immunol  2003 ; 3:304-16; PMID:12669021 ;  http://dx.doi.org/10.1038/nri1055 10.,Non-OADS,/arxiv_data1/oa_pdf/13/01/onci-2-e26097.PMC3862635.pdf
J Exp Med   1991 ; 173:1017 -20; PMID:2007850 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/13/01/onci-2-e26097.PMC3862635.pdf
Annu Rev Immunol   2005 ; 23:225-74; PMID :15771571 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/13/01/onci-2-e26097.PMC3862635.pdf
Tissue Antigens   2003 ; 61:335-43; PMID:12753652 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/13/01/onci-2-e26097.PMC3862635.pdf
Nat Rev Immunol 2003 ; 3:781- 90; PMID:14523385 ; http://dx.doi.org/10.1038/ nri1199 15.,Non-OADS,/arxiv_data1/oa_pdf/13/01/onci-2-e26097.PMC3862635.pdf
Proc Natl Acad Sci U S A   2003 ; 100:9452 -7; PMID:12878725 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/13/01/onci-2-e26097.PMC3862635.pdf
Proc Natl Acad Sci U S A   2011 ; 108:4081 -6; PMID:21321202 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/13/01/onci-2-e26097.PMC3862635.pdf
Science   1999 ; 285:730-2; PMID:10426994 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/13/01/onci-2-e26097.PMC3862635.pdf
Proc Natl Acad Sci U S A   2005 ; 102:7641 -6; PMID :15894612 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/13/01/onci-2-e26097.PMC3862635.pdf
Nat Immunol   2006 ; 7:524-32; PMID:16582911 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/13/01/onci-2-e26097.PMC3862635.pdf
Nat Immunol   2002 ; 3:1142 -9; PMID:12426565 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/13/01/onci-2-e26097.PMC3862635.pdf
Nat Immunol  2003 ; 4:565-72;  PMID:12740576 ; http://dx.doi.org/10.1038/ni930 24.,Non-OADS,/arxiv_data1/oa_pdf/13/01/onci-2-e26097.PMC3862635.pdf
Structure  2003 ; 11:411-22;  PMID:12679019 ; http://dx.doi.org/10.1016/ S0969-2126(03)00047-9 25.,OADS,/arxiv_data1/oa_pdf/13/01/onci-2-e26097.PMC3862635.pdf
Immunity  2003 ; 19:803-12;  PMID:14670298 ; http://dx.doi.org/10.1016/ S1074-7613(03)00320-0 26.,OADS,/arxiv_data1/oa_pdf/13/01/onci-2-e26097.PMC3862635.pdf
Proc Natl Acad Sci U S A   1998 ; 95:12510 -5; PMID:9770516 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/13/01/onci-2-e26097.PMC3862635.pdf
Immunogenetics   2001 ; 53:279-87; PMID :11491531 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/13/01/onci-2-e26097.PMC3862635.pdf
Nat Rev Immunol 2007 ; 7:737- 44; PMID:17673918 ; http://dx.doi.org/10.1038/ nri2144 29.,Non-OADS,/arxiv_data1/oa_pdf/13/01/onci-2-e26097.PMC3862635.pdf
Front Immunol   2012 ; 3:299; PMID:23056001 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/13/01/onci-2-e26097.PMC3862635.pdf
Immunity   2000 ; 12:721-7; PMID:10894171 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/13/01/onci-2-e26097.PMC3862635.pdf
Nat Immunol   2000 ; 1:119-26; PMID:11248803 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/13/01/onci-2-e26097.PMC3862635.pdf
PLoS One  2007 ; 2:e518 ; PMID:17565371 ;  http://dx.doi.org/10.1371/journal.pone.0000518 33.,Non-OADS,/arxiv_data1/oa_pdf/13/01/onci-2-e26097.PMC3862635.pdf
Immunity  2001 ; 14:123-33; PMID:11239445 ;  http://dx.doi.org/10.1016/S1074-7613(01)00095-4 34.,OADS,/arxiv_data1/oa_pdf/13/01/onci-2-e26097.PMC3862635.pdf
J Exp Med 2012 ; 209:2409 - 22; PMID:23166357 ; http://dx.doi.org/10.1084/ jem.20120565 36.,Non-OADS,/arxiv_data1/oa_pdf/13/01/onci-2-e26097.PMC3862635.pdf
Immunology  2009 ; 128:1-6; PMID:19689730 ;  http://dx.doi.org/10.1111/j.1365-2567.2009.03147.x 38.,Non-OADS,/arxiv_data1/oa_pdf/13/01/onci-2-e26097.PMC3862635.pdf
Cell Cycle  2011 ; 10:3346 - 58; PMID:21941086 ; http://dx.doi.org/10.4161/ cc.10.19.17630 42.,OADS,/arxiv_data1/oa_pdf/13/01/onci-2-e26097.PMC3862635.pdf
Nature  2007 ; 445:656-60;  PMID:17251933 ; http://dx.doi.org/10.1038/ nature05529 43.,Non-OADS,/arxiv_data1/oa_pdf/13/01/onci-2-e26097.PMC3862635.pdf
Semin Cancer Biol 2006 ;  16:344-7; PMID:16914325 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/13/01/onci-2-e26097.PMC3862635.pdf
Clin Cancer Res 2008 ;  14:3520 -8; PMID:18519785 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/13/01/onci-2-e26097.PMC3862635.pdf
Cancer Res 2005 ; 65:6321 -9;  PMID:16024634 ; http://dx.doi.org/10.1158/0008- 5472.CAN-04-4252 47.,Non-OADS,/arxiv_data1/oa_pdf/13/01/onci-2-e26097.PMC3862635.pdf
Oncogene  2009 ; 28:2370 -82; PMID:19430493 ;  http://dx.doi.org/10.1038/onc.2009.117 49.,Non-OADS,/arxiv_data1/oa_pdf/13/01/onci-2-e26097.PMC3862635.pdf
Blood  2013 ;  122:684-93; PMID:23801635 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/13/01/onci-2-e26097.PMC3862635.pdf
Cancer Res   2012 ; 72:5463 -72; PMID:22915757 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/13/01/onci-2-e26097.PMC3862635.pdf
Cancer Res   2012 ; 72:460-71; PMID:22102694 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/13/01/onci-2-e26097.PMC3862635.pdf
Nature  2002 ; 419:734-8;  PMID:12384702 ; http://dx.doi.org/10.1038/ nature0111253.,OADS,/arxiv_data1/oa_pdf/13/01/onci-2-e26097.PMC3862635.pdf
Front Biosci  2008 ; 13:3448 -56;  PMID:18508446 ; http://dx.doi.org/10.2741/2939 55.,OADS,/arxiv_data1/oa_pdf/13/01/onci-2-e26097.PMC3862635.pdf
Cancer Res   2008 ; 68:6368 -76; PMID:18676862 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/13/01/onci-2-e26097.PMC3862635.pdf
Nat Rev Microbiol 2005 ; 3:59- 69; PMID :15608700 ; http://dx.doi.org/10.1038/ nrmicro1066 57.,OADS,/arxiv_data1/oa_pdf/13/01/onci-2-e26097.PMC3862635.pdf
Eur J Immunol 2008 ; 38:2952 - 6; PMID:18979514 ; http://dx.doi.org/10.1002/ eji.200838823 58.,Non-OADS,/arxiv_data1/oa_pdf/13/01/onci-2-e26097.PMC3862635.pdf
Proc Natl Acad Sci U S A   1999 ; 96:6879 -84; PMID:10359807 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/13/01/onci-2-e26097.PMC3862635.pdf
Nature   2001 ; 413:165-71; PMID :11557981 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/13/01/onci-2-e26097.PMC3862635.pdf
Proc Natl Acad Sci U S A 2001 ; 98:11521 - 6; PMID:11562472 ; http://dx.doi.org/10.1073/ pnas.201238598 61.,OADS,/arxiv_data1/oa_pdf/13/01/onci-2-e26097.PMC3862635.pdf
Nat Immunol  2005 ; 6:928- 37; PMID:16116470 ; http://dx.doi.org/10.1038/ ni1239 63.,Non-OADS,/arxiv_data1/oa_pdf/13/01/onci-2-e26097.PMC3862635.pdf
J Exp Med   2005 ; 202:583-8; PMID:16129707 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/13/01/onci-2-e26097.PMC3862635.pdf
Semin Immunol  2006 ; 18:176-85;  PMID:16675266 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/13/01/onci-2-e26097.PMC3862635.pdf
Immunity  2008 ; 28:571- 80; PMID:18394936 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/13/01/onci-2-e26097.PMC3862635.pdf
Blood  2013 ; 121:5025 -33; PMID:23649470 ;  http://dx.doi.org/10.1182/blood-2012-12-471607 68.,Non-OADS,/arxiv_data1/oa_pdf/13/01/onci-2-e26097.PMC3862635.pdf
Immunity  2009 ; 31:270- 82; PMID :19631564 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/13/01/onci-2-e26097.PMC3862635.pdf
Blood   2005 ; 106:1711 -7; PMID:15886320 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/13/01/onci-2-e26097.PMC3862635.pdf
Int J Cancer 2012 ;  131:1601 -10; PMID:21607945 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/13/01/onci-2-e26097.PMC3862635.pdf
Clin Cancer Res 2009 ; 15:632-40;  PMID:19147769 ; http://dx.doi.org/10.1158/1078- 0432.CCR-08-1305 73.,Non-OADS,/arxiv_data1/oa_pdf/13/01/onci-2-e26097.PMC3862635.pdf
J Innate Immun 2011 ; 3:344-54; PMID :21576922 ;  http://dx.doi.org/10.1159/000327014 74.,Non-OADS,/arxiv_data1/oa_pdf/13/01/onci-2-e26097.PMC3862635.pdf
Rehabil Nurs   2006 ; 31:106-13; PMID:16669572 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/13/01/onci-2-e26097.PMC3862635.pdf
J Hepatol 2012 ; 56:381-8;  PMID:21756848 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/13/01/onci-2-e26097.PMC3862635.pdf
Clin Cancer Res 2009 ; 15:5208 -15;  PMID:19671853 ; http://dx.doi.org/10.1158/1078- 0432.CCR-09-0886 80.,Non-OADS,/arxiv_data1/oa_pdf/13/01/onci-2-e26097.PMC3862635.pdf
Eur J Immunol 2010 ; 40:3255 - 67; PMID:21061445 ; http://dx.doi.org/10.1002/ eji.201040568 81.,Non-OADS,/arxiv_data1/oa_pdf/13/01/onci-2-e26097.PMC3862635.pdf
J Immunother  2011 ; 34:289-96; PMID:21389869 ;  http://dx.doi.org/10.1097/CJI.0b013e31820e1b0d 82.,Non-OADS,/arxiv_data1/oa_pdf/13/01/onci-2-e26097.PMC3862635.pdf
FEBS Lett  2007 ;  581:1317 -22; PMID:17349632 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/13/01/onci-2-e26097.PMC3862635.pdf
J Leukoc Biol 2012 ; 91:321- 31; PMID:22124136 ; http://dx.doi.org/10.1189/ jlb.071133985.,Non-OADS,/arxiv_data1/oa_pdf/13/01/onci-2-e26097.PMC3862635.pdf
J Clin Invest 2012 ; 122:3718 - 30; PMID:22945631 ; http://dx.doi.org/10.1172/ JCI61931 86.,Non-OADS,/arxiv_data1/oa_pdf/13/01/onci-2-e26097.PMC3862635.pdf
Nat Rev Cancer 2012 ;  12:252-64; PMID:22437870 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/13/01/onci-2-e26097.PMC3862635.pdf
J Immunol  2012 ;  189:5493 -7; PMID:23183896 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/13/01/onci-2-e26097.PMC3862635.pdf
"Int J Cancer 2009 ; 125:212-21; PMID:19358282 ;  http://dx.doi.org/10.1002/ijc.24351 89. von Strandmann  EP, Hansen  HP, Reiners  KS,  Schnell  R, Borchmann  P, Merkert  S, Simhadri  VR,  Draube  A, Reiser  M, Purr I, et al.",OADS,/arxiv_data1/oa_pdf/13/01/onci-2-e26097.PMC3862635.pdf
Blood  2006 ; 107:1955 -62; PMID:16210338 ;  http://dx.doi.org/10.1182/blood-2005-05-217790.,Non-OADS,/arxiv_data1/oa_pdf/13/01/onci-2-e26097.PMC3862635.pdf
Leukemia  2012 ; 26:830-4;  PMID:22005785 ; http://dx.doi.org/10.1038/ leu.2011.288 91.,Non-OADS,/arxiv_data1/oa_pdf/13/01/onci-2-e26097.PMC3862635.pdf
Cancer Immunol Immunother  2008 ; 57:411-23;  PMID:17717662 ; http://dx.doi.org/10.1007/ s00262-007-0383-3 92.,Non-OADS,/arxiv_data1/oa_pdf/13/01/onci-2-e26097.PMC3862635.pdf
Blood  2005 ; 106:1544 -51;  PMID :15890688 ; http://dx.doi.org/10.1182/ blood-2004-11-4365 93.,Non-OADS,/arxiv_data1/oa_pdf/13/01/onci-2-e26097.PMC3862635.pdf
Immunol  Cell Biol  2013 ; 91:435-40; PMID:23628805 ;  http://dx.doi.org/10.1038/icb.2013.17 94.,Non-OADS,/arxiv_data1/oa_pdf/13/01/onci-2-e26097.PMC3862635.pdf
"OncoImmunology 2013; 2:e26404; http://dx.doi.org/10.4161/onci.26404REG3β contributes to the immunosuppressive  microenvironment of pancreatic cancer emma Folch-Puy experimental Pathology Department; IIBB-C sIC; Centro de Investigación Biomédica en r ed de e nfermedades h epáticas y Digestivas (CIB ereh D); Barcelona, s pain Keywords:  macrophage polarization, pancreatic ductal adenocarcinoma, REG3 β Abbreviations: PDAC, pancreatic ductal adenocarcinoma; REG3 β, regenerating islet-derived 3 β;   STAT3, signal transducer and activator of transcription 3; TAM, tumor-associated macrophage The levels of regenerating islet-derived 3 β (reG3 β) in the serum and pancreatic juice of patients affected by pancre - atic ductal adenocarcinomas are increased.",Non-OADS,/arxiv_data1/oa_pdf/ce/10/onci-2-e26404.PMC3862636.pdf
Immunotherapy 2011; 3:517-37; PMID:21463193 ;  http://dx.doi.org/10.2217/imt.11.10 2.,Non-OADS,/arxiv_data1/oa_pdf/ce/10/onci-2-e26404.PMC3862636.pdf
Gut 2011 ; 60:861-8; PMID:20966025 ;  http://dx.doi.org/10.1136/gut.2010.226092 3.,Non-OADS,/arxiv_data1/oa_pdf/ce/10/onci-2-e26404.PMC3862636.pdf
Nat Rev Gastroenterol Hepatol   2012 ; 9:454-67; PMID:22710569 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ce/10/onci-2-e26404.PMC3862636.pdf
J Clin Invest 2012 ;  122:787-95; PMID:22378047 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ce/10/onci-2-e26404.PMC3862636.pdf
Am J Physiol  Regul Integr Comp Physiol 2012 ; 302:R1067 - 75; PMID:22422663 ; http://dx.doi.org/10.1152/ ajpregu.00320.2011 6.,Non-OADS,/arxiv_data1/oa_pdf/ce/10/onci-2-e26404.PMC3862636.pdf
Gut 2007 ; 56:1091 - 7; PMID:17409121 ; http://dx.doi.org/10.1136/ gut.2006.116087 7.,Non-OADS,/arxiv_data1/oa_pdf/ce/10/onci-2-e26404.PMC3862636.pdf
Cancer Res  2013 ; 73:5682 -94; PMID:23867474 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ce/10/onci-2-e26404.PMC3862636.pdf
Science  2011 ; 331:1612 - 6; PMID:21436454 ; http://dx.doi.org/10.1126/ science.1198443 10.,Non-OADS,/arxiv_data1/oa_pdf/ce/10/onci-2-e26404.PMC3862636.pdf
Oncogene  2013 ;  (Forthcoming ); PMID:23851493 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ce/10/onci-2-e26404.PMC3862636.pdf
"OncoImmunology 2013; 2:e26384; http://dx.doi.org/10.4161/onci.26384Crucial role of inflammatory monocytes   in antitumor immunity arnaud Pommier1,2, Bruno Lucas1,2, and a rmelle Prévost-Blondel1,2,* 1CNrs u Mr8104; IN serM u 1016; Cochin Institute; Paris, France; 2Paris Descartes u niversity; Cochin Institute; Paris, France Keywords:  inflammatory monocytes, inflammatory DCs, ROS, CD4+ regulatory T cells, immunosurveillance, melanoma, vitiligo although the role of myeloid cells in oncogenesis and tumor progression remains poorly understood, these cells are  mainly ascribed with pro-tumor properties.",Non-OADS,/arxiv_data1/oa_pdf/78/c5/onci-2-e26384.PMC3862637.pdf
PLoS Biol 2011; 9:e1001162;  PMID:21980263 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/78/c5/onci-2-e26384.PMC3862637.pdf
PLoS One 2011; 6:e20235;  PMID:21633700 ; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/78/c5/onci-2-e26384.PMC3862637.pdf
Proc Natl Acad Sci U S A 2013; 110:13085-90;  PMID:23878221 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/78/c5/onci-2-e26384.PMC3862637.pdf
J Clin Invest 2010; 120:2030- 9; PMID:20501944 ; http://dx.doi.org/10.1172/ JCI42002 5.,Non-OADS,/arxiv_data1/oa_pdf/78/c5/onci-2-e26384.PMC3862637.pdf
Cancer Res 2004; 64:1496-501; PMID:14973052 ; http://dx.doi.org/10.1158/0008- 5472.CAN-03-2828 6.,Non-OADS,/arxiv_data1/oa_pdf/78/c5/onci-2-e26384.PMC3862637.pdf
Annu Rev Immunol  2009; 27:669-92;  PMID:19132917 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/78/c5/onci-2-e26384.PMC3862637.pdf
J Exp Med 1999; 189:1343-54; PMID:10209050 ; http://dx.doi.org/10.1084/ jem.189.8.13438.,Non-OADS,/arxiv_data1/oa_pdf/78/c5/onci-2-e26384.PMC3862637.pdf
Immunity 2008; 28:546-58; PMID:18387831 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/78/c5/onci-2-e26384.PMC3862637.pdf
PLoS Pathog  2010; 6:e1001045;  PMID:20714353 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/78/c5/onci-2-e26384.PMC3862637.pdf
Immunity 2013; 38:729- 41; PMID:23562161 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/78/c5/onci-2-e26384.PMC3862637.pdf
"OncoImmunology 2013; 2:e26293; http://dx.doi.org/10.4161/onci.26293APLP2 regulates   the expression of MHC class I molecules   on irradiated Ewing’s sarcoma cells haley L Peters1,†, ying y an1, and Joyce c s olheim1,2,3,* 1eppley Institute; University of Nebraska Medical c enter; Omaha, N e Usa;   2Department of Biochemistry and Molecular Biology; University of Nebraska Medical c enter; Omaha, N e Usa;   3Department of Pathology and Microbiology; University of Nebraska Medical c enter; Omaha, N e Usa †current a ffiliation: Department of s tem c ell Transplantation and c ellular Therapy; University of Texas MD a nderson c ancer c enter; h ouston, TX U sa Keywords:  amyloid β (A4) precursor-like protein 2, Ewing’s sarcoma, HLA, immune evasion, immunotherapy,   MHC class I molecule, pediatric cancer, radiation therapy Abbreviations: APLP2, amyloid β (A4) precursor-like protein 2; APP, amyloid precursor protein; CTL, cytotoxic T lymphocyte;  EWS, Ewing’s sarcoma; IFN, interferon.",Non-OADS,/arxiv_data1/oa_pdf/1c/5c/onci-2-e26293.PMC3862638.pdf
Oncologist  2006; 11:503-19;  PMID:16720851 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1c/5c/onci-2-e26293.PMC3862638.pdf
Cancer Lett 2007; 254:1-10; PMID:17250957 ;  http://dx.doi.org/10.1016/j.canlet.2006.12.009 3.,OADS,/arxiv_data1/oa_pdf/1c/5c/onci-2-e26293.PMC3862638.pdf
Ann Oncol 2009; 20(Suppl 4):140-2;  PMID:19454436 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1c/5c/onci-2-e26293.PMC3862638.pdf
Pediatr Clin North Am 2010; 57:83-96; PMID:20307713 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/1c/5c/onci-2-e26293.PMC3862638.pdf
Cancer Treat Rev 2010; 36:318- 27; PMID:20223596 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/1c/5c/onci-2-e26293.PMC3862638.pdf
Cancer Biol Ther  2003; 2:579-86;  PMID:14614331 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1c/5c/onci-2-e26293.PMC3862638.pdf
Immunobiology  1999; 200:1-20;  PMID:10084692 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1c/5c/onci-2-e26293.PMC3862638.pdf
J Pathol 2009; 218:222-31; PMID:19274709 ;  http://dx.doi.org/10.1002/path.2537 10.,Non-OADS,/arxiv_data1/oa_pdf/1c/5c/onci-2-e26293.PMC3862638.pdf
Int J Cancer 1999; 80:781-90;  PMID:10048982 ; http://dx.doi.org/10.1002/ (SICI)1097-0215(19990301)80:5<781::AID-IJC24>3.0.CO;2-A 12.,Non-OADS,/arxiv_data1/oa_pdf/1c/5c/onci-2-e26293.PMC3862638.pdf
J Surg Oncol  2011; 103:380-5;  PMID:21400519 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1c/5c/onci-2-e26293.PMC3862638.pdf
Cancer Sci 2006; 97:1374-80; PMID:16995877 ;  http://dx.doi.org/10.1111/j.1349-7006.2006.00317.x 14.,Non-OADS,/arxiv_data1/oa_pdf/1c/5c/onci-2-e26293.PMC3862638.pdf
Cancer Immunol Immunother 2009; 58:1419-31; PMID:19184004 ;  http://dx.doi.org/10.1007/s00262-009-0657-z 15.,Non-OADS,/arxiv_data1/oa_pdf/1c/5c/onci-2-e26293.PMC3862638.pdf
Mol Neurodegener  2006; 1:5; PMID:16930452 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1c/5c/onci-2-e26293.PMC3862638.pdf
Biochem Soc Trans 2007; 35:416-20;  PMID:17371289 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1c/5c/onci-2-e26293.PMC3862638.pdf
J Pathol 2008; 215:155- 63; PMID:18393365 ; http://dx.doi.org/10.1002/ path.234319.,Non-OADS,/arxiv_data1/oa_pdf/1c/5c/onci-2-e26293.PMC3862638.pdf
J Neurochem  2004; 91:423-8;  PMID :15447675 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1c/5c/onci-2-e26293.PMC3862638.pdf
FEBS Lett 1999; 442:95-8; PMID:9923612 ; http://dx.doi.org/10.1016/ S0014-5793(98)01635-4 21.,OADS,/arxiv_data1/oa_pdf/1c/5c/onci-2-e26293.PMC3862638.pdf
J Neurosci Res 2008; 86:744- 54; PMID:17828772 ; http://dx.doi.org/10.1002/ jnr.21532 26.,Non-OADS,/arxiv_data1/oa_pdf/1c/5c/onci-2-e26293.PMC3862638.pdf
Proc Natl Acad Sci U S A 2007; 104:14140-5;  PMID:17709753 ; http://dx.doi.org/10.1073/ pnas.0704070104 27.,OADS,/arxiv_data1/oa_pdf/1c/5c/onci-2-e26293.PMC3862638.pdf
J Biol Chem 2003; 278:12618- 23; PMID:12506118 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/1c/5c/onci-2-e26293.PMC3862638.pdf
Supplemental Materials Supplemental materials may be found here: http://www.landesbioscience.com/journals/oncoimmunology/article/26293/,Non-OADS,/arxiv_data1/oa_pdf/1c/5c/onci-2-e26293.PMC3862638.pdf
Immunogenetics 2008; 60:303-13;  PMID:18452037 ;  http://dx.doi.org/10.1007/s00251-008-0296-0 29.,Non-OADS,/arxiv_data1/oa_pdf/1c/5c/onci-2-e26293.PMC3862638.pdf
Immunol Res 2011; 51:39-44; PMID:21826533 ;  http://dx.doi.org/10.1007/s12026-011-8238-6 32.,Non-OADS,/arxiv_data1/oa_pdf/1c/5c/onci-2-e26293.PMC3862638.pdf
J Exp Med 2006; 203:1259-71; PMID:16636135 ; http://dx.doi.org/10.1084/ jem.20052494 33.,Non-OADS,/arxiv_data1/oa_pdf/1c/5c/onci-2-e26293.PMC3862638.pdf
Cancer Biol Ther 2013; 14:752- 60; PMID:23792571 ; http://dx.doi.org/10.4161/ cbt.25183 35.,Non-OADS,/arxiv_data1/oa_pdf/1c/5c/onci-2-e26293.PMC3862638.pdf
PLoS One 2012; 7:e32542;  PMID:22396773 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1c/5c/onci-2-e26293.PMC3862638.pdf
Nature 2005; 436:1186-90;  PMID:15995699 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1c/5c/onci-2-e26293.PMC3862638.pdf
Cancer Immunol Immunother 2007; 56:227- 36; PMID:16783578 ; http://dx.doi.org/10.1007/ s00262-006-0183-1 39.,Non-OADS,/arxiv_data1/oa_pdf/1c/5c/onci-2-e26293.PMC3862638.pdf
J Immunol 2011;  186 :1538-45;  PMID:21191066 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1c/5c/onci-2-e26293.PMC3862638.pdf
Clin Cancer Res 2010; 16:3901-9; PMID:20542985 ;  http://dx.doi.org/10.1158/1078-0432.CCR-10-0735 41.,Non-OADS,/arxiv_data1/oa_pdf/1c/5c/onci-2-e26293.PMC3862638.pdf
Cancer 1993;  71:237-48;  PMID:8416722 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1c/5c/onci-2-e26293.PMC3862638.pdf
Cancer Immunol  Immunother 1994; 39:73-83;  PMID:7519127 ;  http://dx.doi.org/10.1007/BF0152531244.,Non-OADS,/arxiv_data1/oa_pdf/1c/5c/onci-2-e26293.PMC3862638.pdf
J Pathol 2009; 218:222-31; PMID:19274709 ;  http://dx.doi.org/10.1002/path.2537 45.,Non-OADS,/arxiv_data1/oa_pdf/1c/5c/onci-2-e26293.PMC3862638.pdf
Eur J Immunol 1994; 24:1285- 92; PMID:8206088 ; http://dx.doi.org/10.1002/ eji.1830240607 49.,Non-OADS,/arxiv_data1/oa_pdf/1c/5c/onci-2-e26293.PMC3862638.pdf
Immunogenetics 1999; 49:312-20; PMID:10079295 ; http://dx.doi.org/10.1007/ s002510050498 51.,Non-OADS,/arxiv_data1/oa_pdf/1c/5c/onci-2-e26293.PMC3862638.pdf
Hum Immunol 1981; 3:277-99; PMID :7035415 ;  http://dx.doi.org/10.1016/0198-8859(81)90065-3 52.,Non-OADS,/arxiv_data1/oa_pdf/1c/5c/onci-2-e26293.PMC3862638.pdf
Oncogene 2005; 24:3285- 96; PMID:15735702 ; http://dx.doi.org/10.1038/ sj.onc.1208492,Non-OADS,/arxiv_data1/oa_pdf/1c/5c/onci-2-e26293.PMC3862638.pdf
"This mechanism operates through mitochondrial depolarization, cytochrome c release and the activation  *Correspondence to: Romain Boidot; Email: rboidot@cgfl.fr Submitted: 08/30/2013; Accepted: 08/31/2013Citation: Végran F, Boidot R. Survivin-3B promotes chemoresistance and immune escape by inhibiting caspase-8 and -6 in cancer cells  OncoImmunology 2013; 2:e26328; http://dx.doi.org/10.4161/onci.26328Survivin-3B promotes chemoresistance   and immune escape by inhibiting caspase-8   and -6 in cancer cells Frédérique Végran1 and r omain Boidot2,* 1INserM u 866; Department of Tumor Biology and Pathology; u nit of Molecular Biology; Dijon, France;   2Centre Georges-François Leclerc; Department of Tumor Biology and Pathology; u nit of Molecular Biology; Dijon, France Keywords:  caspase-6, caspase-8, survivin-3B, tumorigenesis, tumor escape, treatment response Abbreviations: BIR, baculovirus IAP repeat; DISC, death-inducing signaling complex; NK, natural killer; S-3B: survivin-3B survivin-3B ( s-3B), an alternative splice isoform of survivin, plays a key role in tumorigenesis.",Non-OADS,/arxiv_data1/oa_pdf/f6/2c/onci-2-e26328.PMC3862639.pdf
Biochem Biophys Res Commun 2004; 314:902- 7; PMID:14741722 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f6/2c/onci-2-e26328.PMC3862639.pdf
Cell Cycle   2007 ; 6:1502 -9; PMID:17582222 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f6/2c/onci-2-e26328.PMC3862639.pdf
Oncol  Res 2010 ; 18:541-7; PMID:20939430 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f6/2c/onci-2-e26328.PMC3862639.pdf
Oncoimmunology  2012 ; 1:38-47; PMID:22720210 ;  http://dx.doi.org/10.4161/onci.1.1.18312 6.,Non-OADS,/arxiv_data1/oa_pdf/f6/2c/onci-2-e26328.PMC3862639.pdf
Endocr Relat Cancer 2011 ; 18:783- 92; PMID:21878572 ; http://dx.doi.org/10.1530/ ERC-11-0105,Non-OADS,/arxiv_data1/oa_pdf/f6/2c/onci-2-e26328.PMC3862639.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/6f/45/jpr-7-001.PMC3862644.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpJournal of Pain Research 2014:7 1–3Journal of Pain Research Dove press submit your manuscript | www.dovepress.co m Dove press  1Edito Rialopen access to scientific and medical research open access Full text article http: //dx.doi.org/10.2147/JPR.S5814 8a practical and ethical solution to the opioid  scheduling conundrum Michael E Schatman1 Beth d darnall2 1Foundation for Ethics in Pain  Care, Bellevue, W a, USa; 2Stanford  University School of Medicine,   division of Pain Medicine, Palo alto,   Ca, USa Correspondence: Michael E Schatman   Foundation for Ethics in Pain Care,   1601 114th ave.",Non-OADS,/arxiv_data1/oa_pdf/6f/45/jpr-7-001.PMC3862644.pdf
"Journal of Pain Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-pain-research-journa lThe Journal of Pain Research is an international, peer-reviewed, open  access, online journal that welcomes laboratory and clinical findings  in the fields of pain research and the prevention and management  of pain.",Non-OADS,/arxiv_data1/oa_pdf/6f/45/jpr-7-001.PMC3862644.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/6f/45/jpr-7-001.PMC3862644.pdf
Available from:  http://www.medscape.com/viewarticle/777126.,Non-OADS,/arxiv_data1/oa_pdf/6f/45/jpr-7-001.PMC3862644.pdf
"Available from: http://www.fda.gov/RegulatoryInformation/  Legislation/ucm148726.ht m. Accessed October 31, 2013.",Non-OADS,/arxiv_data1/oa_pdf/6f/45/jpr-7-001.PMC3862644.pdf
"Available from: http://www.justice.gov/dea/docs/ drugs_of_abuse_2011.pd f. Accessed November 3, 2013.",OADS,/arxiv_data1/oa_pdf/6f/45/jpr-7-001.PMC3862644.pdf
"Available from: http://www.cdc.gov/media/releases/2013/ p0220_drug_overdose_deaths.htm l. Accessed November 3, 2013.",OADS,/arxiv_data1/oa_pdf/6f/45/jpr-7-001.PMC3862644.pdf
"Available from: https://www.incb.org/incb/en/publications/ annual-reports/annual-report-2012.htm l. Accessed November 3,  2013.",Non-OADS,/arxiv_data1/oa_pdf/6f/45/jpr-7-001.PMC3862644.pdf
Available  from: http://www.who.int/cancer/palliative/painladder/en /.,Non-OADS,/arxiv_data1/oa_pdf/6f/45/jpr-7-001.PMC3862644.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/fb/9d/ijgm-7-021.PMC3862645.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of General Medicine 2014:7 21–27International Journal of General Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  21Case reportopen access to scientific and medical research open access Full text article http: //dx.doi.org/10.2147/IJGM.S5130 2an unusual case of malignancy-   related hypercalcemia Mary-anne Doyle Janine C Malcolm Division of endocrinology, University  of ottawa, ottawa, oN, Canada Correspondence: Mary-anne Doyle   ottawa Hospital, 1967 riverside   Drive, 4th Floor, ottawa, oN,   Canada, K1H 7W9   email madoyle@ toh.on.ca Objective:  To report the case of a 28-year-old woman who presented with hypercalcemia (total  calcium =4.11 mmol/L), elevated parathyroid hormone (PTH) 24.6  pmol/L, normal parathyroid  hormone-related peptide 7.8 pg/mL, and a 63 mm × 57 mm, poorly differentiated neuroendocrine  carcinoma (small-cell type) pancreatic mass with liver metastases.",Non-OADS,/arxiv_data1/oa_pdf/fb/9d/ijgm-7-021.PMC3862645.pdf
"Available at http://www.stjoes.ca/pdfs/PHPT%20position2003.pd f.  Accessed September 18, 2013.",Non-OADS,/arxiv_data1/oa_pdf/fb/9d/ijgm-7-021.PMC3862645.pdf
"International Journal of General Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-general-medicine-journa lThe International Journal of General Medicine is an international,  peer-reviewed open-access journal that focuses on general and internal  medicine, pathogenesis, epidemiology, diagnosis, monitoring and treat - ment protocols.",Non-OADS,/arxiv_data1/oa_pdf/fb/9d/ijgm-7-021.PMC3862645.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/fb/9d/ijgm-7-021.PMC3862645.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/03/99/tcrm-9-491.PMC3862646.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2013:9 491–504Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  491ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S5207 8national Drug Formulary review of statin  therapeutic group using the multiattribute   scoring tool azuana Ramli1,3 syed Mohamed aljunid1,2 saperi sulong2 Faridah aryani Md Yusof3 1United nations University  international institute for global  health (Un U-iigh), Kuala lumpur,   Malaysia; 2international Centre for  Casemix and Clinical Coding (iTCC),   Universiti Kebangsaan Malaysia  Medical Centre, Kuala lumpur,   Malaysia; 3Pharmaceutical services  Division, Ministry of health, Petaling  Jaya, Malaysia Correspondence: azuana Ramli   C/o syed Mohamed aljunid, UnU-iigh  Building, UKM Medical Center, Jalan  Yaacob latiff, Cheras, 56000   Kuala lumpur, Malaysia   Tel +60 39 171 5394   Fax +60 39 171 5402   email azuanaramli@yahoo.co mPurpose:  HMG-CoA reductase inhibitors (statins) are extensively used in treating  hypercholesterolemia.",Non-OADS,/arxiv_data1/oa_pdf/03/99/tcrm-9-491.PMC3862646.pdf
The strengths and formulation  locally available were searched using the Quest 2  search  engine on the NPCB website at http://portal.bpfk.gov.my /.,OADS,/arxiv_data1/oa_pdf/03/99/tcrm-9-491.PMC3862646.pdf
"After checking through landmark trials reported by Trial- Results Centre website at http://www.trialresultscenter.org /,21  drug evaluations and comparisons of the statins in MM,20 as  well as other meta-analysis and review papers available on  statins and discussing them, the committee decided to use the  efficacy values reported in STELLAR (Statin Therapies for  Elevated Lipid Levels compared Across doses to Rosuvastatin)  trial22–24 to score these criteria.",Non-OADS,/arxiv_data1/oa_pdf/03/99/tcrm-9-491.PMC3862646.pdf
Relevant trials were sought in Trial- Results Centre via ( http://www.trialresultscenter.org /)21 and  reviewed.,OADS,/arxiv_data1/oa_pdf/03/99/tcrm-9-491.PMC3862646.pdf
Results of trials are mainly accessed through Trials-Results Centre website at http://www.trialresultscenter.org /.,Non-OADS,/arxiv_data1/oa_pdf/03/99/tcrm-9-491.PMC3862646.pdf
Available at: http://www.whocc.no/atc_ddd_index /.,OADS,/arxiv_data1/oa_pdf/03/99/tcrm-9-491.PMC3862646.pdf
"Available at: http://www.trialresultscenter.org/sNb.as p.  Accessed February 22, 2012.",Non-OADS,/arxiv_data1/oa_pdf/03/99/tcrm-9-491.PMC3862646.pdf
Available at: http://www.ncbi.nlm.nih.,Non-OADS,/arxiv_data1/oa_pdf/03/99/tcrm-9-491.PMC3862646.pdf
"Available at: http://www.sciencedirect.com/science/ article/pii/S014067360211600 X. Accessed July 22, 2013.",Non-OADS,/arxiv_data1/oa_pdf/03/99/tcrm-9-491.PMC3862646.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/03/99/tcrm-9-491.PMC3862646.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/03/99/tcrm-9-491.PMC3862646.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/61/80/rru-6-001.PMC3862648.pdf
"Information on how to request permission may be found at: http://www.dovepress.com/permissions.phpResearch and Reports in Urology 2014:6 1–16Research and Reports in Urology Dove press submit your manuscript | www.dovepress.co m Dove press  1Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/RRU.S4003 4Pharmacotherapy of overactive bladder in adults:  a review of efficacy, tolerability, and quality of life Jyotsna Jayarajan Sidney B Radomski Division of Urology, Department   of Surgery, Toronto Western   Hospital (University Health   Network), University of T oronto,    T oronto, Ontario, Canada Correspondence: Sidney B Radomski   T oronto Western Hospital, Main Pavilion,   8th Floor, Room 304, 399 Bathurst St,   T oronto, Ontario, M5T 2S8, Canada   T el +1 416 603 5800 ext 5713   Fax +1 416 603 5391   email sidney.radomski@uhn.c aIntroduction:  Overactive bladder (OAB) is a prevalent condition that has a significant impact  on quality of life.",Non-OADS,/arxiv_data1/oa_pdf/61/80/rru-6-001.PMC3862648.pdf
"The lower dose of 25 mg is recom - mended in patients with severe renal impairment (glomerular  filtration rate 15 to 29 mL/min/1.73 m2), moderate hepatic  impairment (Child-Pugh Class B [ http://www.accessdata.fda.",Non-OADS,/arxiv_data1/oa_pdf/61/80/rru-6-001.PMC3862648.pdf
"Available  from: http://www.arhp.org/uploadDocs/OABQRG.pd f. Accessed  September 27, 2013.",OADS,/arxiv_data1/oa_pdf/61/80/rru-6-001.PMC3862648.pdf
Available from: http://www.accessdata.,OADS,/arxiv_data1/oa_pdf/61/80/rru-6-001.PMC3862648.pdf
"Available from: http://www.accessdata.fda.gov/drugsatfda_docs/ label/2012/021595s009lbl.pd f.  Accessed October 18, 2013.",Non-OADS,/arxiv_data1/oa_pdf/61/80/rru-6-001.PMC3862648.pdf
"Available from: http://www.accessdata.fda.gov/drugsatfda_docs/ label/2010/021513s006lbl.pd f.  Accessed October 18, 2013.",Non-OADS,/arxiv_data1/oa_pdf/61/80/rru-6-001.PMC3862648.pdf
"Research and Reports in Urology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/research-and-reports-in-urology-journa lResearch and Reports in Urology is an international, peer-reviewed,  open access journal publishing original research, reports, editorials,  reviews and commentaries on all aspects of adult and pediatric urology  in the clinic and laboratory including the following topics: Pathology,  pathophysiology of urological disease; Investigation and treatment of urological disease; Pharmacology of drugs used for the treatment of  urological disease.",Non-OADS,/arxiv_data1/oa_pdf/61/80/rru-6-001.PMC3862648.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/61/80/rru-6-001.PMC3862648.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/57/77/idr-7-009.PMC3862651.pdf
"Information on how to request permission may be found at: http://www.dovepress.com/permissions.phpInfection and Drug Resistance 2014:7 9–14Infection and Drug Resistance Dove press submit your manuscript | www.dovepress.co m Dove press  9RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IDR.S4435 8Limiting and controlling carbapenem-resistant  Klebsiella pneumoniae Lisa Saidel-Odes1,2 Abraham Borer1,2 1Infection Control and Hospital  epidemiology Unit, 2Infectious  Diseases Institute, Soroka University  Medical Center and the Faculty  of Health Sciences, Ben-Gurion  University of the Negev,    Beer-Sheva, Israel Correspondence: Lisa Saidel-Odes   Infectious Diseases Institute,   Soroka University Medical Center,   PO Box 151, Beer-Sheva 84101, Israel   Tel +972 8 640 0370   Fax +972 8 640 3534   email saidelod@bgu.ac.i lAbstract:  Carbapenem-resistant Klebsiella pneumoniae  (CRKP) is resistant to almost all  antimicrobial agents, is associated with substantial morbidity and mortality, and poses a serious threat  to public health.",Non-OADS,/arxiv_data1/oa_pdf/57/77/idr-7-009.PMC3862651.pdf
"Infection and Drug Resistance Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/infection-and-drug-resistance-journa lInfection and Drug Resistance is an international, peer-reviewed open- access journal that focuses on the optimal treatment of infection (bacte - rial, fungal and viral) and the development and institution of preventive  strategies to minimize the development and spread of resistance.",Non-OADS,/arxiv_data1/oa_pdf/57/77/idr-7-009.PMC3862651.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/57/77/idr-7-009.PMC3862651.pdf
Available from: http://www.cdc.gov/hai/organisms/ cre/cre-toolkit /.,OADS,/arxiv_data1/oa_pdf/57/77/idr-7-009.PMC3862651.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/de/ae/ppa-8-001.PMC3862652.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2014:8 1–13Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  1OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S5452 0electronically monitored medication adherence  predicts hospitalization in heart failure patients Barbara riegel1,2 george J Knafl3 1University of Pennsylvania school of  nursing, 2University of Pennsylvania  leonard Davis institute, Philadelphia,   PA, UsA; 3University of north  carolina school of n ursing,    chapel hill, nc, UsA correspondence: Barbara riegel   University of Pennsylvania school  of nursing, 418 curie Boulevard,  Philadelphia, PA 19104-4217, UsA   Tel +1 215 898 9927   Fax +1 240 282 7707   email briegel@nursing.upenn.ed uBackground:  Hospitalization contributes enormously to health care costs associated with heart  failure.",Non-OADS,/arxiv_data1/oa_pdf/de/ae/ppa-8-001.PMC3862652.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal focusing on the growing importance of patient  preference and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/de/ae/ppa-8-001.PMC3862652.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/de/ae/ppa-8-001.PMC3862652.pdf
Available from:  http://www.who.int/chp/knowledge/publications/adherence_full_report.,Non-OADS,/arxiv_data1/oa_pdf/de/ae/ppa-8-001.PMC3862652.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/30/fb/cpaa-5-193.PMC3862653.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Pharmacology: Advances and Applications 2013:5 193–199Clinical Pharmacology: Advances and Applications Dove press submit your manuscript | www.dovepress.co m Dove press  193OriginAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CPAA.S5438 1hemodialysis does not alter in vitro hepatic  CYP3A4 and CYP2D6 metabolic activity   in uremic serum Brian s Decker1,2 Kalisha D O’n eill1,2 Mary A Chambers1,2 James e slaven3 Zhangsheng Yu3 David r Jones2,4 sharon M Moe1,2 1Division of nephrology, 2Department  of Medicine, 3Department of  Biostatistics, 4Division of Clinical  Pharmacology, Department of  Medicine, school of Medicine, indiana  University, indianapolis, in, UsA Correspondence: Brian s Decker   indiana University school of Medicine,   950 West Walnut st, r2-202, indianapolis,   in 46254, UsA   Tel +1 317 278 2865   Fax +1 317 274 8575   email bsdecker@iu.ed uAbstract:  There is a paucity of studies evaluating the change in liver metabolism in subjects  receiving hemodialysis.",Non-OADS,/arxiv_data1/oa_pdf/30/fb/cpaa-5-193.PMC3862653.pdf
"Clinical Pharmacology: Advances and Applications Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-pharmacology-advances-and-applications-journa lClinical Pharmacology: Advances and Applications is an international,  peer-reviewed, open access journal publishing original research, reports,  reviews and commentaries on all areas of drug experience in humans.",Non-OADS,/arxiv_data1/oa_pdf/30/fb/cpaa-5-193.PMC3862653.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/30/fb/cpaa-5-193.PMC3862653.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/5d/38/ijgm-7-013.PMC3862654.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of General Medicine 2014:7 13–19International Journal of General Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  13OrIGInal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJGM.S5380 0accuracy of diagnoses predicted from   a simple patient questionnaire stratified   by the duration of general ambulatory   training: an observational study Takanori Uehara1,2 Masatomi Ikusaka1 Y oshiyuki Ohira1 Mitsuyasu Ohta1,2 Kazutaka noda1 T omoko Tsukamoto1 T oshihiko Takada1 Masahito Miyahara1 1Department of General Medicine,   chiba University hospital, 2Division  of rotated collaboration systems for  local healthcare, Graduate school  of Medicine, chiba University, chiba,   Japan correspondence: Takanori Uehara   Department of General Medicine,   chiba University hospital, 1-8-1 Inohana,   chuo-ku, chiba 260-8677, Japan   Tel +81 43 222 7171   Fax +81 43 224 4758   email takanori.ue@nifty.co mPurpose:  To compare the diagnostic accuracy of diseases predicted from patient responses  to a simple questionnaire completed prior to examination by doctors with different levels of  ambulatory training in general medicine.",Non-OADS,/arxiv_data1/oa_pdf/5d/38/ijgm-7-013.PMC3862654.pdf
"International Journal of General Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-general-medicine-journa lThe International Journal of General Medicine is an international,  peer-reviewed open-access journal that focuses on general and internal  medicine, pathogenesis, epidemiology, diagnosis, monitoring and treat - ment protocols.",Non-OADS,/arxiv_data1/oa_pdf/5d/38/ijgm-7-013.PMC3862654.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/5d/38/ijgm-7-013.PMC3862654.pdf
"OncoImmunology 2013; 2:e26296;  http://dx.doi.org/10.4161/onci.26296Non-replicating Toxoplasma gondii  reverses  tumor-associated immunosuppression Barbara a Fox, Kiah L s anders, and David J Bzik* Department of Microbiology and Immunology; Geisel s chool of Medicine at Dartmouth; Lebanon, N h usa Keywords:  anticancer vaccines, cancer immunotherapy, CD8+ T cells, non-replicating Toxoplasma gondii ,  reversing tumor-derived immunosuppression we examined the efficacy of using attenuated non-replicating Toxoplasma gondii  uracil auxotrophs that can be safely  delivered as anticancer immunotherapeutics.",Non-OADS,/arxiv_data1/oa_pdf/dd/f8/onci-2-e26296.PMC3862683.pdf
Immunity 2013; 39:61- 73; PMID:23890064 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/dd/f8/onci-2-e26296.PMC3862683.pdf
Infect Immun 2005; 73:703-11;  PMID :15664908 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/dd/f8/onci-2-e26296.PMC3862683.pdf
Infect Immun 2012; 80:476-82; PMID:22104110 ;  http://dx.doi.org/10.1128/IAI.05974-11 4.,Non-OADS,/arxiv_data1/oa_pdf/dd/f8/onci-2-e26296.PMC3862683.pdf
PLoS Pathog  2012; 8:e1002825;  PMID:22910631 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/dd/f8/onci-2-e26296.PMC3862683.pdf
PLoS Pathog 2011; 7:e1002236;  PMID :21931552 ; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/dd/f8/onci-2-e26296.PMC3862683.pdf
Cell Host Microbe 2010; 8:484-95; PMID:21147463 ;  http://dx.doi.org/10.1016/j.chom.2010.11.005 7.,OADS,/arxiv_data1/oa_pdf/dd/f8/onci-2-e26296.PMC3862683.pdf
Nature 2002; 415:926-9;  PMID:11859373 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/dd/f8/onci-2-e26296.PMC3862683.pdf
Infect Immun 2010; 78:3744- 52; PMID:20605980 ; http://dx.doi.org/10.1128/ IAI.00287-10 9.,Non-OADS,/arxiv_data1/oa_pdf/dd/f8/onci-2-e26296.PMC3862683.pdf
Cancer Res 2013; 73:3842-51;  PMID:23704211 ; http://dx.doi.org/10.1158/0008- 5472.CAN-12-1974 10.,Non-OADS,/arxiv_data1/oa_pdf/dd/f8/onci-2-e26296.PMC3862683.pdf
J Immunol 2013; 190:469- 78; PMID:23225891 ; http://dx.doi.org/10.4049/ jimmunol.1201209,Non-OADS,/arxiv_data1/oa_pdf/dd/f8/onci-2-e26296.PMC3862683.pdf
"OncoImmunology 2013; 2:e 25913; http://dx.doi.org/10.4161/onci.25913Intratumoral mast cells promote   the growth of pancreatic cancer ying Ma1,2,* and s tephen e u llrich1,2,3 1Department of Immunology; The u niversity of Texas MD a nderson Cancer Center; h ouston, TX usa ; 2Center for Cancer Immunology r esearch; The u niversity of Texas   MD a nderson Cancer Center; h ouston, TX usa ; 3The u niversity of Texas Graduate s chool of Biomedical s ciences at h ouston; h ouston, TX usa Keywords:  mast cells, pancreatic cancer, pancreatic stellate cells, tumor microenvironment we have recently discovered that mast cells promote pancreatic tumorigenesis by exacerbating the cellular and extracel - lular signaling in the desmoplastic microenvironment.",Non-OADS,/arxiv_data1/oa_pdf/7b/a3/onci-2-e25964.PMC3862685.pdf
CA Cancer J Clin 2013; 63:11-30;  PMID:23335087 ; http://dx.doi.org/10.3322/ caac.21166 2.,Non-OADS,/arxiv_data1/oa_pdf/7b/a3/onci-2-e25964.PMC3862685.pdf
J Cell Biochem  2007; 101:887-907;  PMID:17266048 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/7b/a3/onci-2-e25964.PMC3862685.pdf
Cell 2011; 144:646-74; PMID:21376230 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/7b/a3/onci-2-e25964.PMC3862685.pdf
Gut 2011; 60:861-8; PMID:20966025 ;  http://dx.doi.org/10.1136/gut.2010.2260925.,Non-OADS,/arxiv_data1/oa_pdf/7b/a3/onci-2-e25964.PMC3862685.pdf
Gastroenterology 2013; 144:1230-40;  PMID:23622132 ; http://dx.doi.org/10.1053/j.,Non-OADS,/arxiv_data1/oa_pdf/7b/a3/onci-2-e25964.PMC3862685.pdf
Int Rev Cell Mol Biol 2009; 275:89-131;  PMID:19491054 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/7b/a3/onci-2-e25964.PMC3862685.pdf
Clin Cancer Res 2011; 17:7015-23; PMID:21976550 ;  http://dx.doi.org/10.1158/1078-0432.CCR-11-06078.,Non-OADS,/arxiv_data1/oa_pdf/7b/a3/onci-2-e25964.PMC3862685.pdf
Surgery 2011; 149:576- 84; PMID:21167541 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/7b/a3/onci-2-e25964.PMC3862685.pdf
Cancer Res 2013; 73:3927-37; PMID:23633481 ; http://dx.doi.org/10.1158/0008- 5472.CAN-12-4479,Non-OADS,/arxiv_data1/oa_pdf/7b/a3/onci-2-e25964.PMC3862685.pdf
"OncoImmunology 2013; 2:e26261;  http://dx.doi.org/10.4161/onci.26261Potentiating antitumor immunity   with α GC-loaded exosomes ulf Gehrmann, s tefanie h iltbrunner, Tanja I Näslund†, and s usanne Gabrielsson†,* Translational Immunology u nit; Department of Medicine; s olna, Karolinska Institutet; s tockholm, s weden †These authors contributed equally to this manuscript.",Non-OADS,/arxiv_data1/oa_pdf/bf/9d/onci-2-e26261.PMC3862686.pdf
J  Clin Invest 2008; 118:1991-2001;  PMID:18523649 ;  http://dx.doi.org/10.1172/JCI35180 2.,Non-OADS,/arxiv_data1/oa_pdf/bf/9d/onci-2-e26261.PMC3862686.pdf
J Exp Med 1999;  189:1121-8;  PMID:10190903 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/bf/9d/onci-2-e26261.PMC3862686.pdf
Cancer Res 2013; 73:3865-76;   PMID:23658368 ; http://dx.doi.org/10.1158/0008- 5472.CAN-12-39184.,Non-OADS,/arxiv_data1/oa_pdf/bf/9d/onci-2-e26261.PMC3862686.pdf
Ann N Y Acad Sci 2009;  1174:61-7;  PMID:19769737 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bf/9d/onci-2-e26261.PMC3862686.pdf
J Clin Invest 2005; 115:2572- 83;  PMID:16138194 ; http://dx.doi.org/10.1172/ JCI24762 6.,Non-OADS,/arxiv_data1/oa_pdf/bf/9d/onci-2-e26261.PMC3862686.pdf
Nat Immunol  2010; 11:313-20;  PMID:20190758 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/bf/9d/onci-2-e26261.PMC3862686.pdf
Nat Rev Immunol  2009; 9:581-93;  PMID:19498381 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/bf/9d/onci-2-e26261.PMC3862686.pdf
"OncoImmunology 2013; 2:e26286;  http://dx.doi.org/10.4161/onci.26286Blockade of PD-1 immunosuppression   boosts CAR T-cell therapy Liza B John1,2, Michael h Kershaw1,2,3,4, and Phillip K Darcy1,2,3,4 1Cancer Immunology Program; Peter MacCallum Cancer Centre; e ast Melbourne, VIC australia; 2sir Peter MacCallum Department of Oncology; u niversity of Melbourne;  Parkville, australia; 3Department of Pathology; u niversity of Melbourne; Parkville, australia; 4Department of Immunology; Monash u niversity; Clayton, australia Keywords:  chimeric antigen receptor, adoptive immunotherapy, PD-1 blockade, cancer, immune response The presence of an immunosuppressive microenvironment can limit the full potential of adoptive T  cell immunotherapy.",Non-OADS,/arxiv_data1/oa_pdf/af/f1/onci-2-e26286.PMC3862687.pdf
Blood 2011; 118:6050-6;  PMID:21984804 ; http://dx.doi.org/10.1182/ blood-2011-05-354449 2.,Non-OADS,/arxiv_data1/oa_pdf/af/f1/onci-2-e26286.PMC3862687.pdf
N Engl J Med 2011 ; 365:725- 33; PMID:21830940 ; http://dx.doi.org/10.1056/ NEJMoa1103849 3.,OADS,/arxiv_data1/oa_pdf/af/f1/onci-2-e26286.PMC3862687.pdf
Nat Rev Cancer 2012 ;  12:252-64; PMID:22437870 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/af/f1/onci-2-e26286.PMC3862687.pdf
N Engl J Med 2012 ; 366:2443 -54; PMID:22658127 ;  http://dx.doi.org/10.1056/NEJMoa12006905.,OADS,/arxiv_data1/oa_pdf/af/f1/onci-2-e26286.PMC3862687.pdf
Clin Cancer Res 2008 ; 14:3044 -51;  PMID:18483370 ; http://dx.doi.org/10.1158/1078- 0432.CCR-07-4079 6.,Non-OADS,/arxiv_data1/oa_pdf/af/f1/onci-2-e26286.PMC3862687.pdf
Cancer Res 2010 ; 70:9591 -8; PMID:21098715 ;  http://dx.doi.org/10.1158/0008-5472.CAN-10-28848.,Non-OADS,/arxiv_data1/oa_pdf/af/f1/onci-2-e26286.PMC3862687.pdf
Clin Cancer Res 2013 ;  PMID:23873688 ; http://dx.doi.org/10.1158/1078- 0432.CCR-13-0458 9.,Non-OADS,/arxiv_data1/oa_pdf/af/f1/onci-2-e26286.PMC3862687.pdf
"OncoImmunology 2013; 2:e26443; http://dx.doi.org/10.4161/onci.26443Monocyte-derived dendritic cells Emerging players in the antitumor immune response sabine Kuhn1,2 and Franca r onchese1,* 1Malaghan Institute of Medical r esearch; w ellington, New Zealand; 2Victoria u niversity of w ellington; w ellington, New Zealand Keywords:  immunotherapy, dendritic cells, TLR-ligands, inflammation, monocyte-derived dendritic cells Abbreviations: DC, dendritic cell; dLN, draining lymph node; LN, lymph node; LPS, lipopolysaccharide;   moDC, monocyte-derived dendritic cell; TLR, Toll-like receptor.",Non-OADS,/arxiv_data1/oa_pdf/3c/8f/onci-2-e26443.PMC3862688.pdf
Semin Immunol 2008; 20:286- 95; PMID:18951039 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/3c/8f/onci-2-e26443.PMC3862688.pdf
Immunol Cell Biol 2012; 90:310-3;  PMID:21606943 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3c/8f/onci-2-e26443.PMC3862688.pdf
OncoImmunology 2012; 1: 699-739;  PMID:22934262 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3c/8f/onci-2-e26443.PMC3862688.pdf
J Immunol 2013; 191:1984-92; PMID:23858033 ;  http://dx.doi.org/10.4049/jimmunol.13011355.,Non-OADS,/arxiv_data1/oa_pdf/3c/8f/onci-2-e26443.PMC3862688.pdf
Cancer Immunol Immunother 2012;  61:2333-42;  PMID:22714285 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3c/8f/onci-2-e26443.PMC3862688.pdf
Immunity  2012; 36:1047-59;  PMID:22749354 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3c/8f/onci-2-e26443.PMC3862688.pdf
"OncoImmunology 2013; 2:e26260; http://dx.doi.org/10.4161/onci.26260Autophagy-dependent suppression of cancer  immunogenicity and effector mechanisms   of innate and adaptive immunity abhishek D Garg*, a leksandra M Dudek, and Patrizia a gostinis* Cell Death r esearch & Therapy (CD rT) u nit; Department for Cellular and Molecular Medicine; K u Leuven; Leuven, Belgium Keywords:  chaperone-mediated autophagy, calreticulin, damage-associated molecular patterns, dendritic  cells, immunogenic cell death, photodynamic therapy, reactive oxygen species, T lymphocytes The inspection of the mechanisms through which autophagy modulates immunogenic cell death revealed that the  autophagic response of cancer cells to reactive oxygen species-dependent endoplasmic reticulum stress suppresses the  exposure of calreticulin on the cell surface, the phenotypic maturation of dendritic cells (DCs) as well as their ability to  release interleukin-6 and to support the proliferative expansion of (interferon γ -producing) CD4+ and CD8+ T lymphocytes.",Non-OADS,/arxiv_data1/oa_pdf/f9/ff/onci-2-e26260.PMC3862689.pdf
Annu Rev Immunol 2013; 31:51-72;  PMID :23157435 ; http://dx.doi.org/10.1146/ annurev-immunol-032712-100008 2.,Non-OADS,/arxiv_data1/oa_pdf/f9/ff/onci-2-e26260.PMC3862689.pdf
Cell Death Differ 2013 ;  Forthcoming ; PMID:23686135 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f9/ff/onci-2-e26260.PMC3862689.pdf
Cytokine Growth Factor Rev 2013 ; 24:319- 33; PMID:23391812 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/f9/ff/onci-2-e26260.PMC3862689.pdf
Cold Spring Harb Symp Quant Biol 2011 ; 76:389- 96; PMID:22442109 ; http://dx.doi.org/10.1101/ sqb.2012.76.011015 6.,OADS,/arxiv_data1/oa_pdf/f9/ff/onci-2-e26260.PMC3862689.pdf
Autophagy  2013 ; 9:1292-1307;  PMID:23800749 ;  http://dx.doi.org/10.4161/auto.25399 .,Non-OADS,/arxiv_data1/oa_pdf/f9/ff/onci-2-e26260.PMC3862689.pdf
Cancer Immunol Immunother  2012 ; 61:215-21;  PMID:22193987 ; http://dx.doi.org/10.1007/ s00262-011-1184-28.,Non-OADS,/arxiv_data1/oa_pdf/f9/ff/onci-2-e26260.PMC3862689.pdf
EMBO J 2012 ;  31:1062 -79; PMID:22252128 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f9/ff/onci-2-e26260.PMC3862689.pdf
Autophagy   2012 ; 8:1312 -24; PMID:22889744 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f9/ff/onci-2-e26260.PMC3862689.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e7/28/opth-7-2287.PMC3862693.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2013:7 2287–2288Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2287Letteropen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/OPTH.S5741 8Letter to the editor: immediate implications   of improved surgical efficiency Daniel Gologorsky1 timothy G Murray1,2 1Bascom Palmer eye Institute, Anne  Bates Leach eye Hospital, University  of Miami Miller School of Medicine,   Miami, FL, USA; 2Murray Ocular  Oncology and retina, Miami, FL, USA Correspondence: timothy G Murray   Murray Ocular Oncology and retina,  6705 red road, Suite 412, Miami,   FL 33143, USA   email tmurray@murraymd.co mDear editor Earlier this year we published our analysis regarding the improved surgical efficiencies  that commenced with the transition from the Accurus (Alcon Surgical, Fort Worth,  TX, USA) to the Constellation Vision System (Alcon Surgical) integrated vitrectomy  platform.1 The results of our study demonstrated that the transition to the Constellation  platform resulted in an increase in the number of patient operations per day (from 7.55  to 8.53, a 12.98% increase), with a concurrent and statistically significant decrease in  surgical room time (occurring without compromise to patient evaluated outcomes).",Non-OADS,/arxiv_data1/oa_pdf/e7/28/opth-7-2287.PMC3862693.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/e7/28/opth-7-2287.PMC3862693.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/e7/28/opth-7-2287.PMC3862693.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/4e/02/ndt-9-1885.PMC3862695.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2013:9 1885–1888Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1885Case seriesopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S4364 4Navigated transcranial magnetic stimulation   in preoperative planning for the treatment   of motor area cavernous angiomas Wellingson silva Paiva1 erich Talamoni Fonoff1 Marco antonio Marcolin2 edson Bor-seng-shu1 eberval Gadelha Figueiredo1 Manoel Jacobsen T eixeira1 1Division of Neurosurgery,  Department of Neurology, school  of Medicine, University of sao Paulo,  sao Paulo, Brazil; 2Transcranial  Magnetic stimulation Laboratory,  institute of Psychiatry, school of  Medicine, University of sao Paulo,  sao Paulo, Brazil Correspondence: Wellingson silva Paiva   University of sao Paulo Medical school,  225 eneas aguiar, street number 255,   Office 4080, Sao Paulo, 05403010, Brazil   Tel +55 11 2661 7226   Fax +55 11 2548 6906   email wellingsonpaiva@yahoo.com.b rAbstract:  Since the introduction of microscopic techniques, radical surgery for cavernous  angiomas has become a recommended treatment option.",Non-OADS,/arxiv_data1/oa_pdf/4e/02/ndt-9-1885.PMC3862695.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing  on concise rapid reporting of clinical or pre-clinical studies on a  range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/4e/02/ndt-9-1885.PMC3862695.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/4e/02/ndt-9-1885.PMC3862695.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/90/d7/oajsm-4-251.PMC3862696.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOpen Access Journal of Sports Medicine 2013:4 251–260Open Access Journal of Sports Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  251OriginAl reSeArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OAJSM.S5241 7Video abstract Point your Smar tPhone at the code abo ve.,Non-OADS,/arxiv_data1/oa_pdf/90/d7/oajsm-4-251.PMC3862696.pdf
"Or use: http://dvpr.es/168B4N jcomparison of injury incidences between football  teams playing in different climatic regions John W Orchard1 Markus Waldén2 Martin hägglund3 Jessica J Orchard1 ian chivers4 hugh Seward5 Jan ekstrand2 1School of Public health, University  of Sydney, Sydney, nSW, Australia;  2Department of Medical and health  Sciences, Division of community  Medicine, linköping University,  linköping, Sweden; 3Department of  Medical and health Sciences, Division  of Physiotherapy, linköping University,  linköping, Sweden; 4native Seeds,  cheltenham, Vic, Australia; 5Australian  Football league Medical Officers  Association, Melbourne, Vic, Australia correspondence: John W Orchard   Sports Medicine, University of Sydney,  corner Western Ave & Physics rd,   Sydney, nSW 2006, Australia   email johnworchard@gmail.co mAbstract:  Australian Football League (AFL) teams in northern (warmer) areas generally have  higher rates of injury than those in southern (cooler) areas.",Non-OADS,/arxiv_data1/oa_pdf/90/d7/oajsm-4-251.PMC3862696.pdf
"Open Access Journal of Sports Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/open-access-journal-of-sports-medicine-journa lOpen Access Journal of Sports Medicine is an international,  peer-reviewed, open access journal publishing original research,  reports, reviews and commentaries on all areas of sports  medicine.",Non-OADS,/arxiv_data1/oa_pdf/90/d7/oajsm-4-251.PMC3862696.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/90/d7/oajsm-4-251.PMC3862696.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/64/07/opth-8-031.PMC3862697.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 31–33Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  31Case repO rtopen access to scientific and medical research Open access Full text article http: //dx.doi.org/10.2147/OPTH.S4790 1rapid growth of an orbital hemangiopericytoma  with atypical histopathological findings Luiz Frederico pacheco1,2 Bruno F Fernandes1 Cristina Miyamoto1,3 shawn C Maloney1 Bryan arthurs1 Miguel N Burnier Jr1,3 1Department of Ophthalmology,   McGill University Health Center,   Montreal, QC, Canada; 2Faculty of  Medicine, Federal University of rio  de Janeiro, rio De Janeiro, Brazil;   3Department of Ophthalmology,   Federal University of são paulo, são  paulo, Brazil Correspondence: shawn C Maloney   Department of Ophthalmology, Henry C  Witelson Ocular pathology Laboratory,  McGill University Health Center,   room 216, Duff Medical Building,   3775 University street, Montreal,   QC H3a-2B4, Canada   tel +1 514 398 7192 ext 00384   Fax +1 514 398 5728   email shawn.maloney@mail.mcgill.c aAbstract:  Hemangiopericytoma is a rare vascular tumor that originates from pericytes.",Non-OADS,/arxiv_data1/oa_pdf/64/07/opth-8-031.PMC3862697.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/64/07/opth-8-031.PMC3862697.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/64/07/opth-8-031.PMC3862697.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/28/8a/opth-7-2289.PMC3862698.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2013:7 2289–2297Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2289Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S5044 6assessment of dry eye signs and symptoms   and ocular tolerance of a preservative-free  lacrimal substitute (hylabak®) versus a preserved  lacrimal substitute (systane®) used for 3 months  in patients after lasiK Yuri s astakhov sergei Y astakhov alla B lisochkina University Department of  Ophthalmology, state educational  establishment of higher Professional  education, saint Petersburg Pavlov  state Medical University and of the  Federal service for surveillance of  healthcare and social Development of  the russian Federation, st Petersburg,  russia Correspondence: Yuri s astakhov   University Department of  Ophthalmology, state educational  establishment of higher Professional  education, saint Petersburg Pavlov state  Medical University and of the Federal  service for surveillance of healthcare  and social Development of the russian  Federation, 6/8 lva Tolstogo st,  Branch 1,   st Petersburg 197022, russia   Tel +7 812 499 7173   Fax +7 812 499 7173   email astakhov@spmu.rssi.r uAbstract:  Laser-assisted in situ keratomileusis (LASIK) is commonly used to correct refractive  defects.",Non-OADS,/arxiv_data1/oa_pdf/28/8a/opth-7-2289.PMC3862698.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/28/8a/opth-7-2289.PMC3862698.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/28/8a/opth-7-2289.PMC3862698.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/3b/9c/ott-6-1789.PMC3862699.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2013:6 1789–1803OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1789Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S5217 2chemotherapy and egFr tyrosine kinase   inhibitors for treatment of brain metastases   from non-small-cell lung cancer: survival   analysis in 210 patients Yun Fan Zhiyu huang luo Fang lulu Miu nengming lin lei gong haifeng Yu haiyan Yang Weimin Mao Key laboratory Diagnosis and  Treatment Technology on Thoracic  Oncology ( esophagus, lung), Zhejiang  cancer hospital, Zhejiang, People’s  republic of china correspondence: Weimin Mao   Key laboratory Diagnosis and Treatment  Technology on Thoracic Oncology  (esophagus, lung), Zhejiang cancer  hospital, 38 guangji road, hangzhou,  Zhejiang 310022, People’s republic of  china   Tel +86 571 8812 2191   Fax +86 571 8812 2589   email maoweimin bm@163.co mBackground:  Chemotherapy and epidermal growth factor receptor (EGFR) tyrosine kinase  inhibitors are controversial in the treatment of patients with brain metastases from non-small- cell lung cancer (NSCLC).",Non-OADS,/arxiv_data1/oa_pdf/3b/9c/ott-6-1789.PMC3862699.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/3b/9c/ott-6-1789.PMC3862699.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/3b/9c/ott-6-1789.PMC3862699.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/39/6b/jpr-6-755.PMC3862700.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpJournal of Pain Research 2013:6 755–763Journal of Pain Research Dove press submit your manuscript | www.dovepress.co m Dove press  755ORiginal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JPR.S5220 5The use of metformin is associated   with decreased lumbar radiculopathy pain amber Taylor1 anton h Westveld2,6 Magdalena szkudlinska1 Prathima guruguri1 emil annabi3 amol Patwardhan3 Theodore J Price4 hussein n Yassine5 1Department of Medicine, University  of arizona, Tucson, aZ, Usa;   2statistics laboratory, Bio5 institute,  statistics giDP, University of arizona,  Tucson, aZ, Usa; 3Department of  anesthesia, University of arizona,  Tucson, aZ, Usa; 4Department of  Pharmacology, University of arizona,  Tucson, aZ, Usa; 5Department of  Medicine, University of southern  california, la, ca, Usa; 6Faculty  of esTeM, University of canberra,  canberra, acT, australia correspondence: hussein Yassine   Department of Medicine,   University of southern california,   2250 alcazar st, los angeles,   ca 90030, Usa   Phone +1 323 442 1909   Fax +1 323 442 2082   email hyassine@usc.ed u    Theodore Price   Department of Pharmacology, University   of arizona, 1501n campbell ave,   PO Box 245050, Tucson, aZ 85724, Usa   Tel +1 520 471 0360   email tjprice@email.arizona.ed uAbstract:  Lumbar radiculopathy pain represents a major public health problem, with few  effective long-term treatments.",Non-OADS,/arxiv_data1/oa_pdf/39/6b/jpr-6-755.PMC3862700.pdf
We used the R software environ - ment version 3.0 ( http://www.r-project.org /) for statistical  analysis.,OADS,/arxiv_data1/oa_pdf/39/6b/jpr-6-755.PMC3862700.pdf
"Journal of Pain Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-pain-research-journa lThe Journal of Pain Research is an international, peer-reviewed, open  access, online journal that welcomes laboratory and clinical findings  in the fields of pain research and the prevention and management  of pain.",Non-OADS,/arxiv_data1/oa_pdf/39/6b/jpr-6-755.PMC3862700.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/39/6b/jpr-6-755.PMC3862700.pdf
Available from: http://www.R-project.org /.,Non-OADS,/arxiv_data1/oa_pdf/39/6b/jpr-6-755.PMC3862700.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/70/21/opth-8-023.PMC3862701.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 23–29Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  23Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S5500 4Dose uniformity of loteprednol etabonate  ophthalmic gel (0.5%) compared with branded  and generic prednisolone acetate ophthalmic  suspension (1%) Zora T Marlowe stephen r Davio Pharmaceutical Product Development,   global Pharmaceutical research   and Development, Bausch and lomb,   inc, rochester, nY, Usa Correspondence: Zora T Marlowe   Pharmaceutical Product Development,  global Pharmaceutical r&D,   1400 north goodman street,   rochester, nY 14609, Usa   Tel +1 585 338 6061   Fax +1 585 338 0179   email z ora.marlowe@bausch.co mIntroduction:  Loteprednol etabonate (LE) ophthalmic gel 0.5% (Lotemax®) is a new  polycarbophil-based, nonsettling topical ophthalmic formulation.",Non-OADS,/arxiv_data1/oa_pdf/70/21/opth-8-023.PMC3862701.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/70/21/opth-8-023.PMC3862701.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/70/21/opth-8-023.PMC3862701.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c0/ea/ijgm-6-897.PMC3862733.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of General Medicine 2013:6 897–903International Journal of General Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  897OrIGInal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJGM.S5136 4Inhibition of the early asthmatic response   to inhaled allergen by the 5-lipoxygenase  activating protein inhibitor GsK2190915:   a dose–response study Dave singh1 Malcolm Boyce2 Virginia norris3 sandra e Kent3 Jane h Bentley3 1University of Manchester, Medicines  evaluation Unit, University hospital  of south Manchester, Manchester, UK;   2hammersmith Medicines research,   london, UK; 3Glaxo smithKline,   Middlesex, UK correspondence: Virginia norris   GlaxosmithKline, Brentford,   Middlesex, TW8 9Gs, UK   Tel +44 20 8047 6634   Fax +44 20 8047 0666   email v irginia.h.norris@gsk.co mBackground:  GSK2190915, a 5-lipoxygenase activating protein inhibitor, inhibits the  production of cysteinyl leukotrienes and leukotriene B4 and 5-oxo-6,8,11,14-eicosatetraenoic  acid.",Non-OADS,/arxiv_data1/oa_pdf/c0/ea/ijgm-6-897.PMC3862733.pdf
"International Journal of General Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-general-medicine-journa lThe International Journal of General Medicine is an international,  peer-reviewed open-access journal that focuses on general and internal  medicine, pathogenesis, epidemiology, diagnosis, monitoring and treat - ment protocols.",Non-OADS,/arxiv_data1/oa_pdf/c0/ea/ijgm-6-897.PMC3862733.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c0/ea/ijgm-6-897.PMC3862733.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b7/43/opth-8-035.PMC3862735.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 35–42Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  35Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S5337 0rate of ectasia and incidence of irregular  topography in patients with unidentified  preoperative risk factors undergoing   femtosecond laser-assisted lasiK Majid Moshirfar1 Jared g smedley2 Valliammai Muthappan1 allison Jarsted3 erik M Ostler1 1John a Moran eye Center, University  of Utah, salt lake City, UT, Usa;   2College of human Medicine, Michigan  state University, lansing, M i, Usa;   3Department of Ophthalmology,   state University of new York Upstate  Medical University, syracuse, nY, Usa Correspondence: Majid Moshirfar   John a Moran eye Center, Old Mill   Medical Center, 6360 south 3000 east,   suite 200, salt lake City,   Utah 84121, Usa   Tel +1 801 585 3937   Fax +1 801 947 9286   email m ajid.moshirfar@hsc.utah.ed uPurpose:  To report the rate of postoperative ectasia after laser-assisted in situ keratomileusis  (LASIK) with femtosecond laser-assisted flap creation, in a population of patients with no  identified preoperative risk factors.",Non-OADS,/arxiv_data1/oa_pdf/b7/43/opth-8-035.PMC3862735.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/b7/43/opth-8-035.PMC3862735.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b7/43/opth-8-035.PMC3862735.pdf
"Available from: http://www.duffeylaser.com/physicians_resources.ph p.  Accessed July 25, 2013.",Non-OADS,/arxiv_data1/oa_pdf/b7/43/opth-8-035.PMC3862735.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/93/53/jmdh-7-001.PMC3862736.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpJournal of Multidisciplinary Healthcare 2014:7 1–9Journal of Multidisciplinary Healthcare Dove press submit your manuscript | www.dovepress.co m Dove press  1SHort reportopen access to scientific and medical research open Access Full text Article http: //dx.doi.org/10.2147/JMDH.S5485 1Interprofessional faculty development:   integration of oral health into the geriatric  diabetes curriculum, from theory to practice Georgia Dounis1 Marcia Ditmyer2 Susan VanBeuge3 Sue Schuerman4 Mildred McClain1 Kiki Dounis1,5 Connie Mobley2 1Department of Clinical Sciences,   2Department of Biomedical Sciences,   3Department of p hysiological Nursing,   4Department of p hysical therapy,   University of Nevada Las Vegas School  of Dental Medicine, Las Vegas, NV,   USA; 5Department of Family Medicine,   University of Nevada School of  Medicine, reno, NV, USA Correspondence: Georgia Dounis   University of Nevada Las Vegas School  of Dental Medicine, 1001 Shadow Lane,  #235 D MS 7425, Las Vegas,   NV 89106, USA   tel +1 702 774 2667   Fax +1 702 774 2672   email georgia.dounis@unlv.ed uBackground:  Health care workforce shortages and an increase demand for health care services  by an older demographic challenged by oral–systemic conditions are being recognized across  health care systems.",Non-OADS,/arxiv_data1/oa_pdf/93/53/jmdh-7-001.PMC3862736.pdf
"Available from: http://www.cdc.gov/diabetes/pubs/pdf/ndfs_2011.pd f.  Accessed November 10, 2013.",Non-OADS,/arxiv_data1/oa_pdf/93/53/jmdh-7-001.PMC3862736.pdf
Available from:http://www.cihc.ca/resources.,Non-OADS,/arxiv_data1/oa_pdf/93/53/jmdh-7-001.PMC3862736.pdf
Available from: https://www.cms.gov/ Quality Initiatives GenInfo/downloads/VBPRoadmap_OEA_1-16_508.,OADS,/arxiv_data1/oa_pdf/93/53/jmdh-7-001.PMC3862736.pdf
Available from: http://www.nap.edu/openbook.php?isbn =030908723 6.,Non-OADS,/arxiv_data1/oa_pdf/93/53/jmdh-7-001.PMC3862736.pdf
Available  from: http://www.nap.edu/catalog.php?record_id =1348 6.,Non-OADS,/arxiv_data1/oa_pdf/93/53/jmdh-7-001.PMC3862736.pdf
"Available from: http://www.aacn.nche.edu/education-resources/ ipecreport.pd f. Accessed November 10, 2013.",Non-OADS,/arxiv_data1/oa_pdf/93/53/jmdh-7-001.PMC3862736.pdf
"A Word from the   President: “Interprofessional collaboration: we are willing – can we  find the way?” Available from: https://www.aamc.org/newsroom/ reporter/may08/88258/may08_word.htm l. Accessed November 10,  2013.",Non-OADS,/arxiv_data1/oa_pdf/93/53/jmdh-7-001.PMC3862736.pdf
"Journal of Multidisciplinary Healthcare Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-multidisciplinary-healthcare-journa lThe Journal of Multidisciplinary Healthcare is an international, peer- reviewed open-access journal that aims to represent and publish research  in healthcare areas delivered by practitioners of different disciplines.",Non-OADS,/arxiv_data1/oa_pdf/93/53/jmdh-7-001.PMC3862736.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/93/53/jmdh-7-001.PMC3862736.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/1c/0f/jbm-4-161.PMC3862737.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpJournal of Blood Medicine 2013:4 161–162Journal of Blood Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  161Letteropen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/JBM.S5546 4Severe hypernatremia and hyperchloremia   in an elderly patient with IgG-kappa type Kenrick Berend St elisabeth Hospital, Willemstad,   Curaçao Correspondence: Kenrick Berend   St elisabeth Hospital, 193 JHJ  Hamelbergweg, Willemstad, Curaçao   email kenber2@me.co mDear editor Imashuku et al1 describe a 77-year-old male patient with multiple myeloma who was  admitted to the hospital after suffering a pelvic bone fracture due to a road traffic  accident.",Non-OADS,/arxiv_data1/oa_pdf/1c/0f/jbm-4-161.PMC3862737.pdf
"Journal of Blood Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/Journal-of-blood-medicine-journa lThe Journal of Blood Medicine is an international, peer-reviewed, open  access, online journal publishing laboratory, experimental and clinical aspects  of all topics pertaining to blood based medicine including but not limited to:  Transfusion Medicine; Blood collection, Donor issues, Transmittable diseases,  and Blood banking logistics; Immunohematology; Artificial and alternative blood based therapeutics; Hematology; Biotechnology/nanotechnology of  blood related medicine; Legal aspects of blood medicine; Historical perspec - tives.",Non-OADS,/arxiv_data1/oa_pdf/1c/0f/jbm-4-161.PMC3862737.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/1c/0f/jbm-4-161.PMC3862737.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e8/49/opth-8-015.PMC3862739.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 15–21Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  15Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S5508 0in patients with neovascular age-related   macular degeneration, physical activity   may influence C-reactive protein levels Y ousif subhi amardeep singh Mads Krüger Falk T orben lykke sørensen Department of Ophthalmology,   Clinical eye research Unit,   Copenhagen University hospital   roskilde and the University   of Copenhagen, Copenhagen,   Denmark Correspondence: Torben lykke  sørensen   Clinical eye research Unit, Department   of Ophthalmology, Copenhagen   University hospital roskilde,   7-13 Køgevej, roskilde 4000, Denmark   Tel +45 4732 3900   Fax +45 4636 2645   email torbenls@dadlnet.d kPurpose:  Association of neovascular age-related macular degeneration (AMD) with C-reactive  protein (CRP) was previously reported, indicating a relation to systemic low-grade inflammation.",Non-OADS,/arxiv_data1/oa_pdf/e8/49/opth-8-015.PMC3862739.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/e8/49/opth-8-015.PMC3862739.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/e8/49/opth-8-015.PMC3862739.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/1f/b7/opth-7-2281.PMC3862740.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2013:7 2281–2285Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2281Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OPTH.S5550 8Meta-analysis of the effect of posterior   mucosal flap anastomosis in primary   external dacryocystorhinostomy Amal A Bukhari Ophthalmology Department,   King Abdulaziz University Hospital,   Jeddah, Saudi Arabia Correspondence: Amal A Bukhari   Ophthalmology Department, King  Abdulaziz University Hospital,   PO Box 80215, Jeddah 21589,   Saudi Arabia   Tel +966 2640 2888   Fax +966 2640 8349   email aabukhari@kau.edu.s aPurpose:  We aimed to compare the outcomes of primary external dacryocystorhinostomy and  silicone tube with anterior and posterior mucosal flap anastomosis, versus dacryocystorhinostomy  and silicone intubation with anterior mucosal flap anastomosis.",Non-OADS,/arxiv_data1/oa_pdf/1f/b7/opth-7-2281.PMC3862740.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/1f/b7/opth-7-2281.PMC3862740.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/1f/b7/opth-7-2281.PMC3862740.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/24/f3/ijn-9-001.PMC3862741.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 1–15International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  1RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJN.S5263 4Nanotechnology-based drug delivery systems   and herbal medicines: a review Bruna vidal Bonifácio Patricia Bento da Silva Matheus Aparecido dos  Santos Ramos Kamila Maria Silveira Negri Taís Maria Bauab Marlus Chorilli School of Pharmaceutical  Sciences, Postgraduate Program in  Pharmaceutical Sciences, São Paulo  State University, Araraquara, Brazil Correspondence: Marlus Chorilli   School of Pharmaceutical Sciences,  Postgraduate Program in Pharmaceutical  Sciences, São Paulo State University,  Rodovia Araraquara-Jaú, km 01,  Araraquara, SP, CeP 14801-902, Brazil   T el +55 16 3301 6998   Fax +55 16 3301 6760   email chorilli@fcfar.unesp.b rAbstract:  Herbal medicines have been widely used around the world since ancient times.",Non-OADS,/arxiv_data1/oa_pdf/24/f3/ijn-9-001.PMC3862741.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/24/f3/ijn-9-001.PMC3862741.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/24/f3/ijn-9-001.PMC3862741.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a4/89/ndt-10-001.PMC3862743.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2014:10 1–12Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S4708 7analysis of individual items on the attention- deficit/hyperactivity disorder symptom rating  scale in children and adults: the effects of age  and sex in pivotal trials of lisdexamfetamine  dimesylate richard h Weisler1,2 lenard a adler3 scott h Kollins4 David W goodman5 Mohamed hamdani5 Bryan Dirks6 ann c childress7 1Duke University Medical center,  Durham, N c, Usa; 2University  of North carolina at chapel hill,  chapel hill, N c, Usa; 3New York  University school of Medicine and  Psychiatry service, New York Va   harbor healthcare system, New  York, NY, Usa; 4Duke University  Medical center, Durham, N c, Usa;  5Johns hopkins University school of  Medicine, Baltimore, MD, Usa; 6shire  Development llc, Wayne, P a, Usa;  7center for Psychiatry and Behavioral  Medicine, Las Vegas, NV, USA correspondence: richard h Weisler   700 Spring Forest Road, Suite 125,  Raleigh, NC 27609, USA   Tel +1 919 872 5900   Fax +1 919 878 0942   email rw eisler@aol.co mBackground:  Attention-deficit/hyperactivity disorder (ADHD) symptom presentation across  age and sex has not been fully elucidated.",Non-OADS,/arxiv_data1/oa_pdf/a4/89/ndt-10-001.PMC3862743.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing  on concise rapid reporting of clinical or pre-clinical studies on a  range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/a4/89/ndt-10-001.PMC3862743.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/a4/89/ndt-10-001.PMC3862743.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/10/69/nss-5-143.PMC3862774.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNature and Science of Sleep 2013:5 143–145Nature and Science of Sleep Dove press submit your manuscript | www.dovepress.co m Dove press  143PerSPectiveSopen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/NSS.S5567 9T oward a classification of medications   for sleep and circadian rhythm disorders Michael J thorpy1 thomas roth2,3 1Sleep-Wake Disorders center,   Montefiore Medical center, Albert   einstein college of Medicine of   Yeshiva University, Bronx, New Y ork,   NY, USA; 2University of Michigan  School of Medicine, Ann Arbor, 3Sleep   Disorders and research center,    Henry Ford Hospital, Detroit,    Michigan, USA correspondence: thomas roth   Henry Ford Hospital, 2799 West Grand  Boulevard, Detroit, Mi 48202, USA   email tr oth1@hfhs.or g    Michael J thorpy   Montefiore Medical Center,   111 east 210th Street, Bronx,   New York, NY 10467, USA   email michael.thorpy@einstein.yu.ed uAbstract:  While some systems classify medications according to therapeutic class, others are  based on the mechanism of action of the drugs.",Non-OADS,/arxiv_data1/oa_pdf/10/69/nss-5-143.PMC3862774.pdf
"Nature and Science of Sleep Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/nature-and-science-of-sleep-journa lNature and Science of Sleep is an international, peer-reviewed, open  access journal covering all aspects of sleep science and sleep medicine,  including the neurophysiology and functions of sleep, the genetics of  sleep, sleep and society, biological rhythms, dreaming, sleep disorders and  therapy, and strategies to optimize healthy sleep.",Non-OADS,/arxiv_data1/oa_pdf/10/69/nss-5-143.PMC3862774.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/10/69/nss-5-143.PMC3862774.pdf
"http://www.usp.org/sites/default/files/usp_pdf/ EN/healthcareProfessionals/2011-03-11uspmgwithexampledrugs.pd f.  Accessed November 7, 2013.",Non-OADS,/arxiv_data1/oa_pdf/10/69/nss-5-143.PMC3862774.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/aa/e2/opth-8-011.PMC3862775.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 11–14Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  11Case repO rtopen access to scientific and medical research Open access Full text article http: //dx.doi.org/10.2147/OPTH.S54973a case of conjunctival mucoepidermoid  carcinoma in australia thomas p Moloney1 tanya trinh2 Jonathon J Farrah1,2 1Department of Ophthalmology,  the royal Brisbane and Women’s  Hospital, Herston, QLD, australia;  2Department of Ophthalmology,  Mater Misericordiae Hospital,   south Brisbane, QLD, australia Correspondence: thomas Moloney   Department of Ophthalmology,   the royal Brisbane and Women’s  Hospital, Herston, QLD, australia   email thomas.moloney@health.qld.gov.a uAbstract:  Conjunctival mucoepidermoid carcinoma is a very rare but highly aggressive  conjunctival neoplasm with 42 previously reported cases.",Non-OADS,/arxiv_data1/oa_pdf/aa/e2/opth-8-011.PMC3862775.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/aa/e2/opth-8-011.PMC3862775.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/aa/e2/opth-8-011.PMC3862775.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Marais BJ, Pai M. New approaches and emerging technologies in the diagnosis of childhood tuberculosis.",Non-OADS,/arxiv_data1/oa_pdf/31/13/thoraxjnl-2012-203086.PMC3862980.pdf
http://labs.fhcrc.org/pepe/dabs/ppsoft.,Non-OADS,/arxiv_data1/oa_pdf/31/13/thoraxjnl-2012-203086.PMC3862980.pdf
"WHO case de ﬁnitions of HIV for surveillance and revised clinical staging and immunological classi ﬁcation of HIV-related disease in adults and children , 2006. http://www.who.int/hiv/pub/guidelines/HIVstaging150307.pdf (accessed Nov 2012).",Non-OADS,/arxiv_data1/oa_pdf/31/13/thoraxjnl-2012-203086.PMC3862980.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2013-003635).,Non-OADS,/arxiv_data1/oa_pdf/4d/ae/bmjopen-2013-003635.PMC3863117.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/4d/ae/bmjopen-2013-003635.PMC3863117.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003739).,Non-OADS,/arxiv_data1/oa_pdf/09/1c/bmjopen-2013-003739.PMC3863118.pdf
2011. http://www.censusindia.gov.in/default.aspx (accessed 20 Aug 2012).,OADS,/arxiv_data1/oa_pdf/09/1c/bmjopen-2013-003739.PMC3863118.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2013-004106).,Non-OADS,/arxiv_data1/oa_pdf/e5/b5/bmjopen-2013-004106.PMC3863119.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/e5/b5/bmjopen-2013-004106.PMC3863119.pdf
2010 [cited 21 October 2011].http://www.dh.gov.uk/en/MediaCentre/Pressreleases/DH_118861 5.,Non-OADS,/arxiv_data1/oa_pdf/e5/b5/bmjopen-2013-004106.PMC3863119.pdf
http://www.nlm.nih.gov/mesh/ 16.,OADS,/arxiv_data1/oa_pdf/e5/b5/bmjopen-2013-004106.PMC3863119.pdf
http://guidance.nice.org.uk/ 26.,Non-OADS,/arxiv_data1/oa_pdf/e5/b5/bmjopen-2013-004106.PMC3863119.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003769).,Non-OADS,/arxiv_data1/oa_pdf/58/92/bmjopen-2013-003769.PMC3863120.pdf
"However, in spite of very extensive documentationissued to guide CCGs as they established themselves (see http://www.england.nhs.uk/resources/resources-for-ccgs/, accessed June 2013) the exact nature of CCG accountabil-ity relationships remains ill-de ﬁned and somewhat under- speciﬁed.",Non-OADS,/arxiv_data1/oa_pdf/58/92/bmjopen-2013-003769.PMC3863120.pdf
"The indicators that have been published so far vary in scope, from those focused on reducing mortality tothose requiring the provision of particular services, such as ensuring patients with a stroke have a visit from a spe- cialist nurse (http://www.nice.org.uk/aboutnice/cof/cof.jsp).",Non-OADS,/arxiv_data1/oa_pdf/58/92/bmjopen-2013-003769.PMC3863120.pdf
Health Serv J 2012. http://www.hsj.co.uk/news/policy/ lansley-expects-nearly-all-ccgs-to-be-authorised-by-deadline/5045904.article#.Upce2cRcXS4 (accessed 28 Nov 2013).,Non-OADS,/arxiv_data1/oa_pdf/58/92/bmjopen-2013-003769.PMC3863120.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2013-003606).,Non-OADS,/arxiv_data1/oa_pdf/b9/d4/bmjopen-2013-003606.PMC3863122.pdf
See http://www.fda.gov/TobaccoProducts/GuidanceCompliance RegulatoryInformation 35.,Non-OADS,/arxiv_data1/oa_pdf/b9/d4/bmjopen-2013-003606.PMC3863122.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-002900).,Non-OADS,/arxiv_data1/oa_pdf/9a/1b/bmjopen-2013-002900.PMC3863123.pdf
"Data sharing statement Researchers can request access to anonymised patient-level data from GSK clinical studies to conduct further research through the GSK website at the following URL address: https://clinicalstudydata.gsk.com Open Access This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 3.0) license, which permits others to distribute, remix, adapt, build upon this work non- commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.",Non-OADS,/arxiv_data1/oa_pdf/36/fa/bmjopen-2013-003570.PMC3863124.pdf
http://www.eopyy.gov.,Non-OADS,/arxiv_data1/oa_pdf/36/fa/bmjopen-2013-003570.PMC3863124.pdf
http://www.corisbio.com/Products/Human-Field/Rota.php (accessed 16 Jan 2013).,OADS,/arxiv_data1/oa_pdf/36/fa/bmjopen-2013-003570.PMC3863124.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2013-004135).,Non-OADS,/arxiv_data1/oa_pdf/32/76/bmjopen-2013-004135.PMC3863125.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/32/76/bmjopen-2013-004135.PMC3863125.pdf
"2012. http://www.effectivehealthcare.ahrq.gov/reports/final.cfm 10 Tannenbaum C, Agnew R, Benedetti A, et al.BMJ Open 2013; 3:e004135.",OADS,/arxiv_data1/oa_pdf/32/76/bmjopen-2013-004135.PMC3863125.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003638).,Non-OADS,/arxiv_data1/oa_pdf/d0/5b/bmjopen-2013-003638.PMC3863126.pdf
"Report on the global AIDS epidemic, 2010. http://www.unaids.org/globalreport/global_report.htm (accessed 1 Jul 2013).",Non-OADS,/arxiv_data1/oa_pdf/d0/5b/bmjopen-2013-003638.PMC3863126.pdf
Laboratory guidelines for enumerating CD4 T Lymphocytes in the context of HIV/AIDS.Regional Office for South-East Asia 2007. http://www.who.int/hiv/amds/LaboratoryGuideEnumeratingCD4TLymphocytes.pdf(accessed 1 Jul 2013).,Non-OADS,/arxiv_data1/oa_pdf/d0/5b/bmjopen-2013-003638.PMC3863126.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2013-003982).,Non-OADS,/arxiv_data1/oa_pdf/08/82/bmjopen-2013-003982.PMC3863127.pdf
"http://www.un.org/News/Press/docs//2011/ga11138.doc.htm Martin E, de Leeuw E. BMJ Open 2013; 3:e003982.",Non-OADS,/arxiv_data1/oa_pdf/08/82/bmjopen-2013-003982.PMC3863127.pdf
http://www.who.int/entity/fctc/reporting/party_reports/CookIslands_2012_report_final.pdf 22.,OADS,/arxiv_data1/oa_pdf/08/82/bmjopen-2013-003982.PMC3863127.pdf
http://www.who.int/entity/fctc/reporting/party_reports/vanuatu_2012_report.pdf 23.,Non-OADS,/arxiv_data1/oa_pdf/08/82/bmjopen-2013-003982.PMC3863127.pdf
http://www.who.int/entity/tobacco/framework/cop/party_reports/palau_report.pdf 24.,Non-OADS,/arxiv_data1/oa_pdf/08/82/bmjopen-2013-003982.PMC3863127.pdf
http://www.tobaccocontrolgrants.com/Pages/2/About-the-BI-Grants-Program 25.,Non-OADS,/arxiv_data1/oa_pdf/08/82/bmjopen-2013-003982.PMC3863127.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003946).,Non-OADS,/arxiv_data1/oa_pdf/ec/56/bmjopen-2013-003946.PMC3863128.pdf
The survey was designed and hosted using http://www.SurveyMonkey.com (SurveyMonkey Copyright 1999 –2009).,OADS,/arxiv_data1/oa_pdf/ec/56/bmjopen-2013-003946.PMC3863128.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/ec/56/bmjopen-2013-003946.PMC3863128.pdf
2008. http://www.healthychildren.org (accessed 6 Jun 2012).,Non-OADS,/arxiv_data1/oa_pdf/ec/56/bmjopen-2013-003946.PMC3863128.pdf
"New Zealand Ministry of Health, 2010. http://www.health.",Non-OADS,/arxiv_data1/oa_pdf/ec/56/bmjopen-2013-003946.PMC3863128.pdf
"Statistics New Zealand, 2005. http://www2.stats.govt.nz/domino/external/web/carsweb.nsf/ (accessed 14 Jun 2013).",Non-OADS,/arxiv_data1/oa_pdf/ec/56/bmjopen-2013-003946.PMC3863128.pdf
"OECD Publishing, 2013. http://dx.doi.org/10.1787/eag-2013-en (accessed 25 Jul 2013).",Non-OADS,/arxiv_data1/oa_pdf/ec/56/bmjopen-2013-003946.PMC3863128.pdf
"Statistics New Zealand, 2006. http://www.stats.govt.nz/Census/2006CensusHomePage/QuickStats/quickstats-about-a-subject/education-and-training.aspx (accessed 28 May 2013).",OADS,/arxiv_data1/oa_pdf/ec/56/bmjopen-2013-003946.PMC3863128.pdf
Toview these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003965).,Non-OADS,/arxiv_data1/oa_pdf/b7/2a/bmjopen-2013-003965.PMC3863129.pdf
Events (incident cases) are reported as actual numbers and per-centages with 95% CI using http://www.vassarstats.net/ prop1.html.,OADS,/arxiv_data1/oa_pdf/b7/2a/bmjopen-2013-003965.PMC3863129.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/b7/2a/bmjopen-2013-003965.PMC3863129.pdf
http://www.nice.org.uk/nicemedia/live/12695/47195/47195.pdf(accessed 8-7-2013).,Non-OADS,/arxiv_data1/oa_pdf/b7/2a/bmjopen-2013-003965.PMC3863129.pdf
http://vejledninger.dsam.dk/akut/ ?mode=chart&chartId=17 (accessed 9-7-2013).,OADS,/arxiv_data1/oa_pdf/b7/2a/bmjopen-2013-003965.PMC3863129.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003963).,Non-OADS,/arxiv_data1/oa_pdf/0a/6b/bmjopen-2013-003963.PMC3863130.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/0a/6b/bmjopen-2013-003963.PMC3863130.pdf
Inf Ter Sist Nac Salud 2009;33:28. http://www.msc.es/en/ biblioPublic/publicaciones/recursos_propios/infMedic/docs/vol33_1nuevasIndAutorizadas2008.pdf (accessed 17 Dec 2012).,Non-OADS,/arxiv_data1/oa_pdf/0a/6b/bmjopen-2013-003963.PMC3863130.pdf
http://www10.gencat.net/catsalut/eng/coneix_models.htm (accessed 17 Dec 2012).,OADS,/arxiv_data1/oa_pdf/0a/6b/bmjopen-2013-003963.PMC3863130.pdf
http://www.idescat.cat/pub/?id=aec&lang=en (accessed17 Dec 2012).,OADS,/arxiv_data1/oa_pdf/0a/6b/bmjopen-2013-003963.PMC3863130.pdf
April 2009; Bulletin 48. http://www.farmaindustria.es (accessed 15 Apr 2013).,Non-OADS,/arxiv_data1/oa_pdf/0a/6b/bmjopen-2013-003963.PMC3863130.pdf
28122-65. http://www.boe.es/boe/dias/2006/07/27/pdfs/A28122 – 28165.pdf (accessed 17 Dec 2012).,Non-OADS,/arxiv_data1/oa_pdf/0a/6b/bmjopen-2013-003963.PMC3863130.pdf
40884 – 90. http://www.boe.es/boe/dias/2006/11/22/pdfs/A40884 –40890.pdf (accessed 17 Dec 2012).,Non-OADS,/arxiv_data1/oa_pdf/0a/6b/bmjopen-2013-003963.PMC3863130.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-004152).,Non-OADS,/arxiv_data1/oa_pdf/8e/cd/bmjopen-2013-004152.PMC3863131.pdf
"http://dx.doi.org/10.1016/j.redox.2013.11.002Abbreviations: AngII, angiotensin II; RAS, renin –angiotensin system; MnSOD, manganese superoxide dismutase; CuZnSOD, copper/zinc superoxide dismutase;AT 1R, angiotensin type 1 receptor; NOX, NADPH oxidase; MIMS, mitochondrial inter-membrane space; Ikv, neuronal potassium current; ROS, reactive oxygen species ☆This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which per-mits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.",OADS,/arxiv_data1/oa_pdf/b6/14/main.PMC3863132.pdf
"http://dx.doi.org/10.1016/j.redox.2013.10.009☆This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which per-mits non-commercial use, distribution, and reproduction in any medium, providedthe original author and source are credited.",OADS,/arxiv_data1/oa_pdf/af/ff/main.PMC3863133.pdf
"Asian S pine J ournal 253 Copyright Ⓒ 2013 by Korean Society of Spine Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e4/9b/asj-7-253.PMC3863649.pdf
Keywords: Lumbar spine; Lumbar disc herniation; Lumbar spinal stenosis; Lumbar pain; Epidural fibrosisBasic Study Asian Spine J 2013;7(4):253-259  •  http://dx.doi.org/10.4184/asj.2013.7.4.253 ASJ Asian Spine Journal,Non-OADS,/arxiv_data1/oa_pdf/e4/9b/asj-7-253.PMC3863649.pdf
"260 Asian Spine J 2013;7(4):260-266 Copyright Ⓒ 2013 by Korean Society of Spine Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ac/fe/asj-7-260.PMC3863650.pdf
"Keywords : Spinal fusion ; Osteotomy ; Kyphosis , Post traumaticClinical Study Asian Spine J 2013;7(4):260-266  •  http://dx.doi.org/10.4184/asj.2013.7.4.260 ASJ Asian Spine Journal Introduction  One of the worst complications of vertebral fractures is  post-traumatic kyphosis (PTK).",Non-OADS,/arxiv_data1/oa_pdf/ac/fe/asj-7-260.PMC3863650.pdf
"Posterior surgery in post-traumatic kyphosis Asian S pine J ournal 261 Copyright Ⓒ 2013 by Korean Society of Spine Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ac/fe/asj-7-260.PMC3863650.pdf
"Magnification error in cervical spine Asian S pine J ournal 267 Copyright Ⓒ 2013 by Korean Society of Spine Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/52/10/asj-7-267.PMC3863651.pdf
"Keywords:  Cervical spine; Magnification error; Digital radiography; Body mass index; Picture archiving and communication systemClinical Study Asian Spine J 2013;7(4):267-272  •  http://dx.doi.org/10.4184/asj.2013.7.4.267 ASJ Asian Spine Journal Introduction In the past, conventional hard-copy radiography images  have been used.",Non-OADS,/arxiv_data1/oa_pdf/52/10/asj-7-267.PMC3863651.pdf
"Risk factors for adjacent segment degeneration: more than 5 years after fusion Asian S pine J ournal 273 Copyright Ⓒ 2013 by Korean Society of Spine Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b3/e0/asj-7-273.PMC3863652.pdf
"Keywords:  Lumbar; Adjacent segment degeneration; Fusion; Pedicle screw fixationClinical Study Asian Spine J 2013;7(4):273-281  •  http://dx.doi.org/10.4184/asj.2013.7.4.273 ASJ Asian Spine Journal Introduction When a structural deformation or nerve compression is so severe that simple decompression alone does not  produce satisfactory outcomes for degenerative lumbar  disease, extensive decompression and lumbar vertebral",Non-OADS,/arxiv_data1/oa_pdf/b3/e0/asj-7-273.PMC3863652.pdf
"Jan Polak 282 Asian Spine J 2013;7(4):282-288 Copyright Ⓒ 2013 by Korean Society of Spine Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/17/af/asj-7-282.PMC3863653.pdf
"Keywords:  Scoliosis treatment; Skeletal muscle hypertonicity; Contracture; Musculoskeletal disease; Spinal curvatureClinical Study Asian Spine J 2013;7(4):282-288  •  http://dx.doi.org/10.4184/asj.2013.7.4.282 ASJ Asian Spine Journal Introduction Scolioses have been described for the first time by Galen  in the second century AD, and it is interesting that this  was done in his book “De moto musculorum.",Non-OADS,/arxiv_data1/oa_pdf/17/af/asj-7-282.PMC3863653.pdf
"Seventy-one cases ascertaining that scoliosis straightening is possible Asian S pine J ournal 283 Copyright Ⓒ 2013 by Korean Society of Spine Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/17/af/asj-7-282.PMC3863653.pdf
"Cervical fusion with dynamic rotational plates Asian S pine J ournal 289 Copyright Ⓒ 2013 by Korean Society of Spine Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0a/b4/asj-7-289.PMC3863654.pdf
"Keywords:  Cervical spine; Cervical radiculopathy; Dynamic rotational plateClinical Study Asian Spine J 2013;7(4):289-293  •  http://dx.doi.org/10.4184/asj.2013.7.4.289 ASJ Asian Spine Journal Introduction The static cervical plate was used to compensate the  subsidence and gave sufficient biomechanical stability in  surgical segments [1,2].",Non-OADS,/arxiv_data1/oa_pdf/0a/b4/asj-7-289.PMC3863654.pdf
"294 Asian Spine J 2013;7(4):294-300 Copyright Ⓒ 2013 by Korean Society of Spine Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7f/55/asj-7-294.PMC3863655.pdf
Keywords: Osteoporosis; Spinal fractures; Vertebroplasty; Surgical revisionClinical Study Asian Spine J 2013;7(4):294-300  •  http://dx.doi.org/10.4184/asj.2013.7.4.294 ASJ Asian Spine Journal Introduction Percutaneous vertebroplasty (PVP) was introduced by  Galibert et al.,Non-OADS,/arxiv_data1/oa_pdf/7f/55/asj-7-294.PMC3863655.pdf
"Revision surgery following bone cement augmentation Asian S pine J ournal 295 Copyright Ⓒ 2013 by Korean Society of Spine Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7f/55/asj-7-294.PMC3863655.pdf
"Pain, disability and satisfaction of patients with OVCFs  Asian S pine J ournal 301 Copyright Ⓒ 2013 by Korean Society of Spine Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e3/78/asj-7-301.PMC3863656.pdf
Keywords: Osteoporotic vertebral compression fracture; Pain; Disability; SatisfactionClinical Study Asian Spine J 2013;7(4):301-307  •  http://dx.doi.org/10.4184/asj.2013.7.4.301 ASJ Asian Spine Journal Introduction Osteoporotic vertebral compression fractures (OVCFs)  are the most common complication of osteoporosis.,Non-OADS,/arxiv_data1/oa_pdf/e3/78/asj-7-301.PMC3863656.pdf
"308 Asian Spine J 2013;7(4):308-313 Copyright Ⓒ 2013 by Korean Society of Spine Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c1/ec/asj-7-308.PMC3863657.pdf
"Keywords:  Osteoporotic vertebral fracture; Fat infiltration; Back extensor muscle; Bone mineral densityClinical Study Asian Spine J 2013;7(4):308-313  •  http://dx.doi.org/10.4184/asj.2013.7.4.308 ASJ Asian Spine Journal Introduction As the aging population has been rapidly increasing,  osteoporosis has been emerging as an important public  health issue because it can cause many problems such as  fracture, disability, and associated complications which  result in significant medical, social, and economic prob - lems and eventually to higher social costs [1,2].",Non-OADS,/arxiv_data1/oa_pdf/c1/ec/asj-7-308.PMC3863657.pdf
"Fat infiltration of back muscles on osteoporotic vertebral fractures Asian S pine J ournal 309 Copyright Ⓒ 2013 by Korean Society of Spine Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c1/ec/asj-7-308.PMC3863657.pdf
"314 Asian Spine J 2013;7(4):314-321 Copyright Ⓒ 2013 by Korean Society of Spine Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/58/e0/asj-7-314.PMC3863658.pdf
"Keywords:  Nucleoplasty; Radiofrequency treatment; Axial back pain; Degenerate disc diseaseClinical Study Asian Spine J 2013;7(4):314-321  •  http://dx.doi.org/10.4184/asj.2013.7.4.314 ASJ Asian Spine Journal Introduction Low back pain has a worldwide prevalence of 30% to 40%  [1,2].",Non-OADS,/arxiv_data1/oa_pdf/58/e0/asj-7-314.PMC3863658.pdf
"Nucleoplasty in discogenic axial back pain Asian S pine J ournal 315 Copyright Ⓒ 2013 by Korean Society of Spine Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/58/e0/asj-7-314.PMC3863658.pdf
"322 Asian Spine J 2013;7(4):322-334 Copyright Ⓒ 2013 by Korean Society of Spine Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/72/26/asj-7-322.PMC3863659.pdf
Keywords: Claudication; Low back pain; SpondylolisthesisClinical Study Asian Spine J 2013;7(4):322-334  •  http://dx.doi.org/10.4184/asj.2013.7.4.322 ASJ Asian Spine Journal Introduction Lumbar disc degenerative disease is the most common  cause of Low back pain throughout the world [1-3].,Non-OADS,/arxiv_data1/oa_pdf/72/26/asj-7-322.PMC3863659.pdf
"Lumbar disc degenerative disease Asian S pine J ournal 323 Copyright Ⓒ 2013 by Korean Society of Spine Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/72/26/asj-7-322.PMC3863659.pdf
Available  from: http://www.ncbi.nlm.nih.gov/pubmedhealth/ PMH0001706/.,Non-OADS,/arxiv_data1/oa_pdf/72/26/asj-7-322.PMC3863659.pdf
Available  from: http://www.mdguidelines.com/degeneration- lumbar-intervertebral-disc.,Non-OADS,/arxiv_data1/oa_pdf/72/26/asj-7-322.PMC3863659.pdf
"Vertebral artery dissection-associated cervical radiculopathy Asian S pine J ournal 335 Copyright Ⓒ 2013 by Korean Society of Spine Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/66/83/asj-7-335.PMC3863660.pdf
"Keywords:  Vertebral artery dissection; Neck pain; Radiculopathy; Cervical spineCase Report Asian Spine J 2013;7(4):335-338  •  http://dx.doi.org/10.4184/asj.2013.7.4.335 ASJ Asian Spine Journal Introduction In patients presenting with neck pain and arm weakness  a multitude of pathologies, ranging from the benign to  those potentially fatal, must be considered in the differ - ential diagnosis.",Non-OADS,/arxiv_data1/oa_pdf/66/83/asj-7-335.PMC3863660.pdf
"Ventral schwannoma of thoracolumbar spine Asian S pine J ournal 339 Copyright Ⓒ 2013 by Korean Society of Spine Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/10/55/asj-7-339.PMC3863661.pdf
Keywords:  Spinal schwannoma; Intradural lesion; Ventral schwannoma; GiantCase Report Asian Spine J 2013;7(4):339-344  •  http://dx.doi.org/10.4184/asj.2013.7.4.339 ASJ Asian Spine Journal Introduction Spinal schwannomas are common benign intradural  extramedullary spinal neoplasms; they comprise ap - proximately 30% of all spinal tumors [1].,Non-OADS,/arxiv_data1/oa_pdf/10/55/asj-7-339.PMC3863661.pdf
"Delayed aortic pseudoaneurysm in pyogenic spondylitis    Asian S pine J ournal 345 Copyright Ⓒ 2013 by Korean Society of Spine Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c5/f8/asj-7-345.PMC3863662.pdf
Keywords:  False aneurysm; Endovascular procedure; Stents; SpondylitisCase Report Asian Spine J 2013;7(4):345-350  •  http://dx.doi.org/10.4184/asj.2013.7.4.345 ASJ Asian Spine Journal Introduction  Anterior debridement and reconstruction remains the  mainstay of surgical treatment for pyogenic spondylodis - citis [1].,Non-OADS,/arxiv_data1/oa_pdf/c5/f8/asj-7-345.PMC3863662.pdf
"Tuberculosis sacrum Asian S pine J ournal 351 Copyright Ⓒ 2013 by Korean Society of Spine Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7d/3a/asj-7-351.PMC3863663.pdf
Keywords: Tuberculosis; Sacroiliac joint; Antibiotics; MonoparesisCase Report Asian Spine J 2013;7(4):351-354  •  http://dx.doi.org/10.4184/asj.2013.7.4.351 ASJ Asian Spine Journal Introduction Musculoskeletal tuberculosis accounts for 3% of all cases  of tuberculosis [1].,Non-OADS,/arxiv_data1/oa_pdf/7d/3a/asj-7-351.PMC3863663.pdf
"Arachnoiditis following caudal epidural injection Asian S pine J ournal 355 Copyright Ⓒ 2013 by Korean Society of Spine Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f8/fc/asj-7-355.PMC3863664.pdf
Keywords:  Caudal; Epidural; Low back pain; Sciatica; ArachnoiditisCase Report Asian Spine J 2013;7(4):355-358  •  http://dx.doi.org/10.4184/asj.2013.7.4.355 ASJ Asian Spine Journal Introduction Chronic low back pain is a major health condition.,Non-OADS,/arxiv_data1/oa_pdf/f8/fc/asj-7-355.PMC3863664.pdf
"Concept of gunshot wound spine Asian S pine J ournal 359 Copyright Ⓒ 2013 by Korean Society of Spine Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/eb/8b/asj-7-359.PMC3863665.pdf
"Keywords: Gunshot spine; Gunshot wound spine; Bullet injury spineReview Article Asian Spine J 2013;7(4):359-364  •  http://dx.doi.org/10.4184/asj.2013.7.4.359 ASJ Asian Spine Journal Introduction The incidence of firearm injury in the civilian popula - tion has remarkably increased in recent years, and among  these, gunshot wound (GSW) to the spine is particularly  devastating because the ideal management of GSW spine  remains a matter of controversy.",Non-OADS,/arxiv_data1/oa_pdf/eb/8b/asj-7-359.PMC3863665.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Decreased Expression of TLR-9 and Cytokines in the  Presence of Bacteria in Patients with Otitis Media  with Effusion Ho Yun Lee1·Y oung Il Kim2·Jin Woo Lee2·Jae Y ong Byun1·Moon Suh Park1·Seung Geun Y eo1,2 1Department of Otolaryngology, Kyung Hee University School of Medicine, Seoul;   2Medical Science Research Institute, Kyung Hee University Medical Center, Seoul, KoreaClinical and Experimental Otorhinolaryngology    Vol.",Non-OADS,/arxiv_data1/oa_pdf/bf/3e/ceo-6-195.PMC3863666.pdf
"4: 195- 200, December 2013 http://dx.doi.org/10.3342/ceo.2013.6.4.195 Original Article INTRODUCTION Otitis media with effusion (OME) is defined as the presence of  fluid in the middle ear without signs or symptoms of acute in - fection.",Non-OADS,/arxiv_data1/oa_pdf/bf/3e/ceo-6-195.PMC3863666.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Compound Heterozygosity for Two Novel SLC26A4   Mutations in a Large Iranian Pedigree with Pendred  Syndrome Nasrin Y azdanpanahi1·Mohammad Amin Tabatabaiefar2,3·Effat Farrokhi2·Narges Abdian2·Nader Bagheri2  Shirin Shahbazi2·Zahra Noormohammadi4·Morteza Hashemzadeh Chaleshtori2 1Department of Biochemistry, Falavarjan Branch, Islamic Azad University, Isfahan, Iran; 2Cellular and Molecular Research Center, School of  Medicine, Shahrekord University of Medical Sciences, Shahrekord, Iran; 3Department of Medical Genetics, School of Medicine, Ahvaz  Jundishapur University of Medical Sciences, Ahvaz, Iran; 4Department of Biology, Science and Research Branch, Islamic Azad University,  Tehran, IranClinical and Experimental Otorhinolaryngology    Vol.",Non-OADS,/arxiv_data1/oa_pdf/59/9b/ceo-6-201.PMC3863667.pdf
"4: 201- 208, December 2013 http://dx.doi.org/10.3342/ceo.2013.6.4.201 Original Article INTRODUCTION Up to now over 400 syndromic forms of hearing loss (HL) have  been described [1].",Non-OADS,/arxiv_data1/oa_pdf/59/9b/ceo-6-201.PMC3863667.pdf
"To date, more than 200 mutations have been identi - fied for SLC26A4  (http://www.healthcare.uiowa.edu/labs/pen- dredandbor/slcMutations.htm).",Non-OADS,/arxiv_data1/oa_pdf/59/9b/ceo-6-201.PMC3863667.pdf
0.4.0 (http://frodo.wi.mit.edu/ primer3/) and Oligo ver.,OADS,/arxiv_data1/oa_pdf/59/9b/ceo-6-201.PMC3863667.pdf
"[3] and the model de - scribed in Pendred/Bor homepage (http://www.healthcare.edu/ labs/pendredandbor/domains.htm), c.863-864insT and c.881- 882delAC lead to amino acid changes at intracellular region be - tween the sixth and seventh transmembrane domains of the pro- tein (Fig.",Non-OADS,/arxiv_data1/oa_pdf/59/9b/ceo-6-201.PMC3863667.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Capacity of Rectified Vestibular Evoked Myogenic  Potential in Correcting Asymmetric Muscle  Contraction Power Kun Woo Kim1·Jae Yun Jung1·Jeong Hyun Lee1·Myung-Whan Suh2 1Department of Otolaryngology-Head and Neck Surgery, Dankook University College of Medicine, Cheonan;   2Department of Otorhinolaryngology, Seoul National University Hospital, Seoul, KoreaClinical and Experimental Otorhinolaryngology    Vol.",Non-OADS,/arxiv_data1/oa_pdf/89/c1/ceo-6-209.PMC3863668.pdf
"4: 209- 213, December 2013 http://dx.doi.org/10.3342/ceo.2013.6.4.209 Original Article INTRODUCTION Vestibular evoked myogenic potential (VEMP) is an inhibitory  myogenic potential that results from ipsilateral saccular stimula - tion and can be measured from the contracted ipsilateral sterno - cleidomastoid (SCM) muscle.",Non-OADS,/arxiv_data1/oa_pdf/89/c1/ceo-6-209.PMC3863668.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Small-Group Counseling in a Modified Tinnitus  Retraining Therapy for Chronic Tinnitus  Shi-Nae Park ·Seong-Cheon Bae ·Dong-Kee Kim ·Y ong-Soo Park ·Sang-Won Y eo ·So-Y oung Park Department of Otorhinolaryngology-Head and Neck Surgery, The Catholic University of Korea College of Medicine, Seoul, KoreaClinical and Experimental Otorhinolaryngology    Vol.",Non-OADS,/arxiv_data1/oa_pdf/66/d1/ceo-6-214.PMC3863669.pdf
